0001731122-23-000664.txt : 20230414 0001731122-23-000664.hdr.sgml : 20230414 20230414163645 ACCESSION NUMBER: 0001731122-23-000664 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 83 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230414 DATE AS OF CHANGE: 20230414 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GBT Technologies Inc. CENTRAL INDEX KEY: 0001471781 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742] IRS NUMBER: 270603137 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-54530 FILM NUMBER: 23821678 BUSINESS ADDRESS: STREET 1: 2500 BROADWAY SUITE F125 CITY: SANTA MONICA STATE: CA ZIP: 90404 BUSINESS PHONE: 424-238-4589 MAIL ADDRESS: STREET 1: 2500 BROADWAY SUITE F125 CITY: SANTA MONICA STATE: CA ZIP: 90404 FORMER COMPANY: FORMER CONFORMED NAME: Gopher Protocol Inc. DATE OF NAME CHANGE: 20150225 FORMER COMPANY: FORMER CONFORMED NAME: Forex International Trading Corp. DATE OF NAME CHANGE: 20090908 10-K/A 1 e4603_10ka.htm FORM 10-K/A
0001471781 true 2022 FY 0001471781 2022-01-01 2022-12-31 0001471781 2022-06-30 0001471781 2023-04-14 0001471781 GTCH:BFBorgersCPAPCMember 2022-01-01 2022-12-31 0001471781 2022-12-31 0001471781 2021-12-31 0001471781 us-gaap:SeriesBPreferredStockMember 2022-12-31 0001471781 us-gaap:SeriesBPreferredStockMember 2021-12-31 0001471781 us-gaap:SeriesCPreferredStockMember 2022-12-31 0001471781 us-gaap:SeriesCPreferredStockMember 2021-12-31 0001471781 us-gaap:SeriesDPreferredStockMember 2022-12-31 0001471781 us-gaap:SeriesDPreferredStockMember 2021-12-31 0001471781 us-gaap:SeriesGPreferredStockMember 2022-12-31 0001471781 us-gaap:SeriesGPreferredStockMember 2021-12-31 0001471781 us-gaap:SeriesHPreferredStockMember 2022-12-31 0001471781 us-gaap:SeriesHPreferredStockMember 2021-12-31 0001471781 2021-01-01 2021-12-31 0001471781 us-gaap:CommonStockMember 2020-12-31 0001471781 GTCH:TreasuryStocksMember 2020-12-31 0001471781 GTCH:StockLoanReceivableMember 2020-12-31 0001471781 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001471781 us-gaap:RetainedEarningsMember 2020-12-31 0001471781 2020-12-31 0001471781 us-gaap:CommonStockMember 2021-12-31 0001471781 GTCH:TreasuryStocksMember 2021-12-31 0001471781 GTCH:StockLoanReceivableMember 2021-12-31 0001471781 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001471781 us-gaap:RetainedEarningsMember 2021-12-31 0001471781 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001471781 GTCH:TreasuryStocksMember 2021-01-01 2021-12-31 0001471781 GTCH:StockLoanReceivableMember 2021-01-01 2021-12-31 0001471781 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001471781 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001471781 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001471781 GTCH:TreasuryStocksMember 2022-01-01 2022-12-31 0001471781 GTCH:StockLoanReceivableMember 2022-01-01 2022-12-31 0001471781 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001471781 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001471781 us-gaap:CommonStockMember 2022-12-31 0001471781 GTCH:TreasuryStocksMember 2022-12-31 0001471781 GTCH:StockLoanReceivableMember 2022-12-31 0001471781 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001471781 us-gaap:RetainedEarningsMember 2022-12-31 0001471781 2021-10-25 2021-10-26 0001471781 2022-01-28 0001471781 GTCH:RWJPartiesMember 2022-12-31 0001471781 GTCH:MrLightHouseLTDMember GTCH:PurchaseAndSaleAgreementMember 2020-09-01 2020-09-18 0001471781 2021-07-31 0001471781 2022-04-30 0001471781 GTCH:TouchPointGroupHoldingMember 2022-02-01 2022-02-22 0001471781 GTCH:MahaserMember 2022-01-01 2022-12-31 0001471781 us-gaap:RestrictedStockMember 2022-01-01 2022-12-31 0001471781 2022-03-02 0001471781 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001471781 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001471781 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001471781 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001471781 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001471781 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001471781 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2022-01-01 2022-12-31 0001471781 us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-12-31 0001471781 us-gaap:SeriesBPreferredStockMember 2021-01-01 2021-12-31 0001471781 us-gaap:SeriesCPreferredStockMember 2022-01-01 2022-12-31 0001471781 us-gaap:SeriesCPreferredStockMember 2021-01-01 2021-12-31 0001471781 us-gaap:SeriesHPreferredStockMember 2022-01-01 2022-12-31 0001471781 us-gaap:SeriesHPreferredStockMember 2021-01-01 2021-12-31 0001471781 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001471781 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001471781 GTCH:StockPurchaseAgreementMember GTCH:SeriesAConvertiblePreferredStockMember 2022-01-03 2022-01-28 0001471781 GTCH:StockPurchaseAgreementMember 2022-01-03 2022-01-28 0001471781 GTCH:StockPurchaseAgreementMember 2022-01-28 0001471781 GTCH:TouchpointGroupHoldingsIncMember 2022-02-02 2022-02-22 0001471781 GTCH:TouchpointGroupHoldingsIncMember 2022-02-23 0001471781 GTCH:TouchpointGroupHoldingsIncMember us-gaap:CommonStockMember 2022-02-23 0001471781 GTCH:TouchpointGroupHoldingsIncMember 2022-01-01 2022-12-31 0001471781 GTCH:GTXAgreementMember 2022-01-01 2022-12-31 0001471781 GTCH:GBTTokenizeMember 2022-01-01 2022-12-31 0001471781 GTCH:GBTTokenizeMetAlertMember 2022-01-01 2022-09-30 0001471781 GTCH:PromissoryNoteMember 2022-01-01 2022-09-30 0001471781 GTCH:GTXAgreementMember 2022-12-31 0001471781 GTCH:GTXAgreementMember 2021-12-31 0001471781 GTCH:SurgeHoldingsMember GTCH:AssetPurchaseAgreementMember 2019-09-29 2019-09-30 0001471781 GTCH:SurgeHoldingsMember GTCH:AssetPurchaseAgreementMember 2022-01-01 2022-01-07 0001471781 GTCH:SurgeHoldingsMember GTCH:AltCorpExchangeAgreementMember 2020-06-23 0001471781 GTCH:StanleyHillsLLCMember 2021-01-02 0001471781 GTCH:StanleyHillsLLCMember us-gaap:CommonStockMember 2021-01-02 0001471781 GTCH:SurgeHoldingsIncMember 2022-01-01 2022-01-07 0001471781 GTCH:SurgeHoldingsIncMember 2022-01-01 2022-12-31 0001471781 GTCH:SurgeHoldingsIncMember 2022-12-31 0001471781 2022-01-31 0001471781 GTCH:AltcorpMember us-gaap:SeriesHPreferredStockMember 2019-06-01 2019-06-17 0001471781 GTCH:AltcorpMember 2019-02-01 2019-02-06 0001471781 GTCH:GBTSharesMember 2021-12-31 0001471781 GTCH:GBTSharesMember 2021-01-01 2021-12-31 0001471781 2021-12-01 2021-12-31 0001471781 GTCH:StanleyHillsLLCMember 2021-12-31 0001471781 GTCH:TokenizeAgreementMember 2021-05-28 0001471781 GTCH:TokenizeAgreementMember 2021-05-07 2021-05-28 0001471781 2020-03-31 0001471781 2018-01-01 2018-12-31 0001471781 GTCH:GBTTechnologiesSAMember 2022-12-31 0001471781 GTCH:GBTTechnologiesSAMember 2021-12-31 0001471781 GTCH:DiagonalLendingMember 2022-12-31 0001471781 GTCH:DiagonalLendingMember 2021-12-31 0001471781 GTCH:RedstartHoldingsMember 2022-12-31 0001471781 GTCH:RedstartHoldingsMember 2021-12-31 0001471781 GTCH:GBTTechnologiesMember us-gaap:SeriesHPreferredStockMember 2019-06-01 2019-06-17 0001471781 GTCH:GBTTechnologiesMember us-gaap:SeriesHPreferredStockMember 2019-06-17 0001471781 GTCH:IGOR1CORPMember 2022-12-31 0001471781 GTCH:RedstartHoldingsCorpMember GTCH:SecuritiesPurchaseAgreementMember 2020-08-01 2020-08-04 0001471781 GTCH:RedstartHoldingsCorpMember GTCH:SecuritiesPurchaseAgreementMember 2020-08-04 0001471781 GTCH:RedstartHoldingsCorpMember GTCH:SecuritiesPurchaseAgreementMember 2021-01-01 2021-12-31 0001471781 GTCH:RedstartHoldingsCorpMember GTCH:SecuritiesPurchaseAgreementMember 2021-08-01 2021-08-04 0001471781 GTCH:RedstartHoldingsCorp2Member GTCH:SecuritiesPurchaseAgreementMember 2020-09-01 2020-09-15 0001471781 GTCH:RedstartHoldingsCorpMember GTCH:SecuritiesPurchaseAgreementMember 2020-09-01 2020-09-15 0001471781 GTCH:RedstartHoldingsCorpMember GTCH:SecuritiesPurchaseAgreementMember 2020-09-15 0001471781 GTCH:RedstartHoldingsCorp2Member GTCH:SecuritiesPurchaseAgreementMember 2021-01-01 2021-12-31 0001471781 GTCH:RedstartHoldingsCorp4Member GTCH:SecuritiesPurchaseAgreementMember 2021-02-01 2021-02-10 0001471781 GTCH:RedstartHoldingsCorpMember GTCH:SecuritiesPurchaseAgreementMember 2022-02-10 0001471781 GTCH:RedstartHoldingsCorp4Member GTCH:SecuritiesPurchaseAgreementMember 2021-01-01 2021-12-31 0001471781 GTCH:RedstartHoldingsCorp4Member GTCH:SecuritiesPurchaseAgreementMember 2021-03-01 2021-03-15 0001471781 GTCH:RedstartHoldingsCorpMember GTCH:SecuritiesPurchaseAgreementMember 2021-03-15 0001471781 GTCH:RedstartHoldingsCorp5Member GTCH:SecuritiesPurchaseAgreementMember 2021-01-01 2021-12-31 0001471781 GTCH:RedstartHoldingsCorpMember GTCH:SecuritiesPurchaseAgreementMember 2021-05-26 0001471781 GTCH:RedstartHoldingsCorp5Member GTCH:SecuritiesPurchaseAgreementMember 2021-12-31 0001471781 GTCH:RedstartHoldingsCorpMember GTCH:SecuritiesPurchaseAgreementMember 2021-09-01 2021-09-21 0001471781 GTCH:RedstartHoldingsCorpMember GTCH:SecuritiesPurchaseAgreementMember 2022-01-01 2022-12-31 0001471781 GTCH:PromissoryNoteMember 2019-02-01 2019-02-27 0001471781 GTCH:IliadMember GTCH:SecuritiesPurchaseAgreementMember 2021-07-01 2021-07-20 0001471781 2020-08-02 2020-08-20 0001471781 GTCH:IliadMember 2021-01-01 2021-12-31 0001471781 us-gaap:ConvertibleNotesPayableMember GTCH:IliadMember 2022-12-31 0001471781 us-gaap:ConvertibleNotesPayableMember GTCH:IliadMember 2021-12-31 0001471781 GTCH:SixthStreetLendingLLCMember GTCH:SecuritiesPurchaseAgreementMember 2021-11-02 2021-11-08 0001471781 GTCH:SixthStreetLendingLLCMember GTCH:SecuritiesPurchaseAgreementMember 2021-11-08 0001471781 GTCH:SixthStreetMember 2022-01-01 2022-12-31 0001471781 GTCH:DiagonalLendingLLCMember GTCH:SecuritiesPurchaseAgreementMember 2022-05-02 2022-05-05 0001471781 GTCH:DiagonalLendingLLCMember GTCH:SecuritiesPurchaseAgreementMember 2022-05-05 0001471781 GTCH:DiagonalLendingMember 2022-01-01 2022-12-31 0001471781 GTCH:DiagonalLending1Member 2022-12-31 0001471781 GTCH:DiagonalLendingLLCMember GTCH:SecuritiesPurchaseAgreementMember 2022-09-02 2022-09-13 0001471781 GTCH:DiagonalLendingLLCMember GTCH:SecuritiesPurchaseAgreementMember 2022-09-13 0001471781 GTCH:DiagonalLendingMember us-gaap:ConvertibleDebtMember 2022-09-30 0001471781 GTCH:StanleyHillsLLCMember 2019-05-03 2019-12-31 0001471781 GTCH:StanleyHillsLLCMember 2020-02-26 0001471781 GTCH:StanleyHillsLLCMember 2022-12-31 0001471781 GTCH:StanleyHillsLLCMember 2022-01-01 2022-12-31 0001471781 GTCH:StanleyHillsLLCMember us-gaap:ConvertibleDebtMember 2022-12-31 0001471781 us-gaap:ConvertibleNotesPayableMember 2022-01-01 2022-12-31 0001471781 us-gaap:ConvertibleNotesPayableMember 2021-01-01 2021-12-31 0001471781 us-gaap:ConvertibleNotesPayableMember 2022-12-31 0001471781 us-gaap:ConvertibleNotesPayableMember 2021-12-31 0001471781 us-gaap:ConvertibleNotesPayableMember 2020-12-31 0001471781 GTCH:RWJAdvancedMarketingLLCMember 2022-12-31 0001471781 GTCH:RWJAdvancedMarketingLLCMember 2021-12-31 0001471781 GTCH:SBALoanMember 2022-12-31 0001471781 GTCH:SBALoanMember 2021-12-31 0001471781 GTCH:RWJAdvancedMarketingLLCMember 2019-12-31 0001471781 GTCH:EIDLMember 2020-06-01 2020-06-22 0001471781 GTCH:SBALoanMember 2021-10-02 0001471781 GTCH:SBALoanMember 2021-10-03 2021-10-05 0001471781 GTCH:AlphaEdaMember 2022-12-31 0001471781 GTCH:AlphaEdaMember 2021-12-31 0001471781 GTCH:PromissoryNoteMember 2021-01-01 2021-12-31 0001471781 GTCH:PromissoryNoteMember 2020-01-01 2020-12-31 0001471781 GTCH:PromissoryNoteMember 2020-12-31 0001471781 GTCH:PromissoryNoteMember 2021-12-31 0001471781 GTCH:AlphaEdaMember 2022-12-31 0001471781 GTCH:AlphaEdaMember 2021-12-31 0001471781 us-gaap:InvestorMember GTCH:SecuritiesPurchaseAgreementMember 2019-12-01 2019-12-23 0001471781 us-gaap:InvestorMember GTCH:SecuritiesPurchaseAgreementMember 2019-05-01 2019-05-15 0001471781 us-gaap:InvestorMember GTCH:SecuritiesPurchaseAgreementMember 2019-01-01 2019-12-31 0001471781 srt:MinimumMember 2022-12-31 0001471781 srt:MinimumMember 2021-01-01 2021-12-31 0001471781 srt:MaximumMember 2021-01-01 2021-12-31 0001471781 srt:MinimumMember 2022-01-01 2022-12-31 0001471781 srt:MaximumMember 2022-01-01 2022-12-31 0001471781 srt:MinimumMember 2021-12-31 0001471781 srt:MaximumMember 2022-12-31 0001471781 srt:MaximumMember 2021-12-31 0001471781 2019-12-31 0001471781 2020-01-01 2020-12-31 0001471781 2022-07-07 0001471781 GTCH:BoardOfDirectorsMember 2021-10-03 2021-10-26 0001471781 GTCH:JointVentureAgreementMember 2022-01-01 2022-12-31 0001471781 us-gaap:SeriesBPreferredStockMember 2011-11-01 0001471781 GTCH:AltcorpMember us-gaap:SeriesHPreferredStockMember 2019-06-17 0001471781 2021-12-02 2021-12-17 0001471781 GTCH:WarrantsOneMember 2022-12-31 0001471781 GTCH:WarrantsTwoMember 2022-12-31 0001471781 GTCH:WarrantsThreeMember 2022-12-31 0001471781 GTCH:WarrantsFourMember 2022-12-31 0001471781 GTCH:WarrantsFiveMember 2022-12-31 0001471781 GTCH:WarrantsSixMember 2022-12-31 0001471781 GTCH:WarrantsSevenMember 2022-12-31 0001471781 GTCH:WarrantsEightMember 2022-12-31 0001471781 GTCH:WarrantsNineMember 2022-12-31 0001471781 GTCH:WarrantsTenMember 2022-12-31 0001471781 GTCH:RWJAdvancedMarketingLLCMember 2017-08-30 2017-09-02 0001471781 srt:DirectorMember 2018-04-01 2018-04-06 0001471781 GTCH:DavisMember GTCH:EmploymentAgreementMember 2018-12-30 2019-01-02 0001471781 GTCH:TokenizeAgreementMember GTCH:GreenwichMember 2020-03-01 2020-03-06 0001471781 GTCH:BitSpeedAgreementMember 2019-10-01 2019-10-10 0001471781 GTCH:TokenizeAgreementMember 2020-03-01 2020-03-06 0001471781 GTCH:YelloPartnersIncMember 2022-12-31 0001471781 GTCH:YelloPartnersIncMember 2021-12-31 0001471781 GTCH:AlphaEdaLLCMember 2022-11-15 0001471781 GTCH:AlphaEdaLLCMember 2021-11-02 2021-11-15 0001471781 GTCH:AlphaEdaLLCMember 2022-06-02 2022-06-20 0001471781 GTCH:StanleyHillsLLCMember 2021-01-01 2021-12-31 0001471781 GTCH:StanleyHillsLLCMember us-gaap:ConvertibleDebtMember 2021-12-31 0001471781 GTCH:SURGMember 2022-01-02 2022-01-07 0001471781 GTCH:RWJAgreementMember 2022-12-31 0001471781 GTCH:RWJAgreementMember 2022-01-01 2022-12-31 0001471781 GTCH:SecuritiesPurchaseAgreementMember GTCH:SeniorSecuredRedeemableConvertibleDebentureMember 2018-12-03 0001471781 2020-07-01 2020-07-28 0001471781 2020-10-01 2020-10-16 0001471781 GTCH:SURGSharesMember 2022-06-03 2022-06-24 0001471781 GTCH:GBTTechnologiesMember 2018-01-01 2018-12-31 0001471781 GTCH:GBTTechnologiesMember 2022-12-31 0001471781 2022-05-01 2022-05-17 0001471781 GTCH:LiquidityRiskMember 2022-12-31 0001471781 GTCH:CustomersMember 2022-01-01 2022-12-31 0001471781 GTCH:CustomersMember 2021-01-01 2021-12-31 0001471781 GTCH:GlenEaglesAcquisitionLPMember us-gaap:SubsequentEventMember 2023-01-01 2023-01-24 0001471781 GTCH:GlenEaglesAcquisitionLPMember us-gaap:SubsequentEventMember 2023-01-24 0001471781 us-gaap:SubsequentEventMember 2023-02-27 2023-03-02 0001471781 us-gaap:SubsequentEventMember 2023-03-02 0001471781 GTCH:DiagonalLendingMember us-gaap:SubsequentEventMember 2023-03-02 0001471781 us-gaap:SubsequentEventMember GTCH:DLConvertibleNoteMember 2023-02-27 2023-03-02 0001471781 us-gaap:SubsequentEventMember GTCH:DLConvertibleNoteMember 2023-02-26 2023-03-02 0001471781 us-gaap:SubsequentEventMember GTCH:DLConvertibleNoteMember 2023-03-02 0001471781 GTCH:GBTMember 2022-06-10 0001471781 GTCH:MetaverseAgreementMember 2022-01-01 2022-06-10 0001471781 us-gaap:SubsequentEventMember 2023-03-01 2023-03-14 0001471781 us-gaap:SubsequentEventMember GTCH:GBTTechnologiesIncMember 2023-04-03 0001471781 us-gaap:SubsequentEventMember 2023-04-01 2023-04-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K/A

Amendment No. 1

  

 ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended: December 31, 2022

 

 TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number: 000-54530

 

GBT TECHNOLOGIES INC.

(Exact name of registrant as specified in its charter)

 

N/A

(Former name of registrant as specified in its charter)

 

Nevada   27-0603137
State or other jurisdiction of   I.R.S. Employer
incorporation or organization   Identification Number

 

2450 Colorado Ave., Suite 100E, Santa Monica, CA 90404

(Address of principal executive offices)

 

Issuer’s telephone number: 888-685-7336

 

Securities registered under Section 12(b) of the Exchange Act: None

 

Securities registered under Section 12(g) of the Exchange Act: Common Stock, $0.00001 par value per share

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15 (d) of the Act. Yes  No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.) Yes  No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes No

 

 

 

 

Indicate by check mark if disclosure of delinquent filers in response to Item 405 of Regulation S-K is not contained herein, and will be contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-KA.

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definition of “accelerated filer, large accelerated filer or smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer Smaller Reporting Company

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes No

 

As of June 30, 2022, the market value of our common stock held by non-affiliates was approximately $2,266,899 which is computed based upon the closing price on that date of the Common Stock of the registrant on the OTC PINK maintained by OTC Markets Group Inc. of $0.0024. For purposes of this response, the registrant has assumed that its directors, executive officers and beneficial owners of 5% or more of its Common Stock are deemed affiliates of the registrant.

 

As of April 14, 2023, 2,930,101,819 shares of common stock, $.00001 par value per share, of the registrant were outstanding.

 

Documents incorporated by reference: None

 

 

 

 

EXPLANATORY NOTE

 

GBT Technologies, Inc. (the “Company”) is filing this Amendment No. 1 on Form 10-K/A (the “Amendment”) to amend missing prior year Auditor opinion as of December 31, 2021, originally filed with the U.S. Securities and Exchange Commission (the “SEC”) on April 12, 2023 (the “Original 10-K”), as well as to amend its current Auditor PCAOB number.

  

Pursuant to the rules of the SEC, Part IV, Item 15 of the original Form 10-K has been amended to include currently-dated certifications from our Chief Executive Officer, who serves as our principal executive officer and principal financial officer, as required by Sections 302 and 906 of the Sarbanes-Oxley Act of 2002. The certifications of the Chief Executive Officer are included in this Form 10-K/A as Exhibits 31.1 and 32.1.

 

Except as described above, this Amendment does not amend, modify or update the information in, or exhibits to, the Original 10-K, and we have not updated disclosures included therein to reflect any subsequent developments or events. This Amendment should be read in conjunction with the Original 10-K and with our other filings made with the SEC subsequent to the filing of the Original 10-K.

  

 

 

 

FORM 10-K

 

FOR THE FISCAL YEAR ENDED DECEMBER 31, 2022

 

INDEX

 

    Page
PART I    2
ITEM 1. BUSINESS 2
ITEM 1A. RISK FACTORS 21
ITEM 1B. UNRESOLVED STAFF COMMENTS 28
ITEM 2. PROPERTIES 28
ITEM 3. LEGAL PROCEEDINGS 28
ITEM 4. MINE SAFETY DISCLOSURES 31
     
PART II    32
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES 32
ITEM 6. RESERVED 35
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 35
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 58
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA 58
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE 58
ITEM 9A. CONTROLS AND PROCEDURES 59
ITEM 9B. OTHER INFORMATION 60
ITEM 9C  DISCLOSURES REGARDING FOREIGN JURISDICATIONS THAT PREVENT INSPECTIONS  60
PART III    60
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 60
ITEM 11. EXECUTIVE COMPENSATION 64
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS 65
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE 66
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES 70
ITEM 15. EXHIBITS 71
ITEM 16. FORM 10-K SUMMARY 73
  SIGNATURES 74
     
  INDEX TO FINANCIAL STATEMENTS F-1

 

i

 

STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

 

In this annual report, references to “GBT”, “GOPH”, “GTCH” or “the Company,” or “we,” or “us,” and “our” refer to GBT Technologies Inc. or f/k/a Gopher Protocol Inc. Except for the historical information contained herein, some of the statements in this report contain forward-looking statements that involve risks and uncertainties. These statements are found in the sections entitled “Business,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and “Quantitative and Qualitative Disclosures about Market Risk.” They include statements concerning: our business strategy; expectations of market and customer response; liquidity and capital expenditures; future sources of revenues; expansion of our proposed product line; and trends in industry activity generally. In some cases, you can identify forward-looking statements by words such as “may,” “will,” “should,” “expect,” “plan,” “could,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “potential,” “goal,” or “continue” or similar terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including, but not limited to, the risks outlined under “Risk Factors,” that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. For example, assumptions that could cause actual results to vary materially from future results include, but are not limited to our ability to successfully develop and market our products to customers; our ability to generate customer demand for our products in our target markets; the development of our target markets and market opportunities; our ability to manufacture suitable products at a competitive cost; market pricing for our products and for competing products; the extent of increasing competition; technological developments in our target markets and the development of alternate, competing technologies in them; and sales of shares by existing shareholders. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Unless we are required to do so under U.S. federal securities laws or other applicable laws, we do not intend to update or revise any forward-looking statements.

 

Below is a summary of material factors that make an investment in our securities speculative or risky. Importantly, this summary does not address all of the risks and uncertainties that we face. Additional discussion of the risks and uncertainties summarized in this risk factor summary, as well as other risks and uncertainties that we face, can be found under ‘Risk Factors’ in Part I, Item 1A of this Annual Report on Form 10-K/A. The below summary is qualified in its entirety by that more complete discussion of such risks and uncertainties. You should consider carefully the risks and uncertainties described under ‘Risk Factors’ in Part I, Item 1A of this Annual Report on Form 10-K/A as part of your evaluation of an investment in our securities.

 

  We have a limited operating history in an evolving industry, which makes it difficult to evaluate our future prospects and may increase the risk that we will not be successful.

 

  Our limited operating history makes it difficult for us to evaluate our future business prospects and make decisions based on those estimates of our future performance.

 

  The COVID-19 outbreak caused disruptions in our development operations, which have resulted in delays in existing projects and may have additional negative impacts on our operations.

 

  Our results of operations have not resulted in profitability and we may not be able to achieve profitability going forward.

 

  We have not generated positive cash flow from operations and our ability to generate positive cash flow is uncertain. If we are unable to generate positive cash flow or obtain sufficient capital when needed, our business and future prospects will be adversely affected and we could be forced to suspend or discontinue operations.

 

  We will require additional capital to support business growth and this capital might not be available on acceptable terms, if at all.

 

  We depend upon key personnel and need additional personnel.

 

  Our business requires substantial capital and if we are unable to maintain adequate cash flows from operations our profitability and financial condition will suffer and jeopardize our ability to continue operations.

 

  There is currently a limited public market for our common stock. Failure to further develop or maintain a trading market could negatively affect the value of our common stock and make it difficult or impossible for you to sell your stock.

 

  If we fail to maintain an effective system of internal controls, we may not be able to accurately report our financial results or prevent fraud. As a result, current and potential stockholders could lose confidence in our financial reporting, which would harm our business and the trading price of our stock.

 

  Because we are quoted on the OTC PINK marketplace instead of a national securities exchange, our investors may experience significant volatility in the market price of our stock and have difficulty selling their shares.

 

  Our stock price and trading volume may be volatile, which could result in substantial losses for our stockholders.

 

  We have not paid dividends in the past and have no immediate plans to pay cash dividends.

 

  Shares eligible for future sale may adversely affect the market for our Common Stock.

 

  You may experience future dilution as a result of future equity offerings.

 

  Our charter documents and Nevada law may inhibit a takeover that stockholders consider favorable.

 

  There are limitations on director/officer liability.

 

  Penny stock regulations may impose certain restrictions on marketability of our securities.

 

  FINRA sales practice requirements may limit a stockholder’s ability to buy and sell our stock.

 

1

 

 

PART I

 

ITEM 1. DESCRIPTION OF BUSINESS

 

OVERVIEW

 

GBT Technologies Inc. (formally known as Gopher Protocol Inc., the “Company”, “GBT”, “Gopher”, “Gopher Protocol” “GOPH” or “GTCH”) was incorporated on July 22, 2009 under the laws of the State of Nevada. GBT is targeting growing markets such as development of Internet of Things (IoT) and Artificial Intelligence (AI) enabled networking and tracking technologies, including wireless mesh network technology platform and fixed solutions, development of an intelligent human body vitals device, asset-tracking IoT, and wireless mesh networks. Effective August 5, 2019, the Company changed its name from Gopher Protocol Inc. to GBT Technologies Inc. The Company derived revenues from the provision of IT consulting services. The Company derived revenues from (i) the provision of IT consulting or licensing services; and (ii) from selling electronic products through e-commerce platforms like Amazon and eBay.

 

GBT Tokenize Joint Venture (totally Impaired in 2021)

 

On March 6, 2020, the Company through Greenwich, entered into a Joint Venture and Territorial License Agreement (the “Tokenize Agreement”) with Tokenize-It, S.A. (“Tokenize”), which is owned by a Costa Rica Trust represented by Pablo Gonzalez (“Gonzalez”). Gonzalez also represents Gonzalez Costa Rica Trust, which holds a note in the principal amount of $10,000,000 and is also a shareholder of the Company. Under the Tokenize Agreement, the parties formed GBT Tokenize Corp., a Nevada corporation (“GBT Tokenize”). The purpose of GBT Tokenize is to develop, maintain and support source codes for its proprietary technologies including advanced mobile chip technologies, tracking, radio technologies, AI core engine, electronic design automation, mesh, games, data storage, networking, IT services, business process outsourcing development services, customer service, technical support and quality assurance for business, customizable and dedicated inbound and outbound calls solutions, as well as digital communications processing for enterprises and startups (“Technology Portfolio”), throughout the State of California. Upon generating any revenue from the Technology Portfolio, the Joint Venture will earn the first right of refusal for other territories. The Company pledged its 50% ownership in GBT Tokenize and its 100% ownership of Greenwich to Tokenize to secure its Technology Portfolio investment. The Company shall appoint two directors and Tokenize shall appoint one director of GBT Tokenize. Tokenize shall contribute the services and resources for the development of the Technology Portfolio to GBT Tokenize. The Company shall contribute 2,000,000 shares of common stock of the Company (“GBT Shares”) to GBT Tokenize. Tokenize and the Company will each own 50% of GBT Tokenize. The shares were valued at $5,500,000. In addition, GBT Tokenize and Gonzalez entered into a Consulting Agreement in which Gonzalez is engaged to provide services for $33,333 per month payable quarterly which may be paid in shares of common stock calculated by the amount owed divided by the Company’s 10-day VWAP. Gonzalez will provide services in connection with the development of the business as well as GBT Tokenize’s capital raising efforts. The term of the Consulting Agreement was two years. During the year ended December 31, 2021, Gonzalez assigned all his accrued balances of $424,731 to Stanley Hills in a private transaction that the Company is not part to. The closing of the Tokenize Agreement occurred on March 9, 2020. Through this Joint Venture the parties commenced development of an intelligent human vital signs’ device, which we currently refer to as the qTerm. The platform is an expansion of the existing license agreement with GBT Tokenize Corp., which provided GBT Tokenize Corp. with an exclusive territory of California to develop certain of the Company’s technology. As the nature of the platform cannot be restricted only to California, the Company’s joint venture GBT Tokenize Corp. will be compensated with additional two hundred million shares of the Company to strengthen its funding, subject to board approval. A provisional patent application for the qTerm Medical Device was filed on March 30, 2020 with the USPTO. The application has been assigned serial number 63001564. The Joint Venture completed successfully the first prototype. There is no guarantee that the Company will be successful in researching, developing or implementing this product into the market. In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed and granted regulatory approval, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps. On May 28, 2021, the parties agreed to amend the Tokenize Agreement to expand territory granted for the Technology Portfolio under the license to GBT Tokenize to include the entire continental United States. The Company has further agreed to issue GBT Tokenize an additional 14,000,000 shares of common stock of the Company. The shares were valued at $15,400,000. At March 31, 2020, the Company evaluated the carrying amount of this joint venture investment and determined it was fully impaired and recorded an impairment charge of $5,500,000 was taken. At December 31, 2021, the Company evaluated the carrying amount of this joint venture investment and determined that this investment was fully impaired and as a result an impairment charge of $15,400,000. Although the investment was impaired, the product development is still ongoing. The carrying amount of this investment December 31, 2022 and 2021, was $0 and $0, respectively.

 

2

 

 

Magic Agreement

 

As explained above, on April 11, 2022 the Company, through its wholly owned subsidiary, Greenwich International Holdings, a Costa Rica corporation (“Greenwich”), entered into a Master Joint Venture and Territorial License Agreement (the “Tokenize Agreement”) with Magic International Argentina FC, S.L. (“Magic”) and Tokenize which replaced a prior joint venture entered between the parties.

 

The purpose of Tokenize is to develop, maintain and support source codes for its proprietary technologies including advanced mobile chip technologies, tracking, radio technologies, AI core engine, electronic design automation, mesh, games, data storage, networking, IT services, business process outsourcing development services, customer service, technical support and quality assurance for business, customizable and dedicated inbound and outbound calls solutions, as well as digital communications processing for enterprises and startups (“Technology Portfolio”), throughout the world, which Technology Portfolio was previously licensed to the Company for the State of California.

 

The Tokenize Agreement provides that the Company shall contribute 150,000,000 shares of common stock of the Company (“GBT Shares”) to Tokenize. Sergio Fridman is the manager of Magic and the beneficial owner of all outstanding securities of Magic. Magic will contribute cash of $250,000 into Tokenize for a promissory note and agreed to further fund Tokenize with all funds reasonably needed for implementation of the business purposes as described in the Tokenize Agreement. The GBT Shares will not be transferable for a period of five years.

 

Magic and the Company each own 50% of the outstanding shares of common stock of Tokenize. The Company pledged its 50% ownership in Tokenize and its 100% ownership of Greenwich (the “Pledged Securities”) to Magic for providing that Magic may take possession of such Pledged Securities in the event the Company executes, delivers and performs any future agreement or document or judgement resulting in the creation of any lien, pledge, mortgage, claim, charge or encumbrance upon any assets of the Company. The Company shall appoint two directors and Magic shall appoint one director of Tokenize.

 

3

 

 

On June 16, 2022 the parties amended the Tokenize Agreement to further define the constitution of the Board of Directors. As such, Section 4.2 of the Tokenize Agreement was amended and restated to provide that the Board of GBT Tokenize Corp. shall consist of two Directors, one of whom shall be appointed by GBT Tokenize Corp. and the other shall be appointed by the Company.

 

MetAlert (prior name – GTX Corp)

 

On April 12, 2022, GBT Tokenize Corp (“GBT Tokenize”), a Nevada corporation which the Company owns 50% of the outstanding shares of common stock, entered into a series of agreements with GTX Corp (“GTX”) and various note holders of GTX pursuant to which Tokenize acquire convertible promissory notes of GTX of $100,000 (the “GTX Notes”). In addition, GBT Tokenize acquired 76,923 (GBT acquired 5,000,000 in the original deal, where GTX to perform a corporate action of 1:65 reverse split on September 20, 2022) shares of common stock of GTX for $150,000 – in total FV of $12,538 as of December 31, 2022 based on level 1 stock price in OTC markets.

 

The GTX Notes bear 10% interest and 50% of the principal may be converted into shares of common stock on a one-time basis at a conversion price of $0.01 per share. The remaining 50% of the principal must be paid in cash. The closing occurred on April 12, 2022.

 

GTX changed its name into MetAlert Inc. on or about September 20, 2022.

 

On September 30, 2022, GBT Tokenize, loaned MetAlert Inc., a Nevada corporation (f/k/a GTX Corp.) (“MetAlert”) $90,000. For such loan, MetAlert provided Tokenize with a promissory note of $90,000 which is due and payable together with interest of 5% upon the earlier of September 19, 2023 or when declared by Tokenize.

 

MetAlert designs, manufactures and sells various interrelated and complementary products and services in the wearable technology and IoMT (Internet of Medical Things) marketplace.

 

As of December 31, 2022 and 2021, the notes had an outstanding balance of $190,000 and $0 respectively and accrued interest of $8,475 and $0 respectively.

 

As of December 31, 2022 and 2021, the marketable security had a FV of $12,538 and $0, respectively.

 

Revenue Sharing Agreement – Variable Interest Entity (VIE)

 

On February 18, 2022, the Company, effective March 1, 2022 entered into a Revenue Sharing Agreement (“RSA”) with Mahaser LTD. (“Mahaser”) pursuant to which the Company acquired the opportunity to share in revenues generated by Mahaser with respect to e-commerce sales through the online retail platform in the United States of America. Mahaser owns an e-commerce platform as a store which is the legal, exclusive owner of Ravenholm Electronics. The Company will operate the e-commerce platform and will be entitled to 95% for all revenue generated by and received by Mahaser for the period from March 1, 2022 through December 31, 2022. The RSA provides that the Company will be entitled to appoint a manager to Mahaser. As consideration, the Company will pay Mahaser $100,000 no later than March 1, 2022 and issue Mahaser 1,000,000 shares of the Company’s restricted common stock. The Company shall have no obligations to make any further payments to Mahaser. For any further extensions, the Company will have the option to extend the RSA for annual payment of $200,000, which can be payable with the Company’s shares of common stock payable based on 20 days VWAP prior to issuance. On March 16, 2022 the parties entered into Amendment No. 1 to the to the RSA, where all consideration to be paid or issued to Mahaser will be deferred until such time where the e-commerce platform generated in cumulative revenue of $1,000,000. On March 31, 2022, the parties entered into Amendment No. 2 to the RSA, where Mahaser agreed to pay the Company 100% per year for all revenue generated by and received by seller from the sales by Amazon within the United States of America as follows for the period from March 1, 2022 through December 31, 2022. The Company will be responsible for 100% of the cost of goods sold as well. In addition, the Company is entitled to earn 100% revenues and cost of goods sold of the test run period from February 1, 2022 to February 28, 2022.

 

4

 

 

Wireless mesh networking

 

Wireless mesh networks consist of LAN/MAN/WAN solutions that are infrastructural-intensive, may rely on regulated frequencies and bandwidth, often have so-called “last mile” problems areas where either economics or population density make it too expensive for current solutions to cover, and difficult to manage centrally. The Company’s GopherInsight platform makes it easy to add and manage last mile capacity. The solution is easily integrated into existing networks. The Company’s AI platform is designed for easy integration with, and management of, additional coverage for customer networks.

 

Wireless mesh networking markets

 

The Company potentially will target telecommunications providers, corporate entities that run LAN or wide-area networks, universities, and government entities.

 

Wireless mesh networking markets competition

 

The competitors for wireless mesh networking solutions, and AI solutions, are the entities themselves that have their own capability. The Company’s strategy is to integrate and “wrap around” those solutions to make them more efficient, less costly, and less infrastructural-intensive, while at the same time solving last mile problems to the end user.

 

Prepaid services – completely disposed of in 2020 – and Final Litigation Settlement in 2022

 

On September 1, 2017, the Company entered into an Asset Purchase Agreement with a third party, RWJ Advanced Marketing, LLC, a Georgia corporation. The Company entered into this Asset Purchase Agreement to acquire terminals in approximately 9,400 locations by which, and at which, the Company planned to deploy its IoT/asset tracking technology. The operations consist primarily of the sale of phones and phone card products, including PINS for cell minutes, SIM cards for cell minutes, as well as gift cards and prepaid long-distance cards. The Company incorporated a wholly-owned subsidiary, UGopherServices Corp. (“UGopherServices”), to operate the acquired assets. The assets acquired in the purchase consisted of racks that contain 9-12 items per rack that are displayed in retail locations, mainly convenience stores; and payment terminals at those same points of sale.

 

On March 16, 2018, the Company entered into and closed an asset purchase agreement dated March 1, 2018 with ECS Prepaid, LLC (“ECS”), a Missouri limited liability company, pursuant to which the Company purchased certain assets from ECS, including, but not limited to, the processing prepaid platform, servers, POS terminals, customer list, a processing software program and goodwill, $1,100,000 of which $100,000 was paid on the Closing Date and the balance is to be paid pursuant to a secured promissory note of $1,000,000. In addition, the Company issued 500,000 shares of common stock of the Company and warrants to purchase 500,000 shares of common stock that are exercisable for a period of five years at a fixed exercise price of $1.85 per share. The note is secured by the assets acquired by the Company from ECS and the Company is required to make ten equal principal payments of $100,000 commencing on April 15, 2018. The Company may prepay the note at any time without penalty.

 

On April 2, 2018, the Company entered into and closed an asset purchase agreement with Electronic Check Services, Inc. (“Electronic Check”), a Missouri corporation, pursuant to which the Company purchased certain assets from Electronic Check, including, but not limited to, assets associated with software that validates written check authenticity. The purchase price was $75,000 in cash, and the Company issued 250,000 shares of common stock of the Company and warrants to purchase 250,000 shares of common stock that are exercisable for five years at $2.70 per share.

 

5

 

 

On April 2, 2018, the Company entered into and closed an asset purchase agreement with Central State Legal Services, Inc. (“CSLS”), a Missouri corporation, pursuant to which the Company purchased certain assets from CSLS, including, but not limited to, assets associated with a system to recover funds from returned checks, for $25,000 in cash. The Company entered into these asset purchase agreements to acquire the software needed to process transactions for its prepaid business, and to acquire additional terminal locations by which the Company will deploy its technology. On a combined basis, there are approximately 9,400 points of sale as a result of acquiring certain assets from both RWJ Advanced Marketing LLC and ECS. altcOn or around November 10, 2017, UGopherServices experienced a suspension of operations on the terminals that the Company acquired in its acquisition on September 1, 2017 from RWJ Advanced Marketing LLC. Management of the Company believes that this shutdown came as a result of the decision of Paypal Holdings Inc. (“Paypal”) decision to suspend operations of TIO Networks (“TIO”), and appears to have affected all of TIO’s customers. TIO was acquired by Paypal in or around July 2017. Prior to the suspension, the Company received no notice from TIO, or from RWJ Advanced Marketing LLC, which sold the assets to UGopherServices, that the suspension would be taking place. Although the Company worked diligently to contain the fallout from the suspension of operations by TIO, the vast majority of the customers that were acquired as part of the transaction defected as a result. The subsequent acquisition of ECS was done partly to stem the customer defections, as many of the customers of UgopherServices sought the services of ECS. In doing so, the Company got many, though not all, of the customers back.

 

The Company entered into the Confidential Settlement Agreement and Mutual Release (“RJW Agreement”) by and between RWJ Advanced Marketing, LLC, Robert Warren Jackson, Gregory Bauer (collectively the “RJW Parties”) and W.L. Petrey Wholesale Company, Inc., (“Petrey”) on one hand; and GBT Technologies Inc., on behalf of itself and its agents (collectively the GBT Parties”), on the other hand. The Company the RJW Agreement effective September 26, 2022 with final signatures delivered to the Company on or about October 5, 2022. Pursuant to the RJW Agreement, the parties have agreed to settle, release, and otherwise resolve all known or unknown claims between them and agreed to jointly stipulate, move, or otherwise dismiss the lawsuits filed in the United States District Court of Nevada (Case No. 2:20-cv- 02078), in the Superior Court of the State of California, County of Los Angeles, Central District (Case Nos. 19STCV03320 and 20STCV32709), and in the United States District Court of the Central District of California (Case No. 2:20-cv-09399-RGK-AGR) with prejudice. The parties agreed and stipulated to release all funds currently being held in a blocked account of $19,809 with 50% distributed to the RWJ Parties and 50% distributed the Company or its assignee. The Parties also entered into the InComm Assignment Agreement (“IAA”) which assigned, transferred and conveyed all proceeds derived from the RWJ Parties’ agreements with Interactive Communications International, Inc., and its affiliate Hi Technology Corp., including but not limited to that Master Distribution and Service Agreement between Interactive Communications International, Inc. and Petrey d/b/a UGO-HUB dated August 29, 2016, as amended (collectively referred to as the “InComm Proceeds”), and which shall divide the InComm Proceeds 90% to the Company or its assignee and 10% to the RWJ Parties or their assignee. Finally, the Company agreed to pay $40,000 to the RWJ Parties or their assignee. The Company accrued $49,847 expenses represent the final amounts due to the RJW Parties.

 

6

 

 

 On September 30, 2019, the Company entered into an Asset Purchase Agreement with Surge Holdings, Inc., a Nevada corporation (“SURG”) pursuant to which the Company agreed to sell and assign to SURG all the assets and certain specified liabilities of its ECS Prepaid, Electronic Check and the CSLS businesses for $5,000,000 to be paid through the issuance of 3,333,333 shares of SURG’s common stock and a convertible promissory note in favor of the Company for $4,000,000. The 3,333,333 shares of SURG’s common stock have been pledged to a third party for providing working capital needs of the Company. The convertible promissory note was issued to AltCorp Trading, LLC a wholly owned subsidiary of the Company. On January 7, 2022, the Company received payments from Surgepays Inc. (formerly known as Surge Holdings, Inc.) in total of $3,750,000 pursuant to the terms of the Settlement Agreement dated December 22, 2021.

 

On September 18, 2020, the Company entered into a Purchase and Sale Agreement with Mr. LightHouse LTD., an Israeli corporation (“MLH”) pursuant to which the Company agreed to sell and assign to MLH, effective July 1, 2020 all the shares, and certain specified liabilities, of Ugopherservices Corp. (“UGO”), a wholly owned subsidiary of the Company, for $100,000 to be paid through the delivery of a promissory note payable to the Company (the “Note”), upon the terms and subject to the limitations and conditions set forth in the Note. There is no material relationship between the Company, on one hand, and MLH, on the other hand. At December 31, 2020, the Company determined that this note receivable was not collectible and took an impairment charge of $100,000. During July 2021, MLH effected a $50,000 payment on the Note. During April 2022, MLH effected a second payment for additional $50,000 on the Note exhausting the Note balance.

 

On March 8, 2020, SURG filed a lawsuit against its transfer agent, Vstock with respect to the transfer of SURG common stock that is currently in possession of the Company and assigned to Stanley Hills, LLC. On January 1, 2021, SURG, AltCorp and Stanley Hills, LLC (“Stanley”) entered into a Mutual Release and Settlement Agreement (“Settlement Agreement”). Pursuant to the terms of the Settlement Agreement, SURG agreed to amend the AltCorp Exchange Agreement where SURG acknowledged a debt of $3,300,000 (the “Debt”) to be paid in 33 monthly payments of $100,000 payable in shares of common stock of SURG at a per share price equal the volume weighted average price of Surg’s common stock during the 10 trading days immediately preceding the issuance. The Company paid $650,000 in cash and the remaining by shares. The SURG common stock issued to Altcorp was pledged since August 12, 2020 for the benefit of Stanley to secure Stanley’s note payable by the Company. Accordingly, the SURG Common Stock issued to AltCorp as a result of the Settlement Agreement were pledged to Stanley. As of December 31, 2021 there were no surge shares pledges after the final settlement signed on December 22, 2021 and that replaced all prior settlement agreement. The final settlement SURG agreed to make total payments of $4,200,000 to the Company on or prior to January 7, 2022. This $4.2 million amount consists of $450,000 paid by SURG in November and December 2021, $100,000 to be paid on or about January 4, 2022, and $3,650,000 to be paid on or prior to January 7, 2022 of which $375,000 will be held in escrow as described before. The $3,750,000 was recorded as other receivable as of December 31, 2021. As of December 31, 2022 and 2021, the Company recorded an outstanding payable to Stanley of $927,136 and $1,862,928, respectively, recorded under accrued expenses.

 

7

 

 

Subsequently, SURG was a party to two lawsuits in, the Eighth Judicial District Court for Clark County, Nevada involving AltCorp, Stanley and Glen Eagles Acquisition LP (the “AltCorp Parties.”). Each of these lawsuits were disputes relating to the total consideration SURG was to pay the Company under the APA.

 

On October 18, 2021, the AltCorp Parties, the Company, and SURG entered into a Memorandum of Understanding (the “MOU”) to set up a framework for an attempt to settle the two lawsuits.

 

On December 22, 2021 (the “Effective Date”), pursuant to the framework in the MOU, the AltCorp Parties (and an additional third party), the Company, ECS, and SURG, Kevin Brian Cox (SURG’s Chief Executive Officer) – in his individual capacity, entered into a Resolution of Purchase, Mutual Release, and Settlement Agreement (the “Final Settlement Agreement”) to settle the two lawsuits and resolve all disputes related to the consideration paid by SURG to the Company in connection with the APA.

 

The Final Settlement Agreement, among other resolutions, provides the following:

 

  (i) From the total consideration of the Final Settlement Agreement, of $375,000 (“Escrow Amount”) will be deposited by SURG in escrow. SURG has acquired the Company’s rights to a certain Master Distribution and Service Agreement (“MDA”). Under certain circumstances, if the result of the Company’s lawsuit against a third party (the “GBT Lawsuit”) is a monetary judgment without the assignment or legal decree of ownership of the MDA, the Company shall be entitled to receive the Escrow Amount and shall assign to SURG the first $1,000,000 the Company recovers from the defendants in the GBT Lawsuit. In the event that the Company does not prevail in the GBT Lawsuit then it shall be entitled to release of the Escrow Amount but shall be responsible for any fees and costs obligation sought by the defendants in the GBT Lawsuit.

 

  (ii) SURG agreed to make total payments of $4,200,000 to Stanley on or prior to January 7, 2022. This $4.2 million consists of $450,000 paid to the Company in November and December 2021, $100,000 to be paid on or about January 4, 2022, and $3,650,000 to be paid on or prior to January 7, 2022 of which $375,000 will be held in escrow as described before. The final settlement SURG agreed to make total payments of $4,200,000 to the Company’s trust account on or prior to January 7, 2022. The $3,750,000 was recorded as other receivable as of December 31, 2021. The entire of $3,750,000 was paid in January 2022.

 

  (iii)

Potential payments to third parties.

 

The Final Settlement Agreement replaces all prior agreements between the parties. In addition, within three trading days of the last payment related to the $4.2 million payment to Stanley being made, the parties shall make filings with the state District Court in Clark County, Nevada to dismiss both lawsuits, including, regarding the lawsuit filed by AltCorp Trading, LLC, the dismissal of the lawsuit as to VStock Transfer, LLC. The parties agreed to a full mutual release of any disputes or claims between the parties.

 

The final settlement of $3,750,000 was received by the Company in 2022 and paid out $3,750,000 to the third parties in 2022.

 

As the Company committed to assign certain revenue share agreement to SURG as part of the Company’s settlement with RWJ Agreement, on October 5, 2022 and as cumulation of all settlement agreements the Company issued a request to the SURG regarding release of certain escrow funds and the execution of an assignment of rights as contemplated in the afore referenced agreement (See Footnote 18 Contingencies).

 

8

 

 

UGO, ECS Prepaid, Electronic Check Services and the Central State Legal Services businesses have been presented as discontinued operations on the accompanying financial statements.

 

GBT Technologies, S.A. (“GBT”) (fully impaired in 2019)

 

On June 17, 2019, the Company, AltCorp Trading LLC, a Costa Rica company and a wholly-owned subsidiary of the Company (“AltCorp”), GBT Technologies, S.A., a Costa Rica company (“GBT-CR”) and Pablo Gonzalez, a shareholder’s representative of GBT-CR (“Gonzalez”), entered into and closed an Exchange Agreement (the “GBT Exchange Agreement”) pursuant to which the parties exchanged certain securities. In accordance with the Exchange Agreement, AltCorp acquired 625,000 shares of GBT-CR representing 25% of its issued and outstanding shares of common stock from Gonzalez for the issuance of 20,000 shares of Series H Convertible Preferred Stock of the Company and a Convertible Note of $10,000,000 issued by the Company (the “Gopher Convertible Note”) as well as the transfer and assignment of a Promissory Note payable by Gopher Protocol Costa Rica Sociedad De Responsabilidad Limitada to the Company of $5,000,000 dated February 6, 2019 (of which the underlying security for this Promissory Note is 30,000,000 restricted shares of common stock of Mobiquity Technologies, Inc. (“Mobiquity”) and 60,000,000 restricted shares of common stock of Mobiquity.

 

The Gopher Convertible Note bears Interest of 6% and is payable at maturity on December 31, 2021. At the election of Gonzalez, the Gopher Convertible Note can be converted into a maximum of 20,000 shares of Series H Preferred Stock. Each share of Series H Preferred Stock is convertible, at the option of the holder but subject to the Company increasing its authorized shares of common stock, into such number of shares of common stock of the Company as determined by dividing the Stated Value ($500 per share) by the conversion price ($500 per share). The Series H Preferred Stock has no liquidation preference, does not pay dividends and the holder of Series H Preferred Stock shall be entitled to one vote for each share of common stock that the Series H Preferred Stock may be convertible into. Upon conversion of the Gopher Convertible Note and the 20,000 shares of Series H Preferred Stock, Gonzalez would be entitled to less than 50% of the resulting outstanding shares of common stock of the Company following conversion in full and, as a result, such transaction is not considered a change of control.

 

On May 19, 2021, the Company, entered into a Mutual Release and Settlement Agreement and Irrevocable Assignment of Note Balance Principal and Accrued Interest (the “Gonzalez Agreement”) with third party, GBT-CR, IGOR 1 Corp and Gonzalez Pursuant to the Gonzalez Agreement, without any party admission of liability and to avoid litigation, the parties had agreed to (i) extend the GBT Convertible Note maturity date to December 31,2022, (ii) amend the GBT Convertible Note terms to include a beneficial ownership blocker of 4.99% and a modified conversion feature to the GBT Convertible Note with 15% discount to the market price during the 20 trading day period ending on the latest complete trading day prior to the conversion date and (iii) provided for an assignment of the GBT Convertible Note by Gonzalez to a third party. As a result of the change in terms of this convertible note, the Company took a charge related to the modification of debt of $13,777,480 during the year ended December 31, 2021. This convertible note is recorded as derivative liability because of the discounted price on conversion.

 

GBT-CR is in the business of the strategic management of BPO (Business Process Outsourcing) digital communications processing for enterprises and startups, distributed ledger technology development, AI development and fintech software development and applications.

 

The Company accounted for its investment in GBT-CR using the equity method of accounting; however, in 2020, the Company owned less than 20% after GBT-CR issued additional shares to other investors therefore exercised no control over GBT-CR; therefore, this investment is currently accounted for under the cost method. Moreover, on March 19, 2020, California Governor Gavin Newsom issued a stay-at-home order to protect the health and well-being of all Californians and to establish consistency across the state in order to slow the spread of COVID-19. California was therefore under strict quarantine control and travel has been severely restricted, resulting in disruptions to work, communications, and access to files (due to limited access to facilities). The stay-at-home order was lifted in California only on January 25, 2021. As such, the Company was unable to access or to contact GBT-CR on an on-going basis, and cannot get information about GBT-CR.

 

Joint Ventures

 

GBT Tokenize-It, S.A (Fully Impaired in 2021)

 

On March 6, 2020, the Company through its wholly owned subsidiary, Greenwich International Holdings, a Costa Rica corporation (“Greenwich”), entered into a Joint Venture and Territorial License Agreement (the “Tokenize Agreement”) with Tokenize-It, S.A. (“Tokenize”), which is owned by a Costa Rica Trust represented by Pablo Gonzalez (“Gonzalez”). Gonzalez also represents Gonzalez Costa Rica Trust, which holds a note of $10,000,000 and is also a shareholder of the Company. Under the Tokenize Agreement, the parties formed GBT Tokenize Corp., a Nevada corporation (“GBT Tokenize”). The purpose of GBT Tokenize is to develop, maintain and support source codes for its proprietary technologies including advanced mobile chip technologies, tracking, radio technologies, AI core engine, electronic design automation, mesh, games, data storage, networking, IT services, business process outsourcing development services, customer service, technical support and quality assurance for business, customizable and dedicated inbound and outbound calls solutions, as well as digital communications processing for enterprises and startups (“Technology Portfolio”), throughout the State of California. Upon generating any revenue from the Technology Portfolio, the Joint Venture will earn the first right of refusal for other territories.

 

9

 

 

The Company pledged its 50% ownership in GBT Tokenize and its 100% ownership of Greenwich to Tokenize to secure its Technology Portfolio investment. The Company shall appoint two directors and Tokenize shall appoint one director of GBT Tokenize.

 

Tokenize shall contribute the services and resources for the development of the Technology Portfolio to GBT Tokenize. The Company shall contribute 2,000,000 shares of common stock of the Company (“GBT Shares”) to GBT Tokenize. Tokenize and the Company will each own 50% of GBT Tokenize. The shares were valued at $5,500,000.

 

In addition, GBT Tokenize and Gonzalez entered into a Consulting Agreement in which Gonzalez is engaged to provide services of $33,333 per month payable quarterly which may be paid in shares of common stock calculated by the amount owed divided by the Company’s 10-day VWAP. Gonzalez will provide services in connection with the development of the business as well as GBT Tokenize’s capital raising efforts. The term of the Consulting Agreement is two years. During year ended December 31, 2022, Gonzalez assigned all his accrued balances of $424,731 to Stanley Hills in a private transaction that the Company is not part to. The closing of the Tokenize Agreement occurred on March 9, 2020.

 

Through this Joint Venture the parties commenced development of an intelligent human vital signs’ device, which we currently refer to as the qTerm. The platform is an expansion of the existing license agreement with GBT Tokenize Corp., which provided GBT Tokenize Corp. with an exclusive territory of California to develop certain of the Company’s technology. As the nature of the platform cannot be restricted only to California, the Company’s joint venture GBT Tokenize Corp. will be compensated with additional two hundred million shares of the Company to strengthen its funding, subject to board approval. A provisional patent application for the qTerm Medical Device was filed on March 30, 2020 with the USPTO. The application has been assigned serial number 63001564. The Joint Venture completed successfully the first prototype. There is no guarantee that the Company will be successful in researching, developing or implementing this product into the market. In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed and granted regulatory approval, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product. There is no guarantee the Company will be successful in any or all of these critical steps.

 

10

 

 

At March 31, 2020, the Company evaluated the carrying amount of this joint venture investment and determined this investment was fully impaired and as a result an impairment charge of $5,500,000 was taken. At September 30, 2021, the Company evaluated the carrying amount of this joint venture investment and determined this investment was fully impaired and as a result an impairment charge of $15,400,000 was taken.

 

Although the investment was impaired, the product development is still ongoing. The carrying amount of this investment at December 31, 2022 and 2021, was $0 and $0, respectively.

 

On May 28, 2021, the parties agreed to amend the Tokenize Agreement to expand territory granted for the Technology Portfolio under the license to GBT Tokenize to include the entire continental United States. The Company has further agreed to issue GBT Tokenize an additional 14,000,000 shares of common stock of the Company. The shares were valued at $15,400,000.

 

On September 30, 2021 Tokenize, in an agreement that the Company is not a party to, irrevocably assigned all its rights in GBT Tokenize, including all its rights per the Tokenize Agreement, The Gonzalez Consulting agreement and the pledge agreement, to the benefit of Magic International Argentina FC, S.L a third party (“Magic”). On June 30, 2021 Magic irrevocably assigned to Stanley Hills, LLC its credit balance accrued until June 30,2021 per the consulting agreement

 

GBT Bitspeed Corp (Fully Impaired in 2019)

 

On October 10, 2019, the Company entered into a Joint Venture Agreement (the “BitSpeed Agreement”) with BitSpeed LLC, which is owned by Douglas Davis, the Company’s Chief Executive Officer, to form GBT BitSpeed Corp., a Nevada company (“GBT BitSpeed”). The purpose of GBT BitSpeed is to develop, maintain and support its proprietary Extreme Transfer Software Application Concurrency, a software application to transfer secure, accelerated transmission of large file data over networks, and connection to cloud storage, Network-Attached Storage (NAS) and Storage Area Networks (SANs) (“Concurrency”). BitSpeed shall contribute the services and resources for the development of Concurrency to GBT BitSpeed. The Company shall contribute 10,000,000 shares of common stock (valued at $17,900,000) of the Company to GBT BitSpeed. BitSpeed and the Company will each own 50% of GBT BitSpeed. The Company shall appoint two directors and BitSpeed shall appoint one director of GBT BitSpeed. In addition, GBT BitSpeed and Mr. Davis entered into a Consulting Agreement in which Mr. Davis is engaged to provide services for $10,000 per month payable quarterly which may be paid in shares of common stock calculated by the amount owed divided by the Company’s 20-day VWAP. Mr. Davis will provide services in connection with the development of the business as well as GBT BitSpeed’s capital raising efforts. The term of the Consulting Agreement was two years. The closing of the BitSpeed Agreement occurred on October 14, 2019. On April 11, 2020, Douglas Davis resigned as Chief Executive Officer of the Company so that he may fully devote all of his efforts to GBT Tokenize Corp., the Company’s joint venture, which intends to develop a new product. Mr. Davis’ resignation was not the result of any disagreements with management or board of directors of the Company. On June 16, 2022 the parties amended the Bitspeed Agreement to further define the constitution of the Board of Directors. As such, Section 4.2 of the Bitspeed Agreement was amended and restated to provide that the Board of GBT Bitspeed Corp. shall consist of two Directors, one of whom shall be appointed by Bitspeed LLC and the other shall be appointed by the Company.

 

11

 

  

Latinex (contra-equity account)

 

On January 8, 2019, the Company entered into a Stock Pledge Agreement with Latin American Exchange Latinex Casa de Cambio, S.A., a Costa Rica corporation (“Latinex”), to provide that Latinex may maintain its required regulatory capital as required by various regulators. The Company has pledged 4,006 restricted shares of its common stock valued at $7,610,147 (based on the closing price on the grant date) for three years on an annual payment of $375,000 paid in quarterly installments of $93,750. In lieu of cash payment, Latinex may pay the Company in virtual currency of WISE Network S.A. valued at a 50% discount of its offering price of $10 per token. If Latinex’s required capital has decreased below $5,000,000, Latinex is permitted to sell the pledged shares of common stock only in an amount to ensure that Latinex can satisfy the required capital levels. The Company must consent to such sale of the shares of common stock, which may not be unreasonably withheld. Upon expiration of the agreement, the remaining shares of common stock shall be returned to the Company free and clear of all liens. The Company has recorded the value of these shares of common stock as a stock loan receivable which is presented as a contra-equity account in the accompanying consolidated balance sheets. At December 31, 2019, the Company wrote off the accrued interest income as Latinex did not perform any payment and the Company has no mean to enforce this payment. Latinex agreed in principle to return the pledged 4,006 restricted shares to the Company for cancellation. The 4,006 restricted shares have not yet been returned to the Company as of December 31, 2022.

 

Regulatory

 

GBT Tokenize seeks approval filing for its qTerm device with the United Stated Food and Drug Administration (“FDA”). The FDA classifies medical devices from Class 1 – 3, each of which must be subjected to robust evaluations and reviews to comply with manufacturing quality control (QC) standards. The FDA regulates the marketing/sale of medical device products in the U.S. and monitors the safety of all regulated medical products. FDA Section 201(h) of the Food, Drug & Cosmetic Act (FD&C Act) defines a device as: an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including a component part or accessory which is recognized in the official National Formulary, or the United States Pharmacopoeia, or any supplement to them, intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease in man or other animals, or intended to affect the structure or any function of the body of man or other animals. GBT Tokenize engaged M Squared Associates (M2) to assist with developing the FDA premarket strategy for its qTerm device. The process of filing for FDA clearance involves development of a sound regulatory strategy for pathway to market, including required preclinical and performance testing, software verification and validation activities and ensuring user needs are met. In addition, GBT/tokenize will partner with M2 to finalize technical design documentation, device labeling claims and intended use. Other aspects that will be evaluated include manufacturing processes, usability / human factors and the development of valid scientific evidence. The company will work with M2 to develop a detailed description of the device’s software and algorithm training requirements, including design specifications. qTerm computer program will be reviewed for its control functions and other required performance testing plans and criteria according to FDA guidance documentation. Even though not required by law, there is no guarantee that the Company will be successful in obtaining any regulatory approval. In order to successfully implement this concept, the Company will need to raise adequate capital to support its compliance research and, if successfully researched, developed and granted regulatory approval, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps.

 

The Company seeks to conduct business with the US government agencies and hired a consulting firm for general guidance with the GSA (General Services Administration) application process. GSA approval status describes an organization that have been approved to sell to the US Government through the U.S. General Services Administration (GSA). The GSA is an independent agency of the United States Government that was established in 1949 to help manage, approve, and facilitate government contracts, products, bids and verify that product and services properly sourced under the US Government guidelines. The GSA is the purchasing department of the US Government and lists contracts or schedules potential vendors that can bid on to get government business. To become eligible to bid on a GSA schedule, it is required to complete several important steps, among them are registering in the government’s SAM (System for Award Management), and providing previous customer contact information as a means for the GSA to perform a past performance evaluation. More information can be found on GSA web site at: https://www.gsa.gov. The Company applied and received their extension notice for SAM registration #832011626/91FW3 until May 2023. The active status makes GBT eligible to potentially contract business with US government contractors and sub-contractors, local cities or receive federal funds. SAM (www.sam.gov) is a central registration system for government contractors and suppliers. To remain eligible to do business with the federal government, an entity must renew its registration with SAM every year.

 

12

 

 

Intellectual Property

 

To date, the Company, has filed for different patents covering certain fields of its technologies, as well as trademarks. These patents and trademarks, as well as various websites and social media platforms, comprise the Company’s intellectual properties. On February 27, 2020 GBT Technologies, S.A., as successor in interest to Hermes Roll, LLC had notified the Company that it was in default on its Amended and Restated Territorial License Agreement (“ARTLA”) dated June 15, 2015 and that the ARTLA had been cancelled and rescinded.

 

On January 31, 2020, in the arbitration titled GBT Technologies Inc. (k/n/a Gopher Protocol, Inc. v. Discover Growth Fund, LLC (“Discover”) (JAMS Ref. No. 1260005395), the Company was informed that a final award was entered (the “Final Award”). The Final Award affirms that certain sections of the Senior Secured Redeemable Convertible Debenture (the “Debenture”) constitute unenforceable liquidated damages penalties and were stricken. Further, it was determined that neither Discover nor John Kirkland, President and General Partner of Discover, were entitled to recovery of their attorney’s fees. Consequently, and consistent with the expectations of the Company, the arbitrator awarded Discover $4,034,444 plus interest of 7.25% accrued from May 15, 2019 and costs of $55,613.00. On February 18, 2020, the Company filed a motion with the United States District Court District of Nevada (the “Nevada Court”) to confirm the Final Award and a motion to consolidate Discover’s application to confirm the Final Award filed in the U.S. District Court of the Virgin Islands (Case No: 3 :20-cv-00012-CVG-RM) (the “Virgin Island Court”). On February 27, 2020, the Nevada Court denied the Company’s motion to confirm the Final Award and motion to consolidate and further decided that the confirmation of the Final Award should be litigated in the Virgin Island Court. As such, on February 27, 2020, the Company filed a Notice of Entry of Order as well as a Motion to Confirm the Arbitration Award; Address the Outstanding issue regarding whether Discover’s rights are subordinated to other creditors and, thereafter, oversee a commercially reasonable foreclosure sale (Case No: 3 :20-cv-00012-CVG-RM). It was the Company’s position that the Final Award must first be confirmed and all questions regarding the rights of Discover relative to those of other creditors must be determined before any foreclosure sale can proceed. It was further the position of the Company that the previously disclosed foreclosure sale scheduled by Discover is being conducted in a commercially unreasonable manner and that if Discover proceeded forward with the foreclosure sale it did so at its own risk. Nevertheless, on February 28, 2020, Discover advised that it conducted a sale of the Company’s assets. As the date of this report Investor failed to present a deed of sale for the alleged sale that allegedly took place as noticed. The Company filed with Virgin Island Court the motions disputing the validity of the alleged sale. On July 28, 2020, Investor filed in the State of Nevada a motion for attorneys $48,844 and costs $716. The Company filed an answer on August 11, 2020. On October 16, 2020, Investor motion for attorneys $48,844 and costs $716 was denied. This case is still pending with the Federal court and the Court has not taken any substantive action in the matter as of the date of this report.

 

13

 

On March 6, 2020, the Company through its newly acquired wholly owned subsidiary, Greenwich International Holdings, a Costa Rica corporation (“Greenwich”), entered into a Joint Venture and Territorial License Agreement (the “Tokenize Agreement”) with Tokenize-It, S.A. (“Tokenize”) to develop, maintain and support source codes for its proprietary technologies including advanced mobile chip technologies, tracking, radio technologies, AI core engine, electronic design automation, mesh, games, data storage, networking, IT services, business process outsourcing development services, customer service, technical support and quality assurance for business, customizable and dedicated inbound and outbound calls solutions, as well as digital communications processing for enterprises and startups (“Technology Portfolio”). Via this Joint Venture the parties commenced development of a development of an intelligent human vital signs’ device, suggested named qTerm. The Joint Venture completed successfully the first prototype.

 

The following chart represent the Company Intellectual Properties Status:

 

GBT Intellectual Property Status Chart

 

Patents

Title App. No. Country Filing Date Status / Deadline Patent No. Issue Date
System and method for scheduling trucking service, according to demand, at the customer’s or any other location using smartphone application and/or internet web site 62/124,320 US December 15, 2014 Expired N/A N/A
System and method for scheduling categorized delivery and/or service, according to demand, to customer’s location based on smartphone and web site software application 62/176,933 US March 3, 2015 Expired and Converted to Electronic Circuit Non-provisional and PCT N/A N/A
System and method for finding possible bartering partners in both two-party and multi-party scenarios via smartphone/mobile device application 14/545,577 US May 26, 2015 Abandoned N/A N/A
System and method for scheduling gasoline or diesel fill, according to demanding, at the customer’s location 62/231,405 US July 6, 2015 Expired and Converted to Electronic Circuit Non-provisional and PCT N/A N/A
Electronic circuit or microchip with a secured BIOS system, with ROM and RAM memory, working with smartphone software application and 62/282,593 US August 6, 2015 Expired and Converted to Electronic Circuit Non-provisional and PCT N/A N/A
System and method for power saving/reduction within integrated circuits 62/282,808 US August 13, 2015 Expired N/A N/A
System and method for overseeing and monitoring user’s computerized activity to define privacy level 62/283,915 US September 16, 2015 Expired N/A N/A
System, method and computer program for remote disablement and enablement of mobile devices 62/284,353 US September 28, 2015 Expired and Converted to Electronic Circuit Non-provisional and PCT N/A N/A
System, method and computer program for real time emergency communication, beacon, location identification and tracking for mobile devices 62/284,458 US October 1, 2015 Expired and Converted to Electronic Circuit Non-provisional and PCT N/A N/A

14

 

System, method and a computer program for automatic and motion activity detection, activation or deactivation airplane mode for mobile devices 62/284,744 US October 8, 2015 Expired and Converted to Electronic Circuit Non-provisional and PCT N/A N/A
Monolithic multi-dimensional integrated circuits (iCs) on both sides of electronic board including utilization of all package’s planes 62/284,880 US October 13, 2015 Expired N/A N/A
System, method and software for mobile database manage and sharing over private, secured network, in real time 62/284,884 US October 13, 2015 Expired N/A N/A
Method, system and computer software for advertisement using symbols as characters interface 62/285,055 US October 19, 2015 Expired N/A N/A
Monolithic, multi-dimensional, multi-plane, memory structure for integrated circuits 62/285,443 US October 30, 2015 Expired N/A N/A
Automatic, characterized and prioritized consolidation of different credit cards into one card method, point of sale, smartphone applications and computer software 62/285,996 US November 26, 2015 Expired N/A N/A
Electronic circuit within a sticky patch package for global tracking that is working with mobile software application and other electronic circuits on a separate, secured, private network 62/387,789 US January 6, 2016 Expired and Converted to Tracking Devices Non-provisional and PCT N/A N/A
ELECTRONIC CIRCUITS FOR SECURE COMMUNICATIONS AND ASSOCIATED SYSTEMS AND METHODS 15/015,441 US February 4, 2016 Granted U.S. Patent No. 10,521,614 December 31, 2019
ELECTRONIC CIRCUITS FOR SECURE COMMUNICATIONS AND ASSOCIATED SYSTEMS AND METHODS PCT/US2016/016522 PCT February 4, 2016 Expired and Entered National Phase in Europe N/A N/A

 

15

 

SYSTEM AND METHOD FOR POWER SAVING/REDUCTION WITH INTEGRATED CIRCUITS 62/360,525 US July 11, 2016 Expired N/A N/A
System and method for elimination of electromigration and self-heat violations during construction of a mask layout block, maintaining process design rules and layout connectivity 62/494,199 US August 1, 2016 Expired N/A N/A
ELECTRONIC CIRCUITS FOR SECURE COMMUNICATIONS AND ASSOCIATED SYSTEMS AND METHODS 16759244.3 EP September 29, 2017 Pending N/A N/A
TRACKING DEVICES, SYSTEMS AND METHODS USING PATCH PACKAGES WITH EMBEDDED ELECTRONIC CIRCUITS 15/344,619 US November 7, 2016 Granted 10,021,522 July 10, 2018
TRACKING DEVICES, SYSTEMS AND METHODS USING PATCH PACKAGES WITH EMBEDDED ELECTRONIC CIRCUITS PCT/US16/060763 PCT November 7, 2016 Expired and Entered National Phase in Europe N/A N/A
TRACKING DEVICES, SYSTEMS AND METHODS USING PATCH PACKAGES WITH EMBEDDED ELECTRONIC CIRCUITS 16884138.5 EP July 3, 2018 Pending N/A N/A
TRACKING DEVICES, SYSTEMS AND METHODS USING PATCH PACKAGES WITH EMBEDDED ELECTRONIC CIRCUITS 16/028,449 US July 6, 2018 Granted 10,616,715 April 7, 2020
GOPHER RADIO TOKEN 62/631,007 US February 15, 2018 Pending and Converted to GRT Non-provisional N/A N/A
SYSTEMS AND METHOD OF CONVERTING ELECTRONIC TRANSMISSIONS INTO DIGITAL CURRENCY 16/008,069 US June 14, 2018 Abandoned N/A N/A

 

16

 

SYSTEMS AND METHOD OF CONVERTING ELECTRONIC TRANSMISSIONS INTO DIGITAL CURRENCY PCT/US19/16728 PCT February 6, 2019 Expired N/A N/A
System, method and software application for mobile database management and sharing over private, secured network, in real time 62/676,393 US May 25, 2018 Pending and Converted to Mobile Database Sharing Non-provisional N/A N/A
SYSTEMS AND METHODS OF MOBILE DATABASE MANAGEMENT AND SHARING 16/155,093 US October 9, 2018 Granted 10,853,327 December 1, 2020
SYSTEMS AND METHODS OF MOBILE DATABASE MANAGEMENT AND SHARING 17/104,001 US November 25, 2020 Pending N/A N/A
MONOLITHIC, MULTI-DIMENSIONAL, MULTI-PLANE, MEMORY STRUCTURE FOR INTEGRATED CIRCUITS 62/732,026 US September 17, 2018 Pending N/A N/A
MONOLITHIC MULTI-DIMENSIONAL INTEGRATED CIRCUITS (ICS) ON BOTH SIDES OF ELECTRONIC BOARD INCLUDING UTILIZATION OF ALL PACKAGE’S PLANES 62/732,023 US September 17, 2018 Pending N/A N/A
MULTI-DIMENSIONAL INTEGRATED CIRCUITS AND MEMORY STRUCTURE FOR INTEGRATED CIRCUITS AND ASSOCIATED SYSTEMS AND METHODS 16/292,388 US March 5, 2019 Granted 10,854,763 December 1, 2020
MULTI-DIMENSIONAL INTEGRATED CIRCUITS AND MEMORY STRUCTURE FOR INTEGRATED CIRCUITS AND ASSOCIATED SYSTEMS AND METHODS 17/102,928 US November 24, 2020 Pending N/A N/A
MULTI-DIMENSIONAL INTEGRATED CIRCUITS AND MEMORY STRUCTURE FOR INTEGRATED CIRCUITS AND ASSOCIATED SYSTEMS AND METHODS PCT/US19/50266 PCT September 10, 2019 Expired N/A N/A
MULTI-DIMENSIONAL INTEGRATED CIRCUITS AND MEMORY STRUCTURE FOR INTEGRATED CIRCUITS AND ASSOCIATED SYSTEMS AND METHODS 19862631.9 EP March 16, 2021 Pending N/A N/A

 

17

 

MULTI-DIMENSIONAL INTEGRATED CIRCUITS AND MEMORY STRUCTURE FOR INTEGRATED CIRCUITS AND ASSOCIATED SYSTEMS AND METHODS 10-2021-7008024 KR March 17, 2021 Pending N/A N/A
GuardianLIFE Medical Device 63/001,564 US March 30, 2020 Expired N/A N/A
PROXIMITY ALERT FOR USE WITH A PUSH-BUTTON VITAL SIGNS MONITORING SYSTEM 63/012,205 US April 19, 2020 Expired N/A N/A
PUSH-BUTTON AND TOUCH-ACTIVATED VITAL SIGNS MONITORING DEVICES AND METHODS OF MAPPING DISEASE HOT SPOTS AND PROVIDING PROXIMITY ALERTS 16/983,289 US August 3, 2020 Pending N/A N/A
Automatic, characterized and prioritized consolidation of different credit cards into one card method, point of sale, smartphone applications and computer software 63175564 US April 16, 2021 Pending N/A N/A
Method, system and computer software for advertisement, using symbols as characters interface 63177669 US April 21, 2021 Pending N/A N/A
SYSTEMS AND METHODS FOR ELIMINATING ELECTROMIGRATION AND SELF-HEAT VIOLATIONS IN A MASK LAYOUT BLOCK 17315747 US May 10, 2021 Pending N/A N/A
System and method for automatic correction of geometrical design rule violations in integrated circuit mask layout data, maintaining its electrical connectivity (LVS), reliability (RV) and design for manufacturing (DFM) structural correctness 63197635 US June 7, 2021 Pending N/A N/A
REAL-TIME MOVEMENT, POSITION DETECTION, AND IMAGING USING WIRELESS TECHNOLOGY AND ARTIFICIAL INTELLIGENCE 63211573 US June 17, 2021 Pending N/A N/A
SYSTEMS AND METHODS FOR IDENTIFICATION AND ELIMINATION OF GEOMETRICAL DESIGN RULE VIOLATIONS OF A MASK LAYOUT BLOCK 17391292 US August 2, 2021 Pending N/A N/A

 

18

 

SYSTEMS AND METHODS OF REAL-TIME MOVEMENT, POSITION DETECTION, AND IMAGING 17471213 US September 10, 2021 Allowed  11,302,032 April 12, 2022
System and method for automatic correction of electrical connectivity mismatches of a mask layout block, maintaining the process design rules (DRC Clean), connectivity (LVS Clean) correctness, obeying Reliability Verification (RV) and DFM (Design formanufacturability) constraints 63248550 US September 27, 2021 Pending N/A N/A
System and method for Automatic Generation of Integrated Circuits IP (Intellectual property) Layout Blocks 63249150 US September 28, 2021 Pending N/A N/A
Artificial Intelligence Controlled, SKIP ZONE FREE, HF Radio Communication System and Method 63257199 US October 19, 2021 Pending N/A N/A
CONSOLIDATED CREDIT CARDS, AUTOMATED BILLING SYSTEMS, AND FINANCIAL TECHNOLOGIES FOR IMPROVED CREDIT CARD ACCOUNT OPERATIONS 17584427 US January 26, 2022 Pending N/A N/A
SYSTEMS AND METHODS OF WIRELESS COMMUNICATION USING ARTIFICIAL INTELLIGENCE TO OVERCOME SKIP ZONES 17686461 US March 4, 2022 Pending N/A N/A
SYSTEMS AND METHODS OF REAL-TIME MOVEMENT, POSITION DETECTION, AND IMAGING 17694384 US March 14, 2022 Pending  N/A N/A
SYSTEMS AND METHODS OF IMPROVED ADVERTISING USING SYMBOLS AS CHARACTER INTERFACE 17723658 US April 19, 2022 Pending N/A N/A
SYSTEMS AND METHODS OF WIRELESS COMMUNICATION USING ARTIFICIAL INTELLIGENCE TO OVERCOME SKIP ZONES 17736114 US May 4, 2022 Pending N/A N/A
MULTI-DIMENSIONAL INTEGRATED CIRCUITS AND MEMORY STRUCTURE FOR INTEGRATED CIRCUITS AND ASSOCIATED SYSTEMS AND METHODS 17876981 US July 29, 2022 Pending N/A N/A
Multi-Planar, IC Prediction System 63393959 US July 31, 2022 Pending N/A N/A
SYSTEMS AND METHODS OF ELIMINATING CONNECTIVITY MISMATCHES IN A MASK LAYOUT BLOCK 17880055 US August 3, 2022 Pending  N/A N/A
SYSTEMS AND METHODS OF AUTOMATIC GENERATION OF INTEGRATED CIRCUIT IP BLOCKS 17953378   September 27, 2022 Pending N/A N/A
SYSTEMS AND METHODS OF PREDICTIVE MANUFACTURING OF THREE-DIMENSIONAL, MULTI-PLANAR SEMICONDUCTORS 18098140 US January 18, 2023 Pending N/A N/A
MULTI-DIMENSIONAL PHOTONIC INTEGRATED CIRCUITS AND MEMORY STRUCTURE FOR PHOTONIC INTEGRATED CIRCUITS AND ASSOCIATED SYSTEMS AND METHODS 18109291 US February 14, 2023 Pending N/A N/A
SYSTEMS AND METHODS OF ELIMINATING CONNECTIVITY MISMATCHES IN A MASK LAYOUT BLOCK 18110644 US February 16, 2023 Pending N/A N/A

 

19

 

Trademarks

 

Mark App. No. Country Filing Date Status / Deadline Goods/Services/Classes Reg. No. / Reg. Date
GOPHERINSIDE 86/681,308 US July 1, 2015 Abandoned Microchips, in Class 9 N/A
GOPHERINSIGHT 86/737,146 US August 26, 2015 Abandoned Chip carriers, etc., in Class 9 N/A
FRIENDINME 86/755,543 US September 14, 2015 Abandoned Software from mobile phones, etc., in Class 9 N/A
GOPHERNET 86/811,422 US November 5, 2015 Abandoned Communications software for connecting microchips, etc., in Class 9 N/A
GOPHERANTITHEFT 86/855,191 US December 21, 2015 Abandoned Microchips, in Class 9 N/A
GOPHERSKYNET 86/858,936 US December 28, 2015 Abandoned Microchips, in Class 9 N/A
PUZPIX 87/12,1137 US July 29, 2016 Registered Game software, etc., in Class 9 5,356,006 / December 12, 2017
GOPH GOPHER PROTOCOL (and Design) 87/927,131 US May 18, 2018 Abandoned Software for mobile phones, microchips, etc., in Class 9 N/A
G-MONEY 88/132,574 US September 26, 2018 Abandoned Providing digital currency or digital token, in Class 36 N/A
G-CASH 88/132,592 US September 26, 2018 Abandoned Providing digital currency or digital token, in Class 36 N/A

 

Employees

 

As of December 31, 2022, we had 4 full time employees and 1 part time employees. We also utilize outside consultants and contractors as needed.

 

Clients and Customers

 

Sales for both the years ended December 31, 2022 and 2021 were $1,152,555 and $0. The Consulting income from related party for both the years ended December 31, 2022 and 2021 was $45,000 and $180,000. Sales are derived from providing IT consulting services to a related party and sales from amazon and Ebay.

 

20

 

  

On February 18, 2022, the “Company, effective March 1, 2022 entered into RSA with Mahaser LTD. (“MAHASER”) pursuant to which the Company acquired the opportunity to share in revenues generated by MAHASER with respect to e-commerce sales through the world biggest online retail platform in the United States of America. MAHASER owns an e-commerce platform as a store which is the legal, exclusive owner of Ravenholm Electronics. The Company will operate the e-commerce platform and will be entitled to 95% for all revenue generated by and received by MAHASER for the from March 1, 2022 through December 31, 2022. The RSA provides the Company will be entitled to appoint a manager to MAHASER. As consideration, the Company will pay MAHASER $100,000 on March 1, 2022 and issue MAHASER 1,000,000 shares of the Company’s restricted common stock. The Company shall have no obligations to make any further payments to MAHASER. For any further extensions, the Company will have the option to extend the RSA for annual payment of $200,000, which can be payable with the Company’s shares of common stock payable based on 20 days VWAP prior to issuance On March 16, 2022 the parties entered into Amendment No. 1 to the to the RSA, where all consideration to be paid or issued to MAHASER will be deferred until such time where the e-commerce platform generated in cumulative revenue of $1,000,000. On March 31, 2022, the parties entered into Amendment No. 2 to the RSA, where Mahaser agreed to pay the Company 100% per year for all revenue generated by and received by seller from the sales by Amazon within the United States of America as follows from March 1, 2022 through December 31, 2022. The Company will be responsible for 100% of the cost of goods sold as well. In addition, the Company is entitled to earn 100% revenues and cost of goods sold of the test run period from February 1, 2022 to February 28, 2022.

 

On May 17, 2022, Mahaser LLC (“Assignee”) entered into an assignment and assumption of lease agreement by and between 2819 Coldwater LLC (“Assignor”), Sunset Place Holdings LLC (“Lessor”) and Yossi Attia (“Guarantor”). Pursuant to the agreement, Lessor agreed to lease to Assignor certain Standard Industrial/Commercial Multi-Tenant Lease – Gross agreement dated February 7, 2022 (the “Lease”) and expiring on January 31, 2024, which premises commonly known as 8265 Sunset Boulevard, Suite #107, West Hollywood, CA 90046. The base rent payment shall equal $4,100 per month and share of common area operating expense shall equal $200 per month. Guarantor has guaranteed payment of Assignor’s obligations under the Lease and Assignor assigned all of its right, title and interest in the Lease to Assignee and Assignee assumed Assignor’s obligations under the Lease.

 

On February 22, 2022, the Company entered into an Intellectual Property License and Royalty Agreement with Touchpoint Group Holdings, Inc. (“Touchpoint” or “TGHI”) pursuant to which the Company granted TGHI a worldwide license for its technologies for five years in the domains of Internet of Things (IoT) and Artificial Intelligence enabled mobile technologies pertaining to the Company’s digital currency technology (the “Technology”). GBT will charge TGHI royalties based on actual uses by TGHI of the Technology resulting from revenue attributable to the use, performance or other exploitation of the Technology, to the extent applicable, after deducting any taxes that the Company may be required to collect, and deducting any international sales, goods and services, value added taxes or similar taxes which the Company is required to pay, if any, excluding deductions for taxes on the Company net income. TGHI agreed to issue the Company 10,000,000 shares of common stock of TGHI in the FV of $50,000 as a onetime fee for the Company entering this Intellectual Property License and Royalty Agreement, which was booked contract liabilities and amortized over the five-year term. The Company has yet to earn any royalty income in relation to this agreement as of December 31, 2022. The contract liabilities as of December 31, 2022 and 2021 was $41,444 and $0, respectively.

 

ITEM 1A. RISK FACTORS

 

As a Smaller Reporting Company, the Company is not required to include the disclosure under this Item 1A. Risk Factors. Despite the fact that we are not required to provide risk factors, we consider the following factors to be risks to our continued growth and development:

 

21

 

 

WE HAVE A LIMITED OPERATING HISTORY IN AN EVOLVING INDUSTRY, WHICH MAKES IT DIFFICULT TO EVALUATE OUR FUTURE PROSPECTS AND MAY INCREASE THE RISK THAT WE WILL NOT BE SUCCESSFUL.

 

We have a limited operating history in an evolving industry that may not develop as expected. Assessing our business and future prospects is challenging in light of the risks and difficulties we may encounter. These risks and difficulties include our ability to:

 

  accurately forecast our revenues and plan our operating expenses;

 

  successfully expand our business;

 

  assimilate our acquisitions;

 

  adapt to rapidly evolving trends in the ways consumers and businesses interact with technology;

 

  avoid interruptions or disruptions in the offering of our products and our services;

 

  develop a scalable, high-performance technology infrastructure that can efficiently and reliably handle increased usage, as well as the deployment of new features and products;

 

  hire, integrate and retain talented sales, customer service, technology and other personnel; and

 

  effectively manage rapid growth in personnel and operations; and

 

  global COVID-19 pandemic

 

If the demand for our services and/or platforms/products offered or our products under development are not finalized, our business will be harmed. We may not be able to successfully address these risks and difficulties, which could harm our business and results of operations.

 

OUR LIMITED OPERATING HISTORY MAKES IT DIFFICULT FOR US TO EVALUATE OUR FUTURE BUSINESS PROSPECTS AND MAKE DECISIONS BASED ON THOSE ESTIMATES OF OUR FUTURE PERFORMANCE.

 

We have a limited operating history and, as a consequence, it is difficult, if not impossible, to forecast our future results based upon our historical data. Reliance on the historical results may not be representative of the results we will achieve. Because of the uncertainties related to our limited historical operations, we may be hindered in our ability to anticipate and timely adapt to increases or decreases in revenues or expenses. If we make poor budgetary decisions as a result of unreliable historical data, we could be less profitable or continue to incur losses.

 

22

 

 THE COVID-19 OUTBREAK HAS CAUSED DISRUPTIONS IN OUR DEVELOPMENT OPERATIONS, WHICH HAVE RESULTED IN DELAYS ON EXISTING PROJECTS AND MAY HAVE ADDITIONAL NEGATIVE IMPACTS ON OUR OPERATIONS

 

The Company operates in a high-tech marketplace and relies on professionals and partnerships all over the world, which is impacted by the global pandemic, causing the Company’s resources to be affected. Our business operations have been and may continue to be materially and adversely affected by the coronavirus disease COVID-19.

 

An outbreak of respiratory illness caused by COVID-19 emerged in Wuhan city, Hubei province, PRC, in late 2019 and expanded globally. COVID-19 is considered to be highly contagious and poses a serious public health threat.

 

On March 19, 2020, California Governor Gavin Newsom issued a stay-at-home order to protect the health and well-being of all Californians and to establish consistency across the state in order to slow the spread of COVID-19. California was therefore under strict quarantine control and travel has been severely restricted, resulting in disruptions to work, communications, and access to files (due to limited access to facilities). Since then, other measures have been imposed in other countries and major cities in the USA, including Los Angeles, and throughout the world in an effort to contain the COVID-19 outbreak. The World Health Organization (the “WHO”) is closely monitoring and evaluating the situation. On March 11, 2020, the WHO declared the outbreak of COVID-19 a pandemic, expanding its assessment of the threat beyond the global health emergency it had announced in January. Any outbreak of such epidemic illness or other adverse public health developments in the USA or elsewhere in the world may materially and adversely affect the global economy, our markets and our business. The stay-at-home order was lifted in California on January 25, 2021, and as such we were able to relocate our virtual offices space and resume “normal” operations.

 

In the first quarter of 2020, the COVID-19 outbreak caused disruptions in our development operations, which resulted in delays on exiting projects. The State of California and the economy in general has begun to slowly re-open following the introduction of the COVID-19 vaccine. During the fourth quarter of 2021, the omicron variants surfaced and has significantly impacted the United States and globally. However, in the event COVID-19, the omicron variant or other variant is to worsen or again surface any further unforeseen delay in our operations of the development, delivery and assembly process within any of our activities could continue to result in, increased costs and reduced revenue.

 

We cannot foresee whether the outbreak of COVID-19 and its variants will continue to be effectively contained. If the outbreak of COVID-19 is not effectively and timely controlled, our business operations and financial condition may be materially and adversely affected as a result of the deteriorating market outlook for sales, the slowdown in regional and national economic growth, weakened liquidity and financial condition of our customers and vendors or other factors that we cannot foresee. Any of these factors and other factors beyond our control could have an adverse effect on the overall business environment, cause uncertainties, cause our business to suffer in ways that we cannot predict and materially and adversely impact our business, financial condition and results of operations.

 

OUR RESULTS OF OPERATIONS HAVE NOT RESULTED IN PROFITABILITY AND WE MAY NOT BE ABLE TO ACHIEVE PROFITABILITY GOING FORWARD

 

The Company does not accrue or capitalize development costs (or any costs to this effect) and expense it to its profit and loss statements as required by US GAAP. As such, the Company incurred a net income of $5,323,856 for the year ended December 31, 2022 and net loss of $33,930,433 for the year ended December 31, 2021. If we incur additional significant operating losses, our stock price, may decline, perhaps significantly. Our management is developing plans to alleviate the negative trends and conditions described above. Our business plan is speculative and unproven. There is no assurance that we will be successful in executing our business plan or that even if we successfully implement our business plan, that we will be able to curtail our losses now or in the future. Further, as we are an emerging enterprise, we expect that net losses will continue, and our working capital deficiency will increase.

 

23

 

WE HAVE NOT GENERATED POSITIVE CASH FLOW FROM OPERATIONS, AND OUR ABILITY TO GENERATE POSITIVE CASH FLOW IS UNCERTAIN. IF WE ARE UNABLE TO GENERATE POSITIVE CASH FLOW OR OBTAIN SUFFICIENT CAPITAL WHEN NEEDED, OUR BUSINESS AND FUTURE PROSPECTS WILL BE ADVERSELY AFFECTED AND WE COULD BE FORCED TO SUSPEND OR DISCONTINUE OPERATIONS.

 

Our operations have not generated positive cash flow for any period since our inception, and we have funded our operations primarily through the issuance of common stock and short-term and long-term debt and convertible debt. Our limited operating history makes an evaluation of our future prospects difficult. The actual amount of funds that we will need to meet our operating needs will be determined by a number of factors, many of which are beyond our control. These factors include the timing and volume of sales transactions, the success of our marketing strategy, market acceptance of our products, the success of our manufacturing and research and development efforts (including any unanticipated delays), our manufacturing and labor costs, the costs associated with obtaining and enforcing our intellectual property rights, regulatory changes, competition, technological developments in the market, evolving industry standards and the amount of working capital investments we are required to make.

 

Our ability to continue to operate until we are able to generate sufficient our cash flow from operations will depend on our ability to generate sufficient positive cash flow from our operations. If we are unable to generate sufficient cash flow from our operations, our business and future prospects will be adversely affected and we could be forced to suspend or discontinue operations.

 

The Company sustained net income of $5,323,856 and our operating activities used in cash flows of $138,293 for the year ended December 31, 2022. The Company had a working capital deficit of $18,522,046, stockholders’ deficit of $18,830,909 and an accumulated deficit of $299,257,917 at December 31, 2022.

 

WE WILL REQUIRE ADDITIONAL CAPITAL TO SUPPORT BUSINESS GROWTH, AND THIS CAPITAL MIGHT NOT BE AVAILABLE ON ACCEPTABLE TERMS, IF AT ALL.

 

We intend to continue to make investments to support our business growth and we will require additional funds to respond to business challenges, including the need to develop new features and products or enhance our existing products, improve our operating infrastructure or acquire complementary businesses and technologies. Further, we need additional capital to continue operations. Accordingly, we need to engage in equity or debt financings to secure additional funds. We expect that we have sufficient capital to maintain operations through the year of 2023. In order to fully implement our business plan, we will need to raise about $10,000,000 If we raise additional funds through future issuances of equity or convertible debt securities, our existing stockholders could suffer significant dilution, and any new equity securities we issue could have rights, preferences and privileges superior to those of holders of our common stock. Any debt financing that we secure in the future could involve restrictive covenants relating to our capital raising activities and other financial and operational matters, which may make it more difficult for us to obtain additional capital and to pursue business opportunities, including potential acquisitions. We may not be able to obtain additional financing on terms favorable to us, if at all. If we are unable to obtain adequate financing or financing on terms satisfactory to us when we require it, our ability to continue to support our business growth and to respond to business challenges could be impaired, and our business may be harmed.

 

On December 17, 2021 (the “Effective Date”), the “Company entered into an equity financing agreement (the “Equity Financing Agreement”) and a registration rights agreement (the “Registration Rights Agreement”) with GHS Investments LLC (“GHS”), pursuant to which GHS may purchase from the Company, up to that number of shares of common stock of the Company (the “Shares”) for $10,000,000, subject to certain limitations and conditions set forth in the Equity Financing Agreement from time to time over the course of 24 months after an effective registration of the Shares with the Securities and Exchange Commission (the “SEC”) pursuant to the Registration Rights Agreement, is declared effective by the SEC (the “Contract Period”). The Equity Financing Agreement grants the Company the right, from time to time at its sole discretion (subject to certain conditions) during the Contract Period, to direct GHS to purchase shares of Common Stock on any business day (a “Put”), provided that at least ten trading days has passed since the most recent Put. The purchase price of the shares of Common Stock contained in a Put will be 90% of the lowest daily volume weighted average price (VWAP) of the Company’s Common Stock during the ten consecutive trading days preceding the receipt by GHS of the applicable Put notice. Such sales of Common Stock by the Company, if any, may occur from time to time, at the Company’s option, during the Contract Period. Subject to the satisfaction of certain conditions set forth in the Equity Financing Agreement, on each Put the Company will deliver a number of Shares equaling 110% of the dollar amount of each Put. The maximum dollar amount of each Put will not exceed 200% of the average daily trading dollar volume for the Company’s Common Stock during the 10 trading days preceding the Trading Day that GHS receives a Put. No Put will be made in an amount equaling less than $10,000 or greater than $500,000. Puts are further limited to GHS owning no more than 4.99% of the outstanding stock of the Company at any given time. The Equity Financing Agreement and the Registration Rights Agreement contain customary representations, obligations, rights, warranties, agreements and conditions of the parties. The Equity Financing Agreement terminates upon any of the following events: when GHS has purchased $10,000,000 in the Common Stock of the Company pursuant to the Equity Financing Agreement; on the date that is 24 calendar months from the date the Equity Financing Agreement was executed. Actual sales of shares of Common Stock to GHS under the Equity Financing Agreement will depend on a variety of factors to be determined by the Company from time to time, including, among others, market conditions, the trading price of the Common Stock and determinations by the Company as to the appropriate sources of funding for the Company and its operations. On January 12, 2022, the Company filed registration statement for the sale of 5,500,000 shares of common stock pursuant to the Equity Financing Agreement, which was declared effective on February 11, 2022. The Company issued 463,303 shares with net proceeds of $66,942 from the Equity Financing Agreement in February 2022.

 

For year ended December 31, 2022, the Company received $231,867 as proceeds from the equity purchase agreement for issuance of 5,500,000 registered common shares. Post this issuance The Equity Financing Agreement is exhausted and not valid anymore.

24

 

WE DEPEND UPON KEY PERSONNEL AND NEED ADDITIONAL PERSONNEL

 

Our success depends on our inability to attract and retain key personnel including Michael Murray, our President, Mansour Khatib, our CEO, and Dr. Danny Rittman, our CTO, and our inability to do so may materially and adversely affect our business operations. The loss of qualified personnel could have a material and adverse effect on our business operations. Additionally, the success of the Company’s operations will largely depend upon its ability to successfully attract and maintain competent and qualified key management personnel. As with any company with limited resources, there can be no guaranty that the Company will be able to attract such individuals or that the presence of such individuals will necessarily translate into profitability for the Company.

 

OUR BUSINESS REQUIRES SUBSTANTIAL CAPITAL, AND IF WE ARE UNABLE TO MAINTAIN ADEQUATE CASH FLOWS FROM OPERATIONS OUR PROFITABILITY AND FINANCIAL CONDITION WILL SUFFER AND JEOPARDIZE OUR ABILITY TO CONTINUE OPERATIONS

 

We require substantial capital to support our operations. If we are unable to generate adequate cash flows from our operations, maintain adequate financing or other sources of capital are not available, we could be forced to suspend, curtail or reduce our operations, which could harm our revenues, profitability, financial condition and business prospects.

 

THERE IS CURRENTLY A LIMITED PUBLIC MARKET FOR OUR COMMON STOCK. FAILURE TO FURTHER DEVELOP OR MAINTAIN A TRADING MARKET COULD NEGATIVELY AFFECT THE VALUE OF OUR COMMON STOCK AND MAKE IT DIFFICULT OR IMPOSSIBLE FOR YOU TO SELL YOUR STOCK.

 

There is a limited public market for our Common Stock, which is traded on the OTC PINK under the symbol GTCH. We cannot give any assurances that there will ever be a mature, developed market for our common stock. Failure to further develop or maintain an active trading market could negatively affect the value of our shares and make it difficult for you to sell your shares or recover any part of your investment in us. Even if a market for our common stock does develop in a material way, the market price of our common stock may be highly volatile. In addition to the uncertainties relating to our future operating performance and the profitability of our operations, factors such as variations in our interim financial results, or various, as yet unpredictable factors, many of which are beyond our control, may have a negative effect on the market price of our common stock.

 

IF WE FAIL TO MAINTAIN AN EFFECTIVE SYSTEM OF INTERNAL CONTROLS, WE MAY NOT BE ABLE TO ACCURATELY REPORT OUR FINANCIAL RESULTS OR PREVENT FRAUD. AS A RESULT, CURRENT AND POTENTIAL STOCKHOLDERS COULD LOSE CONFIDENCE IN OUR FINANCIAL REPORTING, WHICH WOULD HARM OUR BUSINESS AND THE TRADING PRICE OF OUR STOCK.

 

Effective internal controls are necessary for us to provide reliable financial reports and effectively prevent fraud. If we cannot provide reliable financial reports or prevent fraud, our brand and operating results could be harmed. We have in the past discovered, and may in the future discover, areas of our internal controls that need improvement. For example, for the years ended December 31, 2022 and 2021, we reported that our disclosure controls and procedures were not effective due to the lack of resources and the reliance on outside consultants. We intend to increase management’s review of our financials. We cannot be certain that these measures will ensure that we implement and maintain adequate controls over our financial processes and reporting in the future. Any failure to implement required new or improved controls, or difficulties encountered in their implementation, could harm our operating results or cause us to fail to meet our reporting obligations. Inferior internal controls could also cause investors to lose confidence in our reported financial information, which could have a negative effect on the trading price of our stock.

 

Additional Risks Related to Our Common Stock

 

Because we are quoted on the OTC PINK marketplace instead of a national securities exchange, our investors may experience significant volatility in the market price of our stock and have difficulty selling their shares.

 

Our Common Stock is currently quoted on the OTC Market Group’s OTC PINK marketplace under the ticker symbol “GTCH”. The OTC is a regulated quotation service that displays real-time quotes and last sale prices in over-the-counter securities. Trading in shares quoted on the OTC PINK is often thin and characterized by volatility. This volatility may be caused by a variety of factors, including the lack of readily available price quotations, the absence of consistent administrative supervision of bid and ask quotations, lower trading volume and market conditions. As a result, there may be wide fluctuations in the market price of the shares of our Common Stock for reasons unrelated to operating performance, and this volatility, when it occurs, may have a negative effect on the market price for our securities. Moreover, the OTC PINK is not a stock exchange, and trading of securities on this platform is more sporadic than the trading of securities listed on a national quotation system or stock exchange. Accordingly, our stockholders may not be able to realize a fair price from their shares when they determine to sell them or may have to hold them for a substantial period of time until the market for our Common Stock improves.

 

25

 

Our stock price and trading volume may be volatile, which could result in substantial losses for our stockholders.

 

The equity trading markets may experience periods of volatility, which could result in highly variable and unpredictable pricing of equity securities. The market price of our Common Stock could change in ways that may or may not be related to our business, our industry or our operating performance and financial condition. In addition, the trading volume in our Common Stock has been low and may fluctuate and cause significant price variations to occur. We have experienced significant volatility in the price of our stock. In addition, the stock markets in general can experience considerable price and volume fluctuations.

 

We have not paid dividends in the past and have no immediate plans to pay cash dividends.

 

We plan to reinvest all of our earnings, to the extent we have earnings, to develop and deliver our products and cover operating costs and to otherwise become and remain competitive. We do not plan to pay any cash dividends with respect to our securities in the foreseeable future. We cannot assure you that we would, at any time, generate sufficient surplus cash that would be available for distribution to the holders of our Common Stock as a dividend. Therefore, you should not expect to receive cash dividends on our Common Stock.

 

Shares eligible for future sale may adversely affect the market for our Common Stock.

 

Of the 2,930,101,819 shares of our Common Stock outstanding as of the date of this Annual Report, approximately 766,217,939 are restricted and 2,163,883,880 shares are freely tradable without restriction pursuant to Rule 144. Any substantial sale of our Common Stock pursuant to Rule 144 or pursuant to any resale prospectus may have a material adverse effect on the market price of our Common Stock.

 

You may experience future dilution as a result of future equity offerings.

 

To raise additional capital, we may in the future offer additional shares of our Common Stock or other securities convertible into or exchangeable for our Common Stock at prices that may not be the same as the price per share in this offering. We may sell shares or other securities in any future offering at a price per share that is lower than the price per share paid by investors in this offering, which would result in those newly issued shares being dilutive. In addition, investors purchasing shares or other securities in the future could have rights superior to existing stockholders, which could impair the value of your shares. The price per share at which we sell additional shares of our Common Stock, or securities convertible or exchangeable into shares of our Common Stock, in future transactions may be higher or lower than the price per share paid by investors in this offering.

 

Our charter documents and Nevada law may inhibit a takeover that stockholders consider favorable.

 

Provisions of our certificate of incorporation and bylaws and applicable provisions of Nevada law may delay or discourage transactions involving an actual or potential change in control or change in our management, including transactions in which stockholders might otherwise receive a premium for their shares, or transactions that our stockholders might otherwise deem to be in their best interests. The provisions in our certificate of incorporation and bylaws:

 

  limit who may call stockholder meetings;

 

  do not provide for cumulative voting rights; and

 

  provide that all vacancies may be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum.

 

There are limitations on director/officer liability.

 

As permitted by Nevada law, our certificate of incorporation limits the liability of our directors for monetary damages for breach of a director’s fiduciary duty except for liability in certain instances. As a result of our charter provision and Nevada law, shareholders may have limited rights to recover against directors for breach of fiduciary duty. In addition, our certificate of incorporation provides that we shall indemnify our directors and officers to the fullest extent permitted by law.

 

26

 

 

Penny stock regulations may impose certain restrictions on marketability of our securities.

 

The SEC adopted regulations which generally define a “penny stock” to be any equity security that has a market price of less than $5 per share or an exercise price of less than $5 per share, subject to certain exceptions. A security listed on a national securities exchange is exempt from the definition of a penny stock. Our Common Stock is not currently listed on a national security exchange. Our Common Stock is therefore subject to rules that impose additional sales practice requirements on broker-dealers who sell such securities to persons other than established customers and accredited investors (generally those with assets in excess of $1,000,000 or annual income exceeding $200,000, or $300,000 together with their spouse). For transactions covered by such rules, the broker-dealer must make a special suitability determination for the purchase of such securities and have received the purchaser’s written consent to the transaction prior to the purchase.

 

Additionally, for any transaction involving a penny stock, unless exempt, the rules require the delivery, prior to the transaction, of a risk disclosure document mandated by the SEC relating to the penny stock market. The broker-dealer must also disclose the commission payable to both the broker-dealer and the registered representative, current quotations for the securities and, if the broker-dealer is the sole market maker, the broker dealer must disclose this fact and the broker-dealer’s presumed control over the market. Finally, monthly statements must be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stocks. Broker-dealers must wait two business days after providing buyers with disclosure materials regarding a security before effecting a transaction in such security. Consequently, the “penny stock” rules restrict the ability of broker-dealers to sell our securities and affect the ability of investors to sell our securities in the secondary market and the price at which such purchasers can sell any such securities, thereby affecting the liquidity of the market for our Common Stock.

 

Stockholders should also be aware that, according to the SEC, the market for penny stocks has suffered in recent years from patterns of fraud and abuse. Such patterns include:

 

  control of the market for the security by one or more broker-dealers that are often related to the promoter or issuer;

 

  manipulation of prices through prearranged matching of purchases and sales and false and misleading press releases;

 

  “boiler room” practices involving high pressure sales tactics and unrealistic price projections by inexperienced sales persons;

 

  excessive and undisclosed bid-ask differentials and markups by selling broker-dealers; and

 

  the wholesale dumping of the same securities by promoters and broker-dealers after prices have been manipulated to a desired level, along with the inevitable collapse of those prices with consequent investor losses.

 

FINRA sales practice requirements may limit a stockholder’s ability to buy and sell our stock.

 

The Financial Industry Regulatory Authority (referred to as FINRA) has rules requiring that, in recommending an investment to a customer, a broker-dealer must have reasonable grounds for believing that the investment is suitable for that customer. Prior to recommending speculative or low-priced securities to their non-institutional customers, broker-dealers must make reasonable efforts to obtain information about the customer’s financial status, tax status, investment objectives and other information. Under interpretations of these rules, FINRA has indicated its belief that there is a high probability that speculative or low-priced securities will not be suitable for at least some customers. If these FINRA requirements are applicable to us or our securities, they may make it more difficult for broker-dealers to recommend that at least some of their customers buy our Common Stock, which may limit the ability of our stockholders to buy and sell our common stock and could have an adverse effect on the market for and price of our common stock.

 

27

 

  

ITEM 1B. UNRESOLVED STAFF COMMENTS

 

As a Smaller Reporting Company, the Company is not required to include the disclosure under this Item 1B. Unresolved Staff Comments. At this time, there are no unresolved staff comments.

 

ITEM 2. PROPERTIES

 

The Company leases its virtual office space at 2450 Colorado Ave., Suite 100E, Santa Monica, CA 90404 on a month-to-month lease for $311 per month.

 

Assignment of lease agreement

 

On May 17, 2022, Mahaser LLC (“Assignee”) entered into an assignment and assumption of lease agreement by and between 2819 Coldwater LLC (“Assignor”), Sunset Place Holdings LLC (“Lessor”) and Yossi Attia (“Guarantor”). Pursuant to the agreement, Lessor agreed to lease to Assignor certain Standard Industrial/Commercial Multi-Tenant Lease – Gross agreement dated February 7, 2022 (the “Lease”) and expiring on January 31, 2024, which premises commonly known as 8265 Sunset Boulevard, Suite #107, West Hollywood, CA 90046. The base rent payment shall equal $4,100 per month and share of common area operating expense shall equal $200 per month. Guarantor has guaranteed payment of Assignor’s obligations under the Lease and Assignor assigned all of its right, title and interest in the Lease to Assignee and Assignee assumed Assignor’s obligations under the Lease.

 

ITEM 3. LEGAL PROCEEDINGS

 

Legal Proceedings

 

From time to time, the Company may be involved in various litigation matters, which arise in the ordinary course of business. There is currently no litigation that management believes will have a material impact on the financial position of the Company.

 

28

 

 

On or around January 30, 2019, RWJ Advanced Marketing, LLC, Greg Bauer, and Warren Jackson sued the Company and multiple third and related parties in Superior Court of the State of California – County of Los Angeles, General District in connection with the acquisition of UGO in September 2017. The case number is 19STCV03320 (the “Original Lawsuit”). The complaint in the Original Lawsuit alleges breach of contract, among other causes of action. The Company answered the complaint and filed a cross-complaint against the plaintiffs in the case and third parties on or around February 15, 2019. On or about September 10, 2020, the Company through its agent of service was “served” with a complaint (the Company contested service) that was filed against the Company and third parties by Robert Warren Jackson and Gregory Bauer in Los Angeles Superior Court Case No.: 20STCV32709 (“Second Lawsuit”). In the Original Lawsuit filed, the court rejected the plaintiff’s claims that they were filing a purported quasi-derivative lawsuit. As such, in this current litigation, the plaintiff is now again claiming the action is a derivative lawsuit. On October 13, 2020, the Second Lawsuit was removed by other defendants into Central District of California (CASE NO. 2:20−cv−09399−RGK−AGR). On February 2, 2021 the Central District of California dismissed the entire Second Lawsuit based on “demand futility”. In the Original lawsuit, the Company filed a cross complaint against the plaintiff and other third parties. The court has scheduled various hearings and a trial date set for December 27, 2021 which was later continued by the Court to September 28, 2022. It was the Company’s intention to dividend its holdings of its wholly owned subsidiary Ugopherservices Corp. (“UGO”). As UGO is the main dispute in the litigations described above, the Company elected to sell UGO to a third-party effective July 1, 2020 (See Note 17). On September 17, 2020, the Company terminated Greg Bauer as consultant (resulting from the sale of UGO), which he confirmed in writing. On or about June 14, 2021 the Company stipulated with plaintiff that all third parties will be released and plaintiff may file a new first amendment complaint that will name only the Company. As such, all third parties other than prior transfer agent of the Company have been dismissed from this litigation. The Company is in default on this note.

 

Following the sale of UGO, the Company noticed third parties (including SURG, via its asset manager) to wire the UGO funds to its new bank account. SURG never answered the notice. SURG is the clearing house for UGO. The Company noticed certain third parties that it intends to take legal actions to resolve this issue. On November 12, 2020 the Company filed a complaint in the United States District Court – District of Nevada – Case 2:20-cv-02078 against RWJ, Mr. Bauer, Mr. Jackson and against W.L. Petrey Wholesale Company Inc for fraud, breach of contract, Unjust Enrichment and other claims. On January 28, 2022 the court awarded the Company an injunction against RWJ defendants, where all fee funds generating from resale should be deposited into GBT blocked account, and therefore RWJ Defendants cannot use these funds without court order.

 

The Company entered into the Confidential Settlement Agreement and Mutual Release (“RJW Agreement”) by and between RWJ Advanced Marketing, LLC, Robert Warren Jackson, Gregory Bauer (collectively the “RJW Parties”) and W.L. Petrey Wholesale Company, Inc., (“Petrey”) on one hand; and GBT Technologies Inc., on behalf of itself and its agents (collectively the GBT Parties”), on the other hand. The Company the RJW Agreement effective September 26, 2022 with final signatures delivered to the Company on or about October 5, 2022. Pursuant to the RJW Agreement, the parties have agreed to settle, release, and otherwise resolve all known or unknown claims between them and agreed to jointly stipulate, move, or otherwise dismiss the lawsuits filed in the United States District Court of Nevada (Case No. 2:20-cv- 02078), in the Superior Court of the State of California, County of Los Angeles, Central District (Case Nos. 19STCV03320 and 20STCV32709), and in the United States District Court of the Central District of California (Case No. 2:20-cv-09399-RGK-AGR) with prejudice. The parties agreed and stipulated to release all funds currently being held in a blocked account of $19,809 with 50% distributed to the RWJ Parties and 50% distributed the Company or its assignee. The Parties also entered into the InComm Assignment Agreement (“IAA”) which assigned, transferred and conveyed all proceeds derived from the RWJ Parties’ agreements with Interactive Communications International, Inc., and its affiliate Hi Technology Corp., including but not limited to that Master Distribution and Service Agreement between Interactive Communications International, Inc. and Petrey d/b/a UGO-HUB dated August 29, 2016, as amended (collectively referred to as the “InComm Proceeds”), and which shall divide the InComm Proceeds 90% to the Company or its assignee and 10% to the RWJ Parties or their assignee. Finally, the Company agreed to pay $40,000 to the RWJ Parties or their assignee. The Company accrued $49,847 expenses represent the final amounts due to the RJW Parties.

 

The Company under a different settlement agreement with SURG, committed to assign the IAA. As such, on October 5, 2022 and as cumulation of all settlement agreements the Company issued a request to SURG regarding release of certain escrow funds and the execution of an assignment of rights as contemplated in the afore referenced agreement.

 

29

 

On December 3, 2018, the Company entered into a Securities Purchase Agreement (the “SPA”) with Discover Growth Fund, LLC (the “Investor”) pursuant to which the Company issued a Senior Secured Redeemable Convertible Debenture (the “Debenture”) of $8,340,000. In connection with the issuance of the Debenture and pursuant to the terms of the SPA, the Company issued a Common Stock Purchase Warrant to acquire up to 225,000 shares of common stock for three years (the “Warrant”) on a cash-only basis at an exercise price of $100 per share with respect to 50,000 Warrant Shares, $75 with respect to 75,000 Warrant Shares and $50 with respect to 100,000 Warrant Shares. The holder may not exercise any portion of the Warrants to the extent that the holder would own more than 4.99% of the Company’s outstanding common stock immediately after exercise. The outstanding principal amount may be converted at any time into shares of the Company’s common stock at a conversion price equal to 95% of the Market Price less $5 (the conversion price is lowered by 10% upon the occurrence of each Triggering Event – the current conversion price is 75% of the Market Price less $5). The Market Price is the average of the 5 lowest individual daily volume weighted average prices during the period the Debenture is outstanding.

 

On May 28, 2019, the Investor delivered to the Company a “Notice of Default and Notice of Sale of Collateral” (the “Notice”). On December 23, 2019, in arbitration between the Company and the Investor, an Interim Award was entered in favor of the Investor. On January 31, 2020, the Company was informed that a final award was entered (the “Final Award”). The Final Award affirms that certain sections of the Debenture constitute unenforceable liquidated damages penalties and were stricken. Further, it was determined that the Investor was entitled to recovery of their attorney’s fees. Consequently, the arbitrator awarded Investor $4,034,444 plus interest of 7.25% accrued from May 15, 2019 and costs fee of $55,613.

 

On February 18, 2020, the Company filed a motion with the United States District Court District of Nevada (the “Nevada Court”) to confirm the Final Award and a motion to consolidate Investor’s application to confirm the Final Award filed in the U.S. District Court of the Virgin Islands (Case No: 3 :20-cv-00012-CVG-RM) (the “Virgin Island Court”). On February 27, 2020, the Nevada Court denied the Company’s motion to confirm the Final Award and motion to consolidate and further decided that the confirmation of the Final Award should be litigated in the Virgin Island Court. As such, on February 27, 2020, the Company filed a Notice of Entry of Order as well as a Motion to Confirm the Arbitration Award, address the outstanding issues regarding whether Investor’s rights are subordinated to other creditors and, thereafter, oversee a commercially reasonable foreclosure sale (Case No: 3 :20-cv-00012-CVG-RM). It was the Company’s position that the Final Award must first be confirmed and all questions regarding the rights of Investor relative to those of other creditors must be determined before any foreclosure sale can proceed. It is further the position of the Company that the previously disclosed foreclosure sale scheduled by Investor is being conducted in a commercially unreasonable manner and that if Discover proceeded forward with the foreclosure sale it did so at its own risk. Nevertheless, on February 28, 2020, Investor advised that it conducted a sale of the Company’s assets. As the date of this report Investor failed to present a deed of sale for the alleged sale that allegedly took place as noticed. The Company filed with Virgin Island Court the motions disputing the validity of the alleged sale. On July 28, 2020, Investor filed in the State of Nevada a motion for attorney’s fees $48,844 and costs $716. The Company filed an answer on August 11, 2020.

 

On October 16, 2020, Investor motion for attorney’s fees $48,844 and costs $716 was denied. This case is still pending with the Federal court and the Court has not taken any substantive action in the matter as of the date of this report.

 

GBT Technologies, S.A.

 

On September 14, 2018, the Company entered into an Exclusive Intellectual Property License and Royalty Agreement (the “GBT License Agreement”) with GBT-CR, a fully compliant and regulated crypto currency exchange platform that currently operates in Costa Rica as a decentralized crypto currency platform, pursuant to which, among other things, the Company granted to GBT-CR an exclusive, royalty-bearing right and license relating intellectual property relating to systems and methods of converting electronic transmissions into digital currency as reflected in that certain patent filed with the United Stated Patent and Trademark Office on or about June 14, 2018 (EFS ID: 32893586; Application Number: 16008069; Type: Utility under 35 USC 111(a); Confirmation Number: 6787)(collectively, the “Digital Currently Technology”). Pursuant to the GBT License Agreement, the Company granted GBT-CR an exclusive worldwide license to use the Digital Currency Technology to make, use, sell, lease or otherwise commercialize and dispose of products and devices utilizing the Digital Currently Technology. Under the terms of the GBT License Agreement, the Company is entitled to receive a royalty payment of 2% of gross revenue of each licensed product sold by GBT-CR during the period starting in which revenue is first generated using the licensed products and continuing for five years thereafter. Upon signing the GBT-CR License Agreement, GBT-CR paid the Company $300,000 which is nonrefundable. The Company has recognized the $300,000 as revenue during the years ended December 31, 2018. Upon GBT-CR making available for sale (the “Commercial Event”) an ICO (Initial Coin Offering) (the “Coin”), GBT-CR will make a payment to the Company of $5,000,000. Further, upon the Commercial Event, GBT-CR will grant the Company the ability to acquire 30% of the Coin at a 30% discount of such offering price of the Coin. The GBT License Agreement commenced as of the signing date and, unless terminated in accordance with the termination provisions of the GBT License Agreement, shall remain in force until the expiration of the patent pertaining to the Digital Currency Technology; provided that the right to use trade, secrets shall survive the expiration of the GBT License Agreement provided the Company has not terminated. Prior to the signing of the GBT License Agreement, GBT-CR advanced $200,000 to the Company, which the parties have agreed will be applied toward the $5,000,000 fee when it becomes due. On February 27, 2020 GBT Technologies, S.A., as successor in interest to Hermes Roll, LLC notified the Company that it was in default on its Amended and Restated Territorial License Agreement (“ARTLA”) dated June 15, 2015 and that the ARTLA had been cancelled and rescinded.

30

 

  

In connection with SURG Exchange Agreement – On November 4, 2020, Altcorp and Stanley filed an Ex Parte Motion in the District Court, Clark County, Nevada (Case No: A-20-823039-B, in Dep No: 43) to appoint receiver and issue a temporary restraining Order against SURG and its transfer agent for alleged defaults on prior exchange agreement. On December 4, 2020, the parties entered an interim agreement which set the material terms of a settlement. A final settlement was achieved per the interim agreement terms on January 1, 2021. On March 4, 2021, the Company filed a motion to enforce the settlement agreements, as the Company alleged that SURG owes an additional $240,000 which was due and owing under the settlement agreements. On June 24, 2021, per the June 23, 2020 Agreement, the Company together with AltCorp sent SURG and its transfer agent via registered mail, a true-up shares demand for an additional 14,870,370 SURG shares as calculated per the Agreement. Subsequently, SURG was a party to two lawsuits in state District Court, the Eighth Judicial District Court for Clark County, Nevada involving AltCorp, Stanley and Glen Eagles Acquisition LP (the “AltCorp Parties.”). Each of these lawsuits were ultimately disputes relating to the total consideration SURG was to pay the Company under the APA. On October 18, 2021, the AltCorp Parties, the Company, and SURG entered into a Memorandum of Understanding (the “MOU”) to set up a framework for an attempt to settle the two lawsuits.

 

On December 22, 2021 (the “Effective Date”), pursuant to the framework in the MOU, the AltCorp Parties (and an additional third party), the Company, ECS, and SURG, Kevin Brian Cox (SURG’s Chief Executive Officer) – in his individual capacity, entered into a Resolution of Purchase, Mutual Release, and Settlement Agreement (the “Final Settlement Agreement”) to settle the two lawsuits and resolve all disputes related to the consideration paid by SURG to the Company in connection with the APA. Full and complete payment under the Final Settlement Agreement was received on or about January 7, 2022 and a stipulation and order for dismissal was filed dismissing the action on or about February 1, 2022.

 

On or about July 9, 2021 the Company filed a lawsuit in District Court in Clack County Nevada – Department 19 (Case number A-21-837631-C) against Terry Taylor and TTSG Holdings, Inc for breach of contract, breach of covenant of Good Faith and Fair Dealing, Unjust Enrichment and declaratory relief for failure of providing consulting services per contract they entered. The Company is demanding the return of 240,000 shares issued, return of the $5,000 payments, recission of the consulting agreement, and attorney’s fees and costs. As Terry Taylor and TTSG Holdings failed to appear to a notice of deposition, the Company filed for a summary judgment. On January 20, 2023 the court issued a $708,821 writ of execution against Terry Taylor and TTSG

 

On or about February 2, 2022, GBT was served with a First Amended Complaint (the “Complaint”) initiated by Gregory Mancuso and Rainer AG, a Swiss corporation, Case No. 21SMCV01430, filed in the Superior Court of the State of California for the County of Los Angeles. The Complaint names a number of different parties, including GBT, and asserts, among other things, claims for conversion, unjust enrichment, breach of contract, and breach of implied covenant of fair dealing, which Plaintiffs allege arise out of a brokerage agreement entered into between Plaintiff Rainer AG and co-defendant Consul Group re Dos Mil Veintiuno S.R.L (“Consul”). GBT was sued under an alter ego theory of liability, and its only involvement in the above-referenced chain of events seems to be that its shares were deposited with Rainer by Consul upon the opening of the brokerage account. GBT’s responsive pleading is due on March 17, 2022. GBT will be filling a demurrer to the First Amended Complaint based on a variety of deficiencies with the First Amended Complaint, and will ask the Court to dismiss the claims against GBT.

 

Stock Loan Receivable

 

On January 8, 2019, the Company entered into a Stock Pledge Agreement with Latin American Exchange Latinex Casa de Cambio, S.A., a Costa Rica corporation (“Latinex”), to provide that Latinex may maintain its required regulatory capital as required by various regulators. The Company pledged 4,006 restricted shares of its common stock valued at $7,610,147 (based on the closing price on the grant date) for three years for an annual payment of $375,000 paid in quarterly installments of $93,750. In lieu of cash payment, Latinex may pay the Company in virtual currency of WISE Network S.A. valued at a 50% discount of its offering price of $10 per token. In the event that Latinex’s required capital has decreased below $5,000,000, Latinex is permitted to sell the pledged shares of common stock only in an amount to ensure that Latinex can satisfy the required capital levels. The Company must consent to such sale of the shares of common stock, which may not be unreasonably withheld. Upon expiration of the agreement, the remaining shares of common stock shall be returned to the Company free and clear of all liens. The Company recorded the value of these shares of common stock as a stock loan receivable which is presented as a contra-equity account in the accompanying consolidated balance sheets. At December 31, 2019, the Company wrote off the accrued interest income as Latinex did not perform any payment and the Company has no mean to enforce this payment. Latinex agreed in principle to return the pledged 4,006 restricted shares to the Company for cancellation. The 4,006 restricted shares have not yet been returned to the Company as of December 31, 2022.

 

ITEM 4. MINE SAFERY DISCLOSURES

 

Not applicable.

31

 

  

PART II

 

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.

 

The Company is authorized to issue 10,000,000,000 of its $0.00001 par value common stock and 20,000,000 shares of its $0.00001 par value preferred stock Series B and 10,000 shares of its $0.00001 par value preferred stock Series C, 100,000 shares of its $0.00001 par value preferred Series D shares, 2,000,000 of its $0.00001 par value preferred Series G shares and 40,000 of its $0.00001 par value preferred Series H shares. As of December 31, 2022, 1,535,593,440 shares of common stock, as well as 45,000 shares of preferred stock Series B, 700 shares of preferred stock Series C, zero shares of preferred stock Series D, zero shares of preferred stock Series G and 20,000 shares of preferred stock Series H were issued and outstanding. The Board of Directors reserves the right to issue shares of preferred stock in the future indicating preference or rights as appropriate.

 

Market Information

 

Our common stock commenced quotation on the OTC PINK under the symbol “GTCH”. The Company’s subsequent symbol was “GOPH”. The following table sets forth the range of high and low prices per share of our common stock for each period indicated (after given effect to reverse split of 1 for 100 split in 2019 and 1 for 50 in 2021)

 

Quarters Ended  Mar 31  Jun 30  Sep 30  Dec 31
                         
   High  Low  High  Low  High  Low  High  Low
                                          
2022   $0.350   $0.107   $0.114   $0.002   $0.007   $0.001   $0.002   $0.001 
2021   $5.00   $0.75   $1.70   $0.75   $0.90   $0.35   $0.40   $0.09 

 

Record Holders

 

The number of holders of record for our common stock as of December 31, 2022 was 92.

 

Dividends

 

The Company has not yet adopted any policy regarding payment of dividends. No cash dividends have been paid or declared since the Date of Inception.

 

Securities Authorized for Issuance Under Equity Compensation Plans

 

We presently do not have equity compensation plans authorized.

32

 

Transfer agent change

 

The Company transfer agent is Nevada Agency and Transfer Company (“NATCO”) with a business address at 50 West Liberty Street, Suite 880, Reno NV 89501; NATCO’s website is www.natco.com, and their phone number is (775) 322-0626.

 

Penny Stock

 

Our common stock is considered “penny stock” under the rules of the SEC under the Securities Exchange Act of 1934. The SEC adopted rules that regulate broker-dealer practices in connection with transactions in penny stocks. Penny stocks are generally equity securities with a price of less than $5, other than securities registered on certain national securities exchanges or quoted on the NASDAQ Stock Market System, provided that current price and volume information with respect to transactions in such securities is provided by the exchange or quotation system. The penny stock rules require a broker-dealer, prior to a transaction in a penny stock, to deliver a standardized risk disclosure document prepared by the Commission, that:

 

contains a description of the nature and level of risks in the market for penny stocks in both public offerings and secondary trading;

 

contains a description of the broker’s or dealer’s duties to the customer and of the rights and remedies available to the customer with respect to a violation to such duties or other requirements of Securities’ laws; contains a brief, clear, narrative description of a dealer market, including bid and ask prices for penny stocks and the significance of the spread between the bid and ask price;

 

contains a toll-free telephone number for inquiries on disciplinary actions;
   
defines significant terms in the disclosure document or in the conduct of trading in penny stocks; and

 

contains such other information and is in such form, including language, type, size and format, as the Commission shall require by rule or regulation.

 

The broker-dealer also must provide, prior to effecting any transaction in a penny stock, the customer with:

 

bid and offer quotations for the penny stock;

 

the compensation of the broker-dealer and its salesperson in the transaction;

 

the number of shares to which such bid and ask prices apply, or other comparable information relating to the depth and liquidity of the marker for such stock; and

 

monthly account statements showing the market value of each penny stock held in the customer’s account.

 

33

 

In addition, the penny stock rules that require that prior to a transaction in a penny stock not otherwise exempt from those rules; the broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser’s written acknowledgement of the receipt of a risk disclosure statement, a written agreement to transactions involving penny stocks, and a signed and dated copy of a written suitably statement.

 

These disclosure requirements may have the effect of reducing the trading activity in the secondary market for our stock.

 

Recent Issuances of Unregistered Securities

 

For the year ended December 31, 2022, the Company issued 222,091,971 shares of Company common stock upon the conversion of the convertible promissory note and accrued interest to 1800 Diagonal Lending.

 

For the year ended December 31, 2022, the Company issued 150,000,000 shares of Company common stock to GBT Tokenize for joint venture agreement between Magic International Argentina FC, S.L. The value of the shares of $1,500 was determined based on the FV of the Company’s common stock.

 

For the year ended December 31, 2022, the Company issued 5,500,000 shares of Company common stock to GHS from the Equity Financing Agreement for gross consideration of $231,868, The value of the shares of was determined based on the Equity Financing.

 

For the year ended December 31, 2022, the Company issued 500,000,000 shares of Company common stock to Metaverse for certain equity method investment. The value of the shares of $5,000 was determined based on the FV of the Company’s common stock.

 

For the year ended December 31, 2022, the Company issued 8,580,434 shares of Company common stock upon the conversion of the convertible promissory note and accrued interest to Stanley Hills.

 

For the year ended December 31, 2022, the Company issued 26,343,190 shares of Company common stock upon the conversion of the convertible promissory note and accrued interest to Redstart.

 

For the year ended December 31, 2022, the Company issued 590,117,647 shares of Company common stock upon the conversion of the convertible promissory note and accrued interest to IGOR Corp.

34

 

We claimed exemption from registration under the Securities Act for the sales and issuances of these securities under Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder, in that such sales and issuances did not involve a public offering. All of the purchasers of unregistered securities for which we relied on Section 4(a)(2) and/or Regulation D represented that they were accredited investors as defined under the Securities Act. We claimed such exemption on the basis that (a) the purchasers in each case represented that they intended to acquire the securities for investment only and not with a view to the distribution thereof and that they either received adequate information about the registrant or had access, through employment or other relationships, to such information and (b) appropriate legends were affixed to the stock certificates issued in such transactions.

 

ITEM 6. RESERVED

 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

 

The following discussion should be read in conjunction with our financial statements and related notes included elsewhere in this report. In addition to historical information, this discussion includes forward-looking information that involves risks and assumptions, which could cause actual results to differ materially from management’s expectations. See “Forward-Looking Statements” included in this report.

 

Forward-Looking Statements

 

This Annual Report on Form 10-K/A contains forward looking statements, including without limitation, statements related to our plans, strategies, objectives, expectations, intentions and adequacy of resources. Investors are cautioned that such forward-looking statements involve risks and uncertainties including without limitation the following: (i) our plans, strategies, objectives, expectations and intentions are subject to change at any time at our discretion; (ii) our plans and results of operations will be affected by our ability to manage growth; and (iii) other risks and uncertainties indicated from time to time in our filings with the Securities and Exchange Commission.

 

In some cases, you can identify forward-looking statements by terminology such as “may,’’ ‘‘will,’’ ‘‘should,’’ ‘‘could,’’ ‘‘expects,’’ ‘‘plans,’’ ‘‘intends,’’ ‘‘anticipates,’’ ‘‘believes,’’ ‘‘estimates,’’ ‘‘predicts,’’ ‘‘potential,’’ or ‘‘continue’’ or the negative of such terms or other comparable terminology. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. We are under no duty to update any of the forward-looking statements after the date of this Report.

 

This section of the report should be read together with Footnotes of the Company audited financials. The audited statements of operations for the years ended December 31, 2022 and 2021 are compared in the sections below.

 

35

 

  

General Overview

 

GBT Technologies Inc. (formerly Gopher Protocol Inc.) (the “Company”, “GBT”, or “GTCH”) was incorporated on July 22, 2009 under the laws of the State of Nevada. The Company is targeting growing markets such as development of Internet of Things (IoT) and Artificial Intelligence (AI) enabled networking and tracking technologies, including wireless mesh network technology platform and fixed solutions, development of an intelligent human body vitals device, asset-tracking IoT, and wireless mesh networks, with an AI portfolio. The Company derived revenues from (i) the provision of IT consulting services; and (ii) from selling electronic products through e-commerce platforms like Amazon and eBay.

 

Recent Developments

 

Due to litigation with Discover Fund, in April 2020, GBT was forced to make the decision of changing the Company’s direction by developing a portfolio of intellectual property within the area of microchips technology and design. The years 2019 and 2020 were compounded with recuring legal issues and COVID-19 restrictions creating extremely difficult times and challenges. GBT focused on its core competency in the area of Research & Development (“R&D”) creating an IP portfolio combined of patents, trade secrets and prototypes further defining GBT’s new mission. GBT is now developing IP in areas which will leverage its competencies and experience with the goal of diversifying in various fast-growing semiconductor industries in today’s leading, growing market segments.

 

GBT currently holds 10 patents and has 25 submissions within in the following domains: tracking, 3-D Microchip Design (semiconductors), EDA Software Tools and subsets with, cyber security, ID, telehealth, AI, computer vision, IoT, mesh networks and sectors which it believes are in demand. The Company has been delivering a steady stream of new IPs for portfolio expansion developing new ideas and successful patents, over the past two years.

 

Going forward, GBT will focus on expanding the families of various patents and concentrating on strategic potential partnerships with the goal of integrating these technologies into a broad marketplace, one that will potentially diversify the risk within these areas:

 

1.Build a portfolio pipeline of IP related to microchip technology.

 

2.Seek to actively introduce this new technology to strategic partners, large companies and VC’s creating market opportunities.

 

3.Using market diversification to create access to new fields and future growth.

 

GBT Tokenize Joint Venture

 

On March 6, 2020, the Company through Greenwich, entered into a Joint Venture and Territorial License Agreement (the “Tokenize Agreement”) with Tokenize-It, S.A. (“Tokenize”), which is owned by a Costa Rica Trust represented by Pablo Gonzalez (“Gonzalez”). Gonzalez also represents Gonzalez Costa Rica Trust, which holds a note in the principal amount of $10,000,000 and is also a shareholder of the Company. Under the Tokenize Agreement, the parties formed GBT Tokenize Corp., a Nevada corporation (“GBT Tokenize”). The purpose of GBT Tokenize is to develop, maintain and support source codes for its proprietary technologies including advanced mobile chip technologies, tracking, radio technologies, AI core engine, electronic design automation, mesh, games, data storage, networking, IT services, business process outsourcing development services, customer service, technical support and quality assurance for business, customizable and dedicated inbound and outbound calls solutions, as well as digital communications processing for enterprises and startups (“Technology Portfolio”), throughout the State of California. Upon generating any revenue from the Technology Portfolio, the Joint Venture will earn the first right of refusal for other territories. The Company pledged its 50% ownership in GBT Tokenize and its 100% ownership of Greenwich to Tokenize to secure its Technology Portfolio investment. The Company shall appoint two directors and Tokenize shall appoint one director of GBT Tokenize. Tokenize shall contribute the services and resources for the development of the Technology Portfolio to GBT Tokenize. The Company shall contribute 2,000,000 shares of common stock of the Company (“GBT Shares”) to GBT Tokenize. Tokenize and the Company will each own 50% of GBT Tokenize. The shares were valued at $5,500,000.

 

36

 

  

In addition, GBT Tokenize and Gonzalez entered into a Consulting Agreement in which Gonzalez is engaged to provide services for $33,333 per month payable quarterly which may be paid in shares of common stock calculated by the amount owed divided by the Company’s 10-day VWAP. Gonzalez will provide services in connection with the development of the business as well as GBT Tokenize’s capital raising efforts. The term of the Consulting Agreement is two years. During year ended December 31, 2021, Gonzalez assigned all his accrued balances of $424,731 to Stanley Hills in a private transaction that the Company is not part to. The closing of the Tokenize Agreement occurred on March 9, 2020.

 

Through this Joint Venture the parties commenced development of an intelligent human vital signs’ device, which we currently refer to as the qTerm. The platform is an expansion of the existing license agreement with GBT Tokenize Corp., which provided GBT Tokenize Corp. with an exclusive territory of California to develop certain of the Company’s technology. As the nature of the platform cannot be restricted only to California, the Company’s joint venture GBT Tokenize Corp. will be compensated with additional two hundred million shares of the Company to strengthen its funding, subject to board approval. A provisional patent application for the qTerm Medical Device was filed on March 30, 2020 with the USPTO. The application has been assigned serial number 63001564. The Joint Venture completed successfully the first prototype. There is no guarantee that the Company will be successful in researching, developing or implementing this product into the market. In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed and granted regulatory approval, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps.

 

On May 28, 2021, the parties agreed to amend the Tokenize Agreement to expand territory granted for the Technology Portfolio under the license to GBT Tokenize to include the entire continental United States. The Company has further agreed to issue GBT Tokenize an additional 14,000,000 shares of common stock of the Company. The shares were valued at $15,400,000. At December 31, 2021, the Company evaluated the carrying amount of this joint venture investment and determined that this investment was fully impaired and as a result an impairment charge of $15,400,000 was taken. Although the investment was impaired, the product development is still ongoing.

 

Magic Agreement

 

As explained above, on April 11, 2022 the Company, through its wholly owned subsidiary, Greenwich International Holdings, a Costa Rica corporation (“Greenwich”), entered into a Master Joint Venture and Territorial License Agreement (the “Tokenize Agreement”) with Magic International Argentina FC, S.L. (“Magic”) and Tokenize which replaced a prior joint venture entered between the parties.

 

The purpose of Tokenize is to develop, maintain and support source codes for its proprietary technologies including advanced mobile chip technologies, tracking, radio technologies, AI core engine, electronic design automation, mesh, games, data storage, networking, IT services, business process outsourcing development services, customer service, technical support and quality assurance for business, customizable and dedicated inbound and outbound calls solutions, as well as digital communications processing for enterprises and startups (“Technology Portfolio”), throughout the world, which Technology Portfolio was previously licensed to the Company for the State of California.

 

The Tokenize Agreement provides that the Company shall contribute 150,000,000 shares of common stock of the Company (“GBT Shares”) to Tokenize. Sergio Fridman is the manager of Magic and the beneficial owner of all outstanding securities of Magic. Magic will contribute cash of $250,000 into Tokenize for a promissory note and agreed to further fund Tokenize with all funds reasonably needed for implementation of the business purposes as described in the Tokenize Agreement. The GBT Shares will not be transferable for a period of five years.

 

Magic and the Company each own 50% of the outstanding shares of common stock of Tokenize. The Company pledged its 50% ownership in Tokenize and its 100% ownership of Greenwich (the “Pledged Securities”) to Magic for providing that Magic may take possession of such Pledged Securities in the event the Company executes, delivers and performs any future agreement or document or judgement resulting in the creation of any lien, pledge, mortgage, claim, charge or encumbrance upon any assets of the Company. The Company shall appoint two directors and Magic shall appoint one director of Tokenize.

 

37

 

  

On June 16, 2022 the parties amended the Tokenize Agreement to further define the constitution of the Board of Directors. As such, Section 4.2 of the Tokenize Agreement was amended and restated to provide that the Board of GBT Tokenize Corp. shall consist of two Directors, one of whom shall be appointed by GBT Tokenize Corp. and the other shall be appointed by the Company

 

MetAlert (prior name) GTX Agreement

 

On April 12, 2022, GBT Tokenize Corp (“GBT Tokenize”), a Nevada corporation which the Company owns 50% of the outstanding shares of common stock, entered into a series of agreements with GTX Corp (“GTX”) and various note holders of GTX pursuant to which Tokenize acquire convertible promissory notes of GTX of $100,000 (the “GTX Notes”). In addition, GBT Tokenize acquired 76,923 (GBT acquired 5,000,000 in the original deal, where GTX to perform a corporate action of 1:65 reverse split on September 20, 2022) shares of common stock of GTX for $150,000 - in total FV of $12,538 as of December 31, 2022 based on level 1 stock price in OTC markets.

 

The GTX Notes bear 10% interest and 50% of the principal may be converted into shares of common stock on a one-time basis at a conversion price of $0.01 per share. The remaining 50% of the principal must be paid in cash. The closing occurred on April 12, 2022.

 

GTX changed its name into MetAlert Inc. on or about September 20, 2022.

 

On September 30, 2022, GBT Tokenize, loaned MetAlert Inc., a Nevada corporation (f/k/a GTX Corp.) (“MetAlert”) $90,000. For such loan, MetAlert provided Tokenize with a promissory note of $90,000 which is due and payable together with interest of 5% upon the earlier of September 19, 2023 or when declared by Tokenize.

 

Surge Payment

 

On January 7, 2022, the Company received payments from Surgepays Inc. (formerly known as Surge Holdings, Inc.) in total of $3,750,000 pursuant to the terms of the Settlement Agreement dated December 22, 2021. The $3,750,000 was recorded as other receivable as of December 31, 2021. The entire balance of $3,750,000 was paid in January 2022.

 

On January 28, 2022, the Company entered into a Stock Purchase Agreement with Marko Radisic (the “Seller”) and Touchpoint pursuant to which the Company acquired 10,000 shares of Series A Convertible Preferred Stock (the “Touchpoint Preferred”) from the Seller for $125,000. The Touchpoint Preferred is convertible into 10,000,000 shares of common stock of Touchpoint. On or about February 23, 2022 Touchpoint perform automatic conversion of Series A Convertible Preferred Stock into 10,000,000 shares of common stock of TGHI.

 

On February 18, 2022, the Company, effective March 1, 2022 entered into a Revenue RSA with MAHASER pursuant to which the Company acquired the opportunity to share in revenues generated by MAHASER with respect to e-commerce sales through the world biggest online retail platform in the United States of America. MAHASER owns an e-commerce platform as a store which is the legal, exclusive owner of Ravenholm Electronics. The Company will operate the e-commerce platform and will be entitled to 95% for all revenue generated by and received by MAHASER for the period from March 1, 2022 through December 31, 2022. The RSA provides that the Company will be entitled to appoint a manager to MAHASER. As consideration, the Company will pay MAHASER $100,000 no later than March 1, 2022 and issue MAHASER 1,000,000 shares of the Company’s restricted common stock. The Company shall have no obligations to make any further payments to MAHASER. For any further extensions, the Company will have the option to extend the RSA for annual payment of $200,000, which can be payable with the Company’s shares of common stock payable based on 20 days VWAP prior to issuance. On March 16, 2022 the parties entered into Amendment No. 1 to the to the RSA, where all consideration to be paid or issued to MAHASER will be deferred until such time where the e-commerce platform generated in cumulative revenue of $1,000,000. The Company accounts for the RSA as a consolidated variable interest entity (“VIE”) for the period ended June 30, 2022. On March 31, 2022, the parties entered into Amendment No. 2 to the RSA, where Mahaser agreed to pay the Company 100% per year for all revenue generated by and received by seller from the sales by Amazon within the United States of America as follows for the period from March 1, 2022 through December 31, 2022. The Company will be responsible for 100% of the cost of goods sold as well. In addition, the Company is entitled to earn 100% revenues and cost of goods sold of the test run period from February 1, 2022 to February 28, 2022.

 

38

 

  

On February 22, 2022, the Company entered into an Intellectual Property License and Royalty Agreement with Touchpoint pursuant to which the Company granted TGHI a worldwide license for its technologies for a term of five years in the domains of Internet of Things (IoT) and Artificial Intelligence enabled mobile technologies pertaining to the Company’s digital currency technology (the “Technology”). GBT will charge TGHI earned royalties based on actual uses by TGHI of the Technology resulting from revenue attributable to the use, performance or other exploitation of the Technology, to the extent applicable, after deducting any taxes that the Company may be required to collect, and deducting any international sales, goods and services, value added taxes or similar taxes which the Company is required to pay, if any, excluding deductions for taxes on the Company net income. TGHI agreed to issue the Company 10,000,000 shares of common stock of TGHI for the Company entering this Intellectual Property License and Royalty Agreement.

 

Equity Purchase Agreement and Registration Rights Agreement

 

On December 17, 2021 (the “Effective Date”), the Company entered into an equity financing agreement (the “Equity Financing Agreement”) and a registration rights agreement (the “Registration Rights Agreement”) with GHS Investments LLC (“GHS”), pursuant to which GHS shall purchase from the Company, up to that number of shares of common stock of the Company (the “Shares”) for $10,000,000, subject to certain limitations and conditions set forth in the Equity Financing Agreement from time to time over of 24 months after an effective registration of the Shares with the Securities and Exchange Commission (the “SEC”) pursuant to the Registration Rights Agreement, is declared effective by the SEC (the “Contract Period”).

 

The Equity Financing Agreement grants the Company the right, from time to time at its sole discretion (subject to certain conditions) during the Contract Period, to direct GHS to purchase shares of Common Stock on any business day (a “Put”), provided that at least ten trading days has passed since the most recent Put. The purchase price of the shares of Common Stock contained in a Put will be 90% of the lowest daily volume weighted average price (VWAP) of the Company’s Common Stock during the ten consecutive trading days preceding the receipt by GHS of the applicable Put notice. Such sales of Common Stock by the Company, if any, may occur from time to time, at the Company’s option, during the Contract Period. Subject to the satisfaction of certain conditions set forth in the Equity Financing Agreement, on each Put the Company will deliver a number of Shares equaling 110% of the dollar amount of each Put. The maximum dollar amount of each Put will not exceed 200% of the average daily trading dollar volume for the Company’s Common Stock during the ten trading days preceding the Trading Day that GHS receives a Put. No Put will be made in an amount equaling less than $10,000 or greater than $500,000. Puts are further limited to GHS owning no more than 4.99% of the outstanding stock of the Company at any given time. The Equity Financing Agreement and the Registration Rights Agreement contain customary representations, obligations, rights, warranties, agreements and conditions of the parties. The Equity Financing Agreement terminates upon any of the following events: when GHS has purchased $10,000,000 in the Common Stock of the Company pursuant to the Equity Financing Agreement; on the date that is 24 calendar months from the date the Equity Financing Agreement was executed.

 

Actual sales of shares of Common Stock to GHS under the Equity Financing Agreement will depend on a variety of factors to be determined by the Company from time to time, including, among others, market conditions, the trading price of the Common Stock and determinations by the Company as to the appropriate sources of funding for the Company and its operations. The Company issued 463,303 shares with net proceeds of $66,942 from the Equity Financing Agreement in February 2022.

 

COVID-19 Pandemic

 

The Company operates in a high-tech marketplace and relies on professionals and partnerships all over the world, which is impacted by the global pandemic, causing the Company’s resources to be affected. Our business operations have been and may continue to be materially and adversely affected by the coronavirus disease COVID-19.

 

An outbreak of respiratory illness caused by COVID-19 emerged in Wuhan city, Hubei province, PRC, in late 2019 and has been expanding globally. COVID-19 is considered to be highly contagious and poses a serious public health threat.

 

39

 

On March 19, 2020, California Governor Gavin Newsom issued a stay-at-home order to protect the health and well-being of all Californians and to establish consistency across the state in order to slow the spread of COVID-19. California was therefore under strict quarantine control and travel has been severely restricted, resulting in disruptions to work, communications, and access to files (due to limited access to facilities). Since then, other measures were imposed in other countries and major cities in the USA, including Los Angeles, and throughout the world in an effort to contain the COVID-19 outbreak. The World Health Organization (the “WHO”) is closely monitoring and evaluating the situation. On March 11, 2020, the WHO declared the outbreak of COVID-19 a pandemic, expanding its assessment of the threat beyond the global health emergency it had announced in January. Any outbreak of such epidemic illness or other adverse public health developments in the USA or elsewhere in the world may materially and adversely affect the global economy, our markets and our business. The stay-at-home order was lifted in California only on January 25, 2021.

 

In the first quarter of 2020, the COVID-19 outbreak has caused disruptions in our development operations, which have resulted in delays on exiting projects. A prolonged disruption or any further unforeseen delay in our operations of the development, delivery and assembly process within any of our activities could continue to result in, increased costs and reduced revenue.

 

We cannot foresee whether the outbreak of COVID-19 will be effectively contained, nor can we predict the severity and duration of its impact. If the outbreak of COVID-19 is not effectively and timely controlled, our business operations and financial condition may be materially and adversely affected as a result of the deteriorating market outlook for sales, the slowdown in regional and national economic growth, weakened liquidity and financial condition of our customers and vendors or other factors that we cannot foresee. Any of these factors and other factors beyond our control could have an adverse effect on the overall business environment, cause uncertainties, cause our business to suffer in ways that we cannot predict and materially and adversely impact our business, financial condition and results of operations.

 

Risks and Uncertainties

 

Management is currently evaluating the impact of the COVID-19 pandemic on the Company and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these financial statements.

 

40

 

 

Consideration of Inflation Reduction Act Excise Tax

 

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.

 

Results of Operations:

 

Years ended December 31, 2022 and 2021

 

A comparison of the statements of operations for the year ended December 31, 2022 and 2021 is as follows:

 

   Years Ended December 31,  Change
   2022  2021  $  %
             
Sales  $1,152,555       $1,152,555    100%
Consulting income - related party   45,000    180,000    (135,000)   (300%)
Total Sales   1,197,555    180,000    1,017,555    85%
Cost of sales   817,754        817,754    100%
Gross Profit   379,801    180,000    199,801    53%
Operating                    
expenses   3,178,160    18,655,514    (15,477,354)   (487%)
Loss (income) from operations   2,798,359    18,475,514    15,677,155    (560%)
Other expense (income), net   (8,122,215)   15,454,919    23,577,134    290%
Loss (income) before provision for income taxes   (5,323,856)   33,930,433    39,254,289    737%
Provision for income taxes                
Loss (income) from continued operations   (5,323,856)   33,930,433    39,254,289    737%
                     
Discontinued operations                 
Net loss (income)  $(5,323,856)  $33,930,433   $39,254,289    737%

 

41

 

Sales for both the years ended December 31, 2022 and 2021 were $1,152,555 and $0. The Consulting income from related party for both the years ended December 31, 2022 and 2021 was $45,000 and $180,000. Sales are derived from providing IT consulting services to a related party and sales from amazon and Ebay.

 

Operating expenses for the year ended December 31, 2022 were $3,178,160, compared to $18,655,514 for the same period in 2021. The decrease of $15,477,354 or 487% was principally due to no impairment of assets, decrease in marketing expenses of $477,279, increase in general and administrative expenses of $759,654, and decrease in professional expenses of $309,729 and a gain in bad debt by $50,000 for the year ended December 31, 2022.

 

Other expense for the year ended December 31, 2022 was $8,122,215, an increase of $23,577,134 or 290% from $15,454,919 for the same period in 2021. The increase is principally due to i) a increase of related party licensing income; ii) reduction of amortization of debt discounts by $442,247; iii) reduction of change in FV of derivative liability by $6,594,370; iv) reduction in interest expense and financing costs of $969,629; and v) gain in on RJW settlement of $3,012,355.

 

 Net income for the year ended December 31, 2022 was $5,323,856 compared to the net loss of $33,930,433 for the same period in 2021 due to the factors described above.

 

Liquidity and Capital Resources

 

Going Concern

 

The accompanying CFS have been prepared assuming the Company will continue as a going concern. The Company has an accumulated deficit of $299,257,917 and has a working capital deficit of $18,522,046 as of December 31, 2022, which raises substantial doubt about its ability to continue as a going concern.

 

The Company’s ability to continue as a going concern is dependent upon its ability to generate profitable operations in the future and/or obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management has plans to seek additional capital through some private placement offerings of debt and equity securities. These plans, if successful, will mitigate the factors which raise substantial doubt about the Company’s ability to continue as a going concern. These CFS do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty.

 

Our cash was $106,639 and $155,106 at December 31, 2022 and 2021, respectively. Cash used in operating activities during the year ended December 31, 2022 was $138,293, compared to $1,369,114 during the same period in 2021. The amount used in operating activities for the year ended December 31 2022 was primarily related to a net income of $5,323,856 and offset by amortization of debt discount of $442,247, excess of debt discount and financing costs of $34,175, change in FV of derivative liability of $6,594,370, change in FV of market equity security of $308,802, change on settlement of $3,012,633, and net working capital increase of $9,866,535. Our working capital position changed by going from a working capital deficit of $28,388,581 at December 31, 2021 to a working capital deficit of $18,522,046 at December 31, 2022.

 

The amount used in operating activities for the year ended December 31, 2021 was primarily related to a net loss of $33,930,433 offset by amortization of debt discount of $824,238, excess of debt discount and financing costs of $136,785, change in FV of derivative liability of $1,339,117, loss on modification of debt of $13,777,480, impairment of assets of $15,400,000, realized gain on disposal of market equity security of $11,000, shares issued for services of 281,748, payment of other income with marketable securities of $800,000, and net working capital decrease of $1,612,950.

 

42

 

 

 

Cash flows used in investing activities were $275,000 during the year ended December 31, 2022, compared to $0 for the same period in 2021. The increase is due to the investment in marketable securities during the year ended December 31, 2022.

 

Cash from financing activities for the year ended December 31, 2022 was $364,826, compared to $1,411,186 for the same period in 2021. The increase is due to the issuance of convertible notes in 2022 of $300,000 and proceeds from sales of common stock and related party of 988,094, which is offset by the issuance of notes receivable of $190,000 and repayment of related party of $694,225 and a repayment convertible note of $39,042. Cash from financing activities for the year ended December 31, 2021 was due to the issuance of convertible notes and notes payable in 2021 of $1,517,386 and proceeds from sales of common stock of $106,200.

 

We obtained a net income of $5,323,856 for the year ended December 31, 2022. In addition, we had a working capital deficit of $18,522,046 and accumulated deficit of $299,257,917 at December 31, 2022.

 

Equity Purchase Agreement and Registration Rights Agreement

 

On December 17, 2021 (the “Effective Date”), the Company entered into an equity financing agreement (the “Equity Financing Agreement”) and a registration rights agreement (the “Registration Rights Agreement”) with GHS Investments LLC (“GHS”), pursuant to which GHS shall purchase from the Company, up to that number of shares of common stock of the Company (the “Shares”) for $10,000,000, subject to certain limitations and conditions set forth in the Equity Financing Agreement from time to time over the course of 24 months after an effective registration of the Shares with the Securities and Exchange Commission (the “SEC”) pursuant to the Registration Rights Agreement, is declared effective by the SEC (the “Contract Period”).

 

The Equity Financing Agreement grants the Company the right, from time to time at its sole discretion (subject to certain conditions) during the Contract Period, to direct GHS to purchase shares of Common Stock on any business day (a “Put”), provided that at least ten trading days has passed since the most recent Put. The purchase price of the shares of Common Stock contained in a Put will be 90% of the lowest daily volume weighted average price (VWAP) of the Company’s Common Stock during the ten consecutive trading days preceding the receipt by GHS of the applicable Put notice. Such sales of Common Stock by the Company, if any, may occur from time to time, at the Company’s option, during the Contract Period. Subject to the satisfaction of certain conditions set forth in the Equity Financing Agreement, on each Put the Company will deliver a number of Shares equaling 110% of the dollar amount of each Put. The maximum dollar amount of each Put will not exceed 200% of the average daily trading dollar volume for the Company’s Common Stock during the ten trading days preceding the Trading Day that GHS receives a Put. No Put will be made in an amount equaling less than $10,000 or greater than $500,000. Puts are further limited to GHS owning no more than 4.99% of the outstanding stock of the Company at any given time. The Equity Financing Agreement and the Registration Rights Agreement contain customary representations, obligations, rights, warranties, agreements and conditions of the parties. The Equity Financing Agreement terminates upon any of the following events: when GHS has purchased $10,000,000 in the Common Stock of the Company pursuant to the Equity Financing Agreement; on the date that is 24 calendar months from the date the Equity Financing Agreement was executed.

 

Actual sales of shares of Common Stock to GHS under the Equity Financing Agreement will depend on a variety of factors to be determined by the Company from time to time, including, among others, market conditions, the trading price of the Common Stock and determinations by the Company as to the appropriate sources of funding for the Company and its operations.

 

In September of 2017 we purchased the assets of RWJ Advanced Marketing, LLC, and then after ECS Prepaid LLC, Electronic Check Services, Inc. and Central States Legal Services, Inc. in 2018. RWJ and ECS have historically generated significant revenues which we do not expect to continue in the future, as the Company divested its investment in ECS Prepaid LLC, Electronic Check Services, Inc. and Central States Legal Services, Inc. on or around September 2019, left only with the acquired assets from RWJ Advanced Marketing, LLC which on September 18, 2020, the Company entered into a Purchase and Sale Agreement with Mr. LightHouse LTD., an Israeli corporation (“MLH”) pursuant to which the Company agreed to sell and assign to MLH, effective July 1, 2020 all the shares, and certain specified liabilities, of Ugopherservices Corp., for $100,000 to be paid through the delivery of a promissory note payable to the Company (the “Note”), as disclosed in this report. We intend to continue to make investments to support our business growth and we will require additional funds to respond to business challenges, including the need to develop new features and products or enhance our existing products, improve our operating infrastructure or acquire complementary businesses and technologies. Further, we need additional capital to continue operations. Accordingly, we engaged GHS in equity financings to secure additional funds, as disclosed in this report. We expect that we have sufficient capital to maintain operations through the end of 2023. In order to fully implement our business plan, we will need to raise $10,000,000. The Company will need to raise additional capital in the future of which there is no guarantee that the Company will be able to successfully raise such capital on acceptable terms. With the current cash on hand, cash in our attorney’s trust account and additional cash anticipated to be raised in the future, we believe we will have sufficient cash to meet our obligations for the next 12 months. The Company issued 463,303 shares with net proceeds of $66,942 from the Equity Financing Agreement in February 2022.

43

 

  

$10,000,000 for GBT Technologies S. A. acquisition (assigned to a third-party Igor 1 Corp)

 

In accordance with the acquisition of GBT-CR the Company issued a convertible note of $10,000,000. The convertible note bears interest of 6% and is payable at maturity on December 31, 2022. At the election of the holder, the convertible note can be converted into a maximum of 20,000 shares of Series H Preferred Stock. Each share of Series H Preferred Stock is convertible, at the option of the holder but subject to the Company increasing its authorized shares of common stock, into such number of shares of common stock of the Company as determined by dividing the Stated Value ($500 per share) by the conversion price ($10 per share). On May 19, 2021, the Company, IGOR 1 Corp, and Gonzalez GBTCR (none related parties) entered into a Mutual Release and Settlement Agreement and Irrevocable Assignment of Note Balance Principal and Accrued Interest (the “Gonzalez Agreement”). Pursuant to the Gonzalez Agreement, without any party admission of liability and to avoid litigation, the parties had agreed to (i) extend the GBT Convertible Note maturity date to December 31,2022,(ii) amend the GBT Convertible Note terms to include a beneficial ownership blocker of 4.99% and a modified conversion feature to the GBT Convertible Note with 15% discount to the market price during the 20 trading day period ending on the latest complete trading day prior to the conversion date and (iii) provided for an assignment of the GBT Convertible Note by Gonzalez to a third party. As a result of the change in terms of this convertible note, the Company took a charge for modification of debt of $13,777,480 during the year ended December 31, 2021

 

Glen Eagles Acquisition LP

 

On July 8, 2019, the Company entered a Consulting Agreement with Glen Eagles Acquisition LP (“Glen”) as consultant to provide services in connection with the Company’s acquisition of 25% of GBT Technologies, S.A., a Costa Rican corporation (“GBT-CR”). Consultant will provide analysis, interaction with related professional and other services as requested by the Company to integrate and expand capabilities between GBT-CR and the Company. The Company shall pay Glen $1,000,000 through the issuance of a 6% Convertible Note. At the election of Glen, the Convertible Note can be converted into a maximum of 2,000 shares of Series H Preferred Stock. Each share of Series H Preferred Stock is convertible, at the option of the holder but subject to the Company increasing its authorized shares of common stock, into such number of shares of common stock of the Company as determined by dividing the Stated Value ($500 per share) by the conversion price ($10 per share). The Series H Preferred Stock has no liquidation preference, does not pay dividends and the holder of Series H Preferred Stock shall be entitled to one vote for each share of common stock that the Series H Preferred Stock may be convertible into. In addition, the Company entered into an Amendment of a Common Stock Purchase Warrant held by Glen to acquire nine million shares of common stock that had been assigned to Glen by Guardian Patch LLC. Pursuant to the amendment, the Company agreed to provide that the Common Stock Purchase Warrant may be exercised on a cashless basis and provided a beneficial ownership limitation of 4.99%.

 

On or about June 23, 2020, the Company and AltCorp entered into agreements with SURG and Glen Eagles Acquisition LP (“Glen”) into series of agreements regarding the $4,000,000 SURG Note. Glen converted in full its $1,000,000 convertible note was issued by the Company on July 8, 2019 plus $50,000 of accrued interest, into $1,050,000 of a SURG Note via an assignment of a portion ($1,050,000 of a $4,000,000 face value) of the $4,000,000 SURG Note. In addition, the Company entered into a consulting agreement with Glen for which the Company shall pay to Glen $200,000 via an assignment of a portion ($200,000 of a $4,000,000 face value) of the $4,000,000 SURG Note. Glen in turn converted all its $1,250,000 considerations received into 2,500,000 SURG shares. Per the final settlement agreement with Surge and per allocation of settlement funds agreement, Glen credit balance for the end of 2021 was $662,500 which included $425,000 credit derived from said settlement (which was paid on January 2022), where the open aged credit balance derived from the above, along with cash infusion with Glen as off the date of this report is $512,500. Effective January 2023 the Company agreed with Glen, that the Company will issue Glen a convertible note for it $512,500 entire balance. The convertible note pay interest on the unpaid principal balance hereof at the rate of 10%. Principal and interest on the outstanding balance shall be paid on or prior to December 31, 2023 (the “Maturity Date”). Interest shall be calculated on the basis of a 365-day year and actual days elapsed from the date the balance was created until actual pay-off. In no event shall the interest charged hereunder exceed the maximum permitted under the laws of the State of California. Funding was done or on behalf and order of The Company. The Note has a conversion feature whereby Glen may convert the principal and interest payable hereunder into shares of common stock of the Company at a 15% discount to the market in prior single trade in the last 20 trading days

 

RWJ Acquisition Note

 

In connection with the acquisition of RWJ in September 2017, the Company issued a note. The note accrues interest at 3.5%, was due on December 31, 2019 and was secured by the assets purchased in the acquisition. The Company contests the validity of the note, as such the note has not been repaid. The Company entered into a Confidential Settlement Agreement and Mutual Release (“RJW Agreement”) by and between RWJ Defendants and the Company effective September 26, 2022. Said RJW Agreement voided the RWJ acquisition Note in its entirely. (See ITEM 3. LEGAL PROCEEDINGS)

 

44

 

  

Discover Growth Fund

 

On December 3, 2018, the Company entered into a Securities Purchase Agreement (the “SPA”) with Discover Growth Fund, LLC (the “Investor”) pursuant to which the Company issued a Senior Secured Redeemable Convertible Debenture (the “Debenture”) of $8,340,000. In connection with the issuance of the Debenture and pursuant to the terms of the SPA, the Company issued a Common Stock Purchase Warrant to acquire up to 225,000 shares of common stock for a term of three years (the “Warrant”) on a cash-only basis at an exercise price of $100 per share with respect to 50,000 Warrant Shares, $75 with respect to 75,000 Warrant Shares and $50 with respect to 100,000 Warrant Shares. The holder may not exercise any portion of the Warrants to the extent that the holder would own more than 4.99% of the Company’s outstanding common stock immediately after exercise. The outstanding principal amount may be converted at any time into shares of the Company’s common stock at a conversion price equal to 95% of the Market Price less $5 (the conversion price is lowered by 10% upon the occurrence of each Triggering Event – the current conversion price is 75% of the Market Price less $5). The Market Price is the average of the five lowest individual daily VWAP during the period the Debenture is outstanding.

 

On May 28, 2019, the Investor delivered to the Company a “Notice of Default and Notice of Sale of Collateral” (the “Notice”). On December 23, 2019, in arbitration between the Company and the Investor, an Interim Award was entered in favor of the Investor. On January 31, 2020, the Company was informed that a final award was entered (the “Final Award”). The Final Award affirms that certain sections of the Debenture constitute unenforceable liquidated damages penalties and were stricken. Further, it was determined that the Investor was entitled to recovery of their attorney’s fees. Consequently, the arbitrator awarded $4,034,444 plus interest of 7.25% from May 15, 2019 and costs of $55,613.

 

On February 18, 2020, the Company filed a motion with the United States District Court District of Nevada (the “Nevada Court”) to confirm the Final Award and a motion to consolidate Investor’s application to confirm the Final Award filed in the U.S. District Court of the Virgin Islands (Case No: 3 :20-cv-00012-CVG-RM) (the “Virgin Island Court”). On February 27, 2020, the Nevada Court denied the Company’s motion to confirm the Final Award and motion to consolidate and further decided that the confirmation of the Final Award should be litigated in the Virgin Island Court. As such, on February 27, 2020, the Company filed a Notice of Entry of Order as well as a Motion to Confirm the Arbitration Award, address the outstanding issues regarding whether Investor’s rights are subordinated to other creditors and, thereafter, oversee a commercially reasonable foreclosure sale (Case No: 3 :20-cv-00012-CVG-RM). It was the Company’s position that the final Award must first be confirmed and all questions regarding the rights of Investor relative to those of other creditors must be determined before any foreclosure sale can proceed. It is further the position of the Company that the previously disclosed foreclosure sale scheduled by Investor is being conducted in a commercially unreasonable manner and that if Discover proceeded forward with the foreclosure sale it did so at its own risk. Nevertheless, on February 28, 2020, Investor advised that it conducted a sale of the Company’s assets. As the date of this report Investor failed to present a deed of sale for the alleged sale that allegedly took place as noticed. The Company filed with Virgin Island Court the motions disputing the validity of the alleged sale. On July 28, 2020, Investor filed in the State of Nevada a motion for attorney’s fees $48,844 and cost of $716. The Company filed an answer on August 11, 2020. On October 16, 2020, Investor motion for attorney’s fees $48,844 and cost of $716 was denied. The balance was included in accounts payable for the unearned settlement. As of December 31, 2022, this case is still pending with the Federal court and the Court has not taken any substantive action in the matter as of the date of this report.

 

45

 

  

Redstart Holdings Corp.

 

Paid Off Notes/Converted Notes

 

On August 4, 2020, the Company entered into a Securities Purchase Agreement with Redstart Holdings Corp., an accredited investor (“Redstart”) pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 1”) of $153,600 for $128,000. The Redstart Note No. 1 had a maturity date of November 3, 2021 and the Company agreed to pay interest on the unpaid principal balance of the Redstart Note No. 1 at the rate of 6% from the date on which the Redstart Note No. 1 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 1, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 1. The transactions described above closed on August 5, 2020. The outstanding principal amount of the Redstart Note No. 1 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, Redstart may convert the Redstart Note No. 1 into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 1), the Redstart Note No. 1 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 1. During the year ended December 31, 2021, the entire amount of Note No. 1 of $153,600 plus accrued interest was converted into 226,532 shares of common stock.

 

On September 15, 2020, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 2”) of $93,600 for $78,000. The Redstart Note No. 2 had a maturity date of September 15, 2021 and the Company had agreed to pay interest on the unpaid principal balance of the Redstart Note No. 2 at the rate of 6% from the date on which the Redstart Note No. 2 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 2, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 2. The transactions described above closed on September 16, 2020. The outstanding principal amount of the Redstart Note No. 2 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, Redstart may convert the Redstart Note No. 2 into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 2), the Redstart Note No. 2 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 2. During the year ended December 31, 2021, the entire amount of Note No. 2 of $93,600 plus accrued interest was converted into 89,169 shares of common stock.

 

On December 9, 2020, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 3”) of $100,200 for $83,500. The Redstart Note No. 3 had a maturity date of December 9, 2021 and the Company had agreed to pay interest on the unpaid principal balance of the Redstart Note No. 3 at the rate of 6% from the date on which the Redstart Note No. 3 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 3, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 3. The transactions described above closed on December 11, 2020. The outstanding principal amount of the Redstart Note No. 3 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, Redstart may convert the Redstart Note No. 3 into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 3), the Redstart Note No. 3 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 3. During the year ended December 31, 2021, the entire amount of Note No. 3 of $100,200 plus accrued interest was converted into 135,582 shares of common stock.

46

 

 

On February 10, 2021, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 4”) of $184,200 for $153,500. The Redstart Note No. 4 had a maturity date of February 5, 2022 and the Company had agreed to pay interest on the unpaid principal balance of the Redstart Note No. 4 at the rate of 6% from the date on which the Redstart Note No. 4 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 4, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 4. The transactions described above closed on February 10, 2021. The outstanding principal amount of the Redstart Note No. 4 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, Redstart may convert the Redstart Note No. 4 into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 4), the Redstart Note No. 4 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 4. During the year ended December 31, 2021, the entire amount of Redstart Note No. 4 of $184,200 plus accrued interest was converted into 386,146 shares of common stock.

 

On March 15, 2021, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 5”) of $106,200 for $88,500. The Redstart Note No. 5 had a maturity date of June 15, 2022 and the Company had agreed to pay interest on the unpaid principal balance of the Redstart Note No. 5 at the rate of 6% from the date on which the Redstart Note No. 5 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 5, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 5. The transactions described above closed on March 17, 2021. The outstanding principal amount of the Redstart Note No. 5 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, Redstart may convert the Redstart Note No. 5 into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 5), the Redstart Note No. 5 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 5. During the year ended December 31, 2021, the entire amount of Redstart Note No. 5 of $106,200 plus accrued interest was converted into 317,837 shares of common stock.

 

On May 26, 2021, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 6”) of $106,200 for $88,500. The Redstart Note No. 6 had a maturity date of August 26, 2022 and the Company had agreed to pay interest on the unpaid principal balance of the Redstart Note No. 6 at the rate of 6% from the date on which the Redstart Note No. 6 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 6, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 6. The transactions described above closed on May 28, 2021. The outstanding principal amount of the Redstart Note No. 6 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, Redstart may convert the Redstart Note No. 6 into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 6), the Redstart Note No. 6 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 6. During the year ended December 31, 2021, the entire amount of Redstart Note No. 5 of $106,200 plus accrued interest was fully repaid in total cash of $141,782.

 

47

 

 

 On September 21, 2021, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 7”) of $244,500 for $203,750. The Redstart Note No. 7 had a maturity date of December 22, 2022 and the Company had agreed to pay interest on the unpaid principal balance of the Redstart Note No. 7 at the rate of 2.5% from the date on which the Redstart Note No. 7 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 7, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 7. The transactions described above closed on September 28, 2021. The outstanding principal amount of the Redstart Note No. 7 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, Redstart may convert the Redstart Note No. 7 into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 7), the Redstart Note No. 7 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 7. During the year ended December 31, 2022, Redstart converted the principal amount and $244,500 and accrued interest of the convertible note to 8,580,434 shares of the Company’s common stock. As of December 31, 2022, the note had an outstanding balance of $0 and accrued interest of $0.

Iliad Research and Trading, L.P.

 

On February 27, 2019, the Company entered into a note purchase agreement with a third-party investor – Iliad Research and Trading, L.P.(“Iliad”), pursuant to which the Company issued a promissory note for amount of $2,325,000. The promissory note had an original issue discount of $300,000 and the inventor paid consideration of $2,025,000 to the Company, of which $25,000 was for legal expenses. The outstanding balance of the promissory note is to be paid on the one-year anniversary of the issuance of the note. Interest on the note accrues at 10% compounding daily. Subject to the terms and conditions set forth in the note, the Company may prepay all or any portion of the outstanding balance of the note at any time in an amount in cash equal to 120% of the amount repaid. In connection with transactions that generate less than $1,000,000 in proceeds, the Company had agreed to not issue any debt instrument or incurrence of any debt other than trade payables in the ordinary course of business, any securities or agreements to sell common stock with anti-dilution or price reset/reduction features or any securities that are or may be become convertible or exercisable into common stock with a price that varies with the market price of the common stock (collectively, “Restricted Issuance Transaction”). The outstanding balance of the Note will be increased by 5% in the event the Company enters into a Restricted Issuance Transaction that is approved by Iliad. The original issue discount is being amortized to interest expense over the term of the promissory note.

 

48

 

 

On February 27, 2020, the Company and Iliad entered into an Amendment to the Iliad Note (See Note 10) pursuant to which the maturity date of the Iliad Note was extended to August 27, 2020, provided that the Debt may be converted into shares of common stock of the Company at a conversion price equal to 80% multiplied by the lowest trading daily VWAP for the common stock during the 20 trading day period ending on the latest complete trading day prior to the conversion date, provided for the payment by the Company to Iliad of an extension fee equal to 7.5% of the outstanding balance of the Iliad Note resulting in a new balance of the Iliad Note of $2,765,983 and provided that the Company’s failure to deliver shares of common stock within three trading days of a conversion would result in an event of default. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. Iliad had agreed to restrict its ability to convert the Iliad Note and receive shares of common stock such that the number of shares of common stock held by it and its affiliates after such conversion or exercise does not exceed 9.99% of the then issued and outstanding shares of common stock. On July 20, 2020 the Company and Iliad entered into agreement to extend the maturity of the Iliad Note until February 27, 2021 for an extension fee of $1,000. On February 28, 2021 the Company and Iliad entered into agreement to further extend the maturity of the Iliad Note until May 31, 2021 for $1,000 representing the third extension of the original note. On May 19, 2021, the Company and Iliad entered into agreement to further extend the maturity of the Iliad Note until August 31, 2021 for of $1,000 representing the fourth extension of the original note. On August 20, 2021, the Company and Iliad entered into agreement to further extend the maturity of the Iliad Note until December 31, 2021 for $1,000. During the year ended December 31, 2021, Iliad converted $2,508,737 of its convertible note into 4,053,069 shares of the Company’s common stock. The balance of the Iliad debt at December 31, 2022 and December 31, 2021 was $0 and $0, respectively.

 

Sixth Street Lending LLC – First Note

 

On November 8, 2021, the Company entered into a Securities Purchase Agreement with Sixth Street Lending LLC (“Sixth Street”) pursuant to which the Company issued to Sixth Street a Convertible Promissory Note (the “Sixth Street Note”) of $124,200 for $103,500. The Sixth Street Note had a maturity date of February 8, 2023 and the Company had agreed to pay interest on the unpaid principal balance of the note at 6% from the date on which the note is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the note, provided it makes a payment including a prepayment to Sixth Street as set forth in the Sixth Street Note. The outstanding principal amount of the note may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, Sixth Street may convert the note into shares of the Company’s common stock at a conversion price equal to 85% of the average of the two lowest trading prices with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Sixth Street Note), the note shall become immediately due and payable and the Company shall pay to Sixth Street, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Sixth Street Note. As of December 31, 2022, the entire note was converted into 26,343,190 shares of the Company’s common stock.

 

49

 

 

Outstanding Notes

 

$10,000,000 for GBT Technologies S. A. acquisition

 

In accordance with the acquisition of GBT-CR the Company issued a convertible note in the principal amount of $10,000,000. The convertible note bears interest of 6% and is payable at maturity on December 31, 2021. At the election of the holder, the convertible note can be converted into a maximum of 20,000 shares of Series H Preferred Stock. Each share of Series H Preferred Stock is convertible, at the option of the holder but subject to the Company increasing its authorized shares of common stock, into such number of shares of common stock of the Company as determined by dividing the Stated Value ($500 per share) by the conversion price ($500 per share).

 

On May 19, 2021, the Company, Gonzalez, GBT-CR and IGOR 1 Corp entered into a Mutual Release and Settlement Agreement and Irrevocable Assignment of outstanding balance plus accrued interest (the “Gonzalez Agreement”). Pursuant to the Gonzalez Agreement, without any party admission of liability and to avoid litigation, the parties had agreed to (i) extend the GBT convertible note maturity date to December 31, 2022, (ii) amend the GBT convertible note terms to include a beneficial ownership blocker of 4.99% and a modified conversion feature to the GBT convertible note with 15% discount to the market price during the 20 trading day period ending on the latest complete trading day prior to the conversion date and (iii) provided for an assignment of the GBT convertible note by Gonzalez to a third party. As a result of the change in terms of this convertible note, the Company took a charge related to the modification of debt of $13,777,480 during the year ended December 31, 2021.

 

During the year ended December 31, 2021, IGOR 1 converted $1,284,600 of the convertible note into 4,185,650 shares of the Company’s common stock. On June 24, 2021, the Company transferred 5,500,000 SURG shares received as repayment of $660,000 of this convertible note (See Note 4).

 

During the year ended December 31, 2022, IGOR 1 converted $1,659,669 of the convertible note into 590,117,647 shares of the Company’s common stock.

 

As of December 31, 2022, the note had an outstanding balance of $6,395,531 and accrued interest of $2,027,148.

 

Sixth Street Lending LLC named changed - 1800 Diagonal Lending LLC - Second Note

 

On May 5, 2022, the Company entered into a Securities Purchase Agreement with 1800 Diagonal Lending LLC, an accredited investor (“DL”), pursuant to which the Company issued to DL a Convertible Promissory Note (the “DL Note”) of $244,500 for $203,500. The DL Note had a maturity date of August 4, 2023 and the Company agreed to pay interest on the unpaid principal balance of the DL Note at 6.0% from the date on which the DL Note is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the DL Note at any time from the Issue Date and continuing through 180 days following the Issue Date, provided it makes a payment including a prepayment premium to DL as set forth in the DL Note. The transactions described above funded on May 9, 2022.

 

50

 

 

The outstanding principal amount of the DL Note may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, DL may convert the DL Note into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price during the 20-day period immediately preceding the date of conversion. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the DL Note), the DL Note shall become immediately due and payable and the Company shall pay to DL, in full satisfaction of its obligations hereunder, additional amounts as set forth in the DL Note. In no event shall DL be allowed to effect a conversion if such conversion, along with all other shares of Company common stock beneficially owned by DL and its affiliates would exceed 4.99% of the outstanding shares of the common stock of the Company.

 

Unless the Company shall have first delivered to DL, at least 48 hours prior to the closing of any equity (or debt with an equity component) financing in an amount less than $150,000 (“Future Offering”), written notice describing the proposed Future Offering and providing the Buyer an option during the 48 hour period following delivery of such notice to DL the securities being offered in the Future Offering on the same terms as contemplated by such Future Offering then the Company is restricted from conducting the Future Offering during the period beginning on the Issue Date and ending nine months following the Issue Date.

 

During the year ended December 31, 2022, 1800 Diagonal lending converted $130,400 of the convertible note into 222,091,971 shares of the Company’s common stock.

 

As of December 31, 2022, the note had an outstanding balance of $114,100 and accrued interest of $7,674.

 

Sixth Street Lending LLC - Third Note

 

On September 13, 2022, the Company entered into a Securities Purchase Agreement (dated September 9, 2022) with 1800 Diagonal Lending LLC, an accredited investor (“DL”) pursuant to which the Company issued to DL a Promissory Note (the “DL Note”) of $116,200 with an original issue discount of $12,450 resulting in net proceeds of the Company of $103,750. The DL Note had a maturity date of September 9, 2023 and the Company agreed to pay interest on the unpaid principal balance of the DL Note at the rate of 12.0% from the date on which the DL Note is issued (the “Issue Date”). A one-time interest charge of 12% or $13,944 was applied on the Issue Date to the principal amount owed under the DL Note. Accrued, unpaid interest and outstanding principal, subject to adjustment, shall be paid in ten payments of $13,014.40 resulting in a total payback to DL of $130,144. The first payment is due October 30, 2022 with nine subsequent payments each month thereafter. The Company shall have a five-day grace period with respect to each payment. The Company has right to accelerate payments or prepay in full at any time with no prepayment penalty. This DL Note shall not be secured by any collateral or any assets of the Company. The outstanding principal amount of the DL Note may not be converted into the Company common shares except in the event of default. In the event of default on the DL Note, DL may convert the DL Note into shares of the Company’s common stock at a conversion price equal to 75% of the lowest trading price with a 10-day look back immediately preceding the date of conversion. In addition, upon the occurrence and during the continuation of an event of default (as defined in the DL Note), the DL Note shall become immediately due and payable and the Company shall pay to DL, in full satisfaction of its obligations hereunder, additional amounts as set forth in the DL Note. In no event shall DL be allowed to effect a conversion if such conversion, along with all other shares of Company common stock beneficially owned by DL and its affiliates would exceed 4.99% of the outstanding shares of the common stock of the Company.

 

During the year ended December 31, 2022, the company paid back $39,043 to 1800 Diagonal lending.

 

As of December 31, 2022, the note had an outstanding balance of $77,157 and an interest of $13,944.

 

Sixth Street Lending LLC - Fourth Note

 

51

 

 

On March 1, 2023, the Company entered into a Securities Purchase Agreement, with DL pursuant to which the Company issued to DL a Promissory Note (the “DL Note”) $59,408 with an original issue discount of $6,258 resulting in net proceeds of the Company of $53,150. The DL Note ha a maturity date of June 1, 2024 and the Company agreed to pay interest on the unpaid principal balance of the DL Note at the rate of 12.0% from the date on which the DL Note is issued. A one-time interest charge of 12% or $7,128 was applied on the issuance date of the DL Note to the principal amount owed under the DL Note. Accrued, unpaid interest and outstanding principal, subject to adjustment, shall be paid in ten payments of $6,653.60 resulting in a total payback to DL of $66,536. The first payment is due April 15, 2023 with nine subsequent payments each month thereafter. The Company shall have a five-day grace period with respect to each payment. The Company has right to accelerate payments or prepay in full at any time with no prepayment penalty. This DL Note shall not be secured by any collateral or any assets of the Company. The outstanding principal amount of the DL Note may not be converted into the Company common shares except in the event of default. In the event of default on the DL Note, DL may convert the DL Note into shares of the Company’s common stock at a conversion price equal to 75% of the lowest trading price during the 10-day period immediately preceding the date of conversion. In addition, upon the occurrence and during the continuation of an event of default (as defined in the DL Note), the DL Note shall become immediately due and payable and the Company shall pay to DL, in full satisfaction of its obligations hereunder, additional amounts as set forth in the DL Note. In no event shall DL be allowed to effect a conversion if such conversion, along with all other shares of Company common stock beneficially owned by DL and its affiliates would exceed 4.99% of the outstanding shares of the common stock of the Company.

 

Sixth Street Lending LLC - Fifth Note

 

On March 1, 2023, the Company entered into a Securities Purchase Agreement with DL pursuant to which the Company issued to DL a Convertible Promissory Note (the “DL Convertible Note”) of $62,680 for of $52,150. The DL Convertible Note had a maturity date of June 1, 2024 and the Company agreed to pay interest on the unpaid principal balance of the DL Convertible Note at the rate of 6.0% from the date on which the DL Convertible Note is issued until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the DL Convertible Note, provided it makes a payment including a prepayment to DL as set forth in the DL Convertible Note. The outstanding principal amount of the DL Convertible Note may not be converted prior to the period beginning on the date that is 180 days following the date the DL Convertible Note is issued. Following the 180th day, DL may convert the DL Convertible Note into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price during the 20-day period preceding the date of conversion. In addition, upon the occurrence and during the continuation of an event of default (as defined in the DL Convertible Note), the DL Convertible Note shall become immediately due and payable and the Company shall pay to DL, in full satisfaction of its obligations hereunder, additional amounts as set forth in the DL Convertible Note. In no event shall DL be allowed to effect a conversion if such conversion, along with all other shares of Company common stock beneficially owned by DL and its affiliates would exceed 4.99% of the outstanding shares of the common stock of the Company.

 

SBA Loan

 

On June 22, 2020, the Company received a loan from the Small Business Administration under the Economic Injury Disaster Loan program related to the COVID-19 relief efforts. The loan bears interest at 3.75%, requires monthly principal and interest payments of $731 after 12 months from funding and is due 30 years from the date of issuance. The monthly payments were extended by the SBA to all EIDL borrowers with additional 12 months. Monthly payments will be commenced on or around June 16, 2022. On October 1, 2021, the Company entered an Amended Loan Authorization and Agreement with the SBA providing for the modification of the Original Note providing for monthly principal and interest payments of $1,771 after 24 months from the Original Note commencing on or around June 22, 2022. On March 17, 2022 the SBA notified it deferred the payments to all COVID-19 EIDL loans will have the first payment due extended from 24-months to 30-months from the date of the note. The Modified Note will continue to bear interest at 3.75% and is due 30 years from the date of issuance of the Original Note. The Modified Note is guaranteed by Douglas Davis, the former CEO of the Company and current consultant, as well as by GBT Tokenize Corp. The additional funding of $200,000 was received by the Company on October 5, 2021. The balance of the note at December 31, 2022 and December 31, 2021 was $350,000 and $350,000 plus accrued interest of $23,497 and $20,399, respectively.

 

52

 

 

As of December 31, 2022 and 2021, the nonrelated party convertible notes had total outstanding balance of $6,397,727 and 8,145,233, net of debt discount, and accrued interest of $2,048,766 and $1,547,924, respectively.

 

Alpha Eda Note

 

On November 15, 2020, the Company issued a promissory note to Alpha Eda, LLC (“Alpha”), a related party for $140,000. The note accrues interest at 10%, is unsecured and was due on September 30, 2021. On June 20, 2021 Alpha and the Company extended the note maturity to December 31, 2022. The balance of the note at December 31, 2022 and December 31, 2021 was $140,000 and $140,000 plus accrued interest of $32,178 and $29,104, respectively.

 

Stanley Hills LLC Convertible Note Payable

 

The Company entered into a series of loan agreements with Stanley Hills LLC (“Stanley”) pursuant to which it received more than $1,000,000 in loans (the “Debt”) from May 2019 up to December 2019. On February 26, 2020, in order to induce Stanley to continue to provide funding, the Company and Stanley entered into a letter agreement providing that the current note payable balance due to Stanley of $1,214,900 may be converted into shares of common stock of the Company at a conversion price equal to 85% multiplied by the lowest one trading price for the common stock during the 20-trading day period ending on the latest complete trading day prior to the conversion date. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. Stanley had agreed to restrict its ability to convert the Debt and receive shares of common stock such that the number of shares of common stock held by it and its affiliates after such conversion or exercise does not exceed 4.99% of the then issued and outstanding shares of common stock. During the year ended December 31, 2021, Stanley converted $1,231,466 of its convertible note plus interest into 4,420,758 shares of the Company’s common stock, and during the year ended December 31, 2021, Stanley loaned the Company an additional $325,000. Also, during the year ended December 31, 2021, the Company transferred the SURG shares received as repayment of $800,000 of this convertible note (See Note 5) and converted $126,003 of accrued interest into the principal balance. During the year ended December 31, 2021, Gonzalez assigned all his accrued balances of $424,731 to Stanley in a private transaction that the Company is not part to (See Note 7). The balance of the Stanley convertible note payable at December 31, 2022 and 2021 was $116,605 and $116,605, respectively. The unpaid interest of the Stanley convertible note payable at December 31, 2022 and 2021 was $20,033 and $8,372, respectively. The Stanley debt is secured via a pledge agreement on the SURG shares.

 

53

 

 

Stanley Hills LLC Accounts Payable

 

On January 1, 2021, SURG, AltCorp and Stanley entered into a Mutual Release and Settlement Agreement (“Settlement Agreement”) after Stanley sued SURG. Pursuant to the terms of the Settlement Agreement, SURG agreed to amend the AltCorp Exchange Agreement where SURG acknowledged a debt of $3,300,000 (the “Debt”) to be paid in 33 monthly payments of $100,000 payable in shares of common stock of SURG at a per share price equal the volume weighted average price of Surg’s common stock during the ten (10) trading days immediately preceding the issuance. The Company paid $650,000 in cash and the remaining by shares. The SURG common stock issued to Altcorp has been pledged since August 12, 2020 for the benefit of Stanley to secure Stanley’s note payable by the Company. Accordingly, the SURG Common Stock issued to AltCorp as a result of the Settlement Agreement were pledged to Stanley. SURG paid $400,000 in cash and $800,000 by shares. The SURG common stock issued to Altcorp have been pledged since August 12, 2020 for the benefit of Stanley to secure Stanley’s note payable by the Company. Accordingly, the SURG Common Stock issued to AltCorp as a result of the Settlement Agreement were pledged to Stanley. The final settlement SURG agreed to make total payments of $4,200,000 to the Company on or prior to January 7, 2022. This $4.2 million amount consists of $450,000 paid by SURG in November and December 2021, $100,000 to be paid on or about January 4, 2022, and $3,650,000 to be paid on or prior to January 7, 2022 of which $375,000 will be held in escrow as described before. The $3,750,000 was recorded as other receivable as of December 31, 2021. As of December 31, 2022 and 2021, the Company has recorded an outstanding payable to Stanley of $927,136 and $1,862,928, respectively, recorded under accrued expenses.

 

Consulting income for both the years ended December 31, 2022 and 2021 were $45,000 and $180,000. Consulting income are derived from providing IT consulting services to Stanley and selling electronic products through e-commerce platforms like Amazon and eBay.

 

Off-Balance Sheet Arrangements

 

The Company does not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on the Company’s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

 

Critical Accounting Policies and Use of Estimates

 

Our Management’s Discussion and Analysis of Financial Condition and Results of Operations is based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The preparation of our financial statements in accordance with U.S. GAAP requires us to make certain estimates, judgments and assumptions that affect the reported amount of assets and liabilities as of the date of the financial statements, the reported amounts and classification of revenues and expenses during the periods presented, and the disclosure of contingent assets and liabilities. We evaluate our estimates and assumptions on an ongoing basis and material changes in these estimates or assumptions could occur in the future. Changes in estimates are recorded on the period in which they become known. We base our estimates on historical experience and various other assumptions that we believe to be reasonable under the circumstances and at that time, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily-apparent from other sources. Actual results may differ materially from these estimates if past experience or other assumptions do not turn out to be substantially accurate.

 

We believe that the accounting policies described below are critical to understanding our business, results of operations, and financial condition because they involve significant judgments and estimates used in the preparation of our financial statements. An accounting is deemed to be critical if it requires a judgment or accounting estimate to be made based on assumptions about matters that are highly uncertain, and if different estimates that could have been used, or if changes in the accounting estimates that are reasonably likely to occur periodically, could materially impact our financial statements. Other significant accounting policies, primarily those with lower levels of uncertainty than those discussed below, are also critical to understanding our financial statements. The notes to our financial statements contain additional information related to our accounting policies and should be read in conjunction with this discussion.

 

Presentation of Financial Statements

 

The accompanying financial statements have been prepared in accordance with U.S. GAAP.

 

Stock Split

 

On October 26, 2021, the Company effectuated a 1 for 50 reverse stock split. The share and per share information has been retroactively restated to reflect this reverse stock split.

 

54

 

 

Marketable Equity Securities

 

The Company accounts for marketable equity securities in accordance with ASC Topic 321, Investments – equity securities. Marketable equity securities are reported at FV based on quotations available on securities exchanges with any unrealized gain or loss being reported as a component of other income (expense) on the statement of operations. The portion of marketable equity security expected to be sold within twelve months of the balance sheet date is reported as a current asset. These publicly traded equity securities are valued using quoted prices and are included in Level 1.

 

Revenue Recognition

 

Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“Topic 606”), became effective for the Company on January 1, 2018. The Company’s revenue recognition disclosure reflects its updated accounting policies that are affected by this new standard. The Company applied the “modified retrospective” transition method for open contracts for the implementation of Topic 606. The Company had no significant post-delivery obligations, this new standard did not result in a material recognition of revenue on the Company’s accompanying CFS for the cumulative impact of applying this new standard. The Company made no adjustments to its previously-reported total revenues, as those periods continue to be presented in accordance with its historical accounting practices under Topic 605, Revenue Recognition.

 

Revenue is recognized under Topic 606 as follows:

 

  executed contracts with the Company’s customers that it believes are legally enforceable;

 

  identification of performance obligations in the respective contract;

 

  determination of the transaction price for each performance obligation in the respective contract;

 

  allocation the transaction price to each performance obligation; and

 

  recognition of revenue only when the Company satisfies each performance obligation.

 

These five elements, as applied to each of the Company’s revenue category, is summarized below:

 

  IT consulting services – revenue is recorded on a monthly basis as services are provided; and

 

  License fees and Royalties – revenue is recognized based on the terms of the agreement with its customer.

 

 E-Commerce sales

 

Identify the contract(s) with a customer. ASC 606 defines a contract as “an agreement between two or more parties that creates enforceable rights and obligations”. Since this is an e-commerce sale on the Amazon of eBay websites, the Company just followed the general terms on Amazon or eBay websites and the customer entered into a contract with the Company based on the product listed on the Amazon or eBay websites;

 

Identify the performance obligations in the contract. According to the contract, the Company is responsible for operation exclusively. The Company is entitled to all revenue which is being paid by Amazon or eBay into a designated bank account and the Company is responsible for all product acquisitions as well as shipments. The only performance obligations were the electronic products that were listed on Amazon or eBay websites and the Company determined each order is one single obligation;

 

Determine the transaction price. The transaction price set to be the listed price on the Amazon or eBay websites.;

 

Allocation the transaction price to the performance obligations in the contract.; and

 

Recognize revenue when the Company satisfies a performance obligation. Sales are being recognized upon shipment.

 

55

 

 

Unearned revenue

 

Unearned revenue represents the net amount received for the purchase of products that have not seen shipped to the Company’s customers. On January 28, 2022 awarded the Company with injunction against RWJ Defendants, where all fee funds generating from resale should be deposited into GBT blocked account, and therefore RWJ Defendants cannot use these funds without court order - $19,810 been credited as unearned revenue until court final decision. The Company has $48,921 and $249,384 of unearned revenue at December 31, 2022 and December 31, 2021, respectively.

 

Contract liabilities

 

On February 22, 2022, the Company entered into an Intellectual Property License and Royalty Agreement with Touchpoint Group Holdings, Inc. (“Touchpoint” or “TGHI”) pursuant to which the Company granted TGHI a worldwide license for its technologies for a term of five years in the domains of Internet of Things (IoT) and Artificial Intelligence enabled mobile technologies pertaining to the Company’s digital currency technology (the “Technology”). GBT will charge TGHI earned royalties based on actual uses by TGHI of the Technology resulting from revenue attributable to the use, performance or other exploitation of the Technology, to the extent applicable, after deducting any taxes that the Company may be required to collect, and deducting any international sales, goods and services, value added taxes or similar taxes which the Company is required to pay, if any, excluding deductions for taxes on the Company net income. TGHI agreed to issue the Company 10,000,000 shares of common stock of TGHI in the FV of $50,000 as a one-time fee consideration of the Company entering this Intellectual Property License and Royalty Agreement, which was booked contract liabilities and amortized over the five-year term. The Company have yet to earn any royalty income in relation to this agreement as of December 31, 2022. The contract liabilities as of December 31, 2022 and December 31, 2021 was $41,444 and $0, respectively.

 

Derivative Financial Instruments

 

The Company evaluates all of its agreements to determine if such instruments have derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its FV and is then re-valued at each reporting date, with changes in the FV reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a weighted average Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. As of December 31, 2022, the Company’s only derivative financial instrument was an embedded conversion feature associated with convertible notes payable due to certain provisions that allow for a change in the conversion price based on a percentage of the Company’s stock price at the date of conversion.

 

56

 

 

Fair Value of Financial Instruments

 

For certain of the Company’s financial instruments, including cash, accounts payable, accrued liabilities and short-term debt, the carrying amounts approximate their FV due to their short maturities.

 

FASB ASC Topic 820, Fair Value Measurements and Disclosures, requires disclosure of the FV of financial instruments held by the Company. FASB ASC Topic 825, Financial Instruments, defines FV, and establishes a three-level valuation hierarchy for disclosures of FV measurement that enhances disclosure requirements for FV measures. The carrying amounts reported in the consolidated balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their FV because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:

 

  Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.

 

  Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

 

  Level 3 inputs to the valuation methodology us one or more unobservable inputs which are significant to the FV measurement.

 

The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic 480, Distinguishing Liabilities from Equity, and FASB ASC Topic 815, Derivatives and Hedging.

 

For certain financial instruments, the carrying amounts reported in the balance sheets for cash and current liabilities, including convertible notes payable, each qualify as a financial instrument, and are a reasonable estimate of their FV because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest.

 

The Company uses Level 2 inputs for its valuation methodology for derivative liabilities as their FV were determined by using the Black-Scholes-Merton pricing model based on various assumptions. The Company’s derivative liabilities are adjusted to reflect FV at each period end, with any increase or decrease in the FV being recorded in results of operations as adjustments to FV of derivatives.

 

Income Taxes

 

The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes. ASC 740 requires a company to use the asset and liability method of accounting for income taxes, whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion, or all of, the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

 

Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The Company has no material uncertain tax positions for any of the reporting periods presented and its current on all its tax filings federal and state until 2021 inclusive.

 

Dividends

 

The Company has not yet adopted any policy regarding payment of dividends. No cash dividends have been paid or declared since the Date of Inception.

 

57

 

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

As a Smaller Reporting Company, the Company is not required to include the disclosure under this Item.

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

The information required by Item 8 appears at Page F-1, which appears after the signature page to this report.

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

Previous independent registered public accounting firm

 

On May 27, 2022 (the “Termination Date”), the Company terminated BF Rogers CPA PC (the “Former Auditor”) as the independent registered public accounting firm of the Company. Other than an explanatory paragraph included in the Former Auditor’s audit report for the Registrant’s fiscal years ended December 31, 2021 and 2020 relating to the uncertainty of the Company’s ability to continue as a going concern, the audit reports of the Former Auditor on the Company’s financial statements for the fiscal years ended December 31, 2021 and 2020 did not contain an adverse opinion or disclaimer of opinion, and such reports were not qualified or modified as to uncertainty, audit scope, or accounting principle. During the years ended December 31, 2021 and 2020 and through the date of this Current Report on Form 8-K, the Company has not had any disagreements with the Former Auditor on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure, which disagreements, if not resolved to the Former Auditor’s satisfaction, would have caused them to make reference thereto in their reports on the Company’s financial statements for such years. During the years ended December 31, 2021 and 2020 and through the date of the Termination Date, there were no reportable events, as defined in Item 304(a)(1)(v) of Regulation S-K. The Company requested our Former Auditor furnish us with a letter addressed to the SEC stating whether it agrees with the above statements, which they did.

 

New independent registered public accounting firm

 

On May 27, 2022 (the “Engagement Date”), the Company engaged M.S. Madhava Rao (“New Auditor”) as its independent registered public accounting firm for the Company’s fiscal year ended December 31, 2022. The decision to engage the New Auditor as the Company’s independent registered public accounting firm was approved by the Company’s Board of Directors. During the two most recent fiscal years and through the Engagement Date, the Company has not consulted with the New Auditor regarding either:

 

1. application of accounting principles to any specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements, and neither a written report was provided to the Company nor oral advice was provided that the New Auditor concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue; or

 

2. any matter that was either the subject of a disagreement (as defined in Regulation S-K, Item 304(a)(1) (iv) and the related instructions) or reportable event (as defined in Regulation S-K, Item 304(a)(1)(v)).

 

58

 

  

ITEM 9A. CONTROLS AND PROCEDURES

 

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

 

We maintain a system of disclosure controls and procedures (as defined in Securities Exchange Act Rule 15d-15I) that are designed to ensure that information required to be disclosed in our reports under the Exchange Act, is recorded, processed, summarized and reported within the time periods required under the SEC’s rules and forms and that the information is gathered and communicated to our management, including our Chief Executive Officer (Principal Executive and Financial Officer) to allow for timely decisions regarding required disclosure.

 

As required by SEC Rule 15d-15(b), our Chief Executive Officer (Principal Executive and Financial Officer), carried out an evaluation under the supervision and with the participation of our management, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Exchange Act Rule 15d-14 as of the end of the period covered by this report. Based on the foregoing evaluation, our management concluded that our disclosure controls and procedures are not effective in timely alerting management to material information required to be included in our periodic SEC filings and to ensure that information required to be disclosed in our periodic SEC filings is accumulated and communicated to our management, including our Chief Executive Officer (Principal Executive and Financial Officer) to allow timely decisions regarding required disclosure.

 

MANAGEMENT’S ANNUAL REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING

 

Our management, consisting of our Chief Executive Officer (Principal Executive and Financial Officer), is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting, as defined in Exchange Act Rule 13a-15(f) and 15d-15(f), is a process designed by, or under the supervision of, our principal executive and principal financial officers and effected by our Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission and includes those policies and procedures that:

 

  Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets;

 

  Provide reasonable assurance that transactions are recorded as necessary to permit preparation of our financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and

 

  Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use of disposition of our assets that could have a material effect on the financial statements.

 

59

 

 

Because of its inherent limitations, ICFR reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.

 

Our management assessed the effectiveness of our ICFR reporting as of December 31, 2022. Based on this assessment, management believes that as of December 31, 2022, our ICFR reporting is not effective based on those criteria.

 

This annual report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to rules of the SEC to provide only management’s report in this annual report.

 

CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING

 

There were no changes during our last fiscal year that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

ITEM 9B. OTHER INFORMATION

 

Not applicable

 

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.

 

Not applicable.

 

PART III

 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

Executive Officers and Directors

 

Below are the names and certain information regarding the company’s executive officers and directors.

 

Current Directors/Officers:

 

Name   Age   Title
Dr. Danny Rittman   60   Chief Technology Officer and Director
Mansour Khatib   60   Chief Executive Officer, Chief Financial Officer and Director

 

60

 

  

Dr. Danny Rittman is a veteran software architect and integrated circuit technology expert with over 20 years of experience in the technology sector. From 2014 through the present, Dr. Rittman served as the CTO and as a director of the Company, leading the Company’s technological direction and managing teams of mobile software developers. From 2012, through 2014, Dr. Rittman served as a Senior Integrated Circuit Consultant for Qualcomm / Max Linear, managing teams of integrated circuit designers within the mobile technology arena. From 2007 through 2012, Dr. Rittman served as the Founder and CTO of Micrologic Design Automation, leading the company’s technological direction, including architecture, design and development of EDA software tools. From 2002 through 2007, Dr. Rittman served as an Integrated Circuit CAD / Software Senior Consultant for IBM, managing IC back-end projects and leading back-end CAD and QA software tool development and implementation. From 1995 through 2002, Dr. Rittman served as the Founder and VP of R&D for Bind-key Technologies, leading the company’s technological direction, research and development of EDA software tools for integrated circuits and back-end design. Dr. Rittman received a BS in Electrical Engineeri–g - VLSI Design from the University of Bridgeport, graduating Magna Cum Laude in 1992; a MS in Computer Scien–e - VLSI Design, specializing in Automation Algorithms, from La Salle University, graduating Magna Cum Laude in 1996; and a PhD in Computer Scien–e - VLSI Design, specializing in EDA Concepts and Algorithms, from La Salle University, graduating Summa Cum Laude in 1998. Mr. Rittman is the Company’s CTO and director.

 

Mansour Khatib was appointed as the Company Chief Executive and Financial Officer on April 13, 2020, the Company’s Board of Directors appointed Mansour Khatib, who served as the Chief Marketing Officer and a director of the Company as Chief Executive Officer. Mr. Khatib has also previously served as Interim Chief Executive Officer from May 2018 to July 2018. From 2009 through 2012, Mansour Khatib served as the CEO and CFO of The Merchandise Company, located in Long Beach, California. From 2012 through the present, Mr. Khatib has served as a U.S. Business and Marketing Sales Representative for KB Racking, located in Toronto, Canada. From May 2013 through July 2014, Mr. Khatib served as VP of Marketing for Sun Energy Partners, LLC, developing solar rooftop projects. From July 2014 through the present, Mr. Khatib has served as the CTO for New Energy Ventures, LLC, a company that is developing utility scale projects in New Jersey, California, and smaller projects in Mexico, the Caribbean and Peru. Mr. Khatib received B.A. in Economics from Fachhochschule Wuppertal in Wuppertal, Germany in 1988 and a Bachelors in Electro Engineering & Computer Technology from University Aachen in Aachen, Germany in 1985. Mr. Khatib is the Company’s CEO and director.

 

Family Relationships

 

There are no family relationships among our directors and executive officers. There is no arrangement or understanding between or among our executive officers and directors pursuant to which any director or officer was or is to be selected as a director or officer. None of our directors or executive officers have had direct or indirect material interest in any transaction or proposed transaction, in which the Company was or is a proposed participant, exceeding $120,000.

 

61

 

 

Involvement in Certain Legal Proceedings

 

To our knowledge, during the last ten years, none of our directors and executive officers has:

 

  Had a bankruptcy petition filed by or against any business of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time.

 

  Been convicted in a criminal proceeding or been subject to a pending criminal proceeding, excluding traffic violations and other minor offenses.

 

  Been subject to any order, judgment or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his involvement in any type of business, securities or banking activities.

 

  Been found by a court of competent jurisdiction (in a civil action), the SEC, or the Commodities Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended or vacated.

 

  Been the subject to, or a party to, any sanction or order, not subsequently reverse, suspended or vacated, of any self-regulatory organization, any registered entity, or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

 

Corporate governance

 

On December 17, 2015, the Company established a Nominating and Corporate Governance Committee, a Compensation Committee and an Audit Committee (collectively, the “Committees”) and approved and adopted charters to govern each of the Committees.

 

Currently, there are no members on each of the committees and the board of directors has assumed the roles of each of the committees.

 

Agreements with Officers and Directors

 

On June 30, 2015, the Company appointed Dr. Danny Rittman as Chief Technical Officer and a board member. On April 6, 2018, the Company and Danny Rittman, Chief Technology Officer and a Director of the Company, agreed to amend his employment agreement pursuant to which he will receive salary at the rate of $250,000 annually payable in equal increments of $15,000 per month. An additional $70,000 shall be payable within 15 days of the end of the calendar year. On September 14, 2018, the Company and Dr. Rittman entered into a letter agreement confirming that the Company is the owner of all intellectual property developed by Dr. Rittman relating to the Internet of Things (IoT) and Artificial Intelligence enabled mobile technologies, including a global platform with both mobile and fixed solutions, commencing June 16, 2015 and continuing until Dr. Rittman’s employment agreement is terminated. On August 1, 2021, the Company and Danny Rittman, Chief Technology Officer and a Director of the Company, agreed to amend his employment agreement pursuant to which he will receive salary at the rate of $5,000 per month.

 

On April 16, 2016 (the “Effective Date”), Mansour Khatib and the Company entered into an Employment Agreement (the “Agreement”) pursuant to which Mr. Mansour Khatib agreed to serve as the Chief Marketing Officer of the Company. Mr. Mansour Khatib was also appointed as a director of the Company on the Effective Date. Pursuant to the terms of the Employment Agreement, Mr. Khatib will receive an annual salary of $100,000 upon the Company generating $1,000,000 in revenue during any three (3) month period. There is no understanding or arrangement between Mr. Khatib and any other person pursuant to which he was appointed as an executive officer and director. Mr. Khatib does not have any family relationship with any director, executive officer or person nominated or chosen by us to become a director or an executive officer. Mr. Khatib has not had direct or indirect material interest in any transaction or proposed transaction, in which the Company was or is a proposed participant, exceeding $120,000.

 

62

 

 

Effective August 15, 2016, the Employment Agreement of Mansour Khatib, our CMO, was amended and restated as follows:

 

Upon the Company generating $1,000,000 in revenue during any three (3) month period (the “Threshold Requirement”), the Executive will receive salary at the rate of $100,000 annually (the “Base Salary”); provided, however, that that Company shall pay to Executive $5,000 per month (the “Monthly Salary Advance”) commencing on August 15, 2016, which such Monthly Salary Advance shall be an advance on the Base Salary and shall continue to be paid to Executive until such time that the Company launches its Guardian Patch technology into the consumer markets. Once the Threshold Requirement is met, the Base Salary will be payable in equal increments not less often than monthly in arrears and in any event consistent with the Company’s payroll policy and practices. On August 1, 2021, the Company amend his employment agreement pursuant to which he will receive salary at the rate of $5,000 per month.

 

Delinquent Section 16(a) Reports

 

Section 16(a) of the Exchange Act requires the Company’s executive officers, directors, and persons who beneficially own more than ten percent of a registered class of the Company’s equity securities, to file with the SEC initial reports of ownership and reports of changes in ownership of the Company’s common stock. Such officers, directors, and persons are required by SEC regulation to furnish the Company with copies of all Section 16(a) forms that they file with the SEC.

 

To our knowledge, based solely on review of the copies of such reports and amendments to such reports with respect to the year ended December 31, 2022 filed with the SEC, all required Section 16 reports under the Exchange Act for our directors, executive officers, principal accounting officer and beneficial owners of greater than 10% of our common stock were filed on a timely basis during the year ended December 31, 2022.

 

Code of Ethics

 

We have adopted a Code of Ethics that applies to all officers, directors and employees. The Company will provide to any person without charge a copy of such code of ethics upon written request to the Company at its registered offices.

 

63

 

 

ITEM 11. EXECUTIVE COMPENSATION

 

The following tables set forth all compensation paid to our officers for the years ended December 31, 2022 and 2021.

 

Summary Compensation Table

 

                  Non-Equity  Non-Qualified      
                  Incentive  Deferred      
Name and principal           Stock  Option  Plan  Compensation  All Other   
Position  Year  Salary  Bonus  Awards  Awards  Compensation  Earnings  Compensation  Total
Michael Murray   2021   $   $   $   $   $   $   $5,000   $5,000 
Former President and director(1)   2022   $   $   $   $   $   $   $   $ 
                                              
Danny Rittman   2021   $25,000   $   $   $   $   $   $149,000   $174,000 
Chief Technology Officer and director   2022   $60,000   $   $   $   $   $   $3,671   $63,671 
                                              
Mansour Khatib   2021   $25,000   $   $   $   $   $   $140,000   $165,000 
Chief Executive Officer and director   2022   $60,000   $   $   $   $   $   $140,000   $200,000 

 

(1)On June 17, 2022 Michael Murry Michael Murray resigned as the President and Director of the Company so that he may fully devote all of his efforts to GBT Tokenize Corp. and Metaverse Kit Corp.

 

The compensation discussed herein addresses all compensation awarded to, earned by, or paid to our named executive officer.

 

There are no other stock option plans, retirement, pension, or profit-sharing plans for the benefit of our sole officer and director other than as described herein.

 

Director Compensation

 

During the years ended December 31, 2022 and 2021, there were 2 non-employee directors.

 

Outstanding Equity Awards at Fiscal Year-End

 

As of December 31, 2022, no new warrants was awarded to the executives.

 

64

 

 

 ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

The following table sets forth information with respect to the beneficial ownership of the Common Stock as of March 31, 2023 by (i) each person known by the Company to own beneficially more than 5% of the outstanding Common Stock; (ii) each director of the Company; (iii) each officer of the Company and (iv) all executive officers and directors as a group. Except as otherwise indicated below, each of the entities or persons named in the table has sole voting and investment powers with respect to all shares of Common Stock beneficially owned by it or him as set forth opposite its or his name.

 

    Common   Percentage
    Stock   of
    Beneficially   Common
Name of Beneficial Owner   Owned (1)   Stock (1)
Dr. Danny Rittman (2)     1,980       0.00 %
Mansour Khatib (2)           0.00 %
Metaverse Kit Corp (3)     500,000,000        17.06  %
GBT Tokenize Corp (4)    

166,000,000

      5.67 %
All Officers and Directors as a Group     83,360       0.0 %

 

  (1) Beneficial ownership is determined in accordance with the Rule 13d-3(d)(1) of the Exchange Act, as amended and generally includes voting or investment power with respect to securities. Pursuant to the rules and regulations of the Securities and Exchange Commission, shares of common stock that an individual or group has a right to acquire within 60 days pursuant to the exercise of options or warrants are deemed to be outstanding for the purposes of computing the percentage ownership of such individual or group, but are not deemed to be outstanding for the purposes of computing the percentage ownership of any other person shown in the table. The above is based on 2,930,101,819 shares of common stock outstanding as of March 31, 2023

  

  (2) Current Officer and Director of the Company.

 

  (3) Metaverse Kit Corp is a 50/50 Joint venture between the Company and ldar Gainulin and Maria Belova. which was assigned on June 10, 2022 to ldar Gainulin and Maria Belova. The company contributed 500,000,000 share of the common stock to Metaverse Kit.

 

(4)

GBT Tokenize Corp is a 50/50 Joint venture between the Company and Tokenize-It S.A. which was assigned on June 30, 2021 to Magic International Argentina F.C, S.L. Controlled by Sergio Fridman, a third party GBT Tokenize Corp hold 16,000,000 shares of the Company’s common stock.

On April 11, 2022 the company, through its own subsidiary, Greenwich International Holdings, entered into a Master Joint Venture and Territorial License Agreement (the “Tokenize Agreement”) with Magic Internacional Argentina FC, S.L. (“Magic”) and Tokenize which replaced a prior joint venture entered between the parties, Controlled by Sergio Fridman, a third party GBT Tokenize Corp to hold an additional 150,000,000 shares of the Company’s common stock

 

No Director, executive officer, affiliate or any owner of record or beneficial owner of more than 5% of any class of voting securities of the Company is a party adversary to the Company or has a material interest adverse to the Company.

 

On June 10, 2022, (the Company, entered into a Joint Venture and Territorial License Agreement (the “Metaverse Agreement”) with Ildar Gainulin and Maria Belova (collectively, the “Licensor”). Under the Metaverse Agreement, the parties formed Metaverse Kit Corp., a Nevada corporation (“Metaverse Kit”). The purpose of Metaverse Kit was to develop, maintain and support source codes for its proprietary technologies and comprehensive platform that combines a core virtual reality platform and an extended set of real-world functions to provide a metaverse experience initially within the area of sports and then expanding into virtual worlds of entertainment, live events, gaming, communications and other cross over product opportunities (the “Meta Portfolio”). Under the Metaverse Agreement, Licensor agreed to provide Metaverse Kit with the licensed technology and expertise. In connection therewith, the parties entered an Asset Purchase Agreement (the “Metaverse APA”) concurrently with the Metaverse Agreement whereby Licensor sold Metaverse Kit all source codes pertaining to the Meta Portfolio. Further, Licensor provided an exclusive license to Metaverse Kit throughout the world for the invented product/service and the related platforms relating to the Meta Portfolio and to use the know how to develop, manufacture, sell, market and distribute the Meta Portfolio throughout the world. The Company was required to contribute 500,000,000 shares of common stock of the Company (“GBT Shares”) to Metaverse Kit. Licensor and the Company were to each own 50% of Metaverse Kit. The Company issued 500,000,000 shares to Metaverse for certain equity method investment. The value of the shares of $5,000 was determined based on the FV of the Company’s common stock. The Company pledged its 50% ownership in Metaverse Kit to Igor 1 Corp. to secure a convertible note held by Igor 1 Corp. The Company was to appoint two directors and Licensor was allowed to appoint one director of Metaverse Kit. In addition, Metaverse Kit, Licensor and Elentina Group, LLC (“Elentina”) entered into a Consulting Agreements in which IGBM and Elentina, each were engaged to provide services for $25,000 per month payable quarterly which Metaverse Kit has the option to pay in shares of common stock calculated by the amount owed divided by the Company’s 10-day VWAP. Licensor and Elentina were to provide services in connection with the development of the business as well as Metaverse Kit’s capital raising efforts. The term of the Consulting Agreement was two years. The closing of the Metaverse Agreement occurred on June 13, 2022.

 

On March 14, 2023, the Company received a counter signed Settlement Agreement and Release by Licensor dated March 2, 2023 (“Settlement Agreement”). Pursuant to the Settlement Agreement, the parties agreed that Metaverse Agreement, the Metaverse APA and the Consulting Agreement are void and cancelled. Licensor agreed to pay $5,000 to the Company as settlement payment and surrender their shares in Metaverse Kit.

 

65

 

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.

 

 On September 14, 2018, the Company and Dr. Rittman entered into a letter agreement confirming that the Company is the owner of all intellectual property developed by Dr. Rittman relating to the Internet of Things (IoT) and Artificial Intelligence enabled mobile technologies, including a global platform with both mobile and fixed solutions, commencing June 16, 2015 and continuing until Dr. Rittman’s employment agreement is terminated.

 

On September 1, 2017, the Company entered into and closed an Asset Purchase Agreement with a third party, RWJ Advanced Marketing, LLC (“RWJ”), a Georgia corporation, pursuant to which the Company purchased certain assets from RWJ, including inventory, terminals, licenses and permits and intangible assets. At closing, the Company and Mr. Greg Bauer entered into an Employment Agreement pursuant to which Mr. Bauer was retained as Chief Executive Officer for a term of one year, subject to an automatic extension, unless terminated, for a base salary of $250,000 and a bonus of 10% of net profit generated by the assets acquired. Mr. Bauer was also appointed to the Board of Directors of the Company. As of the closing date, Mr. Murray resigned as Chief Executive Officer of the Company but will remain as a director of the Company. Mr. Bauer, since 2004 through present, has served as executive director with W.L. Petrey Wholesale, Inc. where he was in charge of the UGO/Preway operations. The Company is in litigations in connection with RWJ transaction.

 

On January 1, 2019, the Company and Douglas Davis entered into an Amended and Restated Employment Agreement pursuant to which Mr. Davis was retained as Chief Executive Officer. Mr. Davis served as Interim Chief Executive Officer since July 2018 until his resignation on April 11, 2020. The term of Mr. Davis’ employment was for two years through January 1, 2021. Mr. Davis was entitled to an annual base salary of $250,000, which was to be increased to $400,000 upon the Company up-listing to a national exchange. Mr. Davis was also entitled to the issuance of Stock Options to acquire 50,000 shares of common stock of the Company, exercisable for five years, subject to vesting. The options were to be earned and vested (i) with respect to 20,000 shares of common stock on the date hereof, (ii) 5,000 shares of common stock upon the successful dual list of the Company on an international exchange such as SIX Zurich Stock Exchange or Euronext, (iii) 15,000 shares of common stock upon the successful up listing to a national exchange such as the Nasdaq, NYSE Euronext, TSX, AMEX or other, and (iv) with respect to 5,000 shares of common stock at each of the 6 month anniversaries (July 1, 2019 and January 1, 2020). The exercise price of such options shall be the closing price of the Company on the date prior to such event.

 

On October 10, 2019, the Company entered into a Joint Venture Agreement (the “BitSpeed Agreement”) with BitSpeed LLC, which is owned by Douglas Davis, the Company’s Chief Executive Officer, to form GBT BitSpeed Corp., a Nevada company (“GBT BitSpeed”). The purpose of GBT BitSpeed is to develop, maintain and support its proprietary Extreme Transfer Software Application Concurrency, a software application to transfer secure, accelerated transmission of large file data over networks, and connection to cloud storage, Network-Attached Storage (NAS) and Storage Area Networks (SANs) (“Concurrency”). BitSpeed shall contribute the services and resources for the development of Concurrency to GBT BitSpeed. The Company shall contribute 10 million shares of common stock (valued at $17,900,000) of the Company to GBT BitSpeed. BitSpeed and the Company will each own 50% of GBT BitSpeed. The Company shall appoint two directors and BitSpeed shall appoint one director of GBT BitSpeed. In addition, GBT BitSpeed and Mr. Davis entered into a Consulting Agreement in which Mr. Davis is engaged to provide services for $10,000 per month payable quarterly which may be paid in shares of common stock calculated by the amount owed divided by the Company’s 20-day VWAP. Mr. Davis will provide services in connection with the development of the business as well as GBT BitSpeed’s capital raising efforts. The term of the Consulting Agreement is two years. The closing of the BitSpeed Agreement occurred on October 14, 2019. On April 11, 2020, Douglas Davis resigned as Chief Executive Officer of the Company so that he may fully devote all of his efforts to GBT Tokenize Corp., the Company’s joint venture, which intends to develop a new product. Mr. Davis’ resignation was not the result of any disagreements with management or board of directors of the Company.

 

66

 

 

On March 6, 2020, the Company through Greenwich, entered into the Tokenize Agreement with Tokenize, which is owned by a Costa Rica Trust represented by Gonzalez. Gonzalez also represents Gonzalez Costa Rica Trust, which holds a note of $10,000,000 and is also a shareholder of the Company. Under the Tokenize Agreement, the parties formed GBT Tokenize. The purpose of GBT Tokenize is to develop Technology Portfolio, throughout the State of California. Upon generating any revenue from the Technology Portfolio, the Joint Venture will earn the first right of refusal for other territories. Tokenize shall contribute the services and resources for the development of the Technology Portfolio to GBT Tokenize. The Company contributed 100,000,000 GBT Shares to GBT Tokenize. Tokenize and the Company will each own 50% of GBT Tokenize. The Company pledged its 50% ownership in GBT Tokenize and its 100% ownership of Greenwich to Tokenize to secure its Technology Portfolio investment. The Company shall appoint two directors and Tokenize shall appoint one director of GBT Tokenize. In addition, GBT Tokenize and Gonzalez entered into a Consulting Agreement in which Gonzalez is engaged to provide services for $33,333 per month payable quarterly which may be paid in shares of common stock calculated by the amount owed divided by the Company’s 10-day VWAP. Gonzalez will provide services in connection with the development of the business as well as GBT Tokenize’s capital raising efforts. The term of the Consulting Agreement is two years. The closing of the Tokenize Agreement occurred on March 9, 2020. Via this Joint Venture the parties commenced development of a development of an intelligent human vital signs’ device, suggested named qTerm. The platform is an expansion of the existing license agreement with GBT Tokenize Corp., which provided GBT Tokenize Corp. with an exclusive territory of California to develop certain of the Company’s technology. As the nature of the platform cannot be restricted only to California, the Company’s joint venture GBT Tokenize Corp. will be compensated with additional two hundred million shares of the Company to strengthen its funding, subject to board approval. A provisional patent application for the qTerm Medical Device was filed on March 30, 2020 with the USPTO. The application has been assigned serial number 63001564. The Joint Venture completed successfully the first prototype. There is no guarantee that the Company will be successful in researching, developing or implementing this product into the market. In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed and granted regulatory approval, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps.

 

As explained above, on April 11, 2022 the Company, through its wholly owned subsidiary, Greenwich International Holdings, a Costa Rica corporation (“Greenwich”), entered into a Master Joint Venture and Territorial License Agreement (the “Tokenize Agreement”) with Magic International Argentina FC, S.L. (“Magic”) and Tokenize which replaced a prior joint venture entered between the parties.

 

The purpose of Tokenize is to develop, maintain and support source codes for its proprietary technologies including advanced mobile chip technologies, tracking, radio technologies, AI core engine, electronic design automation, mesh, games, data storage, networking, IT services, business process outsourcing development services, customer service, technical support and quality assurance for business, customizable and dedicated inbound and outbound calls solutions, as well as digital communications processing for enterprises and startups (“Technology Portfolio”), throughout the world, which Technology Portfolio was previously licensed to the Company for the State of California.

 

The Tokenize Agreement provides that the Company shall contribute 150,000,000 shares of common stock of the Company (“GBT Shares”) to Tokenize. Sergio Fridman is the manager of Magic and the beneficial owner of all outstanding securities of Magic. Magic will contribute cash of $250,000 into Tokenize for promissory note and agreed to further fund Tokenize with all funds reasonably needed for implementation of the business purposes as described in the Tokenize Agreement. The GBT Shares will not be transferable for five years. As of June 30, 2022, the Company received the $250,000 fund from Magic but the promissory note agreement has not been finalized yet. Therefore, the Company recorded the $250,000 funds as an account payable.

 

Magic and the Company each own 50% of the outstanding shares of common stock of Tokenize. The Company pledged its 50% ownership in Tokenize and its 100% ownership of Greenwich (the “Pledged Securities”) to Magic for providing that Magic may take possession of such Pledged Securities in the event the Company executes, delivers and performs any future agreement or document or judgement resulting in the creation of any lien, pledge, mortgage, claim, charge or encumbrance upon any assets of the Company. The Company shall appoint two directors and Magic shall appoint one director of Tokenize.

 

On June 16, 2022 the parties amended the Tokenize Agreement to further define the constitution of the Board of Directors. As such, Section 4.2 of the Tokenize Agreement was amended and restated to provide that the Board of GBT Tokenize Corp. shall consist of two Directors, one of whom shall be appointed by GBT Tokenize Corp. and the other shall be appointed by the Company.

 

67

 

 

As of December, 31, 2022 and December 31, 2021, the Company owed $505,000 and $475,000 to Yello Partners, Inc., a Company owned by the Mansour Khatib, the Company’s CEO.

 

Stanley Hills LLC Accounts Payable – Related Party

 

On March 8, 2020, SURG filed a lawsuit against its transfer agent, Vstock from transferring millions of SURG stock is currently in possession by the Company and assigned to Stanley Hills, LLC. On January 1, 2021, SURG, AltCorp and Stanley Hills, LLC (“Stanley”) entered into a Mutual Release and Settlement Agreement (“Settlement Agreement”). Pursuant to the terms of the Settlement Agreement, SURG agreed to amend the AltCorp Exchange Agreement where SURG acknowledged a debt of $3,300,000 (the “Debt”) to be paid in 33 monthly payments of $100,000 payable in shares of common stock of SURG at a per share price equal the volume weighted average price of Surg’s common stock during the ten trading days immediately preceding the issuance. SURG paid $400,000 in cash and $800,000 by shares. The SURG common stock issued to Altcorp have been pledged since August 12, 2020 for the benefit of Stanley to secure Stanley’s note payable by the Company. Accordingly, the SURG Common Stock issued to AltCorp as a result of the Settlement Agreement were pledged to Stanley. As of December 31, 2021 there were no surge shares pledges after the final settlement signed on December 22, 2021 and that replaced all prior settlement agreement. The final settlement SURG agreed to make total payments of $4,200,000 to the Company on or prior to January 7, 2022. This $4.2 million amount consists of $450,000 paid by SURG in November and December 2021, $100,000 to be paid on or about January 4, 2022, and $3,650,000 to be paid on or prior to January 7, 2022 of which $375,000 will be held in escrow as described before. The $3,750,000 was recorded as other receivable as of December 31, 2021. As of December, 31, 2022 and December 31, 2021, the Company recorded an outstanding payable to Stanley of $927,136 and $660,735, respectively, recorded under accrued expenses.

 

Sales to related party for the year ended December 31, 2022 and 2021 were $45,000 and $180,000. Sales are derived from providing IT consulting services to Stanley Hills, a related party. The Company did not provide IT services to Stanley after the quarter ended June 30, 2022.

 

Advanced from Related Party

 

During the year ended December 31, 2022, Mansour Khatib, the Company’s CEO advanced $22,658 cash to the Company for business purposes to fund the e-commerce operations.

 

During the year ended December 31, 2022, the Company repaid $18,384 cash to Mansour Khatib.

 

As of December, 31, 2022 and December 31, 2021, the Company has recorded a due from related party of $0 and $30,049, respectively.

 

As of December, 31, 2022 and December 31, 2021, the Company has recorded a due to related party of $62,003 and $0, respectively.

 

Metaverse Agreement

 

On June 10, 2022, the Company, entered into a Joint Venture and Territorial License Agreement (the “Metaverse Agreement”) with Ildar Gainulin and Maria Belova (collectively, the “Licensor”). Under the Metaverse Agreement, the parties formed Metaverse Kit Corp., a Nevada corporation (“Metaverse Kit”). The purpose of Metaverse Kit was to develop, maintain and support source codes for its proprietary technologies and comprehensive platform that combines a core virtual reality platform and an extended set of real-world functions to provide a metaverse experience initially within the area of sports and then expanding into virtual worlds of entertainment, live events, gaming, communications and other cross over product opportunities (the “Meta Portfolio”). Under the Metaverse Agreement, Licensor agreed to provide Metaverse Kit with the licensed technology and expertise. In connection therewith, the parties entered an Asset Purchase Agreement (the “Metaverse APA”) concurrently with the Metaverse Agreement whereby Licensor sold Metaverse Kit all source codes pertaining to the Meta Portfolio. Further, Licensor provided an exclusive license to Metaverse Kit throughout the world for the invented product/service and the related platforms relating to the Meta Portfolio and to use the know how to develop, manufacture, sell, market and distribute the Meta Portfolio throughout the world. The Company was required to contribute 500,000,000 shares of common stock of the Company (“GBT Shares”) to Metaverse Kit. Licensor and the Company were to each own 50% of Metaverse Kit. The Company pledged its 50% ownership in Metaverse Kit to Igor 1 Corp. to secure a convertible note held by Igor 1 Corp. The Company was to appoint two directors and Licensor was allowed to appoint one director of Metaverse Kit. In addition, Metaverse Kit, Licensor and Elentina Group, LLC (“Elentina”) entered into a Consulting Agreements in which IGBM and Elentina, each were engaged to provide services for $25,000 per month payable quarterly which Metaverse Kit has the option to pay in shares of common stock calculated by the amount owed divided by the Company’s 10-day VWAP. Licensor and Elentina were to provide services in connection with the development of the business as well as Metaverse Kit’s capital raising efforts. The term of the Consulting Agreement was two years. The closing of the Metaverse Agreement occurred on June 13, 2022.

 

68

 

 

On March 14, 2023, the Company received a counter signed Settlement Agreement and Release by Licensor dated March 2, 2023 (“Settlement Agreement”). Pursuant to the Settlement Agreement, the parties agreed that Metaverse Agreement, the Metaverse APA and the Consulting Agreement are void and cancelled. Licensor agreed to pay $5,000 to the Company as settlement payment and surrender their shares in Metaverse Kit.

 

On May 19, 2021, the Company entered into a Mutual Release and Settlement Agreement and Irrevocable Assignment of outstanding balance plus accrued interest (the “Gonzalez Agreement”) with third party, GBT-CR, IGOR 1 Corp and Gonzalez. Pursuant to the Gonzalez Agreement, without any party admission of liability and to avoid litigation, the parties had agreed to (i) extend the GBT convertible note maturity date to December 31, 2022, (ii) amend the GBT convertible note terms to include a beneficial ownership blocker of 4.99% and a modified conversion feature to the GBT convertible note with 15% discount to the market price during the 20 trading day period ending on the latest complete trading day prior to the conversion date and (iii) provided for an assignment of the GBT convertible note by Gonzalez to a third party. As a result of the change in terms of this convertible note, the Company took a charge related to the modification of debt of $13,777,480 during the year ended December 31, 2021.

 

During the year ended December 31, 2021, IGOR 1 converted $1,284,600 of the convertible note into 4,185,650 shares of the Company’s common stock. On June 24, 2021, the Company transferred 5,500,000 SURG shares received as repayment of $660,000 of this convertible note (See Note 10).

 

During the year ended December 31, 2022, IGOR 1 converted $1,659,869 of the convertible note into 590,117,647 shares of the Company’s common stock.

 

On November 15, 2020, the Company issued a promissory note to Alpha Eda, LLC (“Alpha”), a related party, for $140,000. The note accrues interest at 10%, is unsecured and was due on September 30, 2021. On June 20, 2021 Alpha and the Company extended the note maturity to December 31, 2021. On March 30, 2022 Alpha and the Company extended the note maturity to December 31, 2022. The balance of the note at December 31, 2022 and 2021 was $140,000 and $140,000 plus accrued interest of $32,633 and $16,633, respectively.

 

On February 9, 2022 the Board approved the employment of Ms. Rittman the spouse of Mr. Rittman, as an assistant to be paid $1,500 per month. Mr. Rittman recuse himself from voting on the matter due to a conflict.

 

Procedures for Approval of Related Party Transactions

 

Our Board of Directors is in charged with reviewing and approving all potential related party transactions. All such related party transactions must then be reported under applicable SEC rules. We have not adopted other procedures for review, or standards for approval, of such transactions, but instead review them on a case-by-case basis.

 

Director Independence

 

The Company has no outside directors as of December 31, 2022.

 

69

 

 

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

 

The following table shows the fees that were billed for the audit and other services provided by Madhava Rao and BF Borgers CPA PC for the years ended December 31, 2022 and 2021.

 

   Years Ended December 31,
   2022  2021
Audit Fees  $84,161   $94,636 
Audit-Related Fees        
Tax Fees        
All Other Fees        
 Total  $84,161   $94,636 

 

Audit Fees - This category includes the audit of our annual financial statements, review of financial statements included in our Quarterly Reports on Form 10-Q and services that are normally provided by the independent registered public accounting firm in connection with engagements for those years. This category also includes advice on audit and accounting matters that arose during, or as a result of, the audit or the review of interim financial statements.

 

Audit-Related Fees - This category consists of assurance and related services by the independent registered public accounting firm that are reasonably related to the performance of the audit or review of our financial statements and are not reported above under “Audit Fees.” The services for the fees disclosed under this category include consultation regarding our correspondence with the SEC, other accounting consulting and other audit services.

 

Tax Fees - This category consists of professional services rendered by our independent registered public accounting firm for tax compliance and tax advice. The services for the fees disclosed under this category include tax return preparation and technical tax advice.

 

All Other Fees - This category consists of fees for other miscellaneous items.

 

Board of Directors Pre-Approval Process, Policies and Procedures

 

All audit and permissible non-audit services provided by our independent registered public accounting firm must be pre-approved. These services may include audit services, audit-related services, tax services and other services. Pre-approval is generally provided for up to one year and any pre-approval is detailed as to the particular service or category of service. The independent registered public accounting firm and management periodically report to the board of directors regarding the extent of services provided by the independent registered public accounting firm. Consistent with the board of directors’ policy, all audit and permissible non-audit services provided by our independent registered public accounting firm were pre-approved by our board of directors.

 

70

 

 

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES

 

No.   Description
3.1   Certificate of Incorporation of Forex International Trading Corp. (1)
3.2   Bylaws of Forex International Trading Corp. (1)
3.3   Certificate of Designation for Series A Preferred Stock (2)
3.4   Certificate of Designation for Series B Preferred Stock (3)
3.5   Certificate of Designation – Series C Preferred Stock (4)
3.6   Amendment to the Certificate of Designation for the Series B Preferred Stock (5)
3.7   Amendment to the Certificate of Designation for the Series C Preferred Stock(5)
3.8   Certificate of Change filed pursuant to NRS 78.209 (6)
3.9   Articles of Merger filed pursuant to NRS 92.A.200 (6)
3.10   Certificate of Amendment to the Articles of Incorporation of Gopher Protocol Inc. (8)
3.11   Certificate of Change dated July 10, 2019 (23)
3.12   Articles of Merger by and between Gopher Protocol Inc. and GBT Technologies Inc. dated July 10, 2019(23)
3.13   Certificate of Correction to the Certificate of Change (24)
3.14   Certificate of Correction to the Articles of Merger by and between Gopher Protocol Inc. and GBT Technologies Inc. dated July 10, 2019 (24)
3.15   Certificate of Amendment to the Articles of Incorporation of GBT Technologies Inc. dated September 23, 2019(26)
3.16   Certificate of Designation for Series B Preferred Stock (7)
3.17   Certificate of Designation of the Preferences, Rights and Limitations of the Series G Convertible Preferred Stock (15)
3.18   Series H Convertible Preferred Stock Certificate of Designation (21)
4.1   Form of Warrant issued to Robert Warren Jackson, Gregory Bauer, Michael Murray and Guardian Patch, LLC dated September 1, 2017 (14)
4.2   Balloon Note payable by Gopher Protocol Inc. to RWJ Advanced Marketing, LLC dated September 1, 2017 (14)
4.3   Form of Warrant issued to Derron Winfrey, Dennis Winfrey, Mark Garner and JIL Venture dated March 1, 2018 (16)
4.4   Note payable by Gopher Protocol Inc. to ECS, LLC dated March 1, 2018 (16)
4.5   Stock Option issued to Kevin Pickard dated April 16, 2018 (17)
4.6   Stock Option issued to Muhammad Khilji dated April 25, 2018 (18)
4.7   6% Convertible Note payable to Pablo Gonzalez dated June 17, 2019 (21)
4.8   Convertible Note payable to Glen Eagles Acquisition LP (22)
4.9   Amendment to Common Stock Purchase Warrant between Gopher Protocol Inc. and Glen Eagles Acquisition LP (22)
4.10   Second Amendment to Promissory Note between GBT Technologies Inc. and Ilaid Research and Trading LP dated July 20, 2020 (29)
4.11   Convertible Promissory Note August 4, 2020 issued to Redstart Holdings Corp. (30)
4.12   Fourth Amendment to Promissory Note between GBT Technologies Inc. and Iliad Research and Trading, L.P. dated May 14, 2020 – Executed May 19, 2021(31)
4.13   Convertible Promissory Note May 26, 2021 issued to Redstart Holdings Corp. – Executed on May 27, 2021 (32)
4.14   Fifth Amendment to Promissory Note between GBT Technologies Inc. and Iliad Research and Trading LP dated August 19, 2021 executed August 20, 2021 (33)
4.15   Convertible Promissory Note September 21, 2021 issued to Redstart Holdings Corp. – Executed on September 24, 2021, and Funded on September 28, 2021 (34)
4.16   Amended Loan Authorization and Agreement between GBT Technologies Inc. and U.S. Small Business Administration dated October 1, 2021 (35)
4.17   Convertible Promissory Note dated November 8, 2021 issued to Sixth Street Lending LLC (36)
4.18   Description of Securities

 

71

 

 

10.1   Territorial License Agreement dated March 4, 2015, by and between Gopher Protocol Inc. and Hermes Roll LLC (7)
10.2   Amended and Restated Territorial License Agreement dated June 16, 2015 by and between Gopher Protocol Inc. and Hermes Roll LLC (9)
10.3   Letter Agreement dated August 20, 2015 by and between Gopher Protocol Inc. and Dr. Danny Rittman (10)
10.4   Letter Agreement dated March 14, 2016 by and between Gopher Protocol Inc. and Dr. Danny Rittman. (11)
10.5   Amended and Restated Employment Agreement by and between Gopher Protocol Inc. and Dr. Danny Rittman dated April 19, 2016 (12)
10.6   Letter Agreement between the Company and Danny Rittman dated June 29, 2017 (13)
10.7   Asset Purchase Agreement between Gopher Protocol Inc. and RWJ Advanced Marketing, LLC dated September 1, 2017 (14)
10.8   Addendum to Asset Purchase Agreement between Gopher Protocol Inc. and RWJ Advanced Marketing, LLC dated September 1, 2017 (14)
10.9   Employment Agreement between Gopher Protocol Inc. and Gregory Bauer dated September 1, 2017 (14)
10.10   Asset Purchase Agreement between Gopher Protocol Inc. and ECS Prepaid LLC dated March 1, 2018 (16)
10.11   Employment Agreement between Gopher Protocol Inc. and Derron Winfrey dated March 1, 2018(16)
10.12   Employment Agreement between Gopher Protocol Inc. and Mark Garner dated March 1, 2018(16)
10.13   Agreement between Gopher Protocol Inc. and Mobiquity Technologies, Inc. dated September 4, 2018 (19)
10.14   Exclusive Intellectual Property License and Royalty Agreement between Gopher Protocol Inc. and GBT Technologies, S.A. dated September 14, 2018 (20)
10.15   Letter Agreement between Gopher Protocol Inc. and Dr. Danny Rittman dated September 14, 2018 (20)
10.16   Exchange Agreement entered into between Gopher Protocol Inc., Altcorp Trading LLC, GBT Technologies, S.A., a Costa Rica company and Pablo Gonzalez dated June 17, 2019 (21)
10.17   Consulting Agreement entered into between Gopher Protocol Inc. and Glen Eagles Acquisition LP (22)
10.18   Letter Agreement between Mobiquity Technologies, Inc. and GBT Technologies Inc. executed August 2, 2019 Delivered August 6, 2019 (39)
10.19   Stock Purchase Agreement between Mobiquity Technologies, Inc. and GBT Technologies Inc. Dated September 10, 2019 (25)
10.20   Stock Purchase Agreement between Marital Trust GST Subject U/W/O Leopold Salkind and GBT Technologies Inc. dated September 10, 2019 (25)
10.21   Letter Agreement between GBT Technologies Inc. and Stanley Hills LLC dated February 26, 2020 (27)
10.22   Amendment to Promissory Note between GBT Technologies Inc. and Iliad Research and Trading, L.P. dated February 27, 2020 (27)
10.23   Order dated February 27, 2020 issued by the United States District Court District of Nevada (27)
10.24   Joint Venture and Territorial License Agreement by and between GBT Technologies Inc. and Tokenize-It S.A. dated March 6, 2020 (28)
10.25   Consulting Agreement by and between Pablo Gonzalez and GBT Tokenize Corp. dated March 6, 2020 (28) 
10.26   Pledge Agreement by and between GBT Tokenize Corp. and Tokenize-It S.A., dated March 6, 2020 (28)
10.27   Securities Purchase Agreement dated August 4, 2020 between GBT Technologies Inc. and Redstart Holdings Corp. (30)
10.28   Securities Purchase Agreement dated November 8, 2021 between GBT Technologies Inc. and Sixth Street Lending LLC (36)
10.29   Equity Financing Agreement between GBT Technologies Inc. and GHS Investments LLC dated December 17, 2021 (37)
10.30   Registration Rights Agreement between GBT Technologies Inc. and GHS Investments LLC dated December 17, 2021 (37)
10.31   Resolution of Purchase, Mutual Release and Settlement Agreement by and among GBT Technologies Inc. and Parties Listed Therein December 22, 2021(38)
10.33   Finders Fee Agreement between JH Darbie & Co. and GBT Technologies Inc. dated October 14, 2021 (39)
31.1   Certification of Chief Executive Officer (Principal Executive and Financial Officer) pursuant to Rule 13a-14(a) or Rule 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1   Certification of Chief Executive Officer (Principal Executive and Financial Officer) pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

72

 

 

(1) Incorporated by reference to the Form S-1 Registration Statement filed with the SEC on September 9, 2009.
(2) Incorporated by reference to the Form 10-K Annual Report filed with the Securities and Exchange Commission on April 6, 2011
(3) Incorporated by reference to the Form 10-Q Quarterly Report filed with the Securities and Exchange Commission on May 14, 2012
(4) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on September 27, 2012.
(5) Incorporated by reference to the Form 10-Q Quarterly Report filed with the Securities and Exchange Commission on November 20, 2012.
(6) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on February 18, 2015
(7) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on March 12, 2015
(8) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on May 1, 2015
(9) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on June 16, 2015
(10) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on August 21, 2015
(11) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on April 20, 2016
(12) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on April 20, 2016
(13) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on September 30, 2017
(14) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on September 7, 2017
(15) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on January 3, 2018
(16) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on March 21, 2018
(17) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on April 18, 2018
(18) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on April 26, 2018.
(19) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on September 9, 2018.
(20) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on September 18, 2018.
(21) Incorporated by reference to the Form 10-Q Quarterly Report filed with the Securities and Exchange Commission on June 19, 2019.
(22) Incorporated by reference to the Form 10-Q Quarterly Report filed with the Securities and Exchange Commission on July 12, 2019.
(23) Incorporated by reference to the Form 10-Q Quarterly Report filed with the Securities and Exchange Commission on July 15, 2019.
(24) Incorporated by reference to the Form 10-Q Quarterly Report filed with the Securities and Exchange Commission on August 5, 2019.
(39) Incorporated by reference to the Form 10-Q Quarterly Report filed with the Securities and Exchange Commission on August 7, 2019.
(25) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on September 16, 2019.
(26) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on September 25, 2019.
(27) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on March 2, 2020.
(28) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on March 11, 2020.
(29) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on July 24, 2020.
(30) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on August 10, 2020.
(31) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on May 21, 2021.
(32) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on June 1, 2021.
(33) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on August 23, 2021.
(34) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on September 29, 2021.
(35) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on October 6, 2021.
(36) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on November 11, 2021
(37) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on December 20, 2021
(38) Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on December 28, 2021
(39) Incorporated by reference to the Form S-1 Registration Statement filed with the Securities and Exchange Commission on January 12, 2022

 

Item 16. Form 10-K Summary.

 

None

 

73

 

 

Signatures

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  GBT TECHNOLOGIES INC.
     
Dated: April 14, 2023 By: /s/ Mansour Khatib
  Name:  Mansour Khatib
  Title: Chief Executive and Financial Officer
(Principal Executive, Financial and Accounting Officer)

 

In accordance with the Exchange Act, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated.

 

Signature   Title   Date
     
/s/ Mansour Khatib   Chief Executive & financial Officer & Director   April 14, 2023
Mansour Khatib   (Principal Executive, Financial and Accounting Officer)    
     
/s/ Dr. Danny Rittman   Chief Technology Officer and Director   April 14, 2023
Dr. Danny Rittman        

 

74

 

 

GBT TECHNOLOGIES INC.
Consolidated Financial Statements

 

Contents

 

    Page
Financial Statements:    
     
Report of Independent Registered Public Accounting Firm (PCAOB ID: 6662)   F-2
     
Report of Independent Registered Public Accounting Firm for Prior Year Ended December 31, 2021(PCAOB ID: 5041)   F-3
     
Consolidated Balance Sheets as of December 31, 2022 and 2021   F-4
     
Consolidated Statements of Operations for the Years Ended December 31, 2022 and 2021   F-5
     
Consolidated Statement of Stockholders’ Deficit for the Years Ended December 31, 2022 and 2021   F-6
     
Consolidated Statements of Cash Flows for the Years Ended December 31, 2022 and 2021   F-7
     
Notes to Consolidated Financial Statements   F-8

 

F-1

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the shareholders and the board of directors of GBT Technologies, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheet of GBT Technologies, Inc. the "Company") as of December 31, 2022, the related statement of operations, stockholders' equity (deficit), and cash flows for the year then ended, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022, and the results of its operations and its cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States.

 

Substantial Doubt about the Company’s Ability to Continue as a Going Concern

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company has accumulated deficit of $ 299,257,917 as of December 31, 2022 and has incurred recurring operating losses. These conditions raise substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

  

Basis for Opinion

 

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.

 

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

 

Critical Audit Matter

 

The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

 

Completeness of litigation and claims accruals

 

As disclosed in Note 17 to the consolidated financial statements, the Company is involved in various legal proceedings. The Company assesses the need to make a provision or to disclose a contingent liability on a case-by-case basis considering the underlying facts of each litigation. The eventual outcome of the litigations is uncertain and estimation at the balance sheet date involves extensive judgement of management including input from legal counsel due to the complexity of each litigation.

 

Adverse outcomes could significantly impact the Company’s reported operations and balance sheet position. Considering the judgement involved in determining the need to make a provision or disclose litigation, the matter is considered a Critical Audit Matter.

 

Our audit procedures included, among others, obtaining a list of litigation Company’s management and legal counsel, identifying material litigations from the aforementioned list and performing inquiries with the said counsel, obtaining and reading the underlying documents to assess the assumptions used by management in arriving at the conclusions; circulating, obtaining, and reading legal confirmations from the Company’s external legal counsels in respect of material litigations and considered that in our assessment; and verifying the disclosures related to provisions and contingent liabilities in the financial statements to assess consistency with underlying documents.

 

Revenue recognition

 

As described in Note 3 to the consolidated financial statements, management applies FASB Topic 606, Revenue from Contacts with Customers (“ASC 606”) to recognize revenue. Management recognizes revenue in a manner that reasonably reflects the delivery of its services to customers in return for expected consideration. The Company’s revenue includes resale of purchased products through Amazon and also through IT services.

 

The principal considerations for our determination that performing procedures over the full completion of revenue contracts and subsequent payment collections is a critical audit matter. This in turn led to significant effort in performing our audit procedures which were designed to evaluate whether the contractual terms, the timing of revenue recognition and the subsequent collections were appropriately identified and accounted for by management under ASC 606.

 

Our audit procedures included, among others, understanding of controls relating to management’s revenue recognition process, examining transaction related documents, confirming revenues and outstanding receivables at the balance sheet date with a sample of the customers.

 

M.S. Madhava Rao

April 14, 2023

 

Served as Auditor since 2022

 

F-2

 

 

Report of Independent Registered Public Accounting Firm

 

To the shareholders and the board of directors of GBT Technologies, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of GBT Technologies, Inc. the "Company") as of December 31, 2021 and 2020, the related statement of operations, stockholders' equity (deficit), and cash flows for the years then ended, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States.

 

Substantial Doubt about the Company’s Ability to Continue as a Going Concern

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company’s significant operating losses raise substantial doubt about its ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.

 

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

 

Critical Audit Matter

 

The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

 

Completeness of litigation and claims accruals

 

As disclosed in Note 16 to the consolidated financial statements, the Company is involved in various legal proceedings. The Company assesses the need to make a provision or to disclose a contingent liability on a case-by-case basis considering the underlying facts of each litigation. The eventual outcome of the litigations is uncertain and estimation at the balance sheet date involves extensive judgement of management including input from legal counsel due to the complexity of each litigation.

Adverse outcomes could significantly impact the Company’s reported operations and balance sheet position. Considering the judgement involved in determining the need to make a provision or disclose litigation, the matter is considered a Critical Audit Matter.

 

Our audit procedures included, among others, obtaining a list of litigation Company’s management and legal counsel, identifying material litigations from the aforementioned list and performing inquiries with the said counsel, obtaining and reading the underlying documents to assess the assumptions used by management in arriving at the conclusions; circulating, obtaining, and reading legal confirmations from the Company’s external legal counsels in respect of material litigations and considered that in our assessment; and verifying the disclosures related to provisions and contingent liabilities in the financial statements to assess consistency with underlying documents.

 

Revenue recognition in relation to fraud

 

As described in Note 2 to the consolidated financial statements, management applies FASB Topic 606, Revenue from Contacts with Customers (“ASC 606”) to recognize revenue. Management recognizes revenue in a manner that reasonably reflects the delivery of its services to customers in return for expected consideration. The Company’s revenue, inclusive of related party revenue, is IT services revenue recorded on a monthly basis as services are provided.

 

The principal considerations for our determination that performing procedures over the full completion of revenue contracts and subsequent payment collections is a critical audit matter. This in turn led to significant effort in performing our audit procedures which were designed to evaluate whether the contractual terms, the timing of revenue recognition and the subsequent collections were appropriately identified and accounted for by management under ASC 606.

 

Our audit procedures included, among others, understanding of controls relating to management’s revenue recognition process, examining transaction related documents, confirming revenues and outstanding receivables at the balance sheet date with a sample of the customers, and testing collections subsequent to the balance sheet date.

 

/s/ BF Borgers CPA PC

BF Borgers CPA PC

 

Served as Auditor since 2017

Lakewood, CO

March 25, 2022

  

F-3

 

 

GBT TECHNOLOGIES INC.

CONSOLIDATED BALANCE SHEETS

 

                 
ASSETS   December 31,   December 31,
    2022   2021
Current Assets:                
 Cash   $ 106,639     $ 155,106  
 Cash held in trust           112,942  
 Marketable equity security            
 Accounts Receivable     25,244        
 Inventory     11,569        
 Prepaid     12,500        
 Note Receivable     198,475        
 Inventory in Transit            
 Investment     16,198        
 Other receivable           3,750,000  
 Total current assets     370,625       4,018,048  
                 
 Total assets   $ 370,625     $ 4,018,048  
LIABILITIES AND STOCKHOLDERS’ DEFICIT                
Current Liabilities:                
 Accounts payable and accrued expenses (including related parties of $1,539,802 and $2,302,928)   $ 6,240,634     $ 6,896,263  
 Accrued settlement     4,090,057       4,090,057  
 Unearned revenue     48,921       249,384  
 Contract liabilities     41,444        
 Convertible notes payable, current, net of discount of $190,464 and $362,004     6,397,727       8,109,436  
Convertible notes payable, related party, net of discount of $0 and $0     116,605       116,605  
 Notes payable, current, net of discount of $0 and $47,671     41,137       2,612,397  
 Notes payable, current, related party     140,000       140,000  
 Due to related party     62,003        -   
 Derivative liability     1,714,143       10,192,485  
 Total current liabilities     18,892,671       32,406,629  
Convertible note payable, noncurrent, net of discount of $88,403 and $0           35,797  
Note payable, noncurrent     308,863       337,603  
 Total liabilities     19,201,534       32,780,029  
Contingencies (Note 18)            
Stockholders’ Deficit:                
 Series B Preferred stock, $0.00001 par value; 20,000,000 shares authorized;                
 45,000 and 45,000 shares issued respectively            
 Series C Preferred stock, $0.00001 par value; 10,000 shares authorized;                
 700 and 700 shares issued and outstanding respectively            
 Series D Preferred stock, $0.00001 par value; 100,000 shares authorized;                
 0 and 0 shares issued and outstanding respectively            
 Series G Preferred stock, $0.00001 par value; 2,000,000 shares authorized;                
 0 and 0 shares issued and outstanding respectively            
 Series H Preferred stock, $0.00001 par value ($500 stated value); 40,000 shares authorized;                
 20,000 and 20,000 shares issued and outstanding respectively            
                 
 Common stock, $0.00001 par value; 10,000,000,000 shares authorized; 1,535,593,440 and 33,200,198 shares issued and outstanding respectively     15,356       332  
 Treasury stock, at cost; 21 shares respectively     (643,059 )     (643,059 )
 Stock loan receivable     (7,610,147 )     (7,610,147 )
 Additional paid in capital     288,664,858       284,072,666  
 Accumulated deficit     (299,257,917 )     (304,581,773 )
 Total stockholders’ deficit     (18,830,909 )     (28,761,981 )
 Total liabilities and stockholders’ deficit   $ 370,625     $ 4,018,048  

 

The accompanying footnotes are an integral part of these consolidated financial statements.

 

F-4

 

 

GBT TECHNOLOGIES INC.  

CONSOLIDATED STATEMENT OF OPERATIONS

 

                 
    Years Ended December 31,
    2022   2021
Sales   $ 1,152,555        
Consulting Income – Related Party       45,000       180,000  
 Total sales       1,197,555       180,000  
Cost of Goods Sold       817,754        
 Gross Profit       379,801       180,000  
Operating expenses:                
 General and administrative     1,053,282       293,628  
 Marketing     360,335       837,614  
 Professional     1,814,543       2,124,272  
 Impairment of assets           15,400,000  
 Gain on Bad Debt     (50,000 )      
 Total operating expenses     3,178,160       18,655,514  
Loss from operations     (2,798,359 )     (18,475,514 )
Other income (expense):                
 Amortization of debt discount     (442,247 )     (824,238 )
 Change in fair value of derivative liability     6,594,370       (1,339,117 )
 Interest expense and financing costs     (969,629 )     (2,022,584 )
 Realized gain (loss) on disposal of marketable equity security           11,000  
 Gain on RJW settlement     3,012,355        
 Loss on debt modification           (13,777,480 )
 Change in fair value of marketable securities       (310,462 )      
 Other income     237,828       2,497,500  
 Total other income (expense)     8,122,215       (15,454,919 )
Profit (Loss) before income taxes     5,323,856       (33,930,433 )
Income tax expense            
Profit (Loss) from continuing operations     5,323,856       (33,930,433 )
Net Income (Loss)   $ 5,323,856     $ (33,930,433 )
Weighted average common shares outstanding:                
 Basic     696,686,911       19,991,381  
 Diluted       4,646,981,551       19,991,381  
Net Income (Loss) per share (basic and diluted):                
 Basic   $ 0.01     $ (1.70 )
 Diluted     0.00       (1.70 )

 

 The accompanying footnotes are an integral part of the consolidated financial statements.

 

F-5

 

 

GBT TECHNOLOGIES INC.

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIT

  

                                         
                        Total
               Stock  Additional     Stockholders’
   Common Stock  Treasury Stock  Loan  Paid-in  Accumulated  Equity/
   Shares  Amount  Shares  Amount  Receivable  Capital  Deficit  (Deficit)
                        
Balance December 31, 2020   5,133,489    51    1,040    (643,059)   (7,610,147)   251,046,191    (270,651,339)   (27,858,304)
                                         
Common stock issued for conversion of convertible debt and accrued interest   13,821,709    139                5,677,867        5,678,006 
Common stock issued for services   245,000    2                281,748        281,750 
Common stock issued for joint venture   14,000,000    140                15,399,860        15,400,000 
Fair value of beneficial conversion feature of converted                       11,666,999        11,666,999 
Net income (loss)                           (33,930,433)   (33,930,433 
                                         
Balance, December 31, 2021   33,200,198   $332   $1,040   $(643,059)  $(7,610,147)  $284,072,666   $(304,581,773)  $(28,761,981)
                                         
Common stock issued amount for conversion of debt and accrue interest   847,133,242    8,471                2,156,990        2,165,461 
Fair value of derivative liability due to conversions                         2,209,888        2,209,888 
Common stock issued for cash   5,500,000    55                231,812        231,867 
Common stock issued for- Tokenize   150,000,000    1,500                (1,500)        
Equity Method Investment - Meta   500,000,000    5,000                (5,000)        
Cancelation of shares   (240,000)   (2)               2         
Net income (loss)                           5,323,856    5,323,856 
                                         
Balance, December 31, 2022   1,535,593,440   $15,356   $1,040   $(643,059)  $(7,610,147)  $288,664,858   $(299,257,917)  $(18,830,909)

 

The accompanying footnotes are an integral part of these consolidated financial statements.

 

F-6

 

 

GBT TECHNOLOGIES INC.
CONSOLIDATED STATEMENT OF CASH FLOWS

 

           
   Years Ended December 31,
   2022  2021
Cash Flows From Operating Activities:          
Net income (loss)  $5,323,856   $(33,930,433)
Adjustments to reconcile net income to net cash used in operating activities:          
Amortization of debt discount   442,247    824,238 
Change in fair value of derivative liability   (6,594,370)   1,339,117 
Excess of debt discount and financing costs   34,175    136,785 
Shares issued for services       281,748 
Loss on modification of debt       13,777,480 
Impairment of assets       15,400,000 
Realized gain on disposal of market equity security       (11,000)
Loss on exchange of assets        
Change in fair value of market equity security   308,802     
Change on Settlement   (3,012,633)    
Payment of other income with marketable securities       (800,000)
Changes in operating assets and liabilities:          
Accounts receivable   (25,244)    
Other receivable   3,741,525    (3,750,000)
Cash held in trust       289,590 
Prepaid   (12,500)    
Inventory   (11,569)    
Contract liabilities   (8,556)    
Unearned revenue   (200,463)   (291)
Accounts payable and accrued expenses   (123,462)   5,073,651 
Net cash used in operating activities   (138,293)   (1,369,114)
           
Cash Flows From Investing Activities:          
Investment to GTX   (150,000)    
Investment to TGHI   (125,000)    
Net cash used in investing activities   (275,000)    
           
Cash Flows From Financing Activities:          
Issuance of convertible notes   300,000    1,317,386 
Issuance of note receivable   (190,000)    
Proceeds from sales of common stock   231,864    (106,200)
Repayment of related party   (694,225)    
Repayment of convertible note   (39,042)    
Proceeds from related party   756,227     
Issuance of notes payable       200,000 
Net cash provided by financing activities   364,826    1,411,186 
           
Net increase in cash   (48,467)   42,072 
           
Cash, beginning of Year   155,106    113,034 
           
Cash, end of Year  $106,639   $155,106 
           
Cash paid for:          
Interest  $   $2,898 
Income taxes  $   $2,898 
           
Supplemental non-cash investing and financing activities          
Debt discount related to convertible debt  $325,916   $741,100 
Reduction in derivative liability due to conversion  $2,209,888   $11,666,999 
Shares issued for conversion of convertible debt  $2,165,464   $5,678,006 
           
Transfer of marketable equity security to repay convertible note  $   $660,000 
Share issuance for JV Metaverse  $5,000   $ 
Share issuance for JV Tokenize  $1,500   $ 
Transfer of accounts payable to convertible note  $   $424,731 
Transfer of accrued interest to convertible note  $   $202,899 
Cancellation of TTSG Shares  $(2)     

 

The accompanying footnotes are an integral part of these consolidated financial statements.

 

F-7

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

Note 1 - Organization and Basis of Presentation

 

Organization and Line of Business

 

GBT Technologies Inc. (formerly Gopher Protocol Inc.) (the “Company”, “GBT”, or “GTCH”) was incorporated on July 22, 2009 under the laws of the State of Nevada. The Company is targeting growing markets such as development of Internet of Things (IoT) and Artificial Intelligence (AI) enabled networking and tracking technologies, including wireless mesh network technology platform and fixed solutions, development of an intelligent human body vitals device, asset-tracking IoT, and wireless mesh networks. Effective August 5, 2019, the Company changed its name from Gopher Protocol Inc. to GBT Technologies Inc. The Company derived revenues from (i) the provision of IT consulting services; and (ii) from the licensing of its technology. (ii) from selling electronic products through e-commerce platforms.

 

On February 18, 2022 the Company, effective March 1, 2022 entered into a Revenue Sharing Agreement (“RSA”) with Mahaser LTD. (“Mahaser”) pursuant to which the Company shares revenues generated by Mahaser with respect to e-commerce sales through the online retail platform in the United States of America.

 

The audited condensed CFS are prepared by the Company, pursuant to the rules and regulations of the SEC. The information furnished herein reflects all adjustments, consisting only of normal recurring adjustments, which in the opinion of management, are necessary to fairly state the Company’s financial position, the results of its operations, and cash flows for the periods presented.

 

Basis of Presentation

 

The accompanying CFS were prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

 

Stock Split

 

On October 26, 2021, the Company effectuated a 1 for 50 reverse stock split. The share and per share information has been retroactively restated to reflect this reverse stock split.

 

In July 2, 2022 the Company filed a preliminary information statement to the stockholders of record (the “Record Date”) in connection with certain actions to be taken by the written consent by stockholders holding a majority of the voting stock of the Company, dated as of June 28, 2022.

 

F-8

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

To amend the Company’s Articles of Incorporation, (the “Articles of Incorporation”) to increase the number of authorized shares of common stock, par value $0.00001 per share (the “Common Stock”), of the Company from 2,000,000,000 shares to 10,000,000,000 shares. This action concluded on August 11, 2022:

 

    (i) authorize the Company’s Board of Directors to effect, in its sole discretion, a reverse stock split of the Common Stock in a ratio of up to 1-for-500 (the “Reverse Stock Split”), and (ii) authorize the filing of an amendment to the Company’s Articles of Incorporation to implement the Reverse Stock Split and any other action deemed necessary to effectuate the Reverse Stock Split, without further approval or authorization of stockholders, at any time prior to December 31, 2023. This action was not commenced by the Company’s board.

  

Note 2 – Going Concern

 

The accompanying CFS have been prepared assuming the Company will continue as a going concern. The Company has an accumulated deficit of $299,257,917 and has a working capital deficit of $18,552,046 as of December 31, 2022, which raises substantial doubt about its ability to continue as a going concern.

 

The Company’s ability to continue as a going concern is dependent upon its ability to generate profitable operations in the future and/or obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management has plans to seek additional capital through some private placement offerings of debt and equity securities. These plans, if successful, will mitigate the factors which raise substantial doubt about the Company’s ability to continue as a going concern. These CFS do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty.

 

Note 3 – Summary of Significant Accounting Policies

 

Use of Estimates

 

The preparation of CFS in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the CFS and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates in the accompanying CFS include valuation of derivatives and valuation allowance on deferred tax assets.

 

F-9

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

Principles of Consolidation

 

The accompanying CFS include the accounts of the Company and its subsidiaries; the Company’s 50% owned subsidiaries GBT BitSpeed Corp. (currently inactive) and GBT Tokenize Corp; the Company’s 50% owned subsidiary, Gopher Protocol Costa Rica Sociedad De Responsabilidad Limitada (currently inactive), a wholly owned subsidiary, AltCorp Trading LLC, a Costa Rica company (“AltCorp” currently inactive) and Greenwich International Holdings, a Costa Rica corporation (“Greenwich” currently inactive). All significant intercompany transactions and balances were eliminated.

 

For entities determined to be VIEs, an evaluation is required to determine whether the Company is the primary beneficiary. The Company evaluates its economic interests in the entity specifically determining if the Company has both the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance (“the power”) and the obligation to absorb losses or the right to receive benefits that could potentially be significant to the VIE (“the benefits”). When making the determination whether the benefits received from an entity are significant, the Company considers the total economics of the entity, and analyzes whether the Company’s share of the economics is significant. The Company utilizes qualitative factors, and, where applicable, quantitative factors, while performing the analysis.

 

In addition, the Company’s variable interests in Mahaser obligate the Company to absorb deficits and provide it with the right to receive benefits that could potentially be significant to Mahaser. As a result of this analysis, the Company concluded it is the primary beneficiary of Mahaser and therefore consolidates the balance sheets, results of operations and cash flows of Mahaser. The Company performs a qualitative assessment of Mahaser on an ongoing basis to determine if it continues to be the primary beneficiary.

 

Cash Equivalents

 

For the purpose of the statement of cash flows, cash equivalents include time deposits, certificate of deposits, and all highly-liquid debt instruments with original maturities of three months or less. As of December 31, 2022 and 2021, the Company did not have any cash equivalents.

 

Funds in Escrow

 

Restricted cash is $375,000 as part of the SURG settlements proceeds that needs to stay in escrow and $19,694 restricted cash that the court on January 28, 2022 awarded the Company with injunction against RWJ defendants, where all funds generating from resale should be deposited into GBT blocked account, and therefore RWJ defendants cannot use these funds without court order, neither the Company. According to settlement agreement made on September 26, 2022, these funds held in escrow and no longer restricted. The Company entered into the Confidential Settlement Agreement and Mutual Release (“RJW Agreement”) by and between RWJ Advanced Marketing, LLC, Robert Warren Jackson, Gregory Bauer (collectively the “RJW Parties”) and W.L. Petrey Wholesale Company, Inc., (“Petrey”) on one hand; and GBT Technologies Inc., on behalf of itself and its agents (collectively the GBT Parties”), on the other hand. The Company the RJW Agreement effective September 26, 2022 with final signatures delivered to the Company on or about October 5, 2022. Among other agreements the parties agreed and stipulated to release all funds currently being held in a blocked account of $19,694 with 50% distributed to the RWJ Parties and 50% to the Company or its assignee.

 

Marketable Securities

 

The Company accounts for investment securities in accordance with ASC Topic 321, Investments – equity securities. Marketable equity securities are reported at FV based on quotations available on securities exchanges with any unrealized gain or loss being reported as a component of other income (expense) on the statement of operations. The portion of marketable equity security expected to be sold within 12 months of the balance sheet date is reported as a current asset. These publicly traded equity securities are valued using quoted prices and are included in Level 1.

 

F-10

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

Inventory

 

Inventory consists of electronic product ready for sale on Amazon.com. It is stated at the lower of cost or net realizable value and all inventories were returned product from online customers. We value our inventory using the weighted average costing method. Our Company’s policy is to include as a part of inventory any freight incurred to ship the product from our contract vendors to our warehouses. Outbound freight costs to our customers are considered period costs and reflected in selling, general and administrative expenses. We regularly review inventory and consider forecasts of future demand, market conditions and product obsolescence.

 

Note Receivable Paid-Off

 

On September 18, 2020, the Company entered into a Purchase and Sale Agreement with Mr. LightHouse LTD., an Israeli corporation (“MLH”) pursuant to which the Company agreed to sell and assign to MLH, effective July 1, 2020 all the shares, and certain specified liabilities, of Ugopherservices Corp. (“UGO”), a wholly owned subsidiary of the Company for $100,000 to be paid through the delivery of a promissory note payable to the Company (the “Note”), upon the terms and subject to the limitations and conditions set forth in the Note. At December 31, 2020, the Company determined this note was not collectible and took an impairment charge of $100,000. During July 2021, MLH effected a $50,000 payment on the Note. During April 2022, MLH effected a second payment for additional $50,000 on the Note exhausting the Note balance.

 

Derivative Financial Instruments

 

The Company evaluates all of its agreements to determine if such instruments have derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its FV and is then re-valued at each reporting date, with changes in the FV reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a weighted-average Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. As of December 31, 2022 and 2021, the Company’s only derivative financial instrument was an embedded conversion feature associated with convertible notes payable due to certain provisions that allow for a change in the conversion price based on a percentage of the Company’s stock price at the date of conversion.

 

Fair Value of Financial Instruments

 

For certain of the Company’s financial instruments, including cash, accounts payable, accrued liabilities and short-term debt, the carrying amounts approximate their FV due to their short maturities.

 

FASB ASC Topic 820, Fair Value Measurements and Disclosures, requires disclosure of the FV of financial instruments held by the Company. FASB ASC Topic 825, Financial Instruments, defines FV, and establishes a three-level valuation hierarchy for disclosures of FV measurement that enhances disclosure requirements for FV measures. The carrying amounts reported in the consolidated balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their FV because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:

 

F-11

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

  Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.
     
  Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
     
  Level 3 inputs to the valuation methodology use one or more unobservable inputs which are significant to the FV measurement.

 

The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic 480, Distinguishing Liabilities from Equity, and FASB ASC Topic 815, Derivatives and Hedging.

 

For certain financial instruments, the carrying amounts reported in the balance sheets for cash and current liabilities, including convertible notes payable, each qualify as a financial instrument, and are a reasonable estimate of their FV because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest.

 

The Company uses Level 2 inputs for its valuation methodology for derivative liabilities as their FV were determined by using the Black-Scholes-Merton pricing model based on various assumptions. The Company’s derivative liabilities are adjusted to reflect FV at each period end, with any increase or decrease in the FV being recorded in results of operations as adjustments to FV of derivatives.

 

At December 31, 2022 and 2021, the Company identified the following liabilities that are required to be presented on the balance sheet at FV:

 

       
    Fair Value   Fair Value Measurements at
    As of   December 31, 2022
Description   December 31, 2021   Using Fair Value Hierarchy
        Level 1   Level 2   Level 3
Conversion feature on convertible
notes
 
 
 
$

1,714,143
 
 
 
 
 
$
 
 
 
 
 
 
$

1,714,143
 
 
 
 
 
$
 
 
 

 

    Fair Value   Fair Value Measurements at
    As of   December 31, 2021
Description   December 31, 2022   Using Fair Value Hierarchy
        Level 1   Level 2   Level 3
Conversion feature on convertible
notes
 
 
 
$

10,192,485
 
 
 
 
 
$
 
 
 
 
 
 
$
10,192,485  
 
 
 
 
$
 
 
 

 

Treasury Stock

 

Treasury stock is recorded at cost. The re-issuance of treasury shares is accounted for on a first in, first-out basis and any difference between the cost of treasury shares and the re-issuance proceeds are charged or credited to additional paid-in capital.

 

F-12

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

Reclassification

 

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.

 

Revenue Recognition

 

Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“Topic 606”), became effective for the Company on January 1, 2018. The Company’s revenue recognition disclosure reflects its updated accounting policies that are affected by this new standard. The Company applied the “modified retrospective” transition method for open contracts for the implementation of Topic 606. The Company had no significant post-delivery obligations, this new standard did not result in a material recognition of revenue on the Company’s accompanying CFS for the cumulative impact of applying this new standard. The Company made no adjustments to its previously-reported total revenues, as those periods continue to be presented in accordance with its historical accounting practices under Topic 605, Revenue Recognition.

 

Revenue from providing IT consulting services are recognized under Topic 606 in a manner that reasonably reflects the delivery of its services to customers in return for expected consideration and includes the following elements:

 

  executed contracts with the Company’s customers that it believes are legally enforceable;
     
  identification of performance obligations in the respective contract;
     
  determination of the transaction price for each performance obligation in the respective contract;
     
  allocation the transaction price to each performance obligation; and
     
  recognition of revenue only when the Company satisfies each performance obligation.

 

These five elements, as applied to each of the Company’s IT revenue category, is summarized below:

 

  IT consulting services - revenue is recorded on a monthly basis as services are provided.

 

These five elements, as applied to each of the Company’s license revenue category, is summarize below:

 

License services – the one-time related party licensing income recorded as other income upon agreement is executed and services are provided and recognized over the term of five years.

 

E-Commerce sales

 

Identify the contract(s) with a customer. ASC 606 defines a contract as “an agreement between two or more parties that creates enforceable rights and obligations”. Since this is an e-commerce sale on the Amazon of eBay websites, the Company just followed the general terms on Amazon or eBay websites and the customer entered into a contract with the Company based on the product listed on the Amazon or eBay websites;

 

Identify the performance obligations in the contract. According to the contract, the Company is responsible for operation exclusively. The Company is entitled to all revenue which is being paid by Amazon or eBay into a designated bank account and the Company is responsible for all product acquisitions as well as shipments. The only performance obligations were the electronic products that were listed on Amazon or eBay websites and the Company determined each order is one single obligation;

 

F-13

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

Determine the transaction price. The transaction price set to be the listed price on the Amazon or eBay websites.;

 

Allocation the transaction price to the performance obligations in the contract.; and

 

Recognize revenue when the Company satisfies a performance obligation. Sales are being recognized upon shipment.

 

Unearned revenue

 

Unearned revenue represents the net amount received for the purchase of products that have not seen shipped to the Company’s customers. The Company has $48,921 and $249,384 of unearned revenue at December 31, 2022 and 2021, respectively.

 

Contract liabilities

 

On February 22, 2022, the Company entered into an Intellectual Property License and Royalty Agreement with Touchpoint Group Holdings, Inc. (“Touchpoint” or “TGHI”) pursuant to which the Company granted TGHI a worldwide license for its technologies for five years in the domains of Internet of Things (IoT) and Artificial Intelligence enabled mobile technologies pertaining to the Company’s digital currency technology (the “Technology”). GBT will charge TGHI royalties based on actual uses by TGHI of the Technology resulting from revenue attributable to the use, performance or other exploitation of the Technology, to the extent applicable, after deducting any taxes that the Company may be required to collect, and deducting any international sales, goods and services, value added taxes or similar taxes which the Company is required to pay, if any, excluding deductions for taxes on the Company net income. TGHI agreed to issue the Company 10,000,000 shares of common stock of TGHI in the FV of $50,000 as a onetime fee for the Company entering this Intellectual Property License and Royalty Agreement, which was booked contract liabilities and amortized over the  five-year term. The Company has yet to earn any royalty income in relation to this agreement as of December 31, 2022. The contract liabilities as of December 31, 2022 and December 31, 2021 was $41,444 and $0, respectively.

 

Variable Interest Entity

 

On February 18, 2022, the Company, effective March 1, 2022 entered into a Revenue Sharing Agreement (“RSA”) with Mahaser LTD. (“Mahaser”) pursuant to which the Company shares in revenues generated by Mahaser e-commerce sales through the online retail platform in the United States of America. Mahaser owns an e-commerce platform as a store which is the legal, exclusive owner of Ravenholm Electronics. The Company will operate the e-commerce platform and entitled to 95% for all revenue generated by and received by Mahaser from March 1, 2022 through December 31, 2022. The RSA provides that the Company will be entitled to appoint a manager to Mahaser. As consideration, the Company will pay Mahaser $100,000 no later than March 1, 2022 and issue Mahaser 1,000,000 shares of the Company’s restricted common stock. The Company shall have no obligations to make any further payments to Mahaser. For any further extensions, the Company will have the option to extend the RSA for annual payment of $200,000, which can be payable with the Company’s shares of common stock payable based on 20 days VWAP prior to issuance. On March 16, 2022 the parties entered into Amendment No. 1 to the to the RSA, where all consideration to be paid or issued to Mahaser will be deferred until such time where the e-commerce platform generated in cumulative revenue of $1,000,000. On March 31, 2022, the parties entered into Amendment No. 2 to the RSA, where Mahaser agreed to pay the Company 100% per year for all revenue generated by and received by seller from the sales by Amazon within the United States of America as follows from March 1, 2022 through December 31, 2022. The Company will be responsible for 100% of the cost of goods sold as well. In addition, the Company is entitled to earn 100% revenues and cost of goods sold of the period from February 1, 2022 to February 28, 2022.

 

The Company evaluated whether it has a variable interest in Mahaser, whether Mahaser is a VIE and whether the Company has a controlling financial interest in Mahaser. The Company concluded that it has variable interests in Mahaser on the basis of GBT has 100% control over the JV/revenue sharing, and as such should consolidate the JV into its books and records as it assigned 100% financial responsibility. Mahaser’s equity at risk, as defined by GAAP, is considered to be insufficient to finance its activities without additional support, and, therefore, Mahaser is considered a VIE.

 

F-14

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

The following table summarizes the carrying amount of the assets and liabilities of Mahaser included in the Company’s consolidated balance sheets at December 31, 2022 (after elimination of intercompany transactions and balances):

 

     
Assets of consolidated variable interest entity (“VIE”) included in the consolidated balance sheets above (after elimination of intercompany transactions and balances) consist of:   
Current assets:     
Cash and equivalents  $93,581 
Inventory   11,569 
Due From related party   20,270 
Total current assets  $125,420 
      
Liabilities of consolidated VIE included in the consolidated balance sheets above (after elimination of intercompany transactions and balances) consist of:     
Current liabilities     
Total current liabilities  $94,496 
      
Statements of operations of consolidated VIE included in the consolidated statements of operations above (after elimination of intercompany transactions and balances) consist of:     
Statements of operations     
 Sales  $1,107,555 
 Cost of goods sold   817,754 
 Gross profit   289,801 
 General and administrative expenses   330,647 
Net Loss  $40,846 

 

Income Taxes

 

The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes. ASC 740 requires a company to use the asset and liability method of accounting for income taxes, whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion, or all of, the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

 

Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The Company has no material uncertain tax positions for any of the reporting periods presented and its current on all its tax filings federal and state until 2021 inclusive.

 

F-15

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

Basic and Diluted Earnings Per Share

 

Earnings per share is calculated in accordance with ASC Topic 260, Earnings Per Share. Basic earnings per share (“EPS”) is based on the weighted average number of common shares outstanding. Diluted EPS assumes that all dilutive securities are converted. Dilution is computed by applying the treasury stock method. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. Due to the net income incurred potentially dilutive instruments would be anti-dilutive. Accordingly, diluted loss per share is the same as basic loss for all periods presented. The following potentially-dilutive shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would be anti-dilutive.

 

          
   December 31,  December 31,
   2022  2021
Series B preferred stock   45,000    45,000 
Series C preferred stock   700    700 
Series H preferred stock   20,000    20,000 
Warrants   70,770    392,870 
Convertible notes   3,949,223,831    83,722,340 
Total   3,949,360,301    84,180,910 

 

Management’s Evaluation of Subsequent Events

 

The Company evaluates events that have occurred after the balance sheet date of December 31, 2022, through the date which the CFS are issued. Based upon the review, other than described in Note 20 – Subsequent Events, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the CFS.

 

Recent Accounting Pronouncements

 

In August 2020, the FASB issued ASU 2020-06Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. ASU 2020-06 reduces the number of accounting models for convertible debt instruments and convertible preferred stock. For convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in capital, the embedded conversion features no longer are separated from the host contract. ASU 2020-06 also removes certain conditions that should be considered in the derivatives scope exception evaluation under Subtopic 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity, and clarify the scope and certain requirements under Subtopic 815-40. In addition, ASU 2020-06 improves the guidance related to the disclosures and earnings-per-share (EPS) for convertible instruments and contract in entity’s own equity. ASU 2020-06 is effective for public business entities that meet the definition of a SEC filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Board specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. The Company adopted this ASU on the CFS in the year ended December 31, 2021. The adoption had no material impact on the CFS for the year ended December 31, 2022.

 

On April 2021, the FASB issued ASU 2021-04, “Earnings Per Share (Topic 260), Debt— Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options” (“ASU 2021-04”) to clarify the accounting by issuers for modifications or exchanges of equity-classified warrants. The new ASU is available here and effective for all entities in fiscal years starting after December 15, 2021. Early adoption is permitted. The Company adopted this ASU on the CFS in the year ended December 31, 2021. The adoption had no material impact on the CFS for the year ended December 31, 2022.

 

Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying CFS. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

 

F-16

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

Note 4 – Marketable Securities

 

TGHI Agreement

 

On January 28, 2022, the Company entered into a Stock Purchase Agreement with Marko Radisic (the “Seller”) and Touchpoint Group Holdings, Inc. (“TGHI”) pursuant to which the Company acquired 10,000 shares of Series A Convertible Preferred Stock (the “Touchpoint Preferred”) from the Seller for $125,000. The Touchpoint Preferred is convertible into 10,000,000 shares of common stock of Touchpoint. On February 22, 2022, the Company entered into an Intellectual Property License and Royalty Agreement with TGHI pursuant to which the Company granted TGHI a worldwide license for its technologies for five years in the domains of Internet of Things (IoT) and Artificial Intelligence enabled mobile technologies pertaining to the Company’s digital currency technology (the “Technology”). GBT will charge TGHI earned royalties based on actual uses by TGHI of the Technology resulting from revenue attributable to the use, performance or other exploitation of the Technology, to the extent applicable, after deducting any taxes that the Company may be required to collect, and deducting any international sales, goods and services, value added taxes or similar taxes which the Company is required to pay, if any, excluding deductions for taxes on the Company net income. TGHI agreed to issue the Company 10,000,000 shares of common stock of TGHI in the FV of $50,000 as a one-time fee for the Company entering this Intellectual Property License and Royalty Agreement, which was booked contract liabilities and amortized over the five-year term. The Company has yet to earn any royalty income order to this agreement as of December 31, 2022.

 

TGHI converted the Touchpoint Preferred into 10,000,000 shares of common stock of Touchpoint on February 23, 2022 resulting in the Company owning 20,000,000 shares of common stock of Touchpoint in total FV of $6,000 as of December 31, 2022 based on level 1 stock price in OTC markets.

 

MetAlert -prior name GTX Corp

 

On April 12, 2022, GBT Tokenize Corp (“GBT Tokenize”), a Nevada corporation which the Company owns 50% of the outstanding shares of common stock, entered into a series of agreements with GTX Corp (“GTX”) and various note holders of GTX pursuant to which Tokenize acquired a convertible promissory note of GTX of $100,000 (the “GTX Notes”). In addition, GBT Tokenize acquired 76,923 (GBT acquired 5,000,000 in the original deal, where GTX to perform a corporate action of 1:65 reverse split on September 20, 2022) shares of common stock of GTX for $150,0–0 - in total FV of $12,538 as of December 31, 2022 based on level 1 stock price in OTC markets.

 

F-17

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

The GTX Notes bear 10% interest and 50% of the principal may be converted into shares of common stock on a one-time basis at a conversion price of $0.01 per share. The remaining 50% of the principal must be paid in cash. The closing occurred on April 12, 2022.

 

GTX changed its name into Metalert Inc. on or about September 20, 2022.

 

On September 30, 2022, GBT Tokenize, loaned MetAlert Inc., a Nevada corporation (f/k/a GTX Corp.) (“MetAlert”) $90,000. For such loan, MetAlert provided Tokenize a promissory note of $90,000 which is due and payable together with interest of 5% upon the earlier of September 19, 2023 or when declared by Tokenize.

 

MetAlert designs, manufactures and sells various interrelated and complementary products and services in the wearable technology and IoMT (Internet of Medical Things) marketplace.

 

As of December 31, 2022, the notes had an outstanding balance of $190,000 and accrued interest of $8,475.

 

As of December 31, 2022 and December 31, 2021, the marketable security had a FV of $12,538 and $0, respectively.

 

Note 5 – Investment in Surge Holdings, Inc.

 

Surge Holdings, Inc.

 

On September 30, 2019, GBT Technologies Inc. (the “Company”) entered into an Asset Purchase Agreement (“APA”) with Surge Holdings, Inc., a Nevada corporation (“SURG”) pursuant to which the Company agreed to sell and assign to SURG, all the assets and certain specified liabilities, of its ECS Prepaid, Electronic Check Services and the Central State Legal Services businesses for $5,000,000 to be paid through the issuance of 3,333,333 shares of SURG’s common stock (the “SURG Common Stock”) and a convertible promissory note in favor of the Company in the principmountount of $4,000,000 (the “SURG Note”), convertible into SURG’s shares of common stock. On January 7, 2022, the Company received payments from Surgepays Inc. (formerly known as Surge Holdings, Inc.) in total of $3,750,000 pursuant to the terms of the Settlement Agreement dated December 22, 2021.

 

On June 23, 2020, SURG entered into an Exchange Agreement (the “AltCorp Exchange Agreement”) with AltCorp Trading LLC (“AltCorp”) with such AltCorp Exchange Agreement being consented and agreed to by the Company, the parent of AltCorp. At the expiration of the lock-up period, in the event the VWAP for the SURG Common Stock was, during the preceding twenty-day trading period, less than $0.50 per share, AltCorp retained the right to reserve additional shares of SURG Common Stock equal to the True-Up Value as defined in the AltCorp Exchange Agreement.

 

F-18

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

On March 8, 2020, SURG filed a lawsuit against its transfer agent from transferring millions of SURG stock that is currently in possession by the Company and assigned to Stanley Hills, LLC. On January 1, 2021, SURG, AltCorp and Stanley Hills, LLC (“Stanley”) entered into a Mutual Release and Settlement Agreement (“Settlement Agreement”). Pursuant to the terms of the Settlement Agreement, SURG agreed to amend the AltCorp Exchange Agreement where SURG acknowledged a debt of $3,300,000 (the “Debt”) to be paid in 33 monthly payments of $100,000 payable in shares of common stock of SURG at a per share price equal the volume weighted average price of Surg’s common stock during the 10 trading days immediately preceding the issuance. SURG paid $400,000 in cash and $800,000 by shares. The SURG common stock issued to Altcorp have been pledged since August 12, 2020 for the benefit of Stanley to secure Stanley’s note payable by the Company. Accordingly, the SURG Common Stock issued to AltCorp as a result of the Settlement Agreement were pledged to Stanley. As of December 31, 2021 there were no surge shares pledges after the final settlement signed on December 22, 2021 and that replaced all prior settlement agreement. The final settlement SURG agreed to make total payments of $4,200,000 to the Company’s trust account on or prior to January 7, 2022. This $4.2 million amount consists of $450,000 paid by SURG in November and December 2021, $100,000 to be paid on or about January 4, 2022, and $3,650,000 to be paid on or prior to January 7, 2022 of which $375,000 will be held in escrow as described before. The $3,750,000 was recorded as other receivable as of December 31, 2021. As of December 31, 2021, the Company has recorded an outstanding payable balance to Stanley amounted $1,862,928 recorded under accrued expenses.

 

Subsequently, SURG was a party to two lawsuits in state District Court, the Eighth Judicial District Court for Clark County, Nevada involving AltCorp, Stanley and Glen Eagles Acquisition LP (the “AltCorp Parties.”). Each of these lawsuits were ultimately disputes relating to the total consideration SURG was to pay the Company under the APA.

 

On October 18, 2021, the AltCorp Parties, the Company, and SURG entered into a Memorandum of Understanding (the “MOU”) to set up a framework for an attempt to settle the two lawsuits.

 

On December 22, 2021 (the “Effective Date”), pursuant to the framework in the MOU, the AltCorp Parties (and an additional third party), the Company, ECS, and SURG, Kevin Brian Cox (SURG’s Chief Executive Office–) - in his individual capacity, entered into a Resolution of Purchase, Mutual Release, and Settlement Agreement (the “Final Settlement Agreement”) to settle the two lawsuits and resolve all disputes related to the consideration paid by SURG to the Company in connection with the APA.

 

(F)The Final Settlement Agreement, among other resolutions, essentially provides the following: i) From the total consideration of the Final Settlement Agreement, the amount of $375,000 (“Escrow Amount”) will be deposited by SURG in escrow. SURG has acquired the Company’s rights to a certain Master Distribution and Service Agreement (“MDA”). Under certain circumstances, if the result of the Company’s lawsuit against a third party (the “GBT Lawsuit”) is a monetary judgment without the assignment or legal decree of ownership of the MDA, the Company shall be entitled to receive the Escrow Amount and shall assign to SURG the first $1,000,000 the Company recovers from the defendants in the GBT Lawsuit. In the event that the Company does not prevail in the GBT Lawsuit then it shall be entitled to release of the Escrow Amount but shall be responsible for any fees and costs obligation sought by the defendants in the GBT Lawsuit.

 

(ii) SURG agreed to make total payments of $4,200,000 to the Company’s trust account on or prior to January 7, 2022. This $4.2 million amount consists of $450,000 paid to the Company in November and December 2021, $100,000 to be paid on or about January 4, 2022, and $3,650,000 to be paid on or prior to January 7, 2022 of which $375,000 will be held in escrow as described before. The final settlement SURG agreed to make total payments of $4,200,000 to the Company’s trust account on or prior to January 7, 2022. The $3,750,000 was recorded as other receivable as of December 31, 2021. The entire balance of $3,750,000 was paid in January 2022.

 

(iii) Potential payments to third parties.

 

The Final Settlement Agreement replaces all prior agreements between the parties. In addition, within three (3) trading days of the last payment related to the $4.2 million payment to Stanley being made, the parties shall make filings with the state District Court in Clark County, Nevada to dismiss both lawsuits, including, regarding the lawsuit filed by AltCorp Trading, LLC, the dismissal of the lawsuit as to VStock Transfer, LLC. The parties agreed to a full mutual release of any disputes or claims between the parties.

 

The final settlement of $3,750,000 was received by the Company in January 2022 and paid out $3,750,000 to the third parties before December 31, 2022.

 

As the Company committed to assign certain revenue share agreement to SURG as part of the Company’s settlement with RWJ Agreement, on October 5, 2022 and as cumulation of all settlement agreements the Company issued a request to the SURG regarding release of certain escrow funds and the execution of an assignment of rights as contemplated in the aforereferenced agreement.

 

F-19

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

Note 6 - Stock Loan Receivable

 

On January 8, 2019, the Company entered into a Stock Pledge Agreement with Latin American Exchange Latinex Casa de Cambio, S.A., a Costa Rica corporation (“Latinex”), to provide that Latinex may maintain its required regulatory capital as required by various regulators. The Company has pledged 4,006 restricted shares of its common stock valued at $7,610,147 (based on the closing price on the grant date) for a term of three years for an annual payment of $375,000 paid in quarterly installments of $93,750. In lieu of cash payment, Latinex may pay the Company in virtual currency of WISE Network S.A. valued at a 50% discount of its offering price of $10 per token. In the event that Latinex’s required capital has decreased below $5,000,000, Latinex is permitted to sell the pledged shares of common stock only in an amount to ensure that Latinex can satisfy the required capital levels. The Company must consent to such sale of the shares of common stock, which may not be unreasonably withheld. Upon expiration of the agreement, the remaining shares of common stock shall be returned to the Company free and clear of all liens. The Company has recorded the value of these shares of common stock as a stock loan receivable which is presented as a contra-equity account in the accompanying consolidated balance sheets. At December 31, 2019, the Company wrote off the accrued interest income as Latinex did not perform any payment and the Company has no mean to enforce this payment. Latinex agreed in principle to return the pledged 4,006 restricted shares to the Company for cancellation. The 4,006 restricted shares have not yet been returned to the Company as of December 31, 2022.

 

Note 7 – Impaired Investment

 

Investment in GBT Technologies, S.A.

 

On June 17, 2019, the Company, AltCorp Trading LLC, a Costa Rica company and a wholly-owned subsidiary of the Company (“AltCorp”), GBT Technologies, S.A., a Costa Rica company (“GBT-CR”) and Pablo Gonzalez, a shareholder’s representative of GBT-CR (“Gonzalez”), entered into and closed an Exchange Agreement (the “GBT Exchange Agreement”) pursuant to which the parties exchanged certain securities. In accordance with the Exchange Agreement, AltCorp acquired 625,000 shares of GBT-CR representing 25% of its issued and outstanding shares of common stock from Gonzalez for the issuance of 20,000 shares of Series H Convertible Preferred Stock of the Company and a Convertible Note in the principal amount of $10,000,000 issued by the Company (the “Gopher Convertible Note”) as well as the transfer and assignment of a Promissory Note payable by Gopher Protocol Costa Rica Sociedad De Responsabilidad Limitada to the Company in the principal amount of $5,000,000 dated February 6, 2019 (of which the underlying security for this Promissory Note is 30,000,000 restricted shares of common stock of Mobiquity Technologies, Inc. (“Mobiquity”) and 60,000,000 restricted shares of common stock of Mobiquity.

 

The Gopher Convertible Note bears interest of 6% and is payable at maturity on December 31, 2021. At the election of Gonzalez, the Gopher Convertible Note can be converted into a maximum of 20,000 shares of Series H Preferred Stock. Each share of Series H Preferred Stock is convertible, at the option of the holder but subject to the Company increasing its authorized shares of common stock, into such number of shares of common stock of the Company as determined by dividing the Stated Value ($500 per share) by the conversion price ($500 per share). The Series H Preferred Stock has no liquidation preference, does not pay dividends and the holder of Series H Preferred Stock shall be entitled to one vote for each share of common stock that the Series H Preferred Stock may be convertible into. Upon conversion of the Gopher Convertible Note and the 20,000 shares of Series H Preferred Stock, Gonzalez would be entitled to less than 50% of the resulting outstanding shares of common stock of the Company following conversion in full and, as a result, such transaction is not considered a change of control.

 

F-20

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

On May 19, 2021, the Company, entered into a Mutual Release and Settlement Agreement and Irrevocable Assignment of Note Balance Principal and Accrued Interest (the “Gonzalez Agreement”) with third party, GBT-CR, IGOR 1 Corp and Gonzalez. Pursuant to the Gonzalez Agreement, without any party admission of liability and to avoid litigation, the parties had agreed to (i) extend the GBT Convertible Note maturity date to December 31,2022, (ii) amend the GBT Convertible Note terms to include a beneficial ownership blocker of 4.99% and a modified conversion feature to the GBT Convertible Note with 15% discount to the market price during the 20 trading day period ending on the latest complete trading day prior to the conversion date and (iii) provided for an assignment of the GBT Convertible Note by Gonzalez to a third party.

 

GBT-CR is in the business of the strategic management of BPO (Business Process Outsourcing) digital communications processing for enterprises and startups, distributed ledger technology development, AI development and fintech software development and applications.

 

The Company accounted for its investment in GBT-CR using the equity method of accounting; however, in 2020, the Company owned less than 20% after GBT-CR issued additional shares to other investors therefore exercised no control over GBT-CR; therefore, this investment is currently accounted for under the cost method. Moreover, on March 19, 2020, California Governor Gavin Newsom issued a stay-at-home order to protect the health and well-being of all Californians and to establish consistency across the state in order to slow the spread of COVID-19. California was therefore under strict quarantine control and travel has been severely restricted, resulting in disruptions to work, communications, and access to files (due to limited access to facilities). The stay-at-home order was lifted in California only on January 25, 2021. As such, the Company was unable to access or to contact GBT-CR on an on-going basis, and cannot get information about GBT-CR.

 

Investment in Joint Venture

 

On March 6, 2020, the Company through Greenwich, entered into a Joint Venture and Territorial License Agreement (the “Tokenize Agreement”) with Tokenize-It, S.A. (“Tokenize”), which is owned by a Costa Rica Trust represented by Pablo Gonzalez (“Gonzalez”). Gonzalez also represents Gonzalez Costa Rica Trust, which holds a note in the principal amount of $10,000,000 and is also a shareholder of the Company. Under the Tokenize Agreement, the parties formed GBT Tokenize Corp., a Nevada corporation (“GBT Tokenize”). The purpose of GBT Tokenize is to develop, maintain and support source codes for its proprietary technologies including advanced mobile chip technologies, tracking, radio technologies, AI core engine, electronic design automation, mesh, games, data storage, networking, IT services, business process outsourcing development services, customer service, technical support and quality assurance for business, customizable and dedicated inbound and outbound calls solutions, as well as digital communications processing for enterprises and startups (“Technology Portfolio”), throughout the State of California. Upon generating any revenue from the Technology Portfolio, the Joint Venture will earn the first right of refusal for other territories.

 

The Company pledged its 50% ownership in GBT Tokenize and its 100% ownership of Greenwich to Tokenize to secure its Technology Portfolio investment. The Company shall appoint two directors and Tokenize shall appoint one director of GBT Tokenize.

 

Tokenize shall contribute the services and resources for the development of the Technology Portfolio to GBT Tokenize. The Company shall contribute 2,000,000 shares of common stock of the Company (“GBT Shares”) to GBT Tokenize. Tokenize and the Company will each own 50% of GBT Tokenize. The shares were valued at $5,500,000.

 

In addition, GBT Tokenize and Gonzalez entered into a Consulting Agreement in which Gonzalez is engaged to provide services for $33,333 per month payable quarterly which may be paid in shares of common stock calculated by the amount owed divided by the Company’s 10-day VWAP. Gonzalez will provide services in connection with the development of the business as well as GBT Tokenize’s capital raising efforts. The term of the Consulting Agreement is two years. During year ended December 31, 2021, Gonzalez assigned all his accrued balances of $424,731 to Stanley Hills in a private transaction that the Company is not part to. The closing of the Tokenize Agreement occurred on March 9, 2020.

 

F-21

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

Through this Joint Venture the parties commenced development of an intelligent human vital signs’ device, which we currently refer to as the qTerm. The platform is an expansion of the existing license agreement with GBT Tokenize Corp., which provided GBT Tokenize Corp. with an exclusive territory of California to develop certain of the Company’s technology. As the nature of the platform cannot be restricted only to California, the Company’s joint venture GBT Tokenize Corp. will be compensated with additional two hundred million shares of the Company to strengthen its funding, subject to board approval. A provisional patent application for the qTerm Medical Device was filed on March 30, 2020 with the USPTO. The application has been assigned serial number 63001564. The Joint Venture completed successfully the first prototype. There is no guarantee that the Company will be successful in researching, developing or implementing this product into the market. In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed and granted regulatory approval, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps.

 

On May 28, 2021, the parties agreed to amend the Tokenize Agreement to expand territory granted for the Technology Portfolio under the license to GBT Tokenize to include the entire continental United States. The Company has further agreed to issue GBT Tokenize an additional 14,000,000 shares of common stock of the Company. The shares were valued at $15,400,000.

 

At March 31, 2020, the Company evaluated the carrying amount of this joint venture investment and determined that this investment was fully impaired and as a result an impairment charge of $5,500,000 was taken. At December 31, 2021, the Company evaluated the carrying amount of this joint venture investment and determined that this investment was fully impaired and as a result an impairment charge of $15,400,000 was taken.

 

Although the investment was impaired, the product development is still ongoing. The carrying amount of this investment at December 31, 2022 and December 2021, was $0 and $0, respectively.

 

Note 8 – Accounts Payable and Accrued Expenses

 

Accounts payable and accrued expenses at December 31, 2022 and 2021 consist of the following:

 

          
   2022  2021
Accounts payable  $1,530,762   $1,110,127 
Accrued liabilities   1,513,261    3,033,016 
Accrued interest   3,196,611    2,753,120 
Other        
Total  $6,240,634   $6,896,263 

 

Note 9 – Unearned Revenue

 

Unearned revenue represents the net amount received for the purchase of products that have not seen shipped to the Company’s customers. In 2018, the Company ran pre-sales efforts for its pet tracker product and received prepayments for its product. In addition, during 2018, the Company received $200,000 in connection with an intellectual property license and royalty agreement. The Company has $48,921 and $249,384 of unearned revenue at December 31, 2022 and 2021, respectively.

 

F-22

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

Note 10 – Convertible Notes Payable, Non-related Partied and Related Party

 

Convertible notes payable – non related parties at December 31, 2022 and 2021 consist of the following:

 

          
   December 31,  December 31,
   2022  2021
Convertible note payable to GBT Technologies S.A  $6,395,531   $8,055,400 
Convertible notes payable to 1800   191,257    124,200 
Convertible notes payable to Redstart Holdings       244,500 
Total convertible notes payable, non related parties   6,586,788    8,424,100 
Unamortized debt discount   (189,060)   (278,867)
Convertible notes payable – non related parties   6,397,727    8,145,233 
Less current portion   6,397,727    (8,109,436)
Convertible notes payable – non related parties, long-term portion  $   $35,797 

 

$10,000,000 for GBT Technologies S. A. acquisition

 

In accordance with the acquisition of GBT-CR the Company issued a convertible note in the principal amount of $10,000,000. The convertible note bears interest of 6% and is payable at maturity on December 31, 2021. At the election of the holder, the convertible note can be converted into a maximum of 20,000 shares of Series H Preferred Stock. Each share of Series H Preferred Stock is convertible, at the option of the holder but subject to the Company increasing its authorized shares of common stock, into such number of shares of common stock of the Company as determined by dividing the Stated Value ($500 per share) by the conversion price ($500 per share). This convertible note may convert into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion and therefore recorded as derivative liability (see note 12).

 

On May 19, 2021, the Company, Gonzalez, GBT-CR and IGOR 1 Corp entered into a Mutual Release and Settlement Agreement and Irrevocable Assignment of outstanding balance plus accrued interest (the “Gonzalez Agreement”). Pursuant to the Gonzalez Agreement, without any party admission of liability and to avoid litigation, the parties had agreed to (i) extend the GBT convertible note maturity date to December 31, 2022, (ii) amend the GBT convertible note terms to include a beneficial ownership blocker of 4.99% and a modified conversion feature to the GBT convertible note with 15% discount to the market price during the 20 trading day period ending on the latest complete trading day prior to the conversion date and (iii) provided for an assignment of the GBT convertible note by Gonzalez to a third party. As a result of the change in terms of this convertible note, the Company took a charge related to the modification of debt of $13,777,480 during the year ended December 31, 2021. This convertible note is recorded as derivative liability because of the discounted price on conversion (see note 13).

 

During the year ended December 31, 2021, IGOR 1 converted $1,284,600 of the convertible note into 4,185,650 shares of the Company’s common stock. On June 24, 2021, the Company transferred 5,500,000 SURG shares received as repayment of $660,000 of this convertible note (See Note7).

 

During the year ended December 31, 2022, IGOR 1 converted $1,659,869 of the convertible note into 590,117,647 shares of the Company’s common stock.

 

As of December 31, 2022, the note had an outstanding balance of $6,395,531 and accrued interest of $2,027,148.

 

Redstart Holdings Corp.

 

F-23

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

Paid Off Notes/Converted Notes

 

On August 4, 2020, the Company entered into a Securities Purchase Agreement with Redstart Holdings Corp., an accredited investor (“Redstart”) pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 1”) of $153,600 for $128,000. The Redstart Note No. 1 had a maturity date of November 3, 2021 and the Company had agreed to pay interest on the unpaid principal balance of the Redstart Note No. 1 at the rate of 6% from the date on which the Redstart Note No. 1 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 1, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 1. The transactions described above closed on August 5, 2020. The outstanding principal amount of the Redstart Note No. 1 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, Redstart may convert the Redstart Note No. 1 into shares of the Company’s common stock  to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 1), the Redstart Note No. 1 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 1. During the year ended December 31, 2021, the entire amount of Note No. 1 of $153,600 plus accrued interest was converted into 226,532 shares of common stock.

 

On September 15, 2020, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 2”) of $93,600 for $78,000. The Redstart Note No. 2 had a maturity date of September 15, 2021 and the Company had agreed to pay interest on the unpaid principal balance of the Redstart Note No. 2 at the rate of 6% from the date on which the Redstart Note No. 2 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 2, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 2. The transactions described above closed on September 16, 2020. The outstanding principal amount of the Redstart Note No. 2 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, Redstart may convert the Redstart Note No. 2 into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 2), the Redstart Note No. 2 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 2. During the year ended December 31, 2021, the entire amount of Note No. 2 of $93,600 plus accrued interest was converted into 89,169 shares of common stock.

 

F-24

 

  

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

On December 9, 2020, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 3”) of $100,200 for $83,500. The Redstart Note No. 3 had a maturity date of December 9, 2021 and the Company had agreed to pay interest on the unpaid principal balance of the Redstart Note No. 3 at the rate of 6% from the date on which the Redstart Note No. 3 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 3, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 3. The transactions described above closed on December 11, 2020. The outstanding principal amount of the Redstart Note No. 3 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, Redstart may convert the Redstart Note No. 3 into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 3), the Redstart Note No. 3 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 3. During the year ended December 31, 2021, the entire amount of Note No. 3 of $100,200 plus accrued interest was converted into 135,582 shares of common stock.

 

On February 10, 2021, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 4) of $184,200 for a purchase price of $153,500. The Redstart Note No. 4 had a maturity date of February 5, 2022 and the Company had agreed to pay interest on the unpaid principal balance of the Redstart Note No. 4 at the rate of 6% from the date on which the Redstart Note No. 4 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 4, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 4. The transactions described above closed on February 10, 2021. The outstanding principal amount of the Redstart Note No. 4 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, Redstart may convert the Redstart Note No. 4 into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 4), the Redstart Note No. 4 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 4. During the year ended December 31, 2021, the entire amount of Redstart Note No. 4 of $184,200 plus accrued interest was converted into 386,146 shares of common stock.

 

F-25

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

On March 15, 2021, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 5”) of $106,200 for $88,500. The Redstart Note No. 5 had a maturity date of June 15, 2022 and the Company had agreed to pay interest on the unpaid principal balance of the Redstart Note No. 5 at the rate of 6% from the date on which the Redstart Note No. 5 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 5, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 5. The transactions described above closed on March 17, 2021. The outstanding principal amount of the Redstart Note No. 5 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, Redstart may convert the Redstart Note No. 5 into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 5), the Redstart Note No. 5 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 5. During the year ended December 31, 2021, the entire amount of Redstart Note No. 5 of $106,200 plus accrued interest was converted into 317,837 shares of common stock.

 

On May 26, 2021, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 6”) of $106,200 for $88,500. The Redstart Note No. 6 had a maturity date of August 26, 2022 and the Company had agreed to pay interest on the unpaid principal balance of the Redstart Note No. 6 at the rate of 6% from the date on which the Redstart Note No. 6 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 6, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 6. The transactions described above closed on May 28, 2021. The outstanding principal amount of the Redstart Note No. 6 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, Redstart may convert the Redstart Note No. 6 into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 6), the Redstart Note No. 6 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 6. During the year ended December 31, 2021, the entire amount of Redstart Note No. 5 of $106,200 plus accrued interest was fully repaid in total cash of $141,782.

 
On September 21, 2021, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 7”) of $244,500 for $203,750. The Redstart Note No. 7 had a maturity date of December 22, 2022 and the Company agreed to pay interest on the unpaid principal balance of the Redstart Note No. 7 at 2.5% from the date on which the Redstart Note No. 7 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 7, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 7. The transactions described above closed on September 28, 2021. The outstanding principal amount of the Redstart Note No. 7 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, Redstart may convert the Redstart Note No. 7 into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 7), the Redstart Note No. 7 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 7. During the year ended December 31, 2022, Redstart converted the entire note into 7,656,951 shares of the Company’s common stock.

 

F-26

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

Iliad Research and Trading, L.P.

 

On February 27, 2019, the Company entered into a note purchase agreement with a third-party invest–r - Iliad Research and Trading, L.P.(“Iliad”), pursuant to which the Company issued a promissory note for the original principal amount of $2,325,000. The promissory note had an original issue discount of $300,000 and the inventor paid $2,025,000 to the Company, of which $25,000 was paid for legal expenses. The outstanding balance of the promissory note is to be paid on the one-year anniversary of the issuance of the note. Interest on the note accrues at the rate of 10% compounding daily. Subject to the terms and conditions set forth in the note, the Company may prepay all or any portion of the outstanding balance of the note at any time in an amount in cash equal to 120% of the amount repaid. In connection with transactions that generate less than $1,000,000 in proceeds, the Company had agreed to not issue any debt instrument or incurrence of any debt other than trade payables in the ordinary course of business, any securities or agreements to sell common stock with anti-dilution or price reset/reduction features or any securities that are or may be become convertible or exercisable into common stock with a price that varies with the market price of the common stock (collectively, “Restricted Issuance Transaction”). The outstanding balance of the Note will be increased by 5% in the event the Company enters into a Restricted Issuance Transaction that is approved by Iliad. The original issue discount is being amortized to interest expense over the term of the promissory note.

 

On February 27, 2020, the Company and Iliad entered into an Amendment to the Iliad Note pursuant to which the maturity date of the Iliad Note was extended to August 27, 2020, provided that the Debt may be converted into shares of common stock of the Company at a conversion price equal to 80% multiplied by the lowest trading daily VWAP for the common stock during the 20 trading day period ending on the latest complete trading day prior to the conversion date, provided for the payment by the Company to Iliad of an extension fee equal to 7.5% of the outstanding balance of the Iliad Note resulting in a new balance of the Iliad Note of $2,765,983 and provided that the Company’s failure to deliver shares of common stock within three trading days of a conversion would result in an event of default. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. Iliad  agreed to restrict its ability to convert the Iliad Note and receive shares of common stock such that the number of shares of common stock held by it and its affiliates after such conversion or exercise does not exceed 9.99% of the then issued and outstanding shares of common stock. On July 20, 2020 the Company and Iliad entered into agreement to extend the maturity of the Iliad Note until February 27, 2021 for an extension fee of $1,000. On February 28, 2021 the Company and Iliad entered into agreement to further extend the maturity of the Iliad Note until May 31, 2021 for an extension fee of $1,000 representing the third extension of the original note. On May 19, 2021, the Company and Iliad entered into agreement to further extend the maturity of the Iliad Note until August 31, 2021 for an extension fee of $1,000 representing the fourth extension of the original note. On August 20, 2021, the Company and Iliad entered into agreement to further extend the maturity of the Iliad Note until December 31, 2021 for an extension fee of $1,000. During the year ended December 31, 2021, Iliad converted $2,508,737 of its convertible note into 4,053,069 shares of the Company’s common stock. The balance of the Iliad debt at December 31, 2022 and December 31, 2021 was $0 and $0, respectively.

 

Sixth Street Lending LLC – named changed - 1800 Diagonal Lending LLC - First Note

 

On November 8, 2021, the Company entered into a Securities Purchase Agreement with Sixth Street Lending LLC (“Sixth Street”) pursuant to which the Company issued to Sixth Street a Convertible Promissory Note (the “Sixth Street Note”) of $124,200 for $103,500. The Sixth Street Note had a maturity date of February 8, 2023 and the Company agreed to pay interest on the unpaid principal balance of the note at 6% from the date on which the note is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the note, provided it makes a payment including a prepayment to Sixth Street as set forth in the Sixth Street Note. The outstanding principal amount of the note may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, Sixth Street may convert the note into shares of the Company’s common stock at a conversion price equal to 85% of the average of the two lowest trading prices with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Sixth Street Note), the note shall become immediately due and payable and the Company shall pay to Sixth Street, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Sixth Street Note. During the year ended December 31, 2022, Sixth Street converted the entire note into 26,343,190 shares of the Company’s common stock.

 

Outstanding Notes

 

F-27

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

Sixth Street Lending LLC – named changed - 1800 Diagonal Lending LLC - Second Note

 

On May 5, 2022, the Company entered into a Securities Purchase Agreement with 1800 Diagonal Lending LLC, an accredited investor (“DL”), pursuant to which the Company issued to DL a Convertible Promissory Note (the “DL Note”) of $244,500 for $203,500. The DL Note had a maturity date of August 4, 2023 and the Company had agreed to pay interest on the unpaid principal balance of the DL Note at 6.0% from the date on which the DL Note is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the DL Note at any time from the Issue Date and continuing through 180 days following the Issue Date, provided it makes a payment including a prepayment premium to DL as set forth in the DL Note. The transactions described above funded on May 9, 2022.

 

The outstanding principal amount of the DL Note may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, DL may convert the DL Note into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price during the 20-day period immediately preceding the date of conversion. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the DL Note), the DL Note shall become immediately due and payable and the Company shall pay to DL, in full satisfaction of its obligations hereunder, additional amounts as set forth in the DL Note. In no event shall DL be allowed to effect a conversion if such conversion, along with all other shares of Company common stock beneficially owned by DL and its affiliates would exceed 4.99% of the outstanding shares of the common stock of the Company.

 

Unless the Company shall have first delivered to DL, at least 48 hours prior to the closing of any equity (or debt with an equity component) financing in an amount less than $150,000 (“Future Offering”), written notice describing the proposed Future Offering and providing the Buyer an option during the 48 hour period following delivery of such notice to DL the securities being offered in the Future Offering on the same terms as contemplated by such Future Offering then the Company is restricted from conducting the Future Offering during the period beginning on the Issue Date and ending nine months following the Issue Date.

 

During the year ended December 31, 2022, 1800 Diagonal lending converted $130,400 of the convertible note into 222,091,971 shares of the Company’s common stock.

 

As of December 31, 2022, the note had an outstanding balance of $114,100 and accrued interest of $7,674.

 

Sixth Street Lending LLC – named changed - 1800 Diagonal Lending LLC - Third Note

 

On September 13, 2022, the Company entered into a Securities Purchase Agreement (dated September 9, 2022) with 1800 Diagonal Lending LLC, an accredited investor (“DL”) pursuant to which the Company issued to DL a Promissory Note (the “DL Note”) of $116,200 with an original issue discount of $12,450 resulting in net proceeds of the Company of $103,750. The DL Note had a maturity date of September 9, 2023 and the Company had agreed to pay interest on the unpaid principal balance of the DL Note at the rate of 12.0% from the date on which the DL Note is issued (the “Issue Date”). A one-time interest charge of 12% or $13,944 was applied on the Issue Date to the principal amount owed under the DL Note. Accrued, unpaid interest and outstanding principal, subject to adjustment, shall be paid in ten payments of $13,014.40 resulting in a total payback to DL of $130,144. The first payment is due October 30, 2022 with nine subsequent payments each month thereafter. The Company shall have a five-day grace period with respect to each payment. The Company has right to accelerate payments or prepay in full at any time with no prepayment penalty. This DL Note shall not be secured by any collateral or any assets of the Company. The outstanding principal amount of the DL Note may not be converted into the Company common shares except in the event of default. In the event of default on the DL Note, DL may convert the DL Note into shares of the Company’s common stock at a conversion price equal to 75% of the lowest trading price with a 10-day look back immediately preceding the date of conversion. In addition, upon the occurrence and during the continuation of an event of default (as defined in the DL Note), the DL Note shall become immediately due and payable and the Company shall pay to DL, in full satisfaction of its obligations hereunder, additional amounts as set forth in the DL Note. In no event shall DL be allowed to effect a conversion if such conversion, along with all other shares of Company common stock beneficially owned by DL and its affiliates would exceed 4.99% of the outstanding shares of the common stock of the Company.

 

F-28

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

During the year ended December 31, 2022, the company paid back $39,043 to 1800 Diagonal lending.

 

As of December 31, 2022, the note had an outstanding balance of $77,157 and an interest of $13,944.

 

As of December 31, 2022 and December 31, 2021, the nonrelated party convertible notes had total outstanding balance of $6,393,497 and 8,145,233, net of debt discount, and accrued interest of $2,068,799 and $1,547,924, respectively.

 

Convertible notes payable – related parties at December 31, 2022 and 2021 consist of the following:

 

          
   December 31,  December 31,
   2022  2021
Convertible note payable to Stanley Hills   116,605    116,605 
Unamortized debt discount        
Convertible notes payable, net, related party   116,605    116,605 
Less current portion   (116,605)   (116,605)
Convertible notes payable, net, related party, long-term portion  $   $ 

 

Stanley Hills LLC

 

The Company entered into a series of loan agreements with Stanley Hills LLC (“Stanley”) pursuant to which it received more than $1,000,000 in loans (the “Debt”) from May 2019 up to December 2019. On February 26, 2020, in order to induce Stanley to continue to provide funding, the Company and Stanley entered into a letter agreement providing that the current note payable balance due to Stanley of $1,214,900 may be converted into shares of common stock of the Company at a conversion price equal to 85% multiplied by the lowest one trading price for the common stock during the 20-trading day period ending on the latest complete trading day prior to the conversion date. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. Stanley had agreed to restrict its ability to convert the Debt and receive shares of common stock such that the number of shares of common stock held by it and its affiliates after such conversion or exercise does not exceed 4.99% of the then issued and outstanding shares of common stock. During the year ended December 31, 2021, Stanley converted $1,231,466 of its convertible note plus interest into 4,420,758 shares of the Company’s common stock, and during the year ended December 31, 2021, Stanley loaned the Company an additional $325,000. Also, during the year ended December 31, 2021, the Company transferred the SURG shares received as repayment of $800,000 of this convertible note (See Note 10) and also converted $126,003 of accrued interest into the principal balance. During the year ended December 31, 2021, Gonzalez assigned all his accrued balances of $424,731 to Stanley in a private transaction that the Company is not part to (See Note 10). As of December 31, 2022 and 2021 the principal balance of Stanley debt is $116,605 and 116,605 respectively. The unpaid interest of the Stanley debt at December 31, 2022 and 2021 was $20,033 and $8,372, respectively. The Stanley debt is secured via a pledge agreement on the SURG shares.

 

Discounts on convertible notes

 

The Company recognized interest expense of $438,015 and $824,238 during the years ended December 31, 2022 and 2021, respectively, related to the amortization of the debt discount on convertible notes. The unamortized debt discount at December 31, 2022 and 2021 was $189,060 and $278,867, respectively.

 

F-29

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

A roll-forward of the convertible notes payable from December 31, 2020 to December 31, 2022 is below:

 

     
Convertible notes payable, December 31, 2020   13,426,706 
Issued for cash   983,450 
Convertible note issued for accounts payable   625,429 
Accrued interest added to convertible note   234,521 
Payment with marketable securities   (1,460,000)
Payment with cash   (106,200)
Original issue discount   127,550 
Conversion to common stock   (5,649,000)
Debt discount related to new convertible notes   (741,100)
Amortization of debt discounts   819,423 
Convertible notes payable, December 31, 2021  $8,261,839 
Issued for cash   300,000 
Payment with cash   (39,042)
Original issue discount   60,700 
Conversion to common stock   (2,158,971)
Debt discount related to new convertible notes   (352,441)
Amortization of debt discounts   442,247 
Convertible notes payable, December 31, 2022  $6,514,332 

 

Note –11 - Notes Payable, Non-related Parties and Related Party

 

Notes payable, non-related parties at December 31, 2022 and December 31, 2021 consist of the following:

 

          
   December 31,  December 31,
   2022  2021
RWJ acquisition note  $   $2,600,000 
SBA loan   350,000    350,000 
Total notes payable   350,000    2,950,000 
Unamortized debt discount        
Notes payable   350,000    2,950,000 
Less current portion   (41,137)   (2,612,397)
Notes payable, long-term portion  $308,863   $337,603 

 

RWJ Acquisition Note

 

In connection with the acquisition of RWJ in September 2017, the Company issued a note payable. The note accrues interest at 3.5%, was due on December 31, 2019 and is secured by the assets purchased in the acquisition. The Company contests the validity of the note, as such the note has not been repaid as of December 31, 2021. The balance of the note at December 31, 2022 and 2021 was $0 and $2,600,000 plus accrued interest of $0 and $394,666, respectively.

 

F-30

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2021 and 2020

 

 

SBA Loan

 

On June 22, 2020, the Company received a loan from the Small Business Administration under the Economic Injury Disaster Loan program related to the COVID-19 relief efforts. The loan bears interest at 3.75%, requires monthly principal and interest payments of $731 after 12 months from funding and is due 30 years from the date of issuance. The monthly payments have been extended by the SBA to all EIDL borrowers with additional 12 months. Monthly payments will be commenced on or around June 16, 2022. On October 1, 2021, the Company entered an Amended Loan Authorization and Agreement with the SBA providing for the modification of the Original Note providing for monthly principal and interest payments of $1,771 after 24 months from the Original Note commencing on or around June 22, 2022. On March 17, 2022 the SBA notified it deferred the payments to all COVID-19 EIDL loans will have the first payment due extended from 24-months to 30-months from the date of the note. The Modified Note will continue to bear interest at 3.75% and is due 30 years from the date of issuance of the Original Note. The Modified Note is guaranteed by Douglas Davis, the former CEO of the Company and current consultant, as well as by GBT Tokenize Corp. The additional funding of $200,000 was received by the Company on October 5, 2021. The balance of the note at December 31, 2022 and 2021 was $350,000 and $350,000 plus accrued interest of $23,707 and $10,582, respectively.

 

Notes payable, related party at December 31, 2022 and December 31, 2021 consist of the following:

 

          
   December 31,  December 31,
   2022  2021
Alpha Eda note payable  $140,000   $140,000 
Total notes payable, related party   140,000    140,000 
Unamortized debt discount        
Notes payable, net, related party   140,000    140,000 
Less current portion   (140,000)   (140,000)
Notes payable, net, related party, long-term portion  $   $ 

 

Alpha Eda

 

On November 15, 2020, the Company issued a promissory note to Alpha Eda, LLC (“Alpha”), a related party for $140,000. The note accrues interest at 10%, is unsecured and was due on September 30, 2021. On June 20, 2021 Alpha and the Company extended the note maturity to December 31, 2021. The balance of the note at December 31, 2022 and 2021 was $140,000 and $140,000 plus accrued interest of $32,633 and $16,633, respectively.

 

Discounts on Promissory Note

 

The Company recognized interest expense of $0 and $47,671 during the years ended December 31, 2021 and 2020, respectively, related to the amortization of the debt discount on promissory notes. The unamortized debt discount at December 31, 2021 and 2020 was $0.

 

Note 12 – Accrued Settlement

 

In connection with a legal matter filed by the Investor of the $8,340,000 Senior Secured Redeemable Convertible Debenture, on December 23, 2019, in the pending arbitration between the Company and the Investor, an Interim Award was entered in favor of the Investor. On January 31, 2020, the Company was informed that a final award was entered (the “Final Award”). The Final Award affirms that certain sections of the Senior Secured Redeemable Convertible Debenture (the “Debenture”) constitute unenforceable liquidated damages penalties and were stricken. Further, it was determined that the Investor was entitled to recovery of their attorney’s fees. Consequently, the arbitrator awarded Investor an award of $4,034,444 plus interest of 7.25% accrued from May 15, 2019 (presented separately in accounts payable and accrued expenses) and costs of $55,613. (See Note 17). In connection with this settlement, the Company recognized a gain on the settlement of debt of $1,375,556 in 2019 as the difference between the carrying amount of the debt and the amount awarded by the arbitrator (See Note 17). The Company recorded accrued settlement of $4,090,057 and $4,090,057 at December 31, 2022 and 2021, respectively.

 

F-31

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

Note 13 - Derivative Liability

 

Certain of the convertible notes payable discussed in Note 10 have a conversion price that can be adjusted based on the Company’s stock price which results in the conversion feature being recorded as a derivative liability.

 

The FV of the derivative liability is recorded and shown separately under current liabilities. Changes in the FV of the derivative liability is recorded in the statement of operations under other income (expense).

 

The Company uses a weighted average Black-Scholes option pricing model with the following assumptions to measure the FV of derivative liability at December 31, 2022 and 2021:

 

               
    December 31,   December 31,
    2022   2021
Stock price   $ 0.001     $ 0.17  
      4.42-        
Risk free rate     4.76 %     0.19-0.39%  
Volatility     213-277%       167-217%  
      0.0015-       0.102-  
Conversion/ Exercise price   $ 0.0017     $ 0.103  
Dividend rate     0 %     0 %

 

The following table represents the Company’s derivative liability activity for the years ended December 31, 2022 and 2021:

 

     
Derivative liability balance, December 31, 2019  $ 
Issuance of derivative liability during the period   5,767,230 
Fair value of beneficial conversion feature of debt converted   (2,038,392)
Change in derivative liability during the period   1,533,610 
Derivative liability balance, December 31, 2020   5,262,448 
Debt modification   13,777,480 
Issuance of derivative liability during the period   1,480,439 
Fair value of beneficial conversion feature of debt converted   (116,669)
Change in derivative liability during the period   1,339,117 
Derivative liability balance, December 31, 2021  $10,192,485 
Issuance of derivative liability during the period   325,915 
Fair value of beneficial conversion feature of debt converted   (2,209,887)
Change in derivative liability during the period   (6,594,370)
Derivative liability balance, December 31, 2022  $1,714,143 

 

F-32

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

 Note 14 - Stockholders’ Equity

 

Common Stock

 

The Board of Directors of the Company approved, on April 13, 2020, a reverse stock split of all of the Company’s Common Stock, pursuant to which every 50 shares of Common Stock of the Company shall be reverse split, reconstituted and converted into one (1) share of Common Stock of the Company (the “Reverse Stock Split”). The Company submitted an Issuer Company Related Action Notification regarding the Reverse Stock Split to FINRA on April 14, 2020. To effectuate the Reverse Stock Split, the Company filed on April 21, 2020 a Certificate of Change Pursuant to Nevada Revised Statutes (“NRS”) Section 78.209 (the “Certificate of Change”) with the Secretary of State of the State of Nevada subject to FINRA approval. On June 8, 2020 FINRA advised the Company that such request is deficient due to the fact that a holder of an outstanding convertible note of the Company had entered into two settlements with the Securities and Exchange Commission that related to securities laws violations but were in no way related to the Company. As a result, FINRA advised that it is necessary for the protection of investors, the public interest, and to maintain fair and orderly markets that documentation related to the Reverse Stock Split not be processed. The Company appealed the decision made by FINRA on June 15, 2020. On August 4, 2020, FINRA notified the Company that its appeal had been denied. On October 25, 2021 FINRA approved the Reverse Stock Split and on October 26, 2021, the Company effectuated a 1 for 50 reverse stock split.

 

In July 7, 2022 the Company filed a preliminary information statement to the stockholders of record (the “Record Date”) in connection with certain actions to be taken by the written consent by stockholders holding a majority of the voting stock of the Company, dated as of June 28, 2022.

  

  To amend the Company’s Articles of Incorporation, (the “Articles of Incorporation”) to increase the number of authorized shares of common stock, par value $0.00001 per share (the “Common Stock”), of the Company from 2,000,000,000 shares to 10,000,000,000 shares. This action concluded on August 11, 2022.

 

  (i) authorize the Company’s Board of Directors to effect, in its sole discretion, a reverse stock split of the Common Stock in a ratio of up to 1-for-500 (the “Reverse Stock Split”), and (ii) authorize the filing of an amendment to the Company’s Articles of Incorporation to implement the Reverse Stock Split and any other action deemed necessary to effectuate the Reverse Stock Split, without further approval or authorization of stockholders, at any time prior to December 31, 2023. This action was not commenced yet by the Company’s board.

 

 

F-33

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

During the year ended December 31, 2022, the Company had the following transactions in its common stock:

 

  Of 5,500,000 Shares issued for cash of $231,866; and
     
  Of 847,133,242 Shares issued for the conversion of convertible notes of $2,158,969 and accrued interest of $6,491; and
     
  cancelled 240,000 for services rendered
     
  Of 150,000,000 Shares issued to GBT Tokenize for certain joint venture agreement between Magic International Argentina FC, S.L. and the Company. The value of the shares of $1,500 was determined based on the FV of the Company’s common stock; and
     
  Of 500,000,000 Shares issued to Metaverse for certain equity method investment. The value of the shares of $5,000 was determined based on the FV of the Company’s common stock; and

 

Series B Preferred Shares

 

The Series B Preferred Stock has a stated value of $100 per share and is convertible into the Company’s common stock at a conversion price of $30 per share representing 30 posts split common shares. Furthermore, the Series B Preferred Stock votes on an as converted basis and carries standard anti-dilution rights. These rights were subsequently removed, except in cases of stock dividends or splits.

 

As of December 31, 2022 and 2021, there were 45,000 Series B Preferred Shares outstanding.

 

Series C Preferred Shares

 

Each share of Series C Preferred Stock is convertible, at the option of GV, into such number of shares of common stock of the Company as determined by dividing the Stated Value (as defined below) by the Conversion Price (as defined below). The Conversion Price for each share is equal to a 50% discount to the average of the lowest three lowest closing bid prices of the Company’s common stock during the 10-day trading period prior to the conversion with a minimum conversion price of $0.02. The stated value is $11 per share (the “Stated Value”). The Series C Preferred Stock has no liquidation preference, does not pay dividends and the holder of Series C Preferred Stock shall be entitled to one vote for each share of common stock that the Series C Preferred Stock shall be convertible into. GV has contractually agreed to restrict its ability to convert the Series C Preferred Stock and receive shares of the Company’s common stock such that the number of shares of the Company’s common stock held by it and its affiliates after such conversion does not exceed 4.9% of the then issued and outstanding shares of the Company’s common stock.

 

F-34

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

At December 31, 2022 and 2021, GV owns 700 Series C Preferred Shares.

 

The issuance of the Series C Preferred Stock was made in reliance upon exemptions from registration pursuant to Section 4(a)(2) under the Securities Act of 1933 and Rule 506 promulgated under Regulation D thereunder. GV is an accredited investor as defined in Rule 501 of Regulation D promulgated under the Securities Act of 1933.

 

As of December 31, 2022 and 2021, there were 700 Series C Preferred Shares outstanding.

 

Series D Preferred Shares

 

As of December 31, 2022 and 2021, there are 0 and 0 shares of Series D Preferred Shares outstanding, respectively.

 

Series G Preferred Shares

 

As of December 31, 2022 and 2021, there are 0 and 0 shares of Series G Preferred Shares outstanding, respectively.

 

Series H Preferred Shares

 

On June 17, 2019, the Company, AltCorp Trading LLC, a Costa Rica company and a wholly-owned subsidiary of the Company (“AltCorp”), GBT Technologies, S.A., a Costa Rica company (“GBT-CR”) and Pablo Gonzalez, a shareholder’s representative of GBT-CR (“Gonzalez”), entered into and closed an Exchange Agreement (the “GBT Exchange Agreement”) pursuant to which the parties exchanged certain securities. In accordance with the Exchange Agreement, AltCorp acquired 625,000 shares of GBT-CR representing 25% of its issued and outstanding shares of common stock from Gonzalez for the issuance of 20,000 shares of Series H Convertible Preferred Stock of the Company and a Convertible Note of $10,000,000 issued by the Company (the “Gopher Convertible Note”) as well as additional consideration. The Gopher Convertible Note bears interest of 6% and is payable at maturity on December 31, 2021. At the election of Gonzalez, the Gopher Convertible Note can be converted into a maximum of 20,000 shares of Series H Preferred Stock. Each share of Series H Preferred Stock is convertible, at the option of the holder but subject to the Company increasing its authorized shares of common stock, into such number of shares of common stock of the Company as determined by dividing the Stated Value ($500 per share) by the conversion price ($10 per share). The Series H Preferred Stock has no liquidation preference, does not pay dividends and the holder of Series H Preferred Stock shall be entitled to one vote for each share of common stock that the Series H Preferred Stock may be convertible into. On July 8, 2019, the Company entered a Consulting Agreement with Glen Eagles Glen Eagles Acquisition LP (“Glen”) as consultant to provide services in connection with the Company’s acquisition of 25% of GBT-CR. Consultant will provide analysis, interaction with related professional and other services as requested by the Company to integrate and expand capabilities between GBT-CR and the Company. (See Note 14 for further details.)

 

As of December 31, 2022 and 2021, there are 20,000 shares of Series H Preferred Shares outstanding.

 

F-35

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

Warrants

 

The following is a summary of warrant activity.

  

                                 
            Weighted    
        Weighted   Average    
        Average   Remaining   Aggregate
    Warrants   Exercise   Contractual   Intrinsic
    Outstanding   Price   Life   Value
Outstanding, December 31, 2021       392,870     $ 74.97       0.76     $  
Granted                                
Forfeited                                
Exercised                                
Outstanding, December 31, 2022       70,770     $ 205.07       0.30     $  
Exercisable, December 31, 2022       70,770     $ 205.07       0.30     $  

 

The exercise price for warrant outstanding and exercisable at December 31, 2022:

 

           
Outstanding   Exercisable        
Number of   Exercise   Number of   Exercise
Warrants   Price   Warrants   Price
      $ 25.00           $ 25.00  
  60,000       92.50       60,000       92.50  
  10,000       135.00       10,000       135.00  
  400       1,595.00       400       1,595.00  
        2,500.00             2,500.00  
        3,750.00             3,750.00  
        5,000.00             5,000.00  
  200       11,750.00       200       11,750.00  
  150       12,500.00       150       12,500.00  
  20       14,000.00       20       14,000.00  
  70,770               70,770          

 

Equity Purchase Agreement and Registration Rights Agreement

 

On December 17, 2021 (the “Effective Date”), GBT Technologies Inc. (the “Company”) entered into an equity financing agreement (the “Equity Financing Agreement”) and a registration rights agreement (the “Registration Rights Agreement”) with GHS Investments LLC (“GHS”), pursuant to which GHS shall purchase from the Company, up to that number of shares of common stock of the Company (the “Shares”) for $10,000,000, subject to certain limitations and conditions set forth in the Equity Financing Agreement from time to time over the course of 24 months after an effective registration of the Shares with the Securities and Exchange Commission (the “SEC”) pursuant to the Registration Rights Agreement, is declared effective by the SEC (the “Contract Period”).

 

The Equity Financing Agreement grants the Company the right, from time to time at its sole discretion (subject to certain conditions) during the Contract Period, to direct GHS to purchase shares of Common Stock on any business day (a “Put”), provided that at least ten trading days has passed since the most recent Put. The purchase price of the shares of Common Stock contained in a Put will be 90% of the lowest daily volume weighted average price (VWAP) of the Company’s Common Stock during the ten consecutive trading days preceding the receipt by GHS of the applicable Put notice. Such sales of Common Stock by the Company, if any, may occur from time to time, at the Company’s option, during the Contract Period. Subject to the satisfaction of certain conditions set forth in the Equity Financing Agreement, on each Put the Company will deliver an number of Shares equaling 110% of the dollar amount of each Put. The maximum dollar amount of each Put will not exceed 200% of the average daily trading dollar volume for the Company’s Common Stock during the ten trading days preceding the Trading Day that GHS receives a Put. No Put will be made in an amount equaling less than $10,000 or greater than $500,000. Puts are further limited to GHS owning no more than 4.99% of the outstanding stock of the Company at any given time. The Equity Financing Agreement and the Registration Rights Agreement contain customary representations, obligations, rights, warranties, agreements and conditions of the parties. The Equity Financing Agreement terminates upon any of the following events: when GHS has purchased $10,000,000 in the Common Stock of the Company pursuant to the Equity Financing Agreement; on the date that is 24 calendar months from the date the Equity Financing Agreement was executed.

 

F-36

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

Actual sales of shares of Common Stock to GHS under the Equity Financing Agreement will depend on a variety of factors to be determined by the Company from time to time, including, among others, market conditions, the trading price of the Common Stock and determinations by the Company as to the appropriate sources of funding for the Company and its operations.

 

For the year ended December 31, 2022, the Company did not receive any proceeds from the equity purchase agreement.

 

Note 15 - Income Taxes

 

At December 31, 2022 and 2021, the significant components of the deferred tax assets are summarized below:

  

               
    December 31,   December 31,
    2022   2021
Deferred income tax asset                
Net operating loss carryforwards   $ 9,182,327     $ 8,945,238  
Total deferred income tax asset     9,182,327       8,945,238  
Less: valuation allowance     (9,182,327 )     (8,945,238 )
Total deferred income tax asset   $     $  

  

The valuation allowance increased by $237,089 and $712,442 in 2022 and 2021, respectively, as a result of the Company generating additional net operating losses. The Company’s net operating loss carryforward of approximately $31,663,196 begin to expire in 2025.

 

No income tax expense reflected in the consolidated statements of income for the years 2022 and 2021.

 

The reconciliation of the effective income tax rate to the federal statutory rate for the years ended December 31, 2022 and 2021 is as follows:

   

                               
    2022   2021
    Amount   Percent   Amount   Percent
Federal statutory rates   $ 1,118,010       21.0 %   $ (7,125,391 )     21.0 %
State income taxes     425,908       8.0 %     (2,714,435 )     8.0 %
Permanent differences     (1,784,116 )     -33.5 %     9,127,383       -26.9 %
Valuation allowance against net deferred tax assets     237,089       4.5 %     712,442       -2.1 %
Effective rate   $       %   $       %

  

The Company periodically evaluates the likelihood of the realization of deferred tax assets, and adjusts the carrying amount of the deferred tax assets by the valuation allowance to the extent the future realization of the deferred tax assets is not judged to be more likely than not. The Company considers many factors when assessing the likelihood of future realization of its deferred tax assets, including its recent cumulative earnings experience by taxing jurisdiction, expectations of future taxable income or loss, the carryforward periods available to the Company for tax reporting purposes, and other relevant factors.

 

Future changes in the unrecognized tax benefit will have no impact on the effective tax rate due to the existence of the valuation allowance. The Company estimates that the unrecognized tax benefit will not change significantly within the next twelve months. The Company will continue to classify income tax penalties and interest as part of general and administrative expense in its consolidated statements of operations. There were no interest or penalties accrued as of December 31, 2022 and 2021.

 

F-37

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

Note 16 - Related Parties

 

Related parties are natural persons or other entities that have the ability, directly or indirectly, to control another party or exercise significant influence over the party in making financial and operating decisions. Related parties include other parties that are subject to common control or that are subject to common significant influences.

 

On August 1, 2021, the Company and Danny Rittman, Chief Technology Officer and a Director of the Company, agreed to amend his employment agreement pursuant to which he will receive salary of $5,000 per month.

  

On September 1, 2017, the Company entered into and closed an Asset Purchase Agreement with a third party, RWJ Advanced Marketing, LLC (“RWJ”), a Georgia corporation, pursuant to which the Company purchased certain assets from RWJ, including inventory, terminals, licenses and permits and intangible assets. At closing, the Company and Mr. Greg Bauer entered into an Employment Agreement pursuant to which Mr. Bauer was retained as Chief Executive Officer for a term of one year, subject to an automatic extension, unless terminated, for a base salary of $250,000 and a bonus of 10% of net profit generated by the assets acquired. Mr. Bauer was also appointed to the Board of Directors of the Company. As of the closing date, Mr. Murray resigned as Chief Executive Officer of the Company but will remain as a director of the Company. Mr. Bauer, since 2004 through present, has served as executive director with W.L. Petrey Wholesale, Inc. where he was in charge of the UGO/Preway operations. The Company is in litigations in connection with RWJ transaction – See Note 18– - Contingencies.

 

On January 1, 2019, the Company and Douglas Davis entered into an Amended and Restated Employment Agreement pursuant to which Mr. Davis was retained as Chief Executive Officer. Mr. Davis served as Interim Chief Executive Officer since July 2018 until his resignation on April 11, 2020. The term of Mr. Davis’ employment was for two years through January 1, 2021. Mr. Davis was entitled to an annual base salary of $250,000, which was to be increased to $400,000 upon the Company up-listing to a national exchange. Mr. Davis was also entitled to the issuance of Stock Options to acquire of 50,000 shares of common stock of the Company, exercisable for five years, subject to vesting. The options were to be earned and vested (i) with respect to 20,000 shares of common stock on the date hereof, (ii) 5,000 shares of common stock upon the successful dual list of the Company on an international exchange such as SIX Zurich Stock Exchange or Euronext, (iii) 15,000 shares of common stock upon the successful up listing to a national exchange such as the Nasdaq, NYSE Euronext, TSX, AMEX or other, and (iv) with respect to 5,000 shares of common stock at each of the six (6) month anniversaries (July 1, 2019 and January 1, 2020). The exercise price of such options shall be the closing price of the Company on the date prior to such event.

 

On October 10, 2019, the Company entered into a Joint Venture Agreement (the “BitSpeed Agreement”) with BitSpeed LLC, which is owned by Douglas Davis, the Company’s Chief Executive Officer, to form GBT BitSpeed Corp., a Nevada company (“GBT BitSpeed”). The purpose of GBT BitSpeed is to develop, maintain and support its proprietary Extreme Transfer Software Application Concurrency, a software application to transfer secure, accelerated transmission of large file data over networks, and connection to cloud storage, Network-Attached Storage (NAS) and Storage Area Networks (SANs) (“Concurrency”). BitSpeed shall contribute the services and resources for the development of Concurrency to GBT BitSpeed. The Company shall contribute 10 million shares of common stock (valued at $17,900,000) of the Company to GBT BitSpeed. BitSpeed and the Company will each own 50% of GBT BitSpeed. The Company shall appoint two directors and BitSpeed shall appoint one director of GBT BitSpeed. In addition, GBT BitSpeed and Mr. Davis entered into a Consulting Agreement in which Mr. Davis is engaged to provide services for $10,000 per month payable quarterly which may be paid in shares of common stock calculated by the amount owed divided by the Company’s 20-day VWAP. Mr. Davis will provide services in connection with the development of the business as well as GBT BitSpeed’s capital raising efforts. The term of the Consulting Agreement is two years. The closing of the BitSpeed Agreement occurred on October 14, 2019. On April 11, 2020, Douglas Davis resigned as Chief Executive Officer of the Company so that he may fully devote all of his efforts to GBT Tokenize Corp., the Company’s joint venture, which intends to develop a new product. Mr. Davis’ resignation was not the result of any disagreements with management or board of directors of the Company.

 

F-38

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

On March 6, 2020, the Company through Greenwich, entered into the Tokenize Agreement with Tokenize, which is owned by a Costa Rica Trust represented by Gonzalez. Gonzalez also represents Gonzalez Costa Rica Trust, which holds a note of $10,000,000 and is also a shareholder of the Company. Under the Tokenize Agreement, the parties formed GBT Tokenize. The purpose of GBT Tokenize is to develop Technology Portfolio, throughout the State of California. Upon generating any revenue from the Technology Portfolio, the Joint Venture will earn the first right of refusal for other territories. Tokenize shall contribute the services and resources for the development of the Technology Portfolio to GBT Tokenize. The Company contributed 100,000,000 GBT Shares to GBT Tokenize. Tokenize and the Company will each own 50% of GBT Tokenize. The Company pledged its 50% ownership in GBT Tokenize and its 100% ownership of Greenwich to Tokenize to secure its Technology Portfolio investment. The Company shall appoint two directors and Tokenize shall appoint one director of GBT Tokenize. In addition, GBT Tokenize and Gonzalez entered into a Consulting Agreement in which Gonzalez is engaged to provide services for $33,333.33 per month payable quarterly which may be paid in shares of common stock calculated by the amount owed divided by the Company’s 10-day VWAP. Gonzalez will provide services in connection with the development of the business as well as GBT Tokenize’s capital raising efforts. The term of the Consulting Agreement is two years. The closing of the Tokenize Agreement occurred on March 9, 2020. Via this Joint Venture the parties commenced development of a development of an intelligent human vital signs’ device, suggested named qTerm.

  

The platform is an expansion of the existing license agreement with GBT Tokenize Corp., which provided GBT Tokenize Corp. with an exclusive territory of California to develop certain of the Company’s technology. As the nature of the platform cannot be restricted only to California, the Company’s joint venture GBT Tokenize Corp. will be compensated with additional two hundred million shares of the Company to strengthen its funding, subject to board approval. A provisional patent application for the qTerm Medical Device was filed on March 30, 2020 with the USPTO. The application has been assigned serial number 63001564. The Joint Venture completed successfully the first prototype. There is no guarantee that the Company will be successful in researching, developing or implementing this product into the market. In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed and granted regulatory approval, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps.

 

 

F-39

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

  

Yello Partners Inc.

 

As of December 31, 2022 and 2021, the Company has $505,000 and $385,000 owed to Yello Partners, Inc., a Company owned by the CEO.

 

Alpha Eda Note Payable – Related Party

 

On November 15, 2020, the Company issued a promissory note to Alpha Eda, LLC (“Alpha”), a related party, for $140,000. The note accrues interest at 10%, is unsecured and was due on September 30, 2021. On June 20, 2021 Alpha and the Company extended the note maturity to December 31, 2021. The balance of the note at December 31, 2022 and 2021 was $140,000 and $140,000 plus accrued interest of $32,633 and $16,333, respectively.

 

Stanley Hills LLC Convertible Note Payable – Related Party

 

The Company entered into a series of loan agreements with Stanley Hills LLC (“Stanley”) pursuant to which it received more than $1,000,000 in loans (the “Debt”) from May 2019 up to December 2019. On February 26, 2020, in order to induce Stanley to continue to provide funding, the Company and Stanley entered into a letter agreement providing that the current note payable balance due to Stanley of $1,214,900 may be converted into shares of common stock of the Company at a conversion price equal to 85% multiplied by the lowest one trading price for the common stock during the 20-trading day period ending on the latest complete trading day prior to the conversion date. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. Stanley had agreed to restrict its ability to convert the Debt and receive shares of common stock such that the number of shares of common stock held by it and its affiliates after such conversion or exercise does not exceed 4.99% of the then issued and outstanding shares of common stock. During the year ended December 31, 2021, Stanley converted $1,231,466 of its convertible note plus interest into 4,420,758 shares of the Company’s common stock, and during the year ended December 31, 2021, Stanley loaned the Company an additional $325,000. Also, during the year ended December 31, 2021, the Company transferred the SURG shares received as repayment of $800,000 of this convertible note (See Note 10) and converted $126,003 of accrued interest into the principal balance. During the year ended December 31, 2021, Gonzalez assigned all his accrued balances of $424,731 to Stanley in a private transaction that the Company is not part to (See Note 10). The balance of the Stanley convertible note payable at December 31, 2022 and December 31, 2021 was $116,605 and $116,605, respectively. The Stanley debt is secured via a pledge agreement on the SURG shares.

 

F-40

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

Stanley Hills LLC Accounts Payable – Related Party

 

On March 8, 2020, SURG filed a lawsuit against its transfer agent, Vstock from transferring millions of SURG stock that is currently in possession by the Company and assigned to Stanley Hills, LLC. On January 1, 2021, SURG, AltCorp and Stanley Hills, LLC (“Stanley”) entered into a Mutual Release and Settlement Agreement (“Settlement Agreement”). Pursuant to the terms of the Settlement Agreement, SURG agreed to amend the AltCorp Exchange Agreement where SURG acknowledged a debt of $3,300,000 (the “Debt”) to be paid in 33 monthly payments of $100,000 payable in shares of common stock of SURG at a per share price equal the volume weighted average price of Surg’s common stock during the 10 trading days immediately preceding the issuance. SURG paid $400,000 in cash and $800,000 by shares. The SURG common stock issued to Altcorp has been pledged since August 12, 2020 for the benefit of Stanley to secure Stanley’s note payable by the Company. Accordingly, the SURG Common Stock issued to AltCorp as a result of the Settlement Agreement were pledged to Stanley. As of December 31, 2021 there were no surge shares pledges after the final settlement signed on December 22, 2021 and that replaced all prior settlement agreement. The final settlement SURG agreed to make total payments of $4,200,000 to the Company on or prior to January 7, 2022. This $4.2 million amount consists of $450,000 paid by SURG in November and December 2021, $100,000 to be paid on or about January 4, 2022, and $3,650,000 to be paid on or prior to January 7, 2022 of which $375,000 will be held in escrow as described before. The $3,750,000 was recorded as other receivable as of December 31, 2021. As of December 31, 2022, the Company has recorded an outstanding payable balance to Stanley amounted $927,136 recorded under accrued expenses.

 

Consulting income for both the years ended December 31, 2022 and 2021 were $45,000 and $180,000. Consulting income are derived from providing IT consulting services to Stanley Hills, a related party.

 

Note 17 - Legal Proceedings

 

From time to time, the Company may be involved in various litigation matters, which arise in the ordinary course of business. There is currently no litigation that management believes will have a material impact on the financial position of the Company.

 

On or around January 30, 2019, RWJ Advanced Marketing, LLC, Greg Bauer, and Warren Jackson sued the Company and multiple third and related parties in Superior Court of the State of California - County of Los Angeles, General District in connection with the acquisition of UGO in September 2017. The case number is 19STCV03320 (the “Original Lawsuit”). The complaint in the Original Lawsuit alleges breach of contract, among other causes of action. The Company answered the complaint and filed a cross-complaint against the plaintiffs in the case and third parties on or around February 15, 2019. On or about September 10, 2020, the Company through its agent of service was “served” with a complaint (the Company contested service) that was recently filed against the Company and third parties by Robert Warren Jackson and Gregory Bauer in Los Angeles Superior Court Case No.: 20STCV32709 (“Second Lawsuit”). In the Original Lawsuit filed, the court rejected the plaintiff’s claims that they were filing a purported quasi-derivative lawsuit. As such, in this current litigation, the plaintiff is now again claiming the action is a derivative lawsuit. On October 13, 2020, the Second Lawsuit was removed by other defendants into Central District of California (CASE NO. 2:20−cv−09399−RGK−AGR). On February 2, 2021 the Central District of California dismissed the entire Second Lawsuit based on “demand futility”. In the Original lawsuit, the Company filed a cross complaint against the plaintiff and other third parties. Recently, the court has scheduled various hearings and a trial date set for December 27, 2021 which was later continued by the Court to September 28, 2022. It was the Company’s intention to dividend its holdings of its wholly owned subsidiary Ugopher services Corp. (“UGO”). As UGO is the main dispute in the litigations described above, the Company has elected to sell UGO to a third-party effective July 1, 2020. On September 17, 2020, the Company terminated Greg Bauer as consultant (resulting from the sale of UGO), which he confirmed in writing. On or about June 14, 2021 the Company stipulated with plaintiff that all third parties will be released and plaintiff may file a new first amendment complaint that will name only the Company. As such, all third parties other than prior transfer agent of the Company have been dismissed from this litigation.

  

F-41

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

  

Following the sale of UGO, the Company noticed third parties (including SURG, via its asset manager) to wire the UGO funds to its new bank account. SURG never answered the notice. SURG is the clearing house for UGO.The Company noticed certain third parties that it intends to take legal actions to resolve this issue. On November 12, 2020 the Company filed a complaint in the United States District Court – District of Nevada - Case 2:20-cv-02078 against RWJ, Mr. Bauer, Mr. Jackson and against W.L. Petrey Wholesale Company Inc for fraud, breach of contract, Unjust Enrichment and other claims. On January 28, 2022 the court awarded the Company with injunction against RWJ defendants, where all fee funds generating from resale should be deposited into GBT blocked account, and therefore RWJ defendants cannot use these funds without court order.

 

The Company entered into the Confidential Settlement Agreement and Mutual Release (“RJW Agreement”) by and between RWJ Advanced Marketing, LLC, Robert Warren Jackson, Gregory Bauer (collectively the “RJW Parties”) and W.L. Petrey Wholesale Company, Inc., (“Petrey”) on one hand; and GBT Technologies Inc., on behalf of itself and its agents (collectively the GBT Parties”), on the other hand. The Company the RJW Agreement effective September 26, 2022 with final signatures delivered to the Company on or about October 5, 2022. Pursuant to the RJW Agreement, the parties have agreed to settle, release, and otherwise resolve all known or unknown claims between them and agreed to jointly stipulate, move, or otherwise dismiss the lawsuits filed in the United States District Court of Nevada (Case No. 2:20-cv- 02078), in the Superior Court of the State of California, County of Los Angeles, Central District (Case Nos. 19STCV03320 and 20STCV32709), and in the United States District Court of the Central District of California (Case No. 2:20-cv-09399-RGK-AGR) with prejudice. The parties agreed and stipulated to release all funds currently being held in a blocked account of $19,809 with 50% distributed to the RWJ Parties and 50% distributed the Company or its assignee. The Parties also entered into the InComm Assignment Agreement (“IAA”) which assigned, transferred and conveyed all proceeds derived from the RWJ Parties’ agreements with Interactive Communications International, Inc., and its affiliate Hi Technology Corp., including but not limited to that Master Distribution and Service Agreement between Interactive Communications International, Inc. and Petrey d/b/a UGO-HUB dated August 29, 2016, as amended (collectively referred to as the “InComm Proceeds”), and which shall divide the InComm Proceeds 90% to the Company or its assignee and 10% to the RWJ Parties or their assignee. Finally, the Company agreed to pay $40,000 to the RWJ Parties or their assignee. The Company accrued $49,847 expenses represent the final amounts due to the RJW Parties.

 

The Company under a different settlement agreement with SURG, committed to assign the IAA. As such, on October 5, 2022 and as cumulation of all settlement agreements the Company issued a request to SURG regarding release of certain escrow funds and the execution of an assignment of rights as contemplated in the aforereferenced agreement.

 

On December 3, 2018, the Company entered into a Securities Purchase Agreement (the “SPA”) with Discover Growth Fund, LLC (the “Investor”) pursuant to which the Company issued a Senior Secured Redeemable Convertible Debenture (the “Debenture”) of $8,340,000. In connection with the issuance of the Debenture and pursuant to the terms of the SPA, the Company issued a Common Stock Purchase Warrant to acquire up to 225,000 shares of common stock for a term of three years (the “Warrant”) on a cash-only basis at an exercise price of $100 per share with respect to 50,000 Warrant Shares, $75 with respect to 75,000 Warrant Shares and $50 with respect to 100,000 Warrant Shares. The holder may not exercise any portion of the Warrants to the extent that the holder would own more than 4.99% of the Company’s outstanding common stock immediately after exercise. The outstanding principal amount may be converted at any time into shares of the Company’s common stock at a conversion price equal to 95% of the Market Price less $5 (the conversion price is lowered by 10% upon the occurrence of each Triggering Event – the current conversion price is 75% of the Market Price less $5.00). The Market Price is the average of the 5 lowest individual daily volume weighted average prices during the period the Debenture is outstanding. On May 28, 2019, the Investor delivered to the Company a “Notice of Default and Notice of Sale of Collateral” (the “Notice”). On December 23, 2019, in arbitration between the Company and the Investor, an Interim Award was entered in favor of the Investor. On January 31, 2020, the Company was informed that a final award was entered (the “Final Award”). The Final Award affirms that certain sections of the Debenture constitute unenforceable liquidated damages penalties and were stricken. Further, it was determined that the Investor was entitled to recovery of their attorney’s fees. Consequently, the arbitrator awarded Investor an award of $4,034,444 plus interest of 7.25% accrued from May 15, 2019 and costs of $55,613. On February 18, 2020, the Company filed a motion with the United States District Court District of Nevada (the “Nevada Court”) to confirm the Final Award and a motion to consolidate Investor’s application to confirm the Final Award filed in the U.S. District Court of the Virgin Islands (Case No: 3 :20-cv-00012-CVG-RM) (the “Virgin Island Court”). On February 27, 2020, the Nevada Court denied the Company’s motion to confirm the Final Award and motion to consolidate and further decided that the confirmation of the Final Award should be litigated in the Virgin Island Court. As such, on February 27, 2020, the Company filed a Notice of Entry of Order as well as a Motion to Confirm the Arbitration Award, address the outstanding issues regarding whether Investor’s rights are subordinated to other creditors and, thereafter, oversee a commercially reasonable foreclosure sale (Case No: 3 :20-cv-00012-CVG-RM). It was the Company’s position that the Final Award must first be confirmed and all questions regarding the rights of Investor relative to those of other creditors must be determined before any foreclosure sale can proceed. It is further the position of the Company that the previously disclosed foreclosure sale scheduled by Investor is being conducted in a commercially unreasonable manner and that if Discover proceeded forward with the foreclosure sale it did so at its own risk. Nevertheless, on February 28, 2020, Investor advised that it conducted a sale of the Company’s assets. As the date of this report Investor failed to present a deed of sale for the alleged sale that allegedly took place as noticed. The Company filed with Virgin Island Court the motions disputing the validity of the alleged sale. On July 28, 2020, Investor filed in the State of Nevada a motion for attorneys $48,844 and costs $716. The Company filed an answer on August 11, 2020. On October 16, 2020, Investor motion for attorneys $48,844 and costs $716 was denied. This case is still pending with the Federal court and the Court has not taken any substantive action in the matter as of the date of this report.

  

 

F-42

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

In connection with SURG Exchange Agreement (see Note 5) - On November 4, 2020, Altcorp and Stanley filed an Ex Parte Motion in the District Court, Clark County, Nevada (Case No: A-20-823039-B, in Dep No: 43) to appoint receiver and issue a temporary restraining Order against SURG and its transfer agent for alleged defaults on prior exchange agreement. On December 4, 2020, the parties entered an interim agreement which set the material terms of the settlement. A final settlement was achieved per the interim agreement terms on January 1, 2021. On March 4, 2021 the Company filed a motion to enforce settlement agreements, as the Company alleged that SURG owes an additional $240,000 which is due and owing under the settlement agreements.

 

On June 24, 2021 per the June 23, 2020 Agreement, the Company together with AltCorp sent SURG and its transfer agent via registered mail, a true-up shares demand for an additional 14,870,370 SURG shares as calculated per the Agreement. As of the filing date of this report, SURG’s transfer agent did not answer the Company’s request.

 

Subsequently, SURG was a party to two lawsuits in state District Court, the Eighth Judicial District Court for Clark County, Nevada involving AltCorp, Stanley and Glen Eagles Acquisition LP (the “AltCorp Parties.”). Each of these lawsuits were ultimately disputes relating to the total consideration SURG was to pay the Company under the APA.

 

On October 18, 2021, the AltCorp Parties, the Company, and SURG entered into a Memorandum of Understanding (the “MOU”) to set up a framework for an attempt to settle the two lawsuits.

 

On December 22, 2021 (the “Effective Date”), pursuant to the framework in the MOU, the AltCorp Parties (and an additional third party), the Company, ECS, and SURG, Kevin Brian Cox (SURG’s Chief Executive Officer) - in his individual capacity, entered into a Resolution of Purchase, Mutual Release, and Settlement Agreement (the “Final Settlement Agreement”) to settle the two lawsuits and resolve all disputes related to the consideration paid by SURG to the Company in connection with the APA.

 

On or about July 9, 2021 the Company filed a lawsuit in District Court in Clack County Nevada – Department 19 (Case number A-21-837631-C) against Terry Taylor and TTSG Holdings, Inc for breach of contract, breach of covenant of Good Faith and Fair Dealing, Unjust Enrichment and declaratory relief for failure of providing consulting services per contract they entered. The Company is demanding the return of 240,000 shares issued, return of the $5,000 payments, recission of the consulting agreement, and attorney’s fees and costs. As Terry Taylor and TTSG Holdings failed to appear to a notice of deposition, the Company filed for a summary judgment. On January 20, 2023 the court issued a $708,821 writ of execution against Terry Taylor and TTSG

 

Gregory Mancuso and Rainer AG

 

On or about February 2, 2022, GBT was served with a First Amended Complaint (the “Complaint”) initiated by Gregory Mancuso and Rainer AG, a Swiss corporation, Case No. 21SMCV01430, filed in the Superior Court of the State of California for the County of Los Angeles. The Complaint names a number of different parties, including GBT, and asserts, among other things, claims for conversion, unjust enrichment, breach of contract, and breach of implied covenant of fair dealing, which Plaintiffs allege arise out of a brokerage agreement entered into between Plaintiff Rainer AG and co-defendant Consul Group re Dos Mil Veintiuno S.R.L (“Consul”). GBT was sued under an alter ego theory of liability, and its only involvement in the above-referenced chain of events seems to be that its shares were deposited with Rainer by Consul upon the opening of the brokerage account. GBT will be filling a demurrer to the First Amended Complaint based on a variety of deficiencies with the First Amended Complaint, and will ask the Court to dismiss the claims against GBT.

 

 

F-43

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

Note 18 - Contingencies 

 

GBT Technologies, S.A.

 

On September 14, 2018, the Company entered into an Exclusive Intellectual Property License and Royalty Agreement (the “GBT License Agreement”) with GBT-CR, a fully compliant and regulated crypto currency exchange platform that currently operates in Costa Rica as a decentralized crypto currency platform, pursuant to which, among other things, the Company granted to GBT-CR an exclusive, royalty-bearing right and license relating intellectual property relating to systems and methods of converting electronic transmissions into digital currency as reflected in that certain patent filed with the United Stated Patent and Trademark Office on or about June 14, 2018 (EFS ID: 32893586; Application Number: 16008069; Type: Utility under 35 USC 111(a); Confirmation Number: 6787)(collectively, the “Digital Currently Technology”). Pursuant to the GBT License Agreement, the Company granted GBT-CR an exclusive worldwide license to use the Digital Currency Technology to make, use, sell, lease or otherwise commercialize and dispose of products and devices utilizing the Digital Currently Technology. Under the terms of the GBT License Agreement, the Company is entitled to receive a royalty payment of 2% of gross revenue of each licensed product sold by GBT-CR during the period starting in which revenue is first generated using the licensed products and continuing for five years thereafter. Upon signing the GBT-CR License Agreement, GBT-CR paid the Company $300,000 which is nonrefundable. The Company recognized the $300,000 as revenue during the years ended December 31, 2018. Upon GBT-CR making available for sale (the “Commercial Event”) an ICO (Initial Coin Offering) (the “Coin”), GBT-CR will make a payment to the Company of $5,000,000. Further, upon the Commercial Event, GBT-CR will grant the Company the ability to acquire 30% of the Coin at a 30% discount of such offering price of the Coin. The GBT License Agreement commenced as of the signing date and, unless terminated in accordance with the termination provisions of the GBT License Agreement, shall remain in force until the expiration of the patent pertaining to the Digital Currency Technology; provided that the right to use trade secrets shall survive the expiration of the GBT License Agreement provided the Company has not terminated. Prior to the signing of the GBT License Agreement, GBT-CR advanced $200,000 to the Company, which the parties have agreed will be applied toward the $5,000,000 fee when it becomes due. On February 27, 2020 GBT Technologies, S.A., as successor in interest to Hermes Roll, LLC had notified the Company that it was in default on its Amended and Restated Territorial License Agreement (“ARTLA”) dated June 15, 2015 and that the ARTLA had been cancelled and rescinded.

 

Stock Loan Receivable

 

On January 8, 2019, the Company entered into a Stock Pledge Agreement with Latin American Exchange Latinex Casa de Cambio, S.A., a Costa Rica corporation (“Latinex”), to provide that Latinex may maintain its required regulatory capital as required by various regulators. The Company pledged 4,006 restricted shares of its common stock valued at $7,610,147 (based on the closing price on the grant date) for three years for an annual payment of $375,000 paid in quarterly installments of $93,750. In lieu of cash payment, Latinex may pay the Company in virtual currency of WISE Network S.A. valued at a 50% discount of its offering price of $10 per token. In the event that Latinex’s required capital has decreased below $5,000,000, Latinex is permitted to sell the pledged shares of common stock only in an amount to ensure that Latinex can satisfy the required capital levels. The Company must consent to such sale of the shares of common stock, which may not be unreasonably withheld. Upon expiration of the agreement, the remaining shares of common stock shall be returned to the Company free and clear of all liens. The Company recorded the value of these shares of common stock as a stock loan receivable which is presented as a contra-equity account in the accompanying consolidated balance sheets. At December 31, 2019, the Company wrote off the accrued interest income as Latinex did not perform any payment and the Company has no mean to enforce this payment. Latinex agreed in principle to return the pledged 4,006 restricted shares to the Company for cancellation. The 4,006 restricted shares have not yet been returned to the Company as of December 31, 2022.

 

Assignment of lease agreement

 

On May 17, 2022, Mahaser LLC (“Assignee”) entered into an assignment and assumption of lease agreement by and between 2819 Coldwater LLC (“Assignor”), Sunset Place Holdings LLC (“Lessor”) and Yossi Attia (“Guarantor”). Pursuant to the agreement, Lessor agreed to lease to Assignor certain Standard Industrial/Commercial Multi-Tenant Lease – Gross agreement dated February 7, 2022 (the “Lease”) and expiring on January 31, 2024, which premises commonly known as 8265 Sunset Boulevard, Suite #107, West Hollywood, CA 90046. The base rent payment shall equal $4,100 per month and share of common area operating expense shall equal $200 per month. Guarantor has guaranteed payment of Assignor’s obligations under the Lease and Assignor assigned all of its right, title and interest in the Lease to Assignee and Assignee assumed Assignor’s obligations under the Lease.

 

F-44

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

Note 19 – Concentrations

 

Concentration of Credit Risk

 

Financial instruments, which potentially subject the Company to a concentration of credit risk for the years, consist principally of temporary cash investments. There have been no losses in these accounts through December 31, 2022 and 2021.

 

Liquidity risk

 

The Company has an accumulated deficit of $299,257,917 and has a working capital deficit of $18,522,046 as of December 31, 2022, which raises substantial doubt about its ability to continue as a going concern as the Company does not have sufficient funds to discharge its current liabilities.

 

Customers

 

Sales for both the years ended December 31, 2022 and 2021 were $1,152,555 and $0. The Consulting income from related party for both the years ended December 31, 2022 and 2021 was $45,000 and $180,000. Sales are derived from providing IT consulting services to a related party and sales from amazon and Ebay.

 

Note 20 - Subsequent Events

 

On January 24, 2023, the Company issued a convertible promissory note to Glen Eagles Acquisition LP in the principal amount of $512,500. The convertible promissory note bears interest of 10% and is payable at maturity on December 31, 2023.

  

 

F-45

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

On March 1, 2023, the Company entered into a Securities Purchase Agreement, with 1800 Diagonal Lending LLC, an accredited investor (“DL”) pursuant to which the Company issued to DL a Promissory Note (the “DL Note”) of $59,408 with an original issue discount of $6,258 resulting in net proceeds of the Company of $53,150. The DL Note had a maturity date of June 1, 2024 and the Company had agreed to pay interest on the unpaid principal balance of the DL Note at the rate of 12.0% from the date on which the DL Note is issued. A one-time interest charge of 12% or $7,128 was applied on the issuance date of the DL Note to the principal amount owed under the DL Note. Accrued, unpaid interest and outstanding principal, subject to adjustment, shall be paid in ten payments of $6,653.60 resulting in a total payback to DL of $66,536. The first payment is due April 15, 2023 with nine subsequent payments each month thereafter. The Company shall have a five-day grace period with respect to each payment. The Company has right to accelerate payments or prepay in full at any time with no prepayment penalty. This DL Note shall not be secured by any collateral or any assets of the Company.

 

The outstanding principal amount of the DL Note may not be converted into the Company common shares except in the event of default. In the event of default on the DL Note, DL may convert the DL Note into shares of the Company’s common stock at a conversion price equal to 75% of the lowest trading price during the 10 day period immediately preceding the date of conversion. In addition, upon the occurrence and during the continuation of an event of default (as defined in the DL Note), the DL Note shall become immediately due and payable and the Company shall pay to DL, in full satisfaction of its obligations hereunder, additional amounts as set forth in the DL Note. In no event shall DL be allowed to effect a conversion if such conversion, along with all other shares of Company common stock beneficially owned by DL and its affiliates would exceed 4.99% of the outstanding shares of the common stock of the Company.

 

On March 1, 2023, the Company entered into a Securities Purchase Agreement with DL pursuant to which the Company issued to DL a Convertible Promissory Note (the “DL Convertible Note”) of $62,680 for a purchase price of $52,150. The DL Convertible Note had a maturity date of June 1, 2024 and the Company had agreed to pay interest on the unpaid principal balance of the DL Convertible Note at the rate of 6.0% from the date on which the DL Convertible Note is issued until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the DL Convertible Note, provided it makes a payment including a prepayment to DL as set forth in the DL Convertible Note.

 

The outstanding principal amount of the DL Convertible Note may not be converted prior to the period beginning on the date that is 180 days following the date the DL Convertible Note is issued . Following the 180th day, DL may convert the DL Convertible Note into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price during the 20 day period preceding the date of conversion. In addition, upon the occurrence and during the continuation of an event of default (as defined in the DL Convertible Note), the DL Convertible Note shall become immediately due and payable and the Company shall pay to DL, in full satisfaction of its obligations hereunder, additional amounts as set forth in the DL Convertible Note. In no event shall DL be allowed to effect a conversion if such conversion, along with all other shares of Company common stock beneficially owned by DL and its affiliates would exceed 4.99% of the outstanding shares of the common stock of the Company.

 

F-46

 

 

GBT TECHNOLOGIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2022 and 2021

 

 

On June 10, 2022, GBT Technologies, Inc. (the “Company”), entered into a Joint Venture and Territorial License Agreement (the “Metaverse Agreement”) with Ildar Gainulin and Maria Belova (collectively, the “Licensor”).

 

Under the Metaverse Agreement, the parties formed Metaverse Kit Corp., a Nevada corporation (“Metaverse Kit”). The purpose of Metaverse Kit was to develop, maintain and support source codes for its proprietary technologies and comprehensive platform that combines a core virtual reality platform and an extended set of real-world functions to provide a metaverse experience initially within the area of sports and then expanding into virtual worlds of entertainment, live events, gaming, communications and other cross over product opportunities (the “Meta Portfolio”). Under the Metaverse Agreement, Licensor agreed to provide Metaverse Kit with the licensed technology and expertise. In connection therewith, the parties entered an Asset Purchase Agreement (the “Metaverse APA”) concurrently with the Metaverse Agreement whereby Licensor sold Metaverse Kit all source codes pertaining to the Meta Portfolio. Further, Licensor provided an exclusive license to Metaverse Kit throughout the world for the invented product/service and the related platforms relating to the Meta Portfolio and to use the know how to develop, manufacture, sell, market and distribute the Meta Portfolio throughout the world. The Company was required to contribute 500,000,000 shares of common stock of the Company (“GBT Shares”) to Metaverse Kit. Licensor and the Company were to each own 50% of Metaverse Kit. The Company pledged its 50% ownership in Metaverse Kit to Igor 1 Corp. to secure a convertible note held by Igor 1 Corp. The Company was to appoint two directors and Licensor was allowed to appoint one director of Metaverse Kit.

 

In addition, Metaverse Kit, Licensor and Elentina Group, LLC (“Elentina”) entered into a Consulting Agreements in which IGBM and Elentina, each were engaged to provide services for $25,000 per month payable quarterly which Metaverse Kit has the option to pay in shares of common stock calculated by the amount owed divided by the Company’s 10-day VWAP. Licensor and Elentina were to provide services in connection with the development of the business as well as Metaverse Kit’s capital raising efforts. The term of the Consulting Agreement was two years.

 

The closing of the Metaverse Agreement occurred on June 13, 2022.

 

On March 14, 2023, the Company received a counter signed Settlement Agreement and Release by Licensor dated March 2, 2023 (“Settlement Agreement”). Pursuant to the Settlement Agreement, the parties agreed that Metaverse Agreement, the Metaverse APA and the Consulting Agreement are void and cancelled. Licensor agreed to pay $5,000 to the Company as settlement payment and surrender their shares in Metaverse Kit.

 

On February 1, 2023, the Company engaged AlKhatib Consulting Group to provide exclusive representation services in connect with managing market partners, effective on February 1, 2012 for 24 consecutive months.

 

On April 3, 2023, GBT Tokenize Corp. (“Seller”), a subsidiary that is owned 50% by GBT Technologies, Inc (“GBT”) entered into an Asset Purchase Agreement (“APA”) with Trend Innovation Holdings, Inc. ( “TREN”), in which GBT consented, pursuant to which Seller sold certain assets relating to proprietary system and method named Avant-Ai, which is a text-generation, deep learning self-training model (the “System”).

 

In consideration of acquiring the System, TREN is required to issue to the Seller 26,000,000 common shares of TREN (the “Shares”). The Shares will be restricted per Rule 144 as promulgated under the Securities Act of 1933, as amended (the “1933 Act”) and Seller agreed to a lock-up period of nine (9) months following closing (the “Lock Up Term”). In the event that TREN is unable to up-list to Nasdaq either through a business combination or otherwise prior to the expiration of the Lock Up Term, the Seller may request within three (3) business days of the expiration of the Lock-Up Term, that all transactions contemplated by the APA be unwound.

 

In addition, TREN, Seller and GBT entered into a license agreement regarding the System, granting the Seller and/or GBT a perpetual, irrevocable, non-exclusive, non-transferable license for using the System to be used in its own development, as in-house tool, where Seller or GBT may not sublicense its rights hereunder to any customer or client.

 

 

F-47

 

 

EX-4.18 2 e4603_ex4-18.htm EXHIBIT 4.18

 

 

Exhibit 4.18 Description of Securities

 

DESCRIPTION OF SECURITIES

 

General

 

Our authorized capital stock consists of 10,000,000,000 shares of common stock, par value $0.0001 per share, and 20,000,000 shares of preferred stock, par value $0.0001 per share.

 

The following description of our capital stock and provisions of our Articles of Incorporation and Bylaws. You should also refer to our Articles of Incorporation, a copy of which is filed as an exhibit to the registration statement of which this prospectus is a part, and our Bylaws, a copy of which is filed as an exhibit to the registration statement of which this prospectus is a part.

 

Common Stock

 

We are authorized to issue up to a total of 10,000,000,000 shares of common stock, par value $0.0001 per share. Holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of our stockholders. Holders of our common stock have no cumulative voting rights.

 

Further, holders of our common stock have no preemptive or conversion rights or other subscription rights. Upon our liquidation, dissolution or winding-up, holders of our common stock are entitled to share in all assets remaining after payment of all liabilities and the liquidation preferences of any of our outstanding shares of preferred stock. Subject to preferences that may be applicable to any outstanding shares of preferred stock, holders of our common stock are entitled to receive dividends, if any, as may be declared from time to time by our board of directors out of our assets which are legally available.

 

The holders of a majority of the shares of our capital stock, represented in person or by proxy, are necessary to constitute a quorum for the transaction of business at any meeting. If a quorum is present, an action by stockholders entitled to vote on a matter is approved if the number of votes cast in favor of the action exceeds the number of votes cast in opposition to the action, with the exception of the election of directors, which requires a plurality of the votes cast.

 

Preferred Stock

 

Our board of directors will have the authority, without further action by the stockholders, to issue up to 20,000,000 shares of preferred stock in one or more series and to fix the designations, powers, preferences, privileges, and relative participating, optional, or special rights as well as the qualifications, limitations, or restrictions of the preferred stock, including dividend rights, conversion rights, voting rights, terms of redemption, and liquidation preferences, any or all of which may be greater than the rights of the common stock. Our board of directors, without stockholder approval, will be able to issue convertible preferred stock with voting, conversion, or other rights that could adversely affect the voting power and other rights of the holders of common stock. Preferred stock could be issued quickly with terms calculated to delay or prevent a change of control or make removal of management more difficult. Additionally, the issuance of preferred stock may have the effect of decreasing the market price of our common stock, and may adversely affect the voting and other rights of the holders of common stock.

  

 

 

 

Series B Convertible Preferred Stock

 

We are authorized to issue up to a total of 45,000 shares of a series of preferred stock designated as Series B preferred stock, par value $0.0001 per share. Holders of our Series B preferred stock are entitled to vote the number of votes equal to the number of whole shares of common stock into which the shares of Series B preferred stock, held by such holder are convertible as of the record date on all matters submitted to a vote of our stockholders. Holders of our Series B preferred stock are entitled, exclusively and as a separate class, to elect two directors of the Corporation,

 

Further, holders of our Series B preferred stock shall have conversion rights. The holders of our Series B preferred stock have the right to convert each share of Series B preferred stock, at any time, without payment of additional consideration by the holder into 30 shares of our common stock.

  

Series C Convertible Preferred Stock

 

We are authorized to issue up to a total of 10,000 shares of a series of preferred stock designated as Series C preferred stock, par value $0.0001 per share. Holders of our Series C preferred stock are entitled to vote the number of votes equal to the number of whole shares of common stock into which the shares of Series C preferred stock, held by such holder are convertible as of the record date on all matters submitted to a vote of our stockholders. Holders of our Series C preferred stock are entitled, exclusively and as a separate class, to elect two directors of the Corporation,

 

Further, holders of our Series C preferred stock shall have conversion rights. The holders of our Series C preferred stock have the right to convert each share of Series C preferred stock, at any time, without payment of additional consideration by the holder into 8 shares of our common stock.

 

Series H Convertible Preferred Stock

 

We are authorized to issue up to a total of 40,000 shares of a series of preferred stock designated as Series H preferred stock, par value $0.0001 per share. Holders of our Series H preferred stock are entitled to vote the number of votes equal to the number of whole shares of common stock into which the shares of Series H preferred stock, held by such holder are convertible as of the record date on all matters submitted to a vote of our stockholders. Holders of our Series F preferred stock are entitled, exclusively and as a separate class, to elect two directors of the Corporation,

 

Further, holders of our Series H preferred stock shall have conversion rights. The holders of our Series H preferred stock have the right to convert each share of Series H preferred stock, at any time, without payment of additional consideration by the holder into such number of fully paid and non-assessable shares of our common stock as determined by dividing $500 by $10 in effect at the time of such conversion. In lieu of any fractional shares to which the Series H holder would otherwise be entitled, the Company shall pay cash equal to such fraction multiplied by the fair market value of a share of common stock as determined in good faith by our board of directors.]

 

 

 

 

Anti-Takeover Provisions Under Nevada Law.

 

Combinations with Interested Stockholder. Sections 78.411-78.444, inclusive, of the Nevada Revised Statutes (“NRS”) contain provisions governing combinations with an interested stockholder. For purposes of the NRS, “combinations” include: (i) any merger or consolidation with any interested stockholder, (ii) any sale, lease, exchange, mortgage, pledge, transfer or other disposition to any interested stockholder of corporate assets with an aggregate market value equal to 5% or more of the aggregate market value of the corporation’s consolidated assets, 5% or more of the outstanding shares of the corporation or 10% or more of the earning power or net income of the corporation, (iii) the issuance to any interested stockholder of voting shares (except pursuant to a share dividend or similar proportionate distribution) with an aggregate market value equal to 5% or more of the aggregate market value of all the outstanding shares of the corporation, (iv) the dissolution of the corporation if proposed by or on behalf of any interested stockholder, (v) any reclassification of securities, recapitalization or corporate reorganization that will have the effect of increasing the proportionate share of the corporation’s outstanding voting shares held by any interested stockholder and (vi) any receipt by the interested stockholder of the benefit (except proportionately as a stockholder) of any loan, advance, guarantee, pledge or other financial assistance. For purposes of the NRS, an “interested stockholder” is defined to include any beneficial owner of more than 10% of any class of the voting securities of a Nevada corporation and any person who is an affiliate or associate of the corporation and was at any time during the preceding three years the beneficial owner or more than 10% of any class of the voting securities of the Nevada corporation.

 

Subject to certain exceptions, the provisions of the NRS governing combinations with interested stockholders provide that a Nevada corporation may not engage in a combination with an interested stockholder for two years after the date that the person first became an interested stockholder unless the combination or the transaction by which the person first became an interested stockholder is approved by the board of directors before the person first became an interested stockholder.

 

Control Share Acquisitions. The NRS also contains a “control share acquisitions statute.” If applicable to a Nevada corporation this statute restricts the voting rights of certain stockholders referred to as “acquiring persons,” that acquire or offer to acquire ownership of a “controlling interest” in the outstanding voting stock of an “issuing corporation.” For purposes of these provisions a “controlling interest” means with certain exceptions the ownership of outstanding voting stock sufficient to enable the acquiring person to exercise one-fifth or more but less than one-third, one-third or more but less than a majority, or a majority or more of all voting power in the election of directors and “issuing corporation” means a Nevada corporation that has 200 or more stockholders of record, at least 100 of whom have addresses in Nevada appearing on the stock ledger of the corporation, and which does business in Nevada directly or through an affiliated corporation. The voting rights of an acquiring person in the affected shares will be restored only if such restoration is approved by the holders of a majority of the voting power of the corporation. The NRS allows a corporation to “opt-out” of the control share acquisitions statute by providing in such corporation’s articles of incorporation or bylaws that the control share acquisitions statute does not apply to the corporation or to an acquisition of a controlling interest specifically by types of existing or future stockholders, whether or not identified.

 

Articles of Incorporation and Bylaws

 

No Cumulative Voting. Where cumulative voting is permitted in the election of directors, each share is entitled to as many votes as there are directors to be elected and each shareholder may cast all of its votes for a single director nominee or distribute them among two or more director nominees. Thus, cumulative voting makes it easier for a minority shareholder to elect a director. Our articles of incorporation deny shareholders the right to vote cumulatively.

 

Authorized But Unissued Shares. Our articles of incorporation permit the board to authorize the issuance of preferred stock, and to designate the rights and preferences of our preferred stock, without obtaining shareholder approval. One of the effects of undesignated preferred stock may be to enable the board to render more difficult or to discourage a third party’s attempt to obtain control of Gopher Protocol by means of a tender offer, proxy contest, merger, or otherwise. The issuance of shares of preferred stock also may discourage a party from making a bid for the common stock because the issuance may adversely affect the rights of the holders of common stock. For example, preferred stock that we issue may rank prior to the common stock as to dividend rights, liquidation preference, or both, may have special voting rights and may be convertible into shares of common stock. Accordingly, the issuance of shares of preferred stock may discourage bids for our common stock or may otherwise adversely affect the market price of our common stock.

 

Transfer Agent and Registrar

 

The transfer agent and registrar for our common stock is Nevada Agency and Transfer Company (“NATCO”) with a business address at 50 West Liberty Street, Suite 880, Reno NV 89501; NATCO’s website is www.natco.com, and their phone number is (775) 322-0626.

 

 

 

 

EX-31.1 3 e4603_ex31-1.htm EXHIBIT 31.1

 

 

 Exhibit 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002

 

I, Mansour Khatib, Chief Executive Officer, certify that:

 

1. I have reviewed this annual report on Form 10-K/A of GBT Technologies Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant) and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal controls over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial data information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

  

Date: April 14, 2023  /s/ Mansour Khatib
  Mansour Khatib,
  Chief Executive Officer
(Principal Executive and Financial Officer)

 

 

EX-32.1 4 e4603_ex32-1.htm

 

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO

 

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the annual report of GBT Technologies Inc. (the “Company”) on Form 10-K/A for the period ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mansour Khatib, Principal Executive Officer of the Company, certify, pursuant to 18 U.S.C. section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

  

Date: April 14, 2023  /s/ Mansour Khatib
  Mansour Khatib,
  Principal Executive Officer
(Principal Executive and Financial Officer)

  

 

GRAPHIC 5 image_001.jpg GRAPHIC begin 644 image_001.jpg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gtch-20221231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONSOLIDATED STATEMENT OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONSOLIDATED STATEMENT OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Organization and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Going Concern link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Marketable Securities link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Investment in Surge Holdings, Inc. link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Stock Loan Receivable link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Impaired Investment link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Accounts Payable and Accrued Expenses link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Unearned Revenue link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Convertible Notes Payable, Non-related Partied and Related Party link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Notes Payable, Non-related Parties and Related Party link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Accrued Settlement link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Derivative Liability link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Stockholders’ Equity link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Related Parties link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Legal Proceedings link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Concentrations link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Accounts Payable and Accrued Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Convertible Notes Payable, Non-related Partied and Related Party (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Notes Payable, Non-related Parties and Related Party (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Derivative Liability (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Stockholders’ Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Organization and Basis of Presentation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Going Concern (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Summary of Significant Accounting Policies (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Summary of Significant Accounting Policies (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Marketable Securities (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Investment in Surge Holdings, Inc. (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Impaired Investment (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Accounts Payable and Accrued Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Unearned Revenue (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Convertible Notes Payable, Non-related Partied and Related Party (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Convertible Notes Payable, Non-related Partied and Related Party (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Convertible Notes Payable, Non-related Partied and Related Party (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Convertible Notes Payable, Non-related Partied and Related Party (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Notes Payable, Non-related Parties and Related Party (Details) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - Notes Payable, Non-related Parties and Related Party (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - Notes Payable, Non-related Parties and Related Party (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - Accrued Settlement (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - Derivative Liability (Details) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - Derivative Liability (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - Stockholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - Stockholders' Equity (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - Stockholders’ Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - Income Taxes (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - Income Taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000062 - Disclosure - Related Parties (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000063 - Disclosure - Legal Proceedings (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000064 - Disclosure - Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000065 - Disclosure - Concentrations (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000066 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 gtch-20221231_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 gtch-20221231_def.xml XBRL DEFINITION FILE EX-101.LAB 9 gtch-20221231_lab.xml XBRL LABEL FILE Legal Entity [Axis] B F Borgers C P A P C [Member] Class of Stock [Axis] Series B Preferred Stock [Member] Series C Preferred Stock [Member] Series D Preferred Stock [Member] Series G Preferred Stock [Member] Series H Preferred Stock [Member] Equity Components [Axis] Common Stock [Member] Treasury Stocks [Member] Stock Loan Receivable [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Related Party [Axis] R W J Parties [Member] Mr Light House L T D [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Purchase And Sale Agreement [Member] Touch Point Group Holding [Member] Counterparty Name [Axis] Mahaser [Member] Award Type [Axis] Restricted Stock [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Consolidated Entities [Axis] Variable Interest Entity, Primary Beneficiary [Member] Antidilutive Securities [Axis] Warrant [Member] Stock Purchase Agreement [Member] Series A Convertible Preferred Stock [Member] Touchpoint Group Holdings Inc [Member] G T X Agreement [Member] G B T Tokenize [Member] G B T Tokenize Met Alert [Member] Long-Term Debt, Type [Axis] Promissory Note [Member] Surge Holdings [Member] Asset Purchase Agreement [Member] Alt Corp Exchange Agreement [Member] Stanley Hills L L C [Member] Surge Holdings Inc [Member] Altcorp [Member] G B T Shares [Member] Tokenize Agreement [Member] G B T Technologies S A [Member] 1800 [Member] Redstart Holdings [Member] GBT Technologies [Member] IGOR 1 CORP [Member] Redstart Holdings Corp [Member] Securities Purchase Agreement [Member] Redstart Holdings Corp 2 [Member] Redstart Holdings Corp 4 [Member] Redstart Holdings Corp 5 [Member] Debt Instrument [Axis] Iliad [Member] Convertible Notes Payable [Member] Sixth Street Lending L L C [Member] Sixth Street [Member] Diagonal Lending L L C [Member] Diagonal Lending 1 [Member] Convertible Debt [Member] Business Acquisition [Axis] R W J Advanced Marketing L L C [Member] S B A Loan [Member] EIDL [Member] Alpha Eda [Member] Short-Term Debt, Type [Axis] Investor [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Title of Individual [Axis] Board Of Directors [Member] Joint Venture Agreement [Member] Warrants One [Member] Warrants Two [Member] Warrants Three [Member] Warrants Four [Member] Warrants Five [Member] Warrants Six [Member] Warrants Seven [Member] Warrants Eight [Member] Warrants Nine [Member] Warrants Ten [Member] Director [Member] Davis [Member] Employment Agreement [Member] Greenwich [Member] Bit Speed Agreement [Member] Yello Partners Inc [Member] Alpha Eda L L C [Member] S U R G [Member] Transaction Type [Axis] R W J Agreement [Member] Senior Secured Redeemable Convertible Debenture [Member] S U R G Shares [Member] Concentration Risk Type [Axis] Liquidity Risk [Member] Customers [Member] Glen Eagles Acquisition L P [Member] Subsequent Event Type [Axis] Subsequent Event [Member] D L Convertible Note [Member] G B T [Member] Metaverse Agreement [Member] Ownership [Axis] G B T Technologies Inc [Member] Entities [Table] Entity Information [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Auditor Firm ID Auditor Name Auditor Location Statement [Table] Statement [Line Items] ASSETS Current Assets:  Cash  Cash held in trust  Marketable equity security  Accounts Receivable  Inventory  Prepaid  Note Receivable  Inventory in Transit  Investment  Other receivable  Total current assets  Total assets Current Liabilities:  Accounts payable and accrued expenses (including related parties of $1,539,802 and $2,302,928)  Accrued settlement  Unearned revenue  Contract liabilities  Convertible notes payable, current, net of discount of $190,464 and $362,004 Convertible notes payable, related party, net of discount of $0 and $0  Notes payable, current, net of discount of $0 and $47,671  Notes payable, current, related party  Due to related party  Derivative liability  Total current liabilities Convertible note payable, noncurrent, net of discount of $88,403 and $0 Note payable, noncurrent  Total liabilities Contingencies (Note 18) Preferred stock value  Common stock, $0.00001 par value; 10,000,000,000 shares authorized; 1,535,593,440 and 33,200,198 shares issued and outstanding respectively  Treasury stock, at cost; 21 shares respectively  Stock loan receivable  Additional paid in capital  Accumulated deficit  Total stockholders’ deficit  Total liabilities and stockholders’ deficit Accounts payable and accrued expenses related party Note payable discount Note payable discount Discount Note payable discount Preferred stock, par value Preferred stock, authorized Preferred stock, issued Preferred stock, outstanding Common stock, par value Preferred stock, authorized Common stock, outstanding Common stock, issued Treasury stock Income Statement [Abstract] Sales Consulting Income – Related Party    Total sales   Cost of Goods Sold    Gross Profit   Operating expenses:  General and administrative  Marketing  Professional  Impairment of assets  Gain on Bad Debt  Total operating expenses Loss from operations Other income (expense):  Amortization of debt discount  Change in fair value of derivative liability  Interest expense and financing costs  Realized gain (loss) on disposal of marketable equity security  Gain on RJW settlement  Loss on debt modification  Change in fair value of marketable securities    Other income  Total other income (expense) Profit (Loss) before income taxes Income tax expense Profit (Loss) from continuing operations Net Income (Loss) Weighted average common shares outstanding:  Basic  Diluted   Net Income (Loss) per share (basic and diluted):  Basic  Diluted Beginning balance, value Beginning balance, shares Common stock issued amount for conversion of debt and accrue interest Common stock issued for conversion of convertible debt and accrued interest, shares Fair value of derivative liability due to conversions Common stock issued for cash Common stock issued for cash , shares Common stock issued for- Tokenize Common stock issued for- Tokenize ,shares Equity Method Investment - Meta Equity Method Investment - Meta, shares Cancelation of shares Cancelation of shares, shares Common stock issued for services Common stock issued for services , shares Common stock issued for joint venture Common stock issued for joint venture ,shares Fair value of beneficial conversion feature of converted Net income (loss) Ending balance, value Ending balance, shares Statement of Cash Flows [Abstract] Cash Flows From Operating Activities: Net income (loss) Adjustments to reconcile net income to net cash used in operating activities: Amortization of debt discount Change in fair value of derivative liability Excess of debt discount and financing costs Shares issued for services Loss on modification of debt Impairment of assets Realized gain on disposal of market equity security Loss on exchange of assets Change in fair value of market equity security Change on Settlement Payment of other income with marketable securities Accounts receivable Other receivable Cash held in trust Prepaid Inventory Contract liabilities Unearned revenue Accounts payable and accrued expenses Net cash used in operating activities Cash Flows From Investing Activities: Investment to GTX Investment to TGHI Net cash used in investing activities Cash Flows From Financing Activities: Issuance of convertible notes Issuance of note receivable Proceeds from sales of common stock Repayment of related party Repayment of convertible note Proceeds from related party Issuance of notes payable Net cash provided by financing activities Net increase in cash Cash, beginning of Year Cash, end of Year Cash paid for: Interest Income taxes Supplemental non-cash investing and financing activities Debt discount related to convertible debt Reduction in derivative liability due to conversion Shares issued for conversion of convertible debt Transfer of marketable equity security to repay convertible note Share issuance for JV Metaverse Share issuance for JV Tokenize Transfer of accounts payable to convertible note Transfer of accrued interest to convertible note Cancellation of TTSG Shares Accounting Policies [Abstract] Organization and Basis of Presentation Organization, Consolidation and Presentation of Financial Statements [Abstract] Going Concern Summary of Significant Accounting Policies Investments, Debt and Equity Securities [Abstract] Marketable Securities Investments, All Other Investments [Abstract] Investment in Surge Holdings, Inc. Stock Loan Receivable Stock Loan Receivable Equity Method Investments and Joint Ventures [Abstract] Impaired Investment Payables and Accruals [Abstract] Accounts Payable and Accrued Expenses Unearned Revenue Unearned Revenue Debt Disclosure [Abstract] Convertible Notes Payable, Non-related Partied and Related Party Notes Payable Non-related Parties And Related Party Notes Payable, Non-related Parties and Related Party Accrued Settlement Accrued Settlement Derivative Liability Derivative Liability Equity [Abstract] Stockholders’ Equity Income Tax Disclosure [Abstract] Income Taxes Related Party Transactions [Abstract] Related Parties Commitments and Contingencies Disclosure [Abstract] Legal Proceedings Contingencies Risks and Uncertainties [Abstract] Concentrations Subsequent Events [Abstract] Subsequent Events Use of Estimates Principles of Consolidation Cash Equivalents Funds in Escrow Marketable Securities Inventory Note Receivable Paid-Off Derivative Financial Instruments Fair Value of Financial Instruments Treasury Stock Reclassification Revenue Recognition Unearned revenue Contract liabilities Variable Interest Entity Income Taxes Basic and Diluted Earnings Per Share Management’s Evaluation of Subsequent Events Recent Accounting Pronouncements Schedule of fair value, assets and liabilities measured on recurring basis Condensed financial statements Schedule of anti dilutive securities excluded from computation of earnings per share Schedule of accounts payable and accrued expenses Schedule of rollfoward of convertible note Summary of convertible notes payable Schedule of roll forward convertible notes payable Schedule of notes payable Schedule of notes payable related parties Schedule of assumptions to measure fair value Derivative instruments and hedging activities Summary of warrant activity Summary of exercise price for warrant outstanding Schedule Of Components of deferred tax assets Schedule of Effective Income Tax Rate Reconciliation Reverse stock split Common stock, authorized Accumulated deficit Working capital deficit Schedule of Defined Benefit Plans Disclosures [Table] Defined Benefit Plan Disclosure [Line Items] Conversion feature on convertible notes Current assets: Cash and equivalents Inventory Due From related party Total current assets Current liabilities Total current liabilities Sales Cost of goods sold Gross profit General and administrative expenses Net loss Preferred shares Number of potentially dilutive securities Convertible note Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Cash equivalents Restricted cash Escrow amount Consideartion from sale of common stock Impairment of long-lived assets Stockholders equity Unearned revenue Number of shares issued Fair value Term Contract liabilities Consideration paid Consideration shares Annual payment Shares acquired Sales consideration Convertible preferred shares Issuance of shares Company owned shares Principal amount Stock Issued During Period, Shares, Acquisitions Stock Issued During Period, Value, Acquisitions Conversion price Interest rate Convertible debt Accrued interest Marketable securities Business consideration values Sale of common stock Payment of principal Settlement pursuants amount Price per share Debt Cash Repayment of debt Related party, description Escrow amount received Final settlement agreement, description Related party payment Settlement amount Payments for debt Stock Issued for Acquisitions, Shares Number of shares converted Debt conversion, converted instrument, Value Note payable, description Share issued Issuance of shares value Services payable Interest payable Impairment charge Investment Accounts payable Accrued liabilities Other Total Cash received in connection with intellectual property license and royalty agreement Total convertible notes payable Unamortized debt discount Convertible note payable Less current portion Convertible notes payable, long-term portion Convertible note payable to Stanley Hills Unamortized debt discount Convertible notes payable, net, related party Less current portion Convertible notes payable, net, related party, long-term portion Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Line Items] Convertible notes payable, at beginning Issued for cash Convertible note issued for accounts payable Accrued interest added to convertible note Payment with marketable securities Payment with cash Original issue discount Conversion to common stock Debt discount related to new convertible notes Amortization of debt discounts Convertible notes payable, at end Schedule of Short-Term Debt [Table] Short-Term Debt [Line Items] Value of share converted Note maturity date Conversion price (in dollars per share) Conversion price Charge related to modification of debt Convertible note payable, description Accrued interest Purchase Price Note payable, interest rate Consideration Paid for legal fees Maturity date extension fees Amortization of debt discount Conversion of debt Net proceeds Principal amount Convertible note paid Outstanding balance Accrued interest Proceeds from loans Note payable current Convertible shares Convertible note payable Unpaid interest debt Interest expense Unamortized debt discount Schedule of Restructuring and Related Costs [Table] Restructuring Cost and Reserve [Line Items] Total notes payable Total notes payable Unamortized debt discount Notes payable Less current portion Notes payable, long-term portion Total notes payable Total notes payable Notes payable Less current portion Notes payable, net, related party, long-term portion Interest rate Principal periodic payments Interest rate Proceeds from debt Note payable Debt Instrument, Unamortized Discount Legal matter Arbitrator awarded Interest Gain on settlement of debt Accrued settlement Stock price Risk free rate Volatility Conversion/ Exercise price Dividend rate Derivative liability balance, beginning Issuance of derivative liability Fair value of beneficial conversion feature of debt converted Change in derivative liability during the period Debt modification Derivative liability balance, end Warrants Outstanding, Beginning Weighted Average Exercise Price Warrants Outstanding, Beginning Weighted Average Remaining Contractual Life, Outstanding, Beginning Aggregate Intrinsic Value Outstanding, Beginning Warrants Granted Warrants Forfeited Warrants Exercised Warrants Outstanding, End Weighted Average Exercise Price Warrants Outstanding, End Weighted Average Remaining Contractual Life, Outstanding, End Aggregate Intrinsic Value Outstanding, Ending Warrants Exercisable, End Weighted Average Exercise Price Warrants Exercisable at End Weighted Average Remaining Contractual Life Exercisable at End Aggregate Intrinsic Value Outstanding, Exercisable at End Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Number of warrants Outstanding Exercise price of warrants Outstanding Number of warrants Exercisable Exercise price of warrants Exercisable Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Shares issued, shares Shares issued, value Debt conversion, converted instrument, shares Debt conversion, converted instrument, Accrued interest Number of shares cancelled Aggregate Purchase Price Preferred stock, Outstanding Maturity date Dividend per share Deferred income tax asset Net operating loss carryforwards Total deferred income tax asset Less: valuation allowance Total deferred income tax asset Federal statutory rates Federal statutory rates (in percent) State income taxes State income taxes (in percent) Permanent differences Permanent differences (in percent) Valuation allowance against net deferred tax assets Valuation allowance against net deferred tax assets (in percent) Effective rate Effective rate (in percent) Valuation allowance Net operating loss carryforward Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Base Salary Base salary Stock option issued Option vested description Common stock contributed Consideration for services payable Principlal amount Issuance of promissory note Accrued interest Other receivable Accrued expenses Sales amount Offsetting Assets [Table] Offsetting Assets [Line Items] Proceeds from related party debt Accrued expenses Note payable, principal amount Warrants aquire Sought value Legal cost Revenues Payment for expenses Operating expense Concentration Risk [Table] Concentration Risk [Line Items] Accumulated deficit Working capital deficit Net revenues Subsequent Event [Table] Subsequent Event [Line Items] Purchase price Shares issued Sale of common stock Settlement made Ownership percentage Number of shares sold Amount Paid For Common stock issued for conversion of convertible debt and accrued interest. Conversion Feature On Convertible Notes. Cash received in connection with intellectual property license and royalty agreement. Original issue discount. Conversion to common stock. Debt discount related to new convertible notes. Weighted average exercise price warrants outstanding at end, Weighted average exercise price warrants outstanding at beginning. Weighted average exercise price warrants exercisable at end, Weighted average remaining contractual term for equity-based awards excluding options, Exercise price of warrants outstanding. Exercise price of warrants exercisable. Income tax reconciliation permanent differences. Base salary. Information about agreement. Payment for expenses. Assets, Current Assets Liabilities, Current Liabilities Treasury Stock, Value Stockholders' Equity Attributable to Parent Liabilities and Equity Debt Instrument, Unamortized Discount, Current Debt Instrument, Unamortized Discount, Noncurrent Gain (Loss) on Extinguishment of Debt Operating Income (Loss) Amortization of Debt Issuance Costs ChangeInFairValueOfMarketableSecurities Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Earnings Per Share, Basic Shares, Outstanding RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestment LossOnExchangeOfAssets Gain (Loss) Related to Litigation Settlement PaymentOfOtherIncomeWithMarketableSecurities Increase (Decrease) in Accounts Receivable Increase (Decrease) in Other Receivables Increase (Decrease) in Prepaid Expense Increase (Decrease) in Inventories Net Cash Provided by (Used in) Operating Activities InvestmentToGtx InvestmentToTghi Net Cash Provided by (Used in) Investing Activities IssuanceOfNoteReceivable Repayments of Related Party Debt Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents StockLoanReceivableTextBlock UnearnedRevenueTextBlock AccruedSettlementTextBlock Derivatives and Fair Value [Text Block] Marketable Securities, Policy [Policy Text Block] UnearnedRevenuePoliciesTextBlock ContractLiabilitiesPolicyTextBlock Income Tax, Policy [Policy Text Block] Deferred Revenue Contract with Customer, Liability, Current UnamortizedDebtDiscountAtConvertibleNotePayable LessCurrentPortionOfConvertibleNotePayable Payments for Deposits Debt Conversion, Converted Instrument, Rate AccruedInterest Debt Instrument, Unamortized Discount (Premium), Net Interest Payable TotalNotesPayables DebtInstrumentsUnamortizedDiscountCurrent CurrentPortionOfNotesPayables TotalNotesPayableRelatedParty TotalNotesPayableRelatedParties NotesPayableRelatedParties CurrentPortionOfNotePayableRelatedParties Accounts Payable, Interest-Bearing, Interest Rate Debt Instrument, Interest Rate, Effective Percentage Interest Expense, Other Domestic Deposits Derivative Liability [Default Label] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Net of Valuation Allowance InterestPayableRelatedParty Accrued Liabilities and Other Liabilities WorkingCapitalDeficits EX-101.PRE 10 gtch-20221231_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover - USD ($)
12 Months Ended
Dec. 31, 2022
Apr. 14, 2023
Jun. 30, 2022
Entity Information [Line Items]      
Document Type 10-K/A    
Amendment Flag true    
Amendment Description GBT Technologies, Inc. (the “Company”) is filing this Amendment No. 1 on Form 10-K/A (the “Amendment”) to amend missing prior year Auditor opinion as of December 31, 2021, originally filed with the U.S. Securities and Exchange Commission (the “SEC”) on April 12, 2023 (the “Original 10-K”), as well as to amend its current Auditor PCAOB number.    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2022    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2022    
Current Fiscal Year End Date --12-31    
Entity File Number 000-54530    
Entity Registrant Name GBT TECHNOLOGIES INC.    
Entity Central Index Key 0001471781    
Entity Tax Identification Number 27-0603137    
Entity Incorporation, State or Country Code NV    
Entity Address, Address Line One 2450 Colorado Ave.    
Entity Address, Address Line Two Suite 100E    
Entity Address, City or Town Santa Monica    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 90404    
City Area Code 888    
Local Phone Number 685-7336    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 2,266,899
Entity Common Stock, Shares Outstanding   2,930,101,819  
Auditor Firm ID 6662    
Auditor Name M.S. Madhava Rao    
Auditor Location India    
B F Borgers C P A P C [Member]      
Entity Information [Line Items]      
Auditor Firm ID 5041    
Auditor Name BF Borgers CPA PC    
Auditor Location CO    
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current Assets:    
 Cash $ 106,639 $ 155,106
 Cash held in trust 112,942
 Marketable equity security
 Accounts Receivable 25,244
 Inventory 11,569
 Prepaid 12,500
 Note Receivable 198,475
 Inventory in Transit
 Investment 16,198
 Other receivable 3,750,000
 Total current assets 370,625 4,018,048
 Total assets 370,625 4,018,048
Current Liabilities:    
 Accounts payable and accrued expenses (including related parties of $1,539,802 and $2,302,928) 6,240,634 6,896,263
 Accrued settlement 4,090,057 4,090,057
 Unearned revenue 48,921 249,384
 Contract liabilities 41,444
 Convertible notes payable, current, net of discount of $190,464 and $362,004 6,397,727 8,109,436
Convertible notes payable, related party, net of discount of $0 and $0 116,605 116,605
 Notes payable, current, net of discount of $0 and $47,671 41,137 2,612,397
 Notes payable, current, related party 140,000 140,000
 Due to related party 62,003
 Derivative liability 1,714,143 10,192,485
 Total current liabilities 18,892,671 32,406,629
Convertible note payable, noncurrent, net of discount of $88,403 and $0 35,797
Note payable, noncurrent 308,863 337,603
 Total liabilities 19,201,534 32,780,029
Contingencies (Note 18)
 Common stock, $0.00001 par value; 10,000,000,000 shares authorized; 1,535,593,440 and 33,200,198 shares issued and outstanding respectively 15,356 332
 Treasury stock, at cost; 21 shares respectively (643,059) (643,059)
 Stock loan receivable (7,610,147) (7,610,147)
 Additional paid in capital 288,664,858 284,072,666
 Accumulated deficit (299,257,917) (304,581,773)
 Total stockholders’ deficit (18,830,909) (28,761,981)
 Total liabilities and stockholders’ deficit 370,625 4,018,048
Series B Preferred Stock [Member]    
Current Liabilities:    
Preferred stock value
Series C Preferred Stock [Member]    
Current Liabilities:    
Preferred stock value
Series D Preferred Stock [Member]    
Current Liabilities:    
Preferred stock value
Series G Preferred Stock [Member]    
Current Liabilities:    
Preferred stock value
Series H Preferred Stock [Member]    
Current Liabilities:    
Preferred stock value
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Accounts payable and accrued expenses related party $ 1,539,802 $ 2,302,928
Note payable discount 190,464 362,004
Note payable discount 0 0
Discount 0 47,671
Note payable discount $ 88,403 $ 0
Common stock, par value $ 0.00001 $ 0.00001
Preferred stock, authorized 10,000,000,000 10,000,000,000
Common stock, outstanding 1,535,593,440 33,200,198
Common stock, issued 1,535,593,440 33,200,198
Treasury stock 21 21
Series B Preferred Stock [Member]    
Preferred stock, par value $ 0.00001 $ 0.00001
Preferred stock, authorized 20,000,000 20,000,000
Preferred stock, issued 45,000 45,000
Preferred stock, outstanding 45,000 45,000
Series C Preferred Stock [Member]    
Preferred stock, par value $ 0.00001 $ 0.00001
Preferred stock, authorized 10,000 10,000
Preferred stock, issued 700 700
Preferred stock, outstanding 700 700
Series D Preferred Stock [Member]    
Preferred stock, par value $ 0.00001 $ 0.00001
Preferred stock, authorized 100,000 100,000
Preferred stock, issued 0 0
Preferred stock, outstanding 0 0
Series G Preferred Stock [Member]    
Preferred stock, par value $ 0.00001 $ 0.00001
Preferred stock, authorized 2,000,000 2,000,000
Preferred stock, issued 0 0
Preferred stock, outstanding 0 0
Series H Preferred Stock [Member]    
Preferred stock, par value $ 0.00001 $ 0.00001
Preferred stock, authorized 40,000 40,000
Preferred stock, issued 20,000 20,000
Preferred stock, outstanding 20,000 20,000
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
Sales $ 1,152,555
Consulting Income – Related Party   45,000 180,000
 Total sales   1,197,555 180,000
Cost of Goods Sold   817,754
 Gross Profit   379,801 180,000
Operating expenses:    
 General and administrative 1,053,282 293,628
 Marketing 360,335 837,614
 Professional 1,814,543 2,124,272
 Impairment of assets 15,400,000
 Gain on Bad Debt (50,000)
 Total operating expenses 3,178,160 18,655,514
Loss from operations (2,798,359) (18,475,514)
Other income (expense):    
 Amortization of debt discount (442,247) (824,238)
 Change in fair value of derivative liability 6,594,370 (1,339,117)
 Interest expense and financing costs (969,629) (2,022,584)
 Realized gain (loss) on disposal of marketable equity security 11,000
 Gain on RJW settlement 3,012,355
 Loss on debt modification (13,777,480)
 Change in fair value of marketable securities   (310,462)
 Other income 237,828 2,497,500
 Total other income (expense) 8,122,215 (15,454,919)
Profit (Loss) before income taxes 5,323,856 (33,930,433)
Income tax expense
Profit (Loss) from continuing operations 5,323,856 (33,930,433)
Net Income (Loss) $ 5,323,856 $ (33,930,433)
Weighted average common shares outstanding:    
 Basic 696,686,911 19,991,381
 Diluted   4,646,981,551 19,991,381
Net Income (Loss) per share (basic and diluted):    
 Basic $ 0.01 $ (1.70)
 Diluted $ 0.00 $ (1.70)
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT - USD ($)
Common Stock [Member]
Treasury Stocks [Member]
Stock Loan Receivable [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 51 $ (643,059) $ (7,610,147) $ 251,046,191 $ (270,651,339) $ (27,858,304)
Beginning balance, shares at Dec. 31, 2020 5,133,489 1,040        
Common stock issued amount for conversion of debt and accrue interest $ 139 5,677,867 5,678,006
Common stock issued for conversion of convertible debt and accrued interest, shares 13,821,709          
Common stock issued for services $ 2 281,748 281,750
Common stock issued for services , shares 245,000          
Common stock issued for joint venture $ 140 15,399,860 15,400,000
Common stock issued for joint venture ,shares 14,000,000          
Fair value of beneficial conversion feature of converted 11,666,999 11,666,999
Net income (loss) (33,930,433) (33,930,433)
Ending balance, value at Dec. 31, 2021 $ 332 $ (643,059) (7,610,147) 284,072,666 (304,581,773) (28,761,981)
Ending balance, shares at Dec. 31, 2021 33,200,198 1,040        
Common stock issued amount for conversion of debt and accrue interest $ 8,471 2,156,990 2,165,461
Common stock issued for conversion of convertible debt and accrued interest, shares 847,133,242          
Fair value of derivative liability due to conversions   2,209,888 2,209,888
Common stock issued for cash $ 55 231,812 231,867
Common stock issued for cash , shares 5,500,000          
Common stock issued for- Tokenize $ 1,500 (1,500)
Common stock issued for- Tokenize ,shares 150,000,000          
Equity Method Investment - Meta $ 5,000 (5,000)
Equity Method Investment - Meta, shares 500,000,000          
Cancelation of shares $ (2) 2
Cancelation of shares, shares (240,000)          
Net income (loss) 5,323,856 5,323,856
Ending balance, value at Dec. 31, 2022 $ 15,356 $ (643,059) $ (7,610,147) $ 288,664,858 $ (299,257,917) $ (18,830,909)
Ending balance, shares at Dec. 31, 2022 1,535,593,440 1,040        
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash Flows From Operating Activities:    
Net income (loss) $ 5,323,856 $ (33,930,433)
Adjustments to reconcile net income to net cash used in operating activities:    
Amortization of debt discount 442,247 824,238
Change in fair value of derivative liability (6,594,370) 1,339,117
Excess of debt discount and financing costs 34,175 136,785
Shares issued for services 281,748
Loss on modification of debt 13,777,480
Impairment of assets 15,400,000
Realized gain on disposal of market equity security (11,000)
Loss on exchange of assets
Change in fair value of market equity security 308,802
Change on Settlement (3,012,633)
Payment of other income with marketable securities (800,000)
Accounts receivable (25,244)
Other receivable 3,741,525 (3,750,000)
Cash held in trust 289,590
Prepaid (12,500)
Inventory (11,569)
Contract liabilities (8,556)
Unearned revenue (200,463) (291)
Accounts payable and accrued expenses (123,462) 5,073,651
Net cash used in operating activities (138,293) (1,369,114)
Cash Flows From Investing Activities:    
Investment to GTX (150,000)
Investment to TGHI (125,000)
Net cash used in investing activities (275,000)
Cash Flows From Financing Activities:    
Issuance of convertible notes 300,000 1,317,386
Issuance of note receivable (190,000)
Proceeds from sales of common stock 231,864 (106,200)
Repayment of related party (694,225)
Repayment of convertible note (39,042)
Proceeds from related party 756,227
Issuance of notes payable 200,000
Net cash provided by financing activities 364,826 1,411,186
Net increase in cash (48,467) 42,072
Cash, beginning of Year 155,106 113,034
Cash, end of Year 106,639 155,106
Interest 2,898
Income taxes 2,898
Supplemental non-cash investing and financing activities    
Debt discount related to convertible debt 325,916 741,100
Reduction in derivative liability due to conversion 2,209,888 11,666,999
Shares issued for conversion of convertible debt 2,165,464 5,678,006
Transfer of marketable equity security to repay convertible note 660,000
Share issuance for JV Metaverse 5,000
Share issuance for JV Tokenize 1,500
Transfer of accounts payable to convertible note 424,731
Transfer of accrued interest to convertible note 202,899
Cancellation of TTSG Shares $ (2)
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Organization and Basis of Presentation
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Organization and Basis of Presentation

Note 1 - Organization and Basis of Presentation

 

Organization and Line of Business

 

GBT Technologies Inc. (formerly Gopher Protocol Inc.) (the “Company”, “GBT”, or “GTCH”) was incorporated on July 22, 2009 under the laws of the State of Nevada. The Company is targeting growing markets such as development of Internet of Things (IoT) and Artificial Intelligence (AI) enabled networking and tracking technologies, including wireless mesh network technology platform and fixed solutions, development of an intelligent human body vitals device, asset-tracking IoT, and wireless mesh networks. Effective August 5, 2019, the Company changed its name from Gopher Protocol Inc. to GBT Technologies Inc. The Company derived revenues from (i) the provision of IT consulting services; and (ii) from the licensing of its technology. (ii) from selling electronic products through e-commerce platforms.

 

On February 18, 2022 the Company, effective March 1, 2022 entered into a Revenue Sharing Agreement (“RSA”) with Mahaser LTD. (“Mahaser”) pursuant to which the Company shares revenues generated by Mahaser with respect to e-commerce sales through the online retail platform in the United States of America.

 

The audited condensed CFS are prepared by the Company, pursuant to the rules and regulations of the SEC. The information furnished herein reflects all adjustments, consisting only of normal recurring adjustments, which in the opinion of management, are necessary to fairly state the Company’s financial position, the results of its operations, and cash flows for the periods presented.

 

Basis of Presentation

 

The accompanying CFS were prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

 

Stock Split

 

On October 26, 2021, the Company effectuated a 1 for 50 reverse stock split. The share and per share information has been retroactively restated to reflect this reverse stock split.

 

In July 2, 2022 the Company filed a preliminary information statement to the stockholders of record (the “Record Date”) in connection with certain actions to be taken by the written consent by stockholders holding a majority of the voting stock of the Company, dated as of June 28, 2022.

 

To amend the Company’s Articles of Incorporation, (the “Articles of Incorporation”) to increase the number of authorized shares of common stock, par value $0.00001 per share (the “Common Stock”), of the Company from 2,000,000,000 shares to 10,000,000,000 shares. This action concluded on August 11, 2022:

 

    (i) authorize the Company’s Board of Directors to effect, in its sole discretion, a reverse stock split of the Common Stock in a ratio of up to 1-for-500 (the “Reverse Stock Split”), and (ii) authorize the filing of an amendment to the Company’s Articles of Incorporation to implement the Reverse Stock Split and any other action deemed necessary to effectuate the Reverse Stock Split, without further approval or authorization of stockholders, at any time prior to December 31, 2023. This action was not commenced by the Company’s board.

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Going Concern
12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Going Concern

Note 2 – Going Concern

 

The accompanying CFS have been prepared assuming the Company will continue as a going concern. The Company has an accumulated deficit of $299,257,917 and has a working capital deficit of $18,552,046 as of December 31, 2022, which raises substantial doubt about its ability to continue as a going concern.

 

The Company’s ability to continue as a going concern is dependent upon its ability to generate profitable operations in the future and/or obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management has plans to seek additional capital through some private placement offerings of debt and equity securities. These plans, if successful, will mitigate the factors which raise substantial doubt about the Company’s ability to continue as a going concern. These CFS do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty.

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 3 – Summary of Significant Accounting Policies

 

Use of Estimates

 

The preparation of CFS in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the CFS and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates in the accompanying CFS include valuation of derivatives and valuation allowance on deferred tax assets.

 

Principles of Consolidation

 

The accompanying CFS include the accounts of the Company and its subsidiaries; the Company’s 50% owned subsidiaries GBT BitSpeed Corp. (currently inactive) and GBT Tokenize Corp; the Company’s 50% owned subsidiary, Gopher Protocol Costa Rica Sociedad De Responsabilidad Limitada (currently inactive), a wholly owned subsidiary, AltCorp Trading LLC, a Costa Rica company (“AltCorp” currently inactive) and Greenwich International Holdings, a Costa Rica corporation (“Greenwich” currently inactive). All significant intercompany transactions and balances were eliminated.

 

For entities determined to be VIEs, an evaluation is required to determine whether the Company is the primary beneficiary. The Company evaluates its economic interests in the entity specifically determining if the Company has both the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance (“the power”) and the obligation to absorb losses or the right to receive benefits that could potentially be significant to the VIE (“the benefits”). When making the determination whether the benefits received from an entity are significant, the Company considers the total economics of the entity, and analyzes whether the Company’s share of the economics is significant. The Company utilizes qualitative factors, and, where applicable, quantitative factors, while performing the analysis.

 

In addition, the Company’s variable interests in Mahaser obligate the Company to absorb deficits and provide it with the right to receive benefits that could potentially be significant to Mahaser. As a result of this analysis, the Company concluded it is the primary beneficiary of Mahaser and therefore consolidates the balance sheets, results of operations and cash flows of Mahaser. The Company performs a qualitative assessment of Mahaser on an ongoing basis to determine if it continues to be the primary beneficiary.

 

Cash Equivalents

 

For the purpose of the statement of cash flows, cash equivalents include time deposits, certificate of deposits, and all highly-liquid debt instruments with original maturities of three months or less. As of December 31, 2022 and 2021, the Company did not have any cash equivalents.

 

Funds in Escrow

 

Restricted cash is $375,000 as part of the SURG settlements proceeds that needs to stay in escrow and $19,694 restricted cash that the court on January 28, 2022 awarded the Company with injunction against RWJ defendants, where all funds generating from resale should be deposited into GBT blocked account, and therefore RWJ defendants cannot use these funds without court order, neither the Company. According to settlement agreement made on September 26, 2022, these funds held in escrow and no longer restricted. The Company entered into the Confidential Settlement Agreement and Mutual Release (“RJW Agreement”) by and between RWJ Advanced Marketing, LLC, Robert Warren Jackson, Gregory Bauer (collectively the “RJW Parties”) and W.L. Petrey Wholesale Company, Inc., (“Petrey”) on one hand; and GBT Technologies Inc., on behalf of itself and its agents (collectively the GBT Parties”), on the other hand. The Company the RJW Agreement effective September 26, 2022 with final signatures delivered to the Company on or about October 5, 2022. Among other agreements the parties agreed and stipulated to release all funds currently being held in a blocked account of $19,694 with 50% distributed to the RWJ Parties and 50% to the Company or its assignee.

 

Marketable Securities

 

The Company accounts for investment securities in accordance with ASC Topic 321, Investments – equity securities. Marketable equity securities are reported at FV based on quotations available on securities exchanges with any unrealized gain or loss being reported as a component of other income (expense) on the statement of operations. The portion of marketable equity security expected to be sold within 12 months of the balance sheet date is reported as a current asset. These publicly traded equity securities are valued using quoted prices and are included in Level 1.

 

Inventory

 

Inventory consists of electronic product ready for sale on Amazon.com. It is stated at the lower of cost or net realizable value and all inventories were returned product from online customers. We value our inventory using the weighted average costing method. Our Company’s policy is to include as a part of inventory any freight incurred to ship the product from our contract vendors to our warehouses. Outbound freight costs to our customers are considered period costs and reflected in selling, general and administrative expenses. We regularly review inventory and consider forecasts of future demand, market conditions and product obsolescence.

 

Note Receivable Paid-Off

 

On September 18, 2020, the Company entered into a Purchase and Sale Agreement with Mr. LightHouse LTD., an Israeli corporation (“MLH”) pursuant to which the Company agreed to sell and assign to MLH, effective July 1, 2020 all the shares, and certain specified liabilities, of Ugopherservices Corp. (“UGO”), a wholly owned subsidiary of the Company for $100,000 to be paid through the delivery of a promissory note payable to the Company (the “Note”), upon the terms and subject to the limitations and conditions set forth in the Note. At December 31, 2020, the Company determined this note was not collectible and took an impairment charge of $100,000. During July 2021, MLH effected a $50,000 payment on the Note. During April 2022, MLH effected a second payment for additional $50,000 on the Note exhausting the Note balance.

 

Derivative Financial Instruments

 

The Company evaluates all of its agreements to determine if such instruments have derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its FV and is then re-valued at each reporting date, with changes in the FV reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a weighted-average Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. As of December 31, 2022 and 2021, the Company’s only derivative financial instrument was an embedded conversion feature associated with convertible notes payable due to certain provisions that allow for a change in the conversion price based on a percentage of the Company’s stock price at the date of conversion.

 

Fair Value of Financial Instruments

 

For certain of the Company’s financial instruments, including cash, accounts payable, accrued liabilities and short-term debt, the carrying amounts approximate their FV due to their short maturities.

 

FASB ASC Topic 820, Fair Value Measurements and Disclosures, requires disclosure of the FV of financial instruments held by the Company. FASB ASC Topic 825, Financial Instruments, defines FV, and establishes a three-level valuation hierarchy for disclosures of FV measurement that enhances disclosure requirements for FV measures. The carrying amounts reported in the consolidated balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their FV because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:

 

  Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.
     
  Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
     
  Level 3 inputs to the valuation methodology use one or more unobservable inputs which are significant to the FV measurement.

 

The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic 480, Distinguishing Liabilities from Equity, and FASB ASC Topic 815, Derivatives and Hedging.

 

For certain financial instruments, the carrying amounts reported in the balance sheets for cash and current liabilities, including convertible notes payable, each qualify as a financial instrument, and are a reasonable estimate of their FV because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest.

 

The Company uses Level 2 inputs for its valuation methodology for derivative liabilities as their FV were determined by using the Black-Scholes-Merton pricing model based on various assumptions. The Company’s derivative liabilities are adjusted to reflect FV at each period end, with any increase or decrease in the FV being recorded in results of operations as adjustments to FV of derivatives.

 

At December 31, 2022 and 2021, the Company identified the following liabilities that are required to be presented on the balance sheet at FV:

 

       
    Fair Value   Fair Value Measurements at
    As of   December 31, 2022
Description   December 31, 2021   Using Fair Value Hierarchy
        Level 1   Level 2   Level 3
Conversion feature on convertible
notes
 
 
 
$

1,714,143
 
 
 
 
 
$
 
 
 
 
 
 
$

1,714,143
 
 
 
 
 
$
 
 
 

 

    Fair Value   Fair Value Measurements at
    As of   December 31, 2021
Description   December 31, 2022   Using Fair Value Hierarchy
        Level 1   Level 2   Level 3
Conversion feature on convertible
notes
 
 
 
$

10,192,485
 
 
 
 
 
$
 
 
 
 
 
 
$
10,192,485  
 
 
 
 
$
 
 
 

 

Treasury Stock

 

Treasury stock is recorded at cost. The re-issuance of treasury shares is accounted for on a first in, first-out basis and any difference between the cost of treasury shares and the re-issuance proceeds are charged or credited to additional paid-in capital.

 

Reclassification

 

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.

 

Revenue Recognition

 

Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“Topic 606”), became effective for the Company on January 1, 2018. The Company’s revenue recognition disclosure reflects its updated accounting policies that are affected by this new standard. The Company applied the “modified retrospective” transition method for open contracts for the implementation of Topic 606. The Company had no significant post-delivery obligations, this new standard did not result in a material recognition of revenue on the Company’s accompanying CFS for the cumulative impact of applying this new standard. The Company made no adjustments to its previously-reported total revenues, as those periods continue to be presented in accordance with its historical accounting practices under Topic 605, Revenue Recognition.

 

Revenue from providing IT consulting services are recognized under Topic 606 in a manner that reasonably reflects the delivery of its services to customers in return for expected consideration and includes the following elements:

 

  executed contracts with the Company’s customers that it believes are legally enforceable;
     
  identification of performance obligations in the respective contract;
     
  determination of the transaction price for each performance obligation in the respective contract;
     
  allocation the transaction price to each performance obligation; and
     
  recognition of revenue only when the Company satisfies each performance obligation.

 

These five elements, as applied to each of the Company’s IT revenue category, is summarized below:

 

  IT consulting services - revenue is recorded on a monthly basis as services are provided.

 

These five elements, as applied to each of the Company’s license revenue category, is summarize below:

 

License services – the one-time related party licensing income recorded as other income upon agreement is executed and services are provided and recognized over the term of five years.

 

E-Commerce sales

 

Identify the contract(s) with a customer. ASC 606 defines a contract as “an agreement between two or more parties that creates enforceable rights and obligations”. Since this is an e-commerce sale on the Amazon of eBay websites, the Company just followed the general terms on Amazon or eBay websites and the customer entered into a contract with the Company based on the product listed on the Amazon or eBay websites;

 

Identify the performance obligations in the contract. According to the contract, the Company is responsible for operation exclusively. The Company is entitled to all revenue which is being paid by Amazon or eBay into a designated bank account and the Company is responsible for all product acquisitions as well as shipments. The only performance obligations were the electronic products that were listed on Amazon or eBay websites and the Company determined each order is one single obligation;

 

Determine the transaction price. The transaction price set to be the listed price on the Amazon or eBay websites.;

 

Allocation the transaction price to the performance obligations in the contract.; and

 

Recognize revenue when the Company satisfies a performance obligation. Sales are being recognized upon shipment.

 

Unearned revenue

 

Unearned revenue represents the net amount received for the purchase of products that have not seen shipped to the Company’s customers. The Company has $48,921 and $249,384 of unearned revenue at December 31, 2022 and 2021, respectively.

 

Contract liabilities

 

On February 22, 2022, the Company entered into an Intellectual Property License and Royalty Agreement with Touchpoint Group Holdings, Inc. (“Touchpoint” or “TGHI”) pursuant to which the Company granted TGHI a worldwide license for its technologies for five years in the domains of Internet of Things (IoT) and Artificial Intelligence enabled mobile technologies pertaining to the Company’s digital currency technology (the “Technology”). GBT will charge TGHI royalties based on actual uses by TGHI of the Technology resulting from revenue attributable to the use, performance or other exploitation of the Technology, to the extent applicable, after deducting any taxes that the Company may be required to collect, and deducting any international sales, goods and services, value added taxes or similar taxes which the Company is required to pay, if any, excluding deductions for taxes on the Company net income. TGHI agreed to issue the Company 10,000,000 shares of common stock of TGHI in the FV of $50,000 as a onetime fee for the Company entering this Intellectual Property License and Royalty Agreement, which was booked contract liabilities and amortized over the  five-year term. The Company has yet to earn any royalty income in relation to this agreement as of December 31, 2022. The contract liabilities as of December 31, 2022 and December 31, 2021 was $41,444 and $0, respectively.

 

Variable Interest Entity

 

On February 18, 2022, the Company, effective March 1, 2022 entered into a Revenue Sharing Agreement (“RSA”) with Mahaser LTD. (“Mahaser”) pursuant to which the Company shares in revenues generated by Mahaser e-commerce sales through the online retail platform in the United States of America. Mahaser owns an e-commerce platform as a store which is the legal, exclusive owner of Ravenholm Electronics. The Company will operate the e-commerce platform and entitled to 95% for all revenue generated by and received by Mahaser from March 1, 2022 through December 31, 2022. The RSA provides that the Company will be entitled to appoint a manager to Mahaser. As consideration, the Company will pay Mahaser $100,000 no later than March 1, 2022 and issue Mahaser 1,000,000 shares of the Company’s restricted common stock. The Company shall have no obligations to make any further payments to Mahaser. For any further extensions, the Company will have the option to extend the RSA for annual payment of $200,000, which can be payable with the Company’s shares of common stock payable based on 20 days VWAP prior to issuance. On March 16, 2022 the parties entered into Amendment No. 1 to the to the RSA, where all consideration to be paid or issued to Mahaser will be deferred until such time where the e-commerce platform generated in cumulative revenue of $1,000,000. On March 31, 2022, the parties entered into Amendment No. 2 to the RSA, where Mahaser agreed to pay the Company 100% per year for all revenue generated by and received by seller from the sales by Amazon within the United States of America as follows from March 1, 2022 through December 31, 2022. The Company will be responsible for 100% of the cost of goods sold as well. In addition, the Company is entitled to earn 100% revenues and cost of goods sold of the period from February 1, 2022 to February 28, 2022.

 

The Company evaluated whether it has a variable interest in Mahaser, whether Mahaser is a VIE and whether the Company has a controlling financial interest in Mahaser. The Company concluded that it has variable interests in Mahaser on the basis of GBT has 100% control over the JV/revenue sharing, and as such should consolidate the JV into its books and records as it assigned 100% financial responsibility. Mahaser’s equity at risk, as defined by GAAP, is considered to be insufficient to finance its activities without additional support, and, therefore, Mahaser is considered a VIE.

 

The following table summarizes the carrying amount of the assets and liabilities of Mahaser included in the Company’s consolidated balance sheets at December 31, 2022 (after elimination of intercompany transactions and balances):

 

     
Assets of consolidated variable interest entity (“VIE”) included in the consolidated balance sheets above (after elimination of intercompany transactions and balances) consist of:   
Current assets:     
Cash and equivalents  $93,581 
Inventory   11,569 
Due From related party   20,270 
Total current assets  $125,420 
      
Liabilities of consolidated VIE included in the consolidated balance sheets above (after elimination of intercompany transactions and balances) consist of:     
Current liabilities     
Total current liabilities  $94,496 
      
Statements of operations of consolidated VIE included in the consolidated statements of operations above (after elimination of intercompany transactions and balances) consist of:     
Statements of operations     
 Sales  $1,107,555 
 Cost of goods sold   817,754 
 Gross profit   289,801 
 General and administrative expenses   330,647 
Net Loss  $40,846 

 

Income Taxes

 

The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes. ASC 740 requires a company to use the asset and liability method of accounting for income taxes, whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion, or all of, the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

 

Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The Company has no material uncertain tax positions for any of the reporting periods presented and its current on all its tax filings federal and state until 2021 inclusive.

 

Basic and Diluted Earnings Per Share

 

Earnings per share is calculated in accordance with ASC Topic 260, Earnings Per Share. Basic earnings per share (“EPS”) is based on the weighted average number of common shares outstanding. Diluted EPS assumes that all dilutive securities are converted. Dilution is computed by applying the treasury stock method. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. Due to the net income incurred potentially dilutive instruments would be anti-dilutive. Accordingly, diluted loss per share is the same as basic loss for all periods presented. The following potentially-dilutive shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would be anti-dilutive.

 

          
   December 31,  December 31,
   2022  2021
Series B preferred stock   45,000    45,000 
Series C preferred stock   700    700 
Series H preferred stock   20,000    20,000 
Warrants   70,770    392,870 
Convertible notes   3,949,223,831    83,722,340 
Total   3,949,360,301    84,180,910 

 

Management’s Evaluation of Subsequent Events

 

The Company evaluates events that have occurred after the balance sheet date of December 31, 2022, through the date which the CFS are issued. Based upon the review, other than described in Note 20 – Subsequent Events, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the CFS.

 

Recent Accounting Pronouncements

 

In August 2020, the FASB issued ASU 2020-06Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. ASU 2020-06 reduces the number of accounting models for convertible debt instruments and convertible preferred stock. For convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in capital, the embedded conversion features no longer are separated from the host contract. ASU 2020-06 also removes certain conditions that should be considered in the derivatives scope exception evaluation under Subtopic 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity, and clarify the scope and certain requirements under Subtopic 815-40. In addition, ASU 2020-06 improves the guidance related to the disclosures and earnings-per-share (EPS) for convertible instruments and contract in entity’s own equity. ASU 2020-06 is effective for public business entities that meet the definition of a SEC filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Board specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. The Company adopted this ASU on the CFS in the year ended December 31, 2021. The adoption had no material impact on the CFS for the year ended December 31, 2022.

 

On April 2021, the FASB issued ASU 2021-04, “Earnings Per Share (Topic 260), Debt— Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options” (“ASU 2021-04”) to clarify the accounting by issuers for modifications or exchanges of equity-classified warrants. The new ASU is available here and effective for all entities in fiscal years starting after December 15, 2021. Early adoption is permitted. The Company adopted this ASU on the CFS in the year ended December 31, 2021. The adoption had no material impact on the CFS for the year ended December 31, 2022.

 

Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying CFS. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

 

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Marketable Securities
12 Months Ended
Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]  
Marketable Securities

Note 4 – Marketable Securities

 

TGHI Agreement

 

On January 28, 2022, the Company entered into a Stock Purchase Agreement with Marko Radisic (the “Seller”) and Touchpoint Group Holdings, Inc. (“TGHI”) pursuant to which the Company acquired 10,000 shares of Series A Convertible Preferred Stock (the “Touchpoint Preferred”) from the Seller for $125,000. The Touchpoint Preferred is convertible into 10,000,000 shares of common stock of Touchpoint. On February 22, 2022, the Company entered into an Intellectual Property License and Royalty Agreement with TGHI pursuant to which the Company granted TGHI a worldwide license for its technologies for five years in the domains of Internet of Things (IoT) and Artificial Intelligence enabled mobile technologies pertaining to the Company’s digital currency technology (the “Technology”). GBT will charge TGHI earned royalties based on actual uses by TGHI of the Technology resulting from revenue attributable to the use, performance or other exploitation of the Technology, to the extent applicable, after deducting any taxes that the Company may be required to collect, and deducting any international sales, goods and services, value added taxes or similar taxes which the Company is required to pay, if any, excluding deductions for taxes on the Company net income. TGHI agreed to issue the Company 10,000,000 shares of common stock of TGHI in the FV of $50,000 as a one-time fee for the Company entering this Intellectual Property License and Royalty Agreement, which was booked contract liabilities and amortized over the five-year term. The Company has yet to earn any royalty income order to this agreement as of December 31, 2022.

 

TGHI converted the Touchpoint Preferred into 10,000,000 shares of common stock of Touchpoint on February 23, 2022 resulting in the Company owning 20,000,000 shares of common stock of Touchpoint in total FV of $6,000 as of December 31, 2022 based on level 1 stock price in OTC markets.

 

MetAlert -prior name GTX Corp

 

On April 12, 2022, GBT Tokenize Corp (“GBT Tokenize”), a Nevada corporation which the Company owns 50% of the outstanding shares of common stock, entered into a series of agreements with GTX Corp (“GTX”) and various note holders of GTX pursuant to which Tokenize acquired a convertible promissory note of GTX of $100,000 (the “GTX Notes”). In addition, GBT Tokenize acquired 76,923 (GBT acquired 5,000,000 in the original deal, where GTX to perform a corporate action of 1:65 reverse split on September 20, 2022) shares of common stock of GTX for $150,0–0 - in total FV of $12,538 as of December 31, 2022 based on level 1 stock price in OTC markets.

 

The GTX Notes bear 10% interest and 50% of the principal may be converted into shares of common stock on a one-time basis at a conversion price of $0.01 per share. The remaining 50% of the principal must be paid in cash. The closing occurred on April 12, 2022.

 

GTX changed its name into Metalert Inc. on or about September 20, 2022.

 

On September 30, 2022, GBT Tokenize, loaned MetAlert Inc., a Nevada corporation (f/k/a GTX Corp.) (“MetAlert”) $90,000. For such loan, MetAlert provided Tokenize a promissory note of $90,000 which is due and payable together with interest of 5% upon the earlier of September 19, 2023 or when declared by Tokenize.

 

MetAlert designs, manufactures and sells various interrelated and complementary products and services in the wearable technology and IoMT (Internet of Medical Things) marketplace.

 

As of December 31, 2022, the notes had an outstanding balance of $190,000 and accrued interest of $8,475.

 

As of December 31, 2022 and December 31, 2021, the marketable security had a FV of $12,538 and $0, respectively.

 

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Investment in Surge Holdings, Inc.
12 Months Ended
Dec. 31, 2022
Investments, All Other Investments [Abstract]  
Investment in Surge Holdings, Inc.

Note 5 – Investment in Surge Holdings, Inc.

 

Surge Holdings, Inc.

 

On September 30, 2019, GBT Technologies Inc. (the “Company”) entered into an Asset Purchase Agreement (“APA”) with Surge Holdings, Inc., a Nevada corporation (“SURG”) pursuant to which the Company agreed to sell and assign to SURG, all the assets and certain specified liabilities, of its ECS Prepaid, Electronic Check Services and the Central State Legal Services businesses for $5,000,000 to be paid through the issuance of 3,333,333 shares of SURG’s common stock (the “SURG Common Stock”) and a convertible promissory note in favor of the Company in the principmountount of $4,000,000 (the “SURG Note”), convertible into SURG’s shares of common stock. On January 7, 2022, the Company received payments from Surgepays Inc. (formerly known as Surge Holdings, Inc.) in total of $3,750,000 pursuant to the terms of the Settlement Agreement dated December 22, 2021.

 

On June 23, 2020, SURG entered into an Exchange Agreement (the “AltCorp Exchange Agreement”) with AltCorp Trading LLC (“AltCorp”) with such AltCorp Exchange Agreement being consented and agreed to by the Company, the parent of AltCorp. At the expiration of the lock-up period, in the event the VWAP for the SURG Common Stock was, during the preceding twenty-day trading period, less than $0.50 per share, AltCorp retained the right to reserve additional shares of SURG Common Stock equal to the True-Up Value as defined in the AltCorp Exchange Agreement.

 

On March 8, 2020, SURG filed a lawsuit against its transfer agent from transferring millions of SURG stock that is currently in possession by the Company and assigned to Stanley Hills, LLC. On January 1, 2021, SURG, AltCorp and Stanley Hills, LLC (“Stanley”) entered into a Mutual Release and Settlement Agreement (“Settlement Agreement”). Pursuant to the terms of the Settlement Agreement, SURG agreed to amend the AltCorp Exchange Agreement where SURG acknowledged a debt of $3,300,000 (the “Debt”) to be paid in 33 monthly payments of $100,000 payable in shares of common stock of SURG at a per share price equal the volume weighted average price of Surg’s common stock during the 10 trading days immediately preceding the issuance. SURG paid $400,000 in cash and $800,000 by shares. The SURG common stock issued to Altcorp have been pledged since August 12, 2020 for the benefit of Stanley to secure Stanley’s note payable by the Company. Accordingly, the SURG Common Stock issued to AltCorp as a result of the Settlement Agreement were pledged to Stanley. As of December 31, 2021 there were no surge shares pledges after the final settlement signed on December 22, 2021 and that replaced all prior settlement agreement. The final settlement SURG agreed to make total payments of $4,200,000 to the Company’s trust account on or prior to January 7, 2022. This $4.2 million amount consists of $450,000 paid by SURG in November and December 2021, $100,000 to be paid on or about January 4, 2022, and $3,650,000 to be paid on or prior to January 7, 2022 of which $375,000 will be held in escrow as described before. The $3,750,000 was recorded as other receivable as of December 31, 2021. As of December 31, 2021, the Company has recorded an outstanding payable balance to Stanley amounted $1,862,928 recorded under accrued expenses.

 

Subsequently, SURG was a party to two lawsuits in state District Court, the Eighth Judicial District Court for Clark County, Nevada involving AltCorp, Stanley and Glen Eagles Acquisition LP (the “AltCorp Parties.”). Each of these lawsuits were ultimately disputes relating to the total consideration SURG was to pay the Company under the APA.

 

On October 18, 2021, the AltCorp Parties, the Company, and SURG entered into a Memorandum of Understanding (the “MOU”) to set up a framework for an attempt to settle the two lawsuits.

 

On December 22, 2021 (the “Effective Date”), pursuant to the framework in the MOU, the AltCorp Parties (and an additional third party), the Company, ECS, and SURG, Kevin Brian Cox (SURG’s Chief Executive Office–) - in his individual capacity, entered into a Resolution of Purchase, Mutual Release, and Settlement Agreement (the “Final Settlement Agreement”) to settle the two lawsuits and resolve all disputes related to the consideration paid by SURG to the Company in connection with the APA.

 

(F)The Final Settlement Agreement, among other resolutions, essentially provides the following: i) From the total consideration of the Final Settlement Agreement, the amount of $375,000 (“Escrow Amount”) will be deposited by SURG in escrow. SURG has acquired the Company’s rights to a certain Master Distribution and Service Agreement (“MDA”). Under certain circumstances, if the result of the Company’s lawsuit against a third party (the “GBT Lawsuit”) is a monetary judgment without the assignment or legal decree of ownership of the MDA, the Company shall be entitled to receive the Escrow Amount and shall assign to SURG the first $1,000,000 the Company recovers from the defendants in the GBT Lawsuit. In the event that the Company does not prevail in the GBT Lawsuit then it shall be entitled to release of the Escrow Amount but shall be responsible for any fees and costs obligation sought by the defendants in the GBT Lawsuit.

 

(ii) SURG agreed to make total payments of $4,200,000 to the Company’s trust account on or prior to January 7, 2022. This $4.2 million amount consists of $450,000 paid to the Company in November and December 2021, $100,000 to be paid on or about January 4, 2022, and $3,650,000 to be paid on or prior to January 7, 2022 of which $375,000 will be held in escrow as described before. The final settlement SURG agreed to make total payments of $4,200,000 to the Company’s trust account on or prior to January 7, 2022. The $3,750,000 was recorded as other receivable as of December 31, 2021. The entire balance of $3,750,000 was paid in January 2022.

 

(iii) Potential payments to third parties.

 

The Final Settlement Agreement replaces all prior agreements between the parties. In addition, within three (3) trading days of the last payment related to the $4.2 million payment to Stanley being made, the parties shall make filings with the state District Court in Clark County, Nevada to dismiss both lawsuits, including, regarding the lawsuit filed by AltCorp Trading, LLC, the dismissal of the lawsuit as to VStock Transfer, LLC. The parties agreed to a full mutual release of any disputes or claims between the parties.

 

The final settlement of $3,750,000 was received by the Company in January 2022 and paid out $3,750,000 to the third parties before December 31, 2022.

 

As the Company committed to assign certain revenue share agreement to SURG as part of the Company’s settlement with RWJ Agreement, on October 5, 2022 and as cumulation of all settlement agreements the Company issued a request to the SURG regarding release of certain escrow funds and the execution of an assignment of rights as contemplated in the aforereferenced agreement.

 

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Loan Receivable
12 Months Ended
Dec. 31, 2022
Stock Loan Receivable  
Stock Loan Receivable

Note 6 - Stock Loan Receivable

 

On January 8, 2019, the Company entered into a Stock Pledge Agreement with Latin American Exchange Latinex Casa de Cambio, S.A., a Costa Rica corporation (“Latinex”), to provide that Latinex may maintain its required regulatory capital as required by various regulators. The Company has pledged 4,006 restricted shares of its common stock valued at $7,610,147 (based on the closing price on the grant date) for a term of three years for an annual payment of $375,000 paid in quarterly installments of $93,750. In lieu of cash payment, Latinex may pay the Company in virtual currency of WISE Network S.A. valued at a 50% discount of its offering price of $10 per token. In the event that Latinex’s required capital has decreased below $5,000,000, Latinex is permitted to sell the pledged shares of common stock only in an amount to ensure that Latinex can satisfy the required capital levels. The Company must consent to such sale of the shares of common stock, which may not be unreasonably withheld. Upon expiration of the agreement, the remaining shares of common stock shall be returned to the Company free and clear of all liens. The Company has recorded the value of these shares of common stock as a stock loan receivable which is presented as a contra-equity account in the accompanying consolidated balance sheets. At December 31, 2019, the Company wrote off the accrued interest income as Latinex did not perform any payment and the Company has no mean to enforce this payment. Latinex agreed in principle to return the pledged 4,006 restricted shares to the Company for cancellation. The 4,006 restricted shares have not yet been returned to the Company as of December 31, 2022.

 

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Impaired Investment
12 Months Ended
Dec. 31, 2022
Equity Method Investments and Joint Ventures [Abstract]  
Impaired Investment

Note 7 – Impaired Investment

 

Investment in GBT Technologies, S.A.

 

On June 17, 2019, the Company, AltCorp Trading LLC, a Costa Rica company and a wholly-owned subsidiary of the Company (“AltCorp”), GBT Technologies, S.A., a Costa Rica company (“GBT-CR”) and Pablo Gonzalez, a shareholder’s representative of GBT-CR (“Gonzalez”), entered into and closed an Exchange Agreement (the “GBT Exchange Agreement”) pursuant to which the parties exchanged certain securities. In accordance with the Exchange Agreement, AltCorp acquired 625,000 shares of GBT-CR representing 25% of its issued and outstanding shares of common stock from Gonzalez for the issuance of 20,000 shares of Series H Convertible Preferred Stock of the Company and a Convertible Note in the principal amount of $10,000,000 issued by the Company (the “Gopher Convertible Note”) as well as the transfer and assignment of a Promissory Note payable by Gopher Protocol Costa Rica Sociedad De Responsabilidad Limitada to the Company in the principal amount of $5,000,000 dated February 6, 2019 (of which the underlying security for this Promissory Note is 30,000,000 restricted shares of common stock of Mobiquity Technologies, Inc. (“Mobiquity”) and 60,000,000 restricted shares of common stock of Mobiquity.

 

The Gopher Convertible Note bears interest of 6% and is payable at maturity on December 31, 2021. At the election of Gonzalez, the Gopher Convertible Note can be converted into a maximum of 20,000 shares of Series H Preferred Stock. Each share of Series H Preferred Stock is convertible, at the option of the holder but subject to the Company increasing its authorized shares of common stock, into such number of shares of common stock of the Company as determined by dividing the Stated Value ($500 per share) by the conversion price ($500 per share). The Series H Preferred Stock has no liquidation preference, does not pay dividends and the holder of Series H Preferred Stock shall be entitled to one vote for each share of common stock that the Series H Preferred Stock may be convertible into. Upon conversion of the Gopher Convertible Note and the 20,000 shares of Series H Preferred Stock, Gonzalez would be entitled to less than 50% of the resulting outstanding shares of common stock of the Company following conversion in full and, as a result, such transaction is not considered a change of control.

 

On May 19, 2021, the Company, entered into a Mutual Release and Settlement Agreement and Irrevocable Assignment of Note Balance Principal and Accrued Interest (the “Gonzalez Agreement”) with third party, GBT-CR, IGOR 1 Corp and Gonzalez. Pursuant to the Gonzalez Agreement, without any party admission of liability and to avoid litigation, the parties had agreed to (i) extend the GBT Convertible Note maturity date to December 31,2022, (ii) amend the GBT Convertible Note terms to include a beneficial ownership blocker of 4.99% and a modified conversion feature to the GBT Convertible Note with 15% discount to the market price during the 20 trading day period ending on the latest complete trading day prior to the conversion date and (iii) provided for an assignment of the GBT Convertible Note by Gonzalez to a third party.

 

GBT-CR is in the business of the strategic management of BPO (Business Process Outsourcing) digital communications processing for enterprises and startups, distributed ledger technology development, AI development and fintech software development and applications.

 

The Company accounted for its investment in GBT-CR using the equity method of accounting; however, in 2020, the Company owned less than 20% after GBT-CR issued additional shares to other investors therefore exercised no control over GBT-CR; therefore, this investment is currently accounted for under the cost method. Moreover, on March 19, 2020, California Governor Gavin Newsom issued a stay-at-home order to protect the health and well-being of all Californians and to establish consistency across the state in order to slow the spread of COVID-19. California was therefore under strict quarantine control and travel has been severely restricted, resulting in disruptions to work, communications, and access to files (due to limited access to facilities). The stay-at-home order was lifted in California only on January 25, 2021. As such, the Company was unable to access or to contact GBT-CR on an on-going basis, and cannot get information about GBT-CR.

 

Investment in Joint Venture

 

On March 6, 2020, the Company through Greenwich, entered into a Joint Venture and Territorial License Agreement (the “Tokenize Agreement”) with Tokenize-It, S.A. (“Tokenize”), which is owned by a Costa Rica Trust represented by Pablo Gonzalez (“Gonzalez”). Gonzalez also represents Gonzalez Costa Rica Trust, which holds a note in the principal amount of $10,000,000 and is also a shareholder of the Company. Under the Tokenize Agreement, the parties formed GBT Tokenize Corp., a Nevada corporation (“GBT Tokenize”). The purpose of GBT Tokenize is to develop, maintain and support source codes for its proprietary technologies including advanced mobile chip technologies, tracking, radio technologies, AI core engine, electronic design automation, mesh, games, data storage, networking, IT services, business process outsourcing development services, customer service, technical support and quality assurance for business, customizable and dedicated inbound and outbound calls solutions, as well as digital communications processing for enterprises and startups (“Technology Portfolio”), throughout the State of California. Upon generating any revenue from the Technology Portfolio, the Joint Venture will earn the first right of refusal for other territories.

 

The Company pledged its 50% ownership in GBT Tokenize and its 100% ownership of Greenwich to Tokenize to secure its Technology Portfolio investment. The Company shall appoint two directors and Tokenize shall appoint one director of GBT Tokenize.

 

Tokenize shall contribute the services and resources for the development of the Technology Portfolio to GBT Tokenize. The Company shall contribute 2,000,000 shares of common stock of the Company (“GBT Shares”) to GBT Tokenize. Tokenize and the Company will each own 50% of GBT Tokenize. The shares were valued at $5,500,000.

 

In addition, GBT Tokenize and Gonzalez entered into a Consulting Agreement in which Gonzalez is engaged to provide services for $33,333 per month payable quarterly which may be paid in shares of common stock calculated by the amount owed divided by the Company’s 10-day VWAP. Gonzalez will provide services in connection with the development of the business as well as GBT Tokenize’s capital raising efforts. The term of the Consulting Agreement is two years. During year ended December 31, 2021, Gonzalez assigned all his accrued balances of $424,731 to Stanley Hills in a private transaction that the Company is not part to. The closing of the Tokenize Agreement occurred on March 9, 2020.

 

Through this Joint Venture the parties commenced development of an intelligent human vital signs’ device, which we currently refer to as the qTerm. The platform is an expansion of the existing license agreement with GBT Tokenize Corp., which provided GBT Tokenize Corp. with an exclusive territory of California to develop certain of the Company’s technology. As the nature of the platform cannot be restricted only to California, the Company’s joint venture GBT Tokenize Corp. will be compensated with additional two hundred million shares of the Company to strengthen its funding, subject to board approval. A provisional patent application for the qTerm Medical Device was filed on March 30, 2020 with the USPTO. The application has been assigned serial number 63001564. The Joint Venture completed successfully the first prototype. There is no guarantee that the Company will be successful in researching, developing or implementing this product into the market. In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed and granted regulatory approval, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps.

 

On May 28, 2021, the parties agreed to amend the Tokenize Agreement to expand territory granted for the Technology Portfolio under the license to GBT Tokenize to include the entire continental United States. The Company has further agreed to issue GBT Tokenize an additional 14,000,000 shares of common stock of the Company. The shares were valued at $15,400,000.

 

At March 31, 2020, the Company evaluated the carrying amount of this joint venture investment and determined that this investment was fully impaired and as a result an impairment charge of $5,500,000 was taken. At December 31, 2021, the Company evaluated the carrying amount of this joint venture investment and determined that this investment was fully impaired and as a result an impairment charge of $15,400,000 was taken.

 

Although the investment was impaired, the product development is still ongoing. The carrying amount of this investment at December 31, 2022 and December 2021, was $0 and $0, respectively.

 

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Accounts Payable and Accrued Expenses
12 Months Ended
Dec. 31, 2022
Payables and Accruals [Abstract]  
Accounts Payable and Accrued Expenses

Note 8 – Accounts Payable and Accrued Expenses

 

Accounts payable and accrued expenses at December 31, 2022 and 2021 consist of the following:

 

          
   2022  2021
Accounts payable  $1,530,762   $1,110,127 
Accrued liabilities   1,513,261    3,033,016 
Accrued interest   3,196,611    2,753,120 
Other        
Total  $6,240,634   $6,896,263 

 

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.1
Unearned Revenue
12 Months Ended
Dec. 31, 2022
Unearned Revenue  
Unearned Revenue

Note 9 – Unearned Revenue

 

Unearned revenue represents the net amount received for the purchase of products that have not seen shipped to the Company’s customers. In 2018, the Company ran pre-sales efforts for its pet tracker product and received prepayments for its product. In addition, during 2018, the Company received $200,000 in connection with an intellectual property license and royalty agreement. The Company has $48,921 and $249,384 of unearned revenue at December 31, 2022 and 2021, respectively.

 

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Convertible Notes Payable, Non-related Partied and Related Party
12 Months Ended
Dec. 31, 2022
Debt Disclosure [Abstract]  
Convertible Notes Payable, Non-related Partied and Related Party

Note 10 – Convertible Notes Payable, Non-related Partied and Related Party

 

Convertible notes payable – non related parties at December 31, 2022 and 2021 consist of the following:

 

          
   December 31,  December 31,
   2022  2021
Convertible note payable to GBT Technologies S.A  $6,395,531   $8,055,400 
Convertible notes payable to 1800   191,257    124,200 
Convertible notes payable to Redstart Holdings       244,500 
Total convertible notes payable, non related parties   6,586,788    8,424,100 
Unamortized debt discount   (189,060)   (278,867)
Convertible notes payable – non related parties   6,397,727    8,145,233 
Less current portion   6,397,727    (8,109,436)
Convertible notes payable – non related parties, long-term portion  $   $35,797 

 

$10,000,000 for GBT Technologies S. A. acquisition

 

In accordance with the acquisition of GBT-CR the Company issued a convertible note in the principal amount of $10,000,000. The convertible note bears interest of 6% and is payable at maturity on December 31, 2021. At the election of the holder, the convertible note can be converted into a maximum of 20,000 shares of Series H Preferred Stock. Each share of Series H Preferred Stock is convertible, at the option of the holder but subject to the Company increasing its authorized shares of common stock, into such number of shares of common stock of the Company as determined by dividing the Stated Value ($500 per share) by the conversion price ($500 per share). This convertible note may convert into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion and therefore recorded as derivative liability (see note 12).

 

On May 19, 2021, the Company, Gonzalez, GBT-CR and IGOR 1 Corp entered into a Mutual Release and Settlement Agreement and Irrevocable Assignment of outstanding balance plus accrued interest (the “Gonzalez Agreement”). Pursuant to the Gonzalez Agreement, without any party admission of liability and to avoid litigation, the parties had agreed to (i) extend the GBT convertible note maturity date to December 31, 2022, (ii) amend the GBT convertible note terms to include a beneficial ownership blocker of 4.99% and a modified conversion feature to the GBT convertible note with 15% discount to the market price during the 20 trading day period ending on the latest complete trading day prior to the conversion date and (iii) provided for an assignment of the GBT convertible note by Gonzalez to a third party. As a result of the change in terms of this convertible note, the Company took a charge related to the modification of debt of $13,777,480 during the year ended December 31, 2021. This convertible note is recorded as derivative liability because of the discounted price on conversion (see note 13).

 

During the year ended December 31, 2021, IGOR 1 converted $1,284,600 of the convertible note into 4,185,650 shares of the Company’s common stock. On June 24, 2021, the Company transferred 5,500,000 SURG shares received as repayment of $660,000 of this convertible note (See Note7).

 

During the year ended December 31, 2022, IGOR 1 converted $1,659,869 of the convertible note into 590,117,647 shares of the Company’s common stock.

 

As of December 31, 2022, the note had an outstanding balance of $6,395,531 and accrued interest of $2,027,148.

 

Redstart Holdings Corp.

 

Paid Off Notes/Converted Notes

 

On August 4, 2020, the Company entered into a Securities Purchase Agreement with Redstart Holdings Corp., an accredited investor (“Redstart”) pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 1”) of $153,600 for $128,000. The Redstart Note No. 1 had a maturity date of November 3, 2021 and the Company had agreed to pay interest on the unpaid principal balance of the Redstart Note No. 1 at the rate of 6% from the date on which the Redstart Note No. 1 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 1, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 1. The transactions described above closed on August 5, 2020. The outstanding principal amount of the Redstart Note No. 1 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, Redstart may convert the Redstart Note No. 1 into shares of the Company’s common stock  to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 1), the Redstart Note No. 1 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 1. During the year ended December 31, 2021, the entire amount of Note No. 1 of $153,600 plus accrued interest was converted into 226,532 shares of common stock.

 

On September 15, 2020, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 2”) of $93,600 for $78,000. The Redstart Note No. 2 had a maturity date of September 15, 2021 and the Company had agreed to pay interest on the unpaid principal balance of the Redstart Note No. 2 at the rate of 6% from the date on which the Redstart Note No. 2 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 2, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 2. The transactions described above closed on September 16, 2020. The outstanding principal amount of the Redstart Note No. 2 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, Redstart may convert the Redstart Note No. 2 into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 2), the Redstart Note No. 2 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 2. During the year ended December 31, 2021, the entire amount of Note No. 2 of $93,600 plus accrued interest was converted into 89,169 shares of common stock.

 

On December 9, 2020, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 3”) of $100,200 for $83,500. The Redstart Note No. 3 had a maturity date of December 9, 2021 and the Company had agreed to pay interest on the unpaid principal balance of the Redstart Note No. 3 at the rate of 6% from the date on which the Redstart Note No. 3 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 3, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 3. The transactions described above closed on December 11, 2020. The outstanding principal amount of the Redstart Note No. 3 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, Redstart may convert the Redstart Note No. 3 into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 3), the Redstart Note No. 3 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 3. During the year ended December 31, 2021, the entire amount of Note No. 3 of $100,200 plus accrued interest was converted into 135,582 shares of common stock.

 

On February 10, 2021, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 4) of $184,200 for a purchase price of $153,500. The Redstart Note No. 4 had a maturity date of February 5, 2022 and the Company had agreed to pay interest on the unpaid principal balance of the Redstart Note No. 4 at the rate of 6% from the date on which the Redstart Note No. 4 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 4, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 4. The transactions described above closed on February 10, 2021. The outstanding principal amount of the Redstart Note No. 4 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, Redstart may convert the Redstart Note No. 4 into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 4), the Redstart Note No. 4 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 4. During the year ended December 31, 2021, the entire amount of Redstart Note No. 4 of $184,200 plus accrued interest was converted into 386,146 shares of common stock.

 

 

On March 15, 2021, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 5”) of $106,200 for $88,500. The Redstart Note No. 5 had a maturity date of June 15, 2022 and the Company had agreed to pay interest on the unpaid principal balance of the Redstart Note No. 5 at the rate of 6% from the date on which the Redstart Note No. 5 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 5, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 5. The transactions described above closed on March 17, 2021. The outstanding principal amount of the Redstart Note No. 5 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, Redstart may convert the Redstart Note No. 5 into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 5), the Redstart Note No. 5 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 5. During the year ended December 31, 2021, the entire amount of Redstart Note No. 5 of $106,200 plus accrued interest was converted into 317,837 shares of common stock.

 

On May 26, 2021, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 6”) of $106,200 for $88,500. The Redstart Note No. 6 had a maturity date of August 26, 2022 and the Company had agreed to pay interest on the unpaid principal balance of the Redstart Note No. 6 at the rate of 6% from the date on which the Redstart Note No. 6 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 6, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 6. The transactions described above closed on May 28, 2021. The outstanding principal amount of the Redstart Note No. 6 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, Redstart may convert the Redstart Note No. 6 into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 6), the Redstart Note No. 6 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 6. During the year ended December 31, 2021, the entire amount of Redstart Note No. 5 of $106,200 plus accrued interest was fully repaid in total cash of $141,782.

 
On September 21, 2021, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 7”) of $244,500 for $203,750. The Redstart Note No. 7 had a maturity date of December 22, 2022 and the Company agreed to pay interest on the unpaid principal balance of the Redstart Note No. 7 at 2.5% from the date on which the Redstart Note No. 7 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 7, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 7. The transactions described above closed on September 28, 2021. The outstanding principal amount of the Redstart Note No. 7 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, Redstart may convert the Redstart Note No. 7 into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 7), the Redstart Note No. 7 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 7. During the year ended December 31, 2022, Redstart converted the entire note into 7,656,951 shares of the Company’s common stock.

 

Iliad Research and Trading, L.P.

 

On February 27, 2019, the Company entered into a note purchase agreement with a third-party invest–r - Iliad Research and Trading, L.P.(“Iliad”), pursuant to which the Company issued a promissory note for the original principal amount of $2,325,000. The promissory note had an original issue discount of $300,000 and the inventor paid $2,025,000 to the Company, of which $25,000 was paid for legal expenses. The outstanding balance of the promissory note is to be paid on the one-year anniversary of the issuance of the note. Interest on the note accrues at the rate of 10% compounding daily. Subject to the terms and conditions set forth in the note, the Company may prepay all or any portion of the outstanding balance of the note at any time in an amount in cash equal to 120% of the amount repaid. In connection with transactions that generate less than $1,000,000 in proceeds, the Company had agreed to not issue any debt instrument or incurrence of any debt other than trade payables in the ordinary course of business, any securities or agreements to sell common stock with anti-dilution or price reset/reduction features or any securities that are or may be become convertible or exercisable into common stock with a price that varies with the market price of the common stock (collectively, “Restricted Issuance Transaction”). The outstanding balance of the Note will be increased by 5% in the event the Company enters into a Restricted Issuance Transaction that is approved by Iliad. The original issue discount is being amortized to interest expense over the term of the promissory note.

 

On February 27, 2020, the Company and Iliad entered into an Amendment to the Iliad Note pursuant to which the maturity date of the Iliad Note was extended to August 27, 2020, provided that the Debt may be converted into shares of common stock of the Company at a conversion price equal to 80% multiplied by the lowest trading daily VWAP for the common stock during the 20 trading day period ending on the latest complete trading day prior to the conversion date, provided for the payment by the Company to Iliad of an extension fee equal to 7.5% of the outstanding balance of the Iliad Note resulting in a new balance of the Iliad Note of $2,765,983 and provided that the Company’s failure to deliver shares of common stock within three trading days of a conversion would result in an event of default. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. Iliad  agreed to restrict its ability to convert the Iliad Note and receive shares of common stock such that the number of shares of common stock held by it and its affiliates after such conversion or exercise does not exceed 9.99% of the then issued and outstanding shares of common stock. On July 20, 2020 the Company and Iliad entered into agreement to extend the maturity of the Iliad Note until February 27, 2021 for an extension fee of $1,000. On February 28, 2021 the Company and Iliad entered into agreement to further extend the maturity of the Iliad Note until May 31, 2021 for an extension fee of $1,000 representing the third extension of the original note. On May 19, 2021, the Company and Iliad entered into agreement to further extend the maturity of the Iliad Note until August 31, 2021 for an extension fee of $1,000 representing the fourth extension of the original note. On August 20, 2021, the Company and Iliad entered into agreement to further extend the maturity of the Iliad Note until December 31, 2021 for an extension fee of $1,000. During the year ended December 31, 2021, Iliad converted $2,508,737 of its convertible note into 4,053,069 shares of the Company’s common stock. The balance of the Iliad debt at December 31, 2022 and December 31, 2021 was $0 and $0, respectively.

 

Sixth Street Lending LLC – named changed - 1800 Diagonal Lending LLC - First Note

 

On November 8, 2021, the Company entered into a Securities Purchase Agreement with Sixth Street Lending LLC (“Sixth Street”) pursuant to which the Company issued to Sixth Street a Convertible Promissory Note (the “Sixth Street Note”) of $124,200 for $103,500. The Sixth Street Note had a maturity date of February 8, 2023 and the Company agreed to pay interest on the unpaid principal balance of the note at 6% from the date on which the note is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the note, provided it makes a payment including a prepayment to Sixth Street as set forth in the Sixth Street Note. The outstanding principal amount of the note may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, Sixth Street may convert the note into shares of the Company’s common stock at a conversion price equal to 85% of the average of the two lowest trading prices with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Sixth Street Note), the note shall become immediately due and payable and the Company shall pay to Sixth Street, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Sixth Street Note. During the year ended December 31, 2022, Sixth Street converted the entire note into 26,343,190 shares of the Company’s common stock.

 

Outstanding Notes

 

Sixth Street Lending LLC – named changed - 1800 Diagonal Lending LLC - Second Note

 

On May 5, 2022, the Company entered into a Securities Purchase Agreement with 1800 Diagonal Lending LLC, an accredited investor (“DL”), pursuant to which the Company issued to DL a Convertible Promissory Note (the “DL Note”) of $244,500 for $203,500. The DL Note had a maturity date of August 4, 2023 and the Company had agreed to pay interest on the unpaid principal balance of the DL Note at 6.0% from the date on which the DL Note is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the DL Note at any time from the Issue Date and continuing through 180 days following the Issue Date, provided it makes a payment including a prepayment premium to DL as set forth in the DL Note. The transactions described above funded on May 9, 2022.

 

The outstanding principal amount of the DL Note may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180th day, DL may convert the DL Note into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price during the 20-day period immediately preceding the date of conversion. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the DL Note), the DL Note shall become immediately due and payable and the Company shall pay to DL, in full satisfaction of its obligations hereunder, additional amounts as set forth in the DL Note. In no event shall DL be allowed to effect a conversion if such conversion, along with all other shares of Company common stock beneficially owned by DL and its affiliates would exceed 4.99% of the outstanding shares of the common stock of the Company.

 

Unless the Company shall have first delivered to DL, at least 48 hours prior to the closing of any equity (or debt with an equity component) financing in an amount less than $150,000 (“Future Offering”), written notice describing the proposed Future Offering and providing the Buyer an option during the 48 hour period following delivery of such notice to DL the securities being offered in the Future Offering on the same terms as contemplated by such Future Offering then the Company is restricted from conducting the Future Offering during the period beginning on the Issue Date and ending nine months following the Issue Date.

 

During the year ended December 31, 2022, 1800 Diagonal lending converted $130,400 of the convertible note into 222,091,971 shares of the Company’s common stock.

 

As of December 31, 2022, the note had an outstanding balance of $114,100 and accrued interest of $7,674.

 

Sixth Street Lending LLC – named changed - 1800 Diagonal Lending LLC - Third Note

 

On September 13, 2022, the Company entered into a Securities Purchase Agreement (dated September 9, 2022) with 1800 Diagonal Lending LLC, an accredited investor (“DL”) pursuant to which the Company issued to DL a Promissory Note (the “DL Note”) of $116,200 with an original issue discount of $12,450 resulting in net proceeds of the Company of $103,750. The DL Note had a maturity date of September 9, 2023 and the Company had agreed to pay interest on the unpaid principal balance of the DL Note at the rate of 12.0% from the date on which the DL Note is issued (the “Issue Date”). A one-time interest charge of 12% or $13,944 was applied on the Issue Date to the principal amount owed under the DL Note. Accrued, unpaid interest and outstanding principal, subject to adjustment, shall be paid in ten payments of $13,014.40 resulting in a total payback to DL of $130,144. The first payment is due October 30, 2022 with nine subsequent payments each month thereafter. The Company shall have a five-day grace period with respect to each payment. The Company has right to accelerate payments or prepay in full at any time with no prepayment penalty. This DL Note shall not be secured by any collateral or any assets of the Company. The outstanding principal amount of the DL Note may not be converted into the Company common shares except in the event of default. In the event of default on the DL Note, DL may convert the DL Note into shares of the Company’s common stock at a conversion price equal to 75% of the lowest trading price with a 10-day look back immediately preceding the date of conversion. In addition, upon the occurrence and during the continuation of an event of default (as defined in the DL Note), the DL Note shall become immediately due and payable and the Company shall pay to DL, in full satisfaction of its obligations hereunder, additional amounts as set forth in the DL Note. In no event shall DL be allowed to effect a conversion if such conversion, along with all other shares of Company common stock beneficially owned by DL and its affiliates would exceed 4.99% of the outstanding shares of the common stock of the Company.

 

During the year ended December 31, 2022, the company paid back $39,043 to 1800 Diagonal lending.

 

As of December 31, 2022, the note had an outstanding balance of $77,157 and an interest of $13,944.

 

As of December 31, 2022 and December 31, 2021, the nonrelated party convertible notes had total outstanding balance of $6,393,497 and 8,145,233, net of debt discount, and accrued interest of $2,068,799 and $1,547,924, respectively.

 

Convertible notes payable – related parties at December 31, 2022 and 2021 consist of the following:

 

          
   December 31,  December 31,
   2022  2021
Convertible note payable to Stanley Hills   116,605    116,605 
Unamortized debt discount        
Convertible notes payable, net, related party   116,605    116,605 
Less current portion   (116,605)   (116,605)
Convertible notes payable, net, related party, long-term portion  $   $ 

 

Stanley Hills LLC

 

The Company entered into a series of loan agreements with Stanley Hills LLC (“Stanley”) pursuant to which it received more than $1,000,000 in loans (the “Debt”) from May 2019 up to December 2019. On February 26, 2020, in order to induce Stanley to continue to provide funding, the Company and Stanley entered into a letter agreement providing that the current note payable balance due to Stanley of $1,214,900 may be converted into shares of common stock of the Company at a conversion price equal to 85% multiplied by the lowest one trading price for the common stock during the 20-trading day period ending on the latest complete trading day prior to the conversion date. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. Stanley had agreed to restrict its ability to convert the Debt and receive shares of common stock such that the number of shares of common stock held by it and its affiliates after such conversion or exercise does not exceed 4.99% of the then issued and outstanding shares of common stock. During the year ended December 31, 2021, Stanley converted $1,231,466 of its convertible note plus interest into 4,420,758 shares of the Company’s common stock, and during the year ended December 31, 2021, Stanley loaned the Company an additional $325,000. Also, during the year ended December 31, 2021, the Company transferred the SURG shares received as repayment of $800,000 of this convertible note (See Note 10) and also converted $126,003 of accrued interest into the principal balance. During the year ended December 31, 2021, Gonzalez assigned all his accrued balances of $424,731 to Stanley in a private transaction that the Company is not part to (See Note 10). As of December 31, 2022 and 2021 the principal balance of Stanley debt is $116,605 and 116,605 respectively. The unpaid interest of the Stanley debt at December 31, 2022 and 2021 was $20,033 and $8,372, respectively. The Stanley debt is secured via a pledge agreement on the SURG shares.

 

Discounts on convertible notes

 

The Company recognized interest expense of $438,015 and $824,238 during the years ended December 31, 2022 and 2021, respectively, related to the amortization of the debt discount on convertible notes. The unamortized debt discount at December 31, 2022 and 2021 was $189,060 and $278,867, respectively.

 

A roll-forward of the convertible notes payable from December 31, 2020 to December 31, 2022 is below:

 

     
Convertible notes payable, December 31, 2020   13,426,706 
Issued for cash   983,450 
Convertible note issued for accounts payable   625,429 
Accrued interest added to convertible note   234,521 
Payment with marketable securities   (1,460,000)
Payment with cash   (106,200)
Original issue discount   127,550 
Conversion to common stock   (5,649,000)
Debt discount related to new convertible notes   (741,100)
Amortization of debt discounts   819,423 
Convertible notes payable, December 31, 2021  $8,261,839 
Issued for cash   300,000 
Payment with cash   (39,042)
Original issue discount   60,700 
Conversion to common stock   (2,158,971)
Debt discount related to new convertible notes   (352,441)
Amortization of debt discounts   442,247 
Convertible notes payable, December 31, 2022  $6,514,332 

 

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Notes Payable, Non-related Parties and Related Party
12 Months Ended
Dec. 31, 2022
Notes Payable Non-related Parties And Related Party  
Notes Payable, Non-related Parties and Related Party

Note –11 - Notes Payable, Non-related Parties and Related Party

 

Notes payable, non-related parties at December 31, 2022 and December 31, 2021 consist of the following:

 

          
   December 31,  December 31,
   2022  2021
RWJ acquisition note  $   $2,600,000 
SBA loan   350,000    350,000 
Total notes payable   350,000    2,950,000 
Unamortized debt discount        
Notes payable   350,000    2,950,000 
Less current portion   (41,137)   (2,612,397)
Notes payable, long-term portion  $308,863   $337,603 

 

RWJ Acquisition Note

 

In connection with the acquisition of RWJ in September 2017, the Company issued a note payable. The note accrues interest at 3.5%, was due on December 31, 2019 and is secured by the assets purchased in the acquisition. The Company contests the validity of the note, as such the note has not been repaid as of December 31, 2021. The balance of the note at December 31, 2022 and 2021 was $0 and $2,600,000 plus accrued interest of $0 and $394,666, respectively.

 

SBA Loan

 

On June 22, 2020, the Company received a loan from the Small Business Administration under the Economic Injury Disaster Loan program related to the COVID-19 relief efforts. The loan bears interest at 3.75%, requires monthly principal and interest payments of $731 after 12 months from funding and is due 30 years from the date of issuance. The monthly payments have been extended by the SBA to all EIDL borrowers with additional 12 months. Monthly payments will be commenced on or around June 16, 2022. On October 1, 2021, the Company entered an Amended Loan Authorization and Agreement with the SBA providing for the modification of the Original Note providing for monthly principal and interest payments of $1,771 after 24 months from the Original Note commencing on or around June 22, 2022. On March 17, 2022 the SBA notified it deferred the payments to all COVID-19 EIDL loans will have the first payment due extended from 24-months to 30-months from the date of the note. The Modified Note will continue to bear interest at 3.75% and is due 30 years from the date of issuance of the Original Note. The Modified Note is guaranteed by Douglas Davis, the former CEO of the Company and current consultant, as well as by GBT Tokenize Corp. The additional funding of $200,000 was received by the Company on October 5, 2021. The balance of the note at December 31, 2022 and 2021 was $350,000 and $350,000 plus accrued interest of $23,707 and $10,582, respectively.

 

Notes payable, related party at December 31, 2022 and December 31, 2021 consist of the following:

 

          
   December 31,  December 31,
   2022  2021
Alpha Eda note payable  $140,000   $140,000 
Total notes payable, related party   140,000    140,000 
Unamortized debt discount        
Notes payable, net, related party   140,000    140,000 
Less current portion   (140,000)   (140,000)
Notes payable, net, related party, long-term portion  $   $ 

 

Alpha Eda

 

On November 15, 2020, the Company issued a promissory note to Alpha Eda, LLC (“Alpha”), a related party for $140,000. The note accrues interest at 10%, is unsecured and was due on September 30, 2021. On June 20, 2021 Alpha and the Company extended the note maturity to December 31, 2021. The balance of the note at December 31, 2022 and 2021 was $140,000 and $140,000 plus accrued interest of $32,633 and $16,633, respectively.

 

Discounts on Promissory Note

 

The Company recognized interest expense of $0 and $47,671 during the years ended December 31, 2021 and 2020, respectively, related to the amortization of the debt discount on promissory notes. The unamortized debt discount at December 31, 2021 and 2020 was $0.

 

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Accrued Settlement
12 Months Ended
Dec. 31, 2022
Accrued Settlement  
Accrued Settlement

Note 12 – Accrued Settlement

 

In connection with a legal matter filed by the Investor of the $8,340,000 Senior Secured Redeemable Convertible Debenture, on December 23, 2019, in the pending arbitration between the Company and the Investor, an Interim Award was entered in favor of the Investor. On January 31, 2020, the Company was informed that a final award was entered (the “Final Award”). The Final Award affirms that certain sections of the Senior Secured Redeemable Convertible Debenture (the “Debenture”) constitute unenforceable liquidated damages penalties and were stricken. Further, it was determined that the Investor was entitled to recovery of their attorney’s fees. Consequently, the arbitrator awarded Investor an award of $4,034,444 plus interest of 7.25% accrued from May 15, 2019 (presented separately in accounts payable and accrued expenses) and costs of $55,613. (See Note 17). In connection with this settlement, the Company recognized a gain on the settlement of debt of $1,375,556 in 2019 as the difference between the carrying amount of the debt and the amount awarded by the arbitrator (See Note 17). The Company recorded accrued settlement of $4,090,057 and $4,090,057 at December 31, 2022 and 2021, respectively.

 

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Liability
12 Months Ended
Dec. 31, 2022
Derivative Liability  
Derivative Liability

Note 13 - Derivative Liability

 

Certain of the convertible notes payable discussed in Note 10 have a conversion price that can be adjusted based on the Company’s stock price which results in the conversion feature being recorded as a derivative liability.

 

The FV of the derivative liability is recorded and shown separately under current liabilities. Changes in the FV of the derivative liability is recorded in the statement of operations under other income (expense).

 

The Company uses a weighted average Black-Scholes option pricing model with the following assumptions to measure the FV of derivative liability at December 31, 2022 and 2021:

 

               
    December 31,   December 31,
    2022   2021
Stock price   $ 0.001     $ 0.17  
      4.42-        
Risk free rate     4.76 %     0.19-0.39%  
Volatility     213-277%       167-217%  
      0.0015-       0.102-  
Conversion/ Exercise price   $ 0.0017     $ 0.103  
Dividend rate     0 %     0 %

 

The following table represents the Company’s derivative liability activity for the years ended December 31, 2022 and 2021:

 

     
Derivative liability balance, December 31, 2019  $ 
Issuance of derivative liability during the period   5,767,230 
Fair value of beneficial conversion feature of debt converted   (2,038,392)
Change in derivative liability during the period   1,533,610 
Derivative liability balance, December 31, 2020   5,262,448 
Debt modification   13,777,480 
Issuance of derivative liability during the period   1,480,439 
Fair value of beneficial conversion feature of debt converted   (116,669)
Change in derivative liability during the period   1,339,117 
Derivative liability balance, December 31, 2021  $10,192,485 
Issuance of derivative liability during the period   325,915 
Fair value of beneficial conversion feature of debt converted   (2,209,887)
Change in derivative liability during the period   (6,594,370)
Derivative liability balance, December 31, 2022  $1,714,143 

 

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Equity
12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Stockholders’ Equity

 Note 14 - Stockholders’ Equity

 

Common Stock

 

The Board of Directors of the Company approved, on April 13, 2020, a reverse stock split of all of the Company’s Common Stock, pursuant to which every 50 shares of Common Stock of the Company shall be reverse split, reconstituted and converted into one (1) share of Common Stock of the Company (the “Reverse Stock Split”). The Company submitted an Issuer Company Related Action Notification regarding the Reverse Stock Split to FINRA on April 14, 2020. To effectuate the Reverse Stock Split, the Company filed on April 21, 2020 a Certificate of Change Pursuant to Nevada Revised Statutes (“NRS”) Section 78.209 (the “Certificate of Change”) with the Secretary of State of the State of Nevada subject to FINRA approval. On June 8, 2020 FINRA advised the Company that such request is deficient due to the fact that a holder of an outstanding convertible note of the Company had entered into two settlements with the Securities and Exchange Commission that related to securities laws violations but were in no way related to the Company. As a result, FINRA advised that it is necessary for the protection of investors, the public interest, and to maintain fair and orderly markets that documentation related to the Reverse Stock Split not be processed. The Company appealed the decision made by FINRA on June 15, 2020. On August 4, 2020, FINRA notified the Company that its appeal had been denied. On October 25, 2021 FINRA approved the Reverse Stock Split and on October 26, 2021, the Company effectuated a 1 for 50 reverse stock split.

 

In July 7, 2022 the Company filed a preliminary information statement to the stockholders of record (the “Record Date”) in connection with certain actions to be taken by the written consent by stockholders holding a majority of the voting stock of the Company, dated as of June 28, 2022.

  

  To amend the Company’s Articles of Incorporation, (the “Articles of Incorporation”) to increase the number of authorized shares of common stock, par value $0.00001 per share (the “Common Stock”), of the Company from 2,000,000,000 shares to 10,000,000,000 shares. This action concluded on August 11, 2022.

 

  (i) authorize the Company’s Board of Directors to effect, in its sole discretion, a reverse stock split of the Common Stock in a ratio of up to 1-for-500 (the “Reverse Stock Split”), and (ii) authorize the filing of an amendment to the Company’s Articles of Incorporation to implement the Reverse Stock Split and any other action deemed necessary to effectuate the Reverse Stock Split, without further approval or authorization of stockholders, at any time prior to December 31, 2023. This action was not commenced yet by the Company’s board.

 

During the year ended December 31, 2022, the Company had the following transactions in its common stock:

 

  Of 5,500,000 Shares issued for cash of $231,866; and
     
  Of 847,133,242 Shares issued for the conversion of convertible notes of $2,158,969 and accrued interest of $6,491; and
     
  cancelled 240,000 for services rendered
     
  Of 150,000,000 Shares issued to GBT Tokenize for certain joint venture agreement between Magic International Argentina FC, S.L. and the Company. The value of the shares of $1,500 was determined based on the FV of the Company’s common stock; and
     
  Of 500,000,000 Shares issued to Metaverse for certain equity method investment. The value of the shares of $5,000 was determined based on the FV of the Company’s common stock; and

 

Series B Preferred Shares

 

The Series B Preferred Stock has a stated value of $100 per share and is convertible into the Company’s common stock at a conversion price of $30 per share representing 30 posts split common shares. Furthermore, the Series B Preferred Stock votes on an as converted basis and carries standard anti-dilution rights. These rights were subsequently removed, except in cases of stock dividends or splits.

 

As of December 31, 2022 and 2021, there were 45,000 Series B Preferred Shares outstanding.

 

Series C Preferred Shares

 

Each share of Series C Preferred Stock is convertible, at the option of GV, into such number of shares of common stock of the Company as determined by dividing the Stated Value (as defined below) by the Conversion Price (as defined below). The Conversion Price for each share is equal to a 50% discount to the average of the lowest three lowest closing bid prices of the Company’s common stock during the 10-day trading period prior to the conversion with a minimum conversion price of $0.02. The stated value is $11 per share (the “Stated Value”). The Series C Preferred Stock has no liquidation preference, does not pay dividends and the holder of Series C Preferred Stock shall be entitled to one vote for each share of common stock that the Series C Preferred Stock shall be convertible into. GV has contractually agreed to restrict its ability to convert the Series C Preferred Stock and receive shares of the Company’s common stock such that the number of shares of the Company’s common stock held by it and its affiliates after such conversion does not exceed 4.9% of the then issued and outstanding shares of the Company’s common stock.

 

At December 31, 2022 and 2021, GV owns 700 Series C Preferred Shares.

 

The issuance of the Series C Preferred Stock was made in reliance upon exemptions from registration pursuant to Section 4(a)(2) under the Securities Act of 1933 and Rule 506 promulgated under Regulation D thereunder. GV is an accredited investor as defined in Rule 501 of Regulation D promulgated under the Securities Act of 1933.

 

As of December 31, 2022 and 2021, there were 700 Series C Preferred Shares outstanding.

 

Series D Preferred Shares

 

As of December 31, 2022 and 2021, there are 0 and 0 shares of Series D Preferred Shares outstanding, respectively.

 

Series G Preferred Shares

 

As of December 31, 2022 and 2021, there are 0 and 0 shares of Series G Preferred Shares outstanding, respectively.

 

Series H Preferred Shares

 

On June 17, 2019, the Company, AltCorp Trading LLC, a Costa Rica company and a wholly-owned subsidiary of the Company (“AltCorp”), GBT Technologies, S.A., a Costa Rica company (“GBT-CR”) and Pablo Gonzalez, a shareholder’s representative of GBT-CR (“Gonzalez”), entered into and closed an Exchange Agreement (the “GBT Exchange Agreement”) pursuant to which the parties exchanged certain securities. In accordance with the Exchange Agreement, AltCorp acquired 625,000 shares of GBT-CR representing 25% of its issued and outstanding shares of common stock from Gonzalez for the issuance of 20,000 shares of Series H Convertible Preferred Stock of the Company and a Convertible Note of $10,000,000 issued by the Company (the “Gopher Convertible Note”) as well as additional consideration. The Gopher Convertible Note bears interest of 6% and is payable at maturity on December 31, 2021. At the election of Gonzalez, the Gopher Convertible Note can be converted into a maximum of 20,000 shares of Series H Preferred Stock. Each share of Series H Preferred Stock is convertible, at the option of the holder but subject to the Company increasing its authorized shares of common stock, into such number of shares of common stock of the Company as determined by dividing the Stated Value ($500 per share) by the conversion price ($10 per share). The Series H Preferred Stock has no liquidation preference, does not pay dividends and the holder of Series H Preferred Stock shall be entitled to one vote for each share of common stock that the Series H Preferred Stock may be convertible into. On July 8, 2019, the Company entered a Consulting Agreement with Glen Eagles Glen Eagles Acquisition LP (“Glen”) as consultant to provide services in connection with the Company’s acquisition of 25% of GBT-CR. Consultant will provide analysis, interaction with related professional and other services as requested by the Company to integrate and expand capabilities between GBT-CR and the Company. (See Note 14 for further details.)

 

As of December 31, 2022 and 2021, there are 20,000 shares of Series H Preferred Shares outstanding.

 

Warrants

 

The following is a summary of warrant activity.

  

                                 
            Weighted    
        Weighted   Average    
        Average   Remaining   Aggregate
    Warrants   Exercise   Contractual   Intrinsic
    Outstanding   Price   Life   Value
Outstanding, December 31, 2021       392,870     $ 74.97       0.76     $  
Granted                                
Forfeited                                
Exercised                                
Outstanding, December 31, 2022       70,770     $ 205.07       0.30     $  
Exercisable, December 31, 2022       70,770     $ 205.07       0.30     $  

 

The exercise price for warrant outstanding and exercisable at December 31, 2022:

 

           
Outstanding   Exercisable        
Number of   Exercise   Number of   Exercise
Warrants   Price   Warrants   Price
      $ 25.00           $ 25.00  
  60,000       92.50       60,000       92.50  
  10,000       135.00       10,000       135.00  
  400       1,595.00       400       1,595.00  
        2,500.00             2,500.00  
        3,750.00             3,750.00  
        5,000.00             5,000.00  
  200       11,750.00       200       11,750.00  
  150       12,500.00       150       12,500.00  
  20       14,000.00       20       14,000.00  
  70,770               70,770          

 

Equity Purchase Agreement and Registration Rights Agreement

 

On December 17, 2021 (the “Effective Date”), GBT Technologies Inc. (the “Company”) entered into an equity financing agreement (the “Equity Financing Agreement”) and a registration rights agreement (the “Registration Rights Agreement”) with GHS Investments LLC (“GHS”), pursuant to which GHS shall purchase from the Company, up to that number of shares of common stock of the Company (the “Shares”) for $10,000,000, subject to certain limitations and conditions set forth in the Equity Financing Agreement from time to time over the course of 24 months after an effective registration of the Shares with the Securities and Exchange Commission (the “SEC”) pursuant to the Registration Rights Agreement, is declared effective by the SEC (the “Contract Period”).

 

The Equity Financing Agreement grants the Company the right, from time to time at its sole discretion (subject to certain conditions) during the Contract Period, to direct GHS to purchase shares of Common Stock on any business day (a “Put”), provided that at least ten trading days has passed since the most recent Put. The purchase price of the shares of Common Stock contained in a Put will be 90% of the lowest daily volume weighted average price (VWAP) of the Company’s Common Stock during the ten consecutive trading days preceding the receipt by GHS of the applicable Put notice. Such sales of Common Stock by the Company, if any, may occur from time to time, at the Company’s option, during the Contract Period. Subject to the satisfaction of certain conditions set forth in the Equity Financing Agreement, on each Put the Company will deliver an number of Shares equaling 110% of the dollar amount of each Put. The maximum dollar amount of each Put will not exceed 200% of the average daily trading dollar volume for the Company’s Common Stock during the ten trading days preceding the Trading Day that GHS receives a Put. No Put will be made in an amount equaling less than $10,000 or greater than $500,000. Puts are further limited to GHS owning no more than 4.99% of the outstanding stock of the Company at any given time. The Equity Financing Agreement and the Registration Rights Agreement contain customary representations, obligations, rights, warranties, agreements and conditions of the parties. The Equity Financing Agreement terminates upon any of the following events: when GHS has purchased $10,000,000 in the Common Stock of the Company pursuant to the Equity Financing Agreement; on the date that is 24 calendar months from the date the Equity Financing Agreement was executed.

 

Actual sales of shares of Common Stock to GHS under the Equity Financing Agreement will depend on a variety of factors to be determined by the Company from time to time, including, among others, market conditions, the trading price of the Common Stock and determinations by the Company as to the appropriate sources of funding for the Company and its operations.

 

For the year ended December 31, 2022, the Company did not receive any proceeds from the equity purchase agreement.

 

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Income Taxes

Note 15 - Income Taxes

 

At December 31, 2022 and 2021, the significant components of the deferred tax assets are summarized below:

  

               
    December 31,   December 31,
    2022   2021
Deferred income tax asset                
Net operating loss carryforwards   $ 9,182,327     $ 8,945,238  
Total deferred income tax asset     9,182,327       8,945,238  
Less: valuation allowance     (9,182,327 )     (8,945,238 )
Total deferred income tax asset   $     $  

  

The valuation allowance increased by $237,089 and $712,442 in 2022 and 2021, respectively, as a result of the Company generating additional net operating losses. The Company’s net operating loss carryforward of approximately $31,663,196 begin to expire in 2025.

 

No income tax expense reflected in the consolidated statements of income for the years 2022 and 2021.

 

The reconciliation of the effective income tax rate to the federal statutory rate for the years ended December 31, 2022 and 2021 is as follows:

   

                               
    2022   2021
    Amount   Percent   Amount   Percent
Federal statutory rates   $ 1,118,010       21.0 %   $ (7,125,391 )     21.0 %
State income taxes     425,908       8.0 %     (2,714,435 )     8.0 %
Permanent differences     (1,784,116 )     -33.5 %     9,127,383       -26.9 %
Valuation allowance against net deferred tax assets     237,089       4.5 %     712,442       -2.1 %
Effective rate   $       %   $       %

  

The Company periodically evaluates the likelihood of the realization of deferred tax assets, and adjusts the carrying amount of the deferred tax assets by the valuation allowance to the extent the future realization of the deferred tax assets is not judged to be more likely than not. The Company considers many factors when assessing the likelihood of future realization of its deferred tax assets, including its recent cumulative earnings experience by taxing jurisdiction, expectations of future taxable income or loss, the carryforward periods available to the Company for tax reporting purposes, and other relevant factors.

 

Future changes in the unrecognized tax benefit will have no impact on the effective tax rate due to the existence of the valuation allowance. The Company estimates that the unrecognized tax benefit will not change significantly within the next twelve months. The Company will continue to classify income tax penalties and interest as part of general and administrative expense in its consolidated statements of operations. There were no interest or penalties accrued as of December 31, 2022 and 2021.

 

XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Related Parties
12 Months Ended
Dec. 31, 2022
Related Party Transactions [Abstract]  
Related Parties

Note 16 - Related Parties

 

Related parties are natural persons or other entities that have the ability, directly or indirectly, to control another party or exercise significant influence over the party in making financial and operating decisions. Related parties include other parties that are subject to common control or that are subject to common significant influences.

 

On August 1, 2021, the Company and Danny Rittman, Chief Technology Officer and a Director of the Company, agreed to amend his employment agreement pursuant to which he will receive salary of $5,000 per month.

  

On September 1, 2017, the Company entered into and closed an Asset Purchase Agreement with a third party, RWJ Advanced Marketing, LLC (“RWJ”), a Georgia corporation, pursuant to which the Company purchased certain assets from RWJ, including inventory, terminals, licenses and permits and intangible assets. At closing, the Company and Mr. Greg Bauer entered into an Employment Agreement pursuant to which Mr. Bauer was retained as Chief Executive Officer for a term of one year, subject to an automatic extension, unless terminated, for a base salary of $250,000 and a bonus of 10% of net profit generated by the assets acquired. Mr. Bauer was also appointed to the Board of Directors of the Company. As of the closing date, Mr. Murray resigned as Chief Executive Officer of the Company but will remain as a director of the Company. Mr. Bauer, since 2004 through present, has served as executive director with W.L. Petrey Wholesale, Inc. where he was in charge of the UGO/Preway operations. The Company is in litigations in connection with RWJ transaction – See Note 18– - Contingencies.

 

On January 1, 2019, the Company and Douglas Davis entered into an Amended and Restated Employment Agreement pursuant to which Mr. Davis was retained as Chief Executive Officer. Mr. Davis served as Interim Chief Executive Officer since July 2018 until his resignation on April 11, 2020. The term of Mr. Davis’ employment was for two years through January 1, 2021. Mr. Davis was entitled to an annual base salary of $250,000, which was to be increased to $400,000 upon the Company up-listing to a national exchange. Mr. Davis was also entitled to the issuance of Stock Options to acquire of 50,000 shares of common stock of the Company, exercisable for five years, subject to vesting. The options were to be earned and vested (i) with respect to 20,000 shares of common stock on the date hereof, (ii) 5,000 shares of common stock upon the successful dual list of the Company on an international exchange such as SIX Zurich Stock Exchange or Euronext, (iii) 15,000 shares of common stock upon the successful up listing to a national exchange such as the Nasdaq, NYSE Euronext, TSX, AMEX or other, and (iv) with respect to 5,000 shares of common stock at each of the six (6) month anniversaries (July 1, 2019 and January 1, 2020). The exercise price of such options shall be the closing price of the Company on the date prior to such event.

 

On October 10, 2019, the Company entered into a Joint Venture Agreement (the “BitSpeed Agreement”) with BitSpeed LLC, which is owned by Douglas Davis, the Company’s Chief Executive Officer, to form GBT BitSpeed Corp., a Nevada company (“GBT BitSpeed”). The purpose of GBT BitSpeed is to develop, maintain and support its proprietary Extreme Transfer Software Application Concurrency, a software application to transfer secure, accelerated transmission of large file data over networks, and connection to cloud storage, Network-Attached Storage (NAS) and Storage Area Networks (SANs) (“Concurrency”). BitSpeed shall contribute the services and resources for the development of Concurrency to GBT BitSpeed. The Company shall contribute 10 million shares of common stock (valued at $17,900,000) of the Company to GBT BitSpeed. BitSpeed and the Company will each own 50% of GBT BitSpeed. The Company shall appoint two directors and BitSpeed shall appoint one director of GBT BitSpeed. In addition, GBT BitSpeed and Mr. Davis entered into a Consulting Agreement in which Mr. Davis is engaged to provide services for $10,000 per month payable quarterly which may be paid in shares of common stock calculated by the amount owed divided by the Company’s 20-day VWAP. Mr. Davis will provide services in connection with the development of the business as well as GBT BitSpeed’s capital raising efforts. The term of the Consulting Agreement is two years. The closing of the BitSpeed Agreement occurred on October 14, 2019. On April 11, 2020, Douglas Davis resigned as Chief Executive Officer of the Company so that he may fully devote all of his efforts to GBT Tokenize Corp., the Company’s joint venture, which intends to develop a new product. Mr. Davis’ resignation was not the result of any disagreements with management or board of directors of the Company.

 

On March 6, 2020, the Company through Greenwich, entered into the Tokenize Agreement with Tokenize, which is owned by a Costa Rica Trust represented by Gonzalez. Gonzalez also represents Gonzalez Costa Rica Trust, which holds a note of $10,000,000 and is also a shareholder of the Company. Under the Tokenize Agreement, the parties formed GBT Tokenize. The purpose of GBT Tokenize is to develop Technology Portfolio, throughout the State of California. Upon generating any revenue from the Technology Portfolio, the Joint Venture will earn the first right of refusal for other territories. Tokenize shall contribute the services and resources for the development of the Technology Portfolio to GBT Tokenize. The Company contributed 100,000,000 GBT Shares to GBT Tokenize. Tokenize and the Company will each own 50% of GBT Tokenize. The Company pledged its 50% ownership in GBT Tokenize and its 100% ownership of Greenwich to Tokenize to secure its Technology Portfolio investment. The Company shall appoint two directors and Tokenize shall appoint one director of GBT Tokenize. In addition, GBT Tokenize and Gonzalez entered into a Consulting Agreement in which Gonzalez is engaged to provide services for $33,333.33 per month payable quarterly which may be paid in shares of common stock calculated by the amount owed divided by the Company’s 10-day VWAP. Gonzalez will provide services in connection with the development of the business as well as GBT Tokenize’s capital raising efforts. The term of the Consulting Agreement is two years. The closing of the Tokenize Agreement occurred on March 9, 2020. Via this Joint Venture the parties commenced development of a development of an intelligent human vital signs’ device, suggested named qTerm.

  

The platform is an expansion of the existing license agreement with GBT Tokenize Corp., which provided GBT Tokenize Corp. with an exclusive territory of California to develop certain of the Company’s technology. As the nature of the platform cannot be restricted only to California, the Company’s joint venture GBT Tokenize Corp. will be compensated with additional two hundred million shares of the Company to strengthen its funding, subject to board approval. A provisional patent application for the qTerm Medical Device was filed on March 30, 2020 with the USPTO. The application has been assigned serial number 63001564. The Joint Venture completed successfully the first prototype. There is no guarantee that the Company will be successful in researching, developing or implementing this product into the market. In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed and granted regulatory approval, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps.

 

 

Yello Partners Inc.

 

As of December 31, 2022 and 2021, the Company has $505,000 and $385,000 owed to Yello Partners, Inc., a Company owned by the CEO.

 

Alpha Eda Note Payable – Related Party

 

On November 15, 2020, the Company issued a promissory note to Alpha Eda, LLC (“Alpha”), a related party, for $140,000. The note accrues interest at 10%, is unsecured and was due on September 30, 2021. On June 20, 2021 Alpha and the Company extended the note maturity to December 31, 2021. The balance of the note at December 31, 2022 and 2021 was $140,000 and $140,000 plus accrued interest of $32,633 and $16,333, respectively.

 

Stanley Hills LLC Convertible Note Payable – Related Party

 

The Company entered into a series of loan agreements with Stanley Hills LLC (“Stanley”) pursuant to which it received more than $1,000,000 in loans (the “Debt”) from May 2019 up to December 2019. On February 26, 2020, in order to induce Stanley to continue to provide funding, the Company and Stanley entered into a letter agreement providing that the current note payable balance due to Stanley of $1,214,900 may be converted into shares of common stock of the Company at a conversion price equal to 85% multiplied by the lowest one trading price for the common stock during the 20-trading day period ending on the latest complete trading day prior to the conversion date. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. Stanley had agreed to restrict its ability to convert the Debt and receive shares of common stock such that the number of shares of common stock held by it and its affiliates after such conversion or exercise does not exceed 4.99% of the then issued and outstanding shares of common stock. During the year ended December 31, 2021, Stanley converted $1,231,466 of its convertible note plus interest into 4,420,758 shares of the Company’s common stock, and during the year ended December 31, 2021, Stanley loaned the Company an additional $325,000. Also, during the year ended December 31, 2021, the Company transferred the SURG shares received as repayment of $800,000 of this convertible note (See Note 10) and converted $126,003 of accrued interest into the principal balance. During the year ended December 31, 2021, Gonzalez assigned all his accrued balances of $424,731 to Stanley in a private transaction that the Company is not part to (See Note 10). The balance of the Stanley convertible note payable at December 31, 2022 and December 31, 2021 was $116,605 and $116,605, respectively. The Stanley debt is secured via a pledge agreement on the SURG shares.

 

Stanley Hills LLC Accounts Payable – Related Party

 

On March 8, 2020, SURG filed a lawsuit against its transfer agent, Vstock from transferring millions of SURG stock that is currently in possession by the Company and assigned to Stanley Hills, LLC. On January 1, 2021, SURG, AltCorp and Stanley Hills, LLC (“Stanley”) entered into a Mutual Release and Settlement Agreement (“Settlement Agreement”). Pursuant to the terms of the Settlement Agreement, SURG agreed to amend the AltCorp Exchange Agreement where SURG acknowledged a debt of $3,300,000 (the “Debt”) to be paid in 33 monthly payments of $100,000 payable in shares of common stock of SURG at a per share price equal the volume weighted average price of Surg’s common stock during the 10 trading days immediately preceding the issuance. SURG paid $400,000 in cash and $800,000 by shares. The SURG common stock issued to Altcorp has been pledged since August 12, 2020 for the benefit of Stanley to secure Stanley’s note payable by the Company. Accordingly, the SURG Common Stock issued to AltCorp as a result of the Settlement Agreement were pledged to Stanley. As of December 31, 2021 there were no surge shares pledges after the final settlement signed on December 22, 2021 and that replaced all prior settlement agreement. The final settlement SURG agreed to make total payments of $4,200,000 to the Company on or prior to January 7, 2022. This $4.2 million amount consists of $450,000 paid by SURG in November and December 2021, $100,000 to be paid on or about January 4, 2022, and $3,650,000 to be paid on or prior to January 7, 2022 of which $375,000 will be held in escrow as described before. The $3,750,000 was recorded as other receivable as of December 31, 2021. As of December 31, 2022, the Company has recorded an outstanding payable balance to Stanley amounted $927,136 recorded under accrued expenses.

 

Consulting income for both the years ended December 31, 2022 and 2021 were $45,000 and $180,000. Consulting income are derived from providing IT consulting services to Stanley Hills, a related party.

 

XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Legal Proceedings
12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Legal Proceedings

Note 17 - Legal Proceedings

 

From time to time, the Company may be involved in various litigation matters, which arise in the ordinary course of business. There is currently no litigation that management believes will have a material impact on the financial position of the Company.

 

On or around January 30, 2019, RWJ Advanced Marketing, LLC, Greg Bauer, and Warren Jackson sued the Company and multiple third and related parties in Superior Court of the State of California - County of Los Angeles, General District in connection with the acquisition of UGO in September 2017. The case number is 19STCV03320 (the “Original Lawsuit”). The complaint in the Original Lawsuit alleges breach of contract, among other causes of action. The Company answered the complaint and filed a cross-complaint against the plaintiffs in the case and third parties on or around February 15, 2019. On or about September 10, 2020, the Company through its agent of service was “served” with a complaint (the Company contested service) that was recently filed against the Company and third parties by Robert Warren Jackson and Gregory Bauer in Los Angeles Superior Court Case No.: 20STCV32709 (“Second Lawsuit”). In the Original Lawsuit filed, the court rejected the plaintiff’s claims that they were filing a purported quasi-derivative lawsuit. As such, in this current litigation, the plaintiff is now again claiming the action is a derivative lawsuit. On October 13, 2020, the Second Lawsuit was removed by other defendants into Central District of California (CASE NO. 2:20−cv−09399−RGK−AGR). On February 2, 2021 the Central District of California dismissed the entire Second Lawsuit based on “demand futility”. In the Original lawsuit, the Company filed a cross complaint against the plaintiff and other third parties. Recently, the court has scheduled various hearings and a trial date set for December 27, 2021 which was later continued by the Court to September 28, 2022. It was the Company’s intention to dividend its holdings of its wholly owned subsidiary Ugopher services Corp. (“UGO”). As UGO is the main dispute in the litigations described above, the Company has elected to sell UGO to a third-party effective July 1, 2020. On September 17, 2020, the Company terminated Greg Bauer as consultant (resulting from the sale of UGO), which he confirmed in writing. On or about June 14, 2021 the Company stipulated with plaintiff that all third parties will be released and plaintiff may file a new first amendment complaint that will name only the Company. As such, all third parties other than prior transfer agent of the Company have been dismissed from this litigation.

  

Following the sale of UGO, the Company noticed third parties (including SURG, via its asset manager) to wire the UGO funds to its new bank account. SURG never answered the notice. SURG is the clearing house for UGO.The Company noticed certain third parties that it intends to take legal actions to resolve this issue. On November 12, 2020 the Company filed a complaint in the United States District Court – District of Nevada - Case 2:20-cv-02078 against RWJ, Mr. Bauer, Mr. Jackson and against W.L. Petrey Wholesale Company Inc for fraud, breach of contract, Unjust Enrichment and other claims. On January 28, 2022 the court awarded the Company with injunction against RWJ defendants, where all fee funds generating from resale should be deposited into GBT blocked account, and therefore RWJ defendants cannot use these funds without court order.

 

The Company entered into the Confidential Settlement Agreement and Mutual Release (“RJW Agreement”) by and between RWJ Advanced Marketing, LLC, Robert Warren Jackson, Gregory Bauer (collectively the “RJW Parties”) and W.L. Petrey Wholesale Company, Inc., (“Petrey”) on one hand; and GBT Technologies Inc., on behalf of itself and its agents (collectively the GBT Parties”), on the other hand. The Company the RJW Agreement effective September 26, 2022 with final signatures delivered to the Company on or about October 5, 2022. Pursuant to the RJW Agreement, the parties have agreed to settle, release, and otherwise resolve all known or unknown claims between them and agreed to jointly stipulate, move, or otherwise dismiss the lawsuits filed in the United States District Court of Nevada (Case No. 2:20-cv- 02078), in the Superior Court of the State of California, County of Los Angeles, Central District (Case Nos. 19STCV03320 and 20STCV32709), and in the United States District Court of the Central District of California (Case No. 2:20-cv-09399-RGK-AGR) with prejudice. The parties agreed and stipulated to release all funds currently being held in a blocked account of $19,809 with 50% distributed to the RWJ Parties and 50% distributed the Company or its assignee. The Parties also entered into the InComm Assignment Agreement (“IAA”) which assigned, transferred and conveyed all proceeds derived from the RWJ Parties’ agreements with Interactive Communications International, Inc., and its affiliate Hi Technology Corp., including but not limited to that Master Distribution and Service Agreement between Interactive Communications International, Inc. and Petrey d/b/a UGO-HUB dated August 29, 2016, as amended (collectively referred to as the “InComm Proceeds”), and which shall divide the InComm Proceeds 90% to the Company or its assignee and 10% to the RWJ Parties or their assignee. Finally, the Company agreed to pay $40,000 to the RWJ Parties or their assignee. The Company accrued $49,847 expenses represent the final amounts due to the RJW Parties.

 

The Company under a different settlement agreement with SURG, committed to assign the IAA. As such, on October 5, 2022 and as cumulation of all settlement agreements the Company issued a request to SURG regarding release of certain escrow funds and the execution of an assignment of rights as contemplated in the aforereferenced agreement.

 

On December 3, 2018, the Company entered into a Securities Purchase Agreement (the “SPA”) with Discover Growth Fund, LLC (the “Investor”) pursuant to which the Company issued a Senior Secured Redeemable Convertible Debenture (the “Debenture”) of $8,340,000. In connection with the issuance of the Debenture and pursuant to the terms of the SPA, the Company issued a Common Stock Purchase Warrant to acquire up to 225,000 shares of common stock for a term of three years (the “Warrant”) on a cash-only basis at an exercise price of $100 per share with respect to 50,000 Warrant Shares, $75 with respect to 75,000 Warrant Shares and $50 with respect to 100,000 Warrant Shares. The holder may not exercise any portion of the Warrants to the extent that the holder would own more than 4.99% of the Company’s outstanding common stock immediately after exercise. The outstanding principal amount may be converted at any time into shares of the Company’s common stock at a conversion price equal to 95% of the Market Price less $5 (the conversion price is lowered by 10% upon the occurrence of each Triggering Event – the current conversion price is 75% of the Market Price less $5.00). The Market Price is the average of the 5 lowest individual daily volume weighted average prices during the period the Debenture is outstanding. On May 28, 2019, the Investor delivered to the Company a “Notice of Default and Notice of Sale of Collateral” (the “Notice”). On December 23, 2019, in arbitration between the Company and the Investor, an Interim Award was entered in favor of the Investor. On January 31, 2020, the Company was informed that a final award was entered (the “Final Award”). The Final Award affirms that certain sections of the Debenture constitute unenforceable liquidated damages penalties and were stricken. Further, it was determined that the Investor was entitled to recovery of their attorney’s fees. Consequently, the arbitrator awarded Investor an award of $4,034,444 plus interest of 7.25% accrued from May 15, 2019 and costs of $55,613. On February 18, 2020, the Company filed a motion with the United States District Court District of Nevada (the “Nevada Court”) to confirm the Final Award and a motion to consolidate Investor’s application to confirm the Final Award filed in the U.S. District Court of the Virgin Islands (Case No: 3 :20-cv-00012-CVG-RM) (the “Virgin Island Court”). On February 27, 2020, the Nevada Court denied the Company’s motion to confirm the Final Award and motion to consolidate and further decided that the confirmation of the Final Award should be litigated in the Virgin Island Court. As such, on February 27, 2020, the Company filed a Notice of Entry of Order as well as a Motion to Confirm the Arbitration Award, address the outstanding issues regarding whether Investor’s rights are subordinated to other creditors and, thereafter, oversee a commercially reasonable foreclosure sale (Case No: 3 :20-cv-00012-CVG-RM). It was the Company’s position that the Final Award must first be confirmed and all questions regarding the rights of Investor relative to those of other creditors must be determined before any foreclosure sale can proceed. It is further the position of the Company that the previously disclosed foreclosure sale scheduled by Investor is being conducted in a commercially unreasonable manner and that if Discover proceeded forward with the foreclosure sale it did so at its own risk. Nevertheless, on February 28, 2020, Investor advised that it conducted a sale of the Company’s assets. As the date of this report Investor failed to present a deed of sale for the alleged sale that allegedly took place as noticed. The Company filed with Virgin Island Court the motions disputing the validity of the alleged sale. On July 28, 2020, Investor filed in the State of Nevada a motion for attorneys $48,844 and costs $716. The Company filed an answer on August 11, 2020. On October 16, 2020, Investor motion for attorneys $48,844 and costs $716 was denied. This case is still pending with the Federal court and the Court has not taken any substantive action in the matter as of the date of this report.

  

 

 

In connection with SURG Exchange Agreement (see Note 5) - On November 4, 2020, Altcorp and Stanley filed an Ex Parte Motion in the District Court, Clark County, Nevada (Case No: A-20-823039-B, in Dep No: 43) to appoint receiver and issue a temporary restraining Order against SURG and its transfer agent for alleged defaults on prior exchange agreement. On December 4, 2020, the parties entered an interim agreement which set the material terms of the settlement. A final settlement was achieved per the interim agreement terms on January 1, 2021. On March 4, 2021 the Company filed a motion to enforce settlement agreements, as the Company alleged that SURG owes an additional $240,000 which is due and owing under the settlement agreements.

 

On June 24, 2021 per the June 23, 2020 Agreement, the Company together with AltCorp sent SURG and its transfer agent via registered mail, a true-up shares demand for an additional 14,870,370 SURG shares as calculated per the Agreement. As of the filing date of this report, SURG’s transfer agent did not answer the Company’s request.

 

Subsequently, SURG was a party to two lawsuits in state District Court, the Eighth Judicial District Court for Clark County, Nevada involving AltCorp, Stanley and Glen Eagles Acquisition LP (the “AltCorp Parties.”). Each of these lawsuits were ultimately disputes relating to the total consideration SURG was to pay the Company under the APA.

 

On October 18, 2021, the AltCorp Parties, the Company, and SURG entered into a Memorandum of Understanding (the “MOU”) to set up a framework for an attempt to settle the two lawsuits.

 

On December 22, 2021 (the “Effective Date”), pursuant to the framework in the MOU, the AltCorp Parties (and an additional third party), the Company, ECS, and SURG, Kevin Brian Cox (SURG’s Chief Executive Officer) - in his individual capacity, entered into a Resolution of Purchase, Mutual Release, and Settlement Agreement (the “Final Settlement Agreement”) to settle the two lawsuits and resolve all disputes related to the consideration paid by SURG to the Company in connection with the APA.

 

On or about July 9, 2021 the Company filed a lawsuit in District Court in Clack County Nevada – Department 19 (Case number A-21-837631-C) against Terry Taylor and TTSG Holdings, Inc for breach of contract, breach of covenant of Good Faith and Fair Dealing, Unjust Enrichment and declaratory relief for failure of providing consulting services per contract they entered. The Company is demanding the return of 240,000 shares issued, return of the $5,000 payments, recission of the consulting agreement, and attorney’s fees and costs. As Terry Taylor and TTSG Holdings failed to appear to a notice of deposition, the Company filed for a summary judgment. On January 20, 2023 the court issued a $708,821 writ of execution against Terry Taylor and TTSG

 

Gregory Mancuso and Rainer AG

 

On or about February 2, 2022, GBT was served with a First Amended Complaint (the “Complaint”) initiated by Gregory Mancuso and Rainer AG, a Swiss corporation, Case No. 21SMCV01430, filed in the Superior Court of the State of California for the County of Los Angeles. The Complaint names a number of different parties, including GBT, and asserts, among other things, claims for conversion, unjust enrichment, breach of contract, and breach of implied covenant of fair dealing, which Plaintiffs allege arise out of a brokerage agreement entered into between Plaintiff Rainer AG and co-defendant Consul Group re Dos Mil Veintiuno S.R.L (“Consul”). GBT was sued under an alter ego theory of liability, and its only involvement in the above-referenced chain of events seems to be that its shares were deposited with Rainer by Consul upon the opening of the brokerage account. GBT will be filling a demurrer to the First Amended Complaint based on a variety of deficiencies with the First Amended Complaint, and will ask the Court to dismiss the claims against GBT.

 

 

XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Contingencies
12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Contingencies

Note 18 - Contingencies 

GBT Technologies, S.A.

 

On September 14, 2018, the Company entered into an Exclusive Intellectual Property License and Royalty Agreement (the “GBT License Agreement”) with GBT-CR, a fully compliant and regulated crypto currency exchange platform that currently operates in Costa Rica as a decentralized crypto currency platform, pursuant to which, among other things, the Company granted to GBT-CR an exclusive, royalty-bearing right and license relating intellectual property relating to systems and methods of converting electronic transmissions into digital currency as reflected in that certain patent filed with the United Stated Patent and Trademark Office on or about June 14, 2018 (EFS ID: 32893586; Application Number: 16008069; Type: Utility under 35 USC 111(a); Confirmation Number: 6787)(collectively, the “Digital Currently Technology”). Pursuant to the GBT License Agreement, the Company granted GBT-CR an exclusive worldwide license to use the Digital Currency Technology to make, use, sell, lease or otherwise commercialize and dispose of products and devices utilizing the Digital Currently Technology. Under the terms of the GBT License Agreement, the Company is entitled to receive a royalty payment of 2% of gross revenue of each licensed product sold by GBT-CR during the period starting in which revenue is first generated using the licensed products and continuing for five years thereafter. Upon signing the GBT-CR License Agreement, GBT-CR paid the Company $300,000 which is nonrefundable. The Company recognized the $300,000 as revenue during the years ended December 31, 2018. Upon GBT-CR making available for sale (the “Commercial Event”) an ICO (Initial Coin Offering) (the “Coin”), GBT-CR will make a payment to the Company of $5,000,000. Further, upon the Commercial Event, GBT-CR will grant the Company the ability to acquire 30% of the Coin at a 30% discount of such offering price of the Coin. The GBT License Agreement commenced as of the signing date and, unless terminated in accordance with the termination provisions of the GBT License Agreement, shall remain in force until the expiration of the patent pertaining to the Digital Currency Technology; provided that the right to use trade secrets shall survive the expiration of the GBT License Agreement provided the Company has not terminated. Prior to the signing of the GBT License Agreement, GBT-CR advanced $200,000 to the Company, which the parties have agreed will be applied toward the $5,000,000 fee when it becomes due. On February 27, 2020 GBT Technologies, S.A., as successor in interest to Hermes Roll, LLC had notified the Company that it was in default on its Amended and Restated Territorial License Agreement (“ARTLA”) dated June 15, 2015 and that the ARTLA had been cancelled and rescinded.

 

Stock Loan Receivable

 

On January 8, 2019, the Company entered into a Stock Pledge Agreement with Latin American Exchange Latinex Casa de Cambio, S.A., a Costa Rica corporation (“Latinex”), to provide that Latinex may maintain its required regulatory capital as required by various regulators. The Company pledged 4,006 restricted shares of its common stock valued at $7,610,147 (based on the closing price on the grant date) for three years for an annual payment of $375,000 paid in quarterly installments of $93,750. In lieu of cash payment, Latinex may pay the Company in virtual currency of WISE Network S.A. valued at a 50% discount of its offering price of $10 per token. In the event that Latinex’s required capital has decreased below $5,000,000, Latinex is permitted to sell the pledged shares of common stock only in an amount to ensure that Latinex can satisfy the required capital levels. The Company must consent to such sale of the shares of common stock, which may not be unreasonably withheld. Upon expiration of the agreement, the remaining shares of common stock shall be returned to the Company free and clear of all liens. The Company recorded the value of these shares of common stock as a stock loan receivable which is presented as a contra-equity account in the accompanying consolidated balance sheets. At December 31, 2019, the Company wrote off the accrued interest income as Latinex did not perform any payment and the Company has no mean to enforce this payment. Latinex agreed in principle to return the pledged 4,006 restricted shares to the Company for cancellation. The 4,006 restricted shares have not yet been returned to the Company as of December 31, 2022.

 

Assignment of lease agreement

 

On May 17, 2022, Mahaser LLC (“Assignee”) entered into an assignment and assumption of lease agreement by and between 2819 Coldwater LLC (“Assignor”), Sunset Place Holdings LLC (“Lessor”) and Yossi Attia (“Guarantor”). Pursuant to the agreement, Lessor agreed to lease to Assignor certain Standard Industrial/Commercial Multi-Tenant Lease – Gross agreement dated February 7, 2022 (the “Lease”) and expiring on January 31, 2024, which premises commonly known as 8265 Sunset Boulevard, Suite #107, West Hollywood, CA 90046. The base rent payment shall equal $4,100 per month and share of common area operating expense shall equal $200 per month. Guarantor has guaranteed payment of Assignor’s obligations under the Lease and Assignor assigned all of its right, title and interest in the Lease to Assignee and Assignee assumed Assignor’s obligations under the Lease.

 

XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Concentrations
12 Months Ended
Dec. 31, 2022
Risks and Uncertainties [Abstract]  
Concentrations

Note 19 – Concentrations

 

Concentration of Credit Risk

 

Financial instruments, which potentially subject the Company to a concentration of credit risk for the years, consist principally of temporary cash investments. There have been no losses in these accounts through December 31, 2022 and 2021.

 

Liquidity risk

 

The Company has an accumulated deficit of $299,257,917 and has a working capital deficit of $18,522,046 as of December 31, 2022, which raises substantial doubt about its ability to continue as a going concern as the Company does not have sufficient funds to discharge its current liabilities.

 

Customers

 

Sales for both the years ended December 31, 2022 and 2021 were $1,152,555 and $0. The Consulting income from related party for both the years ended December 31, 2022 and 2021 was $45,000 and $180,000. Sales are derived from providing IT consulting services to a related party and sales from amazon and Ebay.

 

XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events
12 Months Ended
Dec. 31, 2022
Subsequent Events [Abstract]  
Subsequent Events

Note 20 - Subsequent Events

 

On January 24, 2023, the Company issued a convertible promissory note to Glen Eagles Acquisition LP in the principal amount of $512,500. The convertible promissory note bears interest of 10% and is payable at maturity on December 31, 2023.

  

 

 

On March 1, 2023, the Company entered into a Securities Purchase Agreement, with 1800 Diagonal Lending LLC, an accredited investor (“DL”) pursuant to which the Company issued to DL a Promissory Note (the “DL Note”) of $59,408 with an original issue discount of $6,258 resulting in net proceeds of the Company of $53,150. The DL Note had a maturity date of June 1, 2024 and the Company had agreed to pay interest on the unpaid principal balance of the DL Note at the rate of 12.0% from the date on which the DL Note is issued. A one-time interest charge of 12% or $7,128 was applied on the issuance date of the DL Note to the principal amount owed under the DL Note. Accrued, unpaid interest and outstanding principal, subject to adjustment, shall be paid in ten payments of $6,653.60 resulting in a total payback to DL of $66,536. The first payment is due April 15, 2023 with nine subsequent payments each month thereafter. The Company shall have a five-day grace period with respect to each payment. The Company has right to accelerate payments or prepay in full at any time with no prepayment penalty. This DL Note shall not be secured by any collateral or any assets of the Company.

 

The outstanding principal amount of the DL Note may not be converted into the Company common shares except in the event of default. In the event of default on the DL Note, DL may convert the DL Note into shares of the Company’s common stock at a conversion price equal to 75% of the lowest trading price during the 10 day period immediately preceding the date of conversion. In addition, upon the occurrence and during the continuation of an event of default (as defined in the DL Note), the DL Note shall become immediately due and payable and the Company shall pay to DL, in full satisfaction of its obligations hereunder, additional amounts as set forth in the DL Note. In no event shall DL be allowed to effect a conversion if such conversion, along with all other shares of Company common stock beneficially owned by DL and its affiliates would exceed 4.99% of the outstanding shares of the common stock of the Company.

 

On March 1, 2023, the Company entered into a Securities Purchase Agreement with DL pursuant to which the Company issued to DL a Convertible Promissory Note (the “DL Convertible Note”) of $62,680 for a purchase price of $52,150. The DL Convertible Note had a maturity date of June 1, 2024 and the Company had agreed to pay interest on the unpaid principal balance of the DL Convertible Note at the rate of 6.0% from the date on which the DL Convertible Note is issued until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the DL Convertible Note, provided it makes a payment including a prepayment to DL as set forth in the DL Convertible Note.

 

The outstanding principal amount of the DL Convertible Note may not be converted prior to the period beginning on the date that is 180 days following the date the DL Convertible Note is issued . Following the 180th day, DL may convert the DL Convertible Note into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price during the 20 day period preceding the date of conversion. In addition, upon the occurrence and during the continuation of an event of default (as defined in the DL Convertible Note), the DL Convertible Note shall become immediately due and payable and the Company shall pay to DL, in full satisfaction of its obligations hereunder, additional amounts as set forth in the DL Convertible Note. In no event shall DL be allowed to effect a conversion if such conversion, along with all other shares of Company common stock beneficially owned by DL and its affiliates would exceed 4.99% of the outstanding shares of the common stock of the Company.

 

On June 10, 2022, GBT Technologies, Inc. (the “Company”), entered into a Joint Venture and Territorial License Agreement (the “Metaverse Agreement”) with Ildar Gainulin and Maria Belova (collectively, the “Licensor”).

 

Under the Metaverse Agreement, the parties formed Metaverse Kit Corp., a Nevada corporation (“Metaverse Kit”). The purpose of Metaverse Kit was to develop, maintain and support source codes for its proprietary technologies and comprehensive platform that combines a core virtual reality platform and an extended set of real-world functions to provide a metaverse experience initially within the area of sports and then expanding into virtual worlds of entertainment, live events, gaming, communications and other cross over product opportunities (the “Meta Portfolio”). Under the Metaverse Agreement, Licensor agreed to provide Metaverse Kit with the licensed technology and expertise. In connection therewith, the parties entered an Asset Purchase Agreement (the “Metaverse APA”) concurrently with the Metaverse Agreement whereby Licensor sold Metaverse Kit all source codes pertaining to the Meta Portfolio. Further, Licensor provided an exclusive license to Metaverse Kit throughout the world for the invented product/service and the related platforms relating to the Meta Portfolio and to use the know how to develop, manufacture, sell, market and distribute the Meta Portfolio throughout the world. The Company was required to contribute 500,000,000 shares of common stock of the Company (“GBT Shares”) to Metaverse Kit. Licensor and the Company were to each own 50% of Metaverse Kit. The Company pledged its 50% ownership in Metaverse Kit to Igor 1 Corp. to secure a convertible note held by Igor 1 Corp. The Company was to appoint two directors and Licensor was allowed to appoint one director of Metaverse Kit.

 

In addition, Metaverse Kit, Licensor and Elentina Group, LLC (“Elentina”) entered into a Consulting Agreements in which IGBM and Elentina, each were engaged to provide services for $25,000 per month payable quarterly which Metaverse Kit has the option to pay in shares of common stock calculated by the amount owed divided by the Company’s 10-day VWAP. Licensor and Elentina were to provide services in connection with the development of the business as well as Metaverse Kit’s capital raising efforts. The term of the Consulting Agreement was two years.

 

The closing of the Metaverse Agreement occurred on June 13, 2022.

 

On March 14, 2023, the Company received a counter signed Settlement Agreement and Release by Licensor dated March 2, 2023 (“Settlement Agreement”). Pursuant to the Settlement Agreement, the parties agreed that Metaverse Agreement, the Metaverse APA and the Consulting Agreement are void and cancelled. Licensor agreed to pay $5,000 to the Company as settlement payment and surrender their shares in Metaverse Kit.

 

On February 1, 2023, the Company engaged AlKhatib Consulting Group to provide exclusive representation services in connect with managing market partners, effective on February 1, 2012 for 24 consecutive months.

 

On April 3, 2023, GBT Tokenize Corp. (“Seller”), a subsidiary that is owned 50% by GBT Technologies, Inc (“GBT”) entered into an Asset Purchase Agreement (“APA”) with Trend Innovation Holdings, Inc. ( “TREN”), in which GBT consented, pursuant to which Seller sold certain assets relating to proprietary system and method named Avant-Ai, which is a text-generation, deep learning self-training model (the “System”).

 

In consideration of acquiring the System, TREN is required to issue to the Seller 26,000,000 common shares of TREN (the “Shares”). The Shares will be restricted per Rule 144 as promulgated under the Securities Act of 1933, as amended (the “1933 Act”) and Seller agreed to a lock-up period of nine (9) months following closing (the “Lock Up Term”). In the event that TREN is unable to up-list to Nasdaq either through a business combination or otherwise prior to the expiration of the Lock Up Term, the Seller may request within three (3) business days of the expiration of the Lock-Up Term, that all transactions contemplated by the APA be unwound.

 

In addition, TREN, Seller and GBT entered into a license agreement regarding the System, granting the Seller and/or GBT a perpetual, irrevocable, non-exclusive, non-transferable license for using the System to be used in its own development, as in-house tool, where Seller or GBT may not sublicense its rights hereunder to any customer or client.

 

XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Use of Estimates

Use of Estimates

 

The preparation of CFS in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the CFS and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates in the accompanying CFS include valuation of derivatives and valuation allowance on deferred tax assets.

 

Principles of Consolidation

Principles of Consolidation

 

The accompanying CFS include the accounts of the Company and its subsidiaries; the Company’s 50% owned subsidiaries GBT BitSpeed Corp. (currently inactive) and GBT Tokenize Corp; the Company’s 50% owned subsidiary, Gopher Protocol Costa Rica Sociedad De Responsabilidad Limitada (currently inactive), a wholly owned subsidiary, AltCorp Trading LLC, a Costa Rica company (“AltCorp” currently inactive) and Greenwich International Holdings, a Costa Rica corporation (“Greenwich” currently inactive). All significant intercompany transactions and balances were eliminated.

 

For entities determined to be VIEs, an evaluation is required to determine whether the Company is the primary beneficiary. The Company evaluates its economic interests in the entity specifically determining if the Company has both the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance (“the power”) and the obligation to absorb losses or the right to receive benefits that could potentially be significant to the VIE (“the benefits”). When making the determination whether the benefits received from an entity are significant, the Company considers the total economics of the entity, and analyzes whether the Company’s share of the economics is significant. The Company utilizes qualitative factors, and, where applicable, quantitative factors, while performing the analysis.

 

In addition, the Company’s variable interests in Mahaser obligate the Company to absorb deficits and provide it with the right to receive benefits that could potentially be significant to Mahaser. As a result of this analysis, the Company concluded it is the primary beneficiary of Mahaser and therefore consolidates the balance sheets, results of operations and cash flows of Mahaser. The Company performs a qualitative assessment of Mahaser on an ongoing basis to determine if it continues to be the primary beneficiary.

 

Cash Equivalents

Cash Equivalents

 

For the purpose of the statement of cash flows, cash equivalents include time deposits, certificate of deposits, and all highly-liquid debt instruments with original maturities of three months or less. As of December 31, 2022 and 2021, the Company did not have any cash equivalents.

 

Funds in Escrow

Funds in Escrow

 

Restricted cash is $375,000 as part of the SURG settlements proceeds that needs to stay in escrow and $19,694 restricted cash that the court on January 28, 2022 awarded the Company with injunction against RWJ defendants, where all funds generating from resale should be deposited into GBT blocked account, and therefore RWJ defendants cannot use these funds without court order, neither the Company. According to settlement agreement made on September 26, 2022, these funds held in escrow and no longer restricted. The Company entered into the Confidential Settlement Agreement and Mutual Release (“RJW Agreement”) by and between RWJ Advanced Marketing, LLC, Robert Warren Jackson, Gregory Bauer (collectively the “RJW Parties”) and W.L. Petrey Wholesale Company, Inc., (“Petrey”) on one hand; and GBT Technologies Inc., on behalf of itself and its agents (collectively the GBT Parties”), on the other hand. The Company the RJW Agreement effective September 26, 2022 with final signatures delivered to the Company on or about October 5, 2022. Among other agreements the parties agreed and stipulated to release all funds currently being held in a blocked account of $19,694 with 50% distributed to the RWJ Parties and 50% to the Company or its assignee.

 

Marketable Securities

Marketable Securities

 

The Company accounts for investment securities in accordance with ASC Topic 321, Investments – equity securities. Marketable equity securities are reported at FV based on quotations available on securities exchanges with any unrealized gain or loss being reported as a component of other income (expense) on the statement of operations. The portion of marketable equity security expected to be sold within 12 months of the balance sheet date is reported as a current asset. These publicly traded equity securities are valued using quoted prices and are included in Level 1.

 

Inventory

Inventory

 

Inventory consists of electronic product ready for sale on Amazon.com. It is stated at the lower of cost or net realizable value and all inventories were returned product from online customers. We value our inventory using the weighted average costing method. Our Company’s policy is to include as a part of inventory any freight incurred to ship the product from our contract vendors to our warehouses. Outbound freight costs to our customers are considered period costs and reflected in selling, general and administrative expenses. We regularly review inventory and consider forecasts of future demand, market conditions and product obsolescence.

 

Note Receivable Paid-Off

Note Receivable Paid-Off

 

On September 18, 2020, the Company entered into a Purchase and Sale Agreement with Mr. LightHouse LTD., an Israeli corporation (“MLH”) pursuant to which the Company agreed to sell and assign to MLH, effective July 1, 2020 all the shares, and certain specified liabilities, of Ugopherservices Corp. (“UGO”), a wholly owned subsidiary of the Company for $100,000 to be paid through the delivery of a promissory note payable to the Company (the “Note”), upon the terms and subject to the limitations and conditions set forth in the Note. At December 31, 2020, the Company determined this note was not collectible and took an impairment charge of $100,000. During July 2021, MLH effected a $50,000 payment on the Note. During April 2022, MLH effected a second payment for additional $50,000 on the Note exhausting the Note balance.

 

Derivative Financial Instruments

Derivative Financial Instruments

 

The Company evaluates all of its agreements to determine if such instruments have derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its FV and is then re-valued at each reporting date, with changes in the FV reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a weighted-average Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. As of December 31, 2022 and 2021, the Company’s only derivative financial instrument was an embedded conversion feature associated with convertible notes payable due to certain provisions that allow for a change in the conversion price based on a percentage of the Company’s stock price at the date of conversion.

 

Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

For certain of the Company’s financial instruments, including cash, accounts payable, accrued liabilities and short-term debt, the carrying amounts approximate their FV due to their short maturities.

 

FASB ASC Topic 820, Fair Value Measurements and Disclosures, requires disclosure of the FV of financial instruments held by the Company. FASB ASC Topic 825, Financial Instruments, defines FV, and establishes a three-level valuation hierarchy for disclosures of FV measurement that enhances disclosure requirements for FV measures. The carrying amounts reported in the consolidated balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their FV because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:

 

  Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.
     
  Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
     
  Level 3 inputs to the valuation methodology use one or more unobservable inputs which are significant to the FV measurement.

 

The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic 480, Distinguishing Liabilities from Equity, and FASB ASC Topic 815, Derivatives and Hedging.

 

For certain financial instruments, the carrying amounts reported in the balance sheets for cash and current liabilities, including convertible notes payable, each qualify as a financial instrument, and are a reasonable estimate of their FV because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest.

 

The Company uses Level 2 inputs for its valuation methodology for derivative liabilities as their FV were determined by using the Black-Scholes-Merton pricing model based on various assumptions. The Company’s derivative liabilities are adjusted to reflect FV at each period end, with any increase or decrease in the FV being recorded in results of operations as adjustments to FV of derivatives.

 

At December 31, 2022 and 2021, the Company identified the following liabilities that are required to be presented on the balance sheet at FV:

 

       
    Fair Value   Fair Value Measurements at
    As of   December 31, 2022
Description   December 31, 2021   Using Fair Value Hierarchy
        Level 1   Level 2   Level 3
Conversion feature on convertible
notes
 
 
 
$

1,714,143
 
 
 
 
 
$
 
 
 
 
 
 
$

1,714,143
 
 
 
 
 
$
 
 
 

 

    Fair Value   Fair Value Measurements at
    As of   December 31, 2021
Description   December 31, 2022   Using Fair Value Hierarchy
        Level 1   Level 2   Level 3
Conversion feature on convertible
notes
 
 
 
$

10,192,485
 
 
 
 
 
$
 
 
 
 
 
 
$
10,192,485  
 
 
 
 
$
 
 
 

 

Treasury Stock

Treasury Stock

 

Treasury stock is recorded at cost. The re-issuance of treasury shares is accounted for on a first in, first-out basis and any difference between the cost of treasury shares and the re-issuance proceeds are charged or credited to additional paid-in capital.

 

Reclassification

Reclassification

 

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.

 

Revenue Recognition

Revenue Recognition

 

Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“Topic 606”), became effective for the Company on January 1, 2018. The Company’s revenue recognition disclosure reflects its updated accounting policies that are affected by this new standard. The Company applied the “modified retrospective” transition method for open contracts for the implementation of Topic 606. The Company had no significant post-delivery obligations, this new standard did not result in a material recognition of revenue on the Company’s accompanying CFS for the cumulative impact of applying this new standard. The Company made no adjustments to its previously-reported total revenues, as those periods continue to be presented in accordance with its historical accounting practices under Topic 605, Revenue Recognition.

 

Revenue from providing IT consulting services are recognized under Topic 606 in a manner that reasonably reflects the delivery of its services to customers in return for expected consideration and includes the following elements:

 

  executed contracts with the Company’s customers that it believes are legally enforceable;
     
  identification of performance obligations in the respective contract;
     
  determination of the transaction price for each performance obligation in the respective contract;
     
  allocation the transaction price to each performance obligation; and
     
  recognition of revenue only when the Company satisfies each performance obligation.

 

These five elements, as applied to each of the Company’s IT revenue category, is summarized below:

 

  IT consulting services - revenue is recorded on a monthly basis as services are provided.

 

These five elements, as applied to each of the Company’s license revenue category, is summarize below:

 

License services – the one-time related party licensing income recorded as other income upon agreement is executed and services are provided and recognized over the term of five years.

 

E-Commerce sales

 

Identify the contract(s) with a customer. ASC 606 defines a contract as “an agreement between two or more parties that creates enforceable rights and obligations”. Since this is an e-commerce sale on the Amazon of eBay websites, the Company just followed the general terms on Amazon or eBay websites and the customer entered into a contract with the Company based on the product listed on the Amazon or eBay websites;

 

Identify the performance obligations in the contract. According to the contract, the Company is responsible for operation exclusively. The Company is entitled to all revenue which is being paid by Amazon or eBay into a designated bank account and the Company is responsible for all product acquisitions as well as shipments. The only performance obligations were the electronic products that were listed on Amazon or eBay websites and the Company determined each order is one single obligation;

 

Determine the transaction price. The transaction price set to be the listed price on the Amazon or eBay websites.;

 

Allocation the transaction price to the performance obligations in the contract.; and

 

Recognize revenue when the Company satisfies a performance obligation. Sales are being recognized upon shipment.

 

Unearned revenue

Unearned revenue

 

Unearned revenue represents the net amount received for the purchase of products that have not seen shipped to the Company’s customers. The Company has $48,921 and $249,384 of unearned revenue at December 31, 2022 and 2021, respectively.

 

Contract liabilities

Contract liabilities

 

On February 22, 2022, the Company entered into an Intellectual Property License and Royalty Agreement with Touchpoint Group Holdings, Inc. (“Touchpoint” or “TGHI”) pursuant to which the Company granted TGHI a worldwide license for its technologies for five years in the domains of Internet of Things (IoT) and Artificial Intelligence enabled mobile technologies pertaining to the Company’s digital currency technology (the “Technology”). GBT will charge TGHI royalties based on actual uses by TGHI of the Technology resulting from revenue attributable to the use, performance or other exploitation of the Technology, to the extent applicable, after deducting any taxes that the Company may be required to collect, and deducting any international sales, goods and services, value added taxes or similar taxes which the Company is required to pay, if any, excluding deductions for taxes on the Company net income. TGHI agreed to issue the Company 10,000,000 shares of common stock of TGHI in the FV of $50,000 as a onetime fee for the Company entering this Intellectual Property License and Royalty Agreement, which was booked contract liabilities and amortized over the  five-year term. The Company has yet to earn any royalty income in relation to this agreement as of December 31, 2022. The contract liabilities as of December 31, 2022 and December 31, 2021 was $41,444 and $0, respectively.

 

Variable Interest Entity

Variable Interest Entity

 

On February 18, 2022, the Company, effective March 1, 2022 entered into a Revenue Sharing Agreement (“RSA”) with Mahaser LTD. (“Mahaser”) pursuant to which the Company shares in revenues generated by Mahaser e-commerce sales through the online retail platform in the United States of America. Mahaser owns an e-commerce platform as a store which is the legal, exclusive owner of Ravenholm Electronics. The Company will operate the e-commerce platform and entitled to 95% for all revenue generated by and received by Mahaser from March 1, 2022 through December 31, 2022. The RSA provides that the Company will be entitled to appoint a manager to Mahaser. As consideration, the Company will pay Mahaser $100,000 no later than March 1, 2022 and issue Mahaser 1,000,000 shares of the Company’s restricted common stock. The Company shall have no obligations to make any further payments to Mahaser. For any further extensions, the Company will have the option to extend the RSA for annual payment of $200,000, which can be payable with the Company’s shares of common stock payable based on 20 days VWAP prior to issuance. On March 16, 2022 the parties entered into Amendment No. 1 to the to the RSA, where all consideration to be paid or issued to Mahaser will be deferred until such time where the e-commerce platform generated in cumulative revenue of $1,000,000. On March 31, 2022, the parties entered into Amendment No. 2 to the RSA, where Mahaser agreed to pay the Company 100% per year for all revenue generated by and received by seller from the sales by Amazon within the United States of America as follows from March 1, 2022 through December 31, 2022. The Company will be responsible for 100% of the cost of goods sold as well. In addition, the Company is entitled to earn 100% revenues and cost of goods sold of the period from February 1, 2022 to February 28, 2022.

 

The Company evaluated whether it has a variable interest in Mahaser, whether Mahaser is a VIE and whether the Company has a controlling financial interest in Mahaser. The Company concluded that it has variable interests in Mahaser on the basis of GBT has 100% control over the JV/revenue sharing, and as such should consolidate the JV into its books and records as it assigned 100% financial responsibility. Mahaser’s equity at risk, as defined by GAAP, is considered to be insufficient to finance its activities without additional support, and, therefore, Mahaser is considered a VIE.

 

The following table summarizes the carrying amount of the assets and liabilities of Mahaser included in the Company’s consolidated balance sheets at December 31, 2022 (after elimination of intercompany transactions and balances):

 

     
Assets of consolidated variable interest entity (“VIE”) included in the consolidated balance sheets above (after elimination of intercompany transactions and balances) consist of:   
Current assets:     
Cash and equivalents  $93,581 
Inventory   11,569 
Due From related party   20,270 
Total current assets  $125,420 
      
Liabilities of consolidated VIE included in the consolidated balance sheets above (after elimination of intercompany transactions and balances) consist of:     
Current liabilities     
Total current liabilities  $94,496 
      
Statements of operations of consolidated VIE included in the consolidated statements of operations above (after elimination of intercompany transactions and balances) consist of:     
Statements of operations     
 Sales  $1,107,555 
 Cost of goods sold   817,754 
 Gross profit   289,801 
 General and administrative expenses   330,647 
Net Loss  $40,846 

 

Income Taxes

Income Taxes

 

The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes. ASC 740 requires a company to use the asset and liability method of accounting for income taxes, whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion, or all of, the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

 

Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The Company has no material uncertain tax positions for any of the reporting periods presented and its current on all its tax filings federal and state until 2021 inclusive.

 

Basic and Diluted Earnings Per Share

Basic and Diluted Earnings Per Share

 

Earnings per share is calculated in accordance with ASC Topic 260, Earnings Per Share. Basic earnings per share (“EPS”) is based on the weighted average number of common shares outstanding. Diluted EPS assumes that all dilutive securities are converted. Dilution is computed by applying the treasury stock method. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. Due to the net income incurred potentially dilutive instruments would be anti-dilutive. Accordingly, diluted loss per share is the same as basic loss for all periods presented. The following potentially-dilutive shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would be anti-dilutive.

 

          
   December 31,  December 31,
   2022  2021
Series B preferred stock   45,000    45,000 
Series C preferred stock   700    700 
Series H preferred stock   20,000    20,000 
Warrants   70,770    392,870 
Convertible notes   3,949,223,831    83,722,340 
Total   3,949,360,301    84,180,910 

 

Management’s Evaluation of Subsequent Events

Management’s Evaluation of Subsequent Events

 

The Company evaluates events that have occurred after the balance sheet date of December 31, 2022, through the date which the CFS are issued. Based upon the review, other than described in Note 20 – Subsequent Events, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the CFS.

 

Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

In August 2020, the FASB issued ASU 2020-06Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. ASU 2020-06 reduces the number of accounting models for convertible debt instruments and convertible preferred stock. For convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in capital, the embedded conversion features no longer are separated from the host contract. ASU 2020-06 also removes certain conditions that should be considered in the derivatives scope exception evaluation under Subtopic 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity, and clarify the scope and certain requirements under Subtopic 815-40. In addition, ASU 2020-06 improves the guidance related to the disclosures and earnings-per-share (EPS) for convertible instruments and contract in entity’s own equity. ASU 2020-06 is effective for public business entities that meet the definition of a SEC filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Board specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. The Company adopted this ASU on the CFS in the year ended December 31, 2021. The adoption had no material impact on the CFS for the year ended December 31, 2022.

 

On April 2021, the FASB issued ASU 2021-04, “Earnings Per Share (Topic 260), Debt— Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options” (“ASU 2021-04”) to clarify the accounting by issuers for modifications or exchanges of equity-classified warrants. The new ASU is available here and effective for all entities in fiscal years starting after December 15, 2021. Early adoption is permitted. The Company adopted this ASU on the CFS in the year ended December 31, 2021. The adoption had no material impact on the CFS for the year ended December 31, 2022.

 

Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying CFS. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

 

XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Schedule of fair value, assets and liabilities measured on recurring basis
       
    Fair Value   Fair Value Measurements at
    As of   December 31, 2022
Description   December 31, 2021   Using Fair Value Hierarchy
        Level 1   Level 2   Level 3
Conversion feature on convertible
notes
 
 
 
$

1,714,143
 
 
 
 
 
$
 
 
 
 
 
 
$

1,714,143
 
 
 
 
 
$
 
 
 

 

    Fair Value   Fair Value Measurements at
    As of   December 31, 2021
Description   December 31, 2022   Using Fair Value Hierarchy
        Level 1   Level 2   Level 3
Conversion feature on convertible
notes
 
 
 
$

10,192,485
 
 
 
 
 
$
 
 
 
 
 
 
$
10,192,485  
 
 
 
 
$
 
 
 

Condensed financial statements
     
Assets of consolidated variable interest entity (“VIE”) included in the consolidated balance sheets above (after elimination of intercompany transactions and balances) consist of:   
Current assets:     
Cash and equivalents  $93,581 
Inventory   11,569 
Due From related party   20,270 
Total current assets  $125,420 
      
Liabilities of consolidated VIE included in the consolidated balance sheets above (after elimination of intercompany transactions and balances) consist of:     
Current liabilities     
Total current liabilities  $94,496 
      
Statements of operations of consolidated VIE included in the consolidated statements of operations above (after elimination of intercompany transactions and balances) consist of:     
Statements of operations     
 Sales  $1,107,555 
 Cost of goods sold   817,754 
 Gross profit   289,801 
 General and administrative expenses   330,647 
Net Loss  $40,846 
Schedule of anti dilutive securities excluded from computation of earnings per share
          
   December 31,  December 31,
   2022  2021
Series B preferred stock   45,000    45,000 
Series C preferred stock   700    700 
Series H preferred stock   20,000    20,000 
Warrants   70,770    392,870 
Convertible notes   3,949,223,831    83,722,340 
Total   3,949,360,301    84,180,910 
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Accounts Payable and Accrued Expenses (Tables)
12 Months Ended
Dec. 31, 2022
Payables and Accruals [Abstract]  
Schedule of accounts payable and accrued expenses
          
   2022  2021
Accounts payable  $1,530,762   $1,110,127 
Accrued liabilities   1,513,261    3,033,016 
Accrued interest   3,196,611    2,753,120 
Other        
Total  $6,240,634   $6,896,263 
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Convertible Notes Payable, Non-related Partied and Related Party (Tables)
12 Months Ended
Dec. 31, 2022
Debt Disclosure [Abstract]  
Schedule of rollfoward of convertible note
          
   December 31,  December 31,
   2022  2021
Convertible note payable to GBT Technologies S.A  $6,395,531   $8,055,400 
Convertible notes payable to 1800   191,257    124,200 
Convertible notes payable to Redstart Holdings       244,500 
Total convertible notes payable, non related parties   6,586,788    8,424,100 
Unamortized debt discount   (189,060)   (278,867)
Convertible notes payable – non related parties   6,397,727    8,145,233 
Less current portion   6,397,727    (8,109,436)
Convertible notes payable – non related parties, long-term portion  $   $35,797 
Summary of convertible notes payable
          
   December 31,  December 31,
   2022  2021
Convertible note payable to Stanley Hills   116,605    116,605 
Unamortized debt discount        
Convertible notes payable, net, related party   116,605    116,605 
Less current portion   (116,605)   (116,605)
Convertible notes payable, net, related party, long-term portion  $   $ 
Schedule of roll forward convertible notes payable
     
Convertible notes payable, December 31, 2020   13,426,706 
Issued for cash   983,450 
Convertible note issued for accounts payable   625,429 
Accrued interest added to convertible note   234,521 
Payment with marketable securities   (1,460,000)
Payment with cash   (106,200)
Original issue discount   127,550 
Conversion to common stock   (5,649,000)
Debt discount related to new convertible notes   (741,100)
Amortization of debt discounts   819,423 
Convertible notes payable, December 31, 2021  $8,261,839 
Issued for cash   300,000 
Payment with cash   (39,042)
Original issue discount   60,700 
Conversion to common stock   (2,158,971)
Debt discount related to new convertible notes   (352,441)
Amortization of debt discounts   442,247 
Convertible notes payable, December 31, 2022  $6,514,332 
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Notes Payable, Non-related Parties and Related Party (Tables)
12 Months Ended
Dec. 31, 2022
Notes Payable Non-related Parties And Related Party  
Schedule of notes payable
          
   December 31,  December 31,
   2022  2021
RWJ acquisition note  $   $2,600,000 
SBA loan   350,000    350,000 
Total notes payable   350,000    2,950,000 
Unamortized debt discount        
Notes payable   350,000    2,950,000 
Less current portion   (41,137)   (2,612,397)
Notes payable, long-term portion  $308,863   $337,603 
Schedule of notes payable related parties
          
   December 31,  December 31,
   2022  2021
Alpha Eda note payable  $140,000   $140,000 
Total notes payable, related party   140,000    140,000 
Unamortized debt discount        
Notes payable, net, related party   140,000    140,000 
Less current portion   (140,000)   (140,000)
Notes payable, net, related party, long-term portion  $   $ 
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Liability (Tables)
12 Months Ended
Dec. 31, 2022
Derivative Liability  
Schedule of assumptions to measure fair value
               
    December 31,   December 31,
    2022   2021
Stock price   $ 0.001     $ 0.17  
      4.42-        
Risk free rate     4.76 %     0.19-0.39%  
Volatility     213-277%       167-217%  
      0.0015-       0.102-  
Conversion/ Exercise price   $ 0.0017     $ 0.103  
Dividend rate     0 %     0 %
Derivative instruments and hedging activities
     
Derivative liability balance, December 31, 2019  $ 
Issuance of derivative liability during the period   5,767,230 
Fair value of beneficial conversion feature of debt converted   (2,038,392)
Change in derivative liability during the period   1,533,610 
Derivative liability balance, December 31, 2020   5,262,448 
Debt modification   13,777,480 
Issuance of derivative liability during the period   1,480,439 
Fair value of beneficial conversion feature of debt converted   (116,669)
Change in derivative liability during the period   1,339,117 
Derivative liability balance, December 31, 2021  $10,192,485 
Issuance of derivative liability during the period   325,915 
Fair value of beneficial conversion feature of debt converted   (2,209,887)
Change in derivative liability during the period   (6,594,370)
Derivative liability balance, December 31, 2022  $1,714,143 
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Equity (Tables)
12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Summary of warrant activity
                                 
            Weighted    
        Weighted   Average    
        Average   Remaining   Aggregate
    Warrants   Exercise   Contractual   Intrinsic
    Outstanding   Price   Life   Value
Outstanding, December 31, 2021       392,870     $ 74.97       0.76     $  
Granted                                
Forfeited                                
Exercised                                
Outstanding, December 31, 2022       70,770     $ 205.07       0.30     $  
Exercisable, December 31, 2022       70,770     $ 205.07       0.30     $  
Summary of exercise price for warrant outstanding
           
Outstanding   Exercisable        
Number of   Exercise   Number of   Exercise
Warrants   Price   Warrants   Price
      $ 25.00           $ 25.00  
  60,000       92.50       60,000       92.50  
  10,000       135.00       10,000       135.00  
  400       1,595.00       400       1,595.00  
        2,500.00             2,500.00  
        3,750.00             3,750.00  
        5,000.00             5,000.00  
  200       11,750.00       200       11,750.00  
  150       12,500.00       150       12,500.00  
  20       14,000.00       20       14,000.00  
  70,770               70,770          
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule Of Components of deferred tax assets
               
    December 31,   December 31,
    2022   2021
Deferred income tax asset                
Net operating loss carryforwards   $ 9,182,327     $ 8,945,238  
Total deferred income tax asset     9,182,327       8,945,238  
Less: valuation allowance     (9,182,327 )     (8,945,238 )
Total deferred income tax asset   $     $  
Schedule of Effective Income Tax Rate Reconciliation
                               
    2022   2021
    Amount   Percent   Amount   Percent
Federal statutory rates   $ 1,118,010       21.0 %   $ (7,125,391 )     21.0 %
State income taxes     425,908       8.0 %     (2,714,435 )     8.0 %
Permanent differences     (1,784,116 )     -33.5 %     9,127,383       -26.9 %
Valuation allowance against net deferred tax assets     237,089       4.5 %     712,442       -2.1 %
Effective rate   $       %   $       %
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.1
Organization and Basis of Presentation (Details Narrative) - $ / shares
12 Months Ended
Oct. 26, 2021
Dec. 31, 2022
Jul. 07, 2022
Dec. 31, 2021
Accounting Policies [Abstract]        
Reverse stock split 1 for 50 1-for-500    
Common stock, par value   $ 0.00001 $ 0.00001 $ 0.00001
Common stock, authorized   10,000,000,000 2,000,000,000 10,000,000,000
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.23.1
Going Concern (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accumulated deficit $ 299,257,917 $ 304,581,773
Working capital deficit $ 18,552,046  
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Defined Benefit Plan Disclosure [Line Items]    
Conversion feature on convertible notes $ 1,714,143 $ 10,192,485
Fair Value, Inputs, Level 1 [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Conversion feature on convertible notes
Fair Value, Inputs, Level 2 [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Conversion feature on convertible notes 1,714,143 10,192,485
Fair Value, Inputs, Level 3 [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Conversion feature on convertible notes
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Details 1) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and equivalents $ 93,581  
Inventory 11,569
Due From related party 20,270  
Total current assets 125,420  
Current liabilities    
Total current liabilities 94,496  
Sales 1,197,555 180,000
Cost of goods sold 817,754
Gross profit 379,801 180,000
General and administrative expenses 1,053,282 293,628
Net loss 5,323,856 $ (33,930,433)
Variable Interest Entity, Primary Beneficiary [Member]    
Current liabilities    
Sales 1,107,555  
Cost of goods sold 817,754  
Gross profit 289,801  
General and administrative expenses 330,647  
Net loss $ 40,846  
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Details 2) - shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Number of potentially dilutive securities 3,949,360,301 84,180,910
Convertible note 3,949,223,831 83,722,340
Warrant [Member]    
Number of potentially dilutive securities 70,770 392,870
Series B Preferred Stock [Member]    
Preferred shares 45,000 45,000
Series C Preferred Stock [Member]    
Preferred shares 700 700
Series H Preferred Stock [Member]    
Preferred shares 20,000 20,000
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Feb. 22, 2022
Dec. 17, 2021
Sep. 18, 2020
Dec. 31, 2022
Apr. 30, 2022
Mar. 02, 2022
Jan. 28, 2022
Dec. 31, 2021
Jul. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Cash equivalents       $ 0       $ 0  
Restricted cash       375,000          
Escrow amount             $ 19,694    
Impairment of long-lived assets       100,000          
Stockholders equity         $ 50,000       $ 50,000
Unearned revenue       48,921       249,384  
Fair value   $ 10,000,000   231,867          
Contract liabilities       $ 41,444       $ 0  
Annual payment           $ 200,000      
Restricted Stock [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Consideration shares       1,000,000          
Mahaser [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Consideration paid       $ 100,000          
Touch Point Group Holding [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Number of shares issued 10,000,000                
Fair value $ 50,000                
Term 5 years                
R W J Parties [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Escrow amount       $ 19,694          
Mr Light House L T D [Member] | Purchase And Sale Agreement [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Consideartion from sale of common stock     $ 100,000            
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.23.1
Marketable Securities (Details Narrative) - USD ($)
1 Months Ended 9 Months Ended 12 Months Ended
Feb. 22, 2022
Jan. 28, 2022
Dec. 17, 2021
Sep. 30, 2022
Dec. 31, 2022
Feb. 23, 2022
Dec. 31, 2021
Fair value     $ 10,000,000   $ 231,867    
Conversion price         $ 0.01    
Convertible debt         $ 6,586,788   $ 8,424,100
Accrued interest         3,196,611   2,753,120
Promissory Note [Member]              
Principal amount       $ 90,000      
Interest rate       5.00%      
G B T Tokenize [Member]              
Fair value         $ 1,500    
Stock Issued During Period, Shares, Acquisitions         76,923    
G B T Tokenize Met Alert [Member]              
Principal amount       $ 90,000      
Common Stock [Member]              
Issuance of shares         5,500,000    
Fair value         $ 55    
Touchpoint Group Holdings Inc [Member]              
Convertible preferred shares           10,000,000  
Issuance of shares 10,000,000            
Fair value $ 50,000       6,000    
Touchpoint Group Holdings Inc [Member] | Common Stock [Member]              
Company owned shares           20,000,000  
Stock Purchase Agreement [Member]              
Sales consideration   $ 125,000          
Convertible preferred shares   10,000,000          
Stock Purchase Agreement [Member] | Series A Convertible Preferred Stock [Member]              
Shares acquired   10,000          
G T X Agreement [Member]              
Fair value         12,538    
Principal amount         $ 100,000    
Stock Issued During Period, Shares, Acquisitions         5,000,000    
Stock Issued During Period, Value, Acquisitions         $ 150    
Convertible debt         190,000    
Accrued interest         8,475    
Marketable securities         $ 12,538   $ 0
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.23.1
Investment in Surge Holdings, Inc. (Details Narrative) - USD ($)
12 Months Ended
Jan. 07, 2022
Sep. 30, 2019
Dec. 31, 2022
Dec. 31, 2021
Jan. 31, 2022
Jan. 28, 2022
Jan. 02, 2021
Jun. 23, 2020
Price per share     $ 0.001 $ 0.17        
Cash     $ 106,639 $ 155,106        
Escrow amount           $ 19,694    
Escrow amount received     $ 1,000,000          
Final settlement agreement, description     SURG agreed to make total payments of $4,200,000 to the Company’s trust account on or prior to January 7, 2022. This $4.2 million amount consists of $450,000 paid to the Company in November and December 2021, $100,000 to be paid on or about January 4, 2022, and $3,650,000 to be paid on or prior to January 7, 2022 of which $375,000 will be held in escrow as described before. The final settlement SURG agreed to make total payments of $4,200,000 to the Company’s trust account on or prior to January 7, 2022. The $3,750,000 was recorded as other receivable as of December 31, 2021. The entire balance of $3,750,000 was paid in January 2022.          
Related party payment     $ 4,200,000          
Settlement amount         $ 3,750,000      
Payments for debt     $ 3,750,000          
Surge Holdings Inc [Member]                
Repayment of debt $ 4,200,000              
Related party, description     This $4.2 million amount consists of $450,000 paid by SURG in November and December 2021, $100,000 to be paid on or about January 4, 2022, and $3,650,000 to be paid on or prior to January 7, 2022 of which $375,000 will be held in escrow as described before. The $3,750,000 was recorded as other receivable as of December 31, 2021. As of December 31, 2021, the Company has recorded an outstanding payable balance to Stanley amounted $1,862,928 recorded under accrued expenses.          
Escrow amount     $ 375,000          
Surge Holdings [Member] | Asset Purchase Agreement [Member]                
Business consideration values   $ 5,000,000            
Sale of common stock   3,333,333            
Payment of principal   $ 4,000,000            
Settlement pursuants amount $ 3,750,000              
Surge Holdings [Member] | Alt Corp Exchange Agreement [Member]                
Price per share               $ 0.50
Stanley Hills L L C [Member]                
Debt             $ 3,300,000  
Cash             400,000  
Repayment of debt     $ 800,000 $ 800,000        
Related party, description     This $4.2 million amount consists of $450,000 paid by SURG in November and December 2021, $100,000 to be paid on or about January 4, 2022, and $3,650,000 to be paid on or prior to January 7, 2022 of which $375,000 will be held in escrow as described before.          
Stanley Hills L L C [Member] | Common Stock [Member]                
Debt             100,000  
Cash             $ 800,000  
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.23.1
Impaired Investment (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Feb. 06, 2019
Dec. 31, 2021
May 28, 2021
Jun. 17, 2019
Dec. 31, 2022
Dec. 31, 2021
Mar. 31, 2020
Debt conversion, converted instrument, Value         $ 2,158,969    
Services payable   $ 33,333          
Interest payable   2,753,120     3,196,611 $ 2,753,120  
Impairment charge   15,400,000       15,400,000 $ 5,500,000
Investment   $ 0     0 $ 0  
Tokenize Agreement [Member]              
Share issued     14,000,000        
Issuance of shares value     $ 15,400,000        
G B T Shares [Member]              
Share issued   2,000,000       2,000,000  
Issuance of shares value           $ 5,500,000  
Altcorp [Member]              
Note payable, description Note payable by Gopher Protocol Costa Rica Sociedad De Responsabilidad Limitada to the Company in the principal amount of $5,000,000 dated February 6, 2019 (of which the underlying security for this Promissory Note is 30,000,000 restricted shares of common stock of Mobiquity Technologies, Inc. (“Mobiquity”) and 60,000,000 restricted shares of common stock of Mobiquity.            
Altcorp [Member] | Series H Preferred Stock [Member]              
Stock Issued for Acquisitions, Shares       625,000      
Number of shares converted       20,000      
Debt conversion, converted instrument, Value       $ 10,000,000      
Stanley Hills L L C [Member]              
Interest payable   $ 424,731     $ 424,731 $ 424,731  
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.23.1
Accounts Payable and Accrued Expenses (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Payables and Accruals [Abstract]    
Accounts payable $ 1,530,762 $ 1,110,127
Accrued liabilities 1,513,261 3,033,016
Accrued interest 3,196,611 2,753,120
Other
Total $ 6,240,634 $ 6,896,263
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.23.1
Unearned Revenue (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2022
Dec. 31, 2021
Unearned Revenue      
Cash received in connection with intellectual property license and royalty agreement $ 200,000    
Unearned revenue   $ 48,921 $ 249,384
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.23.1
Convertible Notes Payable, Non-related Partied and Related Party (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Defined Benefit Plan Disclosure [Line Items]    
Total convertible notes payable $ 6,586,788 $ 8,424,100
Unamortized debt discount (189,060) (278,867)
Convertible note payable 6,397,727 8,145,233
Less current portion 6,397,727 (8,109,436)
Convertible notes payable, long-term portion 35,797
G B T Technologies S A [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Total convertible notes payable 6,395,531 8,055,400
1800 [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Total convertible notes payable 191,257 124,200
Redstart Holdings [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Total convertible notes payable $ 244,500
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.23.1
Convertible Notes Payable, Non-related Partied and Related Party (Details 1) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Debt Disclosure [Abstract]    
Convertible note payable to Stanley Hills $ 116,605 $ 116,605
Unamortized debt discount
Convertible notes payable, net, related party 116,605 116,605
Less current portion (116,605) (116,605)
Convertible notes payable, net, related party, long-term portion
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.23.1
Convertible Notes Payable, Non-related Partied and Related Party (Details 2) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Debt Instrument [Line Items]    
Convertible notes payable, at beginning $ 116,605  
Convertible notes payable, at end 116,605 $ 116,605
Convertible Notes Payable [Member]    
Debt Instrument [Line Items]    
Convertible notes payable, at beginning 8,261,839 13,426,706
Issued for cash 300,000 983,450
Convertible note issued for accounts payable   625,429
Accrued interest added to convertible note   234,521
Payment with marketable securities   (1,460,000)
Payment with cash (39,042) (106,200)
Original issue discount 60,700 127,550
Conversion to common stock (2,158,971) (5,649,000)
Debt discount related to new convertible notes (352,441) (741,100)
Amortization of debt discounts 442,247 819,423
Convertible notes payable, at end $ 6,514,332 $ 8,261,839
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.23.1
Convertible Notes Payable, Non-related Partied and Related Party (Details Narrative) - USD ($)
1 Months Ended 8 Months Ended 12 Months Ended
Sep. 13, 2022
May 05, 2022
Nov. 08, 2021
Aug. 04, 2021
Mar. 15, 2021
Feb. 10, 2021
Aug. 04, 2020
Sep. 21, 2021
Jul. 20, 2021
Sep. 15, 2020
Aug. 20, 2020
Jun. 17, 2019
Feb. 27, 2019
Dec. 31, 2019
Dec. 31, 2022
Dec. 31, 2021
Sep. 30, 2022
Feb. 10, 2022
May 26, 2021
Jan. 02, 2021
Dec. 31, 2020
Feb. 26, 2020
Short-Term Debt [Line Items]                                            
Value of share converted                             $ 2,158,969              
Conversion price (in dollars per share)                             $ 0.01              
Conversion price                             85.00%              
Charge related to modification of debt                             $ 13,777,480              
Convertible note payable, description                             IGOR 1 converted $1,284,600 of the convertible note into 4,185,650 shares of the Company’s common stock. On June 24, 2021, the Company transferred 5,500,000 SURG shares received as repayment of $660,000 of this convertible note IGOR 1 converted $1,659,869 of the convertible note into 590,117,647 shares of the Company’s common stock.            
Convertible debt                             $ 6,586,788 $ 8,424,100            
Cash                             $ 106,639 155,106            
Maturity date extension fees                     $ 1,000                      
Conversion of debt                             847,133,242              
Net proceeds                             $ 300,000 1,317,386            
Convertible note paid                             39,042            
Outstanding balance                             6,393,497 8,145,233            
Accrued interest                             2,068,799 1,547,924            
Note payable current                             41,137 2,612,397            
Accrued interest                             3,196,611 2,753,120            
Convertible note payable                             116,605 116,605            
Interest expense                             969,629 2,022,584            
Unamortized debt discount                             0 0            
Convertible Notes Payable [Member]                                            
Short-Term Debt [Line Items]                                            
Original issue discount                             60,700 127,550            
Convertible note payable                             6,514,332 8,261,839         $ 13,426,706  
Interest expense                             438,015 824,238            
Unamortized debt discount                             189,060 278,867            
Promissory Note [Member]                                            
Short-Term Debt [Line Items]                                            
Original issue discount                         $ 300,000                  
Consideration                         2,025,000                  
Paid for legal fees                         $ 25,000                  
GBT Technologies [Member] | Series H Preferred Stock [Member]                                            
Short-Term Debt [Line Items]                                            
Value of share converted                       $ 10,000,000                    
Note maturity date                       Dec. 31, 2021                    
Number of shares converted                       20,000                    
Conversion price (in dollars per share)                       $ 500                    
IGOR 1 CORP [Member]                                            
Short-Term Debt [Line Items]                                            
Convertible debt                             6,395,531              
Accrued interest                             $ 2,027,148              
Redstart Holdings Corp [Member] | Securities Purchase Agreement [Member]                                            
Short-Term Debt [Line Items]                                            
Value of share converted             $ 153,600 $ 244,500               153,600            
Note maturity date             Nov. 03, 2021 Dec. 22, 2022   Sep. 15, 2021                        
Number of shares converted       226,532                     7,656,951              
Purchase Price             $ 128,000     $ 78,000                        
Note payable, interest rate         6.00%   6.00%     6.00%               6.00% 6.00%      
Redstart Holdings Corp 2 [Member] | Securities Purchase Agreement [Member]                                            
Short-Term Debt [Line Items]                                            
Value of share converted                   $ 93,600           $ 93,600            
Number of shares converted                               89,169            
Redstart Holdings Corp 4 [Member] | Securities Purchase Agreement [Member]                                            
Short-Term Debt [Line Items]                                            
Value of share converted         $ 106,200 $ 184,200                   $ 184,200            
Note maturity date           Feb. 05, 2022                                
Number of shares converted                               386,146            
Purchase Price         $ 88,500 $ 153,500                                
Redstart Holdings Corp 5 [Member] | Securities Purchase Agreement [Member]                                            
Short-Term Debt [Line Items]                                            
Value of share converted                               $ 106,200            
Number of shares converted                               317,837            
Cash                               $ 141,782            
Iliad [Member]                                            
Short-Term Debt [Line Items]                                            
Number of shares converted                               4,053,069            
Iliad [Member] | Convertible Notes Payable [Member]                                            
Short-Term Debt [Line Items]                                            
Amortization of debt discount                             $ 0 $ 0            
Iliad [Member] | Securities Purchase Agreement [Member]                                            
Short-Term Debt [Line Items]                                            
Maturity date extension fees                 $ 1,000                          
Sixth Street Lending L L C [Member] | Securities Purchase Agreement [Member]                                            
Short-Term Debt [Line Items]                                            
Value of share converted     $ 124,200                                      
Note maturity date     Feb. 08, 2023                                      
Purchase Price     $ 103,500                                      
Note payable, interest rate     6.00%                                      
Sixth Street [Member]                                            
Short-Term Debt [Line Items]                                            
Conversion of debt                             26,343,190              
Diagonal Lending L L C [Member] | Securities Purchase Agreement [Member]                                            
Short-Term Debt [Line Items]                                            
Value of share converted $ 116,200 $ 244,500                                        
Note maturity date Sep. 09, 2023 Aug. 04, 2023                                        
Conversion price 75.00%                                          
Purchase Price   $ 203,500                                        
Note payable, interest rate 12.00% 6.00%                                        
Net proceeds $ 103,750                                          
Principal amount $ 13,944                                          
Interest rate 4.99%                                          
1800 [Member]                                            
Short-Term Debt [Line Items]                                            
Convertible note payable, description                             1800 Diagonal lending converted $130,400 of the convertible note into 222,091,971 shares of the Company’s common stock.              
Convertible debt                             $ 191,257 124,200            
Convertible note paid                             39,043              
1800 [Member] | Convertible Debt [Member]                                            
Short-Term Debt [Line Items]                                            
Convertible debt                                 $ 77,157          
Accrued interest                                 $ 13,944          
Diagonal Lending 1 [Member]                                            
Short-Term Debt [Line Items]                                            
Convertible debt                             114,100              
Accrued interest                             7,674              
Stanley Hills L L C [Member]                                            
Short-Term Debt [Line Items]                                            
Convertible debt                             1,231,466 1,231,466            
Cash                                       $ 400,000    
Proceeds from loans                           $ 1,000,000 $ 325,000 $ 325,000            
Note payable current                                           $ 1,214,900
Convertible shares                             4,420,758 4,420,758            
Repayment of debt                             $ 800,000 $ 800,000            
Accrued interest                             424,731 424,731            
Convertible note payable                             116,605 116,605            
Unpaid interest debt                             20,033 8,372            
Stanley Hills L L C [Member] | Convertible Debt [Member]                                            
Short-Term Debt [Line Items]                                            
Convertible debt                             $ 126,003 $ 126,003            
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.23.1
Notes Payable, Non-related Parties and Related Party (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Restructuring Cost and Reserve [Line Items]    
Total notes payable $ 350,000 $ 2,950,000
Unamortized debt discount
Notes payable 350,000 2,950,000
Less current portion (41,137) (2,612,397)
Notes payable, long-term portion 308,863 337,603
S B A Loan [Member]    
Restructuring Cost and Reserve [Line Items]    
Total notes payable 350,000 350,000
R W J Advanced Marketing L L C [Member]    
Restructuring Cost and Reserve [Line Items]    
Total notes payable $ 2,600,000
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.23.1
Notes Payable, Non-related Parties and Related Party (Details 1) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Restructuring Cost and Reserve [Line Items]    
Total notes payable $ 140,000 $ 140,000
Unamortized debt discount
Notes payable 140,000 140,000
Less current portion (140,000) (140,000)
Notes payable, net, related party, long-term portion
Alpha Eda [Member]    
Restructuring Cost and Reserve [Line Items]    
Total notes payable $ 140,000 $ 140,000
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.23.1
Notes Payable, Non-related Parties and Related Party (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Oct. 05, 2021
Jun. 22, 2020
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Oct. 02, 2021
Dec. 31, 2019
Short-Term Debt [Line Items]              
Accrued interest     $ 3,196,611 $ 2,753,120      
Interest expense     969,629 2,022,584      
Debt Instrument, Unamortized Discount     190,464 362,004      
Promissory Note [Member]              
Short-Term Debt [Line Items]              
Interest expense       0 $ 47,671    
Debt Instrument, Unamortized Discount       0 $ 0    
S B A Loan [Member]              
Short-Term Debt [Line Items]              
Principal amount           $ 1,771  
Accrued interest     23,707 10,582      
Interest rate           3.75%  
Proceeds from debt $ 200,000            
Note payable     350,000 350,000      
Alpha Eda [Member]              
Short-Term Debt [Line Items]              
Accrued interest     32,633 16,633      
Note payable     140,000 140,000      
EIDL [Member]              
Short-Term Debt [Line Items]              
Interest rate   3.75%          
Principal periodic payments   $ 731          
Term   30 years          
R W J Advanced Marketing L L C [Member]              
Short-Term Debt [Line Items]              
Interest rate             3.50%
Principal amount     0 2,600,000      
Accrued interest     $ 0 $ 394,666      
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.23.1
Accrued Settlement (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
May 15, 2019
Dec. 23, 2019
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2019
Defined Benefit Plan Disclosure [Line Items]          
Gain on settlement of debt     $ (13,777,480)  
Accrued settlement     $ 4,090,057 $ 4,090,057  
Investor [Member] | Securities Purchase Agreement [Member]          
Defined Benefit Plan Disclosure [Line Items]          
Legal matter   $ 8,340,000      
Arbitrator awarded $ 4,034,444        
Interest rate 7.25%        
Interest $ 55,613        
Gain on settlement of debt         $ 1,375,556
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Liability (Details) - $ / shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Stock price $ 0.001 $ 0.17
Risk free rate 4.76%  
Conversion/ Exercise price $ 0.01  
Dividend rate 0.00% 0.00%
Minimum [Member]    
Stock price $ 4.42  
Risk free rate   0.19%
Volatility 213.00% 167.00%
Conversion/ Exercise price $ 0.0015 $ 0.102
Maximum [Member]    
Risk free rate   0.39%
Volatility 277.00% 217.00%
Conversion/ Exercise price $ 0.0017 $ 0.103
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Liability (Details 1) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Derivative Liability      
Derivative liability balance, beginning $ 10,192,485 $ 5,262,448
Issuance of derivative liability 325,915 1,480,439 5,767,230
Fair value of beneficial conversion feature of debt converted (2,209,887) (116,669) (2,038,392)
Change in derivative liability during the period (6,594,370) 1,339,117 1,533,610
Debt modification   13,777,480  
Derivative liability balance, end $ 1,714,143 $ 10,192,485 $ 5,262,448
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity (Details)
12 Months Ended
Dec. 31, 2022
USD ($)
$ / shares
shares
Equity [Abstract]  
Warrants Outstanding, Beginning 392,870
Weighted Average Exercise Price Warrants Outstanding, Beginning | $ / shares $ 74.97
Weighted Average Remaining Contractual Life, Outstanding, Beginning 9 months 3 days
Aggregate Intrinsic Value Outstanding, Beginning | $
Warrants Granted
Warrants Forfeited
Warrants Exercised
Warrants Outstanding, End 70,770
Weighted Average Exercise Price Warrants Outstanding, End | $ / shares $ 205.07
Weighted Average Remaining Contractual Life, Outstanding, End 3 months 18 days
Aggregate Intrinsic Value Outstanding, Ending | $
Warrants Exercisable, End 70,770
Weighted Average Exercise Price Warrants Exercisable at End | $ / shares $ 205.07
Weighted Average Remaining Contractual Life Exercisable at End 3 months 18 days
Aggregate Intrinsic Value Outstanding, Exercisable at End | $
XML 67 R57.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity (Details 1) - $ / shares
Dec. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of warrants Outstanding 70,770 392,870
Number of warrants Exercisable 70,770  
Warrants One [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of warrants Outstanding  
Exercise price of warrants Outstanding $ 25.00  
Number of warrants Exercisable  
Exercise price of warrants Exercisable $ 25.00  
Warrants Two [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of warrants Outstanding 60,000  
Exercise price of warrants Outstanding $ 92.50  
Number of warrants Exercisable 60,000  
Exercise price of warrants Exercisable $ 92.50  
Warrants Three [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of warrants Outstanding 10,000  
Exercise price of warrants Outstanding $ 135.00  
Number of warrants Exercisable 10,000  
Exercise price of warrants Exercisable $ 135.00  
Warrants Four [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of warrants Outstanding 400  
Exercise price of warrants Outstanding $ 1,595.00  
Number of warrants Exercisable 400  
Exercise price of warrants Exercisable $ 1,595.00  
Warrants Five [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of warrants Outstanding  
Exercise price of warrants Outstanding $ 2,500.00  
Number of warrants Exercisable  
Exercise price of warrants Exercisable $ 2,500.00  
Warrants Six [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of warrants Outstanding  
Exercise price of warrants Outstanding $ 3,750.00  
Number of warrants Exercisable  
Exercise price of warrants Exercisable $ 3,750.00  
Warrants Seven [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of warrants Outstanding  
Exercise price of warrants Outstanding $ 5,000.00  
Number of warrants Exercisable  
Exercise price of warrants Exercisable $ 5,000.00  
Warrants Eight [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of warrants Outstanding 200  
Exercise price of warrants Outstanding $ 11,750.00  
Number of warrants Exercisable 200  
Exercise price of warrants Exercisable $ 11,750.00  
Warrants Nine [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of warrants Outstanding 150  
Exercise price of warrants Outstanding $ 12,500.00  
Number of warrants Exercisable 150  
Exercise price of warrants Exercisable $ 12,500.00  
Warrants Ten [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of warrants Outstanding 20  
Exercise price of warrants Outstanding $ 14,000.00  
Number of warrants Exercisable 20  
Exercise price of warrants Exercisable $ 14,000.00  
XML 68 R58.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Equity (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Oct. 26, 2021
Dec. 17, 2021
Oct. 26, 2021
Jun. 17, 2019
Dec. 31, 2022
Dec. 31, 2021
Jul. 07, 2022
Nov. 01, 2011
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Common stock, par value         $ 0.00001 $ 0.00001 $ 0.00001  
Common stock, authorized         10,000,000,000 10,000,000,000 2,000,000,000  
Reverse stock split 1 for 50       1-for-500      
Shares issued, shares         3,949,223,831 83,722,340    
Debt conversion, converted instrument, shares         847,133,242      
Debt conversion, converted instrument, Value         $ 2,158,969      
Debt conversion, converted instrument, Accrued interest         $ 6,491      
Number of shares cancelled         240,000      
Aggregate Purchase Price   $ 10,000,000     $ 231,867      
Conversion price         $ 0.01      
Series B Preferred Stock [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Conversion price               $ 30
Preferred stock, Outstanding         45,000 45,000    
Series C Preferred Stock [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Preferred stock, Outstanding         700 700    
Series D Preferred Stock [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Preferred stock, Outstanding         0 0    
Series G Preferred Stock [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Preferred stock, Outstanding         0 0    
Series H Preferred Stock [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Preferred stock, Outstanding         20,000 20,000    
Series H Preferred Stock [Member] | Altcorp [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Debt conversion, converted instrument, Value       $ 10,000,000        
Stock Issued for Acquisitions, Shares       625,000        
Number of shares converted       20,000        
Maturity date       Dec. 31, 2021        
Dividend per share       $ 500        
G B T Tokenize [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Aggregate Purchase Price         $ 1,500      
Stock Issued for Acquisitions, Shares         76,923      
Joint Venture Agreement [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Issuance of shares         150,000,000      
Common Stock [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Shares issued, shares         5,500,000      
Shares issued, value         $ 231,866      
Issuance of shares         5,500,000      
Aggregate Purchase Price         $ 55      
Board Of Directors [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Reverse stock split     1-for-500          
XML 69 R59.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Deferred income tax asset    
Net operating loss carryforwards $ 9,182,327 $ 8,945,238
Total deferred income tax asset 9,182,327 8,945,238
Less: valuation allowance (9,182,327) (8,945,238)
Total deferred income tax asset
XML 70 R60.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Details 1) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Federal statutory rates $ 1,118,010 $ (7,125,391)
Federal statutory rates (in percent) 21.00% 21.00%
State income taxes $ 425,908 $ (2,714,435)
State income taxes (in percent) 8.00% 8.00%
Permanent differences $ (1,784,116) $ 9,127,383
Permanent differences (in percent) (33.50%) (26.90%)
Valuation allowance against net deferred tax assets $ 237,089 $ 712,442
Valuation allowance against net deferred tax assets (in percent) 4.50% (2.10%)
Effective rate
XML 71 R61.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Details Narrative) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Valuation allowance $ 237,089 $ 712,442
Net operating loss carryforward $ 31,663,196  
XML 72 R62.htm IDEA: XBRL DOCUMENT v3.23.1
Related Parties (Details Narrative) - USD ($)
1 Months Ended 8 Months Ended 12 Months Ended
Jan. 07, 2022
Nov. 15, 2021
Mar. 06, 2020
Oct. 10, 2019
Jan. 02, 2019
Apr. 06, 2018
Sep. 02, 2017
Jun. 20, 2022
Dec. 31, 2019
Dec. 31, 2022
Dec. 31, 2021
Nov. 15, 2022
Jan. 02, 2021
Feb. 26, 2020
Related Party Transaction [Line Items]                            
Issuance of promissory note                   $ 140,000 $ 140,000      
Note payable current                   41,137 2,612,397      
Convertible debt                   6,586,788 8,424,100      
Accrued interest                   3,196,611 2,753,120      
Convertible note payable                   116,605 116,605      
Cash                   106,639 155,106      
Alpha Eda [Member]                            
Related Party Transaction [Line Items]                            
Accrued interest                   32,633 16,333      
Accrued interest                   32,633 16,633      
Tokenize Agreement [Member]                            
Related Party Transaction [Line Items]                            
Consideration for services payable     $ 33,333                      
Tokenize Agreement [Member] | Greenwich [Member]                            
Related Party Transaction [Line Items]                            
Common stock contributed     10,000,000                      
Bit Speed Agreement [Member]                            
Related Party Transaction [Line Items]                            
Common stock contributed       100,000,000                    
Director [Member]                            
Related Party Transaction [Line Items]                            
Base Salary           $ 250,000                
Davis [Member] | Employment Agreement [Member]                            
Related Party Transaction [Line Items]                            
Base salary         $ 400,000                  
Stock option issued         50,000                  
Option vested description         The options were to be earned and vested (i) with respect to 20,000 shares of common stock on the date hereof, (ii) 5,000 shares of common stock upon the successful dual list of the Company on an international exchange such as SIX Zurich Stock Exchange or Euronext, (iii) 15,000 shares of common stock upon the successful up listing to a national exchange such as the Nasdaq, NYSE Euronext, TSX, AMEX or other, and (iv) with respect to 5,000 shares of common stock at each of the six (6) month anniversaries (July 1, 2019 and January 1, 2020). The exercise price of such options shall be the closing price of the Company on the date prior to such event.                  
R W J Advanced Marketing L L C [Member]                            
Related Party Transaction [Line Items]                            
Base Salary             $ 250,000              
Yello Partners Inc [Member]                            
Related Party Transaction [Line Items]                            
Principlal amount                   505,000 385,000      
Alpha Eda L L C [Member]                            
Related Party Transaction [Line Items]                            
Issuance of promissory note                       $ 140,000    
Interest rate                       10.00%    
Maturity date   Sep. 30, 2021           Dec. 31, 2021            
Stanley Hills L L C [Member]                            
Related Party Transaction [Line Items]                            
Proceeds from loans                 $ 1,000,000 325,000 325,000      
Note payable current                           $ 1,214,900
Convertible debt                   $ 1,231,466 $ 1,231,466      
Convertible shares                   4,420,758 4,420,758      
Repayment of debt                   $ 800,000 $ 800,000      
Accrued interest                   424,731 424,731      
Convertible note payable                   $ 116,605 116,605      
Debt                         $ 3,300,000  
Cash                         400,000  
Related party, description                   This $4.2 million amount consists of $450,000 paid by SURG in November and December 2021, $100,000 to be paid on or about January 4, 2022, and $3,650,000 to be paid on or prior to January 7, 2022 of which $375,000 will be held in escrow as described before.        
Other receivable                     3,750,000      
Accrued expenses                   $ 927,136        
Sales amount                   45,000 180,000      
Stanley Hills L L C [Member] | Common Stock [Member]                            
Related Party Transaction [Line Items]                            
Debt                         100,000  
Cash                         $ 800,000  
Stanley Hills L L C [Member] | Convertible Debt [Member]                            
Related Party Transaction [Line Items]                            
Convertible debt                   $ 126,003 $ 126,003      
S U R G [Member]                            
Related Party Transaction [Line Items]                            
Repayment of debt $ 4,200,000                          
XML 73 R63.htm IDEA: XBRL DOCUMENT v3.23.1
Legal Proceedings (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
May 15, 2019
Jun. 24, 2022
Oct. 16, 2020
Jul. 28, 2020
Dec. 31, 2022
Dec. 31, 2021
Jan. 28, 2022
Dec. 03, 2018
Offsetting Assets [Line Items]                
Escrow amount             $ 19,694  
Proceeds from related party debt         $ 756,227    
Sought value     $ 48,844 $ 48,844        
Legal cost     $ 716 $ 716        
S U R G Shares [Member]                
Offsetting Assets [Line Items]                
Number of shares issued   14,870,370            
Securities Purchase Agreement [Member] | Investor [Member]                
Offsetting Assets [Line Items]                
Arbitrator awarded $ 4,034,444              
Interest rate 7.25%              
Interest $ 55,613              
Securities Purchase Agreement [Member] | Senior Secured Redeemable Convertible Debenture [Member]                
Offsetting Assets [Line Items]                
Note payable, principal amount               $ 8,340,000
Warrants aquire               225,000
R W J Agreement [Member]                
Offsetting Assets [Line Items]                
Escrow amount         19,809      
Proceeds from related party debt         40,000      
Accrued expenses         $ 49,847      
XML 74 R64.htm IDEA: XBRL DOCUMENT v3.23.1
Contingencies (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
May 17, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2018
Revenues   $ 1,197,555 $ 180,000  
Unearned revenue   48,921 249,384  
Operating expense $ 200 3,178,160 $ 18,655,514  
GBT Technologies [Member]        
Revenues       $ 300,000
Payment for expenses       $ 5,000,000
Unearned revenue   $ 200,000    
XML 75 R65.htm IDEA: XBRL DOCUMENT v3.23.1
Concentrations (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Concentration Risk [Line Items]    
Accumulated deficit $ (299,257,917) $ (304,581,773)
Sales 1,152,555
Liquidity Risk [Member]    
Concentration Risk [Line Items]    
Accumulated deficit 299,257,917  
Working capital deficit 18,522,046  
Customers [Member]    
Concentration Risk [Line Items]    
Sales 1,152,555 0
Net revenues $ 45,000 $ 180,000
XML 76 R66.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events (Details Narrative) - USD ($)
1 Months Ended 5 Months Ended 12 Months Ended
Apr. 03, 2023
Mar. 14, 2023
Mar. 02, 2023
Mar. 02, 2023
Jan. 24, 2023
Jun. 10, 2022
Dec. 31, 2022
Dec. 31, 2021
Subsequent Event [Line Items]                
Value of share converted             $ 2,158,969  
Net proceeds             300,000 $ 1,317,386
Interest payable             $ 3,196,611 $ 2,753,120
Metaverse Agreement [Member]                
Subsequent Event [Line Items]                
Sale of common stock           $ 25,000    
G B T [Member]                
Subsequent Event [Line Items]                
Shares issued           500,000,000    
Subsequent Event [Member]                
Subsequent Event [Line Items]                
Value of share converted     $ 59,408          
Note payable, interest rate     12.00% 12.00%        
Note maturity date     Jun. 01, 2024          
Original issue discount     $ 6,258          
Net proceeds     53,150          
Principal amount     7,128 $ 7,128        
Interest payable     6,653 $ 6,653        
Settlement made   $ 5,000            
Number of shares sold 26,000,000              
Subsequent Event [Member] | G B T Technologies Inc [Member]                
Subsequent Event [Line Items]                
Ownership percentage 50.00%              
Subsequent Event [Member] | D L Convertible Note [Member]                
Subsequent Event [Line Items]                
Value of share converted     $ 62,680          
Note payable, interest rate     6.00% 6.00%        
Note maturity date       Jun. 01, 2024        
Purchase price     $ 52,150          
Glen Eagles Acquisition L P [Member] | Subsequent Event [Member]                
Subsequent Event [Line Items]                
Value of share converted         $ 512,500      
Note payable, interest rate         10.00%      
Note maturity date         Dec. 31, 2023      
1800 [Member] | Subsequent Event [Member]                
Subsequent Event [Line Items]                
Interest payable     $ 66,536 $ 66,536        
XML 77 e4603_10ka_htm.xml IDEA: XBRL DOCUMENT 0001471781 2022-01-01 2022-12-31 0001471781 2022-06-30 0001471781 2023-04-14 0001471781 GTCH:BFBorgersCPAPCMember 2022-01-01 2022-12-31 0001471781 2022-12-31 0001471781 2021-12-31 0001471781 us-gaap:SeriesBPreferredStockMember 2022-12-31 0001471781 us-gaap:SeriesBPreferredStockMember 2021-12-31 0001471781 us-gaap:SeriesCPreferredStockMember 2022-12-31 0001471781 us-gaap:SeriesCPreferredStockMember 2021-12-31 0001471781 us-gaap:SeriesDPreferredStockMember 2022-12-31 0001471781 us-gaap:SeriesDPreferredStockMember 2021-12-31 0001471781 us-gaap:SeriesGPreferredStockMember 2022-12-31 0001471781 us-gaap:SeriesGPreferredStockMember 2021-12-31 0001471781 us-gaap:SeriesHPreferredStockMember 2022-12-31 0001471781 us-gaap:SeriesHPreferredStockMember 2021-12-31 0001471781 2021-01-01 2021-12-31 0001471781 us-gaap:CommonStockMember 2020-12-31 0001471781 GTCH:TreasuryStocksMember 2020-12-31 0001471781 GTCH:StockLoanReceivableMember 2020-12-31 0001471781 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001471781 us-gaap:RetainedEarningsMember 2020-12-31 0001471781 2020-12-31 0001471781 us-gaap:CommonStockMember 2021-12-31 0001471781 GTCH:TreasuryStocksMember 2021-12-31 0001471781 GTCH:StockLoanReceivableMember 2021-12-31 0001471781 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001471781 us-gaap:RetainedEarningsMember 2021-12-31 0001471781 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001471781 GTCH:TreasuryStocksMember 2021-01-01 2021-12-31 0001471781 GTCH:StockLoanReceivableMember 2021-01-01 2021-12-31 0001471781 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001471781 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001471781 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001471781 GTCH:TreasuryStocksMember 2022-01-01 2022-12-31 0001471781 GTCH:StockLoanReceivableMember 2022-01-01 2022-12-31 0001471781 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001471781 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001471781 us-gaap:CommonStockMember 2022-12-31 0001471781 GTCH:TreasuryStocksMember 2022-12-31 0001471781 GTCH:StockLoanReceivableMember 2022-12-31 0001471781 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001471781 us-gaap:RetainedEarningsMember 2022-12-31 0001471781 2021-10-25 2021-10-26 0001471781 2022-01-28 0001471781 GTCH:RWJPartiesMember 2022-12-31 0001471781 GTCH:MrLightHouseLTDMember GTCH:PurchaseAndSaleAgreementMember 2020-09-01 2020-09-18 0001471781 2021-07-31 0001471781 2022-04-30 0001471781 GTCH:TouchPointGroupHoldingMember 2022-02-01 2022-02-22 0001471781 GTCH:MahaserMember 2022-01-01 2022-12-31 0001471781 us-gaap:RestrictedStockMember 2022-01-01 2022-12-31 0001471781 2022-03-02 0001471781 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001471781 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001471781 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001471781 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001471781 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001471781 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001471781 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2022-01-01 2022-12-31 0001471781 us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-12-31 0001471781 us-gaap:SeriesBPreferredStockMember 2021-01-01 2021-12-31 0001471781 us-gaap:SeriesCPreferredStockMember 2022-01-01 2022-12-31 0001471781 us-gaap:SeriesCPreferredStockMember 2021-01-01 2021-12-31 0001471781 us-gaap:SeriesHPreferredStockMember 2022-01-01 2022-12-31 0001471781 us-gaap:SeriesHPreferredStockMember 2021-01-01 2021-12-31 0001471781 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001471781 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001471781 GTCH:SeriesAConvertiblePreferredStockMember GTCH:StockPurchaseAgreementMember 2022-01-03 2022-01-28 0001471781 GTCH:StockPurchaseAgreementMember 2022-01-03 2022-01-28 0001471781 GTCH:StockPurchaseAgreementMember 2022-01-28 0001471781 GTCH:TouchpointGroupHoldingsIncMember 2022-02-02 2022-02-22 0001471781 GTCH:TouchpointGroupHoldingsIncMember 2022-02-23 0001471781 GTCH:TouchpointGroupHoldingsIncMember us-gaap:CommonStockMember 2022-02-23 0001471781 GTCH:TouchpointGroupHoldingsIncMember 2022-01-01 2022-12-31 0001471781 GTCH:GTXAgreementMember 2022-01-01 2022-12-31 0001471781 GTCH:GBTTokenizeMember 2022-01-01 2022-12-31 0001471781 GTCH:GBTTokenizeMetAlertMember 2022-01-01 2022-09-30 0001471781 GTCH:PromissoryNoteMember 2022-01-01 2022-09-30 0001471781 GTCH:GTXAgreementMember 2022-12-31 0001471781 GTCH:GTXAgreementMember 2021-12-31 0001471781 GTCH:SurgeHoldingsMember GTCH:AssetPurchaseAgreementMember 2019-09-29 2019-09-30 0001471781 GTCH:SurgeHoldingsMember GTCH:AssetPurchaseAgreementMember 2022-01-01 2022-01-07 0001471781 GTCH:SurgeHoldingsMember GTCH:AltCorpExchangeAgreementMember 2020-06-23 0001471781 GTCH:StanleyHillsLLCMember 2021-01-02 0001471781 GTCH:StanleyHillsLLCMember us-gaap:CommonStockMember 2021-01-02 0001471781 GTCH:SurgeHoldingsIncMember 2022-01-01 2022-01-07 0001471781 GTCH:SurgeHoldingsIncMember 2022-01-01 2022-12-31 0001471781 GTCH:SurgeHoldingsIncMember 2022-12-31 0001471781 2022-01-31 0001471781 GTCH:AltcorpMember us-gaap:SeriesHPreferredStockMember 2019-06-01 2019-06-17 0001471781 GTCH:AltcorpMember 2019-02-01 2019-02-06 0001471781 GTCH:GBTSharesMember 2021-12-31 0001471781 GTCH:GBTSharesMember 2021-01-01 2021-12-31 0001471781 2021-12-01 2021-12-31 0001471781 GTCH:StanleyHillsLLCMember 2021-12-31 0001471781 GTCH:TokenizeAgreementMember 2021-05-28 0001471781 GTCH:TokenizeAgreementMember 2021-05-07 2021-05-28 0001471781 2020-03-31 0001471781 2018-01-01 2018-12-31 0001471781 GTCH:GBTTechnologiesSAMember 2022-12-31 0001471781 GTCH:GBTTechnologiesSAMember 2021-12-31 0001471781 GTCH:DiagonalLendingMember 2022-12-31 0001471781 GTCH:DiagonalLendingMember 2021-12-31 0001471781 GTCH:RedstartHoldingsMember 2022-12-31 0001471781 GTCH:RedstartHoldingsMember 2021-12-31 0001471781 GTCH:GBTTechnologiesMember us-gaap:SeriesHPreferredStockMember 2019-06-01 2019-06-17 0001471781 GTCH:GBTTechnologiesMember us-gaap:SeriesHPreferredStockMember 2019-06-17 0001471781 GTCH:IGOR1CORPMember 2022-12-31 0001471781 GTCH:RedstartHoldingsCorpMember GTCH:SecuritiesPurchaseAgreementMember 2020-08-01 2020-08-04 0001471781 GTCH:RedstartHoldingsCorpMember GTCH:SecuritiesPurchaseAgreementMember 2020-08-04 0001471781 GTCH:RedstartHoldingsCorpMember GTCH:SecuritiesPurchaseAgreementMember 2021-01-01 2021-12-31 0001471781 GTCH:RedstartHoldingsCorpMember GTCH:SecuritiesPurchaseAgreementMember 2021-08-01 2021-08-04 0001471781 GTCH:RedstartHoldingsCorp2Member GTCH:SecuritiesPurchaseAgreementMember 2020-09-01 2020-09-15 0001471781 GTCH:RedstartHoldingsCorpMember GTCH:SecuritiesPurchaseAgreementMember 2020-09-01 2020-09-15 0001471781 GTCH:RedstartHoldingsCorpMember GTCH:SecuritiesPurchaseAgreementMember 2020-09-15 0001471781 GTCH:RedstartHoldingsCorp2Member GTCH:SecuritiesPurchaseAgreementMember 2021-01-01 2021-12-31 0001471781 GTCH:RedstartHoldingsCorp4Member GTCH:SecuritiesPurchaseAgreementMember 2021-02-01 2021-02-10 0001471781 GTCH:RedstartHoldingsCorpMember GTCH:SecuritiesPurchaseAgreementMember 2022-02-10 0001471781 GTCH:RedstartHoldingsCorp4Member GTCH:SecuritiesPurchaseAgreementMember 2021-01-01 2021-12-31 0001471781 GTCH:RedstartHoldingsCorp4Member GTCH:SecuritiesPurchaseAgreementMember 2021-03-01 2021-03-15 0001471781 GTCH:RedstartHoldingsCorpMember GTCH:SecuritiesPurchaseAgreementMember 2021-03-15 0001471781 GTCH:RedstartHoldingsCorp5Member GTCH:SecuritiesPurchaseAgreementMember 2021-01-01 2021-12-31 0001471781 GTCH:RedstartHoldingsCorpMember GTCH:SecuritiesPurchaseAgreementMember 2021-05-26 0001471781 GTCH:RedstartHoldingsCorp5Member GTCH:SecuritiesPurchaseAgreementMember 2021-12-31 0001471781 GTCH:RedstartHoldingsCorpMember GTCH:SecuritiesPurchaseAgreementMember 2021-09-01 2021-09-21 0001471781 GTCH:RedstartHoldingsCorpMember GTCH:SecuritiesPurchaseAgreementMember 2022-01-01 2022-12-31 0001471781 GTCH:PromissoryNoteMember 2019-02-01 2019-02-27 0001471781 GTCH:IliadMember GTCH:SecuritiesPurchaseAgreementMember 2021-07-01 2021-07-20 0001471781 2020-08-02 2020-08-20 0001471781 GTCH:IliadMember 2021-01-01 2021-12-31 0001471781 us-gaap:ConvertibleNotesPayableMember GTCH:IliadMember 2022-12-31 0001471781 us-gaap:ConvertibleNotesPayableMember GTCH:IliadMember 2021-12-31 0001471781 GTCH:SixthStreetLendingLLCMember GTCH:SecuritiesPurchaseAgreementMember 2021-11-02 2021-11-08 0001471781 GTCH:SixthStreetLendingLLCMember GTCH:SecuritiesPurchaseAgreementMember 2021-11-08 0001471781 GTCH:SixthStreetMember 2022-01-01 2022-12-31 0001471781 GTCH:DiagonalLendingLLCMember GTCH:SecuritiesPurchaseAgreementMember 2022-05-02 2022-05-05 0001471781 GTCH:DiagonalLendingLLCMember GTCH:SecuritiesPurchaseAgreementMember 2022-05-05 0001471781 GTCH:DiagonalLendingMember 2022-01-01 2022-12-31 0001471781 GTCH:DiagonalLending1Member 2022-12-31 0001471781 GTCH:DiagonalLendingLLCMember GTCH:SecuritiesPurchaseAgreementMember 2022-09-02 2022-09-13 0001471781 GTCH:DiagonalLendingLLCMember GTCH:SecuritiesPurchaseAgreementMember 2022-09-13 0001471781 us-gaap:ConvertibleDebtMember GTCH:DiagonalLendingMember 2022-09-30 0001471781 GTCH:StanleyHillsLLCMember 2019-05-03 2019-12-31 0001471781 GTCH:StanleyHillsLLCMember 2020-02-26 0001471781 GTCH:StanleyHillsLLCMember 2022-12-31 0001471781 GTCH:StanleyHillsLLCMember 2022-01-01 2022-12-31 0001471781 us-gaap:ConvertibleDebtMember GTCH:StanleyHillsLLCMember 2022-12-31 0001471781 us-gaap:ConvertibleNotesPayableMember 2022-01-01 2022-12-31 0001471781 us-gaap:ConvertibleNotesPayableMember 2021-01-01 2021-12-31 0001471781 us-gaap:ConvertibleNotesPayableMember 2022-12-31 0001471781 us-gaap:ConvertibleNotesPayableMember 2021-12-31 0001471781 us-gaap:ConvertibleNotesPayableMember 2020-12-31 0001471781 GTCH:RWJAdvancedMarketingLLCMember 2022-12-31 0001471781 GTCH:RWJAdvancedMarketingLLCMember 2021-12-31 0001471781 GTCH:SBALoanMember 2022-12-31 0001471781 GTCH:SBALoanMember 2021-12-31 0001471781 GTCH:RWJAdvancedMarketingLLCMember 2019-12-31 0001471781 GTCH:EIDLMember 2020-06-01 2020-06-22 0001471781 GTCH:SBALoanMember 2021-10-02 0001471781 GTCH:SBALoanMember 2021-10-03 2021-10-05 0001471781 GTCH:AlphaEdaMember 2022-12-31 0001471781 GTCH:AlphaEdaMember 2021-12-31 0001471781 GTCH:PromissoryNoteMember 2021-01-01 2021-12-31 0001471781 GTCH:PromissoryNoteMember 2020-01-01 2020-12-31 0001471781 GTCH:PromissoryNoteMember 2020-12-31 0001471781 GTCH:PromissoryNoteMember 2021-12-31 0001471781 GTCH:AlphaEdaMember 2022-12-31 0001471781 GTCH:AlphaEdaMember 2021-12-31 0001471781 us-gaap:InvestorMember GTCH:SecuritiesPurchaseAgreementMember 2019-12-01 2019-12-23 0001471781 us-gaap:InvestorMember GTCH:SecuritiesPurchaseAgreementMember 2019-05-01 2019-05-15 0001471781 us-gaap:InvestorMember GTCH:SecuritiesPurchaseAgreementMember 2019-01-01 2019-12-31 0001471781 srt:MinimumMember 2022-12-31 0001471781 srt:MinimumMember 2021-01-01 2021-12-31 0001471781 srt:MaximumMember 2021-01-01 2021-12-31 0001471781 srt:MinimumMember 2022-01-01 2022-12-31 0001471781 srt:MaximumMember 2022-01-01 2022-12-31 0001471781 srt:MinimumMember 2021-12-31 0001471781 srt:MaximumMember 2022-12-31 0001471781 srt:MaximumMember 2021-12-31 0001471781 2019-12-31 0001471781 2020-01-01 2020-12-31 0001471781 2022-07-07 0001471781 GTCH:BoardOfDirectorsMember 2021-10-03 2021-10-26 0001471781 GTCH:JointVentureAgreementMember 2022-01-01 2022-12-31 0001471781 us-gaap:SeriesBPreferredStockMember 2011-11-01 0001471781 GTCH:AltcorpMember us-gaap:SeriesHPreferredStockMember 2019-06-17 0001471781 2021-12-02 2021-12-17 0001471781 GTCH:WarrantsOneMember 2022-12-31 0001471781 GTCH:WarrantsTwoMember 2022-12-31 0001471781 GTCH:WarrantsThreeMember 2022-12-31 0001471781 GTCH:WarrantsFourMember 2022-12-31 0001471781 GTCH:WarrantsFiveMember 2022-12-31 0001471781 GTCH:WarrantsSixMember 2022-12-31 0001471781 GTCH:WarrantsSevenMember 2022-12-31 0001471781 GTCH:WarrantsEightMember 2022-12-31 0001471781 GTCH:WarrantsNineMember 2022-12-31 0001471781 GTCH:WarrantsTenMember 2022-12-31 0001471781 GTCH:RWJAdvancedMarketingLLCMember 2017-08-30 2017-09-02 0001471781 srt:DirectorMember 2018-04-01 2018-04-06 0001471781 GTCH:DavisMember GTCH:EmploymentAgreementMember 2018-12-30 2019-01-02 0001471781 GTCH:TokenizeAgreementMember GTCH:GreenwichMember 2020-03-01 2020-03-06 0001471781 GTCH:BitSpeedAgreementMember 2019-10-01 2019-10-10 0001471781 GTCH:TokenizeAgreementMember 2020-03-01 2020-03-06 0001471781 GTCH:YelloPartnersIncMember 2022-12-31 0001471781 GTCH:YelloPartnersIncMember 2021-12-31 0001471781 GTCH:AlphaEdaLLCMember 2022-11-15 0001471781 GTCH:AlphaEdaLLCMember 2021-11-02 2021-11-15 0001471781 GTCH:AlphaEdaLLCMember 2022-06-02 2022-06-20 0001471781 GTCH:StanleyHillsLLCMember 2021-01-01 2021-12-31 0001471781 us-gaap:ConvertibleDebtMember GTCH:StanleyHillsLLCMember 2021-12-31 0001471781 GTCH:SURGMember 2022-01-02 2022-01-07 0001471781 GTCH:RWJAgreementMember 2022-12-31 0001471781 GTCH:RWJAgreementMember 2022-01-01 2022-12-31 0001471781 GTCH:SeniorSecuredRedeemableConvertibleDebentureMember GTCH:SecuritiesPurchaseAgreementMember 2018-12-03 0001471781 2020-07-01 2020-07-28 0001471781 2020-10-01 2020-10-16 0001471781 GTCH:SURGSharesMember 2022-06-03 2022-06-24 0001471781 GTCH:GBTTechnologiesMember 2018-01-01 2018-12-31 0001471781 GTCH:GBTTechnologiesMember 2022-12-31 0001471781 2022-05-01 2022-05-17 0001471781 GTCH:LiquidityRiskMember 2022-12-31 0001471781 GTCH:CustomersMember 2022-01-01 2022-12-31 0001471781 GTCH:CustomersMember 2021-01-01 2021-12-31 0001471781 GTCH:GlenEaglesAcquisitionLPMember us-gaap:SubsequentEventMember 2023-01-01 2023-01-24 0001471781 GTCH:GlenEaglesAcquisitionLPMember us-gaap:SubsequentEventMember 2023-01-24 0001471781 us-gaap:SubsequentEventMember 2023-02-27 2023-03-02 0001471781 us-gaap:SubsequentEventMember 2023-03-02 0001471781 GTCH:DiagonalLendingMember us-gaap:SubsequentEventMember 2023-03-02 0001471781 GTCH:DLConvertibleNoteMember us-gaap:SubsequentEventMember 2023-02-27 2023-03-02 0001471781 GTCH:DLConvertibleNoteMember us-gaap:SubsequentEventMember 2023-02-26 2023-03-02 0001471781 GTCH:DLConvertibleNoteMember us-gaap:SubsequentEventMember 2023-03-02 0001471781 GTCH:GBTMember 2022-06-10 0001471781 GTCH:MetaverseAgreementMember 2022-01-01 2022-06-10 0001471781 us-gaap:SubsequentEventMember 2023-03-01 2023-03-14 0001471781 GTCH:GBTTechnologiesIncMember us-gaap:SubsequentEventMember 2023-04-03 0001471781 us-gaap:SubsequentEventMember 2023-04-01 2023-04-03 iso4217:USD shares iso4217:USD shares pure 0001471781 true 2022 FY 10-K/A true 2022-12-31 --12-31 false 000-54530 GBT TECHNOLOGIES INC. NV 27-0603137 2450 Colorado Ave. Suite 100E Santa Monica CA 90404 888 685-7336 No No Yes Yes Non-accelerated Filer true false false 2266899 2930101819 GBT Technologies, Inc. (the “Company”) is filing this Amendment No. 1 on Form 10-K/A (the “Amendment”) to amend missing prior year Auditor opinion as of December 31, 2021, originally filed with the U.S. Securities and Exchange Commission (the “SEC”) on April 12, 2023 (the “Original 10-K”), as well as to amend its current Auditor PCAOB number. 6662 5041 M.S. Madhava Rao India BF Borgers CPA PC CO 106639 155106 112942 25244 11569 12500 198475 16198 3750000 370625 4018048 370625 4018048 1539802 2302928 6240634 6896263 4090057 4090057 48921 249384 41444 190464 362004 6397727 8109436 0 0 116605 116605 0 47671 41137 2612397 140000 140000 62003 1714143 10192485 18892671 32406629 88403 0 35797 308863 337603 19201534 32780029 0.00001 0.00001 20000000 20000000 45000 45000 45000 45000 0.00001 0.00001 10000 10000 700 700 700 700 0.00001 0.00001 100000 100000 0 0 0 0 0.00001 0.00001 2000000 2000000 0 0 0 0 0.00001 0.00001 40000 40000 20000 20000 20000 20000 0.00001 0.00001 10000000000 1535593440 1535593440 33200198 33200198 15356 332 21 21 643059 643059 -7610147 -7610147 288664858 284072666 -299257917 -304581773 -18830909 -28761981 370625 4018048 1152555 45000 180000 1197555 180000 817754 379801 180000 1053282 293628 360335 837614 1814543 2124272 15400000 50000 3178160 18655514 -2798359 -18475514 442247 824238 6594370 -1339117 969629 2022584 11000 3012355 -13777480 310462 237828 2497500 8122215 -15454919 5323856 -33930433 5323856 -33930433 5323856 -33930433 696686911 19991381 4646981551 19991381 0.01 -1.70 0.00 -1.70 5133489 51 1040 -643059 -7610147 251046191 -270651339 -27858304 13821709 139 5677867 5678006 245000 2 281748 281750 14000000 140 15399860 15400000 11666999 11666999 -33930433 -33930433 33200198 332 1040 -643059 -7610147 284072666 -304581773 -28761981 847133242 8471 2156990 2165461 2209888 2209888 5500000 55 231812 231867 150000000 1500 -1500 500000000 5000 -5000 -240000 -2 2 5323856 5323856 1535593440 15356 1040 -643059 -7610147 288664858 -299257917 -18830909 5323856 -33930433 442247 824238 -6594370 1339117 34175 136785 281748 -13777480 15400000 11000 308802 3012633 800000 25244 -3741525 3750000 289590 12500 11569 -8556 -200463 -291 -123462 5073651 -138293 -1369114 150000 125000 -275000 300000 1317386 190000 231864 -106200 694225 39042 756227 200000 364826 1411186 -48467 42072 155106 113034 106639 155106 2898 2898 325916 741100 2209888 11666999 2165464 5678006 660000 5000 1500 424731 202899 -2 <p id="xdx_804_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zh6ravsdDKgd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_826_zIEv0NJzZFA1">Note 1 - <span id="xdx_82B_zaqlNF28Tu55">Organization and Basis of Presentation</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>Organization and Line of Business</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">GBT Technologies Inc. (formerly Gopher Protocol Inc.) (the “Company”, “GBT”, or “GTCH”) was incorporated on July 22, 2009 under the laws of the State of Nevada. The Company is targeting growing markets such as development of Internet of Things (IoT) and Artificial Intelligence (AI) enabled networking and tracking technologies, including wireless mesh network technology platform and fixed solutions, development of an intelligent human body vitals device, asset-tracking IoT, and wireless mesh networks. Effective August 5, 2019, the Company changed its name from Gopher Protocol Inc. to GBT Technologies Inc. The Company derived revenues from (i) the provision of IT consulting services; and (ii) from the licensing of its technology. (ii) from selling electronic products through e-commerce platforms.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 18, 2022 the Company, effective March 1, 2022 entered into a Revenue Sharing Agreement (“RSA”) with Mahaser LTD. (“Mahaser”) pursuant to which the Company shares revenues generated by Mahaser with respect to e-commerce sales through the online retail platform in the United States of America.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The audited condensed CFS are prepared by the Company, pursuant to the rules and regulations of the SEC. The information furnished herein reflects all adjustments, consisting only of normal recurring adjustments, which in the opinion of management, are necessary to fairly state the Company’s financial position, the results of its operations, and cash flows for the periods presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>Basis of Presentation </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying CFS were prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Stock Split </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 26, 2021, the Company effectuated a <span id="xdx_90D_eus-gaap--StockholdersEquityReverseStockSplit_c20211025__20211026_zU57b20buvdj" title="Reverse stock split">1 for 50</span> reverse stock split. The share and per share information has been retroactively restated to reflect this reverse stock split.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In July 2, 2022 the Company filed a preliminary information statement to the stockholders of record (the “Record Date”) in connection with certain actions to be taken by the written consent by stockholders holding a majority of the voting stock of the Company, dated as of June 28, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To amend the Company’s Articles of Incorporation, (the “Articles of Incorporation”) to increase the number of authorized shares of common stock, par value $<span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231_zEXlQ9BpuQlk" title="Common stock, par value">0.00001</span> per share (the “Common Stock”), of the Company from 2,000,000,000 shares to <span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_iI_c20221231_z8wnkkEKgoHk" title="Common stock, authorized">10,000,000,000</span> shares. This action concluded on August 11, 2022:</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) authorize the Company’s Board of Directors to effect, in its sole discretion, a reverse stock split of the Common Stock in a ratio of up to <span id="xdx_900_eus-gaap--StockholdersEquityReverseStockSplit_c20220101__20221231" title="Reverse stock split">1-for-500</span> (the “Reverse Stock Split”), and (ii) authorize the filing of an amendment to the Company’s Articles of Incorporation to implement the Reverse Stock Split and any other action deemed necessary to effectuate the Reverse Stock Split, without further approval or authorization of stockholders, at any time prior to December 31, 2023. This action was not commenced by the Company’s board.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"/> 1 for 50 0.00001 10000000000 1-for-500 <p id="xdx_80F_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zZBRTu9ACfI3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 2 – <span id="xdx_82B_z1hql9UO37Ii">Going Concern</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying CFS have been prepared assuming the Company will continue as a going concern. The Company has an accumulated deficit of $<span id="xdx_90C_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20221231_zfliPMJUfuvl" title="Accumulated deficit">299,257,917</span> and has a working capital deficit of $<span id="xdx_90E_ecustom--WorkingCapitalDeficit_c20220101__20221231_pp0p0" title="Working capital deficit">18,552,046</span> as of December 31, 2022, which raises substantial doubt about its ability to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s ability to continue as a going concern is dependent upon its ability to generate profitable operations in the future and/or obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management has plans to seek additional capital through some private placement offerings of debt and equity securities. These plans, if successful, will mitigate the factors which raise substantial doubt about the Company’s ability to continue as a going concern. These CFS do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty.</p> -299257917 18552046 <p id="xdx_80F_eus-gaap--SignificantAccountingPoliciesTextBlock_zCxMTMIDxNR6" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_82C_zySro50ExKS9">Note 3 – <span id="xdx_826_z6buZQn3UUW1">Summary of Significant Accounting Policies</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_849_eus-gaap--UseOfEstimates_zrX0g7hjlssh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86A_zOLIekEZtuS7">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of CFS in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the CFS and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates in the accompanying CFS include valuation of derivatives and valuation allowance on deferred tax assets.</p> <p id="xdx_002_zrO0MIkTCCfi" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p id="xdx_84E_eus-gaap--ConsolidationPolicyTextBlock_zAsmDwrGjxI8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86F_zDxTdR2h7vLj"><span id="xdx_86D_zIoDp9i2J9A4">Principles of Consolidation</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying CFS include the accounts of the Company and its subsidiaries; the Company’s 50% owned subsidiaries GBT BitSpeed Corp. (currently inactive) and GBT Tokenize Corp; the Company’s 50% owned subsidiary, Gopher Protocol Costa Rica Sociedad De Responsabilidad Limitada (currently inactive), a wholly owned subsidiary, AltCorp Trading LLC, a Costa Rica company (“AltCorp” currently inactive) and Greenwich International Holdings, a Costa Rica corporation (“Greenwich” currently inactive). All significant intercompany transactions and balances were eliminated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For entities determined to be VIEs, an evaluation is required to determine whether the Company is the primary beneficiary. The Company evaluates its economic interests in the entity specifically determining if the Company has both the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance (“the power”) and the obligation to absorb losses or the right to receive benefits that could potentially be significant to the VIE (“the benefits”). When making the determination whether the benefits received from an entity are significant, the Company considers the total economics of the entity, and analyzes whether the Company’s share of the economics is significant. The Company utilizes qualitative factors, and, where applicable, quantitative factors, while performing the analysis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, the Company’s variable interests in Mahaser obligate the Company to absorb deficits and provide it with the right to receive benefits that could potentially be significant to Mahaser. As a result of this analysis, the Company concluded it is the primary beneficiary of Mahaser and therefore consolidates the balance sheets, results of operations and cash flows of Mahaser. The Company performs a qualitative assessment of Mahaser on an ongoing basis to determine if it continues to be the primary beneficiary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_844_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zKGvLUDp39ie" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_868_z4YQy1tMlvu3">Cash Equivalents</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the purpose of the statement of cash flows, cash equivalents include time deposits, certificate of deposits, and all highly-liquid debt instruments with original maturities of three months or less. As of December 31, 2022 and 2021, the Company did <span id="xdx_90D_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20221231_zeWQrGvilklh" title="Cash equivalents"><span id="xdx_90A_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20211231_zlHqnmLDpWN8" title="Cash equivalents">no</span></span>t have any cash equivalents.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84E_ecustom--FundsInEscrowPolicyTextBlock_zAGwFVfYi9K7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_864_zjeYzC1vz9B7">Funds in Escrow</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Restricted cash is $<span id="xdx_906_eus-gaap--RestrictedCashEquivalents_c20221231_pp0p0" title="Restricted cash">375,000</span> as part of the SURG settlements proceeds that needs to stay in escrow and $<span id="xdx_903_eus-gaap--EscrowDeposit_c20220128_pp0p0" title="Escrow amount">19,694</span> restricted cash that the court on January 28, 2022 awarded the Company with injunction against RWJ defendants, where all funds generating from resale should be deposited into GBT blocked account, and therefore RWJ defendants cannot use these funds without court order, neither the Company. According to settlement agreement made on September 26, 2022, these funds held in escrow and no longer restricted. The Company entered into the Confidential Settlement Agreement and Mutual Release (“RJW Agreement”) by and between RWJ Advanced Marketing, LLC, Robert Warren Jackson, Gregory Bauer (collectively the “RJW Parties”) and W.L. Petrey Wholesale Company, Inc., (“Petrey”) on one hand; and GBT Technologies Inc., on behalf of itself and its agents (collectively the GBT Parties”), on the other hand. The Company the RJW Agreement effective September 26, 2022 with final signatures delivered to the Company on or about October 5, 2022. Among other agreements the parties agreed and stipulated to release all funds currently being held in a blocked account of $<span id="xdx_903_eus-gaap--EscrowDeposit_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RWJPartiesMember_pp0p0" title="Escrow amount">19,694</span> with 50% distributed to the RWJ Parties and 50% to the Company or its assignee.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_847_eus-gaap--MarketableSecuritiesPolicy_zp0zJtwwrroa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_860_zU2GUcJypKD9">Marketable Securities</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for investment securities in accordance with ASC Topic 321, <i>Investments – equity securities. </i>Marketable equity securities are reported at FV based on quotations available on securities exchanges with any unrealized gain or loss being reported as a component of other income (expense) on the statement of operations. The portion of marketable equity security expected to be sold within 12 months of the balance sheet date is reported as a current asset. These publicly traded equity securities are valued using quoted prices and are included in Level 1.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_848_eus-gaap--InventoryPolicyTextBlock_zp1dv8St0pE8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86E_zuxv3A17lwNe">Inventory</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventory consists of electronic product ready for sale on Amazon.com. It is stated at the lower of cost or net realizable value and all inventories were returned product from online customers. We value our inventory using the weighted average costing method. Our Company’s policy is to include as a part of inventory any freight incurred to ship the product from our contract vendors to our warehouses. Outbound freight costs to our customers are considered period costs and reflected in selling, general and administrative expenses. We regularly review inventory and consider forecasts of future demand, market conditions and product obsolescence.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_845_ecustom--NoteReceivablePaidOffPolicyTextBlock_zRjzGkMytuId" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_866_zkoIIfHWW4F4">Note Receivable Paid-Off</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 18, 2020, the Company entered into a Purchase and Sale Agreement with Mr. LightHouse LTD<b>.</b>, an Israeli corporation (“MLH”) pursuant to which the Company agreed to sell and assign to MLH, effective July 1, 2020 all the shares, and certain specified liabilities, of Ugopherservices Corp. (“UGO”), a wholly owned subsidiary of the Company for $<span id="xdx_904_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20200901__20200918__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrLightHouseLTDMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAndSaleAgreementMember_pp0p0" title="Consideartion from sale of common stock">100,000</span> to be paid through the delivery of a promissory note payable to the Company (the “Note”), upon the terms and subject to the limitations and conditions set forth in the Note. At December 31, 2020, the Company determined this note was not collectible and took an impairment charge of $<span id="xdx_90E_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_c20220101__20221231_pp0p0" title="Impairment of long-lived assets">100,000</span>. During July 2021, MLH effected a $<span id="xdx_907_ecustom--StockholdersEquitys_c20210731_pp0p0" title="Stockholders equity">50,000</span> payment on the Note. During April 2022, MLH effected a second payment for additional $<span id="xdx_900_ecustom--StockholdersEquitys_c20220430_pp0p0" title="Stockholders equity">50,000</span> on the Note exhausting the Note balance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84A_eus-gaap--DerivativesReportingOfDerivativeActivity_zabBPEYeQti8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_860_z76iOlCldVob">Derivative Financial Instruments</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates all of its agreements to determine if such instruments have derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its FV and is then re-valued at each reporting date, with changes in the FV reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a weighted-average Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. As of December 31, 2022 and 2021, the Company’s only derivative financial instrument was an embedded conversion feature associated with convertible notes payable due to certain provisions that allow for a change in the conversion price based on a percentage of the Company’s stock price at the date of conversion.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_849_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zckgtK5PRNia" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_864_znlkWpCu1JVg">Fair Value of Financial Instruments</span> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For certain of the Company’s financial instruments, including cash, accounts payable, accrued liabilities and short-term debt, the carrying amounts approximate their FV due to their short maturities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FASB ASC Topic 820, <i>Fair Value Measurements and Disclosures</i>, requires disclosure of the FV of financial instruments held by the Company. FASB ASC Topic 825, <i>Financial Instruments</i>, defines FV, and establishes a three-level valuation hierarchy for disclosures of FV measurement that enhances disclosure requirements for FV measures. The carrying amounts reported in the consolidated balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their FV because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets. </span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. </span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 inputs to the valuation methodology use one or more unobservable inputs which are significant to the FV measurement. </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic 480, <i>Distinguishing Liabilities from Equity</i>, and FASB ASC Topic 815, <i>Derivatives and Hedging</i>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For certain financial instruments, the carrying amounts reported in the balance sheets for cash and current liabilities, including convertible notes payable, each qualify as a financial instrument, and are a reasonable estimate of their FV because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company uses Level 2 inputs for its valuation methodology for derivative liabilities as their FV were determined by using the Black-Scholes-Merton pricing model based on various assumptions. The Company’s derivative liabilities are adjusted to reflect FV at each period end, with any increase or decrease in the FV being recorded in results of operations as adjustments to FV of derivatives.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At December 31, 2022 and 2021, the Company identified the following liabilities that are required to be presented on the balance sheet at FV:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zRR2MgaTfXJg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: left; text-indent: -10pt"><span id="xdx_8BC_zY7R2PhdB0W4" style="display: none">Schedule of fair value, assets and liabilities measured on recurring basis</span></td> <td> </td> <td colspan="3" style="text-align: center"> </td> <td> </td> <td colspan="11" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="11" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value Measurements at</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of</span></td> <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="11" style="font-size: 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Using Fair Value Hierarchy</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 1pt 10pt; font-size: 11pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="padding-bottom: 1pt; font-size: 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion feature on convertible<br/> notes</span></td> <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> $</span></td> <td id="xdx_989_ecustom--ConversionFeatureOnConvertibleNotes_c20221231_pp0p0" style="font-size: 11pt; text-align: right" title="Conversion feature on convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/>1,714,143</span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="text-align: left; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> $</span></td> <td id="xdx_986_ecustom--ConversionFeatureOnConvertibleNotes_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="text-align: right; font-size: 11pt" title="Conversion feature on convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> <span style="-sec-ix-hidden: xdx2ixbrl0778">—</span></span></td> <td style="text-align: left; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="text-align: left; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> $</span></td> <td id="xdx_987_ecustom--ConversionFeatureOnConvertibleNotes_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="font-size: 11pt; text-align: right" title="Conversion feature on convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/>1,714,143</span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="text-align: left; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> $</span></td> <td id="xdx_980_ecustom--ConversionFeatureOnConvertibleNotes_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="font-size: 11pt; text-align: right" title="Conversion feature on convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> <span style="-sec-ix-hidden: xdx2ixbrl0782">—</span></span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="11" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value Measurements at</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of</span></td> <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="11" style="font-size: 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Using Fair Value Hierarchy</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 1pt 10pt; font-size: 11pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="padding-bottom: 1pt; font-size: 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion feature on convertible<br/> notes</span></td> <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> $</span></td> <td id="xdx_98A_ecustom--ConversionFeatureOnConvertibleNotes_c20211231_pp0p0" style="font-size: 11pt; text-align: right" title="Conversion feature on convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/>10,192,485</span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="text-align: left; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> $</span></td> <td id="xdx_985_ecustom--ConversionFeatureOnConvertibleNotes_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="text-align: right; font-size: 11pt" title="Conversion feature on convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> <span style="-sec-ix-hidden: xdx2ixbrl0786">—</span></span></td> <td style="text-align: left; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="text-align: left; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> $</span></td> <td id="xdx_986_ecustom--ConversionFeatureOnConvertibleNotes_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="font-size: 11pt; text-align: right" title="Conversion feature on convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,192,485</span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="text-align: left; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> $</span></td> <td id="xdx_987_ecustom--ConversionFeatureOnConvertibleNotes_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="font-size: 11pt; text-align: right" title="Conversion feature on convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> <span style="-sec-ix-hidden: xdx2ixbrl0790">—</span></span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td></tr> </table> <p id="xdx_8A9_z9RZ3PaiTN39" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p id="xdx_84A_ecustom--TreasuryStockPolicyTextBlock_z53vgKzKHWEd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86B_z82Uz9tapew4">Treasury Stock</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Treasury stock is recorded at cost. The re-issuance of treasury shares is accounted for on a first in, first-out basis and any difference between the cost of treasury shares and the re-issuance proceeds are charged or credited to additional paid-in capital.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84F_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zE87gqsoYFae" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_867_zSoQAtXgqjvk">Reclassification</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_849_eus-gaap--RevenueRecognitionPolicyTextBlock_zuJ6Tnc8Pdqc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_867_zQgEAROhFs5d">Revenue Recognition</span> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounting Standards Update (“ASU”) No. 2014-09, <i>Revenue from Contracts with Customers </i>(“<i>Topic 606</i>”), became effective for the Company on January 1, 2018. The Company’s revenue recognition disclosure reflects its updated accounting policies that are affected by this new standard. The Company applied the “modified retrospective” transition method for open contracts for the implementation of <i>Topic 606.</i> The Company had no significant post-delivery obligations, this new standard did not<i> </i>result in a material recognition of revenue on the Company’s accompanying CFS for the cumulative impact of applying this new standard. The Company made no adjustments to its previously-reported total revenues, as those periods continue to be presented in accordance with its historical accounting practices under <i>Topic 605, Revenue Recognition</i>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue from providing IT consulting services are recognized under <i>Topic 606</i> in a manner that reasonably reflects the delivery of its services to customers in return for expected consideration and includes the following elements:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">executed contracts with the Company’s customers that it believes are legally enforceable;</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identification of performance obligations in the respective contract;</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determination of the transaction price for each performance obligation in the respective contract;</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">allocation the transaction price to each performance obligation; and</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recognition of revenue only when the Company satisfies each performance obligation.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">These five elements, as applied to each of the Company’s IT revenue category, is summarized below:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IT consulting services - revenue is recorded on a monthly basis as services are provided.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These five elements, as applied to each of the Company’s license revenue category, is summarize below:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">License services – the one-time related party licensing income recorded as other income upon agreement is executed and services are provided and recognized over the term of five years.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>E-Commerce sales</i> –</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identify the contract(s) with a customer. ASC 606 defines a contract as “an agreement between two or more parties that creates enforceable rights and obligations”. Since this is an e-commerce sale on the Amazon of eBay websites, the Company just followed the general terms on Amazon or eBay websites and the customer entered into a contract with the Company based on the product listed on the Amazon or eBay websites;</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identify the performance obligations in the contract. According to the contract, the Company is responsible for operation exclusively. The Company is entitled to all revenue which is being paid by Amazon or eBay into a designated bank account and the Company is responsible fo</span>r all product acquisitions as well as shipments. The only performance obligations were the electronic products that were listed on Amazon or eBay websites and the Company determined each order is one single obligation;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">Determine the transaction price. The transaction price set to be the listed price on the Amazon or eBay websites.;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">Allocation the transaction price to the performance obligations in the contract.; and</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">Recognize revenue when the Company satisfies a performance obligation. Sales are being recognized upon shipment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"> </p> <p id="xdx_846_ecustom--UnearnedRevenuePoliciesTextBlock_zVIT8uLn0Vl9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86E_z3PnxcPymEH3">Unearned revenue</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Unearned revenue represents the net amount received for the purchase of products that have not seen shipped to the Company’s customers. The Company has $<span id="xdx_905_eus-gaap--DeferredRevenue_c20221231_pp0p0" title="Unearned revenue">48,921</span> and $<span id="xdx_904_eus-gaap--DeferredRevenue_c20211231_pp0p0" title="Unearned revenue">249,384</span> of unearned revenue at December 31, 2022 and 2021, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_846_ecustom--ContractLiabilitiesPolicyTextBlock_zUdGNHffj9ni" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86B_zGu0likrv9hh">Contract liabilities</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 22, 2022, the Company entered into an Intellectual Property License and Royalty Agreement with<b> </b>Touchpoint Group Holdings, Inc. (“Touchpoint” or “TGHI”) pursuant to which the Company granted TGHI a worldwide license for its technologies for five years in the domains of Internet of Things (IoT) and Artificial Intelligence enabled mobile technologies pertaining to the Company’s digital currency technology (the “Technology”). GBT will charge TGHI royalties based on actual uses by TGHI of the Technology resulting from revenue attributable to the use, performance or other exploitation of the Technology, to the extent applicable, after deducting any taxes that the Company may be required to collect, and deducting any international sales, goods and services, value added taxes or similar taxes which the Company is required to pay, if any, excluding deductions for taxes on the Company net income. TGHI agreed to issue the Company <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220201__20220222__dei--LegalEntityAxis__custom--TouchPointGroupHoldingMember_pdd" title="Number of shares issued">10,000,000</span> shares of common stock of TGHI in the FV of $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20220201__20220222__dei--LegalEntityAxis__custom--TouchPointGroupHoldingMember_pp0p0" title="Fair value">50,000</span> as a onetime fee for the Company entering this Intellectual Property License and Royalty Agreement, which was booked contract liabilities and amortized over the <span id="xdx_907_eus-gaap--DebtInstrumentTerm_dtY_c20220201__20220222__dei--LegalEntityAxis__custom--TouchPointGroupHoldingMember_zvYHs19Zl808" style="display: none" title="Term">5</span> five-year term. The Company has yet to earn any royalty income in relation to this agreement as of December 31, 2022. The contract liabilities as of December 31, 2022 and December 31, 2021 was $<span id="xdx_909_eus-gaap--ContractWithCustomerLiabilityCurrent_c20221231_pp0p0" title="Contract liabilities">41,444</span> and $<span id="xdx_90A_eus-gaap--ContractWithCustomerLiabilityCurrent_c20211231_pp0p0" title="Contract liabilities">0</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84D_ecustom--VariableInterestEntityPolicyTextBlock_zs6tgv37q9eg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><i><span id="xdx_86A_zBEyHQL9vE8j">Variable Interest Entity</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On February 18, 2022, the Company, effective March 1, 2022 entered into a Revenue Sharing Agreement (“RSA”) with Mahaser LTD. (“Mahaser”) pursuant to which the Company shares in revenues generated by Mahaser e-commerce sales through the online retail platform in the United States of America. Mahaser owns an e-commerce platform as a store which is the legal, exclusive owner of Ravenholm Electronics. The Company will operate the e-commerce platform and entitled to 95% for all revenue generated by and received by Mahaser from March 1, 2022 through December 31, 2022. The RSA provides that the Company will be entitled to appoint a manager to Mahaser. As consideration, the Company will pay Mahaser $<span id="xdx_90D_ecustom--ConsiderationPaid_c20220101__20221231__srt--CounterpartyNameAxis__custom--MahaserMember_pp0p0" title="Consideration paid">100,000</span> no later than March 1, 2022 and issue Mahaser <span id="xdx_900_ecustom--ConsiderationShares_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_pdd" title="Consideration shares">1,000,000</span> shares of the Company’s restricted common stock. The Company shall have no obligations to make any further payments to Mahaser. For any further extensions, the Company will have the option to extend the RSA for annual payment of $<span id="xdx_904_eus-gaap--DebtInstrumentAnnualPrincipalPayment_c20220302_pp0p0" title="Annual payment">200,000</span>, which can be payable with the Company’s shares of common stock payable based on 20 days VWAP prior to issuance. On March 16, 2022 the parties entered into Amendment No. 1 to the to the RSA, where all consideration to be paid or issued to Mahaser will be deferred until such time where the e-commerce platform generated in cumulative revenue of $1,000,000. On March 31, 2022, the parties entered into Amendment No. 2 to the RSA, where Mahaser agreed to pay the Company 100% per year for all revenue generated by and received by seller from the sales by Amazon within the United States of America as follows from March 1, 2022 through December 31, 2022. The Company will be responsible for 100% of the cost of goods sold as well. In addition, the Company is entitled to earn 100% revenues and cost of goods sold of the period from February 1, 2022 to February 28, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company evaluated whether it has a variable interest in Mahaser, whether Mahaser is a VIE and whether the Company has a controlling financial interest in Mahaser. The Company concluded that it has variable interests in Mahaser on the basis of GBT has 100% control over the JV/revenue sharing, and as such should consolidate the JV into its books and records as it assigned 100% financial responsibility. Mahaser’s equity at risk, as defined by GAAP, is considered to be insufficient to finance its activities without additional support, and, therefore, Mahaser is considered a VIE.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The following table summarizes the carrying amount of the assets and liabilities of Mahaser included in the Company’s consolidated balance sheets at December 31, 2022 (after elimination of intercompany transactions and balances):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"/> <table cellpadding="0" cellspacing="0" id="xdx_89F_esrt--ScheduleOfCondensedFinancialStatementsTableTextBlock_zGpkfdPDh832" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 30pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B2_zXOOrPiXRve9" style="display: none">Condensed financial statements</span></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_496_20221231" style="font-size: 10pt; text-align: center"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets of consolidated variable interest entity (“VIE”) included in the consolidated balance sheets above (after elimination of intercompany transactions and balances) consist of:</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--AssetsCurrentAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 30pt; width: 70%; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and equivalents</span></td><td style="width: 10%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 18%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93,581</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--InventoryNet_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 30pt; font-size: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,569</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_ecustom--DueFromRelatedPartiesCurrents_iI_pp0p0_zJeVmzJn2NBe" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 30pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due From related party</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,270</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--OtherAssetsCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 40pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total current assets</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">125,420</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities of consolidated VIE included in the consolidated balance sheets above (after elimination of intercompany transactions and balances) consist of:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--LiabilitiesCurrentAbstract_iB" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--OtherLiabilitiesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 40pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total current liabilities</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">94,496</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements of operations of consolidated VIE included in the consolidated statements of operations above (after elimination of intercompany transactions and balances) consist of:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements of operations</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 30pt; font-size: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Sales</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20221231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember_pp0p0" style="font-size: 10pt; text-align: right" title="Sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,107,555</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 30pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Cost of goods sold</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--CostOfGoodsAndServicesSold_c20220101__20221231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember_pp0p0" style="font-size: 10pt; text-align: right" title="Cost of goods sold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">817,754</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 30pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Gross profit</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--GrossProfit_c20220101__20221231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember_pp0p0" style="font-size: 10pt; text-align: right" title="Gross profit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">289,801</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 30pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> General and administrative expenses</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--GeneralAndAdministrativeExpense_c20220101__20221231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="General and administrative expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">330,647</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Loss</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--NetIncomeLoss_c20220101__20221231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember_pp0p0" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,846</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AF_zzqn5RN1LoXh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zedV5afJYhQ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_862_zmFm70v7Hbel">Income Taxes</span> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for income taxes in accordance with ASC Topic 740, <i>Income Taxes</i>. ASC 740 requires a company to use the asset and liability method of accounting for income taxes, whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion, or all of, the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The Company has no material uncertain tax positions for any of the reporting periods presented and its current on all its tax filings federal and state until 2021 inclusive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zMV5FqWw2DX1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86B_ztbTx44auKTb">Basic and Diluted Earnings Per Share</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Earnings per share is calculated in accordance with ASC Topic 260, <i>Earnings Per Share</i>. Basic earnings per share (“EPS”) is based on the weighted average number of common shares outstanding. Diluted EPS assumes that all dilutive securities are converted. Dilution is computed by applying the treasury stock method. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. Due to the net income incurred potentially dilutive instruments would be anti-dilutive. Accordingly, diluted loss per share is the same as basic loss for all periods presented. The following potentially-dilutive shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would be anti-dilutive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zt1YeMx7FkW9" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BC_zhzs7l9qSvn5" style="display: none">Schedule of anti dilutive securities excluded from computation of earnings per share</span></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series B preferred stock</span></td><td style="width: 8%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--PreferredStockDividendsShares_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_pdd" style="width: 12%; font-size: 10pt; text-align: right" title="Preferred shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45,000</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--PreferredStockDividendsShares_c20210101__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_pdd" style="width: 12%; font-size: 10pt; text-align: right" title="Preferred shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45,000</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series C preferred stock</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--PreferredStockDividendsShares_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_pdd" style="font-size: 10pt; text-align: right" title="Preferred shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">700</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--PreferredStockDividendsShares_c20210101__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_pdd" style="font-size: 10pt; text-align: right" title="Preferred shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">700</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series H preferred stock</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--PreferredStockDividendsShares_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_pdd" style="font-size: 10pt; text-align: right" title="Preferred shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--PreferredStockDividendsShares_c20210101__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_pdd" style="font-size: 10pt; text-align: right" title="Preferred shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zM5MV5iAKVB4" style="font-size: 10pt; text-align: right" title="Number of potentially dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,770</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_pdd" style="font-size: 10pt; text-align: right" title="Number of potentially dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">392,870</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible notes</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ConversionOfStockSharesIssued1_c20220101__20221231_pdd" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Convertible note"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,949,223,831</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ConversionOfStockSharesIssued1_c20210101__20211231_zFtscU84uYAa" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Convertible note"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,722,340</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_pdd" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of potentially dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,949,360,301</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_zw8esP8VWus4" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of potentially dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84,180,910</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A8_zfyazfaJRwZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><i/></p> <p id="xdx_844_eus-gaap--SubsequentEventsPolicyPolicyTextBlock_zIl77xENJ1Vb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><i><span id="xdx_862_zNU08V6srlkk">Management’s Evaluation of Subsequent Events</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company evaluates events that have occurred after the balance sheet date of December 31, 2022, through the date which the CFS are issued. Based upon the review, other than described in Note 20 – Subsequent Events, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the CFS.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zeYgE36GDtEj" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_860_zj8AW6FZN6P2">Recent Accounting Pronouncements</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In August 2020, the FASB issued ASU 2020-06<b>, </b><i>Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity.</i> ASU 2020-06 reduces the number of accounting models for convertible debt instruments and convertible preferred stock. For convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, <i>Derivatives and Hedging</i>, or that do not result in substantial premiums accounted for as paid-in capital, the embedded conversion features no longer are separated from the host contract. ASU 2020-06 also removes certain conditions that should be considered in the derivatives scope exception evaluation under Subtopic 815-40, <i>Derivatives and Hedging—Contracts in Entity’s Own Equity</i>, and clarify the scope and certain requirements under Subtopic 815-40. In addition, ASU 2020-06 improves the guidance related to the disclosures and earnings-per-share (EPS) for convertible instruments and contract in entity’s own equity. ASU 2020-06 is effective for public business entities that meet the definition of a SEC filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Board specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. The Company adopted this ASU on the CFS in the year ended December 31, 2021. The adoption had no material impact on the CFS for the year ended December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 2021, the FASB issued ASU 2021-04, “<i><span style="text-decoration: underline">Earnings Per Share (Topic 260), Debt— Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options” </span></i>(“<span style="text-decoration: underline">ASU 2021-04</span>”) to clarify the accounting by issuers for modifications or exchanges of equity-classified warrants. The new ASU is available here and effective for all entities in fiscal years starting after December 15, 2021. Early adoption is permitted. The Company adopted this ASU on the CFS in the year ended December 31, 2021. The adoption had no material impact on the CFS for the year ended December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying CFS. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_849_eus-gaap--UseOfEstimates_zrX0g7hjlssh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86A_zOLIekEZtuS7">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of CFS in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the CFS and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates in the accompanying CFS include valuation of derivatives and valuation allowance on deferred tax assets.</p> <p id="xdx_002_zrO0MIkTCCfi" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p id="xdx_84E_eus-gaap--ConsolidationPolicyTextBlock_zAsmDwrGjxI8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86F_zDxTdR2h7vLj"><span id="xdx_86D_zIoDp9i2J9A4">Principles of Consolidation</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying CFS include the accounts of the Company and its subsidiaries; the Company’s 50% owned subsidiaries GBT BitSpeed Corp. (currently inactive) and GBT Tokenize Corp; the Company’s 50% owned subsidiary, Gopher Protocol Costa Rica Sociedad De Responsabilidad Limitada (currently inactive), a wholly owned subsidiary, AltCorp Trading LLC, a Costa Rica company (“AltCorp” currently inactive) and Greenwich International Holdings, a Costa Rica corporation (“Greenwich” currently inactive). All significant intercompany transactions and balances were eliminated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For entities determined to be VIEs, an evaluation is required to determine whether the Company is the primary beneficiary. The Company evaluates its economic interests in the entity specifically determining if the Company has both the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance (“the power”) and the obligation to absorb losses or the right to receive benefits that could potentially be significant to the VIE (“the benefits”). When making the determination whether the benefits received from an entity are significant, the Company considers the total economics of the entity, and analyzes whether the Company’s share of the economics is significant. The Company utilizes qualitative factors, and, where applicable, quantitative factors, while performing the analysis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, the Company’s variable interests in Mahaser obligate the Company to absorb deficits and provide it with the right to receive benefits that could potentially be significant to Mahaser. As a result of this analysis, the Company concluded it is the primary beneficiary of Mahaser and therefore consolidates the balance sheets, results of operations and cash flows of Mahaser. The Company performs a qualitative assessment of Mahaser on an ongoing basis to determine if it continues to be the primary beneficiary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_844_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zKGvLUDp39ie" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_868_z4YQy1tMlvu3">Cash Equivalents</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the purpose of the statement of cash flows, cash equivalents include time deposits, certificate of deposits, and all highly-liquid debt instruments with original maturities of three months or less. As of December 31, 2022 and 2021, the Company did <span id="xdx_90D_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20221231_zeWQrGvilklh" title="Cash equivalents"><span id="xdx_90A_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_do_c20211231_zlHqnmLDpWN8" title="Cash equivalents">no</span></span>t have any cash equivalents.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 0 0 <p id="xdx_84E_ecustom--FundsInEscrowPolicyTextBlock_zAGwFVfYi9K7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_864_zjeYzC1vz9B7">Funds in Escrow</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Restricted cash is $<span id="xdx_906_eus-gaap--RestrictedCashEquivalents_c20221231_pp0p0" title="Restricted cash">375,000</span> as part of the SURG settlements proceeds that needs to stay in escrow and $<span id="xdx_903_eus-gaap--EscrowDeposit_c20220128_pp0p0" title="Escrow amount">19,694</span> restricted cash that the court on January 28, 2022 awarded the Company with injunction against RWJ defendants, where all funds generating from resale should be deposited into GBT blocked account, and therefore RWJ defendants cannot use these funds without court order, neither the Company. According to settlement agreement made on September 26, 2022, these funds held in escrow and no longer restricted. The Company entered into the Confidential Settlement Agreement and Mutual Release (“RJW Agreement”) by and between RWJ Advanced Marketing, LLC, Robert Warren Jackson, Gregory Bauer (collectively the “RJW Parties”) and W.L. Petrey Wholesale Company, Inc., (“Petrey”) on one hand; and GBT Technologies Inc., on behalf of itself and its agents (collectively the GBT Parties”), on the other hand. The Company the RJW Agreement effective September 26, 2022 with final signatures delivered to the Company on or about October 5, 2022. Among other agreements the parties agreed and stipulated to release all funds currently being held in a blocked account of $<span id="xdx_903_eus-gaap--EscrowDeposit_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RWJPartiesMember_pp0p0" title="Escrow amount">19,694</span> with 50% distributed to the RWJ Parties and 50% to the Company or its assignee.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 375000 19694 19694 <p id="xdx_847_eus-gaap--MarketableSecuritiesPolicy_zp0zJtwwrroa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_860_zU2GUcJypKD9">Marketable Securities</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for investment securities in accordance with ASC Topic 321, <i>Investments – equity securities. </i>Marketable equity securities are reported at FV based on quotations available on securities exchanges with any unrealized gain or loss being reported as a component of other income (expense) on the statement of operations. The portion of marketable equity security expected to be sold within 12 months of the balance sheet date is reported as a current asset. These publicly traded equity securities are valued using quoted prices and are included in Level 1.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_848_eus-gaap--InventoryPolicyTextBlock_zp1dv8St0pE8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86E_zuxv3A17lwNe">Inventory</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventory consists of electronic product ready for sale on Amazon.com. It is stated at the lower of cost or net realizable value and all inventories were returned product from online customers. We value our inventory using the weighted average costing method. Our Company’s policy is to include as a part of inventory any freight incurred to ship the product from our contract vendors to our warehouses. Outbound freight costs to our customers are considered period costs and reflected in selling, general and administrative expenses. We regularly review inventory and consider forecasts of future demand, market conditions and product obsolescence.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_845_ecustom--NoteReceivablePaidOffPolicyTextBlock_zRjzGkMytuId" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_866_zkoIIfHWW4F4">Note Receivable Paid-Off</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 18, 2020, the Company entered into a Purchase and Sale Agreement with Mr. LightHouse LTD<b>.</b>, an Israeli corporation (“MLH”) pursuant to which the Company agreed to sell and assign to MLH, effective July 1, 2020 all the shares, and certain specified liabilities, of Ugopherservices Corp. (“UGO”), a wholly owned subsidiary of the Company for $<span id="xdx_904_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20200901__20200918__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrLightHouseLTDMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAndSaleAgreementMember_pp0p0" title="Consideartion from sale of common stock">100,000</span> to be paid through the delivery of a promissory note payable to the Company (the “Note”), upon the terms and subject to the limitations and conditions set forth in the Note. At December 31, 2020, the Company determined this note was not collectible and took an impairment charge of $<span id="xdx_90E_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_c20220101__20221231_pp0p0" title="Impairment of long-lived assets">100,000</span>. During July 2021, MLH effected a $<span id="xdx_907_ecustom--StockholdersEquitys_c20210731_pp0p0" title="Stockholders equity">50,000</span> payment on the Note. During April 2022, MLH effected a second payment for additional $<span id="xdx_900_ecustom--StockholdersEquitys_c20220430_pp0p0" title="Stockholders equity">50,000</span> on the Note exhausting the Note balance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 100000 100000 50000 50000 <p id="xdx_84A_eus-gaap--DerivativesReportingOfDerivativeActivity_zabBPEYeQti8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_860_z76iOlCldVob">Derivative Financial Instruments</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates all of its agreements to determine if such instruments have derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its FV and is then re-valued at each reporting date, with changes in the FV reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a weighted-average Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. As of December 31, 2022 and 2021, the Company’s only derivative financial instrument was an embedded conversion feature associated with convertible notes payable due to certain provisions that allow for a change in the conversion price based on a percentage of the Company’s stock price at the date of conversion.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_849_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zckgtK5PRNia" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_864_znlkWpCu1JVg">Fair Value of Financial Instruments</span> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For certain of the Company’s financial instruments, including cash, accounts payable, accrued liabilities and short-term debt, the carrying amounts approximate their FV due to their short maturities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FASB ASC Topic 820, <i>Fair Value Measurements and Disclosures</i>, requires disclosure of the FV of financial instruments held by the Company. FASB ASC Topic 825, <i>Financial Instruments</i>, defines FV, and establishes a three-level valuation hierarchy for disclosures of FV measurement that enhances disclosure requirements for FV measures. The carrying amounts reported in the consolidated balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their FV because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets. </span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in inactive markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. </span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 inputs to the valuation methodology use one or more unobservable inputs which are significant to the FV measurement. </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic 480, <i>Distinguishing Liabilities from Equity</i>, and FASB ASC Topic 815, <i>Derivatives and Hedging</i>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For certain financial instruments, the carrying amounts reported in the balance sheets for cash and current liabilities, including convertible notes payable, each qualify as a financial instrument, and are a reasonable estimate of their FV because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company uses Level 2 inputs for its valuation methodology for derivative liabilities as their FV were determined by using the Black-Scholes-Merton pricing model based on various assumptions. The Company’s derivative liabilities are adjusted to reflect FV at each period end, with any increase or decrease in the FV being recorded in results of operations as adjustments to FV of derivatives.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At December 31, 2022 and 2021, the Company identified the following liabilities that are required to be presented on the balance sheet at FV:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zRR2MgaTfXJg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: left; text-indent: -10pt"><span id="xdx_8BC_zY7R2PhdB0W4" style="display: none">Schedule of fair value, assets and liabilities measured on recurring basis</span></td> <td> </td> <td colspan="3" style="text-align: center"> </td> <td> </td> <td colspan="11" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="11" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value Measurements at</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of</span></td> <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="11" style="font-size: 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Using Fair Value Hierarchy</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 1pt 10pt; font-size: 11pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="padding-bottom: 1pt; font-size: 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion feature on convertible<br/> notes</span></td> <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> $</span></td> <td id="xdx_989_ecustom--ConversionFeatureOnConvertibleNotes_c20221231_pp0p0" style="font-size: 11pt; text-align: right" title="Conversion feature on convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/>1,714,143</span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="text-align: left; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> $</span></td> <td id="xdx_986_ecustom--ConversionFeatureOnConvertibleNotes_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="text-align: right; font-size: 11pt" title="Conversion feature on convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> <span style="-sec-ix-hidden: xdx2ixbrl0778">—</span></span></td> <td style="text-align: left; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="text-align: left; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> $</span></td> <td id="xdx_987_ecustom--ConversionFeatureOnConvertibleNotes_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="font-size: 11pt; text-align: right" title="Conversion feature on convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/>1,714,143</span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="text-align: left; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> $</span></td> <td id="xdx_980_ecustom--ConversionFeatureOnConvertibleNotes_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="font-size: 11pt; text-align: right" title="Conversion feature on convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> <span style="-sec-ix-hidden: xdx2ixbrl0782">—</span></span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="11" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value Measurements at</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of</span></td> <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="11" style="font-size: 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Using Fair Value Hierarchy</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 1pt 10pt; font-size: 11pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="padding-bottom: 1pt; font-size: 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion feature on convertible<br/> notes</span></td> <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> $</span></td> <td id="xdx_98A_ecustom--ConversionFeatureOnConvertibleNotes_c20211231_pp0p0" style="font-size: 11pt; text-align: right" title="Conversion feature on convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/>10,192,485</span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="text-align: left; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> $</span></td> <td id="xdx_985_ecustom--ConversionFeatureOnConvertibleNotes_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="text-align: right; font-size: 11pt" title="Conversion feature on convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> <span style="-sec-ix-hidden: xdx2ixbrl0786">—</span></span></td> <td style="text-align: left; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="text-align: left; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> $</span></td> <td id="xdx_986_ecustom--ConversionFeatureOnConvertibleNotes_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="font-size: 11pt; text-align: right" title="Conversion feature on convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,192,485</span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="text-align: left; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> $</span></td> <td id="xdx_987_ecustom--ConversionFeatureOnConvertibleNotes_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="font-size: 11pt; text-align: right" title="Conversion feature on convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> <span style="-sec-ix-hidden: xdx2ixbrl0790">—</span></span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td></tr> </table> <p id="xdx_8A9_z9RZ3PaiTN39" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zRR2MgaTfXJg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: left; text-indent: -10pt"><span id="xdx_8BC_zY7R2PhdB0W4" style="display: none">Schedule of fair value, assets and liabilities measured on recurring basis</span></td> <td> </td> <td colspan="3" style="text-align: center"> </td> <td> </td> <td colspan="11" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="11" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value Measurements at</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of</span></td> <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="11" style="font-size: 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Using Fair Value Hierarchy</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 1pt 10pt; font-size: 11pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="padding-bottom: 1pt; font-size: 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion feature on convertible<br/> notes</span></td> <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> $</span></td> <td id="xdx_989_ecustom--ConversionFeatureOnConvertibleNotes_c20221231_pp0p0" style="font-size: 11pt; text-align: right" title="Conversion feature on convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/>1,714,143</span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="text-align: left; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> $</span></td> <td id="xdx_986_ecustom--ConversionFeatureOnConvertibleNotes_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="text-align: right; font-size: 11pt" title="Conversion feature on convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> <span style="-sec-ix-hidden: xdx2ixbrl0778">—</span></span></td> <td style="text-align: left; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="text-align: left; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> $</span></td> <td id="xdx_987_ecustom--ConversionFeatureOnConvertibleNotes_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="font-size: 11pt; text-align: right" title="Conversion feature on convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/>1,714,143</span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="text-align: left; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> $</span></td> <td id="xdx_980_ecustom--ConversionFeatureOnConvertibleNotes_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="font-size: 11pt; text-align: right" title="Conversion feature on convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> <span style="-sec-ix-hidden: xdx2ixbrl0782">—</span></span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="11" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value Measurements at</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of</span></td> <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="11" style="font-size: 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Using Fair Value Hierarchy</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 1pt 10pt; font-size: 11pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="padding-bottom: 1pt; font-size: 11pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion feature on convertible<br/> notes</span></td> <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> $</span></td> <td id="xdx_98A_ecustom--ConversionFeatureOnConvertibleNotes_c20211231_pp0p0" style="font-size: 11pt; text-align: right" title="Conversion feature on convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/>10,192,485</span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="text-align: left; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> $</span></td> <td id="xdx_985_ecustom--ConversionFeatureOnConvertibleNotes_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="text-align: right; font-size: 11pt" title="Conversion feature on convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> <span style="-sec-ix-hidden: xdx2ixbrl0786">—</span></span></td> <td style="text-align: left; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="text-align: left; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> $</span></td> <td id="xdx_986_ecustom--ConversionFeatureOnConvertibleNotes_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="font-size: 11pt; text-align: right" title="Conversion feature on convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,192,485</span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="text-align: left; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> $</span></td> <td id="xdx_987_ecustom--ConversionFeatureOnConvertibleNotes_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="font-size: 11pt; text-align: right" title="Conversion feature on convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/> <span style="-sec-ix-hidden: xdx2ixbrl0790">—</span></span></td> <td style="font-size: 11pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>  </span></td></tr> </table> 1714143 1714143 10192485 10192485 <p id="xdx_84A_ecustom--TreasuryStockPolicyTextBlock_z53vgKzKHWEd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86B_z82Uz9tapew4">Treasury Stock</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Treasury stock is recorded at cost. The re-issuance of treasury shares is accounted for on a first in, first-out basis and any difference between the cost of treasury shares and the re-issuance proceeds are charged or credited to additional paid-in capital.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84F_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zE87gqsoYFae" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_867_zSoQAtXgqjvk">Reclassification</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_849_eus-gaap--RevenueRecognitionPolicyTextBlock_zuJ6Tnc8Pdqc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_867_zQgEAROhFs5d">Revenue Recognition</span> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounting Standards Update (“ASU”) No. 2014-09, <i>Revenue from Contracts with Customers </i>(“<i>Topic 606</i>”), became effective for the Company on January 1, 2018. The Company’s revenue recognition disclosure reflects its updated accounting policies that are affected by this new standard. The Company applied the “modified retrospective” transition method for open contracts for the implementation of <i>Topic 606.</i> The Company had no significant post-delivery obligations, this new standard did not<i> </i>result in a material recognition of revenue on the Company’s accompanying CFS for the cumulative impact of applying this new standard. The Company made no adjustments to its previously-reported total revenues, as those periods continue to be presented in accordance with its historical accounting practices under <i>Topic 605, Revenue Recognition</i>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue from providing IT consulting services are recognized under <i>Topic 606</i> in a manner that reasonably reflects the delivery of its services to customers in return for expected consideration and includes the following elements:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">executed contracts with the Company’s customers that it believes are legally enforceable;</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identification of performance obligations in the respective contract;</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determination of the transaction price for each performance obligation in the respective contract;</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">allocation the transaction price to each performance obligation; and</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recognition of revenue only when the Company satisfies each performance obligation.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">These five elements, as applied to each of the Company’s IT revenue category, is summarized below:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IT consulting services - revenue is recorded on a monthly basis as services are provided.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These five elements, as applied to each of the Company’s license revenue category, is summarize below:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">License services – the one-time related party licensing income recorded as other income upon agreement is executed and services are provided and recognized over the term of five years.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>E-Commerce sales</i> –</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identify the contract(s) with a customer. ASC 606 defines a contract as “an agreement between two or more parties that creates enforceable rights and obligations”. Since this is an e-commerce sale on the Amazon of eBay websites, the Company just followed the general terms on Amazon or eBay websites and the customer entered into a contract with the Company based on the product listed on the Amazon or eBay websites;</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identify the performance obligations in the contract. According to the contract, the Company is responsible for operation exclusively. The Company is entitled to all revenue which is being paid by Amazon or eBay into a designated bank account and the Company is responsible fo</span>r all product acquisitions as well as shipments. The only performance obligations were the electronic products that were listed on Amazon or eBay websites and the Company determined each order is one single obligation;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">Determine the transaction price. The transaction price set to be the listed price on the Amazon or eBay websites.;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">Allocation the transaction price to the performance obligations in the contract.; and</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">Recognize revenue when the Company satisfies a performance obligation. Sales are being recognized upon shipment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"> </p> <p id="xdx_846_ecustom--UnearnedRevenuePoliciesTextBlock_zVIT8uLn0Vl9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86E_z3PnxcPymEH3">Unearned revenue</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Unearned revenue represents the net amount received for the purchase of products that have not seen shipped to the Company’s customers. The Company has $<span id="xdx_905_eus-gaap--DeferredRevenue_c20221231_pp0p0" title="Unearned revenue">48,921</span> and $<span id="xdx_904_eus-gaap--DeferredRevenue_c20211231_pp0p0" title="Unearned revenue">249,384</span> of unearned revenue at December 31, 2022 and 2021, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 48921 249384 <p id="xdx_846_ecustom--ContractLiabilitiesPolicyTextBlock_zUdGNHffj9ni" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86B_zGu0likrv9hh">Contract liabilities</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 22, 2022, the Company entered into an Intellectual Property License and Royalty Agreement with<b> </b>Touchpoint Group Holdings, Inc. (“Touchpoint” or “TGHI”) pursuant to which the Company granted TGHI a worldwide license for its technologies for five years in the domains of Internet of Things (IoT) and Artificial Intelligence enabled mobile technologies pertaining to the Company’s digital currency technology (the “Technology”). GBT will charge TGHI royalties based on actual uses by TGHI of the Technology resulting from revenue attributable to the use, performance or other exploitation of the Technology, to the extent applicable, after deducting any taxes that the Company may be required to collect, and deducting any international sales, goods and services, value added taxes or similar taxes which the Company is required to pay, if any, excluding deductions for taxes on the Company net income. TGHI agreed to issue the Company <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220201__20220222__dei--LegalEntityAxis__custom--TouchPointGroupHoldingMember_pdd" title="Number of shares issued">10,000,000</span> shares of common stock of TGHI in the FV of $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20220201__20220222__dei--LegalEntityAxis__custom--TouchPointGroupHoldingMember_pp0p0" title="Fair value">50,000</span> as a onetime fee for the Company entering this Intellectual Property License and Royalty Agreement, which was booked contract liabilities and amortized over the <span id="xdx_907_eus-gaap--DebtInstrumentTerm_dtY_c20220201__20220222__dei--LegalEntityAxis__custom--TouchPointGroupHoldingMember_zvYHs19Zl808" style="display: none" title="Term">5</span> five-year term. The Company has yet to earn any royalty income in relation to this agreement as of December 31, 2022. The contract liabilities as of December 31, 2022 and December 31, 2021 was $<span id="xdx_909_eus-gaap--ContractWithCustomerLiabilityCurrent_c20221231_pp0p0" title="Contract liabilities">41,444</span> and $<span id="xdx_90A_eus-gaap--ContractWithCustomerLiabilityCurrent_c20211231_pp0p0" title="Contract liabilities">0</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 10000000 50000 P5Y 41444 0 <p id="xdx_84D_ecustom--VariableInterestEntityPolicyTextBlock_zs6tgv37q9eg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><i><span id="xdx_86A_zBEyHQL9vE8j">Variable Interest Entity</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On February 18, 2022, the Company, effective March 1, 2022 entered into a Revenue Sharing Agreement (“RSA”) with Mahaser LTD. (“Mahaser”) pursuant to which the Company shares in revenues generated by Mahaser e-commerce sales through the online retail platform in the United States of America. Mahaser owns an e-commerce platform as a store which is the legal, exclusive owner of Ravenholm Electronics. The Company will operate the e-commerce platform and entitled to 95% for all revenue generated by and received by Mahaser from March 1, 2022 through December 31, 2022. The RSA provides that the Company will be entitled to appoint a manager to Mahaser. As consideration, the Company will pay Mahaser $<span id="xdx_90D_ecustom--ConsiderationPaid_c20220101__20221231__srt--CounterpartyNameAxis__custom--MahaserMember_pp0p0" title="Consideration paid">100,000</span> no later than March 1, 2022 and issue Mahaser <span id="xdx_900_ecustom--ConsiderationShares_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_pdd" title="Consideration shares">1,000,000</span> shares of the Company’s restricted common stock. The Company shall have no obligations to make any further payments to Mahaser. For any further extensions, the Company will have the option to extend the RSA for annual payment of $<span id="xdx_904_eus-gaap--DebtInstrumentAnnualPrincipalPayment_c20220302_pp0p0" title="Annual payment">200,000</span>, which can be payable with the Company’s shares of common stock payable based on 20 days VWAP prior to issuance. On March 16, 2022 the parties entered into Amendment No. 1 to the to the RSA, where all consideration to be paid or issued to Mahaser will be deferred until such time where the e-commerce platform generated in cumulative revenue of $1,000,000. On March 31, 2022, the parties entered into Amendment No. 2 to the RSA, where Mahaser agreed to pay the Company 100% per year for all revenue generated by and received by seller from the sales by Amazon within the United States of America as follows from March 1, 2022 through December 31, 2022. The Company will be responsible for 100% of the cost of goods sold as well. In addition, the Company is entitled to earn 100% revenues and cost of goods sold of the period from February 1, 2022 to February 28, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company evaluated whether it has a variable interest in Mahaser, whether Mahaser is a VIE and whether the Company has a controlling financial interest in Mahaser. The Company concluded that it has variable interests in Mahaser on the basis of GBT has 100% control over the JV/revenue sharing, and as such should consolidate the JV into its books and records as it assigned 100% financial responsibility. Mahaser’s equity at risk, as defined by GAAP, is considered to be insufficient to finance its activities without additional support, and, therefore, Mahaser is considered a VIE.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The following table summarizes the carrying amount of the assets and liabilities of Mahaser included in the Company’s consolidated balance sheets at December 31, 2022 (after elimination of intercompany transactions and balances):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"/> <table cellpadding="0" cellspacing="0" id="xdx_89F_esrt--ScheduleOfCondensedFinancialStatementsTableTextBlock_zGpkfdPDh832" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 30pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B2_zXOOrPiXRve9" style="display: none">Condensed financial statements</span></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_496_20221231" style="font-size: 10pt; text-align: center"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets of consolidated variable interest entity (“VIE”) included in the consolidated balance sheets above (after elimination of intercompany transactions and balances) consist of:</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--AssetsCurrentAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 30pt; width: 70%; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and equivalents</span></td><td style="width: 10%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 18%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93,581</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--InventoryNet_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 30pt; font-size: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,569</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_ecustom--DueFromRelatedPartiesCurrents_iI_pp0p0_zJeVmzJn2NBe" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 30pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due From related party</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,270</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--OtherAssetsCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 40pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total current assets</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">125,420</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities of consolidated VIE included in the consolidated balance sheets above (after elimination of intercompany transactions and balances) consist of:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--LiabilitiesCurrentAbstract_iB" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--OtherLiabilitiesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 40pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total current liabilities</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">94,496</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements of operations of consolidated VIE included in the consolidated statements of operations above (after elimination of intercompany transactions and balances) consist of:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements of operations</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 30pt; font-size: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Sales</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20221231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember_pp0p0" style="font-size: 10pt; text-align: right" title="Sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,107,555</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 30pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Cost of goods sold</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--CostOfGoodsAndServicesSold_c20220101__20221231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember_pp0p0" style="font-size: 10pt; text-align: right" title="Cost of goods sold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">817,754</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 30pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Gross profit</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--GrossProfit_c20220101__20221231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember_pp0p0" style="font-size: 10pt; text-align: right" title="Gross profit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">289,801</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 30pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> General and administrative expenses</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--GeneralAndAdministrativeExpense_c20220101__20221231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="General and administrative expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">330,647</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Loss</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--NetIncomeLoss_c20220101__20221231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember_pp0p0" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,846</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AF_zzqn5RN1LoXh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> 100000 1000000 200000 <table cellpadding="0" cellspacing="0" id="xdx_89F_esrt--ScheduleOfCondensedFinancialStatementsTableTextBlock_zGpkfdPDh832" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 30pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B2_zXOOrPiXRve9" style="display: none">Condensed financial statements</span></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_496_20221231" style="font-size: 10pt; text-align: center"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets of consolidated variable interest entity (“VIE”) included in the consolidated balance sheets above (after elimination of intercompany transactions and balances) consist of:</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--AssetsCurrentAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 30pt; width: 70%; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and equivalents</span></td><td style="width: 10%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 18%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93,581</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--InventoryNet_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 30pt; font-size: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,569</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_ecustom--DueFromRelatedPartiesCurrents_iI_pp0p0_zJeVmzJn2NBe" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 30pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due From related party</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,270</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--OtherAssetsCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 40pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total current assets</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">125,420</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities of consolidated VIE included in the consolidated balance sheets above (after elimination of intercompany transactions and balances) consist of:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--LiabilitiesCurrentAbstract_iB" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--OtherLiabilitiesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 40pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total current liabilities</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">94,496</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements of operations of consolidated VIE included in the consolidated statements of operations above (after elimination of intercompany transactions and balances) consist of:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements of operations</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 30pt; font-size: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Sales</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20221231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember_pp0p0" style="font-size: 10pt; text-align: right" title="Sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,107,555</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 30pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Cost of goods sold</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--CostOfGoodsAndServicesSold_c20220101__20221231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember_pp0p0" style="font-size: 10pt; text-align: right" title="Cost of goods sold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">817,754</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 30pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Gross profit</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--GrossProfit_c20220101__20221231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember_pp0p0" style="font-size: 10pt; text-align: right" title="Gross profit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">289,801</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 30pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> General and administrative expenses</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--GeneralAndAdministrativeExpense_c20220101__20221231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="General and administrative expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">330,647</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Loss</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--NetIncomeLoss_c20220101__20221231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember_pp0p0" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,846</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 93581 11569 20270 125420 94496 1107555 817754 289801 330647 40846 <p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zedV5afJYhQ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_862_zmFm70v7Hbel">Income Taxes</span> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for income taxes in accordance with ASC Topic 740, <i>Income Taxes</i>. ASC 740 requires a company to use the asset and liability method of accounting for income taxes, whereby deferred tax assets are recognized for deductible temporary differences, and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion, or all of, the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under ASC 740, a tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. The Company has no material uncertain tax positions for any of the reporting periods presented and its current on all its tax filings federal and state until 2021 inclusive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zMV5FqWw2DX1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86B_ztbTx44auKTb">Basic and Diluted Earnings Per Share</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Earnings per share is calculated in accordance with ASC Topic 260, <i>Earnings Per Share</i>. Basic earnings per share (“EPS”) is based on the weighted average number of common shares outstanding. Diluted EPS assumes that all dilutive securities are converted. Dilution is computed by applying the treasury stock method. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. Due to the net income incurred potentially dilutive instruments would be anti-dilutive. Accordingly, diluted loss per share is the same as basic loss for all periods presented. The following potentially-dilutive shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would be anti-dilutive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zt1YeMx7FkW9" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BC_zhzs7l9qSvn5" style="display: none">Schedule of anti dilutive securities excluded from computation of earnings per share</span></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series B preferred stock</span></td><td style="width: 8%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--PreferredStockDividendsShares_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_pdd" style="width: 12%; font-size: 10pt; text-align: right" title="Preferred shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45,000</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--PreferredStockDividendsShares_c20210101__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_pdd" style="width: 12%; font-size: 10pt; text-align: right" title="Preferred shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45,000</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series C preferred stock</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--PreferredStockDividendsShares_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_pdd" style="font-size: 10pt; text-align: right" title="Preferred shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">700</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--PreferredStockDividendsShares_c20210101__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_pdd" style="font-size: 10pt; text-align: right" title="Preferred shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">700</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series H preferred stock</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--PreferredStockDividendsShares_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_pdd" style="font-size: 10pt; text-align: right" title="Preferred shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--PreferredStockDividendsShares_c20210101__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_pdd" style="font-size: 10pt; text-align: right" title="Preferred shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zM5MV5iAKVB4" style="font-size: 10pt; text-align: right" title="Number of potentially dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,770</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_pdd" style="font-size: 10pt; text-align: right" title="Number of potentially dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">392,870</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible notes</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ConversionOfStockSharesIssued1_c20220101__20221231_pdd" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Convertible note"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,949,223,831</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ConversionOfStockSharesIssued1_c20210101__20211231_zFtscU84uYAa" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Convertible note"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,722,340</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_pdd" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of potentially dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,949,360,301</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_zw8esP8VWus4" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of potentially dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84,180,910</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A8_zfyazfaJRwZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><i/></p> <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zt1YeMx7FkW9" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BC_zhzs7l9qSvn5" style="display: none">Schedule of anti dilutive securities excluded from computation of earnings per share</span></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series B preferred stock</span></td><td style="width: 8%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--PreferredStockDividendsShares_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_pdd" style="width: 12%; font-size: 10pt; text-align: right" title="Preferred shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45,000</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--PreferredStockDividendsShares_c20210101__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_pdd" style="width: 12%; font-size: 10pt; text-align: right" title="Preferred shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45,000</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series C preferred stock</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--PreferredStockDividendsShares_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_pdd" style="font-size: 10pt; text-align: right" title="Preferred shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">700</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--PreferredStockDividendsShares_c20210101__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_pdd" style="font-size: 10pt; text-align: right" title="Preferred shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">700</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series H preferred stock</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--PreferredStockDividendsShares_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_pdd" style="font-size: 10pt; text-align: right" title="Preferred shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--PreferredStockDividendsShares_c20210101__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_pdd" style="font-size: 10pt; text-align: right" title="Preferred shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zM5MV5iAKVB4" style="font-size: 10pt; text-align: right" title="Number of potentially dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,770</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_pdd" style="font-size: 10pt; text-align: right" title="Number of potentially dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">392,870</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible notes</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ConversionOfStockSharesIssued1_c20220101__20221231_pdd" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Convertible note"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,949,223,831</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ConversionOfStockSharesIssued1_c20210101__20211231_zFtscU84uYAa" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Convertible note"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,722,340</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_pdd" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of potentially dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,949,360,301</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_zw8esP8VWus4" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of potentially dilutive securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84,180,910</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 45000 45000 700 700 20000 20000 70770 392870 3949223831 83722340 3949360301 84180910 <p id="xdx_844_eus-gaap--SubsequentEventsPolicyPolicyTextBlock_zIl77xENJ1Vb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><i><span id="xdx_862_zNU08V6srlkk">Management’s Evaluation of Subsequent Events</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company evaluates events that have occurred after the balance sheet date of December 31, 2022, through the date which the CFS are issued. Based upon the review, other than described in Note 20 – Subsequent Events, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the CFS.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zeYgE36GDtEj" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_860_zj8AW6FZN6P2">Recent Accounting Pronouncements</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In August 2020, the FASB issued ASU 2020-06<b>, </b><i>Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity.</i> ASU 2020-06 reduces the number of accounting models for convertible debt instruments and convertible preferred stock. For convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, <i>Derivatives and Hedging</i>, or that do not result in substantial premiums accounted for as paid-in capital, the embedded conversion features no longer are separated from the host contract. ASU 2020-06 also removes certain conditions that should be considered in the derivatives scope exception evaluation under Subtopic 815-40, <i>Derivatives and Hedging—Contracts in Entity’s Own Equity</i>, and clarify the scope and certain requirements under Subtopic 815-40. In addition, ASU 2020-06 improves the guidance related to the disclosures and earnings-per-share (EPS) for convertible instruments and contract in entity’s own equity. ASU 2020-06 is effective for public business entities that meet the definition of a SEC filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Board specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. The Company adopted this ASU on the CFS in the year ended December 31, 2021. The adoption had no material impact on the CFS for the year ended December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 2021, the FASB issued ASU 2021-04, “<i><span style="text-decoration: underline">Earnings Per Share (Topic 260), Debt— Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options” </span></i>(“<span style="text-decoration: underline">ASU 2021-04</span>”) to clarify the accounting by issuers for modifications or exchanges of equity-classified warrants. The new ASU is available here and effective for all entities in fiscal years starting after December 15, 2021. Early adoption is permitted. The Company adopted this ASU on the CFS in the year ended December 31, 2021. The adoption had no material impact on the CFS for the year ended December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying CFS. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_800_eus-gaap--MarketableSecuritiesTextBlock_z2UVleFEs8R6" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_820_zDubzOrXMLs3">Note 4 – <span id="xdx_824_z76LXRe9q9U4">Marketable Securities</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">TGHI Agreement</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 28, 2022, the Company entered into a Stock Purchase Agreement with Marko Radisic (the “Seller”) and Touchpoint Group Holdings, Inc. (“TGHI”) pursuant to which the Company acquired <span id="xdx_90C_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20220103__20220128__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_pdd" title="Shares acquired">10,000</span> shares of Series A Convertible Preferred Stock (the “Touchpoint Preferred”) from the Seller for $<span id="xdx_90A_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20220103__20220128__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_pp0p0" title="Sales consideration">125,000</span>. The Touchpoint Preferred is convertible into <span id="xdx_901_eus-gaap--PreferredStockConvertibleSharesIssuable_c20220128__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_pdd" title="Convertible preferred shares">10,000,000</span> shares of common stock of Touchpoint. On February 22, 2022, the Company entered into an Intellectual Property License and Royalty Agreement with<b> </b>TGHI pursuant to which the Company granted TGHI a worldwide license for its technologies for five years in the domains of Internet of Things (IoT) and Artificial Intelligence enabled mobile technologies pertaining to the Company’s digital currency technology (the “Technology”). GBT will charge TGHI earned royalties based on actual uses by TGHI of the Technology resulting from revenue attributable to the use, performance or other exploitation of the Technology, to the extent applicable, after deducting any taxes that the Company may be required to collect, and deducting any international sales, goods and services, value added taxes or similar taxes which the Company is required to pay, if any, excluding deductions for taxes on the Company net income. TGHI agreed to issue the Company <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220202__20220222__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TouchpointGroupHoldingsIncMember_pdd" title="Issuance of shares">10,000,000</span> shares of common stock of TGHI in the FV of $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20220202__20220222__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TouchpointGroupHoldingsIncMember_pp0p0" title="Fair value">50,000</span> as a one-time fee for the Company entering this Intellectual Property License and Royalty Agreement, which was booked contract liabilities and amortized over the five-year term. The Company has yet to earn any royalty income order to this agreement as of December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">TGHI converted the Touchpoint Preferred into <span id="xdx_90B_eus-gaap--PreferredStockConvertibleSharesIssuable_c20220223__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TouchpointGroupHoldingsIncMember_pdd" title="Convertible preferred shares">10,000,000</span> shares of common stock of Touchpoint on February 23, 2022 resulting in the Company owning <span id="xdx_90C_eus-gaap--InvestmentOwnedBalanceShares_c20220223__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TouchpointGroupHoldingsIncMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pdd" title="Company owned shares">20,000,000</span> shares of common stock of Touchpoint in total FV of $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TouchpointGroupHoldingsIncMember_pp0p0" title="Fair value">6,000</span> as of December 31, 2022 based on level 1 stock price in OTC markets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">MetAlert -prior name GTX Corp</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On April 12, 2022, GBT Tokenize Corp (“GBT Tokenize”), a Nevada corporation which the Company owns 50% of the outstanding shares of common stock, entered into a series of agreements with GTX Corp (“GTX”) and various note holders of GTX pursuant to which Tokenize acquired a convertible promissory note of GTX of $<span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--GTXAgreementMember_pp0p0">100,000</span></span><span style="font-family: Times New Roman, Times, Serif"> (the “GTX Notes”). In addition, GBT Tokenize acquired <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220101__20221231__dei--LegalEntityAxis__custom--GBTTokenizeMember_pdd">76,923</span></span><span style="font-family: Times New Roman, Times, Serif"> (GBT acquired <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--GTXAgreementMember_pdd">5,000,000</span></span><span style="font-family: Times New Roman, Times, Serif"> in the original deal, where GTX to perform a corporate action of 1:65 reverse split on September 20, 2022) shares of common stock of GTX for $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--GTXAgreementMember_pp0p0">150</span>,0–0 - in total FV of $</span><span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--GTXAgreementMember_pp0p0" style="font-family: Times New Roman, Times, Serif">12,538 </span><span style="font-family: Times New Roman, Times, Serif">as of December 31, 2022 based on level 1 stock price in OTC markets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The GTX Notes bear 10% interest and 50% of the principal may be converted into shares of common stock on a one-time basis at a conversion price of $<span id="xdx_90C_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20221231_pdd" title="Conversion price">0.01</span> per share. The remaining 50% of the principal must be paid in cash. The closing occurred on April 12, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">GTX changed its name into Metalert Inc. on or about September 20, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 30, 2022, GBT Tokenize, loaned MetAlert Inc., a Nevada corporation (f/k/a GTX Corp.) (“MetAlert”) $<span id="xdx_90C_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp0p0_c20220101__20220930__dei--LegalEntityAxis__custom--GBTTokenizeMetAlertMember_zgoioAATOQMb" title="Principal amount">90,000</span>. For such loan, MetAlert provided Tokenize a promissory note of $<span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp0p0_c20220101__20220930__us-gaap--LongtermDebtTypeAxis__custom--PromissoryNoteMember_zDYGwFOIECmg" title="Principal amount">90,000</span> which is due and payable together with interest of <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220101__20220930__us-gaap--LongtermDebtTypeAxis__custom--PromissoryNoteMember_zCfHCiEskYRd" title="Interest rate">5</span>% upon the earlier of September 19, 2023 or when declared by Tokenize.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #444444"><span style="background-color: white">MetAlert designs, manufactures and sells various interrelated and complementary products and services in the wearable technology and IoMT (Internet of Medical Things) marketplace.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #444444"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">As of December 31, 2022, the notes had an outstanding balance of $<span id="xdx_90E_eus-gaap--ConvertibleDebt_c20221231__us-gaap--TypeOfArrangementAxis__custom--GTXAgreementMember_pp0p0" title="Convertible debt">190,000</span> and accrued interest of $<span id="xdx_901_eus-gaap--InterestPayableCurrent_c20221231__us-gaap--TypeOfArrangementAxis__custom--GTXAgreementMember_pp0p0" title="Accrued interest">8,475</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2022 and December 31, 2021, the marketable security had a FV of $<span id="xdx_90A_eus-gaap--MarketableSecurities_c20221231__us-gaap--TypeOfArrangementAxis__custom--GTXAgreementMember_pp0p0" title="Marketable securities">12,538</span> and $<span id="xdx_905_eus-gaap--MarketableSecurities_c20211231__us-gaap--TypeOfArrangementAxis__custom--GTXAgreementMember_pp0p0" title="Marketable securities">0</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 10000 125000 10000000 10000000 50000 10000000 20000000 6000 100000 76923 5000000 150 12538 0.01 90000 90000 0.05 190000 8475 12538 0 <p id="xdx_808_eus-gaap--InvestmentTextBlock_zxTE5AvUwkda" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_82C_zcktsfFhIJHd">Note 5 – <span id="xdx_827_z50Zb68RdeU8">Investment in Surge Holdings, Inc.</span></span> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Surge Holdings, Inc.</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 30, 2019, GBT Technologies Inc. (the “Company”) entered into an Asset Purchase Agreement (“APA”) with Surge Holdings, Inc., a Nevada corporation (“SURG”) pursuant to which the Company agreed to sell and assign to SURG, all the assets and certain specified liabilities, of its ECS Prepaid, Electronic Check Services and the Central State Legal Services businesses for $<span id="xdx_905_eus-gaap--BusinessCombinationConsiderationTransferred1_pp0p0_c20190929__20190930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SurgeHoldingsMember__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember_zyc7bYmLrh97" title="Business consideration values">5,000,000</span> to be paid through the issuance of <span id="xdx_90A_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20190929__20190930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SurgeHoldingsMember__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember_zmOdEJD7CBOi" title="Sale of common stock">3,333,333</span> shares of SURG’s common stock (the “SURG Common Stock”) and a convertible promissory note in favor of the Company in the principmountount of $<span id="xdx_905_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp0p0_c20190929__20190930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SurgeHoldingsMember__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember_z0KcLgxwVJBa" title="Payment of principal">4,000,000</span> (the “SURG Note”), convertible into SURG’s shares of common stock. On January 7, 2022, the Company received payments from Surgepays Inc. (formerly known as Surge Holdings, Inc.) in total of $<span id="xdx_905_ecustom--SettlementPursuantsAmount_c20220101__20220107__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SurgeHoldingsMember__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember_pp0p0" title="Settlement pursuants amount">3,750,000</span> pursuant to the terms of the Settlement Agreement dated December 22, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 23, 2020, SURG entered into an Exchange Agreement (the “AltCorp Exchange Agreement”) with AltCorp Trading LLC (“AltCorp”) with such AltCorp Exchange Agreement being consented and agreed to by the Company, the parent of AltCorp. At the expiration of the lock-up period, in the event the VWAP for the SURG Common Stock was, during the preceding twenty-day trading period, less than $<span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_c20200623__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SurgeHoldingsMember__us-gaap--TypeOfArrangementAxis__custom--AltCorpExchangeAgreementMember_pdd" title="Price per share">0.50</span> per share, AltCorp retained the right to reserve additional shares of SURG Common Stock equal to the True-Up Value as defined in the AltCorp Exchange Agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 8, 2020, SURG filed a lawsuit against its transfer agent from transferring millions of SURG stock that is currently in possession by the Company and assigned to Stanley Hills, LLC. On January 1, 2021, SURG, AltCorp and Stanley Hills, LLC (“Stanley”) entered into a Mutual Release and Settlement Agreement (“Settlement Agreement”). Pursuant to the terms of the Settlement Agreement, SURG agreed to amend the AltCorp Exchange Agreement where SURG acknowledged a debt of $<span id="xdx_900_eus-gaap--DebtCurrent_c20210102__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_pp0p0" title="Debt">3,300,000</span> (the “Debt”) to be paid in 33 monthly payments of $<span id="xdx_906_eus-gaap--DebtCurrent_c20210102__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pp0p0" title="Debt">100,000</span> payable in shares of common stock of SURG at a per share price equal the volume weighted average price of Surg’s common stock during the 10 trading days immediately preceding the issuance. SURG paid $<span id="xdx_904_eus-gaap--Cash_c20210102__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_pp0p0" title="Cash">400,000</span> in cash and $<span id="xdx_90E_eus-gaap--Cash_c20210102__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pp0p0" title="Cash">800,000</span> by shares. The SURG common stock issued to Altcorp have been pledged since August 12, 2020 for the benefit of Stanley to secure Stanley’s note payable by the Company. Accordingly, the SURG Common Stock issued to AltCorp as a result of the Settlement Agreement were pledged to Stanley. As of December 31, 2021 there were no surge shares pledges after the final settlement signed on December 22, 2021 and that replaced all prior settlement agreement. The final settlement SURG agreed to make total payments of $<span id="xdx_901_eus-gaap--RepaymentsOfDebt_c20220101__20220107__dei--LegalEntityAxis__custom--SurgeHoldingsIncMember_pp0p0" title="Repayment of debt">4,200,000</span> to the Company’s trust account on or prior to January 7, 2022. <span id="xdx_90F_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20220101__20221231__dei--LegalEntityAxis__custom--SurgeHoldingsIncMember" title="Related party, description">This $4.2 million amount consists of $450,000 paid by SURG in November and December 2021, $100,000 to be paid on or about January 4, 2022, and $3,650,000 to be paid on or prior to January 7, 2022 of which $375,000 will be held in escrow as described before. The $3,750,000 was recorded as other receivable as of December 31, 2021. As of December 31, 2021, the Company has recorded an outstanding payable balance to Stanley amounted $1,862,928 recorded under accrued expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Subsequently, SURG was a party to two lawsuits in state District Court, the Eighth Judicial District Court for Clark County, Nevada involving AltCorp, Stanley and Glen Eagles Acquisition LP (the “AltCorp Parties.”). Each of these lawsuits were ultimately disputes relating to the total consideration SURG was to pay the Company under the APA.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 18, 2021, the AltCorp Parties, the Company, and SURG entered into a Memorandum of Understanding (the “MOU”) to set up a framework for an attempt to settle the two lawsuits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 22, 2021 (the “Effective Date”), pursuant to the framework in the MOU, the AltCorp Parties (and an additional third party), the Company, ECS, and SURG, Kevin Brian Cox (SURG’s Chief Executive Office–) - in his individual capacity, entered into a Resolution of Purchase, Mutual Release, and Settlement Agreement (the “Final Settlement Agreement”) to settle the two lawsuits and resolve all disputes related to the consideration paid by SURG to the Company in connection with the APA.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(F)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Final Settlement Agreement, among other resolutions, essentially provides the following: i) From the total consideration of the Final Settlement Agreement, the amount of $<span id="xdx_90E_eus-gaap--EscrowDeposit_c20221231__dei--LegalEntityAxis__custom--SurgeHoldingsIncMember_pp0p0" title="Escrow amount">375,000</span> (“Escrow Amount”) will be deposited by SURG in escrow. SURG has acquired the Company’s rights to a certain Master Distribution and Service Agreement (“MDA”). Under certain circumstances, if the result of the Company’s lawsuit against a third party (the “GBT Lawsuit”) is a monetary judgment without the assignment or legal decree of ownership of the MDA, the Company shall be entitled to receive the Escrow Amount and shall assign to SURG the first $<span id="xdx_901_ecustom--EscrowAmountReceived_c20220101__20221231_pp0p0" title="Escrow amount received">1,000,000</span> the Company recovers from the defendants in the GBT Lawsuit. In the event that the Company does not prevail in the GBT Lawsuit then it shall be entitled to release of the Escrow Amount but shall be responsible for any fees and costs obligation sought by the defendants in the GBT Lawsuit.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(ii) <span id="xdx_90A_ecustom--FinalSettlementAgreementDescription_c20220101__20221231" title="Final settlement agreement, description">SURG agreed to make total payments of $4,200,000 to the Company’s trust account on or prior to January 7, 2022. This $4.2 million amount consists of $450,000 paid to the Company in November and December 2021, $100,000 to be paid on or about January 4, 2022, and $3,650,000 to be paid on or prior to January 7, 2022 of which $375,000 will be held in escrow as described before. The final settlement SURG agreed to make total payments of $4,200,000 to the Company’s trust account on or prior to January 7, 2022. The $3,750,000 was recorded as other receivable as of December 31, 2021. The entire balance of $3,750,000 was paid in January 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(iii) Potential payments to third parties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Final Settlement Agreement replaces all prior agreements between the parties. In addition, within three (3) trading days of the last payment related to the $<span id="xdx_903_eus-gaap--ProceedsFromRepaymentsOfRelatedPartyDebt_pn3n3_dm_c20220101__20221231_zmLaCDgSsWv8" title="Related party payment">4.2</span> million payment to Stanley being made, the parties shall make filings with the state District Court in Clark County, Nevada to dismiss both lawsuits, including, regarding the lawsuit filed by AltCorp Trading, LLC, the dismissal of the lawsuit as to VStock Transfer, LLC. The parties agreed to a full mutual release of any disputes or claims between the parties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The final settlement of $<span id="xdx_90C_ecustom--SettlementAmount_c20220131_pp0p0" title="Settlement amount">3,750,000</span> was received by the Company in January 2022 and paid out $<span id="xdx_902_eus-gaap--ProceedsFromShortTermDebt_c20220101__20221231_pp0p0" title="Payments for debt">3,750,000</span> to the third parties before December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As the Company committed to assign certain revenue share agreement to SURG as part of the Company’s settlement with RWJ Agreement, on October 5, 2022 and as cumulation of all settlement agreements the Company issued a request to the SURG regarding release of certain escrow funds and the execution of an assignment of rights as contemplated in the aforereferenced agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 5000000 3333333 4000000 3750000 0.50 3300000 100000 400000 800000 4200000 This $4.2 million amount consists of $450,000 paid by SURG in November and December 2021, $100,000 to be paid on or about January 4, 2022, and $3,650,000 to be paid on or prior to January 7, 2022 of which $375,000 will be held in escrow as described before. The $3,750,000 was recorded as other receivable as of December 31, 2021. As of December 31, 2021, the Company has recorded an outstanding payable balance to Stanley amounted $1,862,928 recorded under accrued expenses. 375000 1000000 SURG agreed to make total payments of $4,200,000 to the Company’s trust account on or prior to January 7, 2022. This $4.2 million amount consists of $450,000 paid to the Company in November and December 2021, $100,000 to be paid on or about January 4, 2022, and $3,650,000 to be paid on or prior to January 7, 2022 of which $375,000 will be held in escrow as described before. The final settlement SURG agreed to make total payments of $4,200,000 to the Company’s trust account on or prior to January 7, 2022. The $3,750,000 was recorded as other receivable as of December 31, 2021. The entire balance of $3,750,000 was paid in January 2022. 4200000 3750000 3750000 <p id="xdx_809_ecustom--StockLoanReceivableTextBlock_zBCicEuRrUeh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_829_z5JFPMB3WX87">Note 6 - <span id="xdx_826_zx6DBP9WGRrl">Stock Loan Receivable</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On January 8, 2019, the Company entered into a Stock Pledge Agreement with Latin American Exchange Latinex Casa de Cambio, S.A., a Costa Rica corporation (“Latinex”), to provide that Latinex may maintain its required regulatory capital as required by various regulators. The Company has pledged 4,006 restricted shares of its common stock valued at $7,610,147 (based on the closing price on the grant date) for a term of three years for an annual payment of $375,000 paid in quarterly installments of $93,750. In lieu of cash payment, Latinex may pay the Company in virtual currency of WISE Network S.A. valued at a 50% discount of its offering price of $10 per token. In the event that Latinex’s required capital has decreased below $5,000,000, Latinex is permitted to sell the pledged shares of common stock only in an amount to ensure that Latinex can satisfy the required capital levels. The Company must consent to such sale of the shares of common stock, which may not be unreasonably withheld. Upon expiration of the agreement, the remaining shares of common stock shall be returned to the Company free and clear of all liens. The Company has recorded the value of these shares of common stock as a stock loan receivable which is presented as a contra-equity account in the accompanying consolidated balance sheets. At December 31, 2019, the Company wrote off the accrued interest income as Latinex did not perform any payment and the Company has no mean to enforce this payment. Latinex agreed in principle to return the pledged 4,006 restricted shares to the Company for cancellation. The 4,006 restricted shares have not yet been returned to the Company as of December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p id="xdx_804_eus-gaap--EquityMethodInvestmentsDisclosureTextBlock_zPPmg7lvuyrk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_828_zOtlbpV42Q69">Note 7 – <span id="xdx_826_zGHltzbEnYbk">Impaired Investment</span></span> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="text-decoration: underline">Investment in GBT Technologies, S.A.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On June 17, 2019, the Company, AltCorp Trading LLC, a Costa Rica company and a wholly-owned subsidiary of the Company (“AltCorp”), GBT Technologies, S.A., a Costa Rica company (“GBT-CR”) and Pablo Gonzalez, a shareholder’s representative of GBT-CR (“Gonzalez”), entered into and closed an Exchange Agreement (the “GBT Exchange Agreement”) pursuant to which the parties exchanged certain securities. In accordance with the Exchange Agreement, AltCorp acquired <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20190601__20190617__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AltcorpMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_pdd" title="Stock Issued for Acquisitions, Shares">625,000</span> shares of GBT-CR representing 25% of its issued and outstanding shares of common stock from Gonzalez for the issuance of <span id="xdx_900_eus-gaap--ConversionOfStockSharesConverted1_c20190601__20190617__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AltcorpMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_pdd" title="Number of shares converted">20,000</span> shares of Series H Convertible Preferred Stock of the Company and a Convertible Note in the principal amount of $<span id="xdx_900_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20190601__20190617__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AltcorpMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_pp0p0" title="Debt conversion, converted instrument, Value">10,000,000</span> issued by the Company (the “Gopher Convertible Note”) as well as the transfer and assignment of a Promissory <span id="xdx_908_ecustom--NotePayableDescription_c20190201__20190206__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AltcorpMember" title="Note payable, description">Note payable by Gopher Protocol Costa Rica Sociedad De Responsabilidad Limitada to the Company in the principal amount of $5,000,000 dated February 6, 2019 (of which the underlying security for this Promissory Note is 30,000,000 restricted shares of common stock of Mobiquity Technologies, Inc. (“Mobiquity”) and 60,000,000 restricted shares of common stock of Mobiquity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Gopher Convertible Note bears interest of 6% and is payable at maturity on December 31, 2021. At the election of Gonzalez, the Gopher Convertible Note can be converted into a maximum of 20,000 shares of Series H Preferred Stock. Each share of Series H Preferred Stock is convertible, at the option of the holder but subject to the Company increasing its authorized shares of common stock, into such number of shares of common stock of the Company as determined by dividing the Stated Value ($500 per share) by the conversion price ($500 per share). The Series H Preferred Stock has no liquidation preference, does not pay dividends and the holder of Series H Preferred Stock shall be entitled to one vote for each share of common stock that the Series H Preferred Stock may be convertible into. Upon conversion of the Gopher Convertible Note and the 20,000 shares of Series H Preferred Stock, Gonzalez would be entitled to less than 50% of the resulting outstanding shares of common stock of the Company following conversion in full and, as a result, such transaction is not considered a change of control.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On May 19, 2021, the Company, entered into a Mutual Release and Settlement Agreement and Irrevocable Assignment of Note Balance Principal and Accrued Interest (the “Gonzalez Agreement”) with third party, GBT-CR, IGOR 1 Corp and Gonzalez. Pursuant to the Gonzalez Agreement, without any party admission of liability and to avoid litigation, the parties had agreed to (i) extend the GBT Convertible Note maturity date to December 31,2022, (ii) amend the GBT Convertible Note terms to include a beneficial ownership blocker of 4.99% and a modified conversion feature to the GBT Convertible Note with 15% discount to the market price during the 20 trading day period ending on the latest complete trading day prior to the conversion date and (iii) provided for an assignment of the GBT Convertible Note by Gonzalez to a third party.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">GBT-CR is in the business of the strategic management of BPO (Business Process Outsourcing) digital communications processing for enterprises and startups, distributed ledger technology development, AI development and fintech software development and applications.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounted for its investment in GBT-CR using the equity method of accounting; however, in 2020, the Company owned less than 20% after GBT-CR issued additional shares to other investors therefore exercised no control over GBT-CR; therefore, this investment is currently accounted for under the cost method. Moreover, on March 19, 2020, California Governor Gavin Newsom issued a stay-at-home order to protect the health and well-being of all Californians and to establish consistency across the state in order to slow the spread of COVID-19. California was therefore under strict quarantine control and travel has been severely restricted, resulting in disruptions to work, communications, and access to files (due to limited access to facilities). The stay-at-home order was lifted in California only on January 25, 2021. As such, the Company was unable to access or to contact GBT-CR on an on-going basis, and cannot get information about GBT-CR.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Investment in Joint Venture</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 6, 2020, the Company through Greenwich, entered into a Joint Venture and Territorial License Agreement (the “Tokenize Agreement”) with Tokenize-It, S.A. (“Tokenize”), which is owned by a Costa Rica Trust represented by Pablo Gonzalez (“Gonzalez”). Gonzalez also represents Gonzalez Costa Rica Trust, which holds a note in the principal amount of $10,000,000 and is also a shareholder of the Company. Under the Tokenize Agreement, the parties formed GBT Tokenize Corp., a Nevada corporation (“GBT Tokenize”). The purpose of GBT Tokenize is to develop, maintain and support source codes for its proprietary technologies including advanced mobile chip technologies, tracking, radio technologies, AI core engine, electronic design automation, mesh, games, data storage, networking, IT services, business process outsourcing development services, customer service, technical support and quality assurance for business, customizable and dedicated inbound and outbound calls solutions, as well as digital communications processing for enterprises and startups (“Technology Portfolio”), throughout the State of California. Upon generating any revenue from the Technology Portfolio, the Joint Venture will earn the first right of refusal for other territories.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company pledged its 50% ownership in GBT Tokenize and its 100% ownership of Greenwich to Tokenize to secure its Technology Portfolio investment. The Company shall appoint two directors and Tokenize shall appoint one director of GBT Tokenize.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Tokenize shall contribute the services and resources for the development of the Technology Portfolio to GBT Tokenize. The Company shall contribute <span id="xdx_90B_eus-gaap--SharesIssued_c20211231__us-gaap--StatementEquityComponentsAxis__custom--GBTSharesMember_pdd" title="Share issued">2,000,000</span> shares of common stock of the Company (“GBT Shares”) to GBT Tokenize. Tokenize and the Company will each own 50% of GBT Tokenize. The shares were valued at $<span id="xdx_90D_eus-gaap--StockIssued1_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--GBTSharesMember_pp0p0" title="Issuance of shares value">5,500,000</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, GBT Tokenize and Gonzalez entered into a Consulting Agreement in which Gonzalez is engaged to provide services for $<span id="xdx_905_ecustom--ServicesPayable_c20211201__20211231_pp0p0" title="Services payable">33,333</span> per month payable quarterly which may be paid in shares of common stock calculated by the amount owed divided by the Company’s 10-day VWAP. Gonzalez will provide services in connection with the development of the business as well as GBT Tokenize’s capital raising efforts. The term of the Consulting Agreement is two years. During year ended December 31, 2021, Gonzalez assigned all his accrued balances of $<span id="xdx_900_eus-gaap--InterestPayableCurrent_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_pp0p0" title="Interest payable">424,731</span> to Stanley Hills in a private transaction that the Company is not part to. The closing of the Tokenize Agreement occurred on March 9, 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Through this Joint Venture the parties commenced development of an intelligent human vital signs’ device, which we currently refer to as the qTerm. The platform is an expansion of the existing license agreement with GBT Tokenize Corp., which provided GBT Tokenize Corp. with an exclusive territory of California to develop certain of the Company’s technology. As the nature of the platform cannot be restricted only to California, the Company’s joint venture GBT Tokenize Corp. will be compensated with additional two hundred million shares of the Company to strengthen its funding, subject to board approval. A provisional patent application for the qTerm Medical Device was filed on March 30, 2020 with the USPTO. The application has been assigned serial number 63001564. The Joint Venture completed successfully the first prototype. There is no guarantee that the Company will be successful in researching, developing or implementing this product into the market. In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed and granted regulatory approval, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 28, 2021, the parties agreed to amend the Tokenize Agreement to expand territory granted for the Technology Portfolio under the license to GBT Tokenize to include the entire continental United States. The Company has further agreed to issue GBT Tokenize an additional <span id="xdx_901_eus-gaap--SharesIssued_c20210528__us-gaap--TypeOfArrangementAxis__custom--TokenizeAgreementMember_pdd" title="Share issued">14,000,000</span> shares of common stock of the Company. The shares were valued at $<span id="xdx_90A_eus-gaap--StockIssued1_c20210507__20210528__us-gaap--TypeOfArrangementAxis__custom--TokenizeAgreementMember_pp0p0" title="Issuance of shares value">15,400,000</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At March 31, 2020, the Company evaluated the carrying amount of this joint venture investment and determined that this investment was fully impaired and as a result an impairment charge of $<span id="xdx_90F_ecustom--ImpairmentCharge_c20200331_pp0p0" title="Impairment charge">5,500,000</span> was taken. At December 31, 2021, the Company evaluated the carrying amount of this joint venture investment and determined that this investment was fully impaired and as a result an impairment charge of $<span id="xdx_901_ecustom--ImpairmentCharge_c20211231_pp0p0" title="Impairment charge">15,400,000</span> was taken.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Although the investment was impaired, the product development is still ongoing. The carrying amount of this investment at December 31, 2022 and December 2021, was $<span id="xdx_90C_eus-gaap--Investments_iI_pp0p0_c20221231_zZjxcrXrEeEg" title="Investment">0</span> and $<span id="xdx_90A_eus-gaap--Investments_c20211231_pp0p0" title="Investment">0</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 625000 20000 10000000 Note payable by Gopher Protocol Costa Rica Sociedad De Responsabilidad Limitada to the Company in the principal amount of $5,000,000 dated February 6, 2019 (of which the underlying security for this Promissory Note is 30,000,000 restricted shares of common stock of Mobiquity Technologies, Inc. (“Mobiquity”) and 60,000,000 restricted shares of common stock of Mobiquity. 2000000 5500000 33333 424731 14000000 15400000 5500000 15400000 0 0 <p id="xdx_800_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zi2KLAduAOg4" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_82C_zDH9DP1s2C5b">Note 8 – <span id="xdx_82D_zN77rCt1qD4c">Accounts Payable and Accrued Expenses</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Accounts payable and accrued expenses at December 31, 2022 and 2021 consist of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zpmfbjf2LIMa" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts Payable and Accrued Expenses (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BE_zur6bqY2m04j" style="display: none">Schedule of accounts payable and accrued expenses</span></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_49B_20221231_zmwXwW4WMtih" style="font-size: 10pt; text-align: center"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_49A_20211231_zWKzt2voAf89" style="font-size: 10pt; text-align: center"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr> <tr id="xdx_407_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzrXB_zwyQ0Ikp4d62" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable</span></td><td style="width: 8%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,530,762</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,110,127</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzrXB_zlMil3dka8w" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued liabilities</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,513,261</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,033,016</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--InterestPayableCurrent_iI_pp0p0_maAPAALzrXB_z1B58vyhZVu" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued interest</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,196,611</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,753,120</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzrXB_z1dLdIDz8Aoh" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1064">—</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1065">—</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzrXB_zyWNBEOzOPU2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,240,634</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,896,263</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b/></p> <table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zpmfbjf2LIMa" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts Payable and Accrued Expenses (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BE_zur6bqY2m04j" style="display: none">Schedule of accounts payable and accrued expenses</span></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_49B_20221231_zmwXwW4WMtih" style="font-size: 10pt; text-align: center"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_49A_20211231_zWKzt2voAf89" style="font-size: 10pt; text-align: center"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr> <tr id="xdx_407_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzrXB_zwyQ0Ikp4d62" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable</span></td><td style="width: 8%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,530,762</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,110,127</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzrXB_zlMil3dka8w" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued liabilities</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,513,261</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,033,016</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--InterestPayableCurrent_iI_pp0p0_maAPAALzrXB_z1B58vyhZVu" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued interest</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,196,611</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,753,120</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzrXB_z1dLdIDz8Aoh" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1064">—</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1065">—</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzrXB_zyWNBEOzOPU2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,240,634</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,896,263</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 1530762 1110127 1513261 3033016 3196611 2753120 6240634 6896263 <p id="xdx_80A_ecustom--UnearnedRevenueTextBlock_zF9ZjgXpUOF7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_821_zr1vQ8VW62sh">Note 9 – <span id="xdx_821_zOrGc62VfDGj">Unearned Revenue</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Unearned revenue represents the net amount received for the purchase of products that have not seen shipped to the Company’s customers. In 2018, the Company ran pre-sales efforts for its pet tracker product and received prepayments for its product. In addition, during 2018, the Company received $<span id="xdx_90C_ecustom--CashReceivedInConnectionWithIntellectualPropertyLicenseAndRoyaltyAgreement_pp0p0_c20180101__20181231_z2ICmo1upZe" title="Cash received in connection with intellectual property license and royalty agreement">200,000</span> in connection with an intellectual property license and royalty agreement. The Company has $<span id="xdx_90B_eus-gaap--DeferredRevenue_iI_pp0p0_c20221231_z2JpNdNMAJJ9" title="Unearned revenue">48,921</span> and $<span id="xdx_90A_eus-gaap--DeferredRevenue_iI_pp0p0_c20211231_zA9mr5qd1Oq3" title="Unearned revenue">249,384</span> of unearned revenue at December 31, 2022 and 2021, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 200000 48921 249384 <p id="xdx_806_eus-gaap--LongTermDebtTextBlock_zpalBbFiiYB7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_82C_zsgdG0iwLAVc">Note 10 – <span id="xdx_82F_zDPd3dAOn4lg">Convertible Notes Payable, Non-related Partied and Related Party</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Convertible notes payable – non related parties at December 31, 2022 and 2021 consist of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--RollfowardOfConvertibleNoteTableTextBlock_zbkaIdsJli5b" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Convertible Notes Payable, Non-related Partied and Related Party (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><span id="xdx_8BB_zFBp35fdhF8" style="display: none">Schedule of rollfoward of convertible note</span></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible note payable to GBT Technologies S.A</span></td><td style="width: 8%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--ConvertibleDebt_iI_pp0p0_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GBTTechnologiesSAMember_zXBlMCOt0HQ" style="width: 12%; font-size: 10pt; text-align: right" title="Total convertible notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,395,531</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--ConvertibleDebt_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GBTTechnologiesSAMember_zfRjguTvogBh" style="width: 12%; font-size: 10pt; text-align: right" title="Total convertible notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,055,400</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible notes payable to 1800</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--ConvertibleDebt_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DiagonalLendingMember_pp0p0" style="font-size: 10pt; text-align: right" title="Total convertible notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">191,257</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--ConvertibleDebt_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DiagonalLendingMember_pp0p0" style="font-size: 10pt; text-align: right" title="Total convertible notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">124,200</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible notes payable to Redstart Holdings</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eus-gaap--ConvertibleDebt_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsMember_pp0p0" style="font-size: 10pt; text-align: right" title="Total convertible notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1096">—</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--ConvertibleDebt_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsMember_pp0p0" style="font-size: 10pt; text-align: right" title="Total convertible notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">244,500</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total convertible notes payable, non related parties</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--ConvertibleDebt_c20221231_pp0p0" style="font-size: 10pt; text-align: right" title="Total convertible notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,586,788</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ConvertibleDebt_c20211231_pp0p0" style="font-size: 10pt; text-align: right" title="Total convertible notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,424,100</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unamortized debt discount</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_ecustom--DebtInstrumentsUnamortizedDiscountNoncurrent_c20221231_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Unamortized debt discount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(189,060</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_ecustom--DebtInstrumentsUnamortizedDiscountNoncurrent_c20211231_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Unamortized debt discount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(278,867</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible notes payable – non related parties</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--OtherNotesPayableCurrent_c20221231_pp0p0" style="font-size: 10pt; text-align: right" title="Convertible note payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,397,727</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--OtherNotesPayableCurrent_c20211231_pp0p0" style="font-size: 10pt; text-align: right" title="Convertible note payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,145,233</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less current portion</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--LessCurrentPortion_c20221231_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Less current portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,397,727</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_ecustom--LessCurrentPortion_c20211231_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Less current portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,109,436</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible notes payable – non related parties, long-term portion</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--ConvertibleLongTermNotesPayable_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Convertible notes payable, long-term portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1116">—</span></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--ConvertibleLongTermNotesPayable_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Convertible notes payable, long-term portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,797</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A7_zPqn5dDsKJA9" style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>$10,000,000 for GBT Technologies S. A. acquisition</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">In accordance with the acquisition of GBT-CR the Company issued a convertible note in the principal amount of $<span id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20190601__20190617__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GBTTechnologiesMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_pp0p0" title="Value of share converted">10,000,000</span>. The convertible note bears interest of 6% and is payable at maturity on <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20190601__20190617__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GBTTechnologiesMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zHSnFraJy5m7" title="Note maturity date">December 31, 2021</span>. At the election of the holder, the convertible note can be converted into a maximum of <span id="xdx_90E_eus-gaap--ConversionOfStockSharesConverted1_c20190601__20190617__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GBTTechnologiesMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_pdd" title="Number of shares converted">20,000</span> shares of Series H Preferred Stock. Each share of Series H Preferred Stock is convertible, at the option of the holder but subject to the Company increasing its authorized shares of common stock, into such number of shares of common stock of the Company as determined by dividing the Stated Value ($500 per share) by the conversion price ($<span id="xdx_900_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20190617__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GBTTechnologiesMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_ztcxfEGD1EXi" title="Conversion price (in dollars per share)">500</span> per share). This convertible note may convert into shares of the Company’s common stock at a conversion price equal to <span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentRate_dp_c20220101__20221231_z7eryOwISiBg" title="Conversion of debt rate">85</span>% of the lowest trading price with a 20-day look back immediately preceding the date of conversion and therefore recorded as derivative liability (see note 12).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On May 19, 2021, the Company, Gonzalez, GBT-CR and IGOR 1 Corp entered into a Mutual Release and Settlement Agreement and Irrevocable Assignment of outstanding balance plus accrued interest (the “Gonzalez Agreement”). Pursuant to the Gonzalez Agreement, without any party admission of liability and to avoid litigation, the parties had agreed to (i) extend the GBT convertible note maturity date to December 31, 2022, (ii) amend the GBT convertible note terms to include a beneficial ownership blocker of 4.99% and a modified conversion feature to the GBT convertible note with 15% discount to the market price during the 20 trading day period ending on the latest complete trading day prior to the conversion date and (iii) provided for an assignment of the GBT convertible note by Gonzalez to a third party. As a result of the change in terms of this convertible note, the Company took a charge related to the modification of debt of $<span id="xdx_90C_ecustom--ChargeRelatedToModificationOfDebt_pp0p0_c20220101__20221231_zVdGlwPxpbaf" title="Charge related to modification of debt">13,777,480</span> during the year ended December 31, 2021. This convertible note is recorded as derivative liability because of the discounted price on conversion (see note 13).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">During the year ended December 31, 2021, <span id="xdx_907_ecustom--ConvertibleNotePayableDescription_c20220101__20221231" title="Convertible note payable, description">IGOR 1 converted $1,284,600 of the convertible note into 4,185,650 shares of the Company’s common stock. On June 24, 2021, the Company transferred 5,500,000 SURG shares received as repayment of $660,000 of this convertible note</span> (See Note7).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">During the year ended December 31, 2022, <span id="xdx_900_ecustom--ConvertibleNotePayableDescription_c20210101__20211231_zXj4EckYaJ7" title="Convertible note payable, description">IGOR 1 converted $1,659,869 of the convertible note into 590,117,647 shares of the Company’s common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">As of December 31, 2022, the note had an outstanding balance of $<span id="xdx_90F_eus-gaap--ConvertibleDebt_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--IGOR1CORPMember_pp0p0" title="Convertible debt">6,395,531</span> and accrued interest of $<span id="xdx_904_ecustom--AccruedInterest_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--IGOR1CORPMember_pp0p0" title="Accrued interest">2,027,148</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Redstart Holdings Corp.</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="text-decoration: underline">Paid Off Notes/Converted Notes</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On August 4, 2020, the Company entered into a Securities Purchase Agreement with Redstart Holdings Corp., an accredited investor (“Redstart”) pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 1”) of $<span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20200801__20200804__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorpMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zMzYu0ChNwvg" title="Value of share converted">153,600</span> for $<span id="xdx_90E_ecustom--PurchasePrice_pp0p0_c20200801__20200804__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorpMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zGeIwUdWIYV8" title="Purchase Price">128,000</span>. The Redstart Note No. 1 had a maturity date of <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20200801__20200804__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorpMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zc8j6a6JcSfj" title="Note maturity date">November 3, 2021</span> and the Company had agreed to pay interest on the unpaid principal balance of the Redstart Note No. 1 at the rate of <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20200804__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorpMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z8mXXE2UD8Tj" title="Note payable, interest rate">6</span>% from the date on which the Redstart Note No. 1 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 1, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 1. The transactions described above closed on August 5, 2020. The outstanding principal amount of the Redstart Note No. 1 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180<sup>th</sup> day, Redstart may convert the Redstart Note No. 1 into shares of the Company’s common stock  to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 1), the Redstart Note No. 1 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 1. During the year ended December 31, 2021, the entire amount of Note No. 1 of $<span id="xdx_900_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorpMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zjJKve3zfRI1" title="Value of share converted">153,600</span> plus accrued interest was converted into <span id="xdx_906_eus-gaap--ConversionOfStockSharesConverted1_c20210801__20210804__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorpMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pdd" title="Number of shares converted">226,532</span> shares of common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On September 15, 2020, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 2”) of $<span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20200901__20200915__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorp2Member__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z7Hz9WN5v7eg" title="Value of share converted">93,600</span> for $<span id="xdx_902_ecustom--PurchasePrice_pp0p0_c20200901__20200915__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorpMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zXkY4lWXPBA9" title="Purchase Price">78,000</span>. The Redstart Note No. 2 had a maturity date of <span id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_dd_c20200901__20200915__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorpMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zQRWOuZTn0n2" title="Note maturity date">September 15, 2021</span> and the Company had agreed to pay interest on the unpaid principal balance of the Redstart Note No. 2 at the rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20200915__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorpMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zuEjbmUZ7Vm5">6</span>% from the date on which the Redstart Note No. 2 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 2, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 2. The transactions described above closed on September 16, 2020. The outstanding principal amount of the Redstart Note No. 2 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180<sup>th</sup> day, Redstart may convert the Redstart Note No. 2 into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 2), the Redstart Note No. 2 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 2. During the year ended December 31, 2021, the entire amount of Note No. 2 of $<span id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorp2Member__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z5HiJtRdA94d" title="Value of share converted">93,600</span> plus accrued interest was converted into <span id="xdx_90D_eus-gaap--ConversionOfStockSharesConverted1_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorp2Member__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zcoYGT4GTC7d" title="Number of shares converted">89,169</span> shares of common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 9, 2020, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 3”) of $100,200 for $83,500. The Redstart Note No. 3 had a maturity date of December 9, 2021 and the Company had agreed to pay interest on the unpaid principal balance of the Redstart Note No. 3 at the rate of 6% from the date on which the Redstart Note No. 3 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 3, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 3. The transactions described above closed on December 11, 2020. The outstanding principal amount of the Redstart Note No. 3 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180<sup>th</sup> day, Redstart may convert the Redstart Note No. 3 into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 3), the Redstart Note No. 3 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 3. During the year ended December 31, 2021, the entire amount of Note No. 3 of $100,200 plus accrued interest was converted into 135,582 shares of common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 10, 2021, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 4) of $<span id="xdx_90B_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20210201__20210210__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorp4Member__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zZmGkr6kt382" title="Value of share converted">184,200</span> for a purchase price of $<span id="xdx_90D_ecustom--PurchasePrice_pp0p0_c20210201__20210210__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorp4Member__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zQIZlkZRaaYj" title="Purchase Price">153,500</span>. The Redstart Note No. 4 had a maturity date of <span id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_dd_c20210201__20210210__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorp4Member__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zrfdQ9mXquIg" title="Note maturity date">February 5, 2022</span> and the Company had agreed to pay interest on the unpaid principal balance of the Redstart Note No. 4 at the rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20220210__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorpMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zbjW1bxiMIj1" title="Note payable, interest rate">6</span>% from the date on which the Redstart Note No. 4 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 4, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 4. The transactions described above closed on February 10, 2021. The outstanding principal amount of the Redstart Note No. 4 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180<sup>th</sup> day, Redstart may convert the Redstart Note No. 4 into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 4), the Redstart Note No. 4 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 4. During the year ended December 31, 2021, the entire amount of Redstart Note No. 4 of $<span id="xdx_907_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorp4Member__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zHvqf7NkGQfg" title="Value of share converted">184,200</span> plus accrued interest was converted into <span id="xdx_906_eus-gaap--ConversionOfStockSharesConverted1_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorp4Member__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zR26nGIXFiPl" title="Number of shares converted">386,146</span> shares of common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 15, 2021, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 5”) of $<span id="xdx_906_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20210301__20210315__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorp4Member__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zygeLiDaYB6" title="Value of share converted">106,200</span> for $<span id="xdx_901_ecustom--PurchasePrice_pp0p0_c20210301__20210315__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorp4Member__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zew1lSEQxn0b" title="Purchase Price">88,500</span>. The Redstart Note No. 5 had a maturity date of June 15, 2022 and the Company had agreed to pay interest on the unpaid principal balance of the Redstart Note No. 5 at the rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20210315__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorpMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zjczhG1bkFm5" title="Note payable, interest rate">6</span>% from the date on which the Redstart Note No. 5 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 5, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 5. The transactions described above closed on March 17, 2021. The outstanding principal amount of the Redstart Note No. 5 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180<sup>th</sup> day, Redstart may convert the Redstart Note No. 5 into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 5), the Redstart Note No. 5 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 5. During the year ended December 31, 2021, the entire amount of Redstart Note No. 5 of $<span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorp5Member__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zNFyDHSsby6" title="Value of share converted">106,200</span> plus accrued interest was converted into <span id="xdx_902_eus-gaap--ConversionOfStockSharesConverted1_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorp5Member__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zW3kPzCl4Wnb" title="Number of shares converted">317,837</span> shares of common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 26, 2021, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 6”) of $106,200 for $88,500. The Redstart Note No. 6 had a maturity date of August 26, 2022 and the Company had agreed to pay interest on the unpaid principal balance of the Redstart Note No. 6 at the rate of <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20210526__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorpMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zafPhlA0rgse" title="Note payable, interest rate">6</span>% from the date on which the Redstart Note No. 6 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 6, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 6. The transactions described above closed on May 28, 2021. The outstanding principal amount of the Redstart Note No. 6 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180<sup>th</sup> day, Redstart may convert the Redstart Note No. 6 into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 6), the Redstart Note No. 6 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 6. During the year ended December 31, 2021, the entire amount of Redstart Note No. 5 of $106,200 plus accrued interest was fully repaid in total cash of $<span id="xdx_907_eus-gaap--Cash_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorp5Member__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z9OqTxxlZ0C4" title="Cash">141,782</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <br/> <span style="background-color: white">On September 21, 2021, the Company entered into a Securities Purchase Agreement with Redstart pursuant to which the Company issued to Redstart a Convertible Promissory Note (the “Redstart Note No. 7”) of $</span><span id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20210901__20210921__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorpMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Value of share converted">244,500</span><span style="background-color: white"> for $203,750. The Redstart Note No. 7 had a maturity date of </span><span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20210901__20210921__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorpMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zSnkv2DDEEt2" title="Note maturity date">December 22, 2022</span><span style="background-color: white"> and the Company agreed to pay interest on the unpaid principal balance of the Redstart Note No. 7 at 2.5% from the date on which the Redstart Note No. 7 is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the Redstart Note No. 7, provided it makes a payment including a prepayment to Redstart as set forth in the Redstart Note No. 7. The transactions described above closed on September 28, 2021. The outstanding principal amount of the Redstart Note No. 7 may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180</span><sup>th</sup><span style="background-color: white"> day, Redstart may convert the Redstart Note No. 7 into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Redstart Note No. 7), the Redstart Note No. 7 shall become immediately due and payable and the Company shall pay to Redstart, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Redstart Note No. 7. During the year ended December 31, 2022, Redstart converted the entire note into </span><span id="xdx_901_eus-gaap--ConversionOfStockSharesConverted1_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsCorpMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pdd" title="Number of shares converted">7,656,951</span><span style="background-color: white"> shares of the Company’s common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Iliad Research and Trading, L.P.</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On February 27, 2019, the Company entered into a note purchase agreement with a third-party invest–r - Iliad Research and Trading, L.P.(“Iliad”), pursuant to which the Company issued a promissory note for the original principal amount of $2,325,000. The promissory note had an original issue discount of $<span id="xdx_904_ecustom--OriginalIssueDiscount_pp0p0_c20190201__20190227__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zN4X86m2VRia" title="Original issue discount">300,000</span> and the inventor paid $<span id="xdx_902_ecustom--Consideration_pp0p0_c20190201__20190227__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zBE90YQ49nf5" title="Consideration">2,025,000</span> to the Company, of which $<span id="xdx_900_eus-gaap--LegalFees_pp0p0_c20190201__20190227__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zkJVVNoFSNA7" title="Paid for legal fees">25,000</span> was paid for legal expenses. The outstanding balance of the promissory note is to be paid on the one-year anniversary of the issuance of the note. Interest on the note accrues at the rate of 10% compounding daily. Subject to the terms and conditions set forth in the note, the Company may prepay all or any portion of the outstanding balance of the note at any time in an amount in cash equal to 120% of the amount repaid. In connection with transactions that generate less than $1,000,000 in proceeds, the Company had agreed to not issue any debt instrument or incurrence of any debt other than trade payables in the ordinary course of business, any securities or agreements to sell common stock with anti-dilution or price reset/reduction features or any securities that are or may be become convertible or exercisable into common stock with a price that varies with the market price of the common stock (collectively, “Restricted Issuance Transaction”). The outstanding balance of the Note will be increased by 5% in the event the Company enters into a Restricted Issuance Transaction that is approved by Iliad. The original issue discount is being amortized to interest expense over the term of the promissory note.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On February 27, 2020, the Company and Iliad entered into an Amendment to the Iliad Note pursuant to which the maturity date of the Iliad Note was extended to August 27, 2020, provided that the Debt may be converted into shares of common stock of the Company at a conversion price equal to 80% multiplied by the lowest trading daily VWAP for the common stock during the 20 trading day period ending on the latest complete trading day prior to the conversion date, provided for the payment by the Company to Iliad of an extension fee equal to 7.5% of the outstanding balance of the Iliad Note resulting in a new balance of the Iliad Note of $2,765,983 and provided that the Company’s failure to deliver shares of common stock within three trading days of a conversion would result in an event of default. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. Iliad  agreed to restrict its ability to convert the Iliad Note and receive shares of common stock such that the number of shares of common stock held by it and its affiliates after such conversion or exercise does not exceed 9.99% of the then issued and outstanding shares of common stock. On July 20, 2020 the Company and Iliad entered into agreement to extend the maturity of the Iliad Note until February 27, 2021 for an extension fee of $<span id="xdx_905_ecustom--MaturityDateExtensionFees_c20210701__20210720__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--IliadMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Maturity date extension fees">1,000</span>. On February 28, 2021 the Company and Iliad entered into agreement to further extend the maturity of the Iliad Note until May 31, 2021 for an extension fee of $1,000 representing the third extension of the original note. On May 19, 2021, the Company and Iliad entered into agreement to further extend the maturity of the Iliad Note until August 31, 2021 for an extension fee of $1,000 representing the fourth extension of the original note. On August 20, 2021, the Company and Iliad entered into agreement to further extend the maturity of the Iliad Note until December 31, 2021 for an extension fee of $<span id="xdx_906_ecustom--MaturityDateExtensionFees_pp0p0_c20200802__20200820_zYAFFI2sZzPi" title="Maturity date extension fees">1,000</span>. During the year ended December 31, 2021, Iliad converted $2,508,737 of its convertible note into <span id="xdx_90D_eus-gaap--ConversionOfStockSharesConverted1_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--IliadMember_zMts9mOEnKTd" title="Number of shares converted">4,053,069</span> shares of the Company’s common stock. The balance of the Iliad debt at December 31, 2022 and December 31, 2021 was $<span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumNet_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--IliadMember_pp0p0" title="Amortization of debt discount">0</span> and $<span id="xdx_902_eus-gaap--DebtInstrumentUnamortizedDiscountPremiumNet_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--IliadMember_pp0p0" title="Amortization of debt discount">0</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Sixth Street Lending LLC – named changed - 1800 Diagonal Lending LLC</i> - First Note</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On November 8, 2021, the Company entered into a Securities Purchase Agreement with Sixth Street Lending LLC (“Sixth Street”) pursuant to which the Company issued to Sixth Street a Convertible Promissory Note (the “Sixth Street Note”) of $<span id="xdx_906_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20211102__20211108__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SixthStreetLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Value of share converted">124,200</span> for $<span id="xdx_90C_ecustom--PurchasePrice_pp0p0_c20211102__20211108__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SixthStreetLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z4HZFpzmz8Rf" title="Purchase Price">103,500</span>. The Sixth Street Note had a maturity date of <span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDate_dd_c20211102__20211108__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SixthStreetLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zqeJbT9SAX6g" title="Note maturity date">February 8, 2023</span> and the Company agreed to pay interest on the unpaid principal balance of the note at <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20211108__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SixthStreetLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zMl0jScvVk4j" title="Note payable, interest rate">6</span>% from the date on which the note is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the note, provided it makes a payment including a prepayment to Sixth Street as set forth in the Sixth Street Note. The outstanding principal amount of the note may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180<sup>th</sup> day, Sixth Street may convert the note into shares of the Company’s common stock at a conversion price equal to 85% of the average of the two lowest trading prices with a 20-day look back immediately preceding the date of conversion. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the Sixth Street Note), the note shall become immediately due and payable and the Company shall pay to Sixth Street, in full satisfaction of its obligations hereunder, additional amounts as set forth in the Sixth Street Note. During the year ended December 31, 2022, Sixth Street converted the entire note into <span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SixthStreetMember_pdd" title="Conversion of debt">26,343,190</span> shares of the Company’s common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Outstanding Notes</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Sixth Street Lending LLC – named changed - 1800 Diagonal Lending LLC</i> - <i>Second Note</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 5, 2022, the Company entered into a Securities Purchase Agreement with 1800 Diagonal Lending LLC, an accredited investor (“DL”), pursuant to which the Company issued to DL a Convertible Promissory Note (the “DL Note”) of $<span id="xdx_909_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20220502__20220505__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Value of share converted">244,500</span> for $<span id="xdx_901_ecustom--PurchasePrice_c20220502__20220505__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Purchase Price">203,500</span>. The DL Note had a maturity date of <span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_dd_c20220502__20220505__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zuXkNIrgQa1e" title="Note maturity date">August 4, 2023</span> and the Company had agreed to pay interest on the unpaid principal balance of the DL Note at <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20220505__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zuDhkew4vwTc" title="Note payable, interest rate">6.0</span>% from the date on which the DL Note is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the DL Note at any time from the Issue Date and continuing through 180 days following the Issue Date, provided it makes a payment including a prepayment premium to DL as set forth in the DL Note. The transactions described above funded on May 9, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The outstanding principal amount of the DL Note may not be converted prior to the period beginning on the date that is 180 days following the Issue Date. Following the 180<sup>th</sup> day, DL may convert the DL Note into shares of <span style="color: #333333">the Company’s </span>common stock <span style="color: #333333">at a conversion price </span>equal to 85% of the lowest trading price during the 20-day period immediately preceding the date of conversion. In addition, upon the occurrence and during the continuation of an Event of Default (as defined in the DL Note), the DL Note shall become immediately due and payable and the Company shall pay to DL, in full satisfaction of its obligations hereunder, additional amounts as set forth in the DL Note. In no event shall DL be allowed to effect a conversion if such conversion, along with all other shares of Company common stock beneficially owned by DL and its affiliates would exceed 4.99% of the outstanding shares of the common stock of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Unless the Company shall have first delivered to DL, at least 48 hours prior to the closing of any equity (or debt with an equity component) financing in an amount less than $150,000 (“Future Offering”), written notice describing the proposed Future Offering and providing the Buyer an option during the 48 hour period following delivery of such notice to DL the securities being offered in the Future Offering on the same terms as contemplated by such Future Offering then the Company is restricted from conducting the Future Offering during the period beginning on the Issue Date and ending nine months following the Issue Date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December 31, 2022, <span id="xdx_908_ecustom--ConvertibleNotePayableDescription_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DiagonalLendingMember_zqCZIOHwhkN6" title="Convertible note payable, description">1800 Diagonal lending converted $130,400 of the convertible note into 222,091,971 shares of the Company’s common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">As of December 31, 2022, the note had an outstanding balance of $<span id="xdx_903_eus-gaap--ConvertibleDebt_iI_pp0p0_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DiagonalLending1Member_zW5SIiYo4upi" title="Convertible debt">114,100</span> and accrued interest of $<span id="xdx_900_ecustom--AccruedInterest_iI_pp0p0_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DiagonalLending1Member_zow1vRnYKSJg" title="Accrued interest">7,674</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Sixth Street Lending LLC – named changed - 1800 Diagonal Lending LLC</i> - <i>Third Note</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 13, 2022, the Company entered into a Securities Purchase Agreement (dated September 9, 2022) with 1800 Diagonal Lending LLC, an accredited investor (“DL”) pursuant to which the Company issued to DL a Promissory Note (the “DL Note”) of $<span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20220902__20220913__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Value of share converted">116,200</span> with an original issue discount of $12,450 resulting in net proceeds of the Company of $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfDebt_c20220902__20220913__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Net proceeds">103,750</span>. The DL Note had a maturity date of <span id="xdx_905_eus-gaap--DebtInstrumentMaturityDate_dd_c20220902__20220913__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zx6poeCBu294" title="Note maturity date">September 9, 2023</span> and the Company had agreed to pay interest on the unpaid principal balance of the DL Note at the rate of 12.0% from the date on which the DL Note is issued (the “Issue Date”). A one-time interest charge of <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20220913__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zQ6IqavLLjgk" title="Note payable, interest rate">12</span>% or $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_c20220913__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Principal amount">13,944</span> was applied on the Issue Date to the principal amount owed under the DL Note. Accrued, unpaid interest and outstanding principal, subject to adjustment, shall be paid in ten payments of $13,014.40 resulting in a total payback to DL of $130,144. The first payment is due October 30, 2022 with nine subsequent payments each month thereafter. The Company shall have a five-day grace period with respect to each payment. The Company has right to accelerate payments or prepay in full at any time with no prepayment penalty. This DL Note shall not be secured by any collateral or any assets of the Company. The outstanding principal amount of the DL Note may not be converted into the Company common shares except in the event of default. In the event of default on the DL Note, DL may convert the DL Note into shares of the Company’s common stock <span style="color: #333333">at a conversion price </span>equal to <span id="xdx_907_eus-gaap--DebtConversionConvertedInstrumentRate_dp_c20220902__20220913__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zD5bRZWgKsp4" title="Conversion price">75</span>% of the lowest trading price with a 10-day look back immediately preceding the date of conversion. In addition, upon the occurrence and during the continuation of an event of default (as defined in the DL Note), the DL Note shall become immediately due and payable and the Company shall pay to DL, in full satisfaction of its obligations hereunder, additional amounts as set forth in the DL Note. In no event shall DL be allowed to effect a conversion if such conversion, along with all other shares of Company common stock beneficially owned by DL and its affiliates would exceed <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220902__20220913__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DiagonalLendingLLCMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zswtmpBcvEL4" title="Interest rate">4.99</span>% of the outstanding shares of the common stock of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December 31, 2022, the company paid back $<span id="xdx_90C_eus-gaap--RepaymentsOfConvertibleDebt_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DiagonalLendingMember_zMnblx3aePCa" title="Convertible note paid">39,043</span> to 1800 Diagonal lending.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">As of December 31, 2022, the note had an outstanding balance of $<span id="xdx_90B_eus-gaap--ConvertibleDebt_iI_pp0p0_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DiagonalLendingMember__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zFkOQ1c6Gaa7" title="Convertible debt">77,157</span> and an interest of $<span id="xdx_90C_ecustom--AccruedInterest_iI_pp0p0_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DiagonalLendingMember__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zHvHbof9tUbg" title="Accrued interest">13,944</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">As of December 31, 2022 and December 31, 2021, the nonrelated party convertible notes had total outstanding balance of $<span id="xdx_903_eus-gaap--OtherLongTermNotesPayable_iI_pp0p0_c20221231_zpXTN0i1QwPa" title="Outstanding balance">6,393,497</span> and <span id="xdx_90E_eus-gaap--OtherLongTermNotesPayable_iI_pp0p0_c20211231_zpfiM7BGzQZ2" title="Outstanding balance">8,145,233</span>, net of debt discount, and accrued interest of $<span id="xdx_902_eus-gaap--InterestPayableCurrentAndNoncurrent_c20221231_pp0p0" title="Accrued interest">2,068,799</span> and $<span id="xdx_905_eus-gaap--InterestPayableCurrentAndNoncurrent_c20211231_pp0p0" title="Accrued interest">1,547,924</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Convertible notes payable – related parties at December 31, 2022 and 2021 consist of the following:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ConvertibleDebtTableTextBlock_zbwX1aTZSynj" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Convertible Notes Payable, Non-related Partied and Related Party (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B0_zqAWzJV3Z501" style="display: none">Summary of convertible notes payable</span></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_490_20221231_z584pSv3qsbb" style="font-size: 10pt; text-align: center"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_497_20211231_zrVGmoTdPXG8" style="font-size: 10pt; text-align: center"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr> <tr id="xdx_405_ecustom--ConvertibleNotePayableToStanleyHills_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible note payable to Stanley Hills</span></td><td style="width: 8%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 12%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116,605</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 12%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116,605</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_ecustom--UnamortizedDebtDiscountAtConvertibleNotePayable_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unamortized debt discount</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1301">—</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1302">—</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_ecustom--OtherConvertibleNotesPayableCurrent_iI_pp0p0_zuRxPuk0EiL8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible notes payable, net, related party</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116,605</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116,605</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_ecustom--LessCurrentPortionOfConvertibleNotePayable_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less current portion</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(116,605</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(116,605</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40F_ecustom--ConvertibleNotesPayableNetRelatedPartyLongtermPortion_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible notes payable, net, related party, long-term portion</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1310">—</span></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1311">—</span></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A5_zxlPQfzU54G3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Stanley Hills LLC</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company entered into a series of loan agreements with Stanley Hills LLC (“Stanley”) pursuant to which it received more than $<span id="xdx_907_eus-gaap--ProceedsFromLoans_c20190503__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_pp0p0" title="Proceeds from loans">1,000,000</span> in loans (the “Debt”) from May 2019 up to December 2019. On February 26, 2020, in order to induce Stanley to continue to provide funding, the Company and Stanley entered into a letter agreement providing that the current note payable balance due to Stanley of $<span id="xdx_90D_eus-gaap--NotesPayableCurrent_c20200226__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_pp0p0" title="Note payable current">1,214,900</span> may be converted into shares of common stock of the Company at a conversion price equal to 85% multiplied by the lowest one trading price for the common stock during the 20-trading day period ending on the latest complete trading day prior to the conversion date. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. Stanley had agreed to restrict its ability to convert the Debt and receive shares of common stock such that the number of shares of common stock held by it and its affiliates after such conversion or exercise does not exceed 4.99% of the then issued and outstanding shares of common stock. During the year ended December 31, 2021, Stanley converted $<span id="xdx_902_eus-gaap--ConvertibleDebt_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_pp0p0" title="Convertible debt">1,231,466</span> of its convertible note plus interest into <span id="xdx_905_ecustom--ConvertibleShares_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_pdd" title="Convertible shares">4,420,758</span> shares of the Company’s common stock, and during the year ended December 31, 2021, Stanley loaned the Company an additional $<span id="xdx_900_eus-gaap--ProceedsFromLoans_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_pp0p0" title="Proceeds from loans">325,000</span>. Also, during the year ended December 31, 2021, the Company transferred the SURG shares received as repayment of $<span id="xdx_904_eus-gaap--RepaymentsOfDebt_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_pp0p0" title="Repayment of debt">800,000</span> of this convertible note (See Note 10) and also converted $<span id="xdx_90D_eus-gaap--ConvertibleDebt_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_pp0p0" title="Convertible debt">126,003</span> of accrued interest into the principal balance. During the year ended December 31, 2021, Gonzalez assigned all his accrued balances of $<span id="xdx_903_eus-gaap--InterestPayableCurrent_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_pp0p0" title="Accrued interest">424,731</span> to Stanley in a private transaction that the Company is not part to (See Note 10). As of December 31, 2022 and 2021 the principal balance of Stanley debt is $<span id="xdx_90C_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_zwX0uqpbnS83" title="Convertible note payable">116,605</span> and <span id="xdx_903_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_zVUnYPw8CYXi" title="Convertible note payable">116,605</span> respectively. The unpaid interest of the Stanley debt at December 31, 2022 and 2021 was $<span id="xdx_906_ecustom--UnpaidInterestDebt_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_pp0p0" title="Unpaid interest debt">20,033</span> and $<span id="xdx_905_ecustom--UnpaidInterestDebt_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_pp0p0" title="Unpaid interest debt">8,372</span>, respectively. The Stanley debt is secured via a pledge agreement on the SURG shares.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Discounts on convertible notes</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognized interest expense of $<span id="xdx_90F_eus-gaap--InterestExpense_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" title="Interest expense">438,015</span> and $<span id="xdx_90D_eus-gaap--InterestExpense_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" title="Interest expense">824,238</span> during the years ended December 31, 2022 and 2021, respectively, related to the amortization of the debt discount on convertible notes. The unamortized debt discount at December 31, 2022 and 2021 was $<span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" title="Unamortized debt discount">189,060</span> and $<span id="xdx_90F_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" title="Unamortized debt discount">278,867</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A roll-forward of the convertible notes payable from December 31, 2020 to December 31, 2022 is below:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfRollForwardConvertibleNotesPayableTableTextBlock_zUPXM173M0q4" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Convertible Notes Payable, Non-related Partied and Related Party (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B7_z9m7v39eSRYk" style="display: none">Schedule of roll forward convertible notes payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; width: 70%; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible notes payable, December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--ConvertibleNotesPayable_iS_pp0p0_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zuAsBIoe7d5" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Convertible notes payable, at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,426,706</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued for cash</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--NotesIssued1_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issued for cash"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">983,450</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible note issued for accounts payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--ConvertibleNoteIssuedForAccountsPayable_pp0p0_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zsXi31Eo7zEg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible note issued for accounts payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">625,429</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued interest added to convertible note</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eus-gaap--InterestOnConvertibleDebtNetOfTax_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accrued interest added to convertible note"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">234,521</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment with marketable securities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_ecustom--PaymentWithMarketableSecurities_pp0p0_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zQUc8rxQFTY9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Payment with marketable securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,460,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment with cash</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--PaymentsForDeposits_iN_pp0p0_di_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zFi7ZSPTApei" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Payment with cash"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(106,200</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Original issue discount</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_ecustom--OriginalIssueDiscount_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Original issue discount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127,550</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion to common stock</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--ConversionToCommonStock_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Conversion to common stock"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,649,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt discount related to new convertible notes</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--DebtDiscountRelatedToNewConvertibleNotes_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Debt discount related to new convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(741,100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization of debt discounts</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--AmortizationOfDebtDiscountPremiums_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amortization of debt discounts"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">819,423</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible notes payable, December 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--ConvertibleNotesPayable_iS_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z5yJtKU06Snc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible notes payable, at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,261,839</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued for cash</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--NotesIssued1_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issued for cash"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">300,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment with cash</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--PaymentsForDeposits_iN_pp0p0_di_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zrPuGDjLRWmc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Payment with cash"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(39,042</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Original issue discount</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--OriginalIssueDiscount_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Original issue discount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,700</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion to common stock</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_ecustom--ConversionToCommonStock_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Conversion to common stock"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,158,971</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt discount related to new convertible notes</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--DebtDiscountRelatedToNewConvertibleNotes_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Debt discount related to new convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(352,441</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization of debt discounts</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--AmortizationOfDebtDiscountPremiums_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amortization of debt discounts"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">442,247</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible notes payable, December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--ConvertibleNotesPayable_iE_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zWUQvykAPIpi" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible notes payable, at end"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,514,332</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A1_zT5aS7YrK0G8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--RollfowardOfConvertibleNoteTableTextBlock_zbkaIdsJli5b" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Convertible Notes Payable, Non-related Partied and Related Party (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><span id="xdx_8BB_zFBp35fdhF8" style="display: none">Schedule of rollfoward of convertible note</span></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible note payable to GBT Technologies S.A</span></td><td style="width: 8%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--ConvertibleDebt_iI_pp0p0_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GBTTechnologiesSAMember_zXBlMCOt0HQ" style="width: 12%; font-size: 10pt; text-align: right" title="Total convertible notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,395,531</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--ConvertibleDebt_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GBTTechnologiesSAMember_zfRjguTvogBh" style="width: 12%; font-size: 10pt; text-align: right" title="Total convertible notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,055,400</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible notes payable to 1800</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--ConvertibleDebt_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DiagonalLendingMember_pp0p0" style="font-size: 10pt; text-align: right" title="Total convertible notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">191,257</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--ConvertibleDebt_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DiagonalLendingMember_pp0p0" style="font-size: 10pt; text-align: right" title="Total convertible notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">124,200</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible notes payable to Redstart Holdings</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eus-gaap--ConvertibleDebt_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsMember_pp0p0" style="font-size: 10pt; text-align: right" title="Total convertible notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1096">—</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--ConvertibleDebt_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedstartHoldingsMember_pp0p0" style="font-size: 10pt; text-align: right" title="Total convertible notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">244,500</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total convertible notes payable, non related parties</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--ConvertibleDebt_c20221231_pp0p0" style="font-size: 10pt; text-align: right" title="Total convertible notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,586,788</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ConvertibleDebt_c20211231_pp0p0" style="font-size: 10pt; text-align: right" title="Total convertible notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,424,100</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unamortized debt discount</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_ecustom--DebtInstrumentsUnamortizedDiscountNoncurrent_c20221231_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Unamortized debt discount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(189,060</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_ecustom--DebtInstrumentsUnamortizedDiscountNoncurrent_c20211231_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Unamortized debt discount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(278,867</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible notes payable – non related parties</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--OtherNotesPayableCurrent_c20221231_pp0p0" style="font-size: 10pt; text-align: right" title="Convertible note payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,397,727</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--OtherNotesPayableCurrent_c20211231_pp0p0" style="font-size: 10pt; text-align: right" title="Convertible note payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,145,233</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less current portion</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--LessCurrentPortion_c20221231_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Less current portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,397,727</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_ecustom--LessCurrentPortion_c20211231_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Less current portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,109,436</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible notes payable – non related parties, long-term portion</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--ConvertibleLongTermNotesPayable_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Convertible notes payable, long-term portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1116">—</span></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--ConvertibleLongTermNotesPayable_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Convertible notes payable, long-term portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,797</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 6395531 8055400 191257 124200 244500 6586788 8424100 -189060 -278867 6397727 8145233 6397727 -8109436 35797 10000000 2021-12-31 20000 500 0.85 13777480 IGOR 1 converted $1,284,600 of the convertible note into 4,185,650 shares of the Company’s common stock. On June 24, 2021, the Company transferred 5,500,000 SURG shares received as repayment of $660,000 of this convertible note IGOR 1 converted $1,659,869 of the convertible note into 590,117,647 shares of the Company’s common stock. 6395531 2027148 153600 128000 2021-11-03 0.06 153600 226532 93600 78000 2021-09-15 0.06 93600 89169 184200 153500 2022-02-05 0.06 184200 386146 106200 88500 0.06 106200 317837 0.06 141782 244500 2022-12-22 7656951 300000 2025000 25000 1000 1000 4053069 0 0 124200 103500 2023-02-08 0.06 26343190 244500 203500 2023-08-04 0.060 1800 Diagonal lending converted $130,400 of the convertible note into 222,091,971 shares of the Company’s common stock. 114100 7674 116200 103750 2023-09-09 0.12 13944 0.75 0.0499 39043 77157 13944 6393497 8145233 2068799 1547924 <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ConvertibleDebtTableTextBlock_zbwX1aTZSynj" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Convertible Notes Payable, Non-related Partied and Related Party (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B0_zqAWzJV3Z501" style="display: none">Summary of convertible notes payable</span></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_490_20221231_z584pSv3qsbb" style="font-size: 10pt; text-align: center"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_497_20211231_zrVGmoTdPXG8" style="font-size: 10pt; text-align: center"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr> <tr id="xdx_405_ecustom--ConvertibleNotePayableToStanleyHills_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible note payable to Stanley Hills</span></td><td style="width: 8%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 12%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116,605</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 12%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116,605</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_ecustom--UnamortizedDebtDiscountAtConvertibleNotePayable_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unamortized debt discount</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1301">—</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1302">—</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_ecustom--OtherConvertibleNotesPayableCurrent_iI_pp0p0_zuRxPuk0EiL8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible notes payable, net, related party</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116,605</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116,605</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_ecustom--LessCurrentPortionOfConvertibleNotePayable_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less current portion</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(116,605</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(116,605</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40F_ecustom--ConvertibleNotesPayableNetRelatedPartyLongtermPortion_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible notes payable, net, related party, long-term portion</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1310">—</span></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1311">—</span></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 116605 116605 116605 116605 -116605 -116605 1000000 1214900 1231466 4420758 325000 800000 126003 424731 116605 116605 20033 8372 438015 824238 189060 278867 <table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfRollForwardConvertibleNotesPayableTableTextBlock_zUPXM173M0q4" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Convertible Notes Payable, Non-related Partied and Related Party (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B7_z9m7v39eSRYk" style="display: none">Schedule of roll forward convertible notes payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; width: 70%; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible notes payable, December 31, 2020</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--ConvertibleNotesPayable_iS_pp0p0_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zuAsBIoe7d5" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Convertible notes payable, at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,426,706</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued for cash</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--NotesIssued1_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issued for cash"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">983,450</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible note issued for accounts payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--ConvertibleNoteIssuedForAccountsPayable_pp0p0_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zsXi31Eo7zEg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible note issued for accounts payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">625,429</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued interest added to convertible note</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eus-gaap--InterestOnConvertibleDebtNetOfTax_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accrued interest added to convertible note"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">234,521</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment with marketable securities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_ecustom--PaymentWithMarketableSecurities_pp0p0_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zQUc8rxQFTY9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Payment with marketable securities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,460,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment with cash</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--PaymentsForDeposits_iN_pp0p0_di_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zFi7ZSPTApei" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Payment with cash"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(106,200</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Original issue discount</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_ecustom--OriginalIssueDiscount_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Original issue discount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127,550</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion to common stock</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--ConversionToCommonStock_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Conversion to common stock"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,649,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt discount related to new convertible notes</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--DebtDiscountRelatedToNewConvertibleNotes_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Debt discount related to new convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(741,100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization of debt discounts</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--AmortizationOfDebtDiscountPremiums_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amortization of debt discounts"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">819,423</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible notes payable, December 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--ConvertibleNotesPayable_iS_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z5yJtKU06Snc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible notes payable, at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,261,839</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued for cash</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--NotesIssued1_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issued for cash"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">300,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment with cash</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--PaymentsForDeposits_iN_pp0p0_di_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zrPuGDjLRWmc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Payment with cash"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(39,042</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Original issue discount</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--OriginalIssueDiscount_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Original issue discount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,700</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion to common stock</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_ecustom--ConversionToCommonStock_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Conversion to common stock"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,158,971</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt discount related to new convertible notes</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--DebtDiscountRelatedToNewConvertibleNotes_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Debt discount related to new convertible notes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(352,441</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization of debt discounts</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--AmortizationOfDebtDiscountPremiums_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_pp0p0" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amortization of debt discounts"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">442,247</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible notes payable, December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--ConvertibleNotesPayable_iE_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zWUQvykAPIpi" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible notes payable, at end"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,514,332</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 13426706 983450 625429 234521 -1460000 106200 127550 -5649000 -741100 819423 8261839 300000 39042 60700 -2158971 -352441 442247 6514332 <p id="xdx_804_ecustom--NotesPayableTextBlock_zYAzuMd9BdFa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_82B_zfYrTGIPmxae">Note –11 - <span id="xdx_82F_zHtJnaPg1uOh">Notes Payable, Non-related Parties and Related Party</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Notes payable, non-related parties at December 31, 2022 and December 31, 2021 consist of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--NotesPayableTableTextBlock_zv9FnxfCMG6h" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Notes Payable, Non-related Parties and Related Party (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B9_z4kSrA0hMZBd" style="display: none">Schedule of notes payable</span></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RWJ acquisition note</span></td><td style="width: 8%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_ecustom--TotalNotesPayable_c20221231__us-gaap--BusinessAcquisitionAxis__custom--RWJAdvancedMarketingLLCMember_pp0p0" style="width: 12%; font-size: 10pt; text-align: right" title="Total notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1393">—</span></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_ecustom--TotalNotesPayable_c20211231__us-gaap--BusinessAcquisitionAxis__custom--RWJAdvancedMarketingLLCMember_pp0p0" style="width: 12%; font-size: 10pt; text-align: right" title="Total notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,600,000</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SBA loan</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--TotalNotesPayable_c20221231__us-gaap--DebtInstrumentAxis__custom--SBALoanMember_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Total notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">350,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_ecustom--TotalNotesPayable_c20211231__us-gaap--DebtInstrumentAxis__custom--SBALoanMember_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Total notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">350,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total notes payable</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--TotalNotesPayables_c20221231_pp0p0" style="font-size: 10pt; text-align: right" title="Total notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">350,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--TotalNotesPayables_c20211231_pp0p0" style="font-size: 10pt; text-align: right" title="Total notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,950,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unamortized debt discount</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_ecustom--DebtInstrumentsUnamortizedDiscountCurrent_iI_pp0p0_c20221231_zwQpc4KO9Qji" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Unamortized debt discount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1405">—</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_ecustom--DebtInstrumentsUnamortizedDiscountCurrent_iI_pp0p0_c20211231_z7b2How1OlR7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Unamortized debt discount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1407">—</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes payable</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--NotePayables_c20221231_pp0p0" style="font-size: 10pt; text-align: right" title="Notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">350,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--NotePayables_c20211231_pp0p0" style="font-size: 10pt; text-align: right" title="Notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,950,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less current portion</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_ecustom--CurrentPortionOfNotesPayables_c20221231_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Less current portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(41,137</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--CurrentPortionOfNotesPayables_c20211231_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Less current portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,612,397</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes payable, long-term portion</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_ecustom--LongTermNotePayables_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Notes payable, long-term portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">308,863</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_ecustom--LongTermNotePayables_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Notes payable, long-term portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">337,603</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AC_zsHR1WbCgUx8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>RWJ Acquisition Note</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with the acquisition of RWJ in September 2017, the Company issued a note payable. The note accrues interest at <span id="xdx_903_eus-gaap--AccountsPayableInterestBearingInterestRate_iI_dp_c20191231__us-gaap--BusinessAcquisitionAxis__custom--RWJAdvancedMarketingLLCMember_zdl1NpqPTVE7" title="Interest rate">3.5</span>%, was due on December 31, 2019 and is secured by the assets purchased in the acquisition. The Company contests the validity of the note, as such the note has not been repaid as of December 31, 2021. The balance of the note at December 31, 2022 and 2021 was $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_c20221231__us-gaap--BusinessAcquisitionAxis__custom--RWJAdvancedMarketingLLCMember_pp0p0" title="Principal amount">0</span> and $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_c20211231__us-gaap--BusinessAcquisitionAxis__custom--RWJAdvancedMarketingLLCMember_pp0p0" title="Principal amount">2,600,000</span> plus accrued interest of $<span id="xdx_90E_eus-gaap--InterestPayableCurrent_c20221231__us-gaap--BusinessAcquisitionAxis__custom--RWJAdvancedMarketingLLCMember_pp0p0" title="Accrued interest">0</span> and $<span id="xdx_909_eus-gaap--InterestPayableCurrent_c20211231__us-gaap--BusinessAcquisitionAxis__custom--RWJAdvancedMarketingLLCMember_pp0p0" title="Accrued interest">394,666</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>SBA Loan</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 22, 2020, the Company received a loan from the Small Business Administration under the Economic Injury Disaster Loan program related to the COVID-19 relief efforts. The loan bears interest at <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200601__20200622__us-gaap--LongtermDebtTypeAxis__custom--EIDLMember_zt6rQgbi8zQb" title="Interest rate">3.75</span>%, requires monthly principal and interest payments of $<span id="xdx_905_eus-gaap--DebtInstrumentPeriodicPayment_c20200601__20200622__us-gaap--LongtermDebtTypeAxis__custom--EIDLMember_pp0p0" title="Principal periodic payments">731</span> after 12 months from funding and is due <span id="xdx_908_eus-gaap--DebtInstrumentTerm_dtY_c20200601__20200622__us-gaap--LongtermDebtTypeAxis__custom--EIDLMember_z7rRyeGDkqcc" title="Term">30</span> years from the date of issuance. The monthly payments have been extended by the SBA to all EIDL borrowers with additional 12 months. Monthly payments will be commenced on or around June 16, 2022. On October 1, 2021, the Company entered an Amended Loan Authorization and Agreement with the SBA providing for the modification of the Original Note providing for monthly principal and interest payments of $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20211002__us-gaap--DebtInstrumentAxis__custom--SBALoanMember_zir8rwDYoLQ1" title="Principal amount">1,771</span> after 24 months from the Original Note commencing on or around June 22, 2022. On March 17, 2022 the SBA notified it deferred the payments to all COVID-19 EIDL loans will have the first payment due extended from 24-months to 30-months from the date of the note. The Modified Note will continue to bear interest at <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_c20211002__us-gaap--DebtInstrumentAxis__custom--SBALoanMember_zoNuwJpJhQ13" title="Interest rate">3.75</span>% and is due 30 years from the date of issuance of the Original Note. The Modified Note is guaranteed by Douglas Davis, the former CEO of the Company and current consultant, as well as by GBT Tokenize Corp. The additional funding of $<span id="xdx_906_eus-gaap--ProceedsFromOtherDebt_c20211003__20211005__us-gaap--DebtInstrumentAxis__custom--SBALoanMember_pp0p0" title="Proceeds from debt">200,000</span> was received by the Company on October 5, 2021. The balance of the note at December 31, 2022 and 2021 was $<span id="xdx_908_eus-gaap--NotesPayable_c20221231__us-gaap--DebtInstrumentAxis__custom--SBALoanMember_pp0p0" title="Note payable">350,000</span> and $<span id="xdx_909_eus-gaap--NotesPayable_c20211231__us-gaap--DebtInstrumentAxis__custom--SBALoanMember_pp0p0" title="Note payable">350,000</span> plus accrued interest of $<span id="xdx_907_eus-gaap--InterestPayableCurrent_c20221231__us-gaap--DebtInstrumentAxis__custom--SBALoanMember_pp0p0" title="Accrued interest">23,707</span> and $<span id="xdx_906_eus-gaap--InterestPayableCurrent_c20211231__us-gaap--DebtInstrumentAxis__custom--SBALoanMember_pp0p0" title="Accrued interest">10,582</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Notes payable, related party at December 31, 2022 and December 31, 2021 consist of the following:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b/></p> <table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfNotePayableRelatedPartiesTableTextblock_zn8abDs1Dstf" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Notes Payable, Non-related Parties and Related Party (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BB_zeM1c6FMfI8i" style="display: none">Schedule of notes payable related parties</span></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alpha Eda note payable</span></td><td style="width: 8%; font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_ecustom--TotalNotesPayableRelatedParty_c20221231__us-gaap--BusinessAcquisitionAxis__custom--AlphaEdaMember_pp0p0" style="border-bottom: Black 1pt solid; width: 12%; font-size: 10pt; text-align: right" title="Total notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,000</span></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%; font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_ecustom--TotalNotesPayableRelatedParty_c20211231__us-gaap--BusinessAcquisitionAxis__custom--AlphaEdaMember_pp0p0" style="border-bottom: Black 1pt solid; width: 12%; font-size: 10pt; text-align: right" title="Total notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,000</span></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total notes payable, related party</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--TotalNotesPayableRelatedParties_c20221231_pp0p0" style="font-size: 10pt; text-align: right" title="Total notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_ecustom--TotalNotesPayableRelatedParties_c20211231_pp0p0" style="font-size: 10pt; text-align: right" title="Total notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unamortized debt discount</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--DebtInstrumentsUnamortizedDiscountCurrent_iI_pp0p0_c20221231_z2WeupVlCiYj" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Unamortized debt discount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1467">—</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_ecustom--DebtInstrumentsUnamortizedDiscountCurrent_iI_pp0p0_c20211231_z18vS4c7SUW7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Unamortized debt discount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1469">—</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes payable, net, related party</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--NotesPayableRelatedParties_c20221231_pp0p0" style="font-size: 10pt; text-align: right" title="Notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--NotesPayableRelatedParties_c20211231_pp0p0" style="font-size: 10pt; text-align: right" title="Notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less current portion</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--CurrentPortionOfNotePayableRelatedParties_c20221231_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Less current portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(140,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--CurrentPortionOfNotePayableRelatedParties_c20211231_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Less current portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(140,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes payable, net, related party, long-term portion</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_ecustom--NotesPayableNetRelatedPartyLongtermPortion_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Notes payable, net, related party, long-term portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1479">—</span></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_ecustom--NotesPayableNetRelatedPartyLongtermPortion_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Notes payable, net, related party, long-term portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1481">—</span></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A0_ziwTLGd5mSh8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Alpha Eda</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 15, 2020, the Company issued a promissory note to Alpha Eda, LLC (“Alpha”), a related party for $140,000. The note accrues interest at 10%, is unsecured and was due on September 30, 2021. On June 20, 2021 Alpha and the Company extended the note maturity to December 31, 2021. The balance of the note at December 31, 2022 and 2021 was $<span id="xdx_901_eus-gaap--NotesPayable_c20221231__us-gaap--DebtInstrumentAxis__custom--AlphaEdaMember_pp0p0" title="Note payable">140,000</span> and $<span id="xdx_900_eus-gaap--NotesPayable_c20211231__us-gaap--DebtInstrumentAxis__custom--AlphaEdaMember_pp0p0" title="Note payable">140,000</span> plus accrued interest of $<span id="xdx_908_eus-gaap--InterestPayableCurrent_c20221231__us-gaap--DebtInstrumentAxis__custom--AlphaEdaMember_pp0p0" title="Accrued interest">32,633</span> and $<span id="xdx_909_eus-gaap--InterestPayableCurrent_c20211231__us-gaap--DebtInstrumentAxis__custom--AlphaEdaMember_pp0p0" title="Accrued interest">16,633</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Discounts on Promissory Note</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognized interest expense of $<span id="xdx_907_eus-gaap--InterestExpense_c20210101__20211231__us-gaap--ShortTermDebtTypeAxis__custom--PromissoryNoteMember_zb2A7DyKpGF7" title="Interest expense">0</span> and $<span id="xdx_903_eus-gaap--InterestExpense_c20200101__20201231__us-gaap--ShortTermDebtTypeAxis__custom--PromissoryNoteMember_zNvWz5INyna7" title="Interest expense">47,671</span> during the years ended December 31, 2021 and 2020, respectively, related to the amortization of the debt discount on promissory notes. The unamortized debt discount at December 31, 2021 and 2020 was $<span id="xdx_909_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20201231__us-gaap--ShortTermDebtTypeAxis__custom--PromissoryNoteMember_z48hr3pUJJp" title="Debt Instrument, Unamortized Discount"><span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20211231__us-gaap--ShortTermDebtTypeAxis__custom--PromissoryNoteMember_zlBs3rYFbQz5" title="Debt Instrument, Unamortized Discount">0</span></span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--NotesPayableTableTextBlock_zv9FnxfCMG6h" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Notes Payable, Non-related Parties and Related Party (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B9_z4kSrA0hMZBd" style="display: none">Schedule of notes payable</span></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RWJ acquisition note</span></td><td style="width: 8%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_ecustom--TotalNotesPayable_c20221231__us-gaap--BusinessAcquisitionAxis__custom--RWJAdvancedMarketingLLCMember_pp0p0" style="width: 12%; font-size: 10pt; text-align: right" title="Total notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1393">—</span></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_ecustom--TotalNotesPayable_c20211231__us-gaap--BusinessAcquisitionAxis__custom--RWJAdvancedMarketingLLCMember_pp0p0" style="width: 12%; font-size: 10pt; text-align: right" title="Total notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,600,000</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SBA loan</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--TotalNotesPayable_c20221231__us-gaap--DebtInstrumentAxis__custom--SBALoanMember_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Total notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">350,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_ecustom--TotalNotesPayable_c20211231__us-gaap--DebtInstrumentAxis__custom--SBALoanMember_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Total notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">350,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total notes payable</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--TotalNotesPayables_c20221231_pp0p0" style="font-size: 10pt; text-align: right" title="Total notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">350,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--TotalNotesPayables_c20211231_pp0p0" style="font-size: 10pt; text-align: right" title="Total notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,950,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unamortized debt discount</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_ecustom--DebtInstrumentsUnamortizedDiscountCurrent_iI_pp0p0_c20221231_zwQpc4KO9Qji" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Unamortized debt discount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1405">—</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_ecustom--DebtInstrumentsUnamortizedDiscountCurrent_iI_pp0p0_c20211231_z7b2How1OlR7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Unamortized debt discount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1407">—</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes payable</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--NotePayables_c20221231_pp0p0" style="font-size: 10pt; text-align: right" title="Notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">350,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--NotePayables_c20211231_pp0p0" style="font-size: 10pt; text-align: right" title="Notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,950,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less current portion</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_ecustom--CurrentPortionOfNotesPayables_c20221231_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Less current portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(41,137</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--CurrentPortionOfNotesPayables_c20211231_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Less current portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,612,397</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes payable, long-term portion</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_ecustom--LongTermNotePayables_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Notes payable, long-term portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">308,863</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_ecustom--LongTermNotePayables_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Notes payable, long-term portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">337,603</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 2600000 350000 350000 350000 2950000 350000 2950000 -41137 -2612397 308863 337603 0.035 0 2600000 0 394666 0.0375 731 P30Y 1771 0.0375 200000 350000 350000 23707 10582 <table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleOfNotePayableRelatedPartiesTableTextblock_zn8abDs1Dstf" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Notes Payable, Non-related Parties and Related Party (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BB_zeM1c6FMfI8i" style="display: none">Schedule of notes payable related parties</span></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alpha Eda note payable</span></td><td style="width: 8%; font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_ecustom--TotalNotesPayableRelatedParty_c20221231__us-gaap--BusinessAcquisitionAxis__custom--AlphaEdaMember_pp0p0" style="border-bottom: Black 1pt solid; width: 12%; font-size: 10pt; text-align: right" title="Total notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,000</span></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%; font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_ecustom--TotalNotesPayableRelatedParty_c20211231__us-gaap--BusinessAcquisitionAxis__custom--AlphaEdaMember_pp0p0" style="border-bottom: Black 1pt solid; width: 12%; font-size: 10pt; text-align: right" title="Total notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,000</span></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total notes payable, related party</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--TotalNotesPayableRelatedParties_c20221231_pp0p0" style="font-size: 10pt; text-align: right" title="Total notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_ecustom--TotalNotesPayableRelatedParties_c20211231_pp0p0" style="font-size: 10pt; text-align: right" title="Total notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unamortized debt discount</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--DebtInstrumentsUnamortizedDiscountCurrent_iI_pp0p0_c20221231_z2WeupVlCiYj" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Unamortized debt discount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1467">—</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_ecustom--DebtInstrumentsUnamortizedDiscountCurrent_iI_pp0p0_c20211231_z18vS4c7SUW7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Unamortized debt discount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1469">—</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes payable, net, related party</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--NotesPayableRelatedParties_c20221231_pp0p0" style="font-size: 10pt; text-align: right" title="Notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--NotesPayableRelatedParties_c20211231_pp0p0" style="font-size: 10pt; text-align: right" title="Notes payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less current portion</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--CurrentPortionOfNotePayableRelatedParties_c20221231_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Less current portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(140,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--CurrentPortionOfNotePayableRelatedParties_c20211231_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Less current portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(140,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes payable, net, related party, long-term portion</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_ecustom--NotesPayableNetRelatedPartyLongtermPortion_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Notes payable, net, related party, long-term portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1479">—</span></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_ecustom--NotesPayableNetRelatedPartyLongtermPortion_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Notes payable, net, related party, long-term portion"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1481">—</span></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 140000 140000 140000 140000 140000 140000 -140000 -140000 140000 140000 32633 16633 0 47671 0 0 <p id="xdx_801_ecustom--AccruedSettlementTextBlock_zTQQZFIzCxVb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_82F_zzjLZe3eAWee">Note 12 – <span id="xdx_82F_zHE2a5q3c55">Accrued Settlement</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with a legal matter filed by the Investor of the $<span id="xdx_90F_eus-gaap--LossContingencyDamagesPaidValue_c20191201__20191223__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Legal matter">8,340,000</span> Senior Secured Redeemable Convertible Debenture, on December 23, 2019, in the pending arbitration between the Company and the Investor, an Interim Award was entered in favor of the Investor. On January 31, 2020, the Company was informed that a final award was entered (the “Final Award”). The Final Award affirms that certain sections of the Senior Secured Redeemable Convertible Debenture (the “Debenture”) constitute unenforceable liquidated damages penalties and were stricken. Further, it was determined that the Investor was entitled to recovery of their attorney’s fees. Consequently, the arbitrator awarded Investor an award of $<span id="xdx_903_ecustom--ArbitratorAwarded_c20190501__20190515__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Arbitrator awarded">4,034,444</span> plus interest of <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20190501__20190515__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zPlisAk8fOl7" title="Interest rate">7.25</span>% accrued from May 15, 2019 (presented separately in accounts payable and accrued expenses) and costs of $<span id="xdx_905_eus-gaap--InterestExpenseOtherDomesticDeposits_c20190501__20190515__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Interest">55,613</span>. (See Note 17). In connection with this settlement, the Company recognized a gain on the settlement of debt of $<span id="xdx_902_eus-gaap--GainsLossesOnRestructuringOfDebt_pp0p0_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z7IalmTOHLgb" title="Gain on settlement of debt">1,375,556</span> in 2019 as the difference between the carrying amount of the debt and the amount awarded by the arbitrator (See Note 17). The Company recorded accrued settlement of $<span id="xdx_905_ecustom--AccruedSettlement_c20221231_pp0p0" title="Accrued settlement">4,090,057</span> and $<span id="xdx_904_ecustom--AccruedSettlement_c20211231_pp0p0" title="Accrued settlement">4,090,057</span> at December 31, 2022 and 2021, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 8340000 4034444 0.0725 55613 1375556 4090057 4090057 <p id="xdx_806_eus-gaap--DerivativesAndFairValueTextBlock_zd2JEmpIuQzl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_821_zMUbmOlx2Ukg">Note 13 - <span id="xdx_82E_zhC1R2fe177d">Derivative Liability</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain of the convertible notes payable discussed in Note 10 have a conversion price that can be adjusted based on the Company’s stock price which results in the conversion feature being recorded as a derivative liability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The FV of the derivative liability is recorded and shown separately under current liabilities. Changes in the FV of the derivative liability is recorded in the statement of operations under other income (expense).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company uses a weighted average Black-Scholes option pricing model with the following assumptions to measure the FV of derivative liability at December 31, 2022 and 2021:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zNnayK3O87la" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Derivative Liability (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-indent: -10pt"><span id="xdx_8B7_zSZ8EDONPrGh" style="display: none">Schedule of assumptions to measure fair value</span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock price</span></td> <td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--SaleOfStockPricePerShare_iI_c20221231_zfKC0CeaRJz4" title="Stock price">0.001</span></span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_c20211231_zVoChm4OLXmg" title="Stock price">0.17</span></span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--SaleOfStockPricePerShare_iI_c20221231__srt--RangeAxis__srt--MinimumMember_z3EYJTZBsLU8" title="Stock price">4.42</span>-</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"/> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk free rate</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20221231_zi9Vm7tq6Yzi" title="Risk free rate">4.76</span></span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20211231__srt--RangeAxis__srt--MinimumMember_zphrIGgaUNog" title="Risk free rate">0.19</span>-<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20211231__srt--RangeAxis__srt--MaximumMember_zzmMRfWUnrt5" title="Risk free rate">0.39</span>%</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pip0_dp_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z2yBDwFNZbB4" title="Volatility">213</span>-<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pip0_dp_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zw9t14k7CGXa" title="Volatility">277</span>%</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pip0_dp_c20210101__20211231__srt--RangeAxis__srt--MinimumMember_zeHfBu9n9iVl" title="Volatility">167</span>-<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pip0_dp_c20210101__20211231__srt--RangeAxis__srt--MaximumMember_zKMRusOx6Yyf" title="Volatility">217</span>%</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20221231__srt--RangeAxis__srt--MinimumMember_zKjEpZR6yyzb" title="Conversion/ Exercise price">0.0015</span>-</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20211231__srt--RangeAxis__srt--MinimumMember_pdd" title="Conversion/ Exercise price">0.102</span>-</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion/ Exercise price</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20221231__srt--RangeAxis__srt--MaximumMember_pdd" title="Conversion/ Exercise price">0.0017</span></span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20211231__srt--RangeAxis__srt--MaximumMember_zU3XxO6ylTTd" title="Conversion/ Exercise price">0.103</span></span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend rate</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20220101__20221231_zXrQxFsuDRy6" title="Dividend rate">0</span></span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20210101__20211231_z1jiIBO8CWp5" title="Dividend rate">0</span></span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> </table> <p id="xdx_8A2_ztwje1KYU653" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table represents the Company’s derivative liability activity for the years ended December 31, 2022 and 2021:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_z8MFi7T8QKcc" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Derivative Liability (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B7_z81jB9hCSt3e" style="display: none">Derivative instruments and hedging activities</span></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability balance, December 31, 2019</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--DerivativeLiabilities_iS_pp0p0_c20200101__20201231_zw1KpTiCgbqa" style="font-size: 10pt; text-align: right" title="Derivative liability balance, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1559">—</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; width: 70%; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance of derivative liability during the period</span></td><td style="width: 10%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_pp0p0_c20200101__20201231_zXvsZKVaNhFf" style="width: 18%; font-size: 10pt; text-align: right" title="Issuance of derivative liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,767,230</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of beneficial conversion feature of debt converted</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_ecustom--FairValueOfBeneficialConversionFeatureOfDebtConverted_pp0p0_c20200101__20201231_zu6EqXfEit8i" style="font-size: 10pt; text-align: right" title="Fair value of beneficial conversion feature of debt converted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,038,392</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in derivative liability during the period</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLos_pp0p0_c20200101__20201231_zBM57Dozt3Of" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Change in derivative liability during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,533,610</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability balance, December 31, 2020</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--DerivativeLiabilities_iS_pp0p0_c20210101__20211231_znKPr4yQHmA5" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Derivative liability balance, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,262,448</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt modification</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--DebtModification_pp0p0_c20210101__20211231_zHaQLQUVKGTi" style="font-size: 10pt; text-align: right" title="Debt modification"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,777,480</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance of derivative liability during the period</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_pp0p0_c20210101__20211231_z0oCXXGnJbj" style="font-size: 10pt; text-align: right" title="Issuance of derivative liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,480,439</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of beneficial conversion feature of debt converted</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--FairValueOfBeneficialConversionFeatureOfDebtConverted_pp0p0_c20210101__20211231_zSL7vGcJ6qJd" style="font-size: 10pt; text-align: right" title="Fair value of beneficial conversion feature of debt converted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(116,669</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in derivative liability during the period</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLos_pp0p0_c20210101__20211231_zrLPwlsPWQpk" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Change in derivative liability during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,339,117</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability balance, December 31, 2021</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--DerivativeLiabilities_iS_pp0p0_c20220101__20221231_zSz6jMe1mTN" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Derivative liability balance, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,192,485</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance of derivative liability during the period</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_pp0p0_c20220101__20221231_zSYyZXMogvTl" style="font-size: 10pt; text-align: right" title="Issuance of derivative liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">325,915</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of beneficial conversion feature of debt converted</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--FairValueOfBeneficialConversionFeatureOfDebtConverted_c20220101__20221231_pp0p0" style="font-size: 10pt; text-align: right" title="Fair value of beneficial conversion feature of debt converted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,209,887</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in derivative liability during the period</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLos_c20220101__20221231_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Change in derivative liability during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,594,370</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability balance, December 31, 2022</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--DerivativeLiabilities_iE_pp0p0_c20220101__20221231_zO4xVmVnn2Oe" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Derivative liability balance, end"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,714,143</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A9_zwUomDfyBCp6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zNnayK3O87la" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Derivative Liability (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-indent: -10pt"><span id="xdx_8B7_zSZ8EDONPrGh" style="display: none">Schedule of assumptions to measure fair value</span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock price</span></td> <td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--SaleOfStockPricePerShare_iI_c20221231_zfKC0CeaRJz4" title="Stock price">0.001</span></span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_c20211231_zVoChm4OLXmg" title="Stock price">0.17</span></span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--SaleOfStockPricePerShare_iI_c20221231__srt--RangeAxis__srt--MinimumMember_z3EYJTZBsLU8" title="Stock price">4.42</span>-</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"/> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk free rate</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20221231_zi9Vm7tq6Yzi" title="Risk free rate">4.76</span></span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20211231__srt--RangeAxis__srt--MinimumMember_zphrIGgaUNog" title="Risk free rate">0.19</span>-<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20211231__srt--RangeAxis__srt--MaximumMember_zzmMRfWUnrt5" title="Risk free rate">0.39</span>%</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pip0_dp_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z2yBDwFNZbB4" title="Volatility">213</span>-<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pip0_dp_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zw9t14k7CGXa" title="Volatility">277</span>%</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pip0_dp_c20210101__20211231__srt--RangeAxis__srt--MinimumMember_zeHfBu9n9iVl" title="Volatility">167</span>-<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pip0_dp_c20210101__20211231__srt--RangeAxis__srt--MaximumMember_zKMRusOx6Yyf" title="Volatility">217</span>%</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 11pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20221231__srt--RangeAxis__srt--MinimumMember_zKjEpZR6yyzb" title="Conversion/ Exercise price">0.0015</span>-</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20211231__srt--RangeAxis__srt--MinimumMember_pdd" title="Conversion/ Exercise price">0.102</span>-</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion/ Exercise price</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20221231__srt--RangeAxis__srt--MaximumMember_pdd" title="Conversion/ Exercise price">0.0017</span></span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20211231__srt--RangeAxis__srt--MaximumMember_zU3XxO6ylTTd" title="Conversion/ Exercise price">0.103</span></span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend rate</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20220101__20221231_zXrQxFsuDRy6" title="Dividend rate">0</span></span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20210101__20211231_z1jiIBO8CWp5" title="Dividend rate">0</span></span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> </table> 0.001 0.17 4.42 0.0476 0.0019 0.0039 2.13 2.77 1.67 2.17 0.0015 0.102 0.0017 0.103 0 0 <table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_z8MFi7T8QKcc" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Derivative Liability (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B7_z81jB9hCSt3e" style="display: none">Derivative instruments and hedging activities</span></td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability balance, December 31, 2019</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--DerivativeLiabilities_iS_pp0p0_c20200101__20201231_zw1KpTiCgbqa" style="font-size: 10pt; text-align: right" title="Derivative liability balance, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1559">—</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; width: 70%; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance of derivative liability during the period</span></td><td style="width: 10%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_pp0p0_c20200101__20201231_zXvsZKVaNhFf" style="width: 18%; font-size: 10pt; text-align: right" title="Issuance of derivative liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,767,230</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of beneficial conversion feature of debt converted</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_ecustom--FairValueOfBeneficialConversionFeatureOfDebtConverted_pp0p0_c20200101__20201231_zu6EqXfEit8i" style="font-size: 10pt; text-align: right" title="Fair value of beneficial conversion feature of debt converted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,038,392</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in derivative liability during the period</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLos_pp0p0_c20200101__20201231_zBM57Dozt3Of" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Change in derivative liability during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,533,610</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability balance, December 31, 2020</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--DerivativeLiabilities_iS_pp0p0_c20210101__20211231_znKPr4yQHmA5" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Derivative liability balance, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,262,448</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt modification</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--DebtModification_pp0p0_c20210101__20211231_zHaQLQUVKGTi" style="font-size: 10pt; text-align: right" title="Debt modification"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,777,480</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance of derivative liability during the period</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_pp0p0_c20210101__20211231_z0oCXXGnJbj" style="font-size: 10pt; text-align: right" title="Issuance of derivative liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,480,439</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of beneficial conversion feature of debt converted</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--FairValueOfBeneficialConversionFeatureOfDebtConverted_pp0p0_c20210101__20211231_zSL7vGcJ6qJd" style="font-size: 10pt; text-align: right" title="Fair value of beneficial conversion feature of debt converted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(116,669</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in derivative liability during the period</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLos_pp0p0_c20210101__20211231_zrLPwlsPWQpk" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Change in derivative liability during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,339,117</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability balance, December 31, 2021</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--DerivativeLiabilities_iS_pp0p0_c20220101__20221231_zSz6jMe1mTN" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Derivative liability balance, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,192,485</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance of derivative liability during the period</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_pp0p0_c20220101__20221231_zSYyZXMogvTl" style="font-size: 10pt; text-align: right" title="Issuance of derivative liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">325,915</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of beneficial conversion feature of debt converted</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--FairValueOfBeneficialConversionFeatureOfDebtConverted_c20220101__20221231_pp0p0" style="font-size: 10pt; text-align: right" title="Fair value of beneficial conversion feature of debt converted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,209,887</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in derivative liability during the period</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLos_c20220101__20221231_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Change in derivative liability during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,594,370</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative liability balance, December 31, 2022</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--DerivativeLiabilities_iE_pp0p0_c20220101__20221231_zO4xVmVnn2Oe" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Derivative liability balance, end"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,714,143</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 5767230 -2038392 1533610 5262448 13777480 1480439 -116669 1339117 10192485 325915 -2209887 -6594370 1714143 <p id="xdx_808_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zewVSdrPXk45" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> <b><span id="xdx_82E_zwyL60KGhGxk">Note 14 - <span id="xdx_82C_zMnhiwGLwM5j">Stockholders’ Equity</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Common Stock</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Board of Directors of the Company approved, on April 13, 2020, a reverse stock split of all of the Company’s Common Stock, pursuant to which every 50 shares of Common Stock of the Company shall be reverse split, reconstituted and converted into one (1) share of Common Stock of the Company (the “Reverse Stock Split”). The Company submitted an Issuer Company Related Action Notification regarding the Reverse Stock Split to FINRA on April 14, 2020. To effectuate the Reverse Stock Split, the Company filed on April 21, 2020 a Certificate of Change Pursuant to Nevada Revised Statutes (“NRS”) Section 78.209 (the “Certificate of Change”) with the Secretary of State of the State of Nevada subject to FINRA approval. On June 8, 2020 FINRA advised the Company that such request is deficient due to the fact that a holder of an outstanding convertible note of the Company had entered into two settlements with the Securities and Exchange Commission that related to securities laws violations but were in no way related to the Company. As a result, FINRA advised that it is necessary for the protection of investors, the public interest, and to maintain fair and orderly markets that documentation related to the Reverse Stock Split not be processed. The Company appealed the decision made by FINRA on June 15, 2020. On August 4, 2020, FINRA notified the Company that its appeal had been denied. On October 25, 2021 FINRA approved the Reverse Stock Split and on October 26, 2021, the Company effectuated a 1 for 50 reverse stock split.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In July 7, 2022 the Company filed a preliminary information statement to the stockholders of record (the “Record Date”) in connection with certain actions to be taken by the written consent by stockholders holding a majority of the voting stock of the Company, dated as of June 28, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">  </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">To amend the Company’s Articles of Incorporation, (the “Articles of Incorporation”) to increase the number of authorized shares of common stock, par value $<span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_c20220707_pdd" title="Common stock, par value">0.00001</span> per share (the “Common Stock”), of the Company from <span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_iI_c20220707_ziHGIZBOZsa7" title="Common stock, authorized"><span id="xdx_907_eus-gaap--CommonStockSharesAuthorized_iI_c20220707_zyPObadSiaE7" title="Common stock, authorized">2,000,000,000</span></span> shares to 10,000,000,000 shares. This action concluded on August 11, 2022.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">(i) authorize the Company’s Board of Directors to effect, in its sole discretion, a reverse stock split of the Common Stock in a ratio of up to <span id="xdx_908_eus-gaap--StockholdersEquityReverseStockSplit_c20211003__20211026__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember" title="Reverse stock split">1-for-500</span> (the “Reverse Stock Split”), and (ii) authorize the filing of an amendment to the Company’s Articles of Incorporation to implement the Reverse Stock Split and any other action deemed necessary to effectuate the Reverse Stock Split, without further approval or authorization of stockholders, at any time prior to December 31, 2023. This action was not commenced yet by the Company’s board. </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December 31, 2022, the Company had the following transactions in its common stock:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of <span id="xdx_904_eus-gaap--ConversionOfStockSharesIssued1_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zM9Y0bPgRNn5" title="Shares issued, shares">5,500,000 Shares issued</span> for cash of $<span id="xdx_907_eus-gaap--ConversionOfStockAmountIssued1_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zl2fVNfzcPZ1" title="Shares issued, value">231,866</span>; and</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Of <span id="xdx_900_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20220101__20221231_zmTpKHwGYDNd" title="Debt conversion, converted instrument, shares"> 847,133,242 Shares issued</span> for the conversion of convertible notes of $<span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20220101__20221231_zRspXqoS4hDj" title="Debt conversion, converted instrument, Value">2,158,969</span> and accrued interest of $<span id="xdx_90A_ecustom--DebtConversionConvertedInstrumentAccruedInterest_pp0p0_c20220101__20221231_zqnoRXUqxo3l" title="Debt conversion, converted instrument, Accrued interest">6,491</span>; and</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">cancelled <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20220101__20221231_zXCteHErZJQ" title="Number of shares cancelled">240,000</span> for services rendered</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--JointVentureAgreementMember_zqKFrIeJ5oB" title="Issuance of shares">150,000,000</span> Shares issued to GBT Tokenize for certain joint venture agreement between Magic International Argentina FC, S.L. and the Company. The value of the shares of $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20220101__20221231__dei--LegalEntityAxis__custom--GBTTokenizeMember_zp35RtbNZSgc" title="Aggregate Purchase Price">1,500</span> was determined based on the FV of the Company’s common stock; and</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of 500,000,000 Shares issued to Metaverse for certain equity method investment. The value of the shares of $5,000 was determined based on the FV of the Company’s common stock; and</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Series B Preferred Shares</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Series B Preferred Stock has a stated value of $100 per share and is convertible into the Company’s common stock at a conversion price of $<span id="xdx_907_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20111101__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zax20xffj8Bg" title="Conversion price">30</span> per share representing 30 posts split common shares. Furthermore, the Series B Preferred Stock votes on an as converted basis and carries standard anti-dilution rights. These rights were subsequently removed, except in cases of stock dividends or splits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2022 and 2021, there were <span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zqUJ8y1qiXbi" title="Preferred stock, Outstanding"><span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zizsku7hKbhe" title="Preferred stock, Outstanding">45,000</span></span> Series B Preferred Shares outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Series C Preferred Shares</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Each share of Series C Preferred Stock is convertible, at the option of GV, into such number of shares of common stock of the Company as determined by dividing the Stated Value (as defined below) by the Conversion Price (as defined below). The Conversion Price for each share is equal to a 50% discount to the average of the lowest three lowest closing bid prices of the Company’s common stock during the 10-day trading period prior to the conversion with a minimum conversion price of $0.02. The stated value is $11 per share (the “Stated Value”). The Series C Preferred Stock has no liquidation preference, does not pay dividends and the holder of Series C Preferred Stock shall be entitled to one vote for each share of common stock that the Series C Preferred Stock shall be convertible into. GV has contractually agreed to restrict its ability to convert the Series C Preferred Stock and receive shares of the Company’s common stock such that the number of shares of the Company’s common stock held by it and its affiliates after such conversion does not exceed 4.9% of the then issued and outstanding shares of the Company’s common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At December 31, 2022 and 2021, GV owns 700 Series C Preferred Shares.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The issuance of the Series C Preferred Stock was made in reliance upon exemptions from registration pursuant to Section 4(a)(2) under the Securities Act of 1933 and Rule 506 promulgated under Regulation D thereunder. GV is an accredited investor as defined in Rule 501 of Regulation D promulgated under the Securities Act of 1933.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2022 and 2021, there were <span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zopH2DOwyw0g" title="Preferred stock, shares outstanding"><span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zdpbL6wQdXUa" title="Preferred stock, shares outstanding">700</span></span> Series C Preferred Shares outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Series D Preferred Shares</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2022 and 2021, there are <span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zjpAvsZt9OJc" title="Preferred stock, Outstanding">0</span> and <span id="xdx_909_eus-gaap--PreferredStockSharesOutstanding_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zgmFBxKwV0i1">0</span> shares of Series D Preferred Shares outstanding, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Series G Preferred Shares</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2022 and 2021, there are <span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zSqcKJXxD7Ma">0</span> and <span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zwX7FgqRsGJ5">0</span> shares of Series G Preferred Shares outstanding, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Series H Preferred Shares</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 17, 2019, the Company, AltCorp Trading LLC, a Costa Rica company and a wholly-owned subsidiary of the Company (“AltCorp”), GBT Technologies, S.A., a Costa Rica company (“GBT-CR”) and Pablo Gonzalez, a shareholder’s representative of GBT-CR (“Gonzalez”), entered into and closed an Exchange Agreement (the “GBT Exchange Agreement”) pursuant to which the parties exchanged certain securities. In accordance with the Exchange Agreement, AltCorp acquired <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20190601__20190617__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AltcorpMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_z4kLTlVFsBHe" title="Stock Issued for Acquisitions, Shares">625,000</span> shares of GBT-CR representing 25% of its issued and outstanding shares of common stock from Gonzalez for the issuance of <span id="xdx_90C_eus-gaap--ConversionOfStockSharesConverted1_c20190601__20190617__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AltcorpMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_z5TSvM486pwb" title="Number of shares converted">20,000</span> shares of Series H Convertible Preferred Stock of the Company and a Convertible Note of $<span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20190601__20190617__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AltcorpMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zGNv25jQ1Ezb" title="Debt conversion, converted instrument, Value">10,000,000</span> issued by the Company (the “Gopher Convertible Note”) as well as additional consideration. The Gopher Convertible Note bears interest of 6% and is payable at maturity on <span id="xdx_907_eus-gaap--DebtInstrumentMaturityDate_dd_c20190601__20190617__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AltcorpMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zGavP8uREzr5" title="Maturity date">December 31, 2021</span>. At the election of Gonzalez, the Gopher Convertible Note can be converted into a maximum of 20,000 shares of Series H Preferred Stock. Each share of Series H Preferred Stock is convertible, at the option of the holder but subject to the Company increasing its authorized shares of common stock, into such number of shares of common stock of the Company as determined by dividing the Stated Value ($<span id="xdx_903_eus-gaap--DividendsPayableAmountPerShare_iI_c20190617__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AltcorpMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zmKl4iBXg4Q8" title="Dividend per share">500</span> per share) by the conversion price ($10 per share). The Series H Preferred Stock has no liquidation preference, does not pay dividends and the holder of Series H Preferred Stock shall be entitled to one vote for each share of common stock that the Series H Preferred Stock may be convertible into. On July 8, 2019, the Company entered a Consulting Agreement with Glen Eagles Glen Eagles Acquisition LP (“Glen”) as consultant to provide services in connection with the Company’s acquisition of 25% of GBT-CR. Consultant will provide analysis, interaction with related professional and other services as requested by the Company to integrate and expand capabilities between GBT-CR and the Company. (See Note 14 for further details.)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2022 and 2021, there are <span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zWq2HoKLYevl"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zrC8j2wIQI89">20,000</span></span> shares of Series H Preferred Shares outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>Warrants</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a summary of warrant activity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">  </p> <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z7FMFAOEcuUc" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BE_z7EbVFXK9Edc" style="display: none">Summary of warrant activity</span></td> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted</span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining</span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise</span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contractual</span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrinsic</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding</span></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price</span></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Life</span></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Value</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 31%; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2021</span></td> <td style="padding: 0pt 0pt 0pt 10pt; width: 1%; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20220101__20221231_zKZuOao60B1g" style="width: 12%; font-size: 10pt; text-align: right" title="Warrants Outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">392,870</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98A_ecustom--WeightedAverageExercisePriceWarrantsOutstandingBeginning_c20220101__20221231_zcpl3a9MaoZg" style="width: 12%; font-size: 10pt; text-align: right" title="Weighted Average Exercise Price Warrants Outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74.97</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 12%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231_zqN7rYWDvpMe" title="Weighted Average Remaining Contractual Life, Outstanding, Beginning">0.76</span></span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_pp0p0_c20220101__20221231_zqeug5k4qw2d" style="width: 12%; font-size: 10pt; text-align: right" title="Aggregate Intrinsic Value Outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1669">—</span></span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20220101__20221231_pdd" style="font-size: 10pt; text-align: right" title="Warrants Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1671">—</span></span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c20220101__20221231_pdd" style="font-size: 10pt; text-align: right" title="Warrants Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1673">—</span></span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20220101__20221231_pdd" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Warrants Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1675">—</span></span></td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2022</span></td> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20220101__20221231_znVpJDODQtL6" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Warrants Outstanding, End"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,770</span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98C_ecustom--WeightedAverageExercisePriceWarrantsOutstandingEnd_c20220101__20221231_pdd" style="font-size: 10pt; text-align: right" title="Weighted Average Exercise Price Warrants Outstanding, End"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">205.07</span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms1_dtY_c20220101__20221231_zC19B41xxaib" title="Weighted Average Remaining Contractual Life, Outstanding, End">0.30</span></span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20220101__20221231_zHFjxWd2gkg3" style="font-size: 10pt; text-align: right" title="Aggregate Intrinsic Value Outstanding, Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1683">—</span></span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable, December 31, 2022</span></td> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c20221231_pdd" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Warrants Exercisable, End"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,770</span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_982_ecustom--WeightedAverageExercisePriceWarrantsExercisableAtEnd_c20220101__20221231_pdd" style="font-size: 10pt; text-align: right" title="Weighted Average Exercise Price Warrants Exercisable at End"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">205.07</span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231_zVcVsVw788jh" title="Weighted Average Remaining Contractual Life Exercisable at End">0.30</span></span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c20221231_pp0p0" style="font-size: 10pt; text-align: right" title="Aggregate Intrinsic Value Outstanding, Exercisable at End"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1691">—</span></span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A3_zPYzn7u8LOI9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The exercise price for warrant outstanding and exercisable at December 31, 2022:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--SummaryOfExercisePriceForWarrantOutstandingTableTextBlock_zg2dggto7J63" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details 1)"> <tr style="vertical-align: bottom"> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span id="xdx_8B3_zIjl7MaBk8bh" style="display: none">Summary of exercise price for warrant outstanding</span></td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"> </td> <td> </td> <td colspan="3" style="text-align: center"> </td> <td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding</span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of</span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise</span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of</span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price</span></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsOneMember_pdd" style="width: 20%; font-size: 10pt; text-align: right" title="Number of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1695">—</span></span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 5%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_981_ecustom--ExercisePriceOfWarrantsOutstanding_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsOneMember_pdd" style="width: 19%; font-size: 10pt; text-align: right" title="Exercise price of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.00</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 5%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsOneMember_pdd" style="width: 19%; font-size: 10pt; text-align: right" title="Number of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1699">—</span></span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 5%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_988_ecustom--ExercisePriceOfWarrantsExercisable_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsOneMember_pdd" style="width: 19%; font-size: 10pt; text-align: right" title="Exercise price of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.00</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsTwoMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--ExercisePriceOfWarrantsOutstanding_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsTwoMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">92.50</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsTwoMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_ecustom--ExercisePriceOfWarrantsExercisable_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsTwoMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">92.50</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsThreeMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--ExercisePriceOfWarrantsOutstanding_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsThreeMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsThreeMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_ecustom--ExercisePriceOfWarrantsExercisable_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsThreeMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsFourMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">400</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_ecustom--ExercisePriceOfWarrantsOutstanding_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsFourMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,595.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsFourMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">400</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_ecustom--ExercisePriceOfWarrantsExercisable_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsFourMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,595.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsFiveMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1727">—</span></span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_ecustom--ExercisePriceOfWarrantsOutstanding_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsFiveMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,500.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsFiveMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1731">—</span></span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--ExercisePriceOfWarrantsExercisable_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsFiveMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,500.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsSixMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1735">—</span></span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_ecustom--ExercisePriceOfWarrantsOutstanding_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsSixMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,750.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsSixMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1739">—</span></span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_ecustom--ExercisePriceOfWarrantsExercisable_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsSixMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,750.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsSevenMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1743">—</span></span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--ExercisePriceOfWarrantsOutstanding_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsSevenMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsSevenMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1747">—</span></span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_ecustom--ExercisePriceOfWarrantsExercisable_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsSevenMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsEightMember_zE8lNFHIhxmc" style="font-size: 10pt; text-align: right" title="Number of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_ecustom--ExercisePriceOfWarrantsOutstanding_iI_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsEightMember_zJ9RPpAX93E2" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,750.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsEightMember_zG82lr2u1JE3" style="font-size: 10pt; text-align: right" title="Number of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_ecustom--ExercisePriceOfWarrantsExercisable_iI_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsEightMember_zrzoau0rxrwb" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,750.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsNineMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_ecustom--ExercisePriceOfWarrantsOutstanding_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsNineMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,500.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsNineMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--ExercisePriceOfWarrantsExercisable_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsNineMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,500.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsTenMember_pdd" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Number of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_ecustom--ExercisePriceOfWarrantsOutstanding_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsTenMember_pdd" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Exercise price of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,000.00</span></td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsTenMember_pdd" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Number of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--ExercisePriceOfWarrantsExercisable_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsTenMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,000.00</span></td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c20221231_pdd" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,770</span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20221231_zkQZXIEgltt1" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,770</span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A3_zi0SbjOXGVH3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i><span style="text-decoration: underline">Equity Purchase Agreement and Registration Rights Agreement</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On December 17, 2021 (the “Effective Date”), GBT Technologies Inc. (the “Company”) entered into an equity financing agreement (the “Equity Financing Agreement”) and a registration rights agreement (the “Registration Rights Agreement”) with GHS Investments LLC (“GHS”), pursuant to which GHS shall purchase from the Company, up to that number of shares of common stock of the Company (the “Shares”) for $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20211202__20211217_z63rScuEjH9" title="Aggregate Purchase Price">10,000,000</span>, subject to certain limitations and conditions set forth in the Equity Financing Agreement from time to time over the course of 24 months after an effective registration of the Shares with the Securities and Exchange Commission (the “SEC”) pursuant to the Registration Rights Agreement, is declared effective by the SEC (the “Contract Period”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Equity Financing Agreement grants the Company the right, from time to time at its sole discretion (subject to certain conditions) during the Contract Period, to direct GHS to purchase shares of Common Stock on any business day (a “Put”), provided that at least ten trading days has passed since the most recent Put. The purchase price of the shares of Common Stock contained in a Put will be 90% of the lowest daily volume weighted average price (VWAP) of the Company’s Common Stock during the ten consecutive trading days preceding the receipt by GHS of the applicable Put notice. Such sales of Common Stock by the Company, if any, may occur from time to time, at the Company’s option, during the Contract Period. Subject to the satisfaction of certain conditions set forth in the Equity Financing Agreement, on each Put the Company will deliver an number of Shares equaling 110% of the dollar amount of each Put. The maximum dollar amount of each Put will not exceed 200% of the average daily trading dollar volume for the Company’s Common Stock during the ten trading days preceding the Trading Day that GHS receives a Put. No Put will be made in an amount equaling less than $10,000 or greater than $500,000. Puts are further limited to GHS owning no more than 4.99% of the outstanding stock of the Company at any given time. The Equity Financing Agreement and the Registration Rights Agreement contain customary representations, obligations, rights, warranties, agreements and conditions of the parties. The Equity Financing Agreement terminates upon any of the following events: when GHS has purchased $10,000,000 in the Common Stock of the Company pursuant to the Equity Financing Agreement; on the date that is 24 calendar months from the date the Equity Financing Agreement was executed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Actual sales of shares of Common Stock to GHS under the Equity Financing Agreement will depend on a variety of factors to be determined by the Company from time to time, including, among others, market conditions, the trading price of the Common Stock and determinations by the Company as to the appropriate sources of funding for the Company and its operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 15.45pt 0 0; text-align: justify">For the year ended December 31, 2022, the Company did not receive any proceeds from the equity purchase agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 15.45pt 0 0; text-align: justify"> </p> 0.00001 2000000000 2000000000 1-for-500 5500000 231866 847133242 2158969 6491 240000 150000000 1500 30 45000 45000 700 700 0 0 0 0 625000 20000 10000000 2021-12-31 500 20000 20000 <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z7FMFAOEcuUc" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BE_z7EbVFXK9Edc" style="display: none">Summary of warrant activity</span></td> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted</span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average</span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining</span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise</span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contractual</span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrinsic</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding</span></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price</span></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Life</span></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Value</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 31%; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2021</span></td> <td style="padding: 0pt 0pt 0pt 10pt; width: 1%; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20220101__20221231_zKZuOao60B1g" style="width: 12%; font-size: 10pt; text-align: right" title="Warrants Outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">392,870</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98A_ecustom--WeightedAverageExercisePriceWarrantsOutstandingBeginning_c20220101__20221231_zcpl3a9MaoZg" style="width: 12%; font-size: 10pt; text-align: right" title="Weighted Average Exercise Price Warrants Outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74.97</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 12%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231_zqN7rYWDvpMe" title="Weighted Average Remaining Contractual Life, Outstanding, Beginning">0.76</span></span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_pp0p0_c20220101__20221231_zqeug5k4qw2d" style="width: 12%; font-size: 10pt; text-align: right" title="Aggregate Intrinsic Value Outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1669">—</span></span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20220101__20221231_pdd" style="font-size: 10pt; text-align: right" title="Warrants Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1671">—</span></span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c20220101__20221231_pdd" style="font-size: 10pt; text-align: right" title="Warrants Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1673">—</span></span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20220101__20221231_pdd" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Warrants Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1675">—</span></span></td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2022</span></td> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20220101__20221231_znVpJDODQtL6" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Warrants Outstanding, End"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,770</span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98C_ecustom--WeightedAverageExercisePriceWarrantsOutstandingEnd_c20220101__20221231_pdd" style="font-size: 10pt; text-align: right" title="Weighted Average Exercise Price Warrants Outstanding, End"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">205.07</span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms1_dtY_c20220101__20221231_zC19B41xxaib" title="Weighted Average Remaining Contractual Life, Outstanding, End">0.30</span></span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_pp0p0_c20220101__20221231_zHFjxWd2gkg3" style="font-size: 10pt; text-align: right" title="Aggregate Intrinsic Value Outstanding, Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1683">—</span></span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable, December 31, 2022</span></td> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c20221231_pdd" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Warrants Exercisable, End"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,770</span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_982_ecustom--WeightedAverageExercisePriceWarrantsExercisableAtEnd_c20220101__20221231_pdd" style="font-size: 10pt; text-align: right" title="Weighted Average Exercise Price Warrants Exercisable at End"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">205.07</span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231_zVcVsVw788jh" title="Weighted Average Remaining Contractual Life Exercisable at End">0.30</span></span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c20221231_pp0p0" style="font-size: 10pt; text-align: right" title="Aggregate Intrinsic Value Outstanding, Exercisable at End"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1691">—</span></span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 392870 74.97 P0Y9M3D 70770 205.07 P0Y3M18D 70770 205.07 P0Y3M18D <table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--SummaryOfExercisePriceForWarrantOutstandingTableTextBlock_zg2dggto7J63" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholders' Equity (Details 1)"> <tr style="vertical-align: bottom"> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span id="xdx_8B3_zIjl7MaBk8bh" style="display: none">Summary of exercise price for warrant outstanding</span></td> <td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"> </td> <td> </td> <td colspan="3" style="text-align: center"> </td> <td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding</span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of</span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise</span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of</span></td> <td style="font-size: 10pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price</span></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsOneMember_pdd" style="width: 20%; font-size: 10pt; text-align: right" title="Number of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1695">—</span></span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 5%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_981_ecustom--ExercisePriceOfWarrantsOutstanding_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsOneMember_pdd" style="width: 19%; font-size: 10pt; text-align: right" title="Exercise price of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.00</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 5%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsOneMember_pdd" style="width: 19%; font-size: 10pt; text-align: right" title="Number of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1699">—</span></span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 5%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_988_ecustom--ExercisePriceOfWarrantsExercisable_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsOneMember_pdd" style="width: 19%; font-size: 10pt; text-align: right" title="Exercise price of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.00</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsTwoMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--ExercisePriceOfWarrantsOutstanding_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsTwoMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">92.50</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsTwoMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_ecustom--ExercisePriceOfWarrantsExercisable_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsTwoMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">92.50</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsThreeMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--ExercisePriceOfWarrantsOutstanding_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsThreeMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsThreeMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_ecustom--ExercisePriceOfWarrantsExercisable_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsThreeMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsFourMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">400</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_ecustom--ExercisePriceOfWarrantsOutstanding_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsFourMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,595.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsFourMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">400</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_ecustom--ExercisePriceOfWarrantsExercisable_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsFourMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,595.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsFiveMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1727">—</span></span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_ecustom--ExercisePriceOfWarrantsOutstanding_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsFiveMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,500.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsFiveMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1731">—</span></span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--ExercisePriceOfWarrantsExercisable_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsFiveMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,500.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsSixMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1735">—</span></span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_ecustom--ExercisePriceOfWarrantsOutstanding_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsSixMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,750.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsSixMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1739">—</span></span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_ecustom--ExercisePriceOfWarrantsExercisable_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsSixMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,750.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsSevenMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1743">—</span></span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--ExercisePriceOfWarrantsOutstanding_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsSevenMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsSevenMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1747">—</span></span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_ecustom--ExercisePriceOfWarrantsExercisable_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsSevenMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsEightMember_zE8lNFHIhxmc" style="font-size: 10pt; text-align: right" title="Number of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_ecustom--ExercisePriceOfWarrantsOutstanding_iI_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsEightMember_zJ9RPpAX93E2" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,750.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsEightMember_zG82lr2u1JE3" style="font-size: 10pt; text-align: right" title="Number of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_ecustom--ExercisePriceOfWarrantsExercisable_iI_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsEightMember_zrzoau0rxrwb" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,750.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsNineMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_ecustom--ExercisePriceOfWarrantsOutstanding_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsNineMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,500.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsNineMember_pdd" style="font-size: 10pt; text-align: right" title="Number of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--ExercisePriceOfWarrantsExercisable_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsNineMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,500.00</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsTenMember_pdd" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Number of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_ecustom--ExercisePriceOfWarrantsOutstanding_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsTenMember_pdd" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Exercise price of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,000.00</span></td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsTenMember_pdd" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Number of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--ExercisePriceOfWarrantsExercisable_c20221231__us-gaap--AwardTypeAxis__custom--WarrantsTenMember_pdd" style="font-size: 10pt; text-align: right" title="Exercise price of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,000.00</span></td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c20221231_pdd" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of warrants Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,770</span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20221231_zkQZXIEgltt1" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of warrants Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,770</span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 25.00 25.00 60000 92.50 60000 92.50 10000 135.00 10000 135.00 400 1595.00 400 1595.00 2500.00 2500.00 3750.00 3750.00 5000.00 5000.00 200 11750.00 200 11750.00 150 12500.00 150 12500.00 20 14000.00 20 14000.00 70770 70770 10000000 <p id="xdx_80A_eus-gaap--IncomeTaxDisclosureTextBlock_zHDaLgcxOJMj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_825_zmyvKUQcxhyb">Note 15 - <span id="xdx_821_zV6vgS7zE6U8">Income Taxes</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">At December 31, 2022 and 2021, the significant components of the deferred tax assets are summarized below:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">  </p> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zrMz9Sn8XIjb" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 20pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B7_zMLPY5DXCIQ7" style="display: none">Schedule Of Components of deferred tax assets</span></td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_490_20221231_zT5Pr0j1ifV7" style="font-size: 10pt; text-align: center"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_495_20211231" style="font-size: 10pt; text-align: center"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr> <tr id="xdx_401_eus-gaap--DeferredIncomeTaxesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income tax asset</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 20pt; width: 56%; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net operating loss carryforwards</span></td> <td style="width: 8%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 12%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,182,327</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 8%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 12%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,945,238</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsGross_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 20pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total deferred income tax asset</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,182,327</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,945,238</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_z8eV3yNvK3S8" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 20pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: valuation allowance</span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,182,327</span></td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,945,238</span></td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total deferred income tax asset</span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1802">—</span></span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1803">—</span></span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A4_zVuSnvUyrmU1" style="font: 10pt Times New Roman, Times, Serif; margin: 0">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The valuation allowance increased by $<span id="xdx_901_eus-gaap--OperatingLossCarryforwardsValuationAllowance_c20221231_pp0p0" title="Valuation allowance">237,089</span> and $<span id="xdx_909_eus-gaap--OperatingLossCarryforwardsValuationAllowance_c20211231_pp0p0" title="Valuation allowance">712,442</span> in 2022 and 2021, respectively, as a result of the Company generating additional net operating losses. The Company’s net operating loss carryforward of approximately $<span id="xdx_904_eus-gaap--OperatingLossCarryforwards_c20221231_pp0p0" title="Net operating loss carryforward">31,663,196</span> begin to expire in 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">No income tax expense reflected in the consolidated statements of income for the years 2022 and 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The reconciliation of the effective income tax rate to the federal statutory rate for the years ended December 31, 2022 and 2021 is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">   </p> <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zz1xY4rCjWnd" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B8_zCctkrYFeS82" style="display: none">Schedule of Effective Income Tax Rate Reconciliation</span></td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Percent</span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Percent</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 40%; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal statutory rates</span></td> <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_980_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20220101__20221231_pp0p0" style="width: 10%; font-size: 10pt; text-align: right" title="Federal statutory rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,118,010</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 10%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20220101__20221231_zywE73EvWd8c" title="Federal statutory rates (in percent)">21.0</span></span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_986_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20210101__20211231_pp0p0" style="width: 10%; font-size: 10pt; text-align: right" title="Federal statutory rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,125,391</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 10%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20210101__20211231_zUYxpyhFW8gd" title="Federal statutory rates (in percent)">21.0</span></span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">State income taxes</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_c20220101__20221231_pp0p0" style="font-size: 10pt; text-align: right" title="State income taxes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">425,908</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20220101__20221231_zK2sKp7Snz7k" title="State income taxes (in percent)">8.0</span></span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_c20210101__20211231_pp0p0" style="font-size: 10pt; text-align: right" title="State income taxes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,714,435</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20210101__20211231_zaRxX0X1TKb6" title="State income taxes (in percent)">8.0</span></span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Permanent differences</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_c20220101__20221231_pp0p0" style="font-size: 10pt; text-align: right" title="Permanent differences"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,784,116</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--IncomeTaxReconciliationPermanentDifferences_dp_c20220101__20221231_zTRazFGTkfxk" title="Permanent differences (in percent)">-33.5</span></span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_c20210101__20211231_pp0p0" style="font-size: 10pt; text-align: right" title="Permanent differences"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,127,383</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--IncomeTaxReconciliationPermanentDifferences_dp_c20210101__20211231_z4KlGc3e5rC7" title="Permanent differences (in percent)">-26.9</span></span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation allowance against net deferred tax assets</span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20220101__20221231_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Valuation allowance against net deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">237,089</span></td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20220101__20221231_zlCTm28ASac7" title="Valuation allowance against net deferred tax assets (in percent)">4.5</span></span></td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Valuation allowance against net deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">712,442</span></td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20210101__20211231_zB8MwI6XIGs" title="Valuation allowance against net deferred tax assets (in percent)">-2.1</span></span></td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective rate</span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_983_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_c20220101__20221231_pp0p0" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Effective rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1845">—</span></span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—<span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_dp_c20220101__20221231_z7XUJagiycf2" title="Effective rate (in percent)"/></span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_981_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_c20210101__20211231_pp0p0" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Effective rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1849">—</span></span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">—<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_dp_c20210101__20211231_z5D2R88sWgFl" title="Effective rate (in percent)"/></span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> </table> <p id="xdx_8A8_zfersBYP0tLj" style="font: 10pt Times New Roman, Times, Serif; margin: 0">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company periodically evaluates the likelihood of the realization of deferred tax assets, and adjusts the carrying amount of the deferred tax assets by the valuation allowance to the extent the future realization of the deferred tax assets is not judged to be more likely than not. The Company considers many factors when assessing the likelihood of future realization of its deferred tax assets, including its recent cumulative earnings experience by taxing jurisdiction, expectations of future taxable income or loss, the carryforward periods available to the Company for tax reporting purposes, and other relevant factors.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Future changes in the unrecognized tax benefit will have no impact on the effective tax rate due to the existence of the valuation allowance. The Company estimates that the unrecognized tax benefit will not change significantly within the next twelve months. The Company will continue to classify income tax penalties and interest as part of general and administrative expense in its consolidated statements of operations. There were no interest or penalties accrued as of December 31, 2022 and 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zrMz9Sn8XIjb" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 20pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B7_zMLPY5DXCIQ7" style="display: none">Schedule Of Components of deferred tax assets</span></td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_490_20221231_zT5Pr0j1ifV7" style="font-size: 10pt; text-align: center"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td id="xdx_495_20211231" style="font-size: 10pt; text-align: center"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr> <tr id="xdx_401_eus-gaap--DeferredIncomeTaxesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income tax asset</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 20pt; width: 56%; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net operating loss carryforwards</span></td> <td style="width: 8%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 12%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,182,327</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 8%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 12%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,945,238</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsGross_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 20pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total deferred income tax asset</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,182,327</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,945,238</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_z8eV3yNvK3S8" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 20pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: valuation allowance</span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,182,327</span></td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,945,238</span></td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total deferred income tax asset</span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1802">—</span></span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1803">—</span></span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 9182327 8945238 9182327 8945238 9182327 8945238 237089 712442 31663196 <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zz1xY4rCjWnd" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B8_zCctkrYFeS82" style="display: none">Schedule of Effective Income Tax Rate Reconciliation</span></td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td> <td style="font-size: 10pt; text-align: right"> </td> <td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Percent</span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Percent</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 40%; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal statutory rates</span></td> <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_980_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20220101__20221231_pp0p0" style="width: 10%; font-size: 10pt; text-align: right" title="Federal statutory rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,118,010</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 10%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20220101__20221231_zywE73EvWd8c" title="Federal statutory rates (in percent)">21.0</span></span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_986_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20210101__20211231_pp0p0" style="width: 10%; font-size: 10pt; text-align: right" title="Federal statutory rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,125,391</span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="width: 3%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 10%; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20210101__20211231_zUYxpyhFW8gd" title="Federal statutory rates (in percent)">21.0</span></span></td> <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">State income taxes</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_c20220101__20221231_pp0p0" style="font-size: 10pt; text-align: right" title="State income taxes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">425,908</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20220101__20221231_zK2sKp7Snz7k" title="State income taxes (in percent)">8.0</span></span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_c20210101__20211231_pp0p0" style="font-size: 10pt; text-align: right" title="State income taxes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,714,435</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20210101__20211231_zaRxX0X1TKb6" title="State income taxes (in percent)">8.0</span></span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Permanent differences</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_c20220101__20221231_pp0p0" style="font-size: 10pt; text-align: right" title="Permanent differences"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,784,116</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--IncomeTaxReconciliationPermanentDifferences_dp_c20220101__20221231_zTRazFGTkfxk" title="Permanent differences (in percent)">-33.5</span></span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_c20210101__20211231_pp0p0" style="font-size: 10pt; text-align: right" title="Permanent differences"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,127,383</span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--IncomeTaxReconciliationPermanentDifferences_dp_c20210101__20211231_z4KlGc3e5rC7" title="Permanent differences (in percent)">-26.9</span></span></td> <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation allowance against net deferred tax assets</span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20220101__20221231_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Valuation allowance against net deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">237,089</span></td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20220101__20221231_zlCTm28ASac7" title="Valuation allowance against net deferred tax assets (in percent)">4.5</span></span></td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Valuation allowance against net deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">712,442</span></td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20210101__20211231_zB8MwI6XIGs" title="Valuation allowance against net deferred tax assets (in percent)">-2.1</span></span></td> <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; font-size: 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective rate</span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_983_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_c20220101__20221231_pp0p0" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Effective rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1845">—</span></span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—<span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_dp_c20220101__20221231_z7XUJagiycf2" title="Effective rate (in percent)"/></span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_981_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_c20210101__20211231_pp0p0" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Effective rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1849">—</span></span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">—<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_dp_c20210101__20211231_z5D2R88sWgFl" title="Effective rate (in percent)"/></span></td> <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> </table> 1118010 0.210 -7125391 0.210 425908 0.080 -2714435 0.080 -1784116 -0.335 9127383 -0.269 237089 0.045 712442 -0.021 <p id="xdx_809_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zvA6N9RGNGt9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_827_zuJza3OUQyte">Note 16 - <span id="xdx_821_z4Mouill2rY">Related Parties</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Related parties are natural persons or other entities that have the ability, directly or indirectly, to control another party or exercise significant influence over the party in making financial and operating decisions. Related parties include other parties that are subject to common control or that are subject to common significant influences.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 1, 2021, the Company and Danny Rittman, Chief Technology Officer and a Director of the Company, agreed to amend his employment agreement pursuant to which he will receive salary of $5,000 per month.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 1, 2017, the Company entered into and closed an Asset Purchase Agreement with a third party, RWJ Advanced Marketing, LLC (“RWJ”), a Georgia corporation, pursuant to which the Company purchased certain assets from RWJ, including inventory, terminals, licenses and permits and intangible assets. At closing, the Company and Mr. Greg Bauer entered into an Employment Agreement pursuant to which Mr. Bauer was retained as Chief Executive Officer for a term of one year, subject to an automatic extension, unless terminated, for a base salary of $<span id="xdx_901_ecustom--BaseSalary_c20170830__20170902__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RWJAdvancedMarketingLLCMember_pp0p0" title="Base Salary">250,000</span> and a bonus of 10% of net profit generated by the assets acquired. Mr. Bauer was also appointed to the Board of Directors of the Company. As of the closing date, Mr. Murray resigned as Chief Executive Officer of the Company but will remain as a director of the Company. Mr. Bauer, since 2004 through present, has served as executive director with W.L. Petrey Wholesale, Inc. where he was in charge of the UGO/Preway operations. The Company is in litigations in connection with RWJ transaction – See Note 18– - Contingencies.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 1, 2019, the Company and Douglas Davis entered into an Amended and Restated Employment Agreement pursuant to which Mr. Davis was retained as Chief Executive Officer. Mr. Davis served as Interim Chief Executive Officer since July 2018 until his resignation on April 11, 2020. The term of Mr. Davis’ employment was for two years through January 1, 2021. Mr. Davis was entitled to an annual base salary of $<span id="xdx_902_ecustom--BaseSalary_pp0p0_c20180401__20180406__srt--TitleOfIndividualAxis__srt--DirectorMember_zi5aVkktVQq7" title="Base Salary">250,000</span>, which was to be increased to $<span id="xdx_90F_eus-gaap--SalariesAndWages_pp0p0_c20181230__20190102__srt--TitleOfIndividualAxis__custom--DavisMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zXXkF61KN7E" title="Base salary">400,000</span> upon the Company up-listing to a national exchange. Mr. Davis was also entitled to the issuance of Stock Options to acquire of <span id="xdx_90E_eus-gaap--OptionIndexedToIssuersEquityShares_c20181230__20190102__srt--TitleOfIndividualAxis__custom--DavisMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_za0yN6NybPle" title="Stock option issued">50,000</span> shares of common stock of the Company, exercisable for five years, subject to vesting. <span id="xdx_90D_ecustom--OptionVestedDescription_c20181230__20190102__srt--TitleOfIndividualAxis__custom--DavisMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_z7nUwmrRva36" title="Option vested description">The options were to be earned and vested (i) with respect to 20,000 shares of common stock on the date hereof, (ii) 5,000 shares of common stock upon the successful dual list of the Company on an international exchange such as SIX Zurich Stock Exchange or Euronext, (iii) 15,000 shares of common stock upon the successful up listing to a national exchange such as the Nasdaq, NYSE Euronext, TSX, AMEX or other, and (iv) with respect to 5,000 shares of common stock at each of the six (6) month anniversaries (July 1, 2019 and January 1, 2020). The exercise price of such options shall be the closing price of the Company on the date prior to such event.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 10, 2019, the Company entered into a Joint Venture Agreement (the “BitSpeed Agreement”) with BitSpeed LLC, which is owned by Douglas Davis, the Company’s Chief Executive Officer, to form GBT BitSpeed Corp., a Nevada company (“GBT BitSpeed”). The purpose of GBT BitSpeed is to develop, maintain and support its proprietary Extreme Transfer Software Application Concurrency, a software application to transfer secure, accelerated transmission of large file data over networks, and connection to cloud storage, Network-Attached Storage (NAS) and Storage Area Networks (SANs) (“Concurrency”). BitSpeed shall contribute the services and resources for the development of Concurrency to GBT BitSpeed. The Company shall contribute 10 million shares of common stock (valued at $17,900,000) of the Company to GBT BitSpeed. BitSpeed and the Company will each own 50% of GBT BitSpeed. The Company shall appoint two directors and BitSpeed shall appoint one director of GBT BitSpeed. In addition, GBT BitSpeed and Mr. Davis entered into a Consulting Agreement in which Mr. Davis is engaged to provide services for $10,000 per month payable quarterly which may be paid in shares of common stock calculated by the amount owed divided by the Company’s 20-day VWAP. Mr. Davis will provide services in connection with the development of the business as well as GBT BitSpeed’s capital raising efforts. The term of the Consulting Agreement is two years. The closing of the BitSpeed Agreement occurred on October 14, 2019. On April 11, 2020, Douglas Davis resigned as Chief Executive Officer of the Company so that he may fully devote all of his efforts to GBT Tokenize Corp., the Company’s joint venture, which intends to develop a new product. Mr. Davis’ resignation was not the result of any disagreements with management or board of directors of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 6, 2020, the Company through Greenwich, entered into the Tokenize Agreement with Tokenize, which is owned by a Costa Rica Trust represented by Gonzalez. Gonzalez also represents Gonzalez Costa Rica Trust, which holds a note of $<span id="xdx_901_ecustom--CommonStockContributed_c20200301__20200306__us-gaap--TypeOfArrangementAxis__custom--TokenizeAgreementMember__dei--LegalEntityAxis__custom--GreenwichMember_z5dkSgmOa9D2" title="Common stock contributed">10,000,000</span> and is also a shareholder of the Company. Under the Tokenize Agreement, the parties formed GBT Tokenize. The purpose of GBT Tokenize is to develop Technology Portfolio, throughout the State of California. Upon generating any revenue from the Technology Portfolio, the Joint Venture will earn the first right of refusal for other territories. Tokenize shall contribute the services and resources for the development of the Technology Portfolio to GBT Tokenize. The Company contributed <span id="xdx_908_ecustom--CommonStockContributed_c20191001__20191010__us-gaap--TypeOfArrangementAxis__custom--BitSpeedAgreementMember_zT0A7heKdbgg" title="Common stock contributed">100,000,000</span> GBT Shares to GBT Tokenize. Tokenize and the Company will each own 50% of GBT Tokenize. The Company pledged its 50% ownership in GBT Tokenize and its 100% ownership of Greenwich to Tokenize to secure its Technology Portfolio investment. The Company shall appoint two directors and Tokenize shall appoint one director of GBT Tokenize. In addition, GBT Tokenize and Gonzalez entered into a Consulting Agreement in which Gonzalez is engaged to provide services for $<span id="xdx_904_ecustom--ConsiderationForServicesPayable_pp0p0_c20200301__20200306__us-gaap--TypeOfArrangementAxis__custom--TokenizeAgreementMember_z0dF7OMXdX74" title="Consideration for services payable">33,333</span>.33 per month payable quarterly which may be paid in shares of common stock calculated by the amount owed divided by the Company’s 10-day VWAP. Gonzalez will provide services in connection with the development of the business as well as GBT Tokenize’s capital raising efforts. The term of the Consulting Agreement is two years. The closing of the Tokenize Agreement occurred on March 9, 2020. Via this Joint Venture the parties commenced development of a development of an intelligent human vital signs’ device, suggested named qTerm.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The platform is an expansion of the existing license agreement with GBT Tokenize Corp., which provided GBT Tokenize Corp. with an exclusive territory of California to develop certain of the Company’s technology. As the nature of the platform cannot be restricted only to California, the Company’s joint venture GBT Tokenize Corp. will be compensated with additional two hundred million shares of the Company to strengthen its funding, subject to board approval. A provisional patent application for the qTerm Medical Device was filed on March 30, 2020 with the USPTO. The application has been assigned serial number 63001564. The Joint Venture completed successfully the first prototype. There is no guarantee that the Company will be successful in researching, developing or implementing this product into the market. In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed and granted regulatory approval, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Yello Partners Inc.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2022 and 2021, the Company has $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YelloPartnersIncMember_pp0p0" title="Principlal amount">505,000</span> and $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YelloPartnersIncMember_pp0p0" title="Principlal amount">385,000</span> owed to Yello Partners, Inc., a Company owned by the CEO.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Alpha Eda Note Payable – Related Party</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 15, 2020, the Company issued a promissory note to Alpha Eda, LLC (“Alpha”), a related party, for $<span id="xdx_909_ecustom--NotePayableRelatedPartiesClassifiedCurrent_iI_pp0p0_c20221115__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AlphaEdaLLCMember_zZ72IHWnf5U4" title="Issuance of promissory note">140,000</span>. The note accrues interest at <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_c20221115__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AlphaEdaLLCMember_z6JomgZkM2d7" title="Interest rate">10</span>%, is unsecured and was due on <span id="xdx_905_eus-gaap--DebtInstrumentMaturityDate_dd_c20211102__20211115__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AlphaEdaLLCMember_zYAWxOJOWGe9" title="Maturity date">September 30, 2021</span>. On June 20, 2021 Alpha and the Company extended the note maturity to <span id="xdx_904_eus-gaap--DebtInstrumentMaturityDate_dd_c20220602__20220620__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AlphaEdaLLCMember_z9iKrwAxJzoi" title="Maturity date">December 31, 2021</span>. The balance of the note at December 31, 2022 and 2021 was $<span id="xdx_90C_ecustom--NotePayableRelatedPartiesClassifiedCurrent_iI_pp0p0_c20221231_zQ88cyLC4Ae" title="Issuance of promissory note">140,000</span> and $<span id="xdx_901_ecustom--NotePayableRelatedPartiesClassifiedCurrent_iI_pp0p0_c20211231_zcJRoyUXqS52" title="Issuance of promissory note">140,000</span> plus accrued interest of $<span id="xdx_90C_ecustom--InterestPayableRelatedParty_iI_pp0p0_c20221231__us-gaap--DebtInstrumentAxis__custom--AlphaEdaMember_zuMewF4SoG6" title="Accrued interest">32,633</span> and $<span id="xdx_904_ecustom--InterestPayableRelatedParty_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--AlphaEdaMember_ziwgPQCvapkc" title="Accrued interest">16,333</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Stanley Hills LLC Convertible Note Payable – Related Party</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company entered into a series of loan agreements with Stanley Hills LLC (“Stanley”) pursuant to which it received more than $<span id="xdx_90E_eus-gaap--ProceedsFromLoans_pp0p0_c20190503__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_zA3gHj2fjYo9" title="Proceeds from loans">1,000,000</span> in loans (the “Debt”) from May 2019 up to December 2019. On February 26, 2020, in order to induce Stanley to continue to provide funding, the Company and Stanley entered into a letter agreement providing that the current note payable balance due to Stanley of $<span id="xdx_90F_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20200226__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_zkdjV4stfcS6" title="Note payable current">1,214,900</span> may be converted into shares of common stock of the Company at a conversion price equal to 85% multiplied by the lowest one trading price for the common stock during the 20-trading day period ending on the latest complete trading day prior to the conversion date. Since the conversion price will vary based on the Company’s stock price, the beneficial conversion feature associated with this note is accounted for as a derivative liability. Stanley had agreed to restrict its ability to convert the Debt and receive shares of common stock such that the number of shares of common stock held by it and its affiliates after such conversion or exercise does not exceed 4.99% of the then issued and outstanding shares of common stock. During the year ended December 31, 2021, Stanley converted $<span id="xdx_90E_eus-gaap--ConvertibleDebt_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_zkx91kwhEZRf" title="Convertible debt">1,231,466</span> of its convertible note plus interest into <span id="xdx_900_ecustom--ConvertibleShares_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_zoI5ZF4zio1i" title="Convertible shares">4,420,758</span> shares of the Company’s common stock, and during the year ended December 31, 2021, Stanley loaned the Company an additional $<span id="xdx_901_eus-gaap--ProceedsFromLoans_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_z9I4PVJeMVKj" title="Proceeds from loans">325,000</span>. Also, during the year ended December 31, 2021, the Company transferred the SURG shares received as repayment of $<span id="xdx_90B_eus-gaap--RepaymentsOfDebt_pp0p0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_zM4GrnBS5d6f" title="Repayment of debt">800,000</span> of this convertible note (See Note 10) and converted $<span id="xdx_902_eus-gaap--ConvertibleDebt_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zZsb4MkLmtO" title="Convertible debt">126,003</span> of accrued interest into the principal balance. During the year ended December 31, 2021, Gonzalez assigned all his accrued balances of $<span id="xdx_902_eus-gaap--InterestPayableCurrent_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_zKt0vShLAhZ5" title="Accrued interest">424,731</span> to Stanley in a private transaction that the Company is not part to (See Note 10). The balance of the Stanley convertible note payable at December 31, 2022 and December 31, 2021 was $<span id="xdx_906_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_zQdlSPlvysQl" title="Convertible note payable">116,605</span> and $<span id="xdx_904_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_zJOZ8xIdH2i" title="Convertible note payable">116,605</span>, respectively. The Stanley debt is secured via a pledge agreement on the SURG shares.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Stanley Hills LLC Accounts Payable – Related Party</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 8, 2020, SURG filed a lawsuit against its transfer agent, Vstock from transferring millions of SURG stock that is currently in possession by the Company and assigned to Stanley Hills, LLC. On January 1, 2021, SURG, AltCorp and Stanley Hills, LLC (“Stanley”) entered into a Mutual Release and Settlement Agreement (“Settlement Agreement”). Pursuant to the terms of the Settlement Agreement, SURG agreed to amend the AltCorp Exchange Agreement where SURG acknowledged a debt of $<span id="xdx_906_eus-gaap--DebtCurrent_iI_pp0p0_c20210102__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_zKUEKCbHfxL9" title="Debt">3,300,000</span> (the “Debt”) to be paid in 33 monthly payments of $<span id="xdx_901_eus-gaap--DebtCurrent_iI_pp0p0_c20210102__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zE50dIa8B2Ul" title="Debt">100,000</span> payable in shares of common stock of SURG at a per share price equal the volume weighted average price of Surg’s common stock during the 10 trading days immediately preceding the issuance. SURG paid $<span id="xdx_909_eus-gaap--Cash_iI_pp0p0_c20210102__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_zhmRzUFDqrm7" title="Cash">400,000</span> in cash and $<span id="xdx_906_eus-gaap--Cash_iI_pp0p0_c20210102__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNsOeXHM6r4k" title="Cash">800,000</span> by shares. The SURG common stock issued to Altcorp has been pledged since August 12, 2020 for the benefit of Stanley to secure Stanley’s note payable by the Company. Accordingly, the SURG Common Stock issued to AltCorp as a result of the Settlement Agreement were pledged to Stanley. As of December 31, 2021 there were no surge shares pledges after the final settlement signed on December 22, 2021 and that replaced all prior settlement agreement. The final settlement SURG agreed to make total payments of $<span id="xdx_900_eus-gaap--RepaymentsOfDebt_pp0p0_c20220102__20220107__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SURGMember_zLyVbBSMlXV7" title="Repayment of debt">4,200,000</span> to the Company on or prior to January 7, 2022. <span id="xdx_901_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember" title="Related party, description">This $4.2 million amount consists of $450,000 paid by SURG in November and December 2021, $100,000 to be paid on or about January 4, 2022, and $3,650,000 to be paid on or prior to January 7, 2022 of which $375,000 will be held in escrow as described before.</span> The $<span id="xdx_905_eus-gaap--OtherReceivables_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_zB72BqILbYS" title="Other receivable">3,750,000</span> was recorded as other receivable as of December 31, 2021. As of December 31, 2022, the Company has recorded an outstanding payable balance to Stanley amounted $<span id="xdx_901_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_znxaywP0ijp6" title="Accrued expenses">927,136</span> recorded under accrued expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Consulting income for both the years ended December 31, 2022 and 2021 were $<span id="xdx_90A_eus-gaap--ProceedsFromSaleOfOtherAssets1_pp0p0_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_zZ8bdC0NfmO9" title="Sales amount">45,000</span> and $<span id="xdx_90C_eus-gaap--ProceedsFromSaleOfOtherAssets1_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StanleyHillsLLCMember_pp0p0" title="Sales amount">180,000</span>. Consulting income are derived from providing IT consulting services to Stanley Hills, a related party.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 250000 250000 400000 50000 The options were to be earned and vested (i) with respect to 20,000 shares of common stock on the date hereof, (ii) 5,000 shares of common stock upon the successful dual list of the Company on an international exchange such as SIX Zurich Stock Exchange or Euronext, (iii) 15,000 shares of common stock upon the successful up listing to a national exchange such as the Nasdaq, NYSE Euronext, TSX, AMEX or other, and (iv) with respect to 5,000 shares of common stock at each of the six (6) month anniversaries (July 1, 2019 and January 1, 2020). The exercise price of such options shall be the closing price of the Company on the date prior to such event. 10000000 100000000 33333 505000 385000 140000 0.10 2021-09-30 2021-12-31 140000 140000 32633 16333 1000000 1214900 1231466 4420758 325000 800000 126003 424731 116605 116605 3300000 100000 400000 800000 4200000 This $4.2 million amount consists of $450,000 paid by SURG in November and December 2021, $100,000 to be paid on or about January 4, 2022, and $3,650,000 to be paid on or prior to January 7, 2022 of which $375,000 will be held in escrow as described before. 3750000 927136 45000 180000 <p id="xdx_80D_eus-gaap--LegalMattersAndContingenciesTextBlock_zfonKLRwK3f9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span>Note 17 - <span><span><span id="xdx_82B_zxaYOEnNYFO9">Legal Proceedings</span></span></span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">From time to time, the Company may be involved in various litigation matters, which arise in the ordinary course of business. There is currently no litigation that management believes will have a material impact on the financial position of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On or around January 30, 2019, RWJ Advanced Marketing, LLC, Greg Bauer, and Warren Jackson sued the Company and multiple third and related parties in Superior Court of the State of California - County of Los Angeles, General District in connection with the acquisition of UGO in September 2017. The case number is 19STCV03320 (the “Original Lawsuit”). The complaint in the Original Lawsuit alleges breach of contract, among other causes of action. The Company answered the complaint and filed a cross-complaint against the plaintiffs in the case and third parties on or around February 15, 2019. On or about September 10, 2020, the Company through its agent of service was “served” with a complaint (the Company contested service) that was recently filed against the Company and third parties by Robert Warren Jackson and Gregory Bauer in Los Angeles Superior Court Case No.: 20STCV32709 (“Second Lawsuit”). In the Original Lawsuit filed, the court rejected the plaintiff’s claims that they were filing a purported quasi-derivative lawsuit. As such, in this current litigation, the plaintiff is now again claiming the action is a derivative lawsuit. On October 13, 2020, the Second Lawsuit was removed by other defendants into Central District of California (CASE NO. 2:20−cv−09399−RGK−AGR). On February 2, 2021 the Central District of California dismissed the entire Second Lawsuit based on “demand futility”. In the Original lawsuit, the Company filed a cross complaint against the plaintiff and other third parties. Recently, the court has scheduled various hearings and a trial date set for December 27, 2021 which was later continued by the Court to September 28, 2022. It was the Company’s intention to dividend its holdings of its wholly owned subsidiary Ugopher services Corp. (“UGO”). As UGO is the main dispute in the litigations described above, the Company has elected to sell UGO to a third-party effective July 1, 2020. On September 17, 2020, the Company terminated Greg Bauer as consultant (resulting from the sale of UGO), which he confirmed in writing. On or about June 14, 2021 the Company stipulated with plaintiff that all third parties will be released and plaintiff may file a new first amendment complaint that will name only the Company. As such, all third parties other than prior transfer agent of the Company have been dismissed from this litigation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Following the sale of UGO, the Company noticed third parties (including SURG, via its asset manager) to wire the UGO funds to its new bank account. SURG never answered the notice. SURG is the clearing house for UGO.The Company noticed certain third parties that it intends to take legal actions to resolve this issue. On November 12, 2020 the Company filed a complaint in the United States District Court – District of Nevada - Case 2:20-cv-02078 against RWJ, Mr. Bauer, Mr. Jackson and against W.L. Petrey Wholesale Company Inc for fraud, breach of contract, Unjust Enrichment and other claims. On January 28, 2022 the court awarded the Company with injunction against RWJ defendants, where all fee funds generating from resale should be deposited into GBT blocked account, and therefore RWJ defendants cannot use these funds without court order.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company entered into the Confidential Settlement Agreement and Mutual Release (“RJW Agreement”) by and between RWJ Advanced Marketing, LLC, Robert Warren Jackson, Gregory Bauer (collectively the “RJW Parties”) and W.L. Petrey Wholesale Company, Inc., (“Petrey”) on one hand; and GBT Technologies Inc., on behalf of itself and its agents (collectively the GBT Parties”), on the other hand. The Company the RJW Agreement effective September 26, 2022 with final signatures delivered to the Company on or about October 5, 2022. Pursuant to the RJW Agreement, the parties have agreed to settle, release, and otherwise resolve all known or unknown claims between them and agreed to jointly stipulate, move, or otherwise dismiss the lawsuits filed in the United States District Court of Nevada (Case No. 2:20-cv- 02078), in the Superior Court of the State of California, County of Los Angeles, Central District (Case Nos. 19STCV03320 and 20STCV32709), and in the United States District Court of the Central District of California (Case No. 2:20-cv-09399-RGK-AGR) with prejudice. The parties agreed and stipulated to release all funds currently being held in a blocked account of $<span id="xdx_90E_eus-gaap--EscrowDeposit_c20221231__us-gaap--TransactionTypeAxis__custom--RWJAgreementMember_pp0p0" title="Escrow amount">19,809</span> with 50% distributed to the RWJ Parties and 50% distributed the Company or its assignee. The Parties also entered into the InComm Assignment Agreement (“IAA”) which assigned, transferred and conveyed all proceeds derived from the RWJ Parties’ agreements with Interactive Communications International, Inc., and its affiliate Hi Technology Corp., including but not limited to that Master Distribution and Service Agreement between Interactive Communications International, Inc. and Petrey d/b/a UGO-HUB dated August 29, 2016, as amended (collectively referred to as the “InComm Proceeds”), and which shall divide the InComm Proceeds 90% to the Company or its assignee and 10% to the RWJ Parties or their assignee. Finally, the Company agreed to pay $<span id="xdx_900_eus-gaap--ProceedsFromRelatedPartyDebt_c20220101__20221231__us-gaap--TransactionTypeAxis__custom--RWJAgreementMember_z9QOUaLPRA66" title="Proceeds from related party debt">40,000</span> to the RWJ Parties or their assignee. The Company accrued $<span id="xdx_905_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_c20221231__us-gaap--TransactionTypeAxis__custom--RWJAgreementMember_pp0p0" title="Accrued expenses">49,847</span> expenses represent the final amounts due to the RJW Parties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company under a different settlement agreement with SURG, committed to assign the IAA. As such, on October 5, 2022 and as cumulation of all settlement agreements the Company issued a request to SURG regarding release of certain escrow funds and the execution of an assignment of rights as contemplated in the aforereferenced agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 3, 2018, the Company entered into a Securities Purchase Agreement (the “SPA”) with Discover Growth Fund, LLC (the “Investor”) pursuant to which the Company issued a Senior Secured Redeemable Convertible Debenture (the “Debenture”) of $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_c20181203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredRedeemableConvertibleDebentureMember_pp0p0" title="Note payable, principal amount">8,340,000</span>. In connection with the issuance of the Debenture and pursuant to the terms of the SPA, the Company issued a Common Stock Purchase Warrant to acquire up to <span id="xdx_908_ecustom--WarrantsAquire_c20181203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredRedeemableConvertibleDebentureMember_pdd" title="Warrants aquire">225,000</span> shares of common stock for a term of three years (the “Warrant”) on a cash-only basis at an exercise price of $100 per share with respect to 50,000 Warrant Shares, $75 with respect to 75,000 Warrant Shares and $50 with respect to 100,000 Warrant Shares. The holder may not exercise any portion of the Warrants to the extent that the holder would own more than 4.99% of the Company’s outstanding common stock immediately after exercise. The outstanding principal amount may be converted at any time into shares of the Company’s common stock at a conversion price equal to 95% of the Market Price less $5 (the conversion price is lowered by 10% upon the occurrence of each Triggering Event – the current conversion price is 75% of the Market Price less $5.00). The Market Price is the average of the 5 lowest individual daily volume weighted average prices during the period the Debenture is outstanding. On May 28, 2019, the Investor delivered to the Company a “Notice of Default and Notice of Sale of Collateral” (the “Notice”). On December 23, 2019, in arbitration between the Company and the Investor, an Interim Award was entered in favor of the Investor. On January 31, 2020, the Company was informed that a final award was entered (the “Final Award”). The Final Award affirms that certain sections of the Debenture constitute unenforceable liquidated damages penalties and were stricken. Further, it was determined that the Investor was entitled to recovery of their attorney’s fees. Consequently, the arbitrator awarded Investor an award of $<span id="xdx_908_ecustom--ArbitratorAwarded_pp0p0_c20190501__20190515__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zsZdONWPit0l" title="Arbitrator awarded">4,034,444</span> plus interest of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20190501__20190515__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z6UQd2kvzgde" title="Interest rate">7.25</span>% accrued from May 15, 2019 and costs of $<span id="xdx_907_eus-gaap--InterestExpenseOtherDomesticDeposits_pp0p0_c20190501__20190515__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zkdVZk8sgoT9" title="Interest">55,613</span>. On February 18, 2020, the Company filed a motion with the United States District Court District of Nevada (the “Nevada Court”) to confirm the Final Award and a motion to consolidate Investor’s application to confirm the Final Award filed in the U.S. District Court of the Virgin Islands (Case No: 3 :20-cv-00012-CVG-RM) (the “Virgin Island Court”). On February 27, 2020, the Nevada Court denied the Company’s motion to confirm the Final Award and motion to consolidate and further decided that the confirmation of the Final Award should be litigated in the Virgin Island Court. As such, on February 27, 2020, the Company filed a Notice of Entry of Order as well as a Motion to Confirm the Arbitration Award, address the outstanding issues regarding whether Investor’s rights are subordinated to other creditors and, thereafter, oversee a commercially reasonable foreclosure sale (Case No: 3 :20-cv-00012-CVG-RM). It was the Company’s position that the Final Award must first be confirmed and all questions regarding the rights of Investor relative to those of other creditors must be determined before any foreclosure sale can proceed. It is further the position of the Company that the previously disclosed foreclosure sale scheduled by Investor is being conducted in a commercially unreasonable manner and that if Discover proceeded forward with the foreclosure sale it did so at its own risk. Nevertheless, on February 28, 2020, Investor advised that it conducted a sale of the Company’s assets. As the date of this report Investor failed to present a deed of sale for the alleged sale that allegedly took place as noticed. The Company filed with Virgin Island Court the motions disputing the validity of the alleged sale. On July 28, 2020, Investor filed in the State of Nevada a motion for attorneys $<span id="xdx_90C_eus-gaap--LossContingencyDamagesSoughtValue_c20200701__20200728_pp0p0" title="Sought value">48,844</span> and costs $<span id="xdx_908_ecustom--LegalCost_c20200701__20200728_pp0p0" title="Legal cost">716</span>. The Company filed an answer on August 11, 2020. On October 16, 2020, Investor motion for attorneys $<span id="xdx_90C_eus-gaap--LossContingencyDamagesSoughtValue_c20201001__20201016_pp0p0" title="Sought value">48,844</span> and costs $<span id="xdx_904_ecustom--LegalCost_c20201001__20201016_pp0p0" title="Legal cost">716</span> was denied. This case is still pending with the Federal court and the Court has not taken any substantive action in the matter as of the date of this report.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with SURG Exchange Agreement (see Note 5) - On November 4, 2020, Altcorp and Stanley filed an Ex Parte Motion in the District Court, Clark County, Nevada (Case No: A-20-823039-B, in Dep No: 43) to appoint receiver and issue a temporary restraining Order against SURG and its transfer agent for alleged defaults on prior exchange agreement. On December 4, 2020, the parties entered an interim agreement which set the material terms of the settlement. A final settlement was achieved per the interim agreement terms on January 1, 2021. On March 4, 2021 the Company filed a motion to enforce settlement agreements, as the Company alleged that SURG owes an additional $240,000 which is due and owing under the settlement agreements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 24, 2021 per the June 23, 2020 Agreement, the Company together with AltCorp sent SURG and its transfer agent via registered mail, a true-up shares demand for an additional <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220603__20220624__us-gaap--StatementEquityComponentsAxis__custom--SURGSharesMember_za69mIssK1wj" title="Number of shares issued">14,870,370</span> SURG shares as calculated per the Agreement. As of the filing date of this report, SURG’s transfer agent did not answer the Company’s request.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Subsequently, SURG was a party to two lawsuits in state District Court, the Eighth Judicial District Court for Clark County, Nevada involving AltCorp, Stanley and Glen Eagles Acquisition LP (the “AltCorp Parties.”). Each of these lawsuits were ultimately disputes relating to the total consideration SURG was to pay the Company under the APA.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 18, 2021, the AltCorp Parties, the Company, and SURG entered into a Memorandum of Understanding (the “MOU”) to set up a framework for an attempt to settle the two lawsuits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 22, 2021 (the “Effective Date”), pursuant to the framework in the MOU, the AltCorp Parties (and an additional third party), the Company, ECS, and SURG, Kevin Brian Cox (SURG’s Chief Executive Officer) - in his individual capacity, entered into a Resolution of Purchase, Mutual Release, and Settlement Agreement (the “Final Settlement Agreement”) to settle the two lawsuits and resolve all disputes related to the consideration paid by SURG to the Company in connection with the APA.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On or about July 9, 2021 the Company filed a lawsuit in District Court in Clack County Nevada – Department 19 (Case number A-21-837631-C) against Terry Taylor and TTSG Holdings, Inc for breach of contract, breach of covenant of Good Faith and Fair Dealing, Unjust Enrichment and declaratory relief for failure of providing consulting services per contract they entered. The Company is demanding the return of 240,000 shares issued, return of the $5,000 payments, recission of the consulting agreement, and attorney’s fees and costs. As Terry Taylor and TTSG Holdings failed to appear to a notice of deposition, the Company filed for a summary judgment. On January 20, 2023 the court issued a $708,821 writ of execution against Terry Taylor and TTSG</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Gregory Mancuso and Rainer AG</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On or about February 2, 2022, GBT was served with a First Amended Complaint (the “Complaint”) initiated by Gregory Mancuso and Rainer AG, a Swiss corporation, Case No. 21SMCV01430, filed in the Superior Court of the State of California for the County of Los Angeles. The Complaint names a number of different parties, including GBT, and asserts, among other things, claims for conversion, unjust enrichment, breach of contract, and breach of implied covenant of fair dealing, which Plaintiffs allege arise out of a brokerage agreement entered into between Plaintiff Rainer AG and co-defendant Consul Group re Dos Mil Veintiuno S.R.L (“Consul”). GBT was sued under an alter ego theory of liability, and its only involvement in the above-referenced chain of events seems to be that its shares were deposited with Rainer by Consul upon the opening of the brokerage account. GBT will be filling a demurrer to the First Amended Complaint based on a variety of deficiencies with the First Amended Complaint, and will ask the Court to dismiss the claims against GBT.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 19809 40000 49847 8340000 225000 4034444 0.0725 55613 48844 716 48844 716 14870370 <p id="xdx_80C_eus-gaap--LossContingencyDisclosures_zD2gPYOeJc4c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: left"><b>Note 18 - <span id="xdx_820_zAvGRkwbSyY4">Contingencies</span> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>GBT Technologies, S.A.</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On September 14, 2018, the Company entered into an Exclusive Intellectual Property License and Royalty Agreement (the “GBT License Agreement”) with GBT-CR, a fully compliant and regulated crypto currency exchange platform that currently operates in Costa Rica as a decentralized crypto currency platform, pursuant to which, among other things, the Company granted to GBT-CR an exclusive, royalty-bearing right and license relating intellectual property relating to systems and methods of converting electronic transmissions into digital currency as reflected in that certain patent filed with the United Stated Patent and Trademark Office on or about June 14, 2018 (EFS ID: 32893586; Application Number: 16008069; Type: Utility under 35 USC 111(a); Confirmation Number: 6787)(collectively, the “Digital Currently Technology”). Pursuant to the GBT License Agreement, the Company granted GBT-CR an exclusive worldwide license to use the Digital Currency Technology to make, use, sell, lease or otherwise commercialize and dispose of products and devices utilizing the Digital Currently Technology. Under the terms of the GBT License Agreement, the Company is entitled to receive a royalty payment of 2% of gross revenue of each licensed product sold by GBT-CR during the period starting in which revenue is first generated using the licensed products and continuing for five years thereafter. Upon signing the GBT-CR License Agreement, GBT-CR paid the Company $<span id="xdx_90C_eus-gaap--Revenues_pp0p0_c20180101__20181231__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zYaU9elNITya" title="Revenues">300,000 </span>which is nonrefundable. The Company recognized the $300,000 as revenue during the years ended December 31, 2018. Upon GBT-CR making available for sale (the “Commercial Event”) an ICO (Initial Coin Offering) (the “Coin”), GBT-CR will make a payment to the Company of $<span id="xdx_908_ecustom--PaymentForExpenses_pp0p0_c20180101__20181231__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zVgMmn8NZpGc" title="Payment for expenses">5,000,000</span>. Further, upon the Commercial Event, GBT-CR will grant the Company the ability to acquire 30% of the Coin at a 30% discount of such offering price of the Coin. The GBT License Agreement commenced as of the signing date and, unless terminated in accordance with the termination provisions of the GBT License Agreement, shall remain in force until the expiration of the patent pertaining to the Digital Currency Technology; provided that the right to use trade secrets shall survive the expiration of the GBT License Agreement provided the Company has not terminated. Prior to the signing of the GBT License Agreement, GBT-CR advanced $<span id="xdx_907_eus-gaap--DeferredRevenue_iI_pp0p0_c20221231__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zfTg9oenR5n1" title="Unearned revenue">200,000</span> to the Company, which the parties have agreed will be applied toward the $5,000,000 fee when it becomes due. On February 27, 2020 GBT Technologies, S.A., as successor in interest to Hermes Roll, LLC had notified the Company that it was in default on its Amended and Restated Territorial License Agreement (“ARTLA”) dated June 15, 2015 and that the ARTLA had been cancelled and rescinded.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Stock Loan Receivable</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On January 8, 2019, the Company entered into a Stock Pledge Agreement with Latin American Exchange Latinex Casa de Cambio, S.A., a Costa Rica corporation (“Latinex”), to provide that Latinex may maintain its required regulatory capital as required by various regulators. The Company pledged 4,006 restricted shares of its common stock valued at $7,610,147 (based on the closing price on the grant date) for three years for an annual payment of $375,000 paid in quarterly installments of $93,750. In lieu of cash payment, Latinex may pay the Company in virtual currency of WISE Network S.A. valued at a 50% discount of its offering price of $10 per token. In the event that Latinex’s required capital has decreased below $5,000,000, Latinex is permitted to sell the pledged shares of common stock only in an amount to ensure that Latinex can satisfy the required capital levels. The Company must consent to such sale of the shares of common stock, which may not be unreasonably withheld. Upon expiration of the agreement, the remaining shares of common stock shall be returned to the Company free and clear of all liens. The Company recorded the value of these shares of common stock as a stock loan receivable which is presented as a contra-equity account in the accompanying consolidated balance sheets. At December 31, 2019, the Company wrote off the accrued interest income as Latinex did not perform any payment and the Company has no mean to enforce this payment. Latinex agreed in principle to return the pledged 4,006 restricted shares to the Company for cancellation. The 4,006 restricted shares have not yet been returned to the Company as of December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i><span style="text-decoration: underline">Assignment of lease agreement</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On May 17, 2022, Mahaser LLC (“Assignee”) entered into an assignment and assumption of lease agreement by and between 2819 Coldwater LLC (“Assignor”), Sunset Place Holdings LLC (“Lessor”) and Yossi Attia (“Guarantor”). Pursuant to the agreement, Lessor agreed to lease to Assignor certain Standard Industrial/Commercial Multi-Tenant Lease – Gross agreement dated February 7, 2022 (the “Lease”) and expiring on January 31, 2024, which premises commonly known as 8265 Sunset Boulevard, Suite #107, West Hollywood, CA 90046. The base rent payment shall equal $4,100 per month and share of common area operating expense shall equal $<span id="xdx_90D_eus-gaap--OperatingExpenses_pp0p0_c20220501__20220517_zuDLkM9LBRv5" title="Operating expense">200</span> per month. Guarantor has guaranteed payment of Assignor’s obligations under the Lease and Assignor assigned all of its right, title and interest in the Lease to Assignee and Assignee assumed Assignor’s obligations under the Lease.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> 300000 5000000 200000 200 <p id="xdx_805_eus-gaap--ConcentrationRiskDisclosureTextBlock_zpG5rXSfLcS9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><b><span id="xdx_825_zEOHJFrR1J6c">Note 19 – <span id="xdx_825_zNrGUxa8Hvsc">Concentrations</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Concentration of Credit Risk</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments, which potentially subject the Company to a concentration of credit risk for the years, consist principally of temporary cash investments. There have been no losses in these accounts through December 31, 2022 and 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Liquidity risk</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has an accumulated deficit of $<span id="xdx_903_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_c20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--LiquidityRiskMember_zzb0pyHdyVpe" title="Accumulated deficit">299,257,917</span> and has a working capital deficit of $<span id="xdx_90A_ecustom--WorkingCapitalDeficits_iI_c20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--LiquidityRiskMember_zBUCsdZUUFje" title="Working capital deficit">18,522,046</span> as of December 31, 2022, which raises substantial doubt about its ability to continue as a going concern as the Company does not have sufficient funds to discharge its current liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Customers</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Sales for both the years ended December 31, 2022 and 2021 were $<span id="xdx_905_ecustom--Sales_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersMember_zAKyuowaZQjd" title="Sales">1,152,555</span> and $<span id="xdx_900_ecustom--Sales_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersMember_zoLlqhyJDXuk" title="Sales">0</span>. The Consulting income from related party for both the years ended December 31, 2022 and 2021 was $<span id="xdx_904_eus-gaap--RevenuesNetOfInterestExpense_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersMember_z15mQ7Qh6Fif" title="Net revenues">45,000</span> and $<span id="xdx_90A_eus-gaap--RevenuesNetOfInterestExpense_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomersMember_zsUkBYJRCrri" title="Net revenues">180,000</span>. Sales are derived from providing IT consulting services to a related party and sales from amazon and Ebay.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 299257917 18522046 1152555 0 45000 180000 <p id="xdx_804_eus-gaap--SubsequentEventsTextBlock_zlyq4wnlqvP7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_821_zOuvSibT6D6e">Note 20 - <span id="xdx_823_ze6wb8nFpxvk">Subsequent Events</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 24, 2023, the Company issued a convertible promissory note to Glen Eagles Acquisition LP in the principal amount of $<span id="xdx_90B_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20230101__20230124__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlenEaglesAcquisitionLPMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zaFwwUJ9qRxe" title="Value of share converted">512,500</span>. The convertible promissory note bears interest of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20230124__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlenEaglesAcquisitionLPMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zE7ZiY7DU9w9" title="Note payable, interest rate">10</span>% and is payable at maturity on <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_pp0p0_dd_c20230101__20230124__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GlenEaglesAcquisitionLPMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z0Gr6aYwAPh" title="Note maturity date">December 31, 2023</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On March 1, 2023, the Company entered into a Securities Purchase Agreement, with 1800 Diagonal Lending LLC, an accredited investor (“DL”) pursuant to which the Company issued to DL a Promissory Note (the “DL Note”) of $<span id="xdx_909_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20230227__20230302__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zviVuYqJMM2i" title="Value of share converted">59,408</span> with an original issue discount of $<span id="xdx_90B_ecustom--OriginalIssueDiscount_pp0p0_c20230227__20230302__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zLvqNOMMiS2l" title="Original issue discount">6,258</span> resulting in net proceeds of the Company of $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOfDebt_pp0p0_c20230227__20230302__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zjrRe3Ruxpj4" title="Net proceeds">53,150</span>. The DL Note had a maturity date of <span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20230227__20230302__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpYMHwYGGPV7" title="Note maturity date">June 1, 2024</span> and the Company had agreed to pay interest on the unpaid principal balance of the DL Note at the rate of 12.0% from the date on which the DL Note is issued. A one-time interest charge of <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20230302__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zXUBmyi9AoL1" title="Note payable, interest rate">12</span>% or $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20230302__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z7b0YTWDHG9b" title="Principal amount">7,128</span> was applied on the issuance date of the DL Note to the principal amount owed under the DL Note. Accrued, unpaid interest and outstanding principal, subject to adjustment, shall be paid in ten payments of $<span id="xdx_904_eus-gaap--InterestPayableCurrent_iI_c20230302__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUdBcLd9j6ue" title="Interest payable">6,653</span>.60 resulting in a total payback to DL of $<span id="xdx_90B_eus-gaap--InterestPayableCurrent_iI_c20230302__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DiagonalLendingMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zfv3SzNF4qx6" title="Interest payable">66,536</span>. The first payment is due April 15, 2023 with nine subsequent payments each month thereafter. The Company shall have a five-day grace period with respect to each payment. The Company has right to accelerate payments or prepay in full at any time with no prepayment penalty. This DL Note shall not be secured by any collateral or any assets of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The outstanding principal amount of the DL Note may not be converted into the Company common shares except in the event of default. In the event of default on the DL Note, DL may convert the DL Note into shares of the Company’s common stock at a conversion price equal to 75% of the lowest trading price during the 10 day period immediately preceding the date of conversion. In addition, upon the occurrence and during the continuation of an event of default (as defined in the DL Note), the DL Note shall become immediately due and payable and the Company shall pay to DL, in full satisfaction of its obligations hereunder, additional amounts as set forth in the DL Note. In no event shall DL be allowed to effect a conversion if such conversion, along with all other shares of Company common stock beneficially owned by DL and its affiliates would exceed 4.99% of the outstanding shares of the common stock of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On March 1, 2023, the Company entered into a Securities Purchase Agreement with DL pursuant to which the Company issued to DL a Convertible Promissory Note (the “DL Convertible Note”) of $<span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20230227__20230302__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--LongtermDebtTypeAxis__custom--DLConvertibleNoteMember_z9MdyejzPaL4" title="Value of share converted">62,680</span> for a purchase price of $<span id="xdx_909_ecustom--PurchasePrice_pp0p0_c20230227__20230302__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--LongtermDebtTypeAxis__custom--DLConvertibleNoteMember_zXUhCzVZfFBc" title="Purchase price">52,150</span>. The DL Convertible Note had a maturity date of <span id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_dd_c20230226__20230302__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--LongtermDebtTypeAxis__custom--DLConvertibleNoteMember_ziFiWTE0ail2" title="Note maturity date">June 1, 2024</span> and the Company had agreed to pay interest on the unpaid principal balance of the DL Convertible Note at the rate of <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20230302__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--LongtermDebtTypeAxis__custom--DLConvertibleNoteMember_zF8RDeVKPmY7" title="Note payable, interest rate">6.0</span>% from the date on which the DL Convertible Note is issued until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise. The Company shall have the right to prepay the DL Convertible Note, provided it makes a payment including a prepayment to DL as set forth in the DL Convertible Note.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The outstanding principal amount of the DL Convertible Note may not be converted prior to the period beginning on the date that is 180 days following the date the DL Convertible Note is issued . Following the 180th day, DL may convert the DL Convertible Note into shares of the Company’s common stock at a conversion price equal to 85% of the lowest trading price during the 20 day period preceding the date of conversion. In addition, upon the occurrence and during the continuation of an event of default (as defined in the DL Convertible Note), the DL Convertible Note shall become immediately due and payable and the Company shall pay to DL, in full satisfaction of its obligations hereunder, additional amounts as set forth in the DL Convertible Note. In no event shall DL be allowed to effect a conversion if such conversion, along with all other shares of Company common stock beneficially owned by DL and its affiliates would exceed 4.99% of the outstanding shares of the common stock of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On June 10, 2022, GBT Technologies, Inc. (the “Company”), entered into a Joint Venture and Territorial License Agreement (the “Metaverse Agreement”) with Ildar Gainulin and Maria Belova (collectively, the “Licensor”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 5.2pt 0 0; text-align: justify; background-color: white">Under the Metaverse Agreement, the parties formed Metaverse Kit Corp., a Nevada corporation (“Metaverse Kit”). The purpose of Metaverse Kit was to develop, maintain and support source codes for its proprietary technologies and comprehensive platform that combines a core virtual reality platform and an extended set of real-world functions to provide a metaverse experience initially within the area of sports and then expanding into virtual worlds of entertainment, live events, gaming, communications and other cross over product opportunities (the “Meta Portfolio”). Under the Metaverse Agreement, Licensor agreed to provide Metaverse Kit with the licensed technology and expertise. In connection therewith, the parties entered an Asset Purchase Agreement (the “Metaverse APA”) concurrently with the Metaverse Agreement whereby Licensor sold Metaverse Kit all source codes pertaining to the Meta Portfolio. Further, Licensor provided an exclusive license to Metaverse Kit throughout the world for the invented product/service and the related platforms relating to the Meta Portfolio and to use the know how to develop, manufacture, sell, market and distribute the Meta Portfolio throughout the world. The Company was required to contribute <span id="xdx_908_eus-gaap--SharesIssued_iI_c20220610__dei--LegalEntityAxis__custom--GBTMember_zVJCD8F5zyZ2" title="Shares issued">500,000,000</span> shares of common stock of the Company (“GBT Shares”) to Metaverse Kit. Licensor and the Company were to each own 50% of Metaverse Kit. The Company pledged its 50% ownership in Metaverse Kit to Igor 1 Corp. to secure a convertible note held by Igor 1 Corp. The Company was to appoint two directors and Licensor was allowed to appoint one director of Metaverse Kit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 5.2pt 0 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">In addition, Metaverse Kit, Licensor and Elentina Group, LLC (“Elentina”) entered into a Consulting Agreements in which IGBM and Elentina, each were engaged to provide services for $<span id="xdx_90F_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20220101__20220610__us-gaap--TypeOfArrangementAxis__custom--MetaverseAgreementMember_zXMiRgrB5V9f" title="Sale of common stock">25,000</span> per month payable quarterly which Metaverse Kit has the option to pay in shares of common stock calculated by the amount owed divided by the Company’s 10-day VWAP. Licensor and Elentina were to provide services in connection with the development of the business as well as Metaverse Kit’s capital raising efforts. The term of the Consulting Agreement was two years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The closing of the Metaverse Agreement occurred on June 13, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On March 14, 2023, the Company received a counter signed Settlement Agreement and Release by Licensor dated March 2, 2023 (“Settlement Agreement”). Pursuant to the Settlement Agreement, the parties agreed that Metaverse Agreement, the Metaverse APA and the Consulting Agreement are void and cancelled. Licensor agreed to pay $<span id="xdx_907_ecustom--SettlementMade_c20230301__20230314__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zMEpapZHDHHj" title="Settlement made">5,000</span> to the Company as settlement payment and surrender their shares in Metaverse Kit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On February 1, 2023, the Company engaged AlKhatib Consulting Group to provide exclusive representation services in connect with managing market partners, effective on February 1, 2012 for 24 consecutive months.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 3, 2023, GBT Tokenize Corp. (“Seller”), a subsidiary that is owned <span id="xdx_905_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_dp_c20230403__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--OwnershipAxis__custom--GBTTechnologiesIncMember_zG9Oyqbz7zoi" title="Ownership percentage">50</span>% by GBT Technologies, Inc (“GBT”) entered into an Asset Purchase Agreement (“APA”) with Trend Innovation Holdings, Inc. ( “TREN”), in which GBT consented, pursuant to which Seller sold certain assets relating to proprietary system and method named Avant-Ai, which is a text-generation, deep learning self-training model (the “System”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 5.2pt 0 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In consideration of acquiring the System, TREN is required to issue to the Seller <span id="xdx_901_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230401__20230403__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpjYEBMpo86i" title="Number of shares sold">26,000,000</span> common shares of TREN (the “Shares”). The Shares will be restricted per Rule 144 as promulgated under the Securities Act of 1933, as amended (the “1933 Act”) and Seller agreed to a lock-up period of nine (9) months following closing (the “Lock Up Term”). In the event that TREN is unable to up-list to Nasdaq either through a business combination or otherwise prior to the expiration of the Lock Up Term, the Seller may request within three (3) business days of the expiration of the Lock-Up Term, that all transactions contemplated by the APA be unwound.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.05pt 5.2pt 0 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, TREN, Seller and GBT entered into a license agreement regarding the System, granting the Seller and/or GBT a perpetual, irrevocable, non-exclusive, non-transferable license for using the System to be used in its own development, as in-house tool, where Seller or GBT may not sublicense its rights hereunder to any customer or client.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> 512500 0.10 2023-12-31 59408 6258 53150 2024-06-01 0.12 7128 6653 66536 62680 52150 2024-06-01 0.060 500000000 25000 5000 0.50 26000000 EXCEL 78 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end
XML 79 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 80 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 81 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 237 399 1 false 97 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://gbtti.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://gbtti.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://gbtti.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONSOLIDATED STATEMENT OF OPERATIONS Sheet http://gbtti.com/role/ConsolidatedStatementOfOperations CONSOLIDATED STATEMENT OF OPERATIONS Statements 4 false false R5.htm 00000005 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT Sheet http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT Statements 5 false false R6.htm 00000006 - Statement - CONSOLIDATED STATEMENT OF CASH FLOWS Sheet http://gbtti.com/role/ConsolidatedStatementOfCashFlows CONSOLIDATED STATEMENT OF CASH FLOWS Statements 6 false false R7.htm 00000007 - Disclosure - Organization and Basis of Presentation Sheet http://gbtti.com/role/OrganizationAndBasisOfPresentation Organization and Basis of Presentation Notes 7 false false R8.htm 00000008 - Disclosure - Going Concern Sheet http://gbtti.com/role/GoingConcern Going Concern Notes 8 false false R9.htm 00000009 - Disclosure - Summary of Significant Accounting Policies Sheet http://gbtti.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 00000010 - Disclosure - Marketable Securities Sheet http://gbtti.com/role/MarketableSecurities Marketable Securities Notes 10 false false R11.htm 00000011 - Disclosure - Investment in Surge Holdings, Inc. Sheet http://gbtti.com/role/InvestmentInSurgeHoldingsInc. Investment in Surge Holdings, Inc. Notes 11 false false R12.htm 00000012 - Disclosure - Stock Loan Receivable Sheet http://gbtti.com/role/StockLoanReceivable Stock Loan Receivable Notes 12 false false R13.htm 00000013 - Disclosure - Impaired Investment Sheet http://gbtti.com/role/ImpairedInvestment Impaired Investment Notes 13 false false R14.htm 00000014 - Disclosure - Accounts Payable and Accrued Expenses Sheet http://gbtti.com/role/AccountsPayableAndAccruedExpenses Accounts Payable and Accrued Expenses Notes 14 false false R15.htm 00000015 - Disclosure - Unearned Revenue Sheet http://gbtti.com/role/UnearnedRevenue Unearned Revenue Notes 15 false false R16.htm 00000016 - Disclosure - Convertible Notes Payable, Non-related Partied and Related Party Notes http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedParty Convertible Notes Payable, Non-related Partied and Related Party Notes 16 false false R17.htm 00000017 - Disclosure - Notes Payable, Non-related Parties and Related Party Notes http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedParty Notes Payable, Non-related Parties and Related Party Notes 17 false false R18.htm 00000018 - Disclosure - Accrued Settlement Sheet http://gbtti.com/role/AccruedSettlement Accrued Settlement Notes 18 false false R19.htm 00000019 - Disclosure - Derivative Liability Sheet http://gbtti.com/role/DerivativeLiability Derivative Liability Notes 19 false false R20.htm 00000020 - Disclosure - Stockholders??? Equity Sheet http://gbtti.com/role/StockholdersEquity Stockholders??? Equity Notes 20 false false R21.htm 00000021 - Disclosure - Income Taxes Sheet http://gbtti.com/role/IncomeTaxes Income Taxes Notes 21 false false R22.htm 00000022 - Disclosure - Related Parties Sheet http://gbtti.com/role/RelatedParties Related Parties Notes 22 false false R23.htm 00000023 - Disclosure - Legal Proceedings Sheet http://gbtti.com/role/LegalProceedings Legal Proceedings Notes 23 false false R24.htm 00000024 - Disclosure - Contingencies Sheet http://gbtti.com/role/Contingencies Contingencies Notes 24 false false R25.htm 00000025 - Disclosure - Concentrations Sheet http://gbtti.com/role/Concentrations Concentrations Notes 25 false false R26.htm 00000026 - Disclosure - Subsequent Events Sheet http://gbtti.com/role/SubsequentEvents Subsequent Events Notes 26 false false R27.htm 00000027 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://gbtti.com/role/SummaryOfSignificantAccountingPolicies 27 false false R28.htm 00000028 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://gbtti.com/role/SummaryOfSignificantAccountingPolicies 28 false false R29.htm 00000029 - Disclosure - Accounts Payable and Accrued Expenses (Tables) Sheet http://gbtti.com/role/AccountsPayableAndAccruedExpensesTables Accounts Payable and Accrued Expenses (Tables) Tables http://gbtti.com/role/AccountsPayableAndAccruedExpenses 29 false false R30.htm 00000030 - Disclosure - Convertible Notes Payable, Non-related Partied and Related Party (Tables) Notes http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyTables Convertible Notes Payable, Non-related Partied and Related Party (Tables) Tables http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedParty 30 false false R31.htm 00000031 - Disclosure - Notes Payable, Non-related Parties and Related Party (Tables) Notes http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyTables Notes Payable, Non-related Parties and Related Party (Tables) Tables http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedParty 31 false false R32.htm 00000032 - Disclosure - Derivative Liability (Tables) Sheet http://gbtti.com/role/DerivativeLiabilityTables Derivative Liability (Tables) Tables http://gbtti.com/role/DerivativeLiability 32 false false R33.htm 00000033 - Disclosure - Stockholders??? Equity (Tables) Sheet http://gbtti.com/role/StockholdersEquityTables Stockholders??? Equity (Tables) Tables http://gbtti.com/role/StockholdersEquity 33 false false R34.htm 00000034 - Disclosure - Income Taxes (Tables) Sheet http://gbtti.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://gbtti.com/role/IncomeTaxes 34 false false R35.htm 00000035 - Disclosure - Organization and Basis of Presentation (Details Narrative) Sheet http://gbtti.com/role/OrganizationAndBasisOfPresentationDetailsNarrative Organization and Basis of Presentation (Details Narrative) Details http://gbtti.com/role/OrganizationAndBasisOfPresentation 35 false false R36.htm 00000036 - Disclosure - Going Concern (Details Narrative) Sheet http://gbtti.com/role/GoingConcernDetailsNarrative Going Concern (Details Narrative) Details http://gbtti.com/role/GoingConcern 36 false false R37.htm 00000037 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesTables 37 false false R38.htm 00000038 - Disclosure - Summary of Significant Accounting Policies (Details 1) Sheet http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails1 Summary of Significant Accounting Policies (Details 1) Details http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesTables 38 false false R39.htm 00000039 - Disclosure - Summary of Significant Accounting Policies (Details 2) Sheet http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails2 Summary of Significant Accounting Policies (Details 2) Details http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesTables 39 false false R40.htm 00000040 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesTables 40 false false R41.htm 00000041 - Disclosure - Marketable Securities (Details Narrative) Sheet http://gbtti.com/role/MarketableSecuritiesDetailsNarrative Marketable Securities (Details Narrative) Details http://gbtti.com/role/MarketableSecurities 41 false false R42.htm 00000042 - Disclosure - Investment in Surge Holdings, Inc. (Details Narrative) Sheet http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative Investment in Surge Holdings, Inc. (Details Narrative) Details http://gbtti.com/role/InvestmentInSurgeHoldingsInc. 42 false false R43.htm 00000043 - Disclosure - Impaired Investment (Details Narrative) Sheet http://gbtti.com/role/ImpairedInvestmentDetailsNarrative Impaired Investment (Details Narrative) Details http://gbtti.com/role/ImpairedInvestment 43 false false R44.htm 00000044 - Disclosure - Accounts Payable and Accrued Expenses (Details) Sheet http://gbtti.com/role/AccountsPayableAndAccruedExpensesDetails Accounts Payable and Accrued Expenses (Details) Details http://gbtti.com/role/AccountsPayableAndAccruedExpensesTables 44 false false R45.htm 00000045 - Disclosure - Unearned Revenue (Details Narrative) Sheet http://gbtti.com/role/UnearnedRevenueDetailsNarrative Unearned Revenue (Details Narrative) Details http://gbtti.com/role/UnearnedRevenue 45 false false R46.htm 00000046 - Disclosure - Convertible Notes Payable, Non-related Partied and Related Party (Details) Notes http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails Convertible Notes Payable, Non-related Partied and Related Party (Details) Details http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyTables 46 false false R47.htm 00000047 - Disclosure - Convertible Notes Payable, Non-related Partied and Related Party (Details 1) Notes http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails1 Convertible Notes Payable, Non-related Partied and Related Party (Details 1) Details http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyTables 47 false false R48.htm 00000048 - Disclosure - Convertible Notes Payable, Non-related Partied and Related Party (Details 2) Notes http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails2 Convertible Notes Payable, Non-related Partied and Related Party (Details 2) Details http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyTables 48 false false R49.htm 00000049 - Disclosure - Convertible Notes Payable, Non-related Partied and Related Party (Details Narrative) Notes http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative Convertible Notes Payable, Non-related Partied and Related Party (Details Narrative) Details http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyTables 49 false false R50.htm 00000050 - Disclosure - Notes Payable, Non-related Parties and Related Party (Details) Notes http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails Notes Payable, Non-related Parties and Related Party (Details) Details http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyTables 50 false false R51.htm 00000051 - Disclosure - Notes Payable, Non-related Parties and Related Party (Details 1) Notes http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails1 Notes Payable, Non-related Parties and Related Party (Details 1) Details http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyTables 51 false false R52.htm 00000052 - Disclosure - Notes Payable, Non-related Parties and Related Party (Details Narrative) Notes http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative Notes Payable, Non-related Parties and Related Party (Details Narrative) Details http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyTables 52 false false R53.htm 00000053 - Disclosure - Accrued Settlement (Details Narrative) Sheet http://gbtti.com/role/AccruedSettlementDetailsNarrative Accrued Settlement (Details Narrative) Details http://gbtti.com/role/AccruedSettlement 53 false false R54.htm 00000054 - Disclosure - Derivative Liability (Details) Sheet http://gbtti.com/role/DerivativeLiabilityDetails Derivative Liability (Details) Details http://gbtti.com/role/DerivativeLiabilityTables 54 false false R55.htm 00000055 - Disclosure - Derivative Liability (Details 1) Sheet http://gbtti.com/role/DerivativeLiabilityDetails1 Derivative Liability (Details 1) Details http://gbtti.com/role/DerivativeLiabilityTables 55 false false R56.htm 00000056 - Disclosure - Stockholders' Equity (Details) Sheet http://gbtti.com/role/StockholdersEquityDetails Stockholders' Equity (Details) Details 56 false false R57.htm 00000057 - Disclosure - Stockholders' Equity (Details 1) Sheet http://gbtti.com/role/StockholdersEquityDetails1 Stockholders' Equity (Details 1) Details 57 false false R58.htm 00000058 - Disclosure - Stockholders??? Equity (Details Narrative) Sheet http://gbtti.com/role/StockholdersEquityDetailsNarrative Stockholders??? Equity (Details Narrative) Details http://gbtti.com/role/StockholdersEquityTables 58 false false R59.htm 00000059 - Disclosure - Income Taxes (Details) Sheet http://gbtti.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://gbtti.com/role/IncomeTaxesTables 59 false false R60.htm 00000060 - Disclosure - Income Taxes (Details 1) Sheet http://gbtti.com/role/IncomeTaxesDetails1 Income Taxes (Details 1) Details http://gbtti.com/role/IncomeTaxesTables 60 false false R61.htm 00000061 - Disclosure - Income Taxes (Details Narrative) Sheet http://gbtti.com/role/IncomeTaxesDetailsNarrative Income Taxes (Details Narrative) Details http://gbtti.com/role/IncomeTaxesTables 61 false false R62.htm 00000062 - Disclosure - Related Parties (Details Narrative) Sheet http://gbtti.com/role/RelatedPartiesDetailsNarrative Related Parties (Details Narrative) Details http://gbtti.com/role/RelatedParties 62 false false R63.htm 00000063 - Disclosure - Legal Proceedings (Details Narrative) Sheet http://gbtti.com/role/LegalProceedingsDetailsNarrative Legal Proceedings (Details Narrative) Details http://gbtti.com/role/LegalProceedings 63 false false R64.htm 00000064 - Disclosure - Contingencies (Details Narrative) Sheet http://gbtti.com/role/ContingenciesDetailsNarrative Contingencies (Details Narrative) Details http://gbtti.com/role/Contingencies 64 false false R65.htm 00000065 - Disclosure - Concentrations (Details Narrative) Sheet http://gbtti.com/role/ConcentrationsDetailsNarrative Concentrations (Details Narrative) Details http://gbtti.com/role/Concentrations 65 false false R66.htm 00000066 - Disclosure - Subsequent Events (Details Narrative) Sheet http://gbtti.com/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://gbtti.com/role/SubsequentEvents 66 false false All Reports Book All Reports e4603_10ka.htm e4603_ex31-1.htm e4603_ex32-1.htm e4603_ex4-18.htm gtch-20221231.xsd gtch-20221231_cal.xml gtch-20221231_def.xml gtch-20221231_lab.xml gtch-20221231_pre.xml image_001.jpg http://fasb.org/srt/2022 http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 83 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "e4603_10ka.htm": { "axisCustom": 0, "axisStandard": 20, "baseTaxonomies": { "http://fasb.org/srt/2022": 1, "http://fasb.org/us-gaap/2022": 699, "http://xbrl.sec.gov/dei/2022": 37 }, "contextCount": 237, "dts": { "calculationLink": { "local": [ "gtch-20221231_cal.xml" ] }, "definitionLink": { "local": [ "gtch-20221231_def.xml" ] }, "inline": { "local": [ "e4603_10ka.htm" ] }, "labelLink": { "local": [ "gtch-20221231_lab.xml" ] }, "presentationLink": { "local": [ "gtch-20221231_pre.xml" ] }, "schema": { "local": [ "gtch-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 622, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 87, "http://gbtti.com/20221231": 59, "http://xbrl.sec.gov/dei/2022": 4, "total": 150 }, "keyCustom": 126, "keyStandard": 273, "memberCustom": 71, "memberStandard": 21, "nsprefix": "GTCH", "nsuri": "http://gbtti.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://gbtti.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - Marketable Securities", "menuCat": "Notes", "order": "10", "role": "http://gbtti.com/role/MarketableSecurities", "shortName": "Marketable Securities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - Investment in Surge Holdings, Inc.", "menuCat": "Notes", "order": "11", "role": "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.", "shortName": "Investment in Surge Holdings, Inc.", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "GTCH:StockLoanReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - Stock Loan Receivable", "menuCat": "Notes", "order": "12", "role": "http://gbtti.com/role/StockLoanReceivable", "shortName": "Stock Loan Receivable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "GTCH:StockLoanReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - Impaired Investment", "menuCat": "Notes", "order": "13", "role": "http://gbtti.com/role/ImpairedInvestment", "shortName": "Impaired Investment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - Accounts Payable and Accrued Expenses", "menuCat": "Notes", "order": "14", "role": "http://gbtti.com/role/AccountsPayableAndAccruedExpenses", "shortName": "Accounts Payable and Accrued Expenses", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "GTCH:UnearnedRevenueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Unearned Revenue", "menuCat": "Notes", "order": "15", "role": "http://gbtti.com/role/UnearnedRevenue", "shortName": "Unearned Revenue", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "GTCH:UnearnedRevenueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - Convertible Notes Payable, Non-related Partied and Related Party", "menuCat": "Notes", "order": "16", "role": "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedParty", "shortName": "Convertible Notes Payable, Non-related Partied and Related Party", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "GTCH:NotesPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - Notes Payable, Non-related Parties and Related Party", "menuCat": "Notes", "order": "17", "role": "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedParty", "shortName": "Notes Payable, Non-related Parties and Related Party", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "GTCH:NotesPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "GTCH:AccruedSettlementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - Accrued Settlement", "menuCat": "Notes", "order": "18", "role": "http://gbtti.com/role/AccruedSettlement", "shortName": "Accrued Settlement", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "GTCH:AccruedSettlementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativesAndFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - Derivative Liability", "menuCat": "Notes", "order": "19", "role": "http://gbtti.com/role/DerivativeLiability", "shortName": "Derivative Liability", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativesAndFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - CONSOLIDATED BALANCE SHEETS", "menuCat": "Statements", "order": "2", "role": "http://gbtti.com/role/ConsolidatedBalanceSheets", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "lang": null, "name": "us-gaap:AssetsHeldInTrustCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - Stockholders\u2019 Equity", "menuCat": "Notes", "order": "20", "role": "http://gbtti.com/role/StockholdersEquity", "shortName": "Stockholders\u2019 Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - Income Taxes", "menuCat": "Notes", "order": "21", "role": "http://gbtti.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - Related Parties", "menuCat": "Notes", "order": "22", "role": "http://gbtti.com/role/RelatedParties", "shortName": "Related Parties", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - Legal Proceedings", "menuCat": "Notes", "order": "23", "role": "http://gbtti.com/role/LegalProceedings", "shortName": "Legal Proceedings", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyDisclosures", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - Contingencies", "menuCat": "Notes", "order": "24", "role": "http://gbtti.com/role/Contingencies", "shortName": "Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyDisclosures", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - Concentrations", "menuCat": "Notes", "order": "25", "role": "http://gbtti.com/role/Concentrations", "shortName": "Concentrations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "26", "role": "http://gbtti.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - Summary of Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "27", "role": "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueMeasurementPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - Summary of Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "28", "role": "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueMeasurementPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - Accounts Payable and Accrued Expenses (Tables)", "menuCat": "Tables", "order": "29", "role": "http://gbtti.com/role/AccountsPayableAndAccruedExpensesTables", "shortName": "Accounts Payable and Accrued Expenses (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "GTCH:AccountsPayableRelatedPartiesCurrents", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://gbtti.com/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "GTCH:AccountsPayableRelatedPartiesCurrents", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "GTCH:RollfowardOfConvertibleNoteTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - Convertible Notes Payable, Non-related Partied and Related Party (Tables)", "menuCat": "Tables", "order": "30", "role": "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyTables", "shortName": "Convertible Notes Payable, Non-related Partied and Related Party (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "GTCH:RollfowardOfConvertibleNoteTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "GTCH:NotesPayableTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "GTCH:NotesPayableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - Notes Payable, Non-related Parties and Related Party (Tables)", "menuCat": "Tables", "order": "31", "role": "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyTables", "shortName": "Notes Payable, Non-related Parties and Related Party (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "GTCH:NotesPayableTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "GTCH:NotesPayableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:DerivativesAndFairValueTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - Derivative Liability (Tables)", "menuCat": "Tables", "order": "32", "role": "http://gbtti.com/role/DerivativeLiabilityTables", "shortName": "Derivative Liability (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DerivativesAndFairValueTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - Stockholders\u2019 Equity (Tables)", "menuCat": "Tables", "order": "33", "role": "http://gbtti.com/role/StockholdersEquityTables", "shortName": "Stockholders\u2019 Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - Income Taxes (Tables)", "menuCat": "Tables", "order": "34", "role": "http://gbtti.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2021-10-252021-10-26", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityReverseStockSplit", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - Organization and Basis of Presentation (Details Narrative)", "menuCat": "Details", "order": "35", "role": "http://gbtti.com/role/OrganizationAndBasisOfPresentationDetailsNarrative", "shortName": "Organization and Basis of Presentation (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R36": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - Going Concern (Details Narrative)", "menuCat": "Details", "order": "36", "role": "http://gbtti.com/role/GoingConcernDetailsNarrative", "shortName": "Going Concern (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "GTCH:WorkingCapitalDeficit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueMeasurementPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "GTCH:ConversionFeatureOnConvertibleNotes", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - Summary of Significant Accounting Policies (Details)", "menuCat": "Details", "order": "37", "role": "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails", "shortName": "Summary of Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueMeasurementPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "GTCH:ConversionFeatureOnConvertibleNotes", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "srt:ScheduleOfCondensedFinancialStatementsTableTextBlock", "GTCH:VariableInterestEntityPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - Summary of Significant Accounting Policies (Details 1)", "menuCat": "Details", "order": "38", "role": "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails1", "shortName": "Summary of Significant Accounting Policies (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "srt:ScheduleOfCondensedFinancialStatementsTableTextBlock", "GTCH:VariableInterestEntityPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - Summary of Significant Accounting Policies (Details 2)", "menuCat": "Details", "order": "39", "role": "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails2", "shortName": "Summary of Significant Accounting Policies (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "GTCH:Sales", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - CONSOLIDATED STATEMENT OF OPERATIONS", "menuCat": "Statements", "order": "4", "role": "http://gbtti.com/role/ConsolidatedStatementOfOperations", "shortName": "CONSOLIDATED STATEMENT OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "GTCH:RevenueFromRelatedParty", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)", "menuCat": "Details", "order": "40", "role": "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "Summary of Significant Accounting Policies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2021-12-022021-12-17", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - Marketable Securities (Details Narrative)", "menuCat": "Details", "order": "41", "role": "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative", "shortName": "Marketable Securities (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:MarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-012022-09-30_custom_PromissoryNoteMember", "decimals": "0", "lang": null, "name": "us-gaap:DebtInstrumentPeriodicPaymentPrincipal", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "us-gaap:DerivativesAndFairValueTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SaleOfStockPricePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - Investment in Surge Holdings, Inc. (Details Narrative)", "menuCat": "Details", "order": "42", "role": "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative", "shortName": "Investment in Surge Holdings, Inc. (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:InvestmentTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "GTCH:EscrowAmountReceived", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtConversionConvertedInstrumentAmount1", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - Impaired Investment (Details Narrative)", "menuCat": "Details", "order": "43", "role": "http://gbtti.com/role/ImpairedInvestmentDetailsNarrative", "shortName": "Impaired Investment (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2021-12-012021-12-31", "decimals": "0", "lang": null, "name": "GTCH:ServicesPayable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - Accounts Payable and Accrued Expenses (Details)", "menuCat": "Details", "order": "44", "role": "http://gbtti.com/role/AccountsPayableAndAccruedExpensesDetails", "shortName": "Accounts Payable and Accrued Expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "p", "GTCH:UnearnedRevenueTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2018-01-012018-12-31", "decimals": "0", "first": true, "lang": null, "name": "GTCH:CashReceivedInConnectionWithIntellectualPropertyLicenseAndRoyaltyAgreement", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - Unearned Revenue (Details Narrative)", "menuCat": "Details", "order": "45", "role": "http://gbtti.com/role/UnearnedRevenueDetailsNarrative", "shortName": "Unearned Revenue (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "GTCH:UnearnedRevenueTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2018-01-012018-12-31", "decimals": "0", "first": true, "lang": null, "name": "GTCH:CashReceivedInConnectionWithIntellectualPropertyLicenseAndRoyaltyAgreement", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "GTCH:RollfowardOfConvertibleNoteTableTextBlock", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ConvertibleDebt", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - Convertible Notes Payable, Non-related Partied and Related Party (Details)", "menuCat": "Details", "order": "46", "role": "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails", "shortName": "Convertible Notes Payable, Non-related Partied and Related Party (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "GTCH:RollfowardOfConvertibleNoteTableTextBlock", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "lang": null, "name": "GTCH:DebtInstrumentsUnamortizedDiscountNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "GTCH:ConvertibleNotePayableToStanleyHills", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - Convertible Notes Payable, Non-related Partied and Related Party (Details 1)", "menuCat": "Details", "order": "47", "role": "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails1", "shortName": "Convertible Notes Payable, Non-related Partied and Related Party (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "GTCH:ConvertibleNotePayableToStanleyHills", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ConvertibleNotesPayable", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - Convertible Notes Payable, Non-related Partied and Related Party (Details 2)", "menuCat": "Details", "order": "48", "role": "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails2", "shortName": "Convertible Notes Payable, Non-related Partied and Related Party (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "GTCH:ScheduleOfRollForwardConvertibleNotesPayableTableTextBlock", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_ConvertibleNotesPayableMember", "decimals": "0", "lang": null, "name": "us-gaap:NotesIssued1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtConversionConvertedInstrumentAmount1", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - Convertible Notes Payable, Non-related Partied and Related Party (Details Narrative)", "menuCat": "Details", "order": "49", "role": "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "shortName": "Convertible Notes Payable, Non-related Partied and Related Party (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:DebtConversionConvertedInstrumentRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT", "menuCat": "Statements", "order": "5", "role": "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit", "shortName": "CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "GTCH:NotesPayableTableTextBlock", "GTCH:NotesPayableTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "GTCH:TotalNotesPayables", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - Notes Payable, Non-related Parties and Related Party (Details)", "menuCat": "Details", "order": "50", "role": "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails", "shortName": "Notes Payable, Non-related Parties and Related Party (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "GTCH:NotesPayableTableTextBlock", "GTCH:NotesPayableTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "GTCH:TotalNotesPayables", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "GTCH:ScheduleOfNotePayableRelatedPartiesTableTextblock", "GTCH:NotesPayableTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "GTCH:TotalNotesPayableRelatedParties", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - Notes Payable, Non-related Parties and Related Party (Details 1)", "menuCat": "Details", "order": "51", "role": "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails1", "shortName": "Notes Payable, Non-related Parties and Related Party (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "GTCH:ScheduleOfNotePayableRelatedPartiesTableTextblock", "GTCH:NotesPayableTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "GTCH:TotalNotesPayableRelatedParties", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InterestPayableCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000052 - Disclosure - Notes Payable, Non-related Parties and Related Party (Details Narrative)", "menuCat": "Details", "order": "52", "role": "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative", "shortName": "Notes Payable, Non-related Parties and Related Party (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "GTCH:NotesPayableTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2021-01-012021-12-31_custom_PromissoryNoteMember", "decimals": "0", "lang": null, "name": "us-gaap:InterestExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2021-01-012021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GainsLossesOnRestructuringOfDebt", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000053 - Disclosure - Accrued Settlement (Details Narrative)", "menuCat": "Details", "order": "53", "role": "http://gbtti.com/role/AccruedSettlementDetailsNarrative", "shortName": "Accrued Settlement (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "GTCH:AccruedSettlementTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2019-12-012019-12-23_us-gaap_InvestorMember_custom_SecuritiesPurchaseAgreementMember", "decimals": "0", "lang": null, "name": "us-gaap:LossContingencyDamagesPaidValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "us-gaap:DerivativesAndFairValueTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SaleOfStockPricePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000054 - Disclosure - Derivative Liability (Details)", "menuCat": "Details", "order": "54", "role": "http://gbtti.com/role/DerivativeLiabilityDetails", "shortName": "Derivative Liability (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "us-gaap:DerivativesAndFairValueTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "us-gaap:DerivativesAndFairValueTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilities", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000055 - Disclosure - Derivative Liability (Details 1)", "menuCat": "Details", "order": "55", "role": "http://gbtti.com/role/DerivativeLiabilityDetails1", "shortName": "Derivative Liability (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "us-gaap:DerivativesAndFairValueTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000056 - Disclosure - Stockholders' Equity (Details)", "menuCat": "Details", "order": "56", "role": "http://gbtti.com/role/StockholdersEquityDetails", "shortName": "Stockholders' Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "lang": null, "name": "GTCH:WeightedAverageExercisePriceWarrantsOutstandingBeginning", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000057 - Disclosure - Stockholders' Equity (Details 1)", "menuCat": "Details", "order": "57", "role": "http://gbtti.com/role/StockholdersEquityDetails1", "shortName": "Stockholders' Equity (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "GTCH:SummaryOfExercisePriceForWarrantOutstandingTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31_custom_WarrantsOneMember", "decimals": "INF", "lang": null, "name": "GTCH:ExercisePriceOfWarrantsOutstanding", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000058 - Disclosure - Stockholders\u2019 Equity (Details Narrative)", "menuCat": "Details", "order": "58", "role": "http://gbtti.com/role/StockholdersEquityDetailsNarrative", "shortName": "Stockholders\u2019 Equity (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "GTCH:DebtConversionConvertedInstrumentAccruedInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000059 - Disclosure - Income Taxes (Details)", "menuCat": "Details", "order": "59", "role": "http://gbtti.com/role/IncomeTaxesDetails", "shortName": "Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - CONSOLIDATED STATEMENT OF CASH FLOWS", "menuCat": "Statements", "order": "6", "role": "http://gbtti.com/role/ConsolidatedStatementOfCashFlows", "shortName": "CONSOLIDATED STATEMENT OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:AmortizationOfDebtDiscountPremium", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000060 - Disclosure - Income Taxes (Details 1)", "menuCat": "Details", "order": "60", "role": "http://gbtti.com/role/IncomeTaxesDetails1", "shortName": "Income Taxes (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwardsValuationAllowance", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000061 - Disclosure - Income Taxes (Details Narrative)", "menuCat": "Details", "order": "61", "role": "http://gbtti.com/role/IncomeTaxesDetailsNarrative", "shortName": "Income Taxes (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwardsValuationAllowance", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "GTCH:NotePayableRelatedPartiesClassifiedCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000062 - Disclosure - Related Parties (Details Narrative)", "menuCat": "Details", "order": "62", "role": "http://gbtti.com/role/RelatedPartiesDetailsNarrative", "shortName": "Related Parties (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31_custom_AlphaEdaMember", "decimals": "0", "lang": null, "name": "GTCH:InterestPayableRelatedParty", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "p", "GTCH:FundsInEscrowPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-01-28", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:EscrowDeposit", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000063 - Disclosure - Legal Proceedings (Details Narrative)", "menuCat": "Details", "order": "63", "role": "http://gbtti.com/role/LegalProceedingsDetailsNarrative", "shortName": "Legal Proceedings (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:LegalMattersAndContingenciesTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2020-10-012020-10-16", "decimals": "0", "lang": null, "name": "us-gaap:LossContingencyDamagesSoughtValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000064 - Disclosure - Contingencies (Details Narrative)", "menuCat": "Details", "order": "64", "role": "http://gbtti.com/role/ContingenciesDetailsNarrative", "shortName": "Contingencies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:LossContingencyDisclosures", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-05-012022-05-17", "decimals": "0", "lang": null, "name": "us-gaap:OperatingExpenses", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000065 - Disclosure - Concentrations (Details Narrative)", "menuCat": "Details", "order": "65", "role": "http://gbtti.com/role/ConcentrationsDetailsNarrative", "shortName": "Concentrations (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "AsOf2022-12-31_custom_LiquidityRiskMember", "decimals": "0", "lang": null, "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtConversionConvertedInstrumentAmount1", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000066 - Disclosure - Subsequent Events (Details Narrative)", "menuCat": "Details", "order": "66", "role": "http://gbtti.com/role/SubsequentEventsDetailsNarrative", "shortName": "Subsequent Events (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-012022-06-10_custom_MetaverseAgreementMember", "decimals": "0", "lang": null, "name": "us-gaap:SaleOfStockConsiderationReceivedOnTransaction", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - Organization and Basis of Presentation", "menuCat": "Notes", "order": "7", "role": "http://gbtti.com/role/OrganizationAndBasisOfPresentation", "shortName": "Organization and Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - Going Concern", "menuCat": "Notes", "order": "8", "role": "http://gbtti.com/role/GoingConcern", "shortName": "Going Concern", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - Summary of Significant Accounting Policies", "menuCat": "Notes", "order": "9", "role": "http://gbtti.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "e4603_10ka.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 97, "tag": { "GTCH_AccountsPayableRelatedPartiesCurrents": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accounts payable and accrued expenses related party" } } }, "localname": "AccountsPayableRelatedPartiesCurrents", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "GTCH_AccruedInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "AccruedInterest", "verboseLabel": "Accrued interest" } } }, "localname": "AccruedInterest", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GTCH_AccruedSettlement": { "auth_ref": [], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accrued settlement", "verboseLabel": "Accrued settlement" } } }, "localname": "AccruedSettlement", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/AccruedSettlementDetailsNarrative", "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "GTCH_AccruedSettlementTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "AccruedSettlementTextBlock", "verboseLabel": "Accrued Settlement" } } }, "localname": "AccruedSettlementTextBlock", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/AccruedSettlement" ], "xbrltype": "textBlockItemType" }, "GTCH_AlphaEdaLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Alpha Eda L L C [Member]" } } }, "localname": "AlphaEdaLLCMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_AlphaEdaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Alpha Eda [Member]" } } }, "localname": "AlphaEdaMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails1", "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_AltCorpExchangeAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Alt Corp Exchange Agreement [Member]" } } }, "localname": "AltCorpExchangeAgreementMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_AltcorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Altcorp [Member]" } } }, "localname": "AltcorpMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ImpairedInvestmentDetailsNarrative", "http://gbtti.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_AmortizationOfDebtDiscountPremiums": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Amortization of debt discounts" } } }, "localname": "AmortizationOfDebtDiscountPremiums", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails2" ], "xbrltype": "monetaryItemType" }, "GTCH_ArbitratorAwarded": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Arbitrator awarded" } } }, "localname": "ArbitratorAwarded", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/AccruedSettlementDetailsNarrative", "http://gbtti.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GTCH_AssetPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asset Purchase Agreement [Member]" } } }, "localname": "AssetPurchaseAgreementMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_BFBorgersCPAPCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "B F Borgers C P A P C [Member]" } } }, "localname": "BFBorgersCPAPCMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "domainItemType" }, "GTCH_BaseSalary": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Base salary.", "label": "Base Salary" } } }, "localname": "BaseSalary", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GTCH_BitSpeedAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Bit Speed Agreement [Member]" } } }, "localname": "BitSpeedAgreementMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_BoardOfDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Board Of Directors [Member]" } } }, "localname": "BoardOfDirectorsMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_CancelationOfShares": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Cancelation of shares" } } }, "localname": "CancelationOfShares", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "GTCH_CancelationOfSharesShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cancelation of shares, shares" } } }, "localname": "CancelationOfSharesShares", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "GTCH_CancellationOfTtsgShares": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Cancellation of TTSG Shares" } } }, "localname": "CancellationOfTtsgShares", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GTCH_CashPaidFor": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash paid for:" } } }, "localname": "CashPaidFor", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "GTCH_CashReceivedInConnectionWithIntellectualPropertyLicenseAndRoyaltyAgreement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash received in connection with intellectual property license and royalty agreement.", "label": "Cash received in connection with intellectual property license and royalty agreement" } } }, "localname": "CashReceivedInConnectionWithIntellectualPropertyLicenseAndRoyaltyAgreement", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/UnearnedRevenueDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GTCH_ChangeInFairValueOfDerivativeLiability": { "auth_ref": [], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Change in fair value of derivative liability" } } }, "localname": "ChangeInFairValueOfDerivativeLiability", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GTCH_ChangeInFairValueOfMarketableSecuritie": { "auth_ref": [], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Change in fair value of market equity security" } } }, "localname": "ChangeInFairValueOfMarketableSecuritie", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GTCH_ChangeInFairValueOfMarketableSecurities": { "auth_ref": [], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfOperations": { "order": 7.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "ChangeInFairValueOfMarketableSecurities", "negatedLabel": "Change in fair value of marketable securities" } } }, "localname": "ChangeInFairValueOfMarketableSecurities", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "GTCH_ChargeRelatedToModificationOfDebt": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Charge related to modification of debt" } } }, "localname": "ChargeRelatedToModificationOfDebt", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GTCH_CommonStockContributed": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock contributed" } } }, "localname": "CommonStockContributed", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "GTCH_CommonStockIssuedForConversionOfConvertibleDebtAndAccruedInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount Paid For Common stock issued for conversion of convertible debt and accrued interest.", "label": "Common stock issued amount for conversion of debt and accrue interest" } } }, "localname": "CommonStockIssuedForConversionOfConvertibleDebtAndAccruedInterest", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "GTCH_CommonStockIssuedForConversionOfConvertibleDebtAndAccruedInterestShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued for conversion of convertible debt and accrued interest, shares" } } }, "localname": "CommonStockIssuedForConversionOfConvertibleDebtAndAccruedInterestShares", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "GTCH_CommonStockIssuedForJointVenture": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock issued for joint venture" } } }, "localname": "CommonStockIssuedForJointVenture", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "GTCH_CommonStockIssuedForJointVentureShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued for joint venture ,shares" } } }, "localname": "CommonStockIssuedForJointVentureShares", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "GTCH_CommonStockIssuedForTokenize": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock issued for- Tokenize" } } }, "localname": "CommonStockIssuedForTokenize", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "GTCH_CommonStockIssuedForTokenizeShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issued for- Tokenize ,shares" } } }, "localname": "CommonStockIssuedForTokenizeShares", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "GTCH_Consideration": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Consideration" } } }, "localname": "Consideration", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GTCH_ConsiderationForServicesPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Consideration for services payable" } } }, "localname": "ConsiderationForServicesPayable", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GTCH_ConsiderationPaid": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Consideration paid" } } }, "localname": "ConsiderationPaid", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GTCH_ConsiderationShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consideration shares" } } }, "localname": "ConsiderationShares", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "GTCH_ContractLiabilitiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ContractLiabilitiesPolicyTextBlock", "verboseLabel": "Contract liabilities" } } }, "localname": "ContractLiabilitiesPolicyTextBlock", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "GTCH_ConversionFeatureOnConvertibleNotes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Conversion Feature On Convertible Notes.", "label": "Conversion feature on convertible notes" } } }, "localname": "ConversionFeatureOnConvertibleNotes", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "GTCH_ConversionToCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Conversion to common stock.", "label": "Conversion to common stock" } } }, "localname": "ConversionToCommonStock", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails2" ], "xbrltype": "monetaryItemType" }, "GTCH_ConvertibleNoteIssuedForAccountsPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Convertible note issued for accounts payable" } } }, "localname": "ConvertibleNoteIssuedForAccountsPayable", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails2" ], "xbrltype": "monetaryItemType" }, "GTCH_ConvertibleNotePayableDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible note payable, description" } } }, "localname": "ConvertibleNotePayableDescription", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative" ], "xbrltype": "stringItemType" }, "GTCH_ConvertibleNotePayableToStanleyHills": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Convertible note payable to Stanley Hills" } } }, "localname": "ConvertibleNotePayableToStanleyHills", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails1" ], "xbrltype": "monetaryItemType" }, "GTCH_ConvertibleNotesPayableNetRelatedPartyLongtermPortion": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Convertible notes payable, net, related party, long-term portion" } } }, "localname": "ConvertibleNotesPayableNetRelatedPartyLongtermPortion", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails1" ], "xbrltype": "monetaryItemType" }, "GTCH_ConvertibleShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible shares" } } }, "localname": "ConvertibleShares", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "GTCH_CurrentPortionOfNotePayableRelatedParties": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "CurrentPortionOfNotePayableRelatedParties", "verboseLabel": "Less current portion" } } }, "localname": "CurrentPortionOfNotePayableRelatedParties", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails1" ], "xbrltype": "monetaryItemType" }, "GTCH_CurrentPortionOfNotesPayables": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "CurrentPortionOfNotesPayables", "verboseLabel": "Less current portion" } } }, "localname": "CurrentPortionOfNotesPayables", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "GTCH_CustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Customers [Member]" } } }, "localname": "CustomersMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_DLConvertibleNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "D L Convertible Note [Member]" } } }, "localname": "DLConvertibleNoteMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_DavisMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Davis [Member]" } } }, "localname": "DavisMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_DebtConversionConvertedInstrumentAccruedInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Debt conversion, converted instrument, Accrued interest" } } }, "localname": "DebtConversionConvertedInstrumentAccruedInterest", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GTCH_DebtDiscountRelatedToConvertibleDebt": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Debt discount related to convertible debt" } } }, "localname": "DebtDiscountRelatedToConvertibleDebt", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GTCH_DebtDiscountRelatedToNewConvertibleNotes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt discount related to new convertible notes.", "label": "Debt discount related to new convertible notes" } } }, "localname": "DebtDiscountRelatedToNewConvertibleNotes", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails2" ], "xbrltype": "monetaryItemType" }, "GTCH_DebtInstrumentUnamortizedDiscounts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Discount" } } }, "localname": "DebtInstrumentUnamortizedDiscounts", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "GTCH_DebtInstrumentsUnamortizedDiscountCurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "DebtInstrumentsUnamortizedDiscountCurrent", "verboseLabel": "Unamortized debt discount" } } }, "localname": "DebtInstrumentsUnamortizedDiscountCurrent", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails", "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails1" ], "xbrltype": "monetaryItemType" }, "GTCH_DebtInstrumentsUnamortizedDiscountNoncurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Unamortized debt discount" } } }, "localname": "DebtInstrumentsUnamortizedDiscountNoncurrent", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "GTCH_DebtModification": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Debt modification" } } }, "localname": "DebtModification", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/DerivativeLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "GTCH_DiagonalLending1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Diagonal Lending 1 [Member]" } } }, "localname": "DiagonalLending1Member", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_DiagonalLendingLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Diagonal Lending L L C [Member]" } } }, "localname": "DiagonalLendingLLCMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_DiagonalLendingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "1800 [Member]" } } }, "localname": "DiagonalLendingMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_DisclosureAccruedSettlementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accrued Settlement" } } }, "localname": "DisclosureAccruedSettlementAbstract", "nsuri": "http://gbtti.com/20221231", "xbrltype": "stringItemType" }, "GTCH_DisclosureDerivativeLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Liability" } } }, "localname": "DisclosureDerivativeLiabilityAbstract", "nsuri": "http://gbtti.com/20221231", "xbrltype": "stringItemType" }, "GTCH_DisclosureNotesPayableNonrelatedPartiesAndRelatedPartyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable Non-related Parties And Related Party" } } }, "localname": "DisclosureNotesPayableNonrelatedPartiesAndRelatedPartyAbstract", "nsuri": "http://gbtti.com/20221231", "xbrltype": "stringItemType" }, "GTCH_DisclosureStockLoanReceivableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Loan Receivable" } } }, "localname": "DisclosureStockLoanReceivableAbstract", "nsuri": "http://gbtti.com/20221231", "xbrltype": "stringItemType" }, "GTCH_DisclosureUnearnedRevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unearned Revenue" } } }, "localname": "DisclosureUnearnedRevenueAbstract", "nsuri": "http://gbtti.com/20221231", "xbrltype": "stringItemType" }, "GTCH_DueFromRelatedPartiesCurrents": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Due From related party" } } }, "localname": "DueFromRelatedPartiesCurrents", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "monetaryItemType" }, "GTCH_DueToRelatedPartyCurrent": { "auth_ref": [], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Due to related party" } } }, "localname": "DueToRelatedPartyCurrent", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "GTCH_EIDLMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "EIDL [Member]" } } }, "localname": "EIDLMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_EarningPerShareBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income (Loss) per share (basic and diluted):" } } }, "localname": "EarningPerShareBasicAndDilutedAbstract", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "stringItemType" }, "GTCH_EmploymentAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information about agreement.", "label": "Employment Agreement [Member]" } } }, "localname": "EmploymentAgreementMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_EquityMethodInvestmentMeta": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Equity Method Investment - Meta" } } }, "localname": "EquityMethodInvestmentMeta", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "GTCH_EquityMethodInvestmentMetaShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investment - Meta, shares" } } }, "localname": "EquityMethodInvestmentMetaShares", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "GTCH_EscrowAmountReceived": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Escrow amount received" } } }, "localname": "EscrowAmountReceived", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GTCH_ExcessOfDebtDiscountAndFinancingCosts": { "auth_ref": [], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Excess of debt discount and financing costs" } } }, "localname": "ExcessOfDebtDiscountAndFinancingCosts", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GTCH_ExercisePriceOfWarrantsExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price of warrants exercisable.", "label": "Exercise price of warrants Exercisable" } } }, "localname": "ExercisePriceOfWarrantsExercisable", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails1" ], "xbrltype": "perShareItemType" }, "GTCH_ExercisePriceOfWarrantsOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price of warrants outstanding.", "label": "Exercise price of warrants Outstanding" } } }, "localname": "ExercisePriceOfWarrantsOutstanding", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails1" ], "xbrltype": "perShareItemType" }, "GTCH_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLos": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Change in derivative liability during the period" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLos", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/DerivativeLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "GTCH_FairValueOfBeneficialConversionFeatureOfDebtConverted": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Fair value of beneficial conversion feature of debt converted" } } }, "localname": "FairValueOfBeneficialConversionFeatureOfDebtConverted", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/DerivativeLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "GTCH_FairValueOfDerivativeLiabilityDueToConversions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Fair value of derivative liability due to conversions" } } }, "localname": "FairValueOfDerivativeLiabilityDueToConversions", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "GTCH_FinalSettlementAgreementDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Final settlement agreement, description" } } }, "localname": "FinalSettlementAgreementDescription", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative" ], "xbrltype": "stringItemType" }, "GTCH_FundsInEscrowPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Funds in Escrow" } } }, "localname": "FundsInEscrowPolicyTextBlock", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "GTCH_GBTMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "G B T [Member]" } } }, "localname": "GBTMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_GBTSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "G B T Shares [Member]" } } }, "localname": "GBTSharesMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ImpairedInvestmentDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_GBTTechnologiesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "G B T Technologies Inc [Member]" } } }, "localname": "GBTTechnologiesIncMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_GBTTechnologiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "GBT Technologies [Member]" } } }, "localname": "GBTTechnologiesMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ContingenciesDetailsNarrative", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_GBTTechnologiesSAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "G B T Technologies S A [Member]" } } }, "localname": "GBTTechnologiesSAMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails" ], "xbrltype": "domainItemType" }, "GTCH_GBTTokenizeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "G B T Tokenize [Member]" } } }, "localname": "GBTTokenizeMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative", "http://gbtti.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_GBTTokenizeMetAlertMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "G B T Tokenize Met Alert [Member]" } } }, "localname": "GBTTokenizeMetAlertMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_GTXAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "G T X Agreement [Member]" } } }, "localname": "GTXAgreementMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_GainOnRjwSettlement": { "auth_ref": [], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfOperations": { "order": 5.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Gain on RJW settlement" } } }, "localname": "GainOnRjwSettlement", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "GTCH_GlenEaglesAcquisitionLPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Glen Eagles Acquisition L P [Member]" } } }, "localname": "GlenEaglesAcquisitionLPMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_GreenwichMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Greenwich [Member]" } } }, "localname": "GreenwichMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_IGOR1CORPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "IGOR 1 CORP [Member]" } } }, "localname": "IGOR1CORPMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_IliadMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Iliad [Member]" } } }, "localname": "IliadMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_ImpairmentCharge": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Impairment charge" } } }, "localname": "ImpairmentCharge", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ImpairedInvestmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GTCH_IncomeTaxReconciliationPermanentDifferences": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Income tax reconciliation permanent differences.", "label": "Permanent differences (in percent)" } } }, "localname": "IncomeTaxReconciliationPermanentDifferences", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/IncomeTaxesDetails1" ], "xbrltype": "percentItemType" }, "GTCH_IncreaseDecreaseInCashHeldInTrust": { "auth_ref": [], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Cash held in trust" } } }, "localname": "IncreaseDecreaseInCashHeldInTrust", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GTCH_InterestPayableRelatedParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "InterestPayableRelatedParty", "verboseLabel": "Accrued interest" } } }, "localname": "InterestPayableRelatedParty", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GTCH_InvestmentCurrent": { "auth_ref": [], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Investment" } } }, "localname": "InvestmentCurrent", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "GTCH_InvestmentToGtx": { "auth_ref": [], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "InvestmentToGtx", "negatedLabel": "Investment to GTX" } } }, "localname": "InvestmentToGtx", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GTCH_InvestmentToTghi": { "auth_ref": [], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "InvestmentToTghi", "negatedLabel": "Investment to TGHI" } } }, "localname": "InvestmentToTghi", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GTCH_IssuanceOfNoteReceivable": { "auth_ref": [], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "IssuanceOfNoteReceivable", "negatedLabel": "Issuance of note receivable" } } }, "localname": "IssuanceOfNoteReceivable", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GTCH_JointVentureAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Joint Venture Agreement [Member]" } } }, "localname": "JointVentureAgreementMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_LegalCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Legal cost" } } }, "localname": "LegalCost", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GTCH_LessCurrentPortion": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Less current portion" } } }, "localname": "LessCurrentPortion", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "GTCH_LessCurrentPortionOfConvertibleNotePayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "LessCurrentPortionOfConvertibleNotePayable", "verboseLabel": "Less current portion" } } }, "localname": "LessCurrentPortionOfConvertibleNotePayable", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails1" ], "xbrltype": "monetaryItemType" }, "GTCH_LiquidityRiskMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liquidity Risk [Member]" } } }, "localname": "LiquidityRiskMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_LongTermNotePayables": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Notes payable, long-term portion" } } }, "localname": "LongTermNotePayables", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "GTCH_LossOnExchangeOfAssets": { "auth_ref": [], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "LossOnExchangeOfAssets", "negatedLabel": "Loss on exchange of assets" } } }, "localname": "LossOnExchangeOfAssets", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GTCH_MahaserMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Mahaser [Member]" } } }, "localname": "MahaserMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_MaturityDateExtensionFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Maturity date extension fees" } } }, "localname": "MaturityDateExtensionFees", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GTCH_MetaverseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Metaverse Agreement [Member]" } } }, "localname": "MetaverseAgreementMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_MrLightHouseLTDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Mr Light House L T D [Member]" } } }, "localname": "MrLightHouseLTDMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_NotePayableDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note payable, description" } } }, "localname": "NotePayableDescription", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ImpairedInvestmentDetailsNarrative" ], "xbrltype": "stringItemType" }, "GTCH_NotePayableRelatedPartiesClassifiedCurrent": { "auth_ref": [], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Notes payable, current, related party", "verboseLabel": "Issuance of promissory note" } } }, "localname": "NotePayableRelatedPartiesClassifiedCurrent", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets", "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GTCH_NotePayables": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Notes payable" } } }, "localname": "NotePayables", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "GTCH_NoteReceivablePaidOffPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note Receivable Paid-Off" } } }, "localname": "NoteReceivablePaidOffPolicyTextBlock", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "GTCH_NotesPayableNetRelatedPartyLongtermPortion": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Notes payable, net, related party, long-term portion" } } }, "localname": "NotesPayableNetRelatedPartyLongtermPortion", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails1" ], "xbrltype": "monetaryItemType" }, "GTCH_NotesPayableRelatedParties": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "NotesPayableRelatedParties", "verboseLabel": "Notes payable" } } }, "localname": "NotesPayableRelatedParties", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails1" ], "xbrltype": "monetaryItemType" }, "GTCH_NotesPayableTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of notes payable" } } }, "localname": "NotesPayableTableTextBlock", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyTables" ], "xbrltype": "textBlockItemType" }, "GTCH_NotesPayableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable, Non-related Parties and Related Party" } } }, "localname": "NotesPayableTextBlock", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedParty" ], "xbrltype": "textBlockItemType" }, "GTCH_OptionVestedDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Option vested description" } } }, "localname": "OptionVestedDescription", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "GTCH_OriginalIssueDiscount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Original issue discount.", "label": "Original issue discount" } } }, "localname": "OriginalIssueDiscount", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails2", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GTCH_OtherConvertibleNotesPayableCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Convertible notes payable, net, related party" } } }, "localname": "OtherConvertibleNotesPayableCurrent", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails1" ], "xbrltype": "monetaryItemType" }, "GTCH_PaymentForExpenses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment for expenses.", "label": "Payment for expenses" } } }, "localname": "PaymentForExpenses", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GTCH_PaymentOfOtherIncomeWithMarketableSecurities": { "auth_ref": [], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "PaymentOfOtherIncomeWithMarketableSecurities", "negatedLabel": "Payment of other income with marketable securities" } } }, "localname": "PaymentOfOtherIncomeWithMarketableSecurities", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GTCH_PaymentWithMarketableSecurities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Payment with marketable securities" } } }, "localname": "PaymentWithMarketableSecurities", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails2" ], "xbrltype": "monetaryItemType" }, "GTCH_PromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Promissory Note [Member]" } } }, "localname": "PromissoryNoteMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative", "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_PurchaseAndSaleAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Purchase And Sale Agreement [Member]" } } }, "localname": "PurchaseAndSaleAgreementMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_PurchasePrice": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Purchase Price", "verboseLabel": "Purchase price" } } }, "localname": "PurchasePrice", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GTCH_RWJAdvancedMarketingLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "R W J Advanced Marketing L L C [Member]" } } }, "localname": "RWJAdvancedMarketingLLCMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails", "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_RWJAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "R W J Agreement [Member]" } } }, "localname": "RWJAgreementMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_RWJPartiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "R W J Parties [Member]" } } }, "localname": "RWJPartiesMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestment": { "auth_ref": [], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestment", "negatedLabel": "Realized gain on disposal of market equity security" } } }, "localname": "RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestment", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GTCH_RedstartHoldingsCorp2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Redstart Holdings Corp 2 [Member]" } } }, "localname": "RedstartHoldingsCorp2Member", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_RedstartHoldingsCorp4Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Redstart Holdings Corp 4 [Member]" } } }, "localname": "RedstartHoldingsCorp4Member", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_RedstartHoldingsCorp5Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Redstart Holdings Corp 5 [Member]" } } }, "localname": "RedstartHoldingsCorp5Member", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_RedstartHoldingsCorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Redstart Holdings Corp [Member]" } } }, "localname": "RedstartHoldingsCorpMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_RedstartHoldingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Redstart Holdings [Member]" } } }, "localname": "RedstartHoldingsMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails" ], "xbrltype": "domainItemType" }, "GTCH_ReductionInDerivativeLiabilityDueToConversion": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Reduction in derivative liability due to conversion" } } }, "localname": "ReductionInDerivativeLiabilityDueToConversion", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GTCH_RevenueFromRelatedParty": { "auth_ref": [], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfOperations": { "order": 2.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Consulting Income \u2013 Related Party" } } }, "localname": "RevenueFromRelatedParty", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "GTCH_RollfowardOfConvertibleNoteTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of rollfoward of convertible note" } } }, "localname": "RollfowardOfConvertibleNoteTableTextBlock", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyTables" ], "xbrltype": "textBlockItemType" }, "GTCH_SBALoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "S B A Loan [Member]" } } }, "localname": "SBALoanMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails", "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_SURGMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "S U R G [Member]" } } }, "localname": "SURGMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_SURGSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "S U R G Shares [Member]" } } }, "localname": "SURGSharesMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_Sales": { "auth_ref": [], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfOperations": { "order": 1.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Sales" } } }, "localname": "Sales", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConcentrationsDetailsNarrative", "http://gbtti.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "GTCH_ScheduleOfNotePayableRelatedPartiesTableTextblock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of notes payable related parties" } } }, "localname": "ScheduleOfNotePayableRelatedPartiesTableTextblock", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyTables" ], "xbrltype": "textBlockItemType" }, "GTCH_ScheduleOfRollForwardConvertibleNotesPayableTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of roll forward convertible notes payable" } } }, "localname": "ScheduleOfRollForwardConvertibleNotesPayableTableTextBlock", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyTables" ], "xbrltype": "textBlockItemType" }, "GTCH_SecuritiesPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Securities Purchase Agreement [Member]" } } }, "localname": "SecuritiesPurchaseAgreementMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/AccruedSettlementDetailsNarrative", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_SeniorSecuredRedeemableConvertibleDebentureMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Senior Secured Redeemable Convertible Debenture [Member]" } } }, "localname": "SeniorSecuredRedeemableConvertibleDebentureMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_SeriesAConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series A Convertible Preferred Stock [Member]" } } }, "localname": "SeriesAConvertiblePreferredStockMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_ServicesPayable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Services payable" } } }, "localname": "ServicesPayable", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ImpairedInvestmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GTCH_SettlementAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Settlement amount" } } }, "localname": "SettlementAmount", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GTCH_SettlementMade": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Settlement made" } } }, "localname": "SettlementMade", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GTCH_SettlementPursuantsAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Settlement pursuants amount" } } }, "localname": "SettlementPursuantsAmount", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GTCH_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for equity-based awards excluding options,", "label": "Weighted Average Remaining Contractual Life Exercisable at End" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails" ], "xbrltype": "durationItemType" }, "GTCH_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining Contractual Life, Outstanding, End" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms1", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails" ], "xbrltype": "durationItemType" }, "GTCH_ShareIssuanceForJvMetaverse": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Share issuance for JV Metaverse" } } }, "localname": "ShareIssuanceForJvMetaverse", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GTCH_ShareIssuanceForJvTokenize": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Share issuance for JV Tokenize" } } }, "localname": "ShareIssuanceForJvTokenize", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GTCH_SharesIssuedForConversionOfConvertibleDebt": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Shares issued for conversion of convertible debt" } } }, "localname": "SharesIssuedForConversionOfConvertibleDebt", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GTCH_SixthStreetLendingLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sixth Street Lending L L C [Member]" } } }, "localname": "SixthStreetLendingLLCMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_SixthStreetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sixth Street [Member]" } } }, "localname": "SixthStreetMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_StanleyHillsLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stanley Hills L L C [Member]" } } }, "localname": "StanleyHillsLLCMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/ImpairedInvestmentDetailsNarrative", "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_StockLoanReceivable": { "auth_ref": [], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stock loan receivable" } } }, "localname": "StockLoanReceivable", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "GTCH_StockLoanReceivableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Loan Receivable [Member]" } } }, "localname": "StockLoanReceivableMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit" ], "xbrltype": "domainItemType" }, "GTCH_StockLoanReceivableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "StockLoanReceivableTextBlock", "verboseLabel": "Stock Loan Receivable" } } }, "localname": "StockLoanReceivableTextBlock", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/StockLoanReceivable" ], "xbrltype": "textBlockItemType" }, "GTCH_StockPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Purchase Agreement [Member]" } } }, "localname": "StockPurchaseAgreementMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_StockholdersEquitys": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stockholders equity" } } }, "localname": "StockholdersEquitys", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GTCH_SummaryOfExercisePriceForWarrantOutstandingTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of exercise price for warrant outstanding" } } }, "localname": "SummaryOfExercisePriceForWarrantOutstandingTableTextBlock", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "GTCH_SurgeHoldingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Surge Holdings Inc [Member]" } } }, "localname": "SurgeHoldingsIncMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_SurgeHoldingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Surge Holdings [Member]" } } }, "localname": "SurgeHoldingsMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_TokenizeAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tokenize Agreement [Member]" } } }, "localname": "TokenizeAgreementMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ImpairedInvestmentDetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_TotalNotesPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Total notes payable" } } }, "localname": "TotalNotesPayable", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "GTCH_TotalNotesPayableRelatedParties": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "TotalNotesPayableRelatedParties", "verboseLabel": "Total notes payable" } } }, "localname": "TotalNotesPayableRelatedParties", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails1" ], "xbrltype": "monetaryItemType" }, "GTCH_TotalNotesPayableRelatedParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "TotalNotesPayableRelatedParty", "verboseLabel": "Total notes payable" } } }, "localname": "TotalNotesPayableRelatedParty", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails1" ], "xbrltype": "monetaryItemType" }, "GTCH_TotalNotesPayables": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "TotalNotesPayables", "verboseLabel": "Total notes payable" } } }, "localname": "TotalNotesPayables", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "GTCH_TouchPointGroupHoldingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Touch Point Group Holding [Member]" } } }, "localname": "TouchPointGroupHoldingMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_TouchpointGroupHoldingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Touchpoint Group Holdings Inc [Member]" } } }, "localname": "TouchpointGroupHoldingsIncMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GTCH_TransferOfAccountsPayableToConvertibleNote": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Transfer of accounts payable to convertible note" } } }, "localname": "TransferOfAccountsPayableToConvertibleNote", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GTCH_TransferOfAccruedInterestToConvertibleNote": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Transfer of accrued interest to convertible note" } } }, "localname": "TransferOfAccruedInterestToConvertibleNote", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GTCH_TransferOfMarketableEquitySecurityToRepayConvertibleNote": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Transfer of marketable equity security to repay convertible note" } } }, "localname": "TransferOfMarketableEquitySecurityToRepayConvertibleNote", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "GTCH_TreasuryStockPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Treasury Stock" } } }, "localname": "TreasuryStockPolicyTextBlock", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "GTCH_TreasuryStockShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Treasury stock" } } }, "localname": "TreasuryStockShare", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "GTCH_TreasuryStocksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Treasury Stocks [Member]" } } }, "localname": "TreasuryStocksMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit" ], "xbrltype": "domainItemType" }, "GTCH_UnamortizedDebtDiscountAtConvertibleNotePayable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "UnamortizedDebtDiscountAtConvertibleNotePayable", "verboseLabel": "Unamortized debt discount" } } }, "localname": "UnamortizedDebtDiscountAtConvertibleNotePayable", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails1" ], "xbrltype": "monetaryItemType" }, "GTCH_UnearnedRevenuePoliciesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UnearnedRevenuePoliciesTextBlock", "verboseLabel": "Unearned revenue" } } }, "localname": "UnearnedRevenuePoliciesTextBlock", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "GTCH_UnearnedRevenueTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UnearnedRevenueTextBlock", "verboseLabel": "Unearned Revenue" } } }, "localname": "UnearnedRevenueTextBlock", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/UnearnedRevenue" ], "xbrltype": "textBlockItemType" }, "GTCH_UnpaidInterestDebt": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Unpaid interest debt" } } }, "localname": "UnpaidInterestDebt", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GTCH_VariableInterestEntityPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Variable Interest Entity" } } }, "localname": "VariableInterestEntityPolicyTextBlock", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "GTCH_WarrantsAquire": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants aquire" } } }, "localname": "WarrantsAquire", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "GTCH_WarrantsEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants Eight [Member]" } } }, "localname": "WarrantsEightMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "GTCH_WarrantsFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants Five [Member]" } } }, "localname": "WarrantsFiveMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "GTCH_WarrantsFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants Four [Member]" } } }, "localname": "WarrantsFourMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "GTCH_WarrantsNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants Nine [Member]" } } }, "localname": "WarrantsNineMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "GTCH_WarrantsOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants One [Member]" } } }, "localname": "WarrantsOneMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "GTCH_WarrantsSevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants Seven [Member]" } } }, "localname": "WarrantsSevenMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "GTCH_WarrantsSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants Six [Member]" } } }, "localname": "WarrantsSixMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "GTCH_WarrantsTenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants Ten [Member]" } } }, "localname": "WarrantsTenMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "GTCH_WarrantsThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants Three [Member]" } } }, "localname": "WarrantsThreeMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "GTCH_WarrantsTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants Two [Member]" } } }, "localname": "WarrantsTwoMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "GTCH_WeightedAverageExercisePriceWarrantsExercisableAtEnd": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price warrants exercisable at end,", "label": "Weighted Average Exercise Price Warrants Exercisable at End" } } }, "localname": "WeightedAverageExercisePriceWarrantsExercisableAtEnd", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "GTCH_WeightedAverageExercisePriceWarrantsOutstandingBeginning": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price warrants outstanding at end,", "label": "Weighted Average Exercise Price Warrants Outstanding, Beginning" } } }, "localname": "WeightedAverageExercisePriceWarrantsOutstandingBeginning", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "GTCH_WeightedAverageExercisePriceWarrantsOutstandingEnd": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price warrants outstanding at beginning.", "label": "Weighted Average Exercise Price Warrants Outstanding, End" } } }, "localname": "WeightedAverageExercisePriceWarrantsOutstandingEnd", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "GTCH_WorkingCapitalDeficit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Working capital deficit" } } }, "localname": "WorkingCapitalDeficit", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GTCH_WorkingCapitalDeficits": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "WorkingCapitalDeficits", "verboseLabel": "Working capital deficit" } } }, "localname": "WorkingCapitalDeficits", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GTCH_YelloPartnersIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Yello Partners Inc [Member]" } } }, "localname": "YelloPartnersIncMember", "nsuri": "http://gbtti.com/20221231", "presentation": [ "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r523", "r525", "r526" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r523", "r525", "r526" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r523", "r525", "r526" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r523", "r525", "r526" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r524" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r512" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r527" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/ContingenciesDetailsNarrative", "http://gbtti.com/role/Cover", "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative", "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative", "http://gbtti.com/role/StockholdersEquityDetailsNarrative", "http://gbtti.com/role/SubsequentEventsDetailsNarrative", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r531" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r528" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/ContingenciesDetailsNarrative", "http://gbtti.com/role/Cover", "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative", "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative", "http://gbtti.com/role/StockholdersEquityDetailsNarrative", "http://gbtti.com/role/SubsequentEventsDetailsNarrative", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r519" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r520" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r513" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r517" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r516" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r522" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r530" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gbtti.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r213", "r399", "r400", "r403", "r404", "r435", "r477", "r481", "r569", "r572", "r573", "r601", "r602", "r603" ], "lang": { "en-us": { "role": { "documentation": "Information by consolidated entity or group of entities.", "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r213", "r399", "r400", "r403", "r404", "r435", "r477", "r481", "r569", "r572", "r573", "r601", "r602", "r603" ], "lang": { "en-us": { "role": { "documentation": "Entity or group of entities consolidated into reporting entity." } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r211", "r212", "r299", "r317", "r482", "r485", "r487" ], "lang": { "en-us": { "role": { "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_DirectorMember": { "auth_ref": [ "r559" ], "lang": { "en-us": { "role": { "documentation": "Person serving on board of directors.", "label": "Director [Member]" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r279", "r281", "r282", "r283", "r342", "r443", "r464", "r478", "r479", "r501", "r507", "r511", "r574", "r591", "r592", "r593", "r594", "r595", "r596" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://gbtti.com/role/DerivativeLiabilityDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r279", "r281", "r282", "r283", "r342", "r443", "r464", "r478", "r479", "r501", "r507", "r511", "r574", "r591", "r592", "r593", "r594", "r595", "r596" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://gbtti.com/role/DerivativeLiabilityDetails" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.", "label": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://gbtti.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment." } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://gbtti.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r279", "r281", "r282", "r283", "r334", "r342", "r367", "r368", "r369", "r442", "r443", "r464", "r478", "r479", "r501", "r507", "r511", "r565", "r574", "r592", "r593", "r594", "r595", "r596" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://gbtti.com/role/DerivativeLiabilityDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r279", "r281", "r282", "r283", "r334", "r342", "r367", "r368", "r369", "r442", "r443", "r464", "r478", "r479", "r501", "r507", "r511", "r565", "r574", "r592", "r593", "r594", "r595", "r596" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://gbtti.com/role/DerivativeLiabilityDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r211", "r212", "r299", "r317", "r486", "r487" ], "lang": { "en-us": { "role": { "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution." } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfCondensedFinancialStatementsTableTextBlock": { "auth_ref": [ "r554", "r600" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows.", "label": "Condensed financial statements" } } }, "localname": "ScheduleOfCondensedFinancialStatementsTableTextBlock", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r559", "r587" ], "lang": { "en-us": { "role": { "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://gbtti.com/role/RelatedPartiesDetailsNarrative", "http://gbtti.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Title of individual, or nature of relationship to individual or group of individuals." } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://gbtti.com/role/RelatedPartiesDetailsNarrative", "http://gbtti.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.", "label": "Accounts Payable and Accrued Expenses" } } }, "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/AccountsPayableAndAccruedExpenses" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r17" ], "calculation": { "http://gbtti.com/role/AccountsPayableAndAccruedExpensesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts payable and accrued expenses (including related parties of $1,539,802 and $2,302,928)", "totalLabel": "Total" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/AccountsPayableAndAccruedExpensesDetails", "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r145", "r166" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.", "label": "Accrued expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r15", "r510" ], "calculation": { "http://gbtti.com/role/AccountsPayableAndAccruedExpensesDetails": { "order": 1.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/AccountsPayableAndAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableInterestBearingInterestRate": { "auth_ref": [ "r128", "r129", "r131", "r132" ], "lang": { "en-us": { "role": { "documentation": "Reflects the effective interest rate as of the balance sheet date on interest-bearing trade payables.", "label": "Accounts Payable, Interest-Bearing, Interest Rate", "verboseLabel": "Interest rate" } } }, "localname": "AccountsPayableInterestBearingInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r262", "r263" ], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesAndOtherLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.", "label": "Accrued Liabilities and Other Liabilities", "verboseLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesAndOtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r19" ], "calculation": { "http://gbtti.com/role/AccountsPayableAndAccruedExpensesDetails": { "order": 2.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/AccountsPayableAndAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r198", "r199", "r415", "r416", "r417", "r418", "r419", "r420" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AcquisitionCosts": { "auth_ref": [ "r137", "r138" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The capitalized costs incurred during the period (excluded from amortization) to purchase, lease or otherwise acquire an unproved property, including costs of lease bonuses and options to purchase or lease properties, the portion of costs applicable to minerals when land including mineral rights is purchased in fee, brokers' fees, recording fees, legal costs, and other costs incurred in acquiring properties.", "label": "Professional" } } }, "localname": "AcquisitionCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r10", "r510" ], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r371", "r372", "r373", "r555", "r556", "r557", "r582" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net income to net cash used in operating activities:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r37", "r46", "r130", "r311" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of debt discount" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r30", "r311", "r423", "r547" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "negatedLabel": "Amortization of debt discount" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r236" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Number of potentially dilutive securities" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails2" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails2" ], "xbrltype": "domainItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/AccruedSettlementDetailsNarrative", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/ImpairedInvestmentDetailsNarrative", "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative", "http://gbtti.com/role/LegalProceedingsDetailsNarrative", "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative", "http://gbtti.com/role/StockholdersEquityDetailsNarrative", "http://gbtti.com/role/SubsequentEventsDetailsNarrative", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r46", "r67" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://gbtti.com/role/ConsolidatedStatementOfOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Impairment of assets", "verboseLabel": "Impairment of assets" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows", "http://gbtti.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r140", "r157", "r181", "r208", "r250", "r253", "r257", "r264", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r399", "r403", "r414", "r510", "r570", "r571", "r589" ], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r177", "r191", "r208", "r264", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r399", "r403", "r414", "r510", "r570", "r571", "r589" ], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets:", "verboseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsHeldInTrustCurrent": { "auth_ref": [ "r550" ], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate within one year of the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.", "label": "Cash held in trust" } } }, "localname": "AssetsHeldInTrustCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "auth_ref": [ "r0", "r1", "r2", "r68", "r70", "r175", "r176" ], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Other receivable" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails1", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r397", "r505", "r506" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails", "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails1", "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r108", "r109", "r397", "r505", "r506" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails", "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails1", "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r113" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "Shares acquired" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r110", "r111", "r112" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business consideration values" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r4", "r55", "r65" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Organization and Basis of Presentation" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/OrganizationAndBasisOfPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_Cash": { "auth_ref": [ "r470", "r471", "r510", "r534" ], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "verboseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r48", "r180", "r483" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r49" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r41", "r48", "r54" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash, end of Year", "periodStartLabel": "Cash, beginning of Year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r41", "r127" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Net increase in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r534" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash equivalents" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental non-cash investing and financing activities" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r184", "r185", "r186", "r208", "r229", "r230", "r233", "r235", "r240", "r241", "r264", "r287", "r289", "r290", "r291", "r294", "r295", "r314", "r315", "r319", "r323", "r329", "r414", "r480", "r532", "r551", "r558" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets", "http://gbtti.com/role/ConsolidatedBalanceSheetsParenthetical", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/ImpairedInvestmentDetailsNarrative", "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative", "http://gbtti.com/role/StockholdersEquityDetailsNarrative", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails2" ], "xbrltype": "domainItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r23", "r147", "r163" ], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Contingencies (Note 18)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r555", "r556", "r582" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit", "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative", "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative", "http://gbtti.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheetsParenthetical", "http://gbtti.com/role/OrganizationAndBasisOfPresentationDetailsNarrative", "http://gbtti.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, authorized", "verboseLabel": "Preferred stock, authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheetsParenthetical", "http://gbtti.com/role/OrganizationAndBasisOfPresentationDetailsNarrative", "http://gbtti.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r9", "r79" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r9", "r510" ], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.00001 par value; 10,000,000,000 shares authorized; 1,535,593,440 and 33,200,198 shares issued and outstanding respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r59", "r60", "r124", "r125", "r261", "r475", "r599" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r65" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Concentrations" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/Concentrations" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r58", "r59", "r60", "r61", "r124", "r126", "r475" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r59", "r60", "r124", "r125", "r261", "r475" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r115", "r489" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r331", "r332", "r333" ], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract liabilities" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r331", "r332", "r333" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "verboseLabel": "Contract liabilities" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConversionOfStockAmountIssued1": { "auth_ref": [ "r51", "r52", "r53" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Shares issued, value" } } }, "localname": "ConversionOfStockAmountIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConversionOfStockSharesConverted1": { "auth_ref": [ "r51", "r52", "r53" ], "lang": { "en-us": { "role": { "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Number of shares converted" } } }, "localname": "ConversionOfStockSharesConverted1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/ImpairedInvestmentDetailsNarrative", "http://gbtti.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ConversionOfStockSharesIssued1": { "auth_ref": [ "r51", "r52", "r53" ], "lang": { "en-us": { "role": { "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Convertible note", "verboseLabel": "Shares issued, shares" } } }, "localname": "ConversionOfStockSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetailsNarrative", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails2" ], "xbrltype": "sharesItemType" }, "us-gaap_ConvertibleDebt": { "auth_ref": [ "r7", "r142", "r159" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.", "label": "Convertible debt", "verboseLabel": "Total convertible notes payable" } } }, "localname": "ConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r73", "r296", "r297", "r302", "r303", "r304", "r307", "r308", "r309", "r310", "r311", "r496", "r497", "r498", "r499", "r500" ], "lang": { "en-us": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleDebtNoncurrent": { "auth_ref": [ "r22" ], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.", "label": "Convertible note payable, noncurrent, net of discount of $88,403 and $0" } } }, "localname": "ConvertibleDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.", "label": "Summary of convertible notes payable" } } }, "localname": "ConvertibleDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertibleLongTermNotesPayable": { "auth_ref": [ "r22" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible notes payable, long-term portion" } } }, "localname": "ConvertibleLongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayable": { "auth_ref": [ "r7", "r142", "r158", "r171" ], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible notes payable, related party, net of discount of $0 and $0", "periodEndLabel": "Convertible notes payable, at end", "periodStartLabel": "Convertible notes payable, at beginning", "verboseLabel": "Convertible note payable" } } }, "localname": "ConvertibleNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails2", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayableCurrent": { "auth_ref": [ "r19" ], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible notes payable, current, net of discount of $190,464 and $362,004" } } }, "localname": "ConvertibleNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayableMember": { "auth_ref": [ "r5", "r141", "r156", "r171" ], "lang": { "en-us": { "role": { "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible Notes Payable [Member]" } } }, "localname": "ConvertibleNotesPayableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails2", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r33", "r446" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods Sold", "verboseLabel": "Cost of goods sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "auth_ref": [ "r51", "r53" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt conversion, converted instrument, Value", "verboseLabel": "Value of share converted" } } }, "localname": "DebtConversionConvertedInstrumentAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/ImpairedInvestmentDetailsNarrative", "http://gbtti.com/role/StockholdersEquityDetailsNarrative", "http://gbtti.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionConvertedInstrumentRate": { "auth_ref": [ "r51", "r53" ], "lang": { "en-us": { "role": { "documentation": "Dividend or interest rate associated with the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction. Noncash are transactions that affect recognized assets or liabilities but that do not result in cash receipts or cash payments. Part noncash refers to that portion of the transaction not resulting in cash receipts or cash payments.", "label": "Debt Conversion, Converted Instrument, Rate", "verboseLabel": "Conversion price" } } }, "localname": "DebtConversionConvertedInstrumentRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "auth_ref": [ "r51", "r53" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.", "label": "Conversion of debt", "verboseLabel": "Debt conversion, converted instrument, shares" } } }, "localname": "DebtConversionConvertedInstrumentSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtCurrent": { "auth_ref": [ "r182" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of debt and lease obligation, classified as current.", "label": "Debt" } } }, "localname": "DebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentAnnualPrincipalPayment": { "auth_ref": [ "r7" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the total principal payments made during the annual reporting period.", "label": "Annual payment" } } }, "localname": "DebtInstrumentAnnualPrincipalPayment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r5", "r6", "r7", "r141", "r142", "r156", "r213", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r424", "r496", "r497", "r498", "r499", "r500", "r552" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/LegalProceedingsDetailsNarrative", "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails", "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature": { "auth_ref": [ "r83" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date.", "label": "Fair value of beneficial conversion feature of converted" } } }, "localname": "DebtInstrumentConvertibleBeneficialConversionFeature", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r74", "r298" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Conversion price", "terseLabel": "Conversion/ Exercise price", "verboseLabel": "Conversion price (in dollars per share)" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/DerivativeLiabilityDetails", "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative", "http://gbtti.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r131", "r134", "r296", "r424", "r497", "r498" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Principlal amount", "terseLabel": "Note payable, principal amount", "verboseLabel": "Principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/LegalProceedingsDetailsNarrative", "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative", "http://gbtti.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r21", "r131", "r308" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/AccruedSettlementDetailsNarrative", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/LegalProceedingsDetailsNarrative", "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative", "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r21", "r131", "r313", "r424" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "verboseLabel": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r21", "r297" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Note payable, interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r192", "r496", "r583" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Note maturity date", "verboseLabel": "Maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative", "http://gbtti.com/role/StockholdersEquityDetailsNarrative", "http://gbtti.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r22", "r213", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r424", "r496", "r497", "r498", "r499", "r500", "r552" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/LegalProceedingsDetailsNarrative", "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails", "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentPeriodicPayment": { "auth_ref": [ "r22", "r154" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payments including both interest and principal payments.", "label": "Principal periodic payments" } } }, "localname": "DebtInstrumentPeriodicPayment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": { "auth_ref": [ "r22" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payments applied to principal.", "label": "Principal amount", "verboseLabel": "Payment of principal" } } }, "localname": "DebtInstrumentPeriodicPaymentPrincipal", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative", "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r22", "r80", "r81", "r82", "r83", "r130", "r131", "r134", "r155", "r213", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r424", "r496", "r497", "r498", "r499", "r500", "r552" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r130", "r134", "r575" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Note payable discount", "verboseLabel": "Debt Instrument, Unamortized Discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheetsParenthetical", "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountCurrent": { "auth_ref": [ "r130", "r134" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.", "label": "Debt Instrument, Unamortized Discount, Current", "terseLabel": "Unamortized debt discount", "verboseLabel": "Note payable discount" } } }, "localname": "DebtInstrumentUnamortizedDiscountCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheetsParenthetical", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent": { "auth_ref": [ "r130", "r134" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of debt discount to be amortized after one year or the normal operating cycle, if longer.", "label": "Debt Instrument, Unamortized Discount, Noncurrent", "verboseLabel": "Note payable discount" } } }, "localname": "DebtInstrumentUnamortizedDiscountNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": { "auth_ref": [ "r130", "r131", "r132", "r133", "r134", "r575" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount (premium).", "label": "Debt Instrument, Unamortized Discount (Premium), Net", "verboseLabel": "Amortization of debt discount" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred income tax asset" } } }, "localname": "DeferredIncomeTaxesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredRevenue": { "auth_ref": [ "r535" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred Revenue", "verboseLabel": "Unearned revenue" } } }, "localname": "DeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ContingenciesDetailsNarrative", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://gbtti.com/role/UnearnedRevenueDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r382" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Total deferred income tax asset" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r578" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "verboseLabel": "Total deferred income tax asset" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r107", "r579" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Net operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r383" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Less: valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/AccruedSettlementDetailsNarrative", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r119", "r405" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative instruments and hedging activities" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/DerivativeLiabilityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r193", "r194", "r413", "r487" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability [Default Label]", "periodEndLabel": "Derivative liability balance, end", "periodStartLabel": "Derivative liability balance, beginning" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/DerivativeLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r193" ], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative liability" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesAndFairValueTextBlock": { "auth_ref": [ "r119", "r123" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivatives and fair value of assets and liabilities.", "label": "Derivatives and Fair Value [Text Block]", "verboseLabel": "Derivative Liability" } } }, "localname": "DerivativesAndFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/DerivativeLiability" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativesReportingOfDerivativeActivity": { "auth_ref": [ "r117" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for derivatives entered into for trading purposes and those entered into for purposes other than trading including where and when derivative financial instruments and derivative commodity instruments and their related gains or losses are reported in the entity's statements of financial position, cash flows, and results of operations.", "label": "Derivative Financial Instruments" } } }, "localname": "DerivativesReportingOfDerivativeActivity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DividendsPayableAmountPerShare": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.", "label": "Dividend per share" } } }, "localname": "DividendsPayableAmountPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r203", "r219", "r220", "r221", "r222", "r223", "r227", "r229", "r233", "r234", "r235", "r237", "r408", "r409", "r459", "r462", "r493" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "verboseLabel": "Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r203", "r219", "r220", "r221", "r222", "r223", "r229", "r233", "r234", "r235", "r237", "r408", "r409", "r459", "r462", "r493" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r56", "r57" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Basic and Diluted Earnings Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r209", "r378", "r391" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Federal statutory rates (in percent)" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/IncomeTaxesDetails1" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r577", "r580" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Valuation allowance against net deferred tax assets (in percent)" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/IncomeTaxesDetails1" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r391", "r577" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.", "label": "Effective rate (in percent)" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/IncomeTaxesDetails1" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r577", "r580" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).", "label": "State income taxes (in percent)" } } }, "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/IncomeTaxesDetails1" ], "xbrltype": "percentItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r79", "r174", "r198", "r199", "r200", "r214", "r215", "r216", "r218", "r224", "r226", "r239", "r266", "r330", "r371", "r372", "r373", "r387", "r388", "r407", "r415", "r416", "r417", "r418", "r419", "r420", "r428", "r465", "r466", "r467" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit", "http://gbtti.com/role/ImpairedInvestmentDetailsNarrative", "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative", "http://gbtti.com/role/LegalProceedingsDetailsNarrative", "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative", "http://gbtti.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investments and Joint Ventures [Abstract]" } } }, "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.", "label": "Impaired Investment" } } }, "localname": "EquityMethodInvestmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ImpairedInvestment" ], "xbrltype": "textBlockItemType" }, "us-gaap_EscrowDeposit": { "auth_ref": [ "r144", "r476" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.", "label": "Escrow amount" } } }, "localname": "EscrowDeposit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative", "http://gbtti.com/role/LegalProceedingsDetailsNarrative", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r304", "r335", "r336", "r337", "r338", "r339", "r340", "r411", "r439", "r440", "r441", "r497", "r498", "r502", "r503", "r504" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r304", "r335", "r340", "r411", "r439", "r502", "r503", "r504" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r304", "r335", "r340", "r411", "r440", "r497", "r498", "r502", "r503", "r504" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r304", "r335", "r336", "r337", "r338", "r339", "r340", "r411", "r441", "r497", "r498", "r502", "r503", "r504" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value of Financial Instruments" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r304", "r335", "r336", "r337", "r338", "r339", "r340", "r439", "r440", "r441", "r497", "r498", "r502", "r503", "r504" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss": { "auth_ref": [ "r412" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) recognized in income for derivative asset (liability) after deduction of derivative liability (asset), measured at fair value using unobservable input (level 3) and still held.", "label": "Change in fair value of derivative liability" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock": { "auth_ref": [ "r120", "r122" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Schedule of assumptions to measure fair value" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/DerivativeLiabilityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues": { "auth_ref": [ "r121", "r122" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of issuances of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Issuance of derivative liability" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/DerivativeLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossRelatedToLitigationSettlement": { "auth_ref": [ "r566" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.", "label": "Gain (Loss) Related to Litigation Settlement", "negatedLabel": "Change on Settlement" } } }, "localname": "GainLossRelatedToLitigationSettlement", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r46", "r75", "r76" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfOperations": { "order": 5.0, "parentTag": "us-gaap_OperatingExpenses", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "negatedLabel": "Gain on Bad Debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnRestructuringOfDebt": { "auth_ref": [ "r77" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://gbtti.com/role/ConsolidatedStatementOfOperations": { "order": 6.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "For a debtor, the aggregate gain (loss) recognized on the restructuring of payables arises from the difference between the book value of the debt before the restructuring and the fair value of the payments on the debt after restructuring is complete.", "label": "Loss on debt modification", "negatedLabel": "Loss on modification of debt", "verboseLabel": "Gain on settlement of debt" } } }, "localname": "GainsLossesOnRestructuringOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/AccruedSettlementDetailsNarrative", "http://gbtti.com/role/ConsolidatedStatementOfCashFlows", "http://gbtti.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r35" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative", "verboseLabel": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r31", "r208", "r250", "r252", "r256", "r258", "r264", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r414", "r495", "r570" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross profit", "totalLabel": "Gross Profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": { "auth_ref": [ "r46", "r67", "r69" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).", "label": "Impairment of long-lived assets" } } }, "localname": "ImpairmentOfLongLivedAssetsHeldForUse", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperations": { "auth_ref": [ "r32", "r47", "r114", "r219", "r220", "r221", "r222", "r232", "r235" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.", "label": "Profit (Loss) from continuing operations" } } }, "localname": "IncomeLossFromContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r28", "r139", "r149", "r168", "r250", "r252", "r256", "r258", "r460", "r495" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Profit (Loss) before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r209", "r379", "r380", "r385", "r389", "r392", "r394", "r395", "r396" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r210", "r225", "r226", "r249", "r377", "r390", "r393", "r463" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income tax expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r197", "r375", "r376", "r380", "r381", "r384", "r386" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "verboseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r577" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Valuation allowance against net deferred tax assets" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r374", "r378" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.", "label": "Effective rate" } } }, "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r577" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).", "label": "Permanent differences" } } }, "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r378" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Federal statutory rates" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r577" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).", "label": "State income taxes" } } }, "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r43", "r50" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r45" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r45" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r444", "r546" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract liabilities" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r488" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Unearned revenue" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r45" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherReceivables": { "auth_ref": [ "r45" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in receivables classified as other.", "label": "Increase (Decrease) in Other Receivables", "negatedLabel": "Other receivable" } } }, "localname": "IncreaseDecreaseInOtherReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r45" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r132", "r152", "r201", "r248", "r422" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest expense", "negatedLabel": "Interest expense and financing costs" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseOtherDomesticDeposits": { "auth_ref": [ "r151" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest expense incurred on other deposits in domestic offices.", "label": "Interest Expense, Other Domestic Deposits", "verboseLabel": "Interest" } } }, "localname": "InterestExpenseOtherDomesticDeposits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/AccruedSettlementDetailsNarrative", "http://gbtti.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestOnConvertibleDebtNetOfTax": { "auth_ref": [ "r228", "r231", "r235" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of interest recognized on convertible debt instrument excluding interest on principal required to be paid in cash.", "label": "Accrued interest added to convertible note" } } }, "localname": "InterestOnConvertibleDebtNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaid": { "auth_ref": [ "r548" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.", "label": "Interest" } } }, "localname": "InterestPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r19" ], "calculation": { "http://gbtti.com/role/AccountsPayableAndAccruedExpensesDetails": { "order": 3.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued interest", "verboseLabel": "Interest payable" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/AccountsPayableAndAccruedExpensesDetails", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/ImpairedInvestmentDetailsNarrative", "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative", "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative", "http://gbtti.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrentAndNoncurrent": { "auth_ref": [ "r146", "r165" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.", "label": "Interest Payable", "verboseLabel": "Accrued interest" } } }, "localname": "InterestPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r189", "r484", "r510" ], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory", "verboseLabel": "Inventory" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r179", "r188", "r238", "r267", "r268", "r269", "r445", "r490" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentOwnedBalanceShares": { "auth_ref": [ "r170", "r472" ], "lang": { "en-us": { "role": { "documentation": "Balance held at close of period in number of shares.", "label": "Company owned shares" } } }, "localname": "InvestmentOwnedBalanceShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_InvestmentTextBlock": { "auth_ref": [ "r560", "r561", "r563", "r564" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investment.", "label": "Investment in Surge Holdings, Inc." } } }, "localname": "InvestmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/InvestmentInSurgeHoldingsInc." ], "xbrltype": "textBlockItemType" }, "us-gaap_Investments": { "auth_ref": [ "r164" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.", "label": "Investment" } } }, "localname": "Investments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ImpairedInvestmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsAllOtherInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, All Other Investments [Abstract]" } } }, "localname": "InvestmentsAllOtherInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, Debt and Equity Securities [Abstract]" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InvestorMember": { "auth_ref": [ "r585", "r586" ], "lang": { "en-us": { "role": { "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value.", "label": "Investor [Member]" } } }, "localname": "InvestorMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/AccruedSettlementDetailsNarrative", "http://gbtti.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": { "auth_ref": [ "r46" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.", "label": "Shares issued for services" } } }, "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_LegalFees": { "auth_ref": [ "r34" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.", "label": "Paid for legal fees" } } }, "localname": "LegalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LegalMattersAndContingenciesTextBlock": { "auth_ref": [ "r71" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.", "label": "Legal Proceedings" } } }, "localname": "LegalMattersAndContingenciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/LegalProceedings" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r18", "r208", "r264", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r400", "r403", "r404", "r414", "r494", "r570", "r589", "r590" ], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r14", "r143", "r161", "r510", "r553", "r562", "r584" ], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 deficit" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r20", "r178", "r208", "r264", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r400", "r403", "r404", "r414", "r510", "r570", "r589", "r590" ], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities:", "verboseLabel": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtTextBlock": { "auth_ref": [ "r78" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-term debt.", "label": "Convertible Notes Payable, Non-related Partied and Related Party" } } }, "localname": "LongTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedParty" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongTermNotesPayable": { "auth_ref": [ "r22" ], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Note payable, noncurrent" } } }, "localname": "LongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails2", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative", "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative", "http://gbtti.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r22", "r72" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails2", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative", "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative", "http://gbtti.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingencyDamagesPaidValue": { "auth_ref": [ "r566", "r567", "r568" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of damages paid to the plaintiff in the legal matter.", "label": "Legal matter" } } }, "localname": "LossContingencyDamagesPaidValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/AccruedSettlementDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyDamagesSoughtValue": { "auth_ref": [ "r566", "r567", "r568" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.", "label": "Sought value" } } }, "localname": "LossContingencyDamagesSoughtValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyDisclosures": { "auth_ref": [ "r277", "r278", "r280", "r282", "r283", "r284", "r285", "r286" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.", "label": "Contingencies" } } }, "localname": "LossContingencyDisclosures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/Contingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_MarketableSecurities": { "auth_ref": [ "r148" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in marketable security.", "label": "Marketable securities" } } }, "localname": "MarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesCurrent": { "auth_ref": [], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in marketable security, classified as current.", "label": "Marketable equity security" } } }, "localname": "MarketableSecuritiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesPolicy": { "auth_ref": [ "r153" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment classified as marketable security.", "label": "Marketable Securities, Policy [Policy Text Block]", "verboseLabel": "Marketable Securities" } } }, "localname": "MarketableSecuritiesPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_MarketableSecuritiesRealizedGainLoss": { "auth_ref": [], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfOperations": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI).", "label": "Realized gain (loss) on disposal of marketable equity security" } } }, "localname": "MarketableSecuritiesRealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.", "label": "Marketable Securities" } } }, "localname": "MarketableSecuritiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/MarketableSecurities" ], "xbrltype": "textBlockItemType" }, "us-gaap_MarketingExpense": { "auth_ref": [ "r35" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs.", "label": "Marketing" } } }, "localname": "MarketingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.", "label": "Ownership percentage" } } }, "localname": "MinorityInterestOwnershipPercentageByParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r205" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows From Financing Activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r205" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r41", "r44", "r47" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows From Investing Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows From Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r29", "r47", "r150", "r167", "r176", "r195", "r196", "r200", "r208", "r217", "r219", "r220", "r221", "r222", "r225", "r226", "r232", "r250", "r252", "r256", "r258", "r264", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r409", "r414", "r495", "r570" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://gbtti.com/role/ConsolidatedStatementOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "totalLabel": "Net Income (Loss)", "verboseLabel": "Net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows", "http://gbtti.com/role/ConsolidatedStatementOfOperations", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r36" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income (expense)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income (expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NotesIssued1": { "auth_ref": [ "r51", "r52", "r53" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of notes issued in noncash investing and financing activities.", "label": "Issued for cash" } } }, "localname": "NotesIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayable": { "auth_ref": [ "r7", "r142", "r159" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.", "label": "Note payable" } } }, "localname": "NotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r17" ], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Notes payable, current, net of discount of $0 and $47,671", "verboseLabel": "Note payable current" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OffsettingAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Offsetting Assets [Line Items]" } } }, "localname": "OffsettingAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OffsettingAssetsTable": { "auth_ref": [ "r26", "r27" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements.", "label": "Offsetting Assets [Table]" } } }, "localname": "OffsettingAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating expense", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations", "http://gbtti.com/role/ContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r250", "r252", "r256", "r258", "r495" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r106" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Net operating loss carryforward" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsValuationAllowance": { "auth_ref": [ "r104" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.", "label": "Valuation allowance" } } }, "localname": "OperatingLossCarryforwardsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OptionIndexedToIssuersEquityShares": { "auth_ref": [ "r118" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of shares that could be issued to net share settle a contract, if applicable. If a contract does not have a fixed or determinable maximum number of shares that may be required to be issued, disclose the fact that a potentially infinite number of shares could be issued to settle the contract.", "label": "Stock option issued" } } }, "localname": "OptionIndexedToIssuersEquityShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r19" ], "calculation": { "http://gbtti.com/role/AccountsPayableAndAccruedExpensesDetails": { "order": 4.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/AccountsPayableAndAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r190", "r510" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Total current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncome": { "auth_ref": [ "r169" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfOperations": { "order": 8.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue and income classified as other.", "label": "Other income" } } }, "localname": "OtherIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherInventoryInTransit": { "auth_ref": [ "r538" ], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of merchandise or supplies to which the entity holds the title but does not hold physical possession because the goods are currently being transported.", "label": "Inventory in Transit" } } }, "localname": "OtherInventoryInTransit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r19", "r510" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Total current liabilities" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLongTermNotesPayable": { "auth_ref": [ "r22" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term notes classified as other, payable after one year or the normal operating cycle, if longer.", "label": "Outstanding balance" } } }, "localname": "OtherLongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNotesPayableCurrent": { "auth_ref": [ "r19" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term notes classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Convertible note payable" } } }, "localname": "OtherNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivables": { "auth_ref": [ "r187" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from parties in nontrade transactions, classified as other.", "label": "Other receivable" } } }, "localname": "OtherReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForDeposits": { "auth_ref": [ "r544", "r545" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid for deposits on goods and services during the period; excludes time deposits and deposits with other institutions, which pertain to financial service entities.", "label": "Payments for Deposits", "negatedLabel": "Payment with cash" } } }, "localname": "PaymentsForDeposits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockConvertibleSharesIssuable": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "Number of common shares issuable upon conversion of preferred stock.", "label": "Convertible preferred shares" } } }, "localname": "PreferredStockConvertibleSharesIssuable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockDividendsShares": { "auth_ref": [ "r79" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of preferred stock issued as dividends during the period. Excludes stock splits.", "label": "Preferred shares" } } }, "localname": "PreferredStockDividendsShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails2" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r8", "r314" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r8", "r314" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, outstanding", "verboseLabel": "Preferred stock, Outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheetsParenthetical", "http://gbtti.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r8", "r510" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock value" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r539" ], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r533" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassification" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProceedsFromIssuanceOfDebt": { "auth_ref": [ "r542" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.", "label": "Issuance of convertible notes", "verboseLabel": "Net proceeds" } } }, "localname": "ProceedsFromIssuanceOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "auth_ref": [ "r38" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.", "label": "Proceeds from sales of common stock" } } }, "localname": "ProceedsFromIssuanceOrSaleOfEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLoans": { "auth_ref": [ "r42" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received from principal payments made on loans related to operating activities.", "label": "Proceeds from loans" } } }, "localname": "ProceedsFromLoans", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromNotesPayable": { "auth_ref": [ "r39" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.", "label": "Issuance of notes payable" } } }, "localname": "ProceedsFromNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromOtherDebt": { "auth_ref": [ "r39" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from debt classified as other.", "label": "Proceeds from debt" } } }, "localname": "ProceedsFromOtherDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r39" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Proceeds from related party", "verboseLabel": "Proceeds from related party debt" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows", "http://gbtti.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.", "label": "Related party payment" } } }, "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfOtherAssets1": { "auth_ref": [ "r42" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from the sale of other assets as part of operating activities.", "label": "Sales amount" } } }, "localname": "ProceedsFromSaleOfOtherAssets1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromShortTermDebt": { "auth_ref": [ "r39" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Payments for debt" } } }, "localname": "ProceedsFromShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r176", "r195", "r196", "r204", "r208", "r217", "r225", "r226", "r250", "r252", "r256", "r258", "r264", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r398", "r401", "r402", "r409", "r414", "r460", "r495", "r508", "r509", "r540", "r570" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net income (loss)" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesNetCurrent": { "auth_ref": [ "r162", "r172", "r510" ], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.", "label": "Note Receivable" } } }, "localname": "ReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r341", "r431", "r432" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/AccruedSettlementDetailsNarrative", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/ImpairedInvestmentDetailsNarrative", "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative", "http://gbtti.com/role/LegalProceedingsDetailsNarrative", "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative", "http://gbtti.com/role/StockholdersEquityDetailsNarrative", "http://gbtti.com/role/SubsequentEventsDetailsNarrative", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionDescriptionOfTransaction": { "auth_ref": [ "r173", "r183", "r425", "r426", "r427", "r430" ], "lang": { "en-us": { "role": { "documentation": "A description of the related party transaction, including transactions to which no amounts or nominal amounts were ascribed and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements. Examples of common related party transactions are, sales, purchases and transfers of realty and personal property, services received or furnished, loans and leases to and from top management and affiliates.", "label": "Related party, description" } } }, "localname": "RelatedPartyTransactionDescriptionOfTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r341", "r431", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r588" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/AccruedSettlementDetailsNarrative", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/ImpairedInvestmentDetailsNarrative", "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative", "http://gbtti.com/role/LegalProceedingsDetailsNarrative", "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative", "http://gbtti.com/role/StockholdersEquityDetailsNarrative", "http://gbtti.com/role/SubsequentEventsDetailsNarrative", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r429", "r430", "r432", "r433", "r434" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Parties" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/RelatedParties" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfConvertibleDebt": { "auth_ref": [ "r40" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Convertible note paid", "negatedLabel": "Repayment of convertible note" } } }, "localname": "RepaymentsOfConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r543" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Repayment of debt" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r40" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "Repayments of Related Party Debt", "negatedLabel": "Repayment of related party" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashEquivalents": { "auth_ref": [ "r473", "r474", "r549", "r597", "r598" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash equivalents restricted as to withdrawal or usage. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted cash" } } }, "localname": "RestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails", "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r11", "r84", "r160", "r468", "r469", "r510" ], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit", "negatedLabel": "Accumulated deficit", "verboseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConcentrationsDetailsNarrative", "http://gbtti.com/role/ConsolidatedBalanceSheets", "http://gbtti.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r174", "r214", "r215", "r216", "r218", "r224", "r226", "r266", "r371", "r372", "r373", "r387", "r388", "r407", "r465", "r467" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r491", "r492" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r202", "r208", "r246", "r247", "r251", "r254", "r255", "r259", "r260", "r261", "r264", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r414", "r460", "r570" ], "calculation": { "http://gbtti.com/role/ConsolidatedStatementOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Total sales", "terseLabel": "Revenues", "verboseLabel": "Sales" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations", "http://gbtti.com/role/ContingenciesDetailsNarrative", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesNetOfInterestExpense": { "auth_ref": [ "r246", "r247", "r251", "r254", "r255", "r259", "r260", "r261" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income after deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Net revenues" } } }, "localname": "RevenuesNetOfInterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SalariesAndWages": { "auth_ref": [ "r541" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.", "label": "Base salary" } } }, "localname": "SalariesAndWages", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received on stock transaction after deduction of issuance costs.", "label": "Consideartion from sale of common stock", "terseLabel": "Sale of common stock", "verboseLabel": "Sales consideration" } } }, "localname": "SaleOfStockConsiderationReceivedOnTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative", "http://gbtti.com/role/SubsequentEventsDetailsNarrative", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of common stock", "verboseLabel": "Number of shares sold" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative", "http://gbtti.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Price per share", "verboseLabel": "Stock price" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/DerivativeLiabilityDetails", "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.", "label": "Schedule of accounts payable and accrued expenses" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/AccountsPayableAndAccruedExpensesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of anti dilutive securities excluded from computation of earnings per share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r581" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r105" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule Of Components of deferred tax assets" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r90", "r91", "r92", "r93", "r94" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/AccruedSettlementDetailsNarrative", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetails", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r103" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r410", "r411" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of fair value, assets and liabilities measured on recurring basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r135", "r136" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r270", "r271", "r272", "r273", "r274", "r275", "r276" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails", "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-Term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r88", "r95" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Summary of warrant activity" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [ "r536", "r537", "r576" ], "lang": { "en-us": { "role": { "documentation": "Series B preferred stock.", "label": "Series B Preferred Stock [Member]" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets", "http://gbtti.com/role/ConsolidatedBalanceSheetsParenthetical", "http://gbtti.com/role/StockholdersEquityDetailsNarrative", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails2" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesCPreferredStockMember": { "auth_ref": [ "r536", "r537", "r576" ], "lang": { "en-us": { "role": { "documentation": "Series C preferred stock.", "label": "Series C Preferred Stock [Member]" } } }, "localname": "SeriesCPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets", "http://gbtti.com/role/ConsolidatedBalanceSheetsParenthetical", "http://gbtti.com/role/StockholdersEquityDetailsNarrative", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails2" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesDPreferredStockMember": { "auth_ref": [ "r536", "r537", "r576" ], "lang": { "en-us": { "role": { "documentation": "Series D preferred stock.", "label": "Series D Preferred Stock [Member]" } } }, "localname": "SeriesDPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets", "http://gbtti.com/role/ConsolidatedBalanceSheetsParenthetical", "http://gbtti.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesGPreferredStockMember": { "auth_ref": [ "r536", "r537", "r576" ], "lang": { "en-us": { "role": { "documentation": "Series G preferred stock.", "label": "Series G Preferred Stock [Member]" } } }, "localname": "SeriesGPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets", "http://gbtti.com/role/ConsolidatedBalanceSheetsParenthetical", "http://gbtti.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesHPreferredStockMember": { "auth_ref": [ "r536", "r537", "r576" ], "lang": { "en-us": { "role": { "documentation": "Series H preferred stock.", "label": "Series H Preferred Stock [Member]" } } }, "localname": "SeriesHPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets", "http://gbtti.com/role/ConsolidatedBalanceSheetsParenthetical", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/ImpairedInvestmentDetailsNarrative", "http://gbtti.com/role/StockholdersEquityDetailsNarrative", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails2" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r361" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Warrants Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": { "auth_ref": [ "r101" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted Average Remaining Contractual Life, Outstanding, Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r368" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Dividend rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/DerivativeLiabilityDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r367" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/DerivativeLiabilityDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r369" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Risk free rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/DerivativeLiabilityDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "auth_ref": [ "r99" ], "lang": { "en-us": { "role": { "documentation": "Number of non-option equity instruments exercised by participants.", "label": "Warrants Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": { "auth_ref": [ "r100" ], "lang": { "en-us": { "role": { "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.", "label": "Number of shares cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "auth_ref": [ "r98" ], "lang": { "en-us": { "role": { "documentation": "Net number of non-option equity instruments granted to participants.", "label": "Warrants Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "auth_ref": [ "r96", "r97" ], "lang": { "en-us": { "role": { "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.", "label": "Number of warrants Outstanding", "periodEndLabel": "Warrants Outstanding, End", "periodStartLabel": "Warrants Outstanding, Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails", "http://gbtti.com/role/StockholdersEquityDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Warrants Exercisable, End", "verboseLabel": "Number of warrants Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails", "http://gbtti.com/role/StockholdersEquityDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails1", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding", "periodEndLabel": "Aggregate Intrinsic Value Outstanding, Ending", "periodStartLabel": "Aggregate Intrinsic Value Outstanding, Beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r102" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Aggregate Intrinsic Value Outstanding, Exercisable at End" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r79" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Share issued", "verboseLabel": "Shares issued" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ImpairedInvestmentDetailsNarrative", "http://gbtti.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Short-Term Debt [Line Items]" } } }, "localname": "ShortTermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-Term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/NotesPayableNon-relatedPartiesAndRelatedPartyDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r55", "r206" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r184", "r185", "r186", "r208", "r229", "r230", "r233", "r235", "r240", "r241", "r264", "r287", "r289", "r290", "r291", "r294", "r295", "r314", "r315", "r319", "r323", "r329", "r414", "r480", "r532", "r551", "r558" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets", "http://gbtti.com/role/ConsolidatedBalanceSheetsParenthetical", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/ImpairedInvestmentDetailsNarrative", "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative", "http://gbtti.com/role/StockholdersEquityDetailsNarrative", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r25", "r79", "r174", "r198", "r199", "r200", "r214", "r215", "r216", "r218", "r224", "r226", "r239", "r266", "r330", "r371", "r372", "r373", "r387", "r388", "r407", "r415", "r416", "r417", "r418", "r419", "r420", "r428", "r465", "r466", "r467" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit", "http://gbtti.com/role/ImpairedInvestmentDetailsNarrative", "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative", "http://gbtti.com/role/LegalProceedingsDetailsNarrative", "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative", "http://gbtti.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets", "http://gbtti.com/role/ConsolidatedBalanceSheetsParenthetical", "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit", "http://gbtti.com/role/ContingenciesDetailsNarrative", "http://gbtti.com/role/DerivativeLiabilityDetails", "http://gbtti.com/role/ImpairedInvestmentDetailsNarrative", "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative", "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails1", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r214", "r215", "r216", "r239", "r446" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets", "http://gbtti.com/role/ConsolidatedBalanceSheetsParenthetical", "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit", "http://gbtti.com/role/ContingenciesDetailsNarrative", "http://gbtti.com/role/DerivativeLiabilityDetails", "http://gbtti.com/role/ImpairedInvestmentDetailsNarrative", "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative", "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails1", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r51", "r52", "r53" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Issuance of shares value" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ImpairedInvestmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r8", "r9", "r84" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock Issued During Period, Shares, Acquisitions", "verboseLabel": "Stock Issued for Acquisitions, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ImpairedInvestmentDetailsNarrative", "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative", "http://gbtti.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Common stock issued for services , shares" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r8", "r9", "r79", "r84" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Common stock issued for cash , shares", "terseLabel": "Issuance of shares", "verboseLabel": "Number of shares issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit", "http://gbtti.com/role/LegalProceedingsDetailsNarrative", "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative", "http://gbtti.com/role/StockholdersEquityDetailsNarrative", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r25", "r79", "r84" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock Issued During Period, Value, Acquisitions" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Common stock issued for services" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r8", "r9", "r79", "r84" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Common stock issued for cash", "terseLabel": "Aggregate Purchase Price", "verboseLabel": "Fair value" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit", "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative", "http://gbtti.com/role/StockholdersEquityDetailsNarrative", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r9", "r12", "r13", "r66", "r510", "r553", "r562", "r584" ], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "Total stockholders\u2019 deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets", "http://gbtti.com/role/ConsolidatedStatementOfStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r89", "r207", "r315", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r330", "r406" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders\u2019 Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityReverseStockSplit": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.", "label": "Reverse stock split" } } }, "localname": "StockholdersEquityReverseStockSplit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/OrganizationAndBasisOfPresentationDetailsNarrative", "http://gbtti.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r421", "r437" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r421", "r437" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r421", "r437" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r421", "r437" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reporting subsequent events.", "label": "Management\u2019s Evaluation of Subsequent Events" } } }, "localname": "SubsequentEventsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r436", "r438" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "Going Concern" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/GoingConcern" ], "xbrltype": "textBlockItemType" }, "us-gaap_TransactionDomain": { "auth_ref": [ "r487" ], "lang": { "en-us": { "role": { "documentation": "Agreement between buyer and seller for the exchange of financial instruments." } } }, "localname": "TransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_TransactionTypeAxis": { "auth_ref": [ "r487" ], "lang": { "en-us": { "role": { "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments.", "label": "Transaction Type [Axis]" } } }, "localname": "TransactionTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/LegalProceedingsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r24", "r86", "r87" ], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury stock, at cost; 21 shares respectively" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r581" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/AccruedSettlementDetailsNarrative", "http://gbtti.com/role/ConvertibleNotesPayableNon-relatedPartiedAndRelatedPartyDetailsNarrative", "http://gbtti.com/role/ImpairedInvestmentDetailsNarrative", "http://gbtti.com/role/InvestmentInSurgeHoldingsInc.DetailsNarrative", "http://gbtti.com/role/LegalProceedingsDetailsNarrative", "http://gbtti.com/role/MarketableSecuritiesDetailsNarrative", "http://gbtti.com/role/RelatedPartiesDetailsNarrative", "http://gbtti.com/role/StockholdersEquityDetailsNarrative", "http://gbtti.com/role/SubsequentEventsDetailsNarrative", "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UnearnedPremiums": { "auth_ref": [ "r461" ], "calculation": { "http://gbtti.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date.", "label": "Unearned revenue" } } }, "localname": "UnearnedPremiums", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r62", "r63", "r64", "r242", "r243", "r244", "r245" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": { "auth_ref": [ "r116", "r399", "r400", "r403", "r404" ], "lang": { "en-us": { "role": { "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.", "label": "Variable Interest Entity, Primary Beneficiary [Member]" } } }, "localname": "VariableInterestEntityPrimaryBeneficiaryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/SummaryOfSignificantAccountingPoliciesDetails2" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r228", "r235" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average common shares outstanding:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r227", "r235" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gbtti.com/role/ConsolidatedStatementOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(b)(2),(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "https://asc.fasb.org/topic&trid=2229140", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "820", "URI": "https://asc.fasb.org/topic&trid=2155941", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=29642582&loc=d3e27862-108397", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=29642582&loc=d3e27881-108397", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28567-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-10(c)(3)(ii)(A))", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126954596&loc=d3e511914-122862", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-10(c)(7)(ii))", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126954596&loc=d3e511914-122862", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(1),(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.4)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.6)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62652-112803", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(c)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(5))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(h))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.4)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-06(3))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123395306&loc=d3e36975-112693", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(21))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "https://asc.fasb.org/topic&trid=2196965", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/subtopic&trid=2127163", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "450", "URI": "https://asc.fasb.org/subtopic&trid=2127197", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=51888271", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.13)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32059-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918703-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919370-209981", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128295416&loc=SL77919784-209982", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(13)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=127002003&loc=SL6242269-115581", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(d)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(m)", "Publisher": "SEC", "Section": "4", "Subparagraph": "(1)(iii)", "Subsection": "08", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r512": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r513": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r514": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r515": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r516": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r517": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r518": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r519": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r521": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r522": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r523": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r524": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r525": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r526": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r527": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r528": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r529": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r531": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r55": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(b))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org/topic&trid=2196928", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r561": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "321", "URI": "https://asc.fasb.org/topic&trid=75115024", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r563": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "https://asc.fasb.org/topic&trid=2196965", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r564": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "325", "URI": "https://asc.fasb.org/topic&trid=2197064", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "12", "Subsection": "04", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r601": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(i)", "Subsection": "01", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r602": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "01", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r603": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "02", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2473-110228", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=6402221&loc=d3e15743-112638", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.C)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 84 0001731122-23-000664-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001731122-23-000664-xbrl.zip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�U0+UQV2P8 MT:Q>:OL;1MAL1WXRN3BDH7T-PS*-)QQE3/9)1WL"NL;WL_[3)BR[&63RH+/# MIAJLGN-1YO\[CO=;3D@4;4&*QP8673:8&GS]]?/N3D5_TJAY_@7ULZ9>V#3E M]\0UVLJ!UA?3H[]J> +PF.:CA[Z]_EC]A"YJ^@S>")K5CH7LT&0C"V[Z5*#G M8G_NONM+"9/Q 3Y FXWA?3J;S:0CD:Z::[;)27;.(LJ1 MZ<.LO! G"POTCE\.-HUE&>C8P^P<-EJ;9MP 7J90_&+%(AE?3:WOL3@*$UW1 M<2X@^ >&J&((WXH@%R%OL,<];R_X#=OWL]@W[X+T6Z MP+8N1!H(.PDO ]16"+-AWPC32V?_'P &HE,V4TR7I<@ZK%T?1Z339-1A>TCQ M$T?*<0T< <"0 -NS\",-PV/P3=<+DIF'S)C VDKLN,[&;U%!Q,^^YIE[R69]UA\F6)8$G)BB0FG8J]GN=(#!FRV!A%LX]JD&:]9%6^3IYMGY0Z&45!Q M?T77>:+J8>&NT(T6V%,:^J0IV>'00+J2F$24N7PXK-Q4E3!OKX#B'V.V#7HE[$LET4G^0NUE%C5(%,X-"+613I[:06X*&BL'"# M3@72J.<^R[N7&'>) 3X#H& (D50L2,.#Q8!T-GJ'#[?"J7:T3EX=.H O+-$$ MU>LW/-#\\7SOVDZO8T@SD6C.Q^Z.(&(0*2'E K60B/'XB C ?SCS'DXJYUPV M)!O940KL\\D8=YD!3V'DC=$N4&?PV9@Q0P7AKK[')BT8HC>A\KEOB:RA-&&I MQ)"+B1,I#1=HDP1T*._1U\>M'4SL^< B7TC":!7Q>75@=7&!^C$8#TGU\2V3 MAOWAV"P.BV?00RC8B53$D!B8N:!('_,R'P43"AHCIQ 4QB!:3CYQ> M-%MXSR-)9?'."*214NPS9 9\$J$IZ\RKGS(T*8>R4!_UNM^&/WY^'MSE(Y$\5Q]]:1P,"]7O)X=GK24FDA_51T?'I;,')^_?]=1W2R177YM(7JF/ M;LZZY^?W%54[UA:22![)JL[>__BFZ3^NAJ5P4/GR4\Q+]='9Z=>+SE.IXU]G MUR/%'-9T>7?^:)CV2?7A]YL]#4SER+6LT\?:Q0@C].LR!*)<']W_:/BWNIN[ MS&WB$(ACT&*<@="W)3$=%?RVXYM-@QL^H+MS8?;!M'%Y>#O+.7X"K96,-73M M+2QF> Y//X4.E!-M(D3L4KT5AV]#L1]&HAF?6V<83A;$ENY6M@O]N>DRU M:%I,@P0-#0Q@TACA%?NW":L74^&B$IEE9?M,]V/+\C%MQ2+7'7>7\R8XZ+9B MHI?2?DA7$2'WW9T@$RE1I8Z;^G>VB\VG/7A?L10HZ-=?/X.>>^'N"U\,?I3M47'AU_WS?>7*\%TP\[Z"+FO0 MV8M%G]I-@F3+U?I@0B;Y'NYL1"*E:L/R.BPY*# 'F"$)6J^4G9XI<2X0F@3: M0'-U(SZF%G0Y$YYM,]M/VIADL*5X@C?J5RW#X @E36XF'! M_GIRW8GT=F1Y#?0BXPDQ[$N)ALHNB:_8>\4X0,0T-AB,O1E7C>HJVQ?I"1OM M#'Q5ZT)VC*#1ZVA# >TD9KTA>&-%!<(VNO[\=;QF@ ;6VY@B% M9'Z8W9VH(R85\\)\@!U9HKA3D9QUN #>3#=X/3DSIQ&+F(PA=L&N$_=C?S(: M/PP:/^B(Y!)"02L&4"('8O=C 8C1T:P6-S$-JQ6,5B;;P$M8.#XKMN*4\%[S-P<3R5CYIOPSN1% M'IFH_Z!DHK%U1.? ,V]\D$O(L@Q3PGQ+A?QF@/$!P9V1)6#!!ZVB;[./W+,E M< ANZG)NB$^GQ="L3DNR*U-*EZQL,:"=WL*M,-XBCCPH8OKE/&P]Y.(?A*\O M8.0*^=FN3V'O,OB;=Z^Q&'-5/, H_C1]XG:') M&M\M^"G M89!2P-/-M#B?3TQ#E5NN52E![8@)C,2,'RF<'O9=$3%T8%/Q:=K1 'J5)\#- M%4&/+&:>%)WQUR\@1EY.E=+EZ5T-Z!QQN'PPG#-D$,BYKX(SA<,A3,2N5Z(!^[+H%(,$=I MK20R)B^6!!<]C_&WQJJWWN?[@[(BZN++/T,S>A60:9@>GR7)3)%Y1EH M7+S3EJ-P_ZPX-3K9W1V12"+-%\)Y)>1.]#IX2LQG*Z-#T.BL#-@6%U51)*.G MJ>%ETL$JK+; =$.,W-TY1IDHO-Q!?"@06#UM.#W37@;62WG/ MJ/RE=J>=7UU7"H4)/> BF2ASY;M/6__+,J_>PJ[BI42SFX#-=;S1\"G/-9R: M?CR>8%FQ=?G]@H%JO@ &LV,UM4HS") MZHG.T4+)Y">]%CU8WLM>XXFSP"5!WW<);DG%/;S1/'ETL#;+]'W!E9$X&'>M M5*1HKV/'57U>O0X*6;?/)G]3:H)E)983>=&VBZ+M+ASPSSYV8\-0'CI]P(S3 MJ" K4/W0)\'=.KRD@"F"8BR2\6PT^\'KQ8AY4=7C8MFHQR-88/?TB(D%FJ^& M+@ 22P:9FV'YTR^)190"%+IM26"7HM*-*UT((6H/<(-5=<0PT+1K=O!()*U+ MDN$W5Y+FA?@%*DG301_?"9P:_'W>F=T.6&V93W]-(Z37-!R"T8U@'^^%U)S)SY+ *62-Z5[ \ M?X\R(1J:A_E:Z.A5@D[[03L&K$'$=@Y\. C#=YK#U&5ES4*Y&7;2BE_%O-C ME_+"PNBEK)HBGQZ[FM<^,M=P>#U3\S&Y!P019H"P<0!\V4AGF/(FI?H&6,6) ME,8M^F$#4/ZH 88<,#LHG+.SNQ.9+Q!//9)KW*(%\5(O"E;=+=;'%A\ICHOQ M:)YQ+<\9H),9LB3MZ(@.;AR-KTV,4@@7Q5M83A_;4<[_17(3G\@<]6",XQ66 MX7EP2 RKQN['O!:'!?T:0S+'^SWAT6XR_Q[#)8I)W8(*US8H %A]PI,0D3/* M=A/9ATDO*>:#LTA:W7Y:=&J-_,ISM42?$?Z /)]&@F-TT ,!$,!I("8W8;IN\P"D/SO ML7S:< _HTV%^)K.K5#!"2-EZH;=/:6E/CBL@+VZ3.V$%TS=CZ6OX'--&[FKP M;@>:L!G'WB-OEOP\;"W1]&WI!_+4@;Q&=(<'"YO$,WC\."[Q@_$DH'G[F/#7 MMPU<6M,@'=4R01(Q!YJN=35, >;5[.8^Q.=7AC^)%_[HV'O@_+LH@&/P0.6 MW:@;+%E/[#2")GRC*">Y'YTT\2%?);I!?+C.EOIDM QDEE@%1>E!07*G.%[, MSQ?QW. ]:&\1<)*<[9+*40D>4F&/B T94]F0L73^U>.#I3;:;&UCBLB;=9J1 M]T.O77Z],OUTV,TIW)F(=D_50\8 ,65*F2H^ 5!$0Y?8[N;551;1<"*=S:5R MN=QTS0-'J)#M*&:!)FNC\=Y>R4.V61OV*^*:?%3X!F%+X>Z+GGE\&K5U:=;N M8J:/RX!9*P2:,:>\N)^9V)'Y+V OW,\9S+L3524\6.--:"Y33.BB7V4N1/)Z M'CE=^,9L\O!:?,+A9J#3HW[_X['DM9W;\A@ZS=N7?QI0U@J/IC"B?#Y54"?. M>F I26%94BE)31 96UTG:KU/C8,G)&I%]"7ZBI>PR9T/>0H\O2"B3MC2$MAU ME&:,H4#9)T;"6>OU+!ZCF_+,W9UHHL+^S?Z$:/Z]B6Y"Y=2S-/2EBNC]/TI6 M$>'[-!S[WN']R=[UQZ[QA&55 &/=]/#9;.QC M]#5A%59C&"KKIL=S9K"^K-_DV!T]N=V=OBT=7E>S;=YKBF71MD*O/M\'>S\S MKP0C'5L0V"RZ"03F*!H;,8F.$]?T'O>1+1@( ;3*4Y1,%U)2P+U#@T-_,CU! MTZ8O;44+DIN3F KE*WL4T,*?=9YB19F^KH$N(/3I\I>T-)/;33SZ2-6)!EDY M]!+1B)"5[NKL2U&5A-]@\I[C/"K4:@])FFPB9X)#(;5C#F\-HS* MQ@2^/FG [TQ?V'.1A3!#&2N_$N 7$1 DZ C7.&\.Y!$Y"KF%F#!I1FY>8Q-9$XA,OF@!5K.('/G&IH!H]<%3B*ZL3& M3KR79$P4VCSW'X6GZ/0I:A49].3JW\(8*B\-5=6T +^:5@OO@*IJ6IP-?%(+ M[X^JN8FH.A56"T+5A8-C"JKR)$GPIUZ\7 ^S+76K=@4K*'9Q:;']5$QYS?5_+UZ<]9>8K%IKCZR M.IV:8[0/OE:,=RLVS;RVV%0%0)4K%]WC7O:AV%Y(L>G*2DK3]='!E\J@^*G[ M,/K46)N2TD'.']C>0]-2]=^NI/2H/GHX^VF9=VG7>[NY#\J>W*1)&\NG$X%S=WE\32!ZE=]IGQ-0W@ZN/R+ M>JM2RJ&EN8^\^"45KZP!'K0'2D$)J"];WCM@=35'1H]^RF7)^Z;U>ECV(V8Y M,U.6?".4"-$%>8J6)CI'7W/+26:P5^R/M M[K# 7)A5& FCYF0_D:B)$N%)U+]XC%1*VV2)\(8OE 76Q2R21Q1F7Z*# M:KR!.WI6M&8'NZ+I-'>#\I;&7L6?.39\B >H<;!24M..F&O5QRH."GHF)Z)Z M*27:J"6 )UG3!'R,N\>GL6=8@A8'B,ER@:EZ_V>2#(1W8EX;#@\LFEY]939=DKI;G)DBR7P )CH)YY8GRY@HAK[E,G- M/Z-#G@G 'BP"*UJAW(4WG*F#AS QDK5]0W\/VQ=+QIME\,VWD4F5$X6]=%9\ M@JU)4P/D!;\I>TS-I4K%="I;G)A MKLCS3.EO&G-:O*"/(%GE9"?50*^P[N( M)=@K;,)7X(J+X17Z!=$\XLZ !.<=NF+)<;OA='L#9E^86T%@)F;,"W+0S3QP MPJ)3[$OH42UH7"HBC*KHL>X R>LF=:R,Q7F0 !.%)VO-B2?%*3\5"&5PE[)>[NG%]%@D"";8BBBS 5.6-!'RJG@]V0^DLV#:JRQ+=>!LL MCU4ED5^3)\72,!&:A: ;/*U(P(K"/5AU)?.SD-E7KBH;CB*RQZLDIOW1UJ+P MCL264JS8DH 4J9G4%& 9H.#8>I\2/N\04D&$2#[.B]J='+-$#0-XNH;M(;K& MP'$? X[NH]+DA^7:[,PDO-W\$Q@?GB.#JAI4TA\!)@>%BM&R!6*( >RX<@M M3CQ,Y0.%IR+B,NQ@,OP8/6RE>GC#RB)9_.=<,-'4O5*V M6,BJ>XL#9]PM:2FD7-0Y*;V8"Z!#(2L_'0!+204EH\_H>A2WAHT/*= M,JS'&K[W>'-*7!?"-*B?B@;Z3*$8!_%FP^^[1$O"DHGHF2GI KS\SSR?!<2& M3Z6HCZW)9LKR2Z35!88.H\?$3,\PHXITN.G'(05$P9XV-)H(I/&8)GFJ>=L= MT?PUAEJL[,#K=[MH2#[T]79@# ?-@UA_X"S?"^&"S:'=SH=E@)CBTXVL !=9=5$Y^V:G.4UXM!;#+!JC))TH XF7P22N4$ M#>2;@4F==K&U,FN/'+:!5C+JS<7A?5K-81?V:&Q^WMXP03)"8HN8D ^QG:&] MBB8'X\Z,=D6ML/!!R5TG &XI,:?:<,E?([4D!RV%N#7OOH,K"0LQ4J"9$],U M J:;W&B,(H_A#R:L%7/#9-[>0F:N"V;.O#Y78<=RYC3B#H.(/<"UJ#\0$A6,P*JC%(AR. \H5I*?<&WMRW'>5F M_WK_/.A$PJX/#:, !?OAA"/@8!85_+1)(7%80IC%J_2%9D\),S9-$Z>Y"K03 M4<&,G8+WI!)FT,Q,D@K&$[4G\6#G'I\(Q[-F/"%MR"@+6Z8157 (-(9BPUB< MPSQ(3L\@#RE'1@F^HK$?[9%WX6WA>#OJ*PZR#\MT7*%V32*[H-6U1MVC#8;- M< )@XK*I(#C&081QD#5=X64E7G"*F6ZR/KZKB4<>^KYD5NB2'53'UT7&WF M"JUO.>VL]&XAU>QK0ZH J+.3R_MVYO+AHE3>K)!JOC[Z^:VO'[>&?NCRM/)]>.@<3/\GJ-IA.&PK4CRDSRD:I8D\;6<_J.K M73QHCXOHC;RRKLAH0L6:=,*]^^CN6:;I]-X6DC3^(2 MH]'4ZF,5 754-C7NK %#B\>AFNZPAW4?K%1\& ;:L;L/1L>8HANVBL354DT/ M^K$4:[.IL5(+G4:9N #&4?!H45<.SQ:/3"EC;6F2;2'9_='&3@+,<<+V MQGHF<)BF%)>!#"0QZW!-90BT68N!2E0AT%!"Z0!ZX@#DZ(DW]'S4]:D\!D2F MHWOC!0ET3L1$ &+?Q"#(I4_GLB @8(4UB?U9#I0 ;QH]C;5-7A#$P=Q^% MH*^9J5,6$*"]_JPWP*G'_S='4V6.9LKL_W*5M *'(+(>07;A26(,L%RL?TT MPY0XD7-%,[G9I)8C2?)/\3__BPMI\(52W );*I?^MHBO".&4 MPU*B#1P%!EI)BZ<^YV80]@*BE<6M1;V[,TO1)^@2(SMCK^:["W@$V7K7<@PX M"2%_($2AHNI14G<=SOP-42QX;?:,C%,F5N*,4XU!>QJ*2Q.91$F"$?@4Z$*@66!=U'5T'X(K@#6\ M1/6,_XH:C=+J4^G,"-TK9,]D.1(,O.2/#V!'HS#*4=2-N*(NJJ2[#E-&>QK# MI&3@S7/MVC#W9QM%+<&FM8&$#V'(#[3ZGYLV="M%7HU$#H52H%9Y?!"3_7<+ ML_HZ^L,(/]6PW:@ ^?TE)Z0;<8.NRJQ! &$_$!FH$4HXD,H!$L%X3%<#3&=4YP MMF$1+/@7RQ1*?Y35[%-XO]P] /!AA,$7TQS&2"?&);TPE(Q0>S+\9+ O,N2+ M1WAKB?T1?P/?^<+;.R\+S_+"(82QA5T5,;3IJ*A(AH@MX-A#CP'QT=VKNN'( M^G&P,93)7[D]H!\?TL/Q?]%]8K8H&=M\\0D/C22(*>.J.$H+X30#]XC*4._V MX_ZD9EZ3K/#C0U*)DLSB9PAZ9">!V7C>7Y^LV&:).1I>Q6/@(\SG2.U_T=M9 M OH?V/&;Z9:S54M@+#+9\3,+Z%58@QNIW+<1-JXZ]S60N!^TQZG7=W@,:WR5 MR?F40<>\1ZD0!^(1> "RJ%"5;GJAC"Z5(;O*25,M6$TKJ9#X'&73WJ_D?T9M M\?3X -UFE,8+M "P%3T;L: F$#! M%I WD"K@@WM48C_J8DHYT_?W& )&6] M&,@I3JJ&K@*\M8B#_! M,4:8M,@9I7[ KZ-^(FX^&4JZ8:@QA[$GPUB,\G\3)?;UJV>4XYKKV6#'"\@^ MAS;)/_3&.*"=X:%EAOLFAPA,W D)T54N!3JX>=.*A?(.3$X==<$ #_5T] M0T(H&*D _YJ2;N-0U1."!@6[X/$!13,R5\R)U$?/IT8=JFFW(PA](.OQ"R", M(#S\D&%K?Z=#77MTFLH.VC[J+83A)^ 0TL MVI"16/51&B%<],QDB#&]1F*&Z3ZJ&\5FV!4D)T[=MA&27,0FC:Z'KX0@102) M%S=>< WAS4( I"XDE.X.SSPL[<)<>3R65\-,##C1@ 12@?,D(I\%V2O9N$B[G(/>=>VKB8 MQ>+Q ='BQ9#K0. L[[E7FI"O(:E)L[)?>#N*A^(?#:C?W42_)X4VT*9&D!C8 M7A>C-(Y/*BJZ2+AWXN0$6<:]B5!'8I@>($.B@>QV3U,Q+H?_S ^^T:8GU\9@ M%9NX:805EM@9N@5M%]BI6%;BR@(@D2@HC%11M,73$NV47=FR6[1(5[$^ MU$#*N0!'BXXOY/ZGEFVD)8KQ40BTOZE#9A9\<(!3&_/O >52IE@F%TUSU0[ M.8P RB;@8%!S_X\D0"\64%&#R3?"DVV#SVJ5'$<011:?7)*(+[Q0)B)6T_@\ MQ(#3_RH^1=CB.?#F*,L;@XRG!QGX38RN^]"%%X[C7;=S&Z[@,^&*8?SH\T@E MF#4F)FLB&++TY1+PO7V?ZU6%(Y.$((:W[WXK!O'LC2^5!S(QL1($8BR]2\CA M#2S7>*8_YQ*A1P?E%O^&B!4S-G-VUV'$<\F(V.N]3)46%EVX>,D.B!G:D"T3 MN0 H+O:$IQ77I*8G?::=9".I*I;B2L+U!96)JGQ3MWZ+P_ 5CNQ2U0Z-Q3(8 MV!^1>_1CB7O45R3N45\N?J7RZR-/86TE)7+YMW2=R[2MQI["_B9MM0A$JZ"A^?TE?_]:8Y% MU_@]4%* 2(::PU0'_;'%%O]I&7W,EPLA-B^;@42?:S]W1=[J5T?E[>I!<&HV M]W&Y91^?55BS+9Q@! \<0??V:8K@%+1=A:RU-_F%66R$KWG\R\5I,NYRLNG) MDQ^:J]>\)NFOVY1"L$;U8:O3< 6RP\I_1,F'7&*5WOG^P&W.SF*Y=?1DE(*8 M#LU+G*GH'^F]?*I?R+8&7,VK0:+*'80=FX-+^7.3#3_J+;":UT(>BIZ U7N) MOV##:U(,"NP%TDZ5_5LT$AQ$NIXD#+"+$&*3^B84LGW"9;V>GS+A&!@%-<'R M04%7':%$8K07Z%RX*HZ4P C)XX-EY\ 6\G!"( Z)19$KF*#C0H#&5Z"H/G_T MC/Z=$U#_^*N'F$U@--!%,OYW'DLFH(I?!MT?$64>8-I+C/RDR_I]OG'Z*AL+ M>OFJ4A==& +V*FD;/&X"7H[?8X]]=@94P^2 %,<]T0QI2>.?)%)%GN#:+U@1B7*H8KO"%Y; MLDJ&* \_5L-/12/UWG^5JK.:IZQGL\8N7:7%_2Z_3G)WM[\_>6G(\A-#44]$ M\46,U9FM'=PVRZEJW MX&**K>(,&'06>,$&5Q;Z$:4L+A&4-: 45'P-&;&+&2EM\M\<$ ):)&C)5=?[ MN]RJS,'.&X\O4>V7>"$P:;?H.C_:MV?#+=\6ZO=,/ M/HGK\2ZELD1O>W5OXV]\$^?ZS9N_>T,_D0SUQ# O,O=@3?ML,HE[DTDFDTF^ MRV3:/>.@A1U^&>S?93+)9#+)#YG,EW,XH\O;!,4CNL]$7$@QL@T&"OLN>1?O MPWH_RQ4?J/YP<\,7]"';@&3,<6FLL0U]D\+NJ7Z>3W.OQ+]DGQ56+6 MW-T]4OF6%7COO>/-]M551ZBYKOYS5N"C-Q=9?CU-.H?/"]%5(;J[JQ]CKK$$ MY2?7GF:1=!*<'^2E7N]"=/N$SQ_8A&B*%WC_!/Y:E\3P9YH)'Q_#2I$+42JY M]U+@*JM07GSFR\4(#\6391R.HW>\Q4A-G.>1*O++91@<)[HT97E6C2)5%'&G M3);^D;O=R/LJ?)]Z1L)^&SC=)IUN(-P3EV_>9RL MA2^W$V;GK^&+_)K9NJN;Z40WHY]2_-G7IR"F [P[O'X"4E7Y2P?T> \?$\P<1;\#I(GRDB[EJ1D6I2L +UBAGR\RH$]01DL MBAA"1TFU;BV;E]?HC[]NW2GZF:45::&?S;MA5Z5ZP+'5TS]EZ7%,-^; M%@,FJK4?#,017U8%ZIW38D#CXQ6_W#"5253'R]WS.+^LY[QQ24 M[Y7MWW#[@[6I5^"$OPC3[\_-QV2'!#HK*^6X?XMJPOH3Q/<-&SQ=*HO(\L$T2.U\4MPG;O M1>R!O5[M*;I,1ND.J,V8?3A.-^=[24;Z,P"B>WXZ^(SO@6Z-4D<(66?9W&_P M!?BWI.%[;CCWHVXX194BFQ;\_!YVYU&?!ZM#I]^G]%_N*E.?J!+^"?[RX5XP M]U0DRB]?OV T8PBGI&\1M#XFN,J6!MX+L\0>PS!Z#+'3\-%#'[N6O>-A,.SW M]0EEI)GS]WO_ZD7.W:[_'HO&/E',*VL&_.7DHB=GJ7Y,IYT@5;R&K9+=G*/H M.3A.. VPB&RX@0+^L4NXW1[$XWAK"[[<[]]C_1CZB61>@UR! MH:=(DR*@ /': _ZV6--5="")"[S[HCFK?NNT:C9'\]*/.^_?OQX_YI=#V(;' MAZ@PZ06?_$Z!IY)68:'RZS0HB*/3@870M=(@=5RC&FW(>*W%*(/1C1:9I#X3 M_P9. +H&@A_@U;(^Y^(JG7[""8 1:!W42;6H].E@PO7;H= MHW+-Y]=2IP2A/_-UL&=QS?E3K"H224<%^7;@)]Q:29-/<=8SND)6H/.119R2 MU%S4$O!1K(3@)7?WU,_>KL8[981W783$&*_JSQ"C6X.,9>@7SW.6N+')Q(B)#HP2>HJ18_76C>6WKGRP:N3Z^4;MP4_B-"B;+@^3\G6Q2A(D1:.:N:SE>U0 MY2 ;YBG+*XEE#1'[0IP&H$!][:;K:*Z &L"CQ1T 'TF(;1&:1@AG6D4TF-=+ MJT=(H%D.*-& $.DX0@6+^Q%6>BH^MW*,1$92+52[@&N[3A;6+C"L&9$AB1O( M-@P1W8'19P>&@B0?PNU\YKA$GK+;[5I@K[&G_MF**1/M?I[]]?CP+=%NO,Q@ MG;XI4EW+I.^\'K6&/ 7I=Z]"V'<-,_YWBV&GG_? KH PK+!;SU-U^5YFH'"< ML8W&]950W5U&8J_XMXJ!)U;>_8&]0[25>F+++R=?8P9*)Y;8%!KO3F0U0:V. MOCV"7_Z]Q6(YTVJ7^7K3J&;0KZ\&^SKN=7:D?XOE9JA7@[.Y*#9[JRYNXK2/ M#R\%:FO?'*AE?R^)T!OZ8EHG1-V@WB70RW[(TO]X'#CW*\+ S\0JAO(6,4)A M[ID\57Z7^.T/"U:C+/#JO#LR5Z6_2_SW?;31&^%A]O,K.:2O7PT\$Z?DFB"# M0.^!:]!E@XJT+#&OB2V?14%SLZ22A QY0[4IAU\;/,,"]&)ZZ ZJ,8 MP@N]?TK YQ\?=!\Q1\"ZW"22DE#+BME>1,;@?:_D]A7_.!O]6X('SZ3I;B#! MR<+^1PZUI(+>61$ 8"*M&)+=@SDLT/N&Y;;0#;SRM>/@P2N2_#G7N'H.- ?6 MX4K#A>5M?&WAX?/BJR$/YI+C]!$'&_G@4(O?#08A8:%^,0CS;[V]%)'+?%9 _?B B$3N.P(2CP^_>T3B ME0S RV(LG[;[N:"^(TGK.V$2%K\B^;H*K&6ZRJINBQ1.'TDFS'VY3.MAASA8 M:MA5?UGR-?N]R=?4EXNBJBV:W"W6!O/.R=$^1Y$S%LSQU2H+8E M?[[EIXM--V M#45TV= M2'D]DPE_?+AA\HQYJ*!+#18W79DN\ 5KMNL@VIJ!>A25^XPU5T^D$.O0 W(" M-R8IO6[W)'KH3DJ!U!^V\Y0RV2"0AL !;X'G=@ I'61;B3"#H-T&B71=';3F M MLV(\(1C:<);'T-K#_D7[LA%[9-"9CBF (#2&S$W@*32$0$395\'0';0W(0 M'Z.T0(L7# %^[Q.B>H7H4SCO(TO/(T(.WVB0$$H<]!(>TSJF<01F*!3LF&<# MH9X#8Q<.U,/I2#[D] (/1O8FVF8QQ0QZ+3(^T2Z$4X67T( #168VD)RM:((G MGY E'%@1^RZ>&6PTRPAVW@9]C.E/T$.CE&L,8I$E1+G8[WAAL#",XZI2F(X9T=9>#Q-1 M F9%^3D%X?5, \\[)H=,VDU#-%?,PQF^X>N71J"8$'X-OB 2VPB8$Q:M6'[* M@5N(8%,2-S(!3HFVA'=%6XUDY+K+^,F4]!AR#.0T\-_U)K<"Z'J"\R+F.H;T MTJH?,QK[KBX%.#IQ,R5WQX.43$J%?LJR7$4XBJIF._$"_!_!?@)]2DD-OST6F@1 M\=O^^(N)Z*!>0T%ZB?_INN8AX=H A@5N/=E-MZ+Y.1%J#$.6;0:!O,4I4Y"E M@L%DIC<-9&.>,6\//!O0MX&O[WJ:[L#PQ,V>L'/M+=@")#[7,-T5S(6"1+E9 M3 H$1 %IHF#,X.J1[)NAO$%+""A0: GY)PA&Z (%9;M8YR:;%Z6YIH&/^ G; M4I,GKD;Y^ "'^8N-AU\8/;V.QETM8O9X@WUX99@3VWN)9,L3D"KJO M"UNWRLRYS140W^U6?U-U?WQ(F6KBN&I*'XB% MXEJA:!%:J8T9D)+[R9>4IBP:'?)&!96)"Z&0SN!-D P;_/;'P< MO(^0;B'\*^+/V<"X<,1J!V\JTU/B^4[#ZO-D/SX@0,2_O9?V/3=$,?UE-$WW MG+3X"@+51V OGOZ'TL"E>6_W8,^@'X<5#G+P JCK60L>4W'A-U%1WGA\I-QKZ#FK&')M8=?N??W:88E=).B@WG6F;AR/425S MU7-G4\%\LJ.M*Q'C9$R"_/FN4P:4R3TF\ 0#-NE]7U34)*DA!CZBR>)[%#'T MZX[HK%M\J[5+CZ%TWDSPZM>18:]Z^5(N%)W %M&?0+\_I$KA=331Y]R.7CK* M+,FEAUS/R,/6DXNN6VOVG[C]$WZ\;.9KZ@#&-EG%Z(+]I$O9+8+LP^S1F/K0 MKAHQI.*XUITS$Q^88##B%K85.:UP#T-?XRFZR01M(6+CZUZ2%+('J2*FLY4# M^#UL9?P?/?304N'"&SI>)Q1PAFS&^D6-7*E4IP(-E25^%%%QCJ[H*,07)3/@ M*]P[\-^)?NGKE@VS:.*4I&'L"*892=5P),;574F:5I&@WR--RW/]3Y^2=SZ+ M%&2C[6U+CK5?DQN&!^E2NM@I1$;2" P4Q;E4;QCAWS#XE]*RBD W?EU:UDO# M>9^\K)>S1/\-S^EG5Q8 MAQ2]%E.2^)"PLQ&+-:Q"?9YECX4?1PUC5M&H_"J.N"%K(AOU M]D+/5W&4VE1]S5:0+ "U=P1-?ZKH,2N##D/=:']N52MRRI[ .J@.)&IU,:NU M:FP^^6X4C31M136N J03]*[WO4KY3##@VZ_')7Z&EL(1Y=1A16D\$+XP2?+! MHP?M@M5%5-K9\"(&/4DL/;2.KX%+9OSD00"W"_@E$_5K/_/YH6J*C:WW45(7 M9[>J5_N.768S .*H,TDY@H>$\1N<_C<'\Y)-5DQLLK=5SP^%.2GVS2CG=54> MF NTY%<[X2JJB7W<*,1[TF,*^(0T'$82A, WEJQB'A.(,QM8&R1;Y$6JF>* M:.++IVP?X(?PBU>4QY'HI7:]F(.@W9\")TY_ \W"FM?' MAS^Y_T261R8G,'9"K[B&8;1BYL ;W73S7QY1F!N8W+:!> D*SE7@&1UM&6=0@VW\*3'B\:]HB39 G4-AC*_&H/4- M5WZ+UQN_%\H67"L/IV:B+,B3E8V'H4VH6Y\T&]UIV;;QA&_[XDY&'8R3=8'- M&K\Q(4/.I%.BC0F3%"/B!(1 (AN0R^BW\ )NJS$R) %D_#"5\"JG#T\B?2CO$ST]+.D MS.S$9#,&8;9@]/]LMN!5%W_QGH&[1K*5\"_X@^:;QE_7TSE1_3B9$^RC_^7: M//KA"U&N?D&Y)1XZ2M! T'-J)^06G!\V2WNAL.IQ56:B[O5#HTNYOCNA"GMA M;!!LH][8SR63<(W*VJY.Y/&ETAY59\U>OMO*KR63#^:GD--5XK!87X(M(>ZD M_%9=&J2RO-!M]5P\"4MV(SGK?5CN[,;\;-UYW>9QYNY-4E8IG8UIW-EK]?.A+ M^<*VP(S6YJ8>J$S;S$\V,Z[M'8W2\&")A9'EL%ZKH_9W/6W06MCK?A-KJO:DT+DP]1E(Y=K%?>?WR>5\@ M!HOJ4.*%K7#82115J@WGBYI>H,2#*O/SQ;G;SC.#:O/DZ?SRTF&Y8J'#"MQ0 MH@SF>,XW^RZQ'1DK?485Z-"5>M76=F!6]1TIZ:UCEYS*XKD9DBH[/0R9;5L: M+=:JU-)-/^!VHV KMH35+%_:3*A9XQ@0LV:]3([DRF <;D[^N>UQWG0K-QOG MS9 -MR?ZLB+R/#TIU5OSP4EP#ANJTYO.S\QI([&]Q>K0]0.B)M:+^F(_%A:5 MH]=9*&II4AQ?V(K6K"RMJKL].H0R[NG=$$@37=YYT]6(".B&UVYI];KASX;N M@"N&SD$M+X2>:;%@XDS_-%^)@R&C=X\#>D?,!"^0J4IS7;B#_*[C6!H-B?Q MM6K=G-1.I-)2S]NM5649:U^7%T>W71;V8']HZF(UT1O;9:TCY*LU0Z5-V3D8 MDN_RLC*8+,/Q,J]Y*Z$;KH9,FQL7M;":MZR!/1>D8H40@F'GI-/2CB*-_4#J M,A>[TY^>A&F3J._;>J-S;NEUJKAH\\;!:7I1VS\NSMIJ&XBJT=9+5_5+GII+*[ MC/*+Z;$P+S>W1+.?;PS/_7-_4.S/-$-<>NT52V];LL"U3EYA86L,4[,8WUE5 MN3++GV66U&3V0@5$/5)?\+W^U5A6J748%LX+4.^ M,V#M(JMW!WUK6#3RUJ4ZJTC-\;B4GXGS9=$Q#J.6OZKY#+=EQN.*/.YHE<6Q M,CAW67V='Y/-PJ45+'D)K&%M$I2[8G<7MOC1=-Z'^6]V\@[,S40EWQ+,:L>M_!KX_VL/#E) M3%M[0K3BMW^<%J4#/M39Z(G$'/?5Z>"XZ7%:49SLN=J"IRO,>1@*M>ZD:PW%3IGW MJY0[FGDD4>Z88EWK"B,F"#Z#K M92L<",Y0;>HA6/1\>#*=Y?#"S.9%K1_,Q46/;QS7P]:BX15%8>'UJ[..HSD+ ML[NK58ZU=IO?K,[.5CN7]#.][PS/,[.Q*.S-L<1:=8.:B[99[ZAVM;H+C/6N M63=W8=7?F0?'K.VI86VZ;?>DD#5"G:F(/;?&MO)UZMQFS:4\[CO5TJ1:&M5I MY1(,!T2OW)@;^W"V/U8'^K)5ILKD@"2-P*P4YI;?YO;3L2&?#B:S-!HD7SNI MG5Y-9KA"K[&?==3A9#!N&Y)ZTAM,=ZRUI;W TP?)WWNS3EU?*,"^&BO[PL9O ML]TZ @$LW 8 M=]'MM>?+T4GCYN:HX?ND3G1/@;*?=FIZG]U32F?.[ESGL'-'E-P 4C29!A>O MX30YFR3RLESA!MS$I(,Y4%7533ETFZ.0JL\&/C ?9/Y89YG6[G3ARSPQ.H]. M);[ Z8TCV2GOJ$5-7)C&6%QXC#.M*[K>L&(;RAL-50,LN>U)V%+&IMDLZ2=#@)#+]E# MH7;8SKWS9,ROJ%9ITG*7#=4,ZH2ZF#%%;5.O3Y>[:6>PG?DJL2=HHV@JO+3= M\?UA79NMFY;:+-GT5*^%)>NT/@YJ^G;EQSA5E/%4[L1>[2,W^X%4=M M]CE]/*F8Q4[YY#.#U;=H3Y::&XX[H6"T:[N6PNYMUDLY*T%3DIG MT%FH3L4QA[7?MDK)W&M65KFL#;C#=#I9:;7<11/VBU!I,,2BM5WZ^/*AO M+\)D9Y6/XCY?+=JMX88W+VP8JIB?3T1%F9_L%#Z9JM9W4ULKNP,^/J^-BV#LU8&Y_3RK$J\PU$* M7R1F%]WL%6K]B6XWW9.\)/4>82C.<>LVQ':E4779ON\(PPIYF/DMS77K,[9> MM/C^?C9?U]Q!?Q@.NWFQ6MG*A+'L-.Q-$7@8RR579I85QC[K[(BMT8=Y[W1I M#IV%>Z&C:E-JZJ#=J$Z:SGZ\W5E62\ZU"7_#9Z6(F M+J63WR4\?Q/.CQ+?WH3.=DR/_5YG M-5Z%AD0H]K%D-"8+,A@/P"9? MG+;5X4_5M:'V:@*PN(YZ82)6!V QJ4EA2>ZIPU!Q"]MJ0^W+HJ\ RXC5';^R MWE8&8:'5+QGNM Z,><\.@\.@75UP9..P'Z^7?KU[&"P%J7,<-0O.D 3K9VGC MKN\NFV&E/%LU^4F)Z1W]8'(N[9WSSNI->($[$\9TNY[),Y(M;LU-OSNR+GF&E0[U2F_7/]&>01:[I.#GIWKOLNI,\Z;?FM?V<[9HDJ2SM!;K M9>%2KN[:,F7*U&E"UJO\<,QZM?S6-F=,J<-,M&"ZU*5=B:F2*]L_%E9G79SM M.L1HU3_;CM(\]\.@=I27/;[;(]69Y;1(W1/F6GVSJFWTW3)H 9=UEG?/[H$< M!E:QW*^;Y"@8D\2Y6F-%B9\5)79Y,.O@""L*@]*>F>RV;%XG"RNBOBW/BTZQ MV@[9ZH+GVG;>;;T/U(FATYWQB M^U6)&I-'?V-SO47)!)M*\R^=UJEM,M9XXS7U6N?<.7/=M4%=:E1WOCIV"7HY M5KF0!WJZ?R3,.1 +Z>@HG1918)@6.PT*HWEQW5[1,D/DI8:VIBN%H[RN6N': M*XSSW*FVHSJ"-*%Y0ZPZ@MWF%D>J/IZN)IL-/W,+LM:@U_/UI&16S>:Y*/94 MIJ+UQK@Z,M<=MDN\H8PYJK&> *,_3WF".V^4F("FU7#)4X%%FW-J 'S( GTH M'(N6,M /WI!JTH:VGNM*<"&]H<7-NS87#!5O--^/)IW:Z)*O"57ZH#CWQ_AF]%?=S:>7?F];LM]8[953'<'-Z//[';V^W>1A^-* MY3S&X$JG&=.*7>HT ?/F+ZT^TQ'[>0!/BV"I=*P74IAZ;:R"XT-I]6XA_K_< MD#\:OJ7N-JPW*5I;E@ M)N.92!!A9 \.B0@U"9M%/,!0RG0".,BTHWM&H$0@C.'IAD@2?B<@N,+38"R$ M-E*QF-*>9!!!(-,@3T"F C)ZK@"A['XI@R4S.7UL&=R+5!1<: N)-+'@H50+ MX'>VQ!;-2@160V*\@FXZQ$;76!:R^:9JB'=UQ?L[^_1/G"U8)!6L28[9&L\C M3X,>\VF%0*H(:8"R M$6&A),8>4>0Q".!R#;=8<<8I%'"S9%&L[TT9$*E82).E')(X#7J,Z*"F5W&K M*;5YINX_W+,_'K/9CA%^2,V77%^8PG4%_E+0:X?)A2''C*?"^@*VE?-8D,F8 M0 3,8VF6M(#($B0])3X]A]($L38YUA$.1926I7"D7#4X I6,E2IS32)LW MBXH'^CSMG4KT@C!^QD3 8@X4L-K[@P'IM MZT&/@#O@N7EE3=7I -"Y@"\*40Z2J3LP.;)O+8U-:E )9?E0+["%@PJDU&NI MB+GU;@'*6P]Y!=[0I 0V0!G;)O/,:CHW,I0\E;0#Z6J'A3E%G')#<&X3PECL MMQ"@C8!&&3"'%JTXPBK(8P[HJM>P,:O%MBY@B:LRU?*(7W-!A$ 7,!#AMW+M M-XVC^=,X>IJE-DGKM3U9^BR<]B[=F]]OCBI$XEJ&%"O<: 7X$DAF@TBC%H$B MB*=AZ4S$E^1S&K/%TAIHPM>$& MPQTI4*_99F,A% I9C+*(*;&BH"4:=%(N?!#<<@70^BX#*#AB_IK'N]Q?W&V\8"& @\(%Q'.=9R^K\": Y(_D@CJD MZ/7ND4J6KR#W'JZ)-AG&Z5@,7B8 HR\YD)_@R_)9GM![?WM3_T 8>$'"V51Z;)9)B([ J8)3K69$"1JS[JY1K6AN5!".^+ /B!T ^&\ ?? MU.V4$2J^Y!+*VVC,54!;./JN^L\^#GY4P"4\2R"( KG+W$&9%/R. ML-@54(O&MO;;-PGE*?#K'%QT;.Z@LR=Q>8B%1CSF+4FE'O1Y-!0M ]; JZCL MGJM !G8Q>0*;R#^$W4^!<5MET*#R:H_[W4(^NL0^D#U*D2@>+"]L>L-Y]MU+ MX6:O@%FIUCI>"\):Q1?%2Z2T@ 21K&*]$9B]7VH' WPGBN!TP=Y>.EX.D.-O MZH@G[ICU!U<^&_I75[>3_G!\_?-/C9.&?9[T1Z/R>5>MSNMJ5>XF'J\8 AW' M?&7$.2M_T7U)=S8MV:\)A5$-2\TSO7(4HY*B8'MF;SPN;ZYG.U<>$4]DO#E_ M3;?J]0@LW.B-$!?GK(_^-V;M'Q$=G9/.:6DGDD(71*-=3?[\VN31 ?6M&5: M]=KN:^^JAOB8OM6D!]3J!5,=4,*3-_W_BCV_<)M!=SCLP\2=U0 C6P)"_LL2 M7NJU@OYHG[%:-NW?X8[@:V\W3]_S^?_ U!+ M P04 " "4A(Y6NSCNQ^8# !_#@ $ &4T-C S7V5X,S(M,2YH=&WE M5]]OXC@0?D?B?YA#NJJ5$B"P/>U2%BF0L$7+%D32T_71)$[QG6-G'6>WW%]_ MXX0@J+;[Z^#A=#PDV#.>^>;SC#,>WH8?YJ-F8WCKNQZ^P?R&X2R<^Z-AIWJC MM+,3#\<+[P&"\&'NOVTE4N@!.-U,0\A2FL,=_0PKF1)A51,6!%2QI(4+<>FR M7I<2]0L MW@MKRY76MT858Y]G-L(/V1[OG00B=HQA>C+XVLGRF\KW$U@2@L1O0]$G; MA+-''"KVN-$8_7CD/VW8FFGH]]K.L#,>G<_9V8*)J-!4E=%,_%4XF\XF;CA; MW,'R?A7(5NG==PWP[:DS8$_J14.M#X*[&[IT?V(L_YOX#N)/02'K=;N]$/L^VJW\6 MN6;)MC6:"8BD$#323 JL7KT!O:% A"@(!T4SJ33(!-Z-<;]HM!&2RT=&\V9C M)J(V7!KE"QY_+.3-1*89$=L+58ZN .U-I4H1IOV^XT(B56DZ0V R!BIB&H-' M(YJNJ8*^8R%QO1Z0'!+&4;3'$M"H4$RC4X05@_\4;8C VD9_*O6UU6^5X MZ7I>/3[&TOLVEH.>9-]:1))SDN78C=3_3)\T#%>U^4^FQB/":^38J%0:7JVQ M,WM==CK3!7[0#EN=A*2,;P??PG;8%B&MK9&'&SD -U.,@_.J/!3[-4W&B>D+ MO6,@7^^6]O&?&&@G[S0;QZ?H(4)\K+Z7T1.B>H&J$WIX]N'X7\3\E8^C:>_@ M\DL*>,XT&]/] ;33O_H289VR\D_7,3T[5W[T>M,_Y^WFW]Q>?HJ2F@;#L[E M5C=*<_'\!U!+ P04 " "4A(Y6@37S$^8BM:0':=],OZVKP :=JN ?K:HDDW[(?W M RW1-A=95$7)CO?7O_M"2I1EITF7;/70 6L22SP>[XZ?.Q[O?/#F[+]O#_N] M@S>OCE["3X'_'9R=G+U]=7CP@'_"TP?N\<&+]R]_$Z=GO[U]]9\[$Y.5S\3> M*"_%F9XK*]ZII?AHYC*+^(-(G*I"3^[ 0!CZP8^;RV*JLV=B= >F^, /_S48 MB-=:I"#G"HQ&!P>O#SYI3UN4)H<9MW/R^?"?3(V96GFS\1#_&RI MDW*&;(U^O-,:CNP.K/Y#P4-\<6R*1!5,[D4JXW,!-(4UJ4[JAYXR/]_SS^\< MWLW&-G]^\ #H'[I_@R4\:*UAZ^H]D0]KKUQ5L%X 0.RY*-5%.9"IGL*?A9[. M2EC]B\-7%S,]UJ5X--Q[*EXJ&Q5J4*F M-\;U+4K_]\J6>K*Z<_B^*H2LRIDI8',E(I:Y+F4J;&E@S\0FL]J6%@UN;Q2- M1O7_S)B=R4+9?@\>QV8^!\ND<9'(92$6,JV4^&$TA-?W1*X*0:]'0F:)V-]( M">?)"S5110&\?)G6\#8E<_NR/YLI,3%I:I8ZFXJDO<$-**:M#9!;OY<79J$M MO&/]2T=%J>.4A7>2Q:;(32&)"@KZQ2J52SL4OYD*9&:J-!$RM4:0E$5I+B":T%1.=*N!$6IA *(=10*F$Y11J"@;CYK>E+-4<-ELSO)P! M 5B#S55<5A;)2=1PR6:!S##'VV<6K8G[O3\[\ZX8$4',,6^S4S2(G<*97Y6 M#1M"#>A-6PO;NLKQ=PG_H*W?(-0,Q1N30B10;Y5P)+$#%J++E)DQF1(+4^*6 M+(228#)$1,P@*A"XF](45EF"YP V;#6>:_@]8=9IG)N$J,]XXLLYF,F%$ID1 M<36O4C#ZEB. M4T5FBG-L(M[UN9=(!X!_;>,4*E9HNXE>Z$1E"5B(IA5%"-6.E43%J<09)H69 MBQ(,B5P&_ARO:)*QD46",R8:*)8&IZ]*SX*3.F,Y$.KW4C4%0:^$7$B=XAIW M?+M@-!#(7<* WP$J2S(,-)]&7T%L %#$*BL4:-%B9)N@I0((6K9Z$"^XO0O4 M!B@N V59*XL5BA_C.]!C!> EQ>?*%-6:61G[<&1<69W!2 '6A88T M5PJ1:BA.)O78?H]<+'&!_ERXX6ZLIO==],"C(X"(*O)I-.WG"F0X 8_!$X/#@B#'_V&*?@_6 M5!::Q&+]QN@X#YW%:44>QGL$-UW4=>M1.^(!N:IB3J2!( 4$= @!$H'S],[0 M"8+\6D%>MX[VG=>9%DHBJ(!3S/B4X(()9CWT:T.QV5YJNP@-P$$4"+7?(WM" M9^O<+)L%K[34^.&Z"1#(\+I#D41-C./8)%\>\Z$MP;<4^KO)A-S^K(X6R3S M+^,!*ASN5ADXE?:"/ZSQQ3/!4F@)"9B#CL]A1@9%4DPLTQAC50;O!$R.9 \K M7&#P V:\J. *#B7)6X96*U*:AA$T-B ME\GYN@*^?:"_?1#=E.3%W.AS(/"YPAT(\W"BE++/6U*^3S9D?)\$B=QVKG:_ MR=5NR+WFK;0D)W"[LX_! ,X'8P7Q#+"8$\M7X.BZ,X:)X\TYXV_2N7])V[=! M&T*'D\-3]G/080P>(Y>NP0?K(8 /H^>B M0M645XADCA MV+0@;Y)QXA+4"FI!9N \;#F0I*.%*)_>B1N'8NVX?"FI.D*@P>[DB[82YODV&IW;2A!<\;$7$Q9-1!CF?.JPA6]- M@"\9GAZ^^;9 A9@IE5GBK8$9= Q]_C#X]$(/_AA;X17""[5*3D_ M2=>H0)#X:$0[%">92+6J_ WSI. K#2PI8B[\9N4T:2TNM[@E)80IY;G45F%J MN-D,;,WS' F3:E%Z>,4V:X"#&/*SBGF5ECH'AA(OQ(G4A4_.$K!1XE@V"KQ$ M.B"%J3$)TBAGVR^1A__;[6UVE03L_O<$[%^2@/6ZV-'TJY?@[09B&!;>_A1' M@$.#,WFN#( =Q)MU5>2G#)'KG5K(1(JW& M%41#5M71$4P5"3=M2,W-[ZZ6 4[NZ?N\/*Y%*:;H>:ELC&"+/;5C8;6%APBH M!&0@')4I2"55TBJ*]>@J,\(;RG(J\;<<'!_^I-J8"4_)%X*)MF%)R?9)V:EQ M#*CJJB8G*SF=%FH*#_J]T"DV_O3QCW7A@"][\4-:;K2YX*ZCS;N%11':0$9T MW$ &H@V$@TJQ\!BS1A5'[8TZ@Y5DBZ";:7R8*2R\ 95N8HT4X371NO'MB-*= M&1I9NJM9Q^ ]+MM!NT(*)9\#.)JHBQ&P#$+/=2KQWMH $Q02E?@&5C>,J5[P M?E8?4A%#N^BFN:@' MFW 7]:Z6)-1''05N,^50BFU#P"-EOS=>7;83,3:_M]#MA2L-YN.BT^T[&)^. M5:8FNFQL+N0=#XAT.&S&W>?8%J9)#?H F2S0QB,QK>#\"%/5 -/ R@0 ,*." M'=0'KC6&D_Y6Y 1K=>"YF74'HU2GEP#SF!B6LC C4F_%>AE%@!&ME 9>'B>-_BZ>>ZJPL\9\#;CJ?T@IKB M&$[3Z.GK0D@;^2T:-*!0@2/8WJ51P&9CM$PJ48P0&ZT%*W(R Z?Z#!TP56"' M]#<$&6T'0<6L2^-,@ NU"4EEZ::E)7&M[$07%O8^@-M<;8]<1)6E6 ?KZL=J M5KIELX0_32KL>K.$9; .CC;4,O+IZFKD6Y+9<3L]=J5EI^0ACN+/E>;@R[H8 M^(PAD7N=7-!J^SW9!)=,@%V,# A0[Q#$OT,?OW_-YJ[88Z0X536,\HL4;0Q@JVD>>+=PT]9H\Q<1U=]6<(<7:F!'&1A"Q]K'0)3&&[Z!/T]H@XNR+>RX&C]S)3V(=/&( M60T7N95O6V%]H58<$:J,53ESF@_$2X\O5!'#40C\=:8&$SV!V7V !\&A<-M? M4B'O !1?)%'SZY97FW)^*O,,J_N;V!&CP["FT^D#8LU-Q>?D![?KHBW#+48+ M)C0#8]L?C9J*Y- HJ1 7\^T07)38F*6H3 N9MJ.FN%#DG+&"FE MO+[[N"]A3>O.[KGD$Y&8HTA?VHLF:7!KF@P".^T2K?RIC[V[>'UI,T=+S5UI M,.^,8*E96K&F..,5;_)R &9?1W8UJ2_AF^L+<>EE!"-.'G>C;!ETA^IL[? W MIF[-QI>ZB=V1)9C !>U;^.J=CRM8-X=I;_* MF5UU 4$S(0M0G%1E5:S7\2]GBB)M/*,"1WA"!!>C5;+C'O+@Y/ JC<%\,[OC M"WUGQ''30OD+[:PAKDS\"JI5W?Y*;E3"BX32M4M=TN$3W"CI=N\2=;?!88%O M2[F'HN!+X@:DX;VQHZWX/J@AR%:(R9X5]R:Y'@8-2,5$)^0K\'R<-D3!4O$* MA+Q^G;,@?S87ZM%P[:O\.BZMF$J7?T#MF!3*_ "PH%/F>NLH+C5LHV& M,B/\;@N-S30X *#A>;)?ZH^(?&-176$0=L'@L[4^5+Q#ZU[0^^M1,RY=SVMH M";X7!M2?-1E =-2\I$_&SR&=\< !_PT7CE(B5R,R5-S#%UQ/V3-!B\ M303L4,*YZ=?!RU'VV*$NMO> T:D$5]Y: C'/_;&P#ZGA1(QU4G=DMNY"\817 M6<7WMO6L6SM8KM@1A&&[NI#S'!/AZUQS(L]U!]%4<-8]QZ8:; VKO7C[PI;T MM-8%MKD/FL0Y!GE&35>/;U=K!W&^5V?<+A'!J_@P5=U>VE&,82P"Z8:VHNVJ M6M,2Z(-!N=,T3EU.J\8>X+"Y21%?ZD3:%DCZY7Z[QP!\]]H$]KZDPM* M)^:BH5IBOGBBOF<[.CM^7]^T<6HKZ+OF,Q8F/1^/Q*\8]K[58X60<5H62I6P MRDIC_OWITU$$2LB,>/>+>/KOQZ.]Y\+1=L"X5&.(J7$+.)E^.EPNET- Z-@, M804'#SX=1OYK"S1XA!FVK+H"%UC4O9]^>GQ?/-S?'XR>[#^Y19.]1"5_HS5\ M]1>?/;S-[SW[,]]K]L_65WMJ_$8\_"8\_FH\_ :]_P-02P,$% @ E(2. M5M[EN/F%%@ U!P! !$ !G=&-H+3(P,C(Q,C,Q+GAS9.U=;7/;.)+^?%=U M_X'GJ[J=JUK'D?,R22;9+5F6'PHM/1U^F MQ]UI;S X9G\UZSX%0KB.8L(/&Q_A M;SKRSOOW[T^BW)14H=S<4C^M^M6)R+X% RPH4B=^< MQ)DE4J0E?1N3HI34@Q)= -T7"W)WPC,X_>EI2A@&QPL UAGQ' 2W4:4!9<=! MN(Z(O[]*R7FJEK14IRC*MFL8Z&N-LDH%/$:E B6]\>P3D2W*O#Q^V3D^[:0E M+V>]SUFAQ2UC2!AS5'GG]!4G@SY<00 M">L,UL"%IJI2^P88$]X,>%M,4D3:>HVXG?.$?_LH#.(#)3Z<<98=\8,W0$W% M(N>D1WB_<>0@[]-1_%-4P2N,*O'@'&$4?2EI9AWG6#2J4(C$?T9%/I[(Q(4J MP@!Z(_RWZ/>:PH"7BU@?\H2D8$)24<@%OAOZNY7)6=$621)2%>VC-!P0'WF M0>\,^*(U39<0LB!59%6V6;FG7*.B@X.I=D?7T]%P<-Z=]<^=L^ZP>]WK.]// M_?YL^JSS3*EC0+F 2\@09[L&@#*M&8U7S=%P?BI5_#_M1B=3VF@^6HO)!/^J MIF7HR,N)^6Q+?XQ,Y/A0A M%S$C*CIZ,SQO&L,SG8UZ__@\&I[W)]._..?]BT%O,'M&*M%\#P3+"Y_\5T<+S-<>+L"LZ[HDQ(SK9L9/6W#YTK@#]!AFX]>$4NB'E7TJQT.88-=]Y*6L^K\/)*VF?D@?X M#@9,#((#/ WYLOLSG]MPNPL&V'T1:]M,8E9[1U9[7IF#L!-5YZ3U_=41-;8/ M@VA..20 3Z +T9VPR:3/T628]7VJ=#"B"D?4X>25M$_%@]4:( J]W/P2VU;3 MS0I^I1AT4D/!LMNGWF2\"L9@*^R+3P%Y"@VAU]^L(0[2?KN>S*S\U[+RTPJ= MI,9HIIC4Z:25M@^.+Q@"BJ$W@7<0ATEG(B>:5?U&5G5:W$G*MT^K?)I\!RE# MW,ZN"8.I%5\3?$RA+]:A8\"SHI(G;+/UZGZES3B]E7$J?,>)/I2VC;\Z MA6\YR<>B!C,II&W;AZL1CD +YFY%S @J2]]:U()GU*(A1_3R4\A8O)F4#3%2 MLEG[RI(X'3WR&MJGVW-(^421H3LX1. 6^2BU>UV&6;_*BC>OPLGJ:)^&BV[D M_O0R]+G2VF6;3!(J6:M*@N_O+P35]!&Q3;9H]EG7Z?9_LZILI9KOK_C M_)3^:F&D3#,09F)!O!-L20DS:,H2'^J];#'8._DDBPCO4] ,J[)XWL>EV6(H-6ZV(F#5 MV698E#6XSA?78K6KSK?2C*,JUZQT985>[:!KL>H+CKFBSM5DL[*5M7O1:]=B M]=;'9YY#!I ?7 -*HPZA:5RG4LX,D.(+:!;GZ?R4?,?)/M1"%(N1GGJ\C!1F M9!1_0BDV]!F YLO41%.[K%/3(F:('N1=2#[QC)H9@LX>L'5J<'N0@R%M=YUG MY,PHG.Z!W&D-<@^(U\Z1.WU&SHR"-(CM6=:(Y&MUGWP/)-L\]NEB[O7X-:(T MHZ4X$+31^L_ U$;PZQ':K8@9*L6I4!_A_XR;/B2] JQZ.C-"34+6GR%IM*=1 MFMHWIC;#LU]0>YLG]%(DN[[9U!&90:D-?W]N, _98"JUHX=68D;RX 'R;6YY M#X2JQ[E31B_$9QX^P76=#>$7P?3#K[PUDS5K\Y4*1( MF\?G?6"1.NB'56%&6/$//0SA-O?$RME&/9KU9&;$%'^1>B3R&8^*,*W2^&?( M-R.@N(3T@5KM'<6J-=NI4WW=B*1X?HRZ;^6(HT;"E4,>*K/-FE=/M!0J^DL6 M(]=>JZ]4;*=&\74VKP:6F#3_;/-%W+2]_8ZJR4Z5BFMZFK?*^EVKXU;V,*HRE5W[:@*SUHV7&3SW(D2Y MX$ /0 V-&8.Z"Q">82":2Q'T0-12F:&HOS3A&0PB7Z10Z=HWD)AA,%^T\ P! M42Y?J,3 1&,&H>9RAF<4B.;"AJJXU1HJ,Q+U%SK\N<$0_Q-/-DW@W(F>>OK M>/ZGHP"MUN)"W#AM2>'\T]&"N MM]N=D>^OBA4=QTD[\R*_LM>,C_3!/#@>434[ 5+_QE\5 M.W4EH[^#O1I$%!!-M[LTBF*1](_]+#-_2'$W.XA!$*:P[V?WL +UXY4FD#S" M&!\,1\]L M?N"C"2+>+!KTO#!>21PY\2"8/2KYP2,K@/" P96@Y/+QZ2X?;T)!?4E)N/YT M%%>'.(F)[1F%@$^9MY&C/"BS79%G ]N:QQW*O)L(;!!@=<]70(J+ZG49!N830>9BM98G6T# M\V*0A.X2$Y\L^'1QVE7'4'VV#3<@M$$@ MG<9/ZT$YM5Z(U_5"O+9>B#?U0KRQ2HB!CX G]46E)!N8G*(-6TX9;XXL&4?5 MN;J1Q#(A*EFWBF%IZJ*HW)!O(?L=(_,=JUB?W/S:]>Y$!(47W[6G4W\=D0V" M3,^Z8L],LGN4O)\ZHDV\#L&6+3-81>A:ZKLVU@_G^A[Q,1PH#DEN^1W+VB%P-QH=!O'FG0;V!VB[R'R$-M.4"!%[^FS;&"Z M%P:,K*#L6U"3;6#VTH>X#Q8^#+HN5V@0'Q&3M@#KB&P0Y'PH71\K3;0JLVU@ M_O)LINP36\7@%62 :Z]RB]*0;P/[TK:[,E(I5+$>2N".;!T>X@9EWS;9#;CTF3L+8/+A^,?*(3H M.)(;26ZG+LE40 MZ749R8D[:3_+'#J/G'6E#R+,\%):MBAY5' MQ51E6RO1)9]CC/#D_^_5H56?9:TDO2@:?X O *)?@1_"T5SW1F"VH&I,OK_$ M/[:A]P'%XJE*2*.V+)ZT=KN8=U%^R"VORVNEP,W0;$H-DE^IN+M/89,>@E'^ MN4/@2E9<:5&?-0@"/M>[(#1>C06\JM&\[#5A^0-I \P@[Z0R#1RB(GNM_Z'" MQ?Z;@^DJJVY?\SG4 %-HW[KKNL7<,QU8H M']M4X_N6KR!;DL([G,(YDG7B)@IK8:KFN@Q2 [K'AJ@G%!;?R36:2R:FS;(6 M% V[M?+8 X.F.1>CUTS-7J*S%Z :WNL[."WUHT.GSKLU(ZQAEJZGMG:2OG%A M$ BN;UGJ/."SI0N$^=?Y!+E'@MSMT)385F$G$/C"2R)6CD/")<&Z)9600N[D MQ?-/([:$-$_*%]6'K=3:!A\+EQXK'\VC _.9;53F6BM/LQ7V;NMQBXU_#**P MIM$\,3EQ]_T-8DN3$V+',M9"S3D7OD6^%HS_'> >"):?H<];XXR&^1J\":&M M .>]R(QV7@LQOQH=%<;(ZI^R^&?&ME$FU@ M#)"8L^6S[V+28_O@BA.2Q+.=.D R'U!Q[Z0!K;5@3* 7NJ+4 ->[?O))RFZ% MK)4^7BBCWJ-=A*@4#YWMK>Y:W5 M281LVI^*]>1=%JA3 K^2Y E))KM$C136RI5;H;177^J!]7;;H,33D+NX#=%, M[KH2ULH=^^A2)]V,!0N=#T^;;ZU,^>LDFE :>5>S(;%UFYH:;F=PP\Y\GFR( M)"K2/""TD*75'!2N+Q@"BD5 >Q0%40U5):%U,$F<*A 9\JV#1WI^W?CZ>C5V M^]5B';!%,114JS*M@U0)?JW&S4!J'3@*KPI"1@KK8-*L"*N!,A);!]5%B+U@ M@/N!2\G]F/C(W2I@U=!8 E?96R1<+Z/YO$*BAK262%8*^ZR0J(;&$DFDX3;B MDP\[=<.RCLX2B<1CE*)!IVU=W-*G1Z@1I252?044"3[2-54?\VJV%8(U);9$ MM@GQ_3FYCV[ZD5:*,^UL8I<"EL@X=9?0"WTXF@OF+P@5W$N\9Q,D_=KE(358 MHH5Z*9^"%#D2E8>),M9O]1 V+VB+S.%J!>AV-.]O('51 ,<415Z\Y&Z/4BB;+I9E6FM4RC?5;B 0,0SC;#< MFQ0&R@:DUIY14HZ/: YBU1%9>C(IFEPNB>]Q>.*]D?SDCS;+5I"X/06(LQHU M!3']+]B>DF%K.$.)5SF84)?UV)&#^6I_'%*Q,<."[DIL661&9""P%85X51RS M&2\I869-%7FVBB+"%/V"@RD]RW\.N1QHS0K;Y/SK71JG>M=3K:U*0Q6:X!H=+,"[_T6>7"2FF[M& >"9=KI M#,0,"L,HP$6$)XJENN_SOT/@C^-WO;=#C@R.'H:SRFN- M6EI;12T:6O'( =/+E;M7=RUFJ<5&4=<57BGIDI)FI+8"K39 Q1&Z0Q!P6)1I3N$+A*K]/J@FEK4N\> &7@71%/#1';D&6PL&V6D)KA=2.^!I7 M0A/"Q_8J5%P+L\W MXOZ&01QO,.5=MXG@"31O90- R7CDB^*^X#5 62LM=K#:'%O;\(PPX!?7$UD$ MEB;CR0@15$IAL_NCWNTFWU2Z0P%+71Z%T3D#34JS%2[9':$UP#HB6X43?H09 MI"L=/A5YMHJB] &ZJS+KB)ZB<,C0#RIDM@I8+]N3%$O7+QBEW*6 K4+O[O3\ M4W@ZNY2/H'Q"36A7A)WF 16Z#&M7'(6+<,X@CD+T@*\&MT4NA&2^GDNZ;V'[ MM<&M,C\B$UV"E)V3N8K.,$!O)$Y,\N:+\$)<Q%1U1Q@BNEV[IVO8'B%43H=;GM@@4L!>IFK\'F8;IG<(&PN Y"X'=O_P# M(GS7R?7+?[P"^MC;4_2XI!U"IW=70Z]'5FN(@^B37<'S(B(]V^8DR<9.U-?' M0:6%Q5NTH3OCC7<4^2>+ DOZF4#Q$$MT_5Y\!"<$OIB.!YTL,,DVKO9TM::I M?Y!U)HF"TR[;T3XU9?_L%EH0N:DM_'@#W8^IQ[?/DE&-YIIN+XO";4*YJW/T MAYA>!:<%B&ID*E-:(5,^017SUFRJFEMDQ:[.'N6LG:W%]T+.P(;// EV^70T M/E_ &Q/ (FH:S>=<",Y*UN!W*_*PGM/E]1U 2M'W3+E&:>8C*J58BT[<$7[E M-B3"X92=T>KLQ]X/+<101%TTN@T+*\C*W,<^!E+:,KP0SZAJ@\7KR:RUJ+1/ M,KA/S22V.F;2<:;+9Q7Y)>U*ZB/O- [A0OA*\K&DF&#K&UL M[5WK<]LV$O]^,_<_\-R93F^FBF/GT21MKJ/8OS_ZLAB-%V?3Z9$3)R[VW3#"Z/T1CHY^_M??_^;0?W[ZQVCD7 0H M]-\YYY$WFN)5]*-SY6[0.^+=JXHP S;7GHJ*!B7$1T)V_?OCW.?ELTY5H^WI"P^,:+XT*<'6?Z MVT#1OB1)'+R+,_$N(\]-,F-K/^-(6["_C8IF(_:CT+>4]>GIR>F6 M\3>51LG3'>V+<;"Y"RF^X\,^BN,H#'PW0?X'-V2:6MPBE,1Z032$?0IW[1*$ MDUN4!)X;'BRID$O'8K,AAC;T,[/5[([-!;3;-=*MDD%_PBZ2R/OC-@I].D^= MHU7@!CQ$M(*)VG8@PB+=;%SR1/M0L,8![3HN3L:>%Z4X MH=^[IG;S J0U<3,N'8C]V25_H,2]"=$">2D)$H"0*IH.1)KB>Q0GK&]/\2(E M:_2)#DB*/IYB[YE.-A!Q%^9F,\5EY.(Y\E!PSY2AM:V[<@"!_KP"M MJJ04'8B3=UKJMYX84#H#T)^0%/F3QSN$8WTG S/H0-@O&+D$(W^.[A%.M8:4 M-._&0]"0*0DHX*LH007XJPB/" K9O$_C #K]FG7!!4J2$$'&F)2@ V'.$:&S2!+/4W^ M3 'RR"DZ\2/T?]'2?=1/-H*F'0@PK_1*G0SBUAV(<8G6;GA-(@^AS!/J!)&U M[V9^8W$,PI!82-BX&R$\.A+AZQM!ZTX"QIL8_9E2WA/J1O2+6%G[P6+7;F/8 M'F)9V(>7S&ET!*+*:XBP"29]0S8&(Q<8GFZX#QW%P+"U8-E/$ $36TO82T ! M'+P:NFZ#"YA,4H)!LC7G=+T>A/&52TAFL_;9&QG'CK,Y306'T [F:G(!NO$U M-69#@SCI%,6)*1BGG<(X-04#/![:<>TIP=@41!,>?2<@F\I^$+->\H&-)0=S M&"+P!*GA =OV= MH9>=P.':AJ"K-S"';E-:0!O+*7H11VM5!4DO C58!&I).]]O M;"HCC+J'_H4"/"<(^\@L^3&A0^7,2)*QE7HY^XHQ8[7K*XAKZOWG+OL30U3571#NE M\NSJ1IELLZO%[')Z/EY.SIT/X\OQU=G$67R:3):+HBB\D#B,O(J4(:M*CVH5 MX$6%?U9[OG+CFZP /8U':]>].V;&/$9A$A<_R_C.*;"GZ6$E"IE M0O<&A=D7?\_;U9H=&Y&55=W*1=S^MBY9R>YCXCD1H7[]_='.1[G$JUB;K^// M6QS'+*O+V(P":LV"?D6BC4I1N5(B@:1E?=&/'#D/*%C?)IEP9O2[E?T3"OTI M7I(T3H#=0D0!L\.I43OH\-ID&U$^7FL>)1',0B^,6@B VB8C%9GP?;7Q%0(, M(B45S$POS0XD &Z;[,2V5S!E^T3%E-NEV@IFAU=&[2#"99/>KPFZG MTI-Z-7\J:&D<$KC_RT#:9 BV>45< M+_DU2&[/TCB)-HAP9T8%>6\UF>G\$=A$(/B6V4M4M*;U,#HZTYFF)A8#*. K M,%EC6YE/-+4UDHW6:32*6@R=_K)+8*L,,UXD<1?[>/[M:@7*6>C&<; *D*]. M<#1A8#JS!(O4FJND?S.=IV@9E0M,U4:1-S>=?(*90 ?7IIF*+P2%+"W55,:3 M2>#)"X+>)FN5I 2E,:Q:UTML\'5HOA1\G*.;Y"K"7H/HN$YBT:)?'VR)\=ID MG,L(KY>(;&"1L+BU10D V4!1H+3)&O)[F7A;B-J:&N";39!M&['3,,+K@T1# M7$%D>NI5W(]5'^M:Z#;U+R9NA#-TV7W.:O-46YJ>>!O91 32)D,L"7+CE#Q! M3"%J:WK*!1M##E1@CE''BR?%S9^U=9.PI>FLJ5[)4M'MZ_%CWP\89#>\=@-_ MBL_>DFS9;AM?NX M145>>EK3F5*PS>"*L,E\I0B8AB%-HD@]I>E8#(I-OC9N9C&#"\HF^'17N,I@ M_G1<1WE)_S[L,2GQHPJ5,U,OX&>FG.\J_/XYQ*DO]8L+%20O54@62_K'Y\G5 MTIE=.+/KR7R\G-+?FSD&EM^$HUBT[5MT&J:YH?"C672S_9WI2:BNFDH YG*W M"O:Y(Y"+"A>$']H"J7(:ZAR:W$MS0]ZJ%FD6&TR0YCCZX^XBS1P:8J55D^U])T&A-J!QE&J^S MSA-L[P[-3O#*UR3(?W0#'E]3/HWB&)X\,&^U-M]OE M(]LB5C@8/:GI="C8Q4"U8&]F3 .J00$EE>NAH[5)W20 = M6-7Q+JCSS#9EKU"R+^C+/.ONU,7G; ,7^3.VP9@20@%ESU)0AXO7:(J_8(+< M,/@+^6R&5T^0?7W/](34M*/TJW>;8I\I3A!!<:*=T+B&IM<&36TJ06K5>!== MI30'CUX8M>GU0U.[-=%)_]E]]D4ZXO_SH#T0*VQI>C$ 5KX4@7U36&7A,JDK+YN-'J34AINBZBZ6"!ZJ+_@5*XP9TKG:U4[V/7!@^8VO1ALD8#JJ%. MK')-^<4^#*%B@5UN9/I06=.Q(T!HTS2W7TNS?==M*7/*!O:NON$#6D4$E>[4 MGCPFQ*5ZI@L=\C2ENHK980=VA#L*PTPKVY!(%?7U^%'3R\L-3/=[X52JW4MOW"ES;MUC.SO[]:79Y/IDOOG7OHOA'YWQR M,3V;+@/')N;B<_6JH6I'=RDFQ7)/H/J J^?#T M)69O)NY=\F//[O 1I-$@UM4_?2PEG&H@F]FNIG2]_L$L44)_GM M4M ]#R&I!9-\._N!U6,D42!XP@N>)Q 2&T]6'VRP)BB',MGDT4-Q7.TW8^QK M-Q49,9#6>):ZE<$:*M98U-7R/7SG1J%0Q@ ]@.7:M-2PLND>M\-:+0D6U1#NMB^:'%971) M)5UG"E.6I]R; 5 #;6QC3J@1SJ_"O%E'+3WIU<2X/"W0 MM#9FCQJ@'&SZY85AX$I/LDKF7 =T%(VIGZ ".V+@GBAJX\=-AE[=4J@/2U. M]D"U8_F$6CS!I]Q>U9 !C6EQ[@>D%\LM>>"+,XT9 :UM8];G4,A?P]Q\CE:( M$.3GE[XT,3A'"C2QC=DA.,BOP:B0E]X.6=^H^0&K%FS,.[5$;E^?D*ABFWAN M5QTEY-'M>J#(CB^CC\FC-/JOM;*TZ$FAKF\#@+ZWS2RM M4CI X6785H5K$HB[0H\6PUC(PPQ**IJ'D)^5@N]+'=1U 2H:2V<"A=5J?DBO MD/[WE???9:]F:&]0ES>W=)H 6$.-R\+I0MAO"+N@=+;2W00-H;6TS+'EP!(J MR*9@;H[NMCLN\6Q5OA!5/4.JJ2PM@(2;$J(4JP9G6>#:&U$P(W)$EM8U'F9# MB4JL,F%Y^H /1#65I>6+A\VI#0:B%4:$/7LFI["T>O$PX]G^.AI#ROYECOJ> MNNQL(SI.2.#1+L=^,<9^]0>EEM>(!*P6KYK@F3QZ8>IG]\-M:\+FM/M.5BOD MJ5XG'%@.T\L9,WKG3X0US>U9>>+=9F6J,BL!F9:KF8%M>:)F1M8OS M8WI45=G]1IMEH$:QRL L_%2;ZA0+]^ M'85!Y:'(BL1OZQ+GS)A.2^R<9G-"1W0BI%L9I9MWW&W %9%?UD4N^#@Y MHVR&RUDY_.,5W8+X@I%+,+\!71'Y55WD@LKA-N<[OV6B6+67EP]7U'.3_5HP M0'[FB05O^51@O*[#*+%W,OZ%";YW2I]P\F]D=IF7?O;4%VPEUAB$E?.A6GSQ M?1ZD1] MA>PW,?HSI1^:L$).B7"^-+"^:[XO]Z>V80A7%8/ M*53P<5ZI";XMX][0:4-2%3#.E8$"T]XQ'1H#*J"^X!QBVTBP=RTT"@E5T#D_ M>TA@V#M<0?RE L7Y:%$4UKO0?#BFDIGSW/*@K'?)2]&92F3.GY=CM-Z%U*<3 MS]GSZF%\Q6ZO8;87H^!\/RR]Z'R7LW=V_'N#6DXYPD!Q,4,E!3FD[# /F\LC M!M,JA,@YVX'O1 RP50Q1F/+$#HBG8H@M,LQ[B*=V0%2/O9?\\OH J/T/3%&" M'0:0BQF$"?@'& O[@E?E29L*G,ZK"="^]W0 M]2Z=6$[3WB+C%8\00 >?'##J='2F2^S;VQ"F&6O* MF6I;Y;!P3+MU/F0L=F@J51FB=;ZKWO\2OJ4>Q(OZEUS6HC-%]+C4;ZD*\>+_ M)9??Z$X5_:4$6JI",Q%P^9#N5-+_Q-%H]T$U6[SB M='*Q)4.+"ZZ49,.=V_I3ZY@L\REM_V_>[BIV_WK^P!Q:^5-$(DUY3%CEL M&4&U5!(&0%\Z*<>0IY+8?V[<&-&?_!=02P,$% @ E(2.5K\664)N1P M(R0% !4 !G=&-H+3(P,C(Q,C,Q7V1E9BYX;6SM?>MSX[:2[_=;=?\';;9J M:[?J3";V/#*3,SWHL7=O)[-XO+IJ$9=90A )2'CM__05(2N(##8 4 M2 .\R%C6PVHNW\D&FCTXQ__^;2,)H^()"&.?_WAX,>??IB@V,=!&"]^_>&W MZU?3Z^/S\Q\F2>K%@1?A&/WZ0XQ_^,__\[__UX3^]X]_>?5J)-7 MKQ1F^QW% 2:_79UO9WM(TU7RR^O7W[]__S'&C]YW3+XE/_IXJ3;A=>JEZV0[ MVT]//Q7_Y'/_UT M\/J_OUQ<^P]HZ;T*8Z8M'_VP&<5FX8T[^/CQX^OLTPUI@_+ICD2;[WCS>L/. M=F;Z:9!N!Y2)W[W./RR3AH*I2TPGX2]))LD%]KTT>RZD'$U "O;;JPW9*_:G M5P>'K]X<_/B4!#]L<,J437"$KM#]A/U+@=Y^Z^(N34,&[&OVR>MC3!]7RF8V MYH&@^U]_6*3^ YWZ\/#@,)_X7RM$Z?.*/K9)N%Q%5+[7W;XT3G 4!EZ*@B,O M8IJZ?D H3>2,2 ;VR=S<(RA.'U :^E[4F5/N+)K99F\C6M*OF=W/5FS9H(]= M*]T*)^B/V>L4^]\>T$W8=^F';D6C!3?^P?>\G#682_=U5U8[P&5F=D MX<7AGQF"TY@^BDF8S.[G!"7T*[._RIA5GT$#NY\P-954/3XB4L9XM!I8N%XO MEQYYIL]0N(A#^NAX<3KU?;R.4_I]0(-S/X6(X_$*+A"CRA>2X$$R/58"+IE2D,J\"5.T4;X2QR_(BABZS[= M!]#7+:#JN-K]X5G!)>B/-9W[E)H1^2$6HA]L[ZIW#]O#7E;MBV^8T= D1'6N(;9-:MRWG,;@ MSD5-'CVS#[V+49-MCRG[V42HL2T=V,N&0O'EE8S3N[E0XPD<,(BWYH2>U\,H MN?0(R3#;WWL#S:C9F].6<96Q@YF:@@$]MJ8VV=!"'&B5XL"4&(=:Q3@T)8;R M^[#?K#TY&-L*T6:.OAV0;7GO-%DO_L#6G"O/,,3&5W$M;3N/?N]A6S4K#C>X M1U=4O:;IS0LJ-76ZYC1^7(&T%49Z@'_^&XOLA']DK>])G76%H+RX8U4.M;&"?S,D/J]*1 M?;*G?GI3GD&O2TL18WA$+^Q(414,Z86A%H= Z5#M]XUM>50;W<-]9%M&5H1?\,MC[C, !!+O0GI9D'4[S*^ M'N@4Q%_?H5=!2#!7CIA2V9 M;HX>@./LFUXMT?*.Q96W8KO2AJQV$VH'^^8IQ.V[*V&3/H,XGNO764 M=GXH-\.K/-,_AW'(5KH+^FN%;_24HCA P89S-J%2]D,:IHRR2%PYF+QB62YK M=JRA/^:4!0\;+B+L5[XZ8BD>F#1UEFR$39#_XP(_O@Y0^)HMBNR';'7,M8;" MVU-J:])GEEM#EEXA(#I/T7*[)8N\.Q1E7W9+!XCH7P_%[R:"0L#BCJ3.U0[+ M*=GP5SP(BF];_O3]XE,[3=$_S<^B] E&BW*DWCW!2R6U%2K"D !E%5(^?IA@ M0O?UO_YP\-..E0@G*/CUAY2L.1+W@4.VFCD,8PP"&DT,.?;-3H[0&'+5U*W=B7 M#FM(.ZUG4D"*?]-5\9S B9OCS[='9T=4;D22X_ET?OREV"TU%,UH>:2W/'[V MTWAUWP:NR+4G%"OP">ITH.5ALTNXH3/R'^8RQ>T[4ZI5-'8-9B']#K163"DS M 6/H+/(6?/U62*Q7<)-;P_9MR] )2GP2KLHY?8"B2Y3NZ+O.-&@%AUTWKM B M3 J_S38;5+R0<(=8#X2<>W I'Q:1:1ROO>@*K3"1 %&F=$;_#:8AM;\=5NW_ M=^V1%)'H647S-6)GE,_C&]+_NX$W,,2CFV(FB H =6IG$. R#D'P?E@(KA]0 M%!WCY,@!@.=C7-)SL((7:X!;_)6WAV5]3KG,@SJ>J #<<[4QDT2IZS&HDC?54I' M=,YA&M3[0 ?AG+'C+(HJ.H\#]/1?Z%FD^!JI(YKG<0VJ?J #<,[9G(0LR?$Z M].6+3)W6$>5SV0:U/]"I-V?MQGLZ#^BSD667,FGD( !#',%"Q#T(R4#'WHTX M/B8K7/*5'[.L2/)\C .A21 .= 0>N0P@2 .=C8O+_R @*$F*?YA\979K1N8$/X9Y17@9"K41;D'!8Q[$8]#C M].99R;<0*F]#3NF6_LM,@WH?]#A=,#;'2>I%_R]"J8RP4*[:J06*_O)K>@B@*[<8+Y?K MN/ X ;>(7%+KU0US#:I^H*/I=58?CV5Q?Z'[4Q+N6N]4]=ZDLU[I ,N@Q@ +.B.Y622V?T]M'+#]-8C(&$=1&*@XVB-O?,D62/2%H_&*-=0 MX0L 8C/0T;0H@_E\<'AWP]*/@56I1F6][KD,@[H>Z#AZB6^(QPJ-7#\O[W $ MIQ-Q"*W7.,0SJ/2!3IX5KOCJKI!8K^@FMZ"*!SIY;EZVTR?_P8L7"(X6X5%: MKW"0:5#O YU(=XO<0FGM7KBV=B\4UNZ!3J0;IO)$ ?K^S>ZB<%'I/LA7.V> M,PA O$-@O!TJ(S?+'RL) )AK4/5#I>JN@S!E!6L9@V=A[,4^ M/?!MDR@!;X)LE/V J @ 8C/HO>M7%$7_%>/O\37R$ARC(#]XB&X\@"'6HR+G M'H1DT)O8WW&TCE./9&&^1%A'J4;J" 0\KD'5#WKI6H2T;RU9WB=>A !_A"- M")@'\1CT,O8\3A'Q?%9F\<1+O8)?$1[\$8[@(6 >Q&/0@.?LA3VF9FR!Q3$) M%4)'M-_D&53ZH''.UTLOBH[6"14@$:Y%%4)'E-[D&53ZH)',ITM$%G1)_$3P M]_2A2#06*9\[P!$08-Y!, :-6#Y]VA5!R+,MA4@TJ%V!@<\XA %/J#XPV-9A MV;;OHON$./ (@ ),;ST.$M9!) 8Z3L_2!T3*N[6,-2:,*,A$-LIZ5)0$ +$9 M]#A=+DLA--4E.NOU#[ ,:GS0T_)\?1>%_EF$/>&YH$3FB+[K'(/J'O2$?.3% MW\AZE?K/I4X(VW=3X8"F-($C$*G+ H(W;*HP7BY9:AKVOUT_> 0ELW6:L.64 MK MG20@; ,=T3-7/R9G(5F> _OA"HGUZF]R"ZIXH -YP1$<)U B<$6]TJB =P,= ML M^+K ON)VN$;FBY J_D*+?EV3YQ^N:*/1+OFT^XWQ4F;1=(X\XP5$89$N; M%WET6:/;:[2[$$TKS3T.)Z\FV]M#UMUC=GD]NS@_F=Z0ER>P^V[X![4+JDC:':(5- MJ7F(6/L 1)"L/=5;[X)+F46P*T9!S*/5:SND'4>4-8REG$-0Z"D=,3P65O8J MT897/SU,]E_6$ E1_KZW(_)7Q#!B#OHEA?L:!]$,._@1:!AB$ZZ0,0==/O>"8A@WL$3CF&(/G6!B#OH M]H,3$,&\0Q!], S1YRX0<0=1D^L$1@+FX<.1,92F28+29'K'"I#ZO.N5@K!* M=WLP=%^TMN=2'K^0^HUMUW(FB]L<50QJY,:@$&B8!P67;?O.GU[R(#CET$\- MZUND1@PP"VZ"S3[WGU$4G,^$T!DSU!VS6 [7*RB',8&F" M,^ (^8?@Z1I\ ;0W9U^?I-E5!O@F,,(&G?U:%K -^U',GFAF]R=ALL*)%WTB M>$T-HA^M61@@_2N[H@KC-0IF*Y37\5<\\W29TWYP-8D(/@B&_6F*V+H)EQH" MAIT+,M6[XC:3:-F8@^ B].["J'P\EOLOX3'V^Y-EO(,(&?<+S+UGMH&D>WSZ M%T*7TJ8H!PB3&,%2$AN\Z4!8,!+BK*P'8T15L7*,TS<-9@!U=@\X1_0MX M!U5LS%_P6XP\$J. 'I>7X5H4>UJG= 0-(?<@'L8._\X MA9%$#! J8YZ%"QPO;A!9JNVJ>=1N 01+ &)CS,M0$E!I57/*>RU1ND$?P7(9 M9E>]R30.CK-[OP6*?2$(@D'V@R)E'@3)F#N@FMKPNQ>M!8L6A]A^4$"F(3#, M)7N6"@])D*A3V@\#GV,0 V/7_3<$>(9Q )S:?W['LOL!?O M(N& @SN'TF+U"CD&E6OLB#X-@DQC7C3WPN \/O968_L? M<$392$[_6 OO+YNT]B,#\0PB8>XHOCLZ->[FSR[Y7Y_F,L?]:!Z['\V5C^K"5L8_FSL?R9%5$5 M8_DSB73V><3&\F=C^3,[(1K+GUD/T5C^S'J(QO)G]F,T:/DS.(>FG-Q3BT?, M8Q9X1YTB-T4^UF+'3DL9($R,[>%8^,YYG-#3,1/SM]A;LIXW?Z(@RP9>BT," M)4,MAJV="-8=7*5\*\1SJLWP C!4BR+4' 8M8PI:#^4#+4:DC0#@<=;:=THE MOK/%)!;CV%48\'!E1P 5M<@SDDD?9+$5/N1;",'!**QJ]LJ M\WG3M^DZ?<"$/8NJX-7'N08:GW_PK&P36.=)LFX+5#[&39#*O$, &8NVYC$L M[AXID+3<>]%)J!H"@)X-"\).V]LOA<'VXZ8L!(2=P73N6J]2%;,E&.045NT, MEKE:QL,IN?7DUO MSNGG)>D&D* <]%B+F:Z*\DY9E.N;V?%_?9Y=G)Q>7?^;M\+)WR5 MG7X":K>Q=4ZVP2;VJE?(M/8SKGI6K5#+(+VI %EE58LY!ZV"N?+Q_/13V0HC M''9KZ/#;9KF1"P!: &-8U7-/92#QZ4T%,+=!1\ Y!(O!\.7]$FM_MM53)&;9 MNH-'"]=UT^-K/0AUY[8=,G'FB&+,,X?T+[0CJ?_87C71(2M')Z43_S0I)=(\_NFT5!G[.Z MKCL)('#;36(WAAUD@: R6^@C?P)/UH3:BCF5!.?A I?H>_:)T%NJ,-Q>%%M+ M >%G+( ,8#U?';H#6!OO*H(\,2 (NX:8M;"1-_@;BL,_H:MAT1![$5#B'%)Z MUSBQ#DIOO>>H#G07 (6=@N:^G_G)[PM*'W"P:Y))?_< ]<,#[%:[A&_13>DP M^A8^]+)AKNI>X8'7[;,^9H6>HBS49'8O7FF:E';K&6(85*UNAT+S^]LJV%$U MJRC;6/Z7:,^\-4'7B#R&?M<#1&,:>Q'L+ T(K+$D,.%6>G]D@7EF1JK(+Z+AWQ34?E'WO)PUF$OP-!^>^5(]F/I]>?)V<7LZ]]!>7/R,*+PS^S M7?DT#HZ\)$QF]W.ZE%'6LK_R1?B9LLVR_B.!_E*>:.+%P22;:H+O)]7) M>I'B$UV(%Q0+'Q& WP]U?K,AD^V87MBZ7B^7'GFFIYUP$8=T$?'BM*@-Q+97 M],$IM]>I,ORQSG Q&=-H:;K);K[);L)>I/GBD6\H92%V-QY2L[CZS59H,\X8B$"R7GL_\CG]Z#.[VZ.21A/LEDFFVG^-LDG MZN>)@?MM5%D^;#P>;.2$#9V4Q_:CXN7*"PDJ.:7X3+YIZ+48."F/[(7%6@FN MW>WRZ=,*Q0GTY+ZM<[R99U),E"UMQ523W5R]R+#I"G^%'E&\!AZ$=W6.-Z,F MVV%]97/Q>C1?XO@5*=<["ZCJR\U0^5*\KTM1FGZ2S;\!X&^3TE=,BN_(4+DJ M_>VY)ZF%HB9*HC8LIU2\9##QB@?[&J5IGF? %Z%A3#P$^6L8N-J8OOCRZ9H@2E0^;-BQ^J">=NAW"?ICS=*D'LM%2:N\-:S3;MAD M,\[@ 4)XD#ALV!OU@\3DWS<__8=1 ;.$4$"\ABUJ(UX^<5_"2?>@(KD:!DQI M)]JW2%UW?0))WS3,X+Y[O[Z5T&H3*)*\85V[; 7[EI:SY1+)U+#,O(U7WSPW M=V BEAOV&MZ']H1DP/.%:%A\-1?B MY-^+Z2?;^?N2M.Q65).IL5.HN!D'9%W-L!;L\&79:^-0S&RH;1NK(Q.C(+^Z M2>>1%^\$N9#78%$<;BAZP7] P3K*0O+K;"8[/A-9U99VTUA3U*45M/4(ARZJ ML[X,S#9)X^AY^^/G$!'*\L/S!7I$D;@>C.IX'7= [-%OKI2_TRF*!B[%5Z+WI@MX; MLT5@^D*O+!:X9-C)!Z)3$'2Q2[<#U6@AW0!9"0M 0._6T'#/WEMAQZ>DJ?\^SN@7_0 MI^0PM:7U7H4\#W-*[P >#@#Q#%TWE91KAB'@8_1@T%AY8%8%UR6GG-_]TC( MEH!-X9^,Z>)+RO2/:=A*=)@M)-W]OI79(2 MSQ>T3.22FSH_*>\<8*X5-N #ET[VDH=I'+!_V*WVHQ=E=:'38X^09[I?SLYZ M,#Y*PZW'2UT*ZZX$6/!\3*=]OD2"UZA,93T:#6;!?85>E\+)&IU1IEMU*!>. ML5?3:JR#NP-3#_LL?4"DLKC"CWR3UEXXQ"Q#,!BKF; )W=H]+W)##H^Q'A8) MZQ \QHH<9H]1DVG)J](<8#TP(KXA5(R5+BPRL 0^O@V%]7JO, HIVEA]@V.< MI+/[3Q@'+/QV4Z+D&D?";H#0&.O!D+ .P6.L(,$G@I,D3^.'\2@160] G5=( MX\8:S7Y",2)>Q%(.@B556Y+FX:9%GH !?% ^Y%1X%_DU#<#%SWUY!'3A>!4E2]'=5 M[$C9'&+I[:2<<>N\AF4693&D/%HS(<%R#6,IYP/=40Z&A95WE-KPLO22DIZR MJ-4^FM/9$"&LVI="YTG!($,]* 7O!V[#NG7+6\[O<1=\N(-,A=NV! CF'5SU M#$/TN0M$W$&F6O>UA CF'?3RF[NJIX>4((S6[,B\J]1V^N1':WJL8G='K&/A M.BVJ>&\:$LX1R>J?'CWS)Q!O_WK]4KLWD /H6]\=:D]/UZ6W1+)-D'RDF>WI M$/BI/#%-'=JTW>T/=YNWPO8]&Y9NK;^R8@BLL8EX)U ANWUOQO8KOWY8PCMX M66G,]E>W*2?A8QB@.(!;D13CA,-N#PSE'+:H+BUE'X+*LO54>669+IDSNK?] M6#Z]_[>!S T(O'V8^I"O\*VV([+Z'$M8?>-LN)=KB, M*A4F,O3@1O2IQ#D/4V8T%WG.ZC0.+G'L Q_?T)\2S\]*13:>$=YCKO-;3-#RF',[/73[ >.S;Z8'@#LQYD"Y*EDD879W,5(R8X'''$FY!C6HN)O*%7(2+A_0S7B?HXN9$J%8NK:G;)S7=PBS; M=^ET0^>>W9 GK57#M16BZ("AC2V@>Q8-,VR'I+[=9:YF\*@1@-2E5@^@%VTJ>N.#;,PQ&.2O@ M@8J25"D&MF("C6& PWZ-DFZ-6FDX6FM]4#MP@]?^PYRUM_Y$\'I5]+X46@'1 MD-L/ ]L Z(G%+?B%=/UAX"IC:U;[9\6.>RS,0%3BC4?Y@I=Z4&;0* \)W!5: M;;8/FWU#G5M1B;(6PTT4CQ.H'7>18:!CCB6866F1>L!U4)OUQ6,<$;$GKTPS M>,G?3J\$%G$/Z?:CN0CR[QX)V'%8$O-=)7O!5HHO, 2AY1S/WGC,O!Q-J)UD MN#EK;&O\@+7AKQD<"5"@R^P*5Q/$ZK [R=HA1-1M:\* MV4O&CR.H=1?V['*KB)=G%$O^1EHH0#=[FK /]9L MB@Y5N.90ODBHA+):YZ$Y*1(5BU*L\+M7(WR1T(E$A9 S5@\;R'+23-6&) M78B$.,ASTR[1]^PC87TTE?$O&>Z#*T>RN1?R:L07#5:K="\2)H&D("#Z^_KNOAXL-])@ M=%.BXZ\ 2EE6$!9C_J/J4CZ-X[47S:FA]L,5_2&_NE U>_S1+Q+EUO*#R)>\ M1(.5KOCBD6\H91$/N^(I:H4J#NJ%*G93379SV5.38BR4/A9*'],>.]6W;)FR M:"YJ;4Q9'%,6QY1%%U,6,^_0O!Y4*XP"%@TQ5)==0[:B3"K=BRZ QZ>;_U9# MH4EX^[.SR@>$ 7W1YHJPC^U9K"R:,+9GL6>[,+9GD4@WF&W/&BA,\ZJ>:4C? M=,7F$9D]5!IL;1^6=B)8MY[]=>K^J5@B'37[C(6"C37[QII]!FR5ZS7[L@(# MJWJ!@>0\]N5U% 3#[*[II\0]B(#Y4U$> LA2);F45(NESA6RJ%LD-Z^,V.- MQ"]'/02)QS2$P[NQW%55W[='1S@[^A./P3B6]. MZG0VUE?C,PFILG-1-155IM,($])G+ZFVU/8)>8:@,):+5&=3MEN'Z,VJ[ -FH[.0?][OQY'ZR2,49),?7KF2S(5YJ>_ MK1I)F=6F^QR@X\B(O]I&LR;MHE/UXR;GOU5>] M?TIE_GR%?I$-N,T.A %3&V\_=&WDL,[7(ESJ2]OPKE:O/(7]4+84!4+3RC(N M>X'9F,%9+ %)0*>_':MK:2>=_\A\7G1M\=&!Z@(KF,)^,%N* J%IK$!+E?^- M-^.*2E]^-E6AA,:[AJ-8#OB*R&"9G8VX979@#'A4=N/",PUB(>)BB>[8^1Y?+TF"U2* M;OY1K?3)8;WTR6[.21A/LEDGFVG_-F$3CW50QCHH+[H.RI@IMF?6BSUW-6.F MV)@I-F:*M4]S+F\FQ#G-34I#".C-0.HO]L+:71O>5C3,9$K9#V4:.@;QBURA-9EC@-YB[2OP;9T;I?369P'=]&')WGJE5:\RPF)@E#CO]8#2 M=3631MR6B.P'H,$LN.$SYOSPD@>!OX-^:K^6=UQ"ZC66_7:%5KD12F;WXHC^ M.J7]:N=S#$%@+&4-"(PZ08E/PA7[<7:OM/MM.9$+ '80",+76![;*>46?S]! M*YR$@O>K0F8_-AQV(]%NU[R]("Z]=H"Z%49:KGUE"4 P#);@P3Y"07)&)2];ODJ8HM#"J\Y@,8:= M) &Q[.W$K7C0=NQ\K7*L/C!VKBX_$]B,L1B2-18!^$IG:V' M2]E;KKR0,(?F)LU.+4_O32-/KYBHG+ W)N:-B7EC8MZ8F#N3_5FQ.?A&&_ @:YN"J[%NW?(VYEB-.5:#&*(QQVK, ML1KF:/CIZ":/F)6UE2M3FV6/,RIJWS*:DU8*VV%[56^R"WUIW)2L91L!25J1Q0>X-; M\'95=V@M>0Q]E!0O'71O7:6R6)\@M^"6U_6&)-9"H< W!$K7E#+@(<_#6[.K M0;J\+:"GO$YFL6YA=B&5&LOBVH44*W7@=.!TUF 6TGDI?VNPF/"I[[.-Z6;Q MF\8!_0NA=N7T:87B!"5%6/>6ZTID^-MZ9/AFNDDQW\2+@TDQXV0SY396_#]* M NL4ZK<8>21&P15Z1/$:J46YOZO+LIEE4DS##7'O1X!2DRRVQ=V@A"BYGLIB47C4 M5JB"[F3#>"'4,)?65,R/FH)AEL&%2+."KU"0I)1) MI?Y7?&)3E:C55"S@&?0<&[/$G;LP?S0#P3Z[9IX($"*:5^YJT<;DM]A;8LK) MGRA@[#-_ CV.^J##,WMS6TSA%#J=A+-N2SM+'Q I>S*D[FMHA%/@J<@"6A:] M[]@%*UNZ(:D!G[.P1DFM3@K MP/FB.-IR"-I*HML%IBW6=A;7O.*7*)W=WWA/HLA$R5#+L6LEAFZ/&O!.%>V; MOH;IPQ>/?*/'>,K,-?+7A*H,\8XS;)ADE.4XJ$J@X!,;N/QS4029-#;#DN$L8A.#2G8X,OT??Z5EIP^ZLRW $P6HD"H=,U M>0,J_)I?-WMY(Z RAW."EN&:Z\/.:JQ*!SJ B*(0$!8FDCKVO)*1)$I\[.]J MQGCO@'('A\93P4O6Y=.;SAFH\*6<(L ;9-EQD'3Z(#J/QM:Y6_W=1Z MY)D+JW5>X1QT7N$'=IO% M.J?@)ERW4;P.G]*'ZY0@E!8I=M(.2/"(VT.K5VDIYZ#6=:_3)4Y4=5WP^<90 M]]76&B[S"QY'.K>,5DN&E3W*$/GM&Y=R8FML@\K6G1B[?^;Q&ZL790'/H(YU M+\\U'@[:*/E@P['5AQ41TZ":=1]5]N\ ^-;N=1GF&3Y]CTT !_>ACRT!QY: M8TM O7A9FBHQM@2TNR4@R_EPN8=3>^,CE-BB'/VQH]/8T6GLZ.1D1Z==I/Q\ M3?P'+U'L[20=9^I"3D.7)S79P$L[8P:R&J\IMHX\6I=,(RRK16D>528OO:4T M<1H>8<;2"=0LPJ,IJDWV3!\L-ENHO:$;U [-*?MADF#RS(*CA::'1WI[:.AF M7/K<8Q7&P7>D\\7X7[LF2@>#TJXX2M=4-4LJ<8S%4:R#Q&93,A9'J7K8A+5% M#G]VOCQ*)@+XHOUL0XD4)F4+G';DMV\,17-UQ:?..O@:?3!Z\!RHR>D[4XVL MVF16M9,& M22\]$7+V7>D.<3+U4N95@>XPYD(OXAD ROA3VU@W8",D4QK+O' MJCYJI95^)]"[(1$Q#6&@N9I/T>]U4T,.>/9K5):K%>08TJGF&CR;Z]ILLP#='I1I'- G MAU](FQ_MV-%NH&>F/@L6#.:(^/0#C]LEG+L'%,UA.6@=Y0$/F.:\HU[R(%CP MZ:=N(+'C%-2QYN2%_2L/VJU8"=^@FKL>N>$-91+2F3WQYG%'XX!:.?R"ZC1V MWKU "R\Z0]Q2@QMO]X;$S4#"B6#0#I+=>R N^@ MRHU=M5A8%':\!()SD4M)K$Q ?"X_U)]22QPMZA UQH(H6--Y%[,2R@#>.!NLUKHI:_+-[ M99>N8) ;F$D% ($RVP.Z79];<(@;($G8!R$R=GV_>?>K;:KS5".X_WHQ6F&P M&[ I"P(":,Q[4=XH76 O%K5>J9.Z 0[ -@B%L02I5MWN>H, "S#;_'*"[?!&H)PN":AY5H6,0UIUUPFTH;'TZ<5 MBA/!(U\CM!P$$=,@",8.W]*K#:FM4)W!#=C:20/B63JI#];<2]C1*^%W]-J* M4&[D]>ZG>B,O:?.N1-"\RU#+KBO$4/33S%5YC),TTT""R"-J/ 2\_:C*:$-% MV[:9WA4N=P@S?A/E[EX*DVA]:_=I]M4&5+#UE[+6^)%I%G4".UHG5.HDF?I_ MK,,D!T18LP <8$'9 G58L)I,((@VP<5^)$B:0*\PU$QY YGVY5AQ-6#335*? ML-E< D$SM(/6UKGZ^L]I\,CB 8*\1;I"(7[A&$.53=5?&-Q"$.M6QA=0QJVK M^6I3U24W./4BB6N<$3;H;@W5).IR1(4%@-2L^:%M?#ET7=HD=%[/B5#1NEOI5%ZZ MI)7#-6M4HSK>-5C:":9[@P2@5*2NZ1V4 5+W.T?N<;89.]6+G .M%SF3@_$J M9[S*&:]RQJN)7C+&PVN]!5]I:K[ISS&5/LC;9Z@AC"FO&]7E2U_!RQ"EA/PG)?SSG1\709PY[7!0WF\:_"T$VP@EU_%O832LLW;M&LH&%9X?<03 MN(972\E<=QI>LBZ1:?BX.XU7G(>'>IV'VV\SY$04IP%PO&H O6E'(=S=2^09 MY(VRQA78*D-#J<_9Z.T;T-NGW&]N=.^-[CUG81O=>V.D]ABI/?9(M3- >^R1 M:ITQ&GNDJ@DWE*$Y/3^Y$%J5'<&MH<[::OTR.;R".APS>@:P$6U2>(PV;!M3 M>*RS$F,*STM(X7GK6@K/6]&%@^;KU"X!'(8:5K=1*(=C2*,?C)GAJ@V3GM< M,L5!B?;=K^I&1K?O@ #/66*QG"2;VVF-=L-ALC35 -Z@]GE,!PB3!Y)E= M00K-"(^4\FI!Y3'Q>0[F&[[1,F94IGX6Z[.Y;]Z4NCM"'KMP+S<*@%\;]3EN M#PR%$;2ZEFPK#P2K)0>1O3J3. &8F'OK_.Z:2O@Z 8V(=^L\[P-UC'$"N#:R M6.X@RUD-_7E>X%L5O]HP%V'CBF#=\:G*,Y-4%2)&ZR(N.[XA,"QI&UE^[T_O M[Y'/HO[VZX?-F<9%")5$@M UUL6AW%HE:UVDWE1P2^X&6@+6(52,]710:Q=0 M*2CD! 9-CD&OJNF]>.O*]4X P&4:PL"21HV<3"15,\,9Z@9.BF+ _B,#:0I3 MWR=K%%RC-,V=E6JI"&_JJ0C%/)/=1/8D&IPP5:'@",7TAW0>>?&.]0:FO*=3 M:;CI-(0FF\F.3_6*)4K36).HT I:,&^AA>JL3V0HIQ7=$"J)YS-%4\4AWW9B ]YO;_7F9SE"V@^"UJ)\FZMQ:M[*QF]G9_93N&N,%DD>K M N1.6R:A"BRZ;"EQF.2-E[W=7\K+@^PE:CV1&?,EQ@7O)Y)]9LP4O#8;P!X? M@6&#:I&_)B&K$C!?$__!2]!T05#&F3C05C;.D 7L^KKAEJ)9MP9?X"0YI@]Q M2&6-_><3;^DMF,/O>5,QO]T.]BD@0@+K+Y)&[,"6,?/K= M(R5_7#W0ND[GE-YA":S;5@X4&.(2>NTELV[UJ]V.Y+>$>$G_$OHG:(63,!6< M'51&NXBHLES@;L,4GI^H9A*VC*-D%E<*1['SE.B>6S;211R59((PU%RHK'%7 M!!FT.IU3BH\4.?H#;D'Y>^MB->EGR=8O_;G(0^"U:^?O"(:-\!C+@],%141WV_(>1W(2UA?G24[=GNY&K=.Z*/G'4F1S)$YS,Z\D&3NR6F2K)>KS$E]%2;?S@A" MYTK)F[U_M0,/RS JL,ZKJ55NYB[R4Q3\CB,Z#3L3#OC<\;_\+_;DB91@G>^U MZC<^QO$C(FG(,D2S']GV,ENX#^ G2'D*^Y^#EJ)8YWGMY3D^"1_# ,6!@76D M_-7V/ST#J4#!5VR!$Q-HG_JNE1>3M4?=":63\6Q+^H CJKGD](^US/GZOLYV M>?R_>2N<_'V23U/RP [,.:#QG]NS;JPK;>%B?DI*S+"UU5R.S('Q7%T!8)*=[!TI0ZIUD<FAVAJ0KS@R-3E1AT'_:$ MS'7XI 3,ELY4B]NA<:D*K#U.008+>D3B=@P<2E-AP(-#4Q,9 N=]3^"'(3QXG(MSFP?XMMO M#VP]HG6^!1E,:]#SJKN9X1,B?IB@+,)C=K_UT>R8 I85^< 7A'X;@=V[&('4 MD3^PR>\H25% E]Y-=,8-_CU+TEMK6G+P@IXX(YH#/4N#K#DEIMJM M.:6!+^@):",PZ'@R$!T%ANI(:K-^$(;L_.N'PX.?FS$[IFNT3GU_O5QG)32I\2D)OVLUB371-5[B;/9Y: MZ]#*=-4;]@;/[L_I]N!*>N J3&PF4Z88!EX@RS^6N+RMM"XD"/,]N7W M)R&A.W%,X-J#C)I//'@TPAYO#U821GND@;ZZ&/E>D]D%'#-'C:3CL7B8DW9. M333=I\:]$:RQ*0O" \C-Q&*JZ1JK"#"0%1L8&"LME&[P+*TL3KEX+79"/;X" QZ7/LG MICKZG?*Q)HH5Q@4C3(5=:B@N+I,*PJ-S:&7EK4R0_^,"/[X.4)B_D/2'W7M( M?[F]0 LORD^@@!FD5 TB)XT?3Q!0_<-H7^*!HB1&O80"C6& PWZMC&Z-6FD) M6FM]T(7]T]'-#?Z&XO!/<41C@V[P&&WHV<0R)B%5&JS_MCD:'T=>DA35T10] M:LTA3J[>"0:8R400O"&[%.P11YY0231 ==X&(.\A4<'U+B&#>(8@, MQLEG')]T@8@[Z/; 4$YW2XP$S,.WIH91^M0%)>X@8Y7O6J(D8!Y$J7,^L":4 M/G=!B3OH]L!0WFI+E 3,@RB],W:!_9=IAJ[A.*6C%_I[&X >>Z%;=N :>Z$; M[X4.=?2*4A^3E=![5Z$Q9J;D[Y$*LH%#2@5!CL.J+*(H+;$'/OYJ8(?W':R9_(\R19HT#0H$ \SG4\ M5:0#=R/60#E=XG6R,N[%0M- "CI=MIW$6R^[" M0H#^[%PA%+AXSQDF]RADH9%]-.%0^EYGGZP!M0,]BA^,GM=R.W>R)F&\F",2 MXB"W?Y?H>_:1,#9*9;SSCT8+*<%[:\L@SOQ!W1&N#G^A /.$!%TNQKQF@W81 M=!SHEH+"\0VFP*[>'^B[H;ZCJXB@*"H!KUP.TLRA>/[O99HH2P72L\ MQG4899+!U\G&\"M:O";T2,?">W)?D/PB63S.>1P5I .Q+'G*!JOVF(MVXSVA M1-A+]F.]NF,^<)*-[+U];)-+?M_8]S\IL=E?A]XFH^*JF>\/U!@NU6&ZC.>N6ZA:,)AR*]U6TUE3V%,5 M8+ I;@UD#M/X_*(HPXS5&)*';7J&Z^<2F M$FK5%"W@&0R6T*SC:;1Z\$X#3_8T-^A,-?]2#;CGL0O>$FM6ZG7JQ1%Z_AQ& M42)3+)?6\G0& <^P'TJWCG^[^B16[);@]M!0IJFB-FN,@AL3S5FE+[?TOY;M M?OL> 'HONRPL'C_V '@1,%IY4G"M!T GM#<%\D'#18FJ- XV!.#+ &X,-.\+ M3KS'4-QYH40Q>,UJ/>T6ZA* 2]E8P-J\OW"L9#U6LK; N3A6LGZYE:Q/EZL( MYW'S2G6L07I3/1PT5+$6RP2^CUW/; 2FU*M:C@ U+>&W!4:4!!)!+X-FG> M1V%ZO4(H4,, H':XGKM((@B#L99[?_O L:C[6-1]+.J^[ZK^B2YF\??0?Q"7 M=*]2#6Y)50JZM[=JG+;R;?>'%MX::KPU9Z;-K+_+(,W1+M26X/;0@I4$E M@Y+'-J10 &9U5I M-A6]\\HE,$3RL:Z!IBH1N%#I7:9R=GY'"17E!"4^";,_ &L60.T,!E(90$.M M5^LEXT2/5BD)[]8IMV\#H^83.Z5SD0B0RKO>FX,JIQM#.G$6DWN&R34BCZ&/ M-D5;0-T+1SD&@H(LEM^%G7E^45]']=)E-\(9L)3DT.U:!EZ;2YRBX@&IEHO) MFOF%]R$*CM>$("X@; ;U"9S!IXM8UGE6JD_7I@KX%97D]/X>^:QPSQP1GWY& MMY:J+YMD&F<0[BX;(/4&6S$ H"@&',B,'N[V:G"&XZ"FD/L M&C"@"" TQJ[;:I>#RA>@KD'"91^$0[O'8/OEH,^L..15Z9S1LH![4,G&*AE? MH57>U229W8L?^CJE,W@(^0<1,>8GJ&TTI#:"3^\:.B(I0(R,19^57N^R?5.R M&.4!KJ$D% .$R:AK0/K^E(A<@Z/!.@B!L5/[L9<\"%X+^JEK2M_Q#&K;6-LG M0*32[=#LOO1WD;%O-9%K&'82#[S(-'; SXK]7R$?A8]L&19=/]0:U+S-/76=T#>']Y 2?!&/. MA+)#ZMIC0:_9,SQ-$I0F@J8_XG&NH:HB#8A=R?,P6$N1+,NXX#J,%XK-)-[4 MFTEDTTQ*\]C33F)V?T^5S^HFYR@T(.18#WB((<-78TC2( (@MZ8!A!22NC44 MB<^_@;"HLT-I^9!GVG&)C64PB!6/Y9R#$%D ABSTG4-JJ#J:0+,@!O9F(.P# M@4/?JQ MQ""UG,>4@6I3"ZN;4/;=;?QE>K.VL60Z>J\:# ,<>Z]::^?&WJO&>Z]JB.I\ M1(FHNU)!6*4S56U?WAP09A?4O;&#U LKH]7&*'4LDV4L^'DLDV6I#1K+9"F" M-^QIZ[>K3WE^B;3=;)G,5.=II;)7(,.04CNWG=[_I4BH]-]/T HGH2"$KT)F MJC=UVQB3)M.0_JW(;ZWL6(1Y3*)1KH CE<&Z:]YF,.@&6=7O&H&X+ MY"Y,"2.??O=( )8L:] YH5<^U]8=]N"J-"=K0B6=(Q)B'C+<5Q,:;SUB[:4! M=\*FVG DV9)TL&RMW;O M+CU!J:5NO:VG;E7FL"=M:^N@;& GN+FX,)VHM>5$DJ%5I[,F-0M6.W338BX9 MZ^6U..;KM$/OXH%:2)^.O8N-:M3*&R;+>Q"IW]S JR36H\ MGV.%&YAT+QN/F.<]PL36+/>;/"UU68?%,X=XK&&"O46.5(<@Z% MZ*TYC\IA:99L%&C ^F(A#?:/GN5%0X2#C)UF)4A(8&O*;=$VH"G:L[S_LW"0 MF1!.%:W+7J^&Y#:%<>H&RLH#=Q]@#GHFOPC_6((R'H0G<@ZEH9HD*B\" MEC*N>V6#BM"ODQ0O$1&[.VI4/3SK?6B6QS6H5H..#[K-C5%PZI&8U<>;^OYZ MNG1*_1%\;3RL:8.-ZUW9XJB#.1.^8K)-\K%L;<*4R\J&(!<*GQB^S4O MX7V@%8@5PX0TFWWFAB)WK%KG'-GX(R]1.KNOA>7(W:V\4?9#HBJ$35Z4Z_5= M@OY8L]2;1Y9PH^9'>5_WH^RFF>3SV.-*J4FHX$B!1QBZQJ_R([O,YU);XT*1 MP5&_V!?(;KW[Y"]3J4&(DOY"#0;WS6.A!FN]*V.A!N.%&J HAPC%I]Z";E:G M_A_K,,FW+7-QM(-HC"$OB[PP@Q+G QUR3D)O@6,ONJ";07K<$FJ;2VMJQZVF M9IAE2+]OS=7 J-E'Z1T*., %$R^1UJ)3*H=3F>40##%4^$*B;2DV]EITG?#8 M;-\U06AI\:4:O[(:3%QR0P9?_K8(H9&;?&,KWP6.%RDB2Y;W*#='?&H7;)%( M3GV9X]KAD"US$+T9$R14LA@/>XV/'DAL-CM[PS;H(?+DHM;_5GR@X5/?OC-C M2"2//59C'%+U.RUFY.4E,"F8B39I3%KJPXYI3&,:TTM,8Y*E+A7+V- IV&KY M2B7F()5]&'LT];Y9%TK*,7O&RJF-+9K&%DUCBR876S1]0:E'=]>JG9D@\MN/ MSC9D$HH$P?!1K_5+2%IZ$>EONY>0_G([^QY3!A_"%6#I*$V-Q&KKUF074K/> M$F*J6@8WQF7 TV0-UQ=#NP+ZD']5II =I#8+*$PGGLMZFBL"6_/1@ZP4#P MZ,+5%&K\0DH^.#!:I#9W8;''KG!FH:#41"NKX'H ;YM49[@],)5%W2Z&L9T\ M$*26-'HKE\;,LLF#.366] -O(2Q H#J'2Z"VD0A\4^V ]8N7LC:=SR>4=U48 MRV/WA'-P=V!#.P/&KQ?[ M],"KWLR@.L9Z>!0EZ/4JQ' )?$<@$O-OG6]T8PGGWG/677--"!+!PZ=W!1P1 M][H/^5 5KJ*M]IR$/M2=H$)CO6X!CB%]&JO9G1?DS0OUP@]XFH )TVTS@#7WNA0,>OYL1KE*:Y MP^F+%T"K597(>J5#+(,G/F,G^2]AC-EQ9V.UMNZGW6'UZ'GNB0UVBTFLAZZK M2+#;S8+E\'+-=$-_*2WBYZU70^DLKH#;7B80W9(3 $K0+_[._G='MR_T+_\? M4$L#!!0 ( )2$CE997;2/Q7( (>7!@ 5 9W1C:"TR,#(R,3(S,5]L M86(N>&UL[;U[<^0VDB_Z_XTXWP'7L['7CE#;[FY[UO;LG!.E5UMSU"U=26W/ M7L>$@RJB2MQFD662I9;FTQ\\^ "))UE%(#5Q=V-F6L5,\ ?BA\0KD?F?_^MI MDZ)'7)1)GOWUB]=??_L%PMDRCY-L_=7%Q\@7Y$_^NI_0]U^__B%"KUXYE/8+SN*\^'AST9;V4%7;\J=O MOOG\^?/76?X8?5/3V7RUR_H>^O7?G[[=5ZLOWGS[;>OO_G[^\O;Y0/>1*^2C'ZM)?ZB MT:*EJ/1>__CCC]^PIXVH)/ET7Z3-.]Y^T\!I2R9/$X.\@*1,?BH9O,M\&56L ML:VO05H)^M>K1NP5_>G5ZS>OWK[^^JF,OV@^/ON"19[B&[Q"K)H_5<];0J R MV6Q3"HK]]E#@E1I,6A3?4/UO,KR.*AS3%_U(7_3ZS_1%?ZI_OHSN7R634,]U X$G_2=HMJC J*^]RKP\GO:E!^6FU)KGA5QW.C*R,DN\_'J=/WX3XX24_>8-_<6('+?%X\T]+@:P#7(^&MH*DS:W5BAXH]N0#9O^&)VC6AB= MH&NT(/\Y0;]QG;U9T.O[JZB\9S78E:_64;3E!@"G5=G\TEF"^H??Z;P8;W!6 MG:1165ZM;JM\^4EA%QSD?9#'&38ED54X.)E<$0Y)Q<10OD),\$ 697\ND=D> M+H^O26FX*'#,P"E-D).&5S[9H?<8I1>'PRDKQB&KN 8Z1JU.PR\PUHHA/!G- M,(V&?X89HP>=83^/9IA&PS_#C-!EABG%@3',A%'# ML)\!,ZQ9KYS]L4NJYY-\L\TS\F?ILG)4ZP19/9K@*U>0*@4X3'- .>0:%T6= M+)3%)$&TR3.[Z5+(^:22%J9('TD(#&5TR*0-!R9W8#.DV<*\*W!4[HIG]K)2 MOX6IEO.VA6F"V6YAJH2"-[X-V;#Q&U'>_.7<[<_>XN0QND^QG@0& M86],L )NZ:"5A,$)&SQIHL+, 55 G0:<6XBI(,QV=1D2796CUP MV81]\LL,6"266A(,HXSPAE1JA%$C#8E!*7.:B8KJ^:Z(LC):4M*7Q\_B$\,2 M:TP!?IDVMF)]]KEJ V+D2,@R2YD88G+S>@S<_/HW^I8$&Z;:LHRWR94.7CNG M&@H$)X$)E=3.Z%?T-U1+SCVQ?E]<)NN'ZN=\5^++NU-]^V/^!,91>?HR*F M,RO#%'8@XW6[5P6OM[TK"@3G@0F5M'U+91 5@G*Z?(/+JDB6E8MSC$;6[P:: M 6Y_KTPA"(8K)G3R#E@C"\WYY3Q*"G:-^/BY_>?/"2[(1WUXOL2/A 5Z ^.J M[)-=XRHDTLU-$PS_1L$=$I)J\.OCJ-5A2^P/BU^@F+6V5A?9=E>5K$JOC<;- MJ!&$A'KH2N;)XO#HIL6HY]@1XDI'B*FAUP#MGU"M-Z-)]@8*R=Z,(]F;%T"R M-Q-)]@8VR=Z.)ME;*"1[.XYD;U\ R=Y.)-G;T!M 69FG24R/5]F%[ 2KO);- MHOXV@LQ@N\T@M5QP CF DS>%.G'4R$.98/T2%0EU$*T+U M!8C./<*75P2_(;H@4^5'7%0)F7$X7/8=I>F/1*.JTM')20T(L<9@U5P&7B!! M?;:+P28GG.W0_:.\R)861QRCCE]G' ?X?8<<@P(,6CFB5#KF;&6_G)(L6I9S M,^G=W=\=QC>5E#>VZ"&V_)!%8#!"BVO(@7?H#OW=WW#U[OCN+O^$L^2?AIN< M"B%_;:X#V#7Y4 )(BVM@R0U^3)J\$?7:WM4B)<.68[OWA<.TOPJPF@>B)$ ^ M*.!9>$%T$%."LS=UF6?K"A>;4WQ?69RWU*(^E\(FL.**6"47G$ .X*2XMD3T MU1V1153XZ) N7KK;!.1[)V69%\\?\LHPFJCE_-T<,,#L[@LHA(*SP(9,NAO0 MBB(J._O*=U>L<3-C-2QS56+^UK1ZD-T"5I:!T?9Z8-+2E$IVRX>96WY1EK@: ML4EFEO?&!1?8+2E,PC#8X8!0VEVG*@$VR19I=9(7V[,G\MYL[409BX8_TCA! M[VAC% ="'!>,$G72"E$MU*AYW&*MHBS%SS\G:5I>7AHBZ6L$/>["&X *V^\* M*1C,,$&3-]R9+&+"Z)+\_^%BZ;O,.(Q;GCK),/,._?:F6@P(&4S8+!,0#_N7 MQ" MB3TR#B&B@,\10P8F#A#=4Q@-K8*D,/]4QL-V%?,<,*PG)!&?6U,J<.*& ME/@<1N.J0:DWG[C@_$=8?(O+81:H%?5X8&4$*YQ3*>5@<, ,3CZ5JK<@O1Y* MX.5#EJ?Y.L'E[<*\1:T4];I!;0#;VYY6R,%@A!F<9FM:4$"W:#$W*TZ3:$WC M#%[BS!QH0B/HC1%&H"T?E%(PV&""-N3"ZQ^^_7;NEK_!<4D35=HW%W62_F*B M&:%VD=&48C!:WXA-O@O,A;WM-0XLE?/($'I<P!6?/:!X,3#_D!W(V",C[9=R:./K6,%!/=:BP8, KG"E)UJVSL> M_L^E5*Q7WY^WBP>U.HJ;\S99&+2Q W0T/(>[,#^"*]^-X\IW(+CRW0BN? >= M*]]-X*@&GRPLWS:A+9WD=/6N3<#GJ^$W)YP"_GY[/H!"<0V-0*F*IM'<&F1*J MM69?,B=/U<-M15945;V_;_:A,HG[6R;;07<+9+UL<,8X I06Q50#<154ZWAR ML>JP.G$D)#/L? #* O>V]WO$:C0,>ME0!ZUZDZ 3A,$$"SIICEF+^S4$ Y#J MT*5&R5"T4(0J-8B!I(0Y-*E$"$ 1285I#ET;N4Y41=E $U09KF9BV@D&YXX+ M.M-$E"U?P7#G>%+_*HH DW><3',)I4B4F^ MRT.$$)&",_6[?TSPA7G/0I!8-3Q06=9-2I[$P!1O:FSP59 MTI2D6.-RXZC<%?B )]V3&OI]DB6;W4;9V17/?36X$E;3 MZ+V'(!I>A4A*',EEPO;K]]&3N;G[S[TUMPI6V]SB0QC-K4 DYPE]"M_<=TF5 MXJO5118GCTF\BU0I_ QROIK?"+.A@5((!!U,R*0+P506Y2O42<^[U7><1T5\ MM3I-"KPD.H9+7SI);VM$,]1VK:@6"\X$.S9IWY<*HZL5:L7GWB#X&XV/_ N9 MFMM M(N70NWMB_EM2<#K-4E8/IVIZ*^6OZ<5-7>\**4]W:7(4K-WHG :G4) ME[;1J:2W-D\>'3J[*.6_S26(Y0T%?!WFJ($U MISC]I\$;7PM)OB?"A6:_*A0])H8SFMYC?Y>"9%#=3:#N6?#6U "2VI)*S.Y. MN]FF^3,+>6 _:#$(^W.VM0'N?&]UDC (8(,G>>:V\AZC-)/W9)^3Y8.>$Y*( MO^B;:G!=W,W^+VSH;]=)$C :7@=+?W/#S[6YCS?O]"TM/O5W84Z"U-V6 M:Q_!:%0)CWQ/[B.Z0>_@W,*Y*Z*LC);T+J_E#HY2TN>%"@-4\5:%0BPX.>S8 M) ?,3M)#7E]ZO=<^ U1)>;U2;9GWR2+!&]Z,2W-CVEN219PE><&B,>/X!L?D MK30Z63^R!'?H,PP)XPOQ&'E[8@6%2-PC2X#!N*FPY4C=M!Q4%X2ZDM @I$CM M]NEA)VH&+/%#06 D$6-2C=U.7#&N$.$'UH2^A41'2MODO+3\;-E M)F/4\!R*R 9]$)!()QZ<2>X8%<&).@U$53Q,>"Z3/W9)G%3/]'UZ8Z(4\V9/ M#"!;DZ*0"PVAI-2BI MFS=2LY]9I#@[B]8I%L-:71JR2%D4_)UGN #O3C=,TC"(X0)1.OD@.H@K]>*, M7:+#9:/:/W3)[K[$?^S(J'7V2/[+%KQ$)^TU?(D9YGKGYWN,J M(GQQRENHE_76N#:X;5OK!&$TO06=% >E$9]A^WV2X^S59WK&_Y!L-;%0!L]] MNL[V'P6F@0S1L^E9FWBVG0:YEHV>-7C94;FN]=XU.,'C[NZ!3#PB] M-->']++I68(2+[]>YX_?Q#CAAH#\H[,!Y(_?S[**I4F]HT^FE@)JVGCWD,0C:Q")#E:-C*("H5J MYE-<+HMD2^V*J1X],>^-K@ IM;T@ XL",C ]$P390(;]!J^3LCX+_W45%A8OTV4H*2=(W+S10A]08B(%BAQJ;EB"M M>%B.,"]T=@!O)8DLZGVYH0$K+3T&**3 T$4"SCY,@H3[Q$ET C$SY//DQ1_V"G<@=0B M?H_Y97#]P_WN.0@N:$!I#O*I'.*"05J^.27(J@_11NOD(XGY98 :9)\%?1E M3% "T["ADT54. @C3C"]#9M>9#%^^M_X65LO2H"$"TA M".,6<4P^5%G_SV62X=?:^BME_;++ +?/*84@(";IT6GX4TL>-?] 5(?F?01" MFCN)+F#6C2O)E"FKO/.1#2O!U1U;?A2?/6E31O09/F[232T-R3 M(6ES0OYY5=SEGU7.V5K)()21H2H)TXG!HXN$S486JD#G,U0E)$W8Q.JJN"[R MQR1;ZJ?,.O$@A-& 5K)F( N/.FJ -OZT$^)&+ZBMX9-R:R=IQ,)8F3Y(M8GA M,O!(T@=F-2Y<.B0EKO.RBM+_+]D:%^)JX2#T4 )6DJ0G"8\J*G@VPG =1)1" M+*QKNM(##>55LL%S;Z?-*ECM$;/X$ 0)5(CD *9\]X0+^6YFRM$"1QJ+T'_L MK9$5H-HV%I[!:&(9D-3"K%\3F1 =^3*G/E(/>:9W$)!%?+6T#ES3VL/G(%I< M TJ*2YLS7S,J%V@W_JG"6:DVW\(S;R/[$$X[D#?Y)O-+JM/>51^@QHY7ZULA-FTN%((1.N;D$E9Y.P+U+8 3?DT$N"((D5WI L1.'54M! 7 4QG;"TN2C+'2Y&D4>A M$HA"6O :(DGR$.FD VDE%5<,R2V6\X>L>UZ_N;]+*F7X.5G$VYBD =>.2(/G M(+BA 25E?J//4+Y"K]]\>?\5:K0\-_^'_*Z(8C(DWCYO[O-4$WU**>6+! :( M#0\4(B"HH,<@/A2@H MJNCQ:6U&JX(Z'=\1+5F(,R%,[CGYAZ*6&CEO,2U-,-N@EBHA$!PQ(9/"6O*@ M[.*EPS,&<)UF4+9,H;<,CJG;$[2K>V.((OB6.11X&A]Q 2G3B M:DTLPU:Q"W7I>RN=.V#\BM/T?V?YY^P61V6>X9COI:A.BLSR?CUF++#[3C,: M81!T[K(J*MA=\D(?BE^2\\L<#D0[R:(&3QD"QBSN^;JV$?3@UK92%A!GC !U=[CK MF!_=W)AK!;IB6>$B6E;)(SZ-JJC&IJVO3MSWI4H3Z.%M2I4L( H9 6KO3[8Z M-%1,U' J6,B8XH1,M=:YP4M\(.4_<(P$48X=TXH HH<*ER&"3($:V2!4HH"X8L*GX4RC@KA.$U(W#'F>NH#B/,JBOJ8*4<^T MT8(=<$:2@T08'3B)+2E>TOV6#WF%[G+TL<2H>L"(N;/&Y'62 M7HC@L_(LC@H5A4S"WK..: %+N4[BB\&N8)O>&23!\$F1Y!2%EVJUE]<,T66%S%D-",QN+U^BM<3\CPS M5@ <3(P%"1 9[FD7Z7I2?C.6*>#&\0+*\3 ,0 M&94N1!X31$PR2/L?1]FG8K>MEL_71;[$F'I9E:VULNV_.6K[Y=1JGT=SRY:?;AXA\P*M=5=(1E #3[X(;E3P? M+SA48'#(8- 1#T'F+H#!Z:)F.H1XLI(T ZT/BN[*( X/GZ^P2MB<0"T#WU$:N+0+_10A KQ7?^ MM&\!'O'XUC9:@RUH^E/#*J7-S3M"O+X1:,3L@G0]0 17;T)< P0PE+&DIN;\_N;H&P MH-Z"<2*#).N?$QJX,C4&@L 8HD:GRYG&=7X*SIB3J'S05(L_\LD'$8S8_/1W M,*TM@!DV[K__Z?6?O_T+%0C>KIQ?/^,TOLCNBEU9J3?G[>+^[8$>M&P29%DP M/+$ U','/1 =E&2HHEK!F?0^*C[ABLZ'ZXN1"2[-9#)J^.23 W214@9Q,*RR M8U03J]-#^(\=W5@OY[@-/9\@8O9,MT1SVDR*^D MR:HDV^'X:HMYWE*7[:!I!?K?,-JGXO*6TI32@O/W8%50 MIHI<&,_18(>J.0@7%\.>AS0[F=?1,![I%%I-? M"C)>RM6S;)XZE1!BJWI$U50[UP[J8#@Y'K-E7WO+"T)1%J.(%X4PWZ8JT9=) M,]$B4Z64>8AOHX*^@\:@_;?71]^__?'HAV_?,.U_>W/T]MLW1S^^^>&KF1:* M=55O<56ES&-)M>91"'E;*&H!M@M%22(XLXRPM.1A/"E;\>!6[F.&HR+#\76! M-\E.ZU4HB_FT5SJ0HE$:R@3GAP68FB&-,#$;CY@LSH+SXX2L$NG(_6M2/9SL MRBK?X*(QFBXKP:"DR/(")V%VOS16N*)D_%G M-?V^Y<3[-CCEW"UABN&IR T_".(V7/[,U$P-,=OLL% M\,\&NNEEO9'+!K>EDDX0!G$LZ-0T(4JHR@_+BKV'NU-<)(\1#07MO+]J5O$Y M +J %T="DWQP8HT J>%7J]BN,L/SRYE5H;GDQJ# O+&>'HZD3/\ &>C>Q"F^ MKSZ0!G3=EAC*!UK]J6%KUG]]83"VR(;0M@;L)D59JZJ>K/_PP]%WW[Z%L@B\ MS+/U'2XV#IL.:E&OELL MF>[%')@F&8 )^<25A,K/&LZ^VDWS\%&-\NP!G8\ MG(8-?P.8E;H_6%,*P[&O-@Q*H:R3@9] MR8S.Z_U=!0YQD6J%B;V+64#&7Z)TIQN9E)*>+TKIH XN1@W%P/!&CVW(EU82 ME504/5+9X&P1PGZ:J"*+^;8W*I!#(R/*@&&(!ICN<([%4BUY+-5_^_;K;\G_ MO:9;09PO?T&OOSTB/S7_024/MQKMJH>\2/Z)8R)Q]/W;[X^^__'MT7??\2WN MMV^/"-:CUS_^T,@G--MDS![F7:161!YM,=O5-H!L-[05,L%MF 68FA=,'J5$ =1]E#AF28.B]#I* MXHOL)-HF9$F@Z0I:::_NP&;(/==?M6AP KGATWAEMCJ(WA6G]S:77"TXF6YP M%249CL^B(J/A]1?+Y6ZS8\O_^ L8_@A;9HLL=F:372W0?J6Q$II-3*4.+-XYHG7<[F1+O1E9J;_A M(E[O&3C1\&WYX7;G&$6?-V'<*R+>CK%K!1\K1T.58NLZ7;Z"YM=R7UUD956P MM"$?LVA#TR/]DTP+ZE-'K?>%5<^OAXMC-?IN+A:EX)0(\/GG,VO MRE4=% .-_E9NNE[Y^(B+^[S$IK%Y)&XO[-3Y?]J@*H=?%RU_/J'.5>B\0ZTJ MP4W<.)Q2OJL78].LGEFC2@!EV6R/47YQ]LSIZP1R ^Z>U9')[5;!L(3$[ M[;C&!Z'34JU<.=X)NJY#^4%VG&=Q*3H)K.7H_ZLY3@3&2)\]Y3A]# M5@K'0%T%],P;:@!EG :FE6G=P3Q(JETP/X 17Z!1"$VQ/G ;O;@T:&KU(%II MQ?TW0%)*G]'962LTN30YG1U50-/,GM59XEH^4RKG/=W51L[>G#0#.;6-F;-^G.KBQN,B6^0:W"94M@9NUTG[S=1DA M]U-W*46#4\8-WY Z7!H)V:\;A;US7^M<[Z-4NJLH/O#G7B\"Z1SJZ:_!&U." M(J4KI\]F:J$;'JWTG'PJ,1B-"J)6U%LK6L"V[:J1@]'29G"*.Z3E+J772%'= M?9E;WNN_H%H9,6W$G?J"#P=UY73WD[O'?EW8^Z#ZCNK\67!N: 978BI78#2 M\B=Y65VMWN5YS)Q1P>_:P0:\OWS028-AD!6B;&-*%D&% MJ2 J"(54[XJ\+*^+?*6]+M.3\$D;!321)\)C6$[C,C"UB6%RB M"H4.=[RI; MUUE%2\MRPR#O-:^B#78OLZ).&(Q]L2$<\JF5;QV]PZ>(>8@9);,*&(:YX=38+:[++QCTM(.3[GU4?,)"Q]'4 M7A;S22L=2)%'0QDPQ-$ 4S.E%0Y.C,7RCUU2LJO,="ZFS7PGB?E-/:4&V<\O MU9*U$+6,J= M*$G"X8P)GB:?<"M-UU- TBN^BY*LO"2S>5Q>96=/U.*1OO! 45ZMJ!^W;A2V MZWF=[[A6HS?CL2E!B[#C"E@S^2':*,_0<10C*AR<>]):P75-$7B%YK0R@[6P MU\$S[2#FTM(,#F/X=C?M"K8*BY)!6"-#5?*F$P/*' G@D#OT$:(?H6%.GH5G MS(<\R_LUJ'N 97?(0<]O*A[':O03\UB4P,RF7)%*NTK\R2+LB6IFG']9E3Q.D=W -^;J1ODH$X6%LPO^@.NNC0=;(W2YH]\SUR#<'Q% _'MBH)4^S@JDY(L7;(UOL@^ M9@6.4NK#2B>*AJ%UKI?YY/B\'TSL'?.\"8SEGK5ZFB"W3(W&\UN1EW//?MXE M >:GN<@J3+YY9=[5E:3\NKPI(?9=W7HBT*RZ&IYF%Z:6;18U["Q@U0P$+ 1M M^%DKWWVFE]]O:8]A(;ANW*RSFZK_0P.WRL@'"68],'9P!%@U+QMAM*;;-%^F M1/XKNEM#YAC;O*3+\17:M"]!F 5Q0R5_V5S1D2ER8K7_^_-MF]I^4'^]F#?' M/P/(UNE/(1.<.A9@YDV\F[_]2AJ_40ENL'H[DS>8AOY85CLZTKOO(BO5@FTB M&RJAW4-6Z 1GV4B@:M:QK1UJC.BJ9Y/'R2I9LJ703':GF1FVL\NKE9W0GBF]=Z39210FO.]$RM-X. M=/<8C+&2,:FI(N[_!:> =A-S[*8GD*WE45O*L XM;#"-QU[*/>7@[.J.7^CE M$)X];$='[_:LY1BO\@)SN;OH"9=G3U41Y45,%K?%\T6%-R6-NT8TR4=,V9?A M2V'MJGK&-_J_TS?KIY/O!<[R.EB];/Z*RH$7F,?YEY=L=7S/2F^Z:D7+!])- M25UK@W.,,ZR_H*"5]M\]M)!E:DNB8.8-9GR:*Z^$.,UF(!#ZF+K4Y+X(S>9. M,YW J.8 U6S#F+_$LM4&Y3J!*ZN;S4#&Z[Q5!:\W5Q4%8(V<*FA2"%Q<-;=Z M.5>"$^)7G*P?R.I_\4@XNL8?=IM[7%RMI* V%M>:\<7XI-742HK,&UL&&*,V M$?B0NDTQ*.+E$ /'(]'PM(Y"/*/PKCJN5:8GULL]/UM=!D0Z]ZHWAE. 24!EZ6F2[LBOKH'>1I<"@*FV*CIP55<$=+9:<*OY6BL=:%]<#6R0V?<9PS,6?&CS\Y-^T;KQ^=F.HDCV^KJ*A,O=: <_CQC_$Z MR6ACH?N(/%CB(R"AM5WGP(%GN4[SV+ S55?2.$Y+%8SA^P!S^0YU,7)Y=-SS MO#C),S)XE>S2!_]WE=RGF/H]T3@B/-6HYCCT4(7Z\S#T"HOZ.Y^_8KVXE"7X!8E==E0>P/OYK-\SJ;HE],S^A_C M?=9E!UD M; G>^L&TJK5T'Z<.@]63, _)>VZ];X9B\JS*!3J'/\<5NO(I<_B^9A.\^M;> M9_9$=[[KJ.MU!CVF.M)JS*88G*U3T#H;V:A\@$I'/FI,Y*.D#("0F@HY,'*@ M"9V2:KAC.(D"+ GO\D\X2_ZIS%-BE@\Z71W"-LY!&^'@#')%Z$B:5ZC1"T"8 M<0NBH18(\HQ8QO15X!-IRN*CHQ,ZFM4.\;W5][AZR,EJZ9&L8>CE3?)WI#RV M,TC[.QZU0NZ.1+6B,&ACQ3>D"U= 7 -U*N@5_2WR3A*]Y;'K "",QNK8%*"3 MQVAQ+!2:>]Y#M]O3.MB18=Q2B?D;J/0@NY%)EH%!"STP:>SI).GF@>]V']7Z M$#C@S@3@?!C/BD-9A5EWCMJ95Y-#9L(^AJ(, MW<_5<=Y2D H(3=!_4KJOY MLE:#2ETQ:^ID[FH+ 4!>2P6==Y]>''W-L,?R-\2.U-_R)*M^(9/#G3I[KETG MZ.:""KYQ:T%4",ZN,2A=R?3?5!4] MS0ZU@[7W $Q] RXR&F:*YQE$J7=@>LYCA16;[^B? [&^U16')*G ME!.1%2]!@F&3 M!$EU,:6)TI/:[D?//1&?X@K^-H!7[UEF#*1K0"GM;#*?WQ%>X',VP32GZA"^ M^+8&T(*T?7\@P_YM%568)R0ZBD9V7(6," MYO@='1WNEJKA[34M]),,*/[O'3_U9<'N"$-8X+N[_ ;35DM2W*O97>Y(3XL1 MF_^U7I,2>?J(O<1&,[\3C$GT5-%A5Q5>2WWFB^9E*.OZ,/F=_L6\1'S=B6 MLZ0.\K0"GYA_WH18F1J:3)S$U$&-#0K48BQ%Y<5F2X9;=EQ)&+56^TFI)>'M MCUAP2M'/6TG:$A%5GLO;:9@([RI3)06BP];0P;XDYJ%.!M/\I!H1#_P";U.5 M63Y,.Z4Y:.E0;-%L-1OVCWY"1F4F1D]9&'D-RM 85:\%GO>*RN6P/SF*"# M9 *EW>&&7FO!\5U^2>JV9C,^;1+9D;J^$JLX.W! M\M)JK-]U],P=&H0\@;\FU8-KCM!Q^MXLX91JM?9PC#(4VDT%+J74X450J]C+ MWO>9%*-.&QK<3))Z%C@J\2GF_WN1+99L)X[TO25.'BE>W0:*DZKG9$_.E1FD M>[+J0>'J!,S2&5(M2$\Z:TF /&3=L*N+(>&853$L!W45,3-PJ 6??QK$0_;Q M7+F'HYYF;);Q46>!GW%*%N%WQ4X=7M=!R=LH[%R!=NBU:L!8A;C"5/JT/1 Q MN@:IJ"! JW5=X&V4Q.:,RW:UL!9+70FSO>KKP+=62KQRCD0F!)!G=-LP(R^2 M5Q:..F$9IH!OII>@ )];,E@YY2N7"+]/HK#&- URM*SHXN>$6%FR@BET7CZ3 M2PE+/ZZ3JF"T!_V?62T8MW?7A!K#W8O4OH=RP/Y)[[5 VGC]W M^;OJ2;U5-A#QN/NH!"?L-?:>0UF3&["IEN!U$-PJ1^_N_NZAF>_6#XD-,9<) MTM B/&5+4P&P32V ,[?UW;N?+Z .5JT!FCK%4A8 8' R5,QA4%)HOX@IEAZW M=8J5M$,1_"E6>^5GWRF6L2 +':HJ .;#:5 GV+9H=NF6&T)AYQB'2)@VA+C MN*00NYM!XI69P?%FRSI((J^Q!P140_&"J)0LDM51=%-S@-;_"6NZZ65ZO:Y_HZ*JIG MP_AG5O%)/1?P(NE,\E#LW BL\GVQ;>>&7' =M*5*H&@V2-_L4'])(Q3)--!U M'!N(0Z:8&JJ18<,95W"2B8;:T9:954(-HRZVS"0/@ MS3&P0^W[XJ&(I0*M(Y4H"Y)0"H"V!4![^!Z<2NZ;+'OOTD#=/MMOV^Q%; +K M<6LW@;=U$>C^60B'!&@CF-:3_H0@==>$$&;: M]$2(6H:7W?'G^-HOJ%L>O)<%2!QQ6Y%)^&Q=QW"&=(3N\3K),CH0DHGS2_GNE+29SN"BA2=%4QP^]QQY3$TN@A&3$[;/@ M:S0-(.6I,+U;1Z,FAC_^O<@J3+Y 14%K.-T7\>N)+X/K^]=WSX.WOP&4[)7% M10"T/@W3<1<]T9T$ P$&4IYO8Z@@#JY9B"* F*#")9.!Q]FG8L$)T20H:K(0 MM%Y<0G3C;C%/8Q^G>;DKL,7I:?]B?4]U#_$1AC.=?M&[X5*20I.=[BI"$VUJJK[R (\ M1M2=4#$A8NX(;1@DG )9/EBNRZ"[7:J4$RC>X8Z=M*29>,D#N[>YL3OD-L>% MT=K>&#F^2BT=W55A<'$T7GM%=$6;G"A1BFE?N:U:$(GVEJ MK&WT+-2*GH>JOLGTLKPQ=-_JMGR=6A ,]NZ)?LCEIK@N5B^[=SZ(U\L3GY%" M#^[08[*PSWQ/D-$^IJ2O4=RO#36#[AM-M2P,GMD!*LTBLXK,G8+: MQ;_]@EHM;TRYRS_A+/FG(U$ZZ8 \&4(VT*01AIR_#(PA-J=].T3BUZ5Y5KOIQ1']3I9#T>;)KA M"J><:D$8[+&@D\\_.W'*E[N[VW>(:P0__:B-<)*MK_,T63JD^#8H>,T9; 7> MRZ>FE0[.*&>(FO!B]'"@T4"_-3K_",ZLXUV99+@L3W&Y+)(M)?\BBX^C,BFO M5M?DZ]&##_KK'7ZJC@F&3YH/,Z4@GTR<7E&1H>-+ DE\PSP5G-J\'*MLG_P_Z M.<0N<9""P?220];&U'&.4*]TUH_$\FEW:M^ NE= &CMN=P1*1,:V*#W-=_?5 MXC[?5>]REF>:\+&PCAEC"O#95\973.P0[MI@6#\:\I#:3!;5PN&)F:PSEDTX MJ^3YFI64CLI>"3FJ0CTR.FG"(>(8N+*KSF83%<_4= KE(,4,/#A#A;2S]-"3 M#"Z]\R3[ F], 7Z](L=6K.\PZ:H-AK&C(>LC(99'B'G_T+D +P1UI4 :^%4) M^&QFU:+CDZ-.\$5:&A7 ,-$%Y9!\G8Y M>#\$I-RI^D@*?<(RVA4#F05'2JD ML8@&33 <' 77: F).N*)Z82?(1E!(="MQ?0I)4KO^1):763+K^=RS6Y=RF]I"+'+/,JZ2'@:HS5&T9]S]IB*=-[9 M+EK!^30:JK3(H!J(JJ";N3-F*M#I;(V#O#]?&P?8G;>-0=@K6QYQ<9^7^%+K M=F,'ZH4K>P]> -[&*XF X MLHC@AFT_W$/FULM/7DQO!D87IZPDU!0%:5*FJ7UG\&USM3$% &"TH6(.9%9H M0^>Q'K(T#]QLHZ3 (GN#T[-VHBN;_&11:C.S1@VOX>KLT'L1Z_3B8"AFQR@% M0:PUF!5L="#9OV$>/"D)'JDK6U4+/W5=ZF17% [KV4._)(!#TH$_D,*)Z4!O M --99JF6-A?CM9"+L7X5.CM0+D;K\KW)=%KG0W5;NFN5 BS;+150+-DU&L'9 M-PJF-F/MS6$RUFJ(,P!E7*'K9;W1Q :W98=.$-2JW )R;DKL/6 WD0*;:^P\6&0K3-W#2R/OECA"O21RD( MACTF=-+- N&6"0N.W4QOCLB?V:LFQ@>-P)Z0_Z5SGAOAM[WCJULG/&+$;H*H MZ"+"\WF=&"+>;38TK<0 4Z5]JJZ81TTI+CBG#U<'*5ZNR'8%V4NT\$1VL5+& M&9I&T!LUC4!;QBFE8!#)!,W(#Y4U+ -8PWJ]>8NKB@?^*&.'W#)%+PIJ26B%&8P>'8,5 ;G< MK(Q1,8"=<:B(PM(8M*#9&CM4>:W8ADEK58*O$CM0= IW'B7%+U&JWZQR5_.[ M]^!6B?XNA%D'BND:B?=%D(Z?X3HYDH3T$[&[@8 Q3D98&B<.0'M5S"'J(4]C M7)0<'5T!N'MGC-#W>CUK;+5Z-[1O_^$M]WR4X M0=O(Z,Y[\D:-(/'HW7;G#>)@B&;'J(E93U2 [M8KJF2_/F!2"4PQRX4"O3QD MDMFO�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end